data_id,data_field,category_id,category_field,Participants,Value Type,Sexed,Debut,Item count,Item Type,Instances,Version,Stability,Strata,Array,level1,level2,level3,level4,level5,level6,level7,level8
12224,Abdominal MRI measurement completed,105,Abdominal MRI,"45,813",Categorical (single),Both sexes,Sep 2015,"48,473",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,0.0,0.0,0.0,0.0,0.0,0.0,0.0
12223,Abdominal MRI measuring method,105,Abdominal MRI,"47,060",Categorical (single),Both sexes,Sep 2015,"49,794",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,0.0,0.0,0.0,0.0,0.0,0.0,0.0
12140,Believed safe to perform abdominal MRI scan,105,Abdominal MRI,"47,922",Categorical (single),Both sexes,Sep 2015,"50,661",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20201,Dixon technique for internal fat - DICOM,105,Abdominal MRI,"40,340",Text,Both sexes,Jul 2014,"41,473",Bulk,Defined (2),Oct 2019,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22434,Abdominal fat ratio,149,Abdominal composition,"9,797","Continuous, fraction",Both sexes,Jan 2020,"9,797",Data,Defined (1),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Abdominal composition,0.0,0.0,0.0,0.0,0.0,0.0
22436,Liver proton density fat fraction (AMRA),149,Abdominal composition,"9,894","Continuous, percent",Both sexes,Jan 2020,"9,894",Data,Defined (1),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Abdominal composition,0.0,0.0,0.0,0.0,0.0,0.0
22435,Muscle fat infiltration,149,Abdominal composition,"9,724","Continuous, percent",Both sexes,Jan 2020,"9,724",Data,Defined (1),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Abdominal composition,0.0,0.0,0.0,0.0,0.0,0.0
22432,Total abdominal adipose tissue index,149,Abdominal composition,"9,978","Continuous, L/m2",Both sexes,Jan 2020,"9,978",Data,Defined (1),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Abdominal composition,0.0,0.0,0.0,0.0,0.0,0.0
22433,Weight-to-muscle ratio,149,Abdominal composition,"9,812","Continuous, kg/L",Both sexes,Jan 2020,"9,812",Data,Defined (1),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Abdominal composition,0.0,0.0,0.0,0.0,0.0,0.0
22410,Total trunk fat volume,149,Abdominal composition,"5,995","Continuous, litres",Both sexes,Jan 2017,"5,995",Data,Defined (1),Oct 2017,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Abdominal composition,0.0,0.0,0.0,0.0,0.0,0.0
22415,Total adipose tissue volume,149,Abdominal composition,"8,524","Continuous, litres",Both sexes,Mar 2019,"8,524",Data,Defined (1),Mar 2019,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Abdominal composition,0.0,0.0,0.0,0.0,0.0,0.0
22416,Total lean tissue volume,149,Abdominal composition,"8,524","Continuous, litres",Both sexes,Mar 2019,"8,524",Data,Defined (1),Mar 2019,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Abdominal composition,0.0,0.0,0.0,0.0,0.0,0.0
22408,Abdominal subcutaneous adipose tissue volume (ASAT),149,Abdominal composition,"9,979","Continuous, litres",Both sexes,Sep 2015,"9,979",Data,Defined (1),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Abdominal composition,0.0,0.0,0.0,0.0,0.0,0.0
22407,Visceral adipose tissue volume (VAT),149,Abdominal composition,"9,978","Continuous, litres",Both sexes,Sep 2015,"9,978",Data,Defined (1),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Abdominal composition,0.0,0.0,0.0,0.0,0.0,0.0
22409,Total thigh muscle volume,149,Abdominal composition,"9,812","Continuous, litres",Both sexes,Jan 2017,"9,812",Data,Defined (1),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Abdominal composition,0.0,0.0,0.0,0.0,0.0,0.0
22405,Anterior thigh lean muscle volume (left),149,Abdominal composition,"5,793","Continuous, litres",Both sexes,Sep 2015,"5,793",Data,Defined (1),Oct 2017,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Abdominal composition,0.0,0.0,0.0,0.0,0.0,0.0
22403,Anterior thigh lean muscle volume (right),149,Abdominal composition,"5,846","Continuous, litres",Both sexes,Sep 2015,"5,846",Data,Defined (1),Oct 2017,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Abdominal composition,0.0,0.0,0.0,0.0,0.0,0.0
22406,Posterior thigh lean muscle volume (left),149,Abdominal composition,"5,793","Continuous, litres",Both sexes,Sep 2015,"5,793",Data,Defined (1),Oct 2017,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Abdominal composition,0.0,0.0,0.0,0.0,0.0,0.0
22404,Posterior thigh lean muscle volume (right),149,Abdominal composition,"5,846","Continuous, litres",Both sexes,Sep 2015,"5,846",Data,Defined (1),Oct 2017,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Abdominal composition,0.0,0.0,0.0,0.0,0.0,0.0
22412,Thigh error indicator (left),149,Abdominal composition,228,Categorical (multiple),Both sexes,Jan 2017,232,Data,Defined (1),Oct 2017,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Abdominal composition,0.0,0.0,0.0,0.0,0.0,0.0
22413,Thigh error indicator (right),149,Abdominal composition,175,Categorical (multiple),Both sexes,Jan 2017,178,Data,Defined (1),Oct 2017,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Abdominal composition,0.0,0.0,0.0,0.0,0.0,0.0
22411,VAT/ASAT error indicator,149,Abdominal composition,25,Categorical (single),Both sexes,Jan 2017,25,Data,Defined (1),Oct 2017,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Abdominal composition,0.0,0.0,0.0,0.0,0.0,0.0
22414,Image quality indicator,149,Abdominal composition,82,Categorical (single),Both sexes,Jan 2017,83,Data,Defined (1),Oct 2017,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Abdominal composition,0.0,0.0,0.0,0.0,0.0,0.0
90012,Overall acceleration average,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90013,Standard deviation of acceleration,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90027,Average acceleration 00:00 - 00:59,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90028,Average acceleration 01:00 - 01:59,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90029,Average acceleration 02:00 - 02:59,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90030,Average acceleration 03:00 - 03:59,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90031,Average acceleration 04:00 - 04:59,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90032,Average acceleration 05:00 - 05:59,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90033,Average acceleration 06:00 - 06:59,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90034,Average acceleration 07:00 - 07:59,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90035,Average acceleration 08:00 - 08:59,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90036,Average acceleration 09:00 - 09:59,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90037,Average acceleration 10:00 - 10:59,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90038,Average acceleration 11:00 - 11:59,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90039,Average acceleration 12:00 - 12:59,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90040,Average acceleration 13:00 - 13:59,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90041,Average acceleration 14:00 - 14:59,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90042,Average acceleration 15:00 - 15:59,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90043,Average acceleration 16:00 - 16:59,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90044,Average acceleration 17:00 - 17:59,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90045,Average acceleration 18:00 - 18:59,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90046,Average acceleration 19:00 - 19:59,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90047,Average acceleration 20:00 - 20:59,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90048,Average acceleration 21:00 - 21:59,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90049,Average acceleration 22:00 - 22:59,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90050,Average acceleration 23:00 - 23:59,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90019,Monday average acceleration,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90020,Tuesday average acceleration,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90021,Wednesday average acceleration,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90022,Thursday average acceleration,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90023,Friday average acceleration,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90024,Saturday average acceleration,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90025,Sunday average acceleration,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90087,No-wear time bias adjusted average acceleration,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90088,No-wear time bias adjusted acceleration standard deviation,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90091,No-wear time bias adjusted acceleration maximum,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90090,No-wear time bias adjusted acceleration minimum,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90089,No-wear time bias adjusted acceleration median,1009,Acceleration averages,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration averages,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90092,Fraction acceleration <= 1 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90093,Fraction acceleration <= 2 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90094,Fraction acceleration <= 3 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90095,Fraction acceleration <= 4 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90096,Fraction acceleration <= 5 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90097,Fraction acceleration <= 6 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90098,Fraction acceleration <= 7 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90099,Fraction acceleration <= 8 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90100,Fraction acceleration <= 9 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90101,Fraction acceleration <= 10 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90102,Fraction acceleration <= 11 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90103,Fraction acceleration <= 12 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90104,Fraction acceleration <= 13 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90105,Fraction acceleration <= 14 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90106,Fraction acceleration <= 15 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90107,Fraction acceleration <= 16 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90108,Fraction acceleration <= 17 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90109,Fraction acceleration <= 18 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90110,Fraction acceleration <= 19 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90111,Fraction acceleration <= 20 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90112,Fraction acceleration <= 25 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90113,Fraction acceleration <= 30 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90114,Fraction acceleration <= 35 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90115,Fraction acceleration <= 40 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90116,Fraction acceleration <= 45 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90117,Fraction acceleration <= 50 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90118,Fraction acceleration <= 55 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90119,Fraction acceleration <= 60 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90120,Fraction acceleration <= 65 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90121,Fraction acceleration <= 70 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90122,Fraction acceleration <= 75 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90123,Fraction acceleration <= 80 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90124,Fraction acceleration <= 85 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90125,Fraction acceleration <= 90 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90126,Fraction acceleration <= 95 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90127,Fraction acceleration <= 100 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90128,Fraction acceleration <= 125 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90129,Fraction acceleration <= 150 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90130,Fraction acceleration <= 175 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90131,Fraction acceleration <= 200 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90132,Fraction acceleration <= 225 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90133,Fraction acceleration <= 250 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90134,Fraction acceleration <= 275 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90135,Fraction acceleration <= 300 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90136,Fraction acceleration <= 325 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90137,Fraction acceleration <= 350 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90138,Fraction acceleration <= 375 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90139,Fraction acceleration <= 400 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90140,Fraction acceleration <= 425 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90141,Fraction acceleration <= 450 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90142,Fraction acceleration <= 475 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90143,Fraction acceleration <= 500 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90144,Fraction acceleration <= 600 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90145,Fraction acceleration <= 700 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90146,Fraction acceleration <= 800 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90147,Fraction acceleration <= 900 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90148,Fraction acceleration <= 1000 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90149,Fraction acceleration <= 1100 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90150,Fraction acceleration <= 1200 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90151,Fraction acceleration <= 1300 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90152,Fraction acceleration <= 1400 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90153,Fraction acceleration <= 1500 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90154,Fraction acceleration <= 1600 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90155,Fraction acceleration <= 1700 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90156,Fraction acceleration <= 1800 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90157,Fraction acceleration <= 1900 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90158,Fraction acceleration <= 2000 milli-gravities,1010,Acceleration intensity distribution,"103,687","Continuous, Fraction",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Acceleration intensity distribution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90016,"Data quality, good calibration",1012,Accelerometer calibration,"103,687",Categorical (single),Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer calibration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90017,"Data quality, calibrated on own data",1012,Accelerometer calibration,"103,687",Categorical (single),Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer calibration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90159,Error tolerance before calibration,1012,Accelerometer calibration,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer calibration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90160,Error tolerance after calibration,1012,Accelerometer calibration,"103,687","Continuous, milli-gravity",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer calibration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90170,Calibration coefficients - mean temperature,1012,Accelerometer calibration,"103,687","Continuous, Celsius",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer calibration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90171,Calibration - number of static points,1012,Accelerometer calibration,"103,687",Integer,Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer calibration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90173,Calibration - maximum x stationary value,1012,Accelerometer calibration,"103,687","Continuous, gravities",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer calibration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90175,Calibration - maximum y stationary value,1012,Accelerometer calibration,"103,687","Continuous, gravities",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer calibration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90177,Calibration - maximum z stationary value,1012,Accelerometer calibration,"103,687","Continuous, gravities",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer calibration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90172,Calibration - minimum x stationary value,1012,Accelerometer calibration,"103,687","Continuous, gravities",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer calibration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90174,Calibration - minimum y stationary value,1012,Accelerometer calibration,"103,687","Continuous, gravities",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer calibration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90176,Calibration - minimum z stationary value,1012,Accelerometer calibration,"103,687","Continuous, gravities",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer calibration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90161,Calibration coefficients - x offset,1012,Accelerometer calibration,"103,687","Continuous, gravities",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer calibration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90164,Calibration coefficients - x slope,1012,Accelerometer calibration,"103,687","Continuous, gravities",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer calibration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90167,Calibration coefficients - x temp,1012,Accelerometer calibration,"103,687","Continuous, Celsius",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer calibration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90162,Calibration coefficients - y offset,1012,Accelerometer calibration,"103,687","Continuous, gravities",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer calibration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90165,Calibration coefficients - y slope,1012,Accelerometer calibration,"103,687","Continuous, gravities",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer calibration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90168,Calibration coefficients - y temp,1012,Accelerometer calibration,"103,687","Continuous, Celsius",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer calibration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90163,Calibration coefficients - z offset,1012,Accelerometer calibration,"103,687","Continuous, gravities",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer calibration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90166,Calibration coefficients - z slope,1012,Accelerometer calibration,"103,687","Continuous, gravities",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer calibration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90169,Calibration coefficients - z temp,1012,Accelerometer calibration,"103,687","Continuous, Celsius",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer calibration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90015,"Data quality, good wear time",1011,Accelerometer wear time duration,"103,687",Categorical (single),Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90003,Start of requested wear period,1011,Accelerometer wear time duration,"103,688",Time,Both sexes,Nov 2013,"103,688",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90010,Start time of wear,1011,Accelerometer wear time duration,"103,687",Time,Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90011,End time of wear,1011,Accelerometer wear time duration,"103,687",Time,Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90026,First weekday of wear,1011,Accelerometer wear time duration,"103,687",Categorical (single),Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90018,Daylight savings crossover,1011,Accelerometer wear time duration,"103,687",Categorical (single),Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90084,Unique hours of wear in a 24 hour cycle (scattered over multiple days),1011,Accelerometer wear time duration,"103,687","Integer, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90085,Unique minutes of wear in a 24 hour cycle (scattered over multiple days),1011,Accelerometer wear time duration,"103,687","Integer, minutes",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90051,Wear duration overall,1011,Accelerometer wear time duration,"103,687","Continuous, days",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90052,Non wear duration overall,1011,Accelerometer wear time duration,"103,687","Continuous, days",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90086,Non wear episodes over 1 hour duration,1011,Accelerometer wear time duration,"103,687",Integer,Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90060,Wear duration during 00:00 - 00:59,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90061,Wear duration during 01:00 - 01:59,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90062,Wear duration during 02:00 - 02:59,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90063,Wear duration during 03:00 - 03:59,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90064,Wear duration during 04:00 - 04:59,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90065,Wear duration during 05:00 - 05:59,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90066,Wear duration during 06:00 - 06:59,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90067,Wear duration during 07:00 - 07:59,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90068,Wear duration during 08:00 - 08:59,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90069,Wear duration during 09:00 - 09:59,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90070,Wear duration during 10:00 - 10:59,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90071,Wear duration during 11:00 - 11:59,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90072,Wear duration during 12:00 - 12:59,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90073,Wear duration during 13:00 - 13:59,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90074,Wear duration during 14:00 - 14:59,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90075,Wear duration during 15:00 - 15:59,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90076,Wear duration during 16:00 - 16:59,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90077,Wear duration during 17:00 - 17:59,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90078,Wear duration during 18:00 - 18:59,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90079,Wear duration during 19:00 - 19:59,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90080,Wear duration during 20:00 - 20:59,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90081,Wear duration during 21:00 - 21:59,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90082,Wear duration during 22:00 - 22:59,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90083,Wear duration during 23:00 - 23:59,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90057,Wear duration during Friday,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90053,Wear duration during Monday,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90058,Wear duration during Saturday,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90059,Wear duration during Sunday,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90056,Wear duration during Thursday,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90054,Wear duration during Tuesday,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90055,Wear duration during Wednesday,1011,Accelerometer wear time duration,"103,687","Continuous, hours",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Accelerometer wear time duration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20552,Behavioural and miscellaneous addictions,141,Addictions,"2,243",Categorical (multiple),Both sexes,Oct 2016,"2,329",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Addictions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20431,Ever addicted to a behaviour or miscellanous,141,Addictions,"9,382",Categorical (single),Both sexes,Oct 2016,"9,382",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Addictions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20406,Ever addicted to alcohol,141,Addictions,"9,382",Categorical (single),Both sexes,Oct 2016,"9,382",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Addictions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20401,Ever addicted to any substance or behaviour,141,Addictions,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Addictions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20456,Ever addicted to illicit or recreational drugs,141,Addictions,"9,382",Categorical (single),Both sexes,Oct 2016,"9,382",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Addictions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20457,Ongoing addiction or dependence on illicit or recreational drugs,141,Addictions,777,Categorical (single),Both sexes,Oct 2016,777,Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Addictions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20503,Ever addicted to prescription or over-the-counter medication,141,Addictions,"9,382",Categorical (single),Both sexes,Oct 2016,"9,382",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Addictions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20504,Ongoing addiction or dependence to over-the-counter medication,141,Addictions,"1,319",Categorical (single),Both sexes,Oct 2016,"1,319",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Addictions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20551,Substance of prescription or over-the-counter medication addiction,141,Addictions,"1,319",Categorical (multiple),Both sexes,Oct 2016,"1,434",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Addictions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20404,Ever physically dependent on alcohol,141,Addictions,"3,592",Categorical (single),Both sexes,Oct 2016,"3,592",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Addictions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20415,Ongoing addiction to alcohol,141,Addictions,"3,592",Categorical (single),Both sexes,Oct 2016,"3,592",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Addictions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20432,Ongoing behavioural or miscellanous addiction,141,Addictions,"2,243",Categorical (single),Both sexes,Oct 2016,"2,243",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Addictions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20117,Alcohol drinker status,100051,Alcohol,"501,626",Categorical (single),Both sexes,Mar 2013,"572,252",Data,Defined (4),Feb 2020,Accruing,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Alcohol,0.0,0.0,0.0,0.0,0.0,0.0
1558,Alcohol intake frequency.,100051,Alcohol,"501,626",Categorical (single),Both sexes,Jan 2012,"572,252",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Alcohol,0.0,0.0,0.0,0.0,0.0,0.0
3731,Former alcohol drinker,100051,Alcohol,"42,272",Categorical (single),Both sexes,Jan 2012,"45,366",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Alcohol,0.0,0.0,0.0,0.0,0.0,0.0
4407,Average monthly red wine intake,100051,Alcohol,"51,828","Integer, glasses",Both sexes,Jan 2012,"56,302",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Alcohol,0.0,0.0,0.0,0.0,0.0,0.0
4418,Average monthly champagne plus white wine intake,100051,Alcohol,"51,828","Integer, glasses",Both sexes,Jan 2012,"56,302",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Alcohol,0.0,0.0,0.0,0.0,0.0,0.0
4429,Average monthly beer plus cider intake,100051,Alcohol,"51,828","Integer, pints",Both sexes,Jan 2012,"56,302",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Alcohol,0.0,0.0,0.0,0.0,0.0,0.0
4440,Average monthly spirits intake,100051,Alcohol,"51,828","Integer, measures",Both sexes,Jan 2012,"56,302",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Alcohol,0.0,0.0,0.0,0.0,0.0,0.0
4451,Average monthly fortified wine intake,100051,Alcohol,"51,828","Integer, glasses",Both sexes,Jan 2012,"56,302",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Alcohol,0.0,0.0,0.0,0.0,0.0,0.0
4462,Average monthly intake of other alcoholic drinks,100051,Alcohol,"51,828","Integer, glasses",Both sexes,Jan 2012,"56,302",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Alcohol,0.0,0.0,0.0,0.0,0.0,0.0
1568,Average weekly red wine intake,100051,Alcohol,"349,095","Integer, glasses",Both sexes,Jan 2012,"396,924",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Alcohol,0.0,0.0,0.0,0.0,0.0,0.0
1578,Average weekly champagne plus white wine intake,100051,Alcohol,"349,094","Integer, glasses",Both sexes,Jan 2012,"396,923",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Alcohol,0.0,0.0,0.0,0.0,0.0,0.0
1588,Average weekly beer plus cider intake,100051,Alcohol,"349,094","Integer, pints",Both sexes,Jan 2012,"396,923",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Alcohol,0.0,0.0,0.0,0.0,0.0,0.0
1598,Average weekly spirits intake,100051,Alcohol,"349,094","Integer, measures",Both sexes,Jan 2012,"396,923",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Alcohol,0.0,0.0,0.0,0.0,0.0,0.0
1608,Average weekly fortified wine intake,100051,Alcohol,"349,094","Integer, glasses",Both sexes,Jan 2012,"396,923",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Alcohol,0.0,0.0,0.0,0.0,0.0,0.0
5364,Average weekly intake of other alcoholic drinks,100051,Alcohol,"146,406","Integer, glasses",Both sexes,Jan 2012,"166,523",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Alcohol,0.0,0.0,0.0,0.0,0.0,0.0
1618,Alcohol usually taken with meals,100051,Alcohol,"395,015",Categorical (single),Both sexes,Jan 2012,"453,225",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Alcohol,0.0,0.0,0.0,0.0,0.0,0.0
1628,Alcohol intake versus 10 years previously,100051,Alcohol,"460,900",Categorical (single),Both sexes,Jan 2012,"526,259",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Alcohol,0.0,0.0,0.0,0.0,0.0,0.0
2664,Reason for reducing amount of alcohol drunk,100051,Alcohol,"219,118",Categorical (single),Both sexes,Jan 2012,"239,160",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Alcohol,0.0,0.0,0.0,0.0,0.0,0.0
10818,Reason for reducing amount of alcohol drunk (pilot),100051,Alcohol,"1,515",Categorical (single),Both sexes,Jan 2012,"1,515",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Alcohol,0.0,0.0,0.0,0.0,0.0,0.0
3859,Reason former drinker stopped drinking alcohol,100051,Alcohol,"19,182",Categorical (single),Both sexes,Jan 2012,"20,324",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Alcohol,0.0,0.0,0.0,0.0,0.0,0.0
10853,Reason former drinker stopped drinking alcohol (pilot),100051,Alcohol,138,Categorical (single),Both sexes,Jan 2012,138,Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Alcohol,0.0,0.0,0.0,0.0,0.0,0.0
20414,Frequency of drinking alcohol,142,Alcohol use,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Alcohol use,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20403,Amount of alcohol drunk on a typical drinking day,142,Alcohol use,"143,665",Categorical (single),Both sexes,Oct 2016,"143,665",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Alcohol use,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20416,Frequency of consuming six or more units of alcohol,142,Alcohol use,"143,665",Categorical (single),Both sexes,Oct 2016,"143,665",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Alcohol use,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20413,Frequency of inability to cease drinking in last year,142,Alcohol use,"85,199",Categorical (single),Both sexes,Oct 2016,"85,199",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Alcohol use,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20407,Frequency of failure to fulfil normal expectations due to drinking alcohol in last year,142,Alcohol use,"85,199",Categorical (single),Both sexes,Oct 2016,"85,199",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Alcohol use,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20412,Frequency of needing morning drink of alcohol after heavy drinking session in last year,142,Alcohol use,"85,199",Categorical (single),Both sexes,Oct 2016,"85,199",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Alcohol use,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20409,Frequency of feeling guilt or remorse after drinking alcohol in last year,142,Alcohol use,"85,199",Categorical (single),Both sexes,Oct 2016,"85,199",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Alcohol use,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20408,Frequency of memory loss due to drinking alcohol in last year,142,Alcohol use,"85,199",Categorical (single),Both sexes,Oct 2016,"85,199",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Alcohol use,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20411,Ever been injured or injured someone else through drinking alcohol,142,Alcohol use,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Alcohol use,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20405,"Ever had known person concerned about, or recommend reduction of, alcohol consumption",142,Alcohol use,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Alcohol use,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20410,Age when known person last commented about drinking habits,142,Alcohol use,"7,023",Integer,Both sexes,Oct 2016,"7,023",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Alcohol use,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100580,Alcohol consumed,100100,Alcoholic beverages yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Alcoholic beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100590,Red wine intake,100100,Alcoholic beverages yesterday,"60,897",Categorical (single),Both sexes,Sep 2012,"89,947",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Alcoholic beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20096,Size of red wine glass drunk,100100,Alcoholic beverages yesterday,"59,442",Categorical (multiple),Both sexes,Sep 2012,"87,733",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Alcoholic beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100630,Rose wine intake,100100,Alcoholic beverages yesterday,"11,410",Categorical (single),Both sexes,Sep 2012,"12,980",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Alcoholic beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20097,Size of rose wine glass drunk,100100,Alcoholic beverages yesterday,"10,890",Categorical (multiple),Both sexes,Sep 2012,"12,441",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Alcoholic beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100670,White wine intake,100100,Alcoholic beverages yesterday,"48,889",Categorical (single),Both sexes,Sep 2012,"68,224",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Alcoholic beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20095,Size of white wine glass drunk,100100,Alcoholic beverages yesterday,"47,036",Categorical (multiple),Both sexes,Sep 2012,"65,482",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Alcoholic beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100710,Beer/cider intake,100100,Alcoholic beverages yesterday,"51,710",Categorical (single),Both sexes,Sep 2012,"72,695",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Alcoholic beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100720,Fortified wine intake,100100,Alcoholic beverages yesterday,"7,588",Categorical (single),Both sexes,Sep 2012,"9,046",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Alcoholic beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100730,Spirits intake,100100,Alcoholic beverages yesterday,"26,532",Categorical (single),Both sexes,Sep 2012,"35,015",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Alcoholic beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100740,Other alcohol intake,100100,Alcoholic beverages yesterday,"6,232",Categorical (single),Both sexes,Sep 2012,"6,608",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Alcoholic beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20550,Activities undertaken to treat anxiety,140,Anxiety,"24,211",Categorical (multiple),Both sexes,Oct 2016,"29,161",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20419,Difficulty concentrating during worst period of anxiety,140,Anxiety,"48,772",Categorical (single),Both sexes,Oct 2016,"48,772",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20541,Difficulty stopping worrying during worst period of anxiety,140,Anxiety,"48,772",Categorical (single),Both sexes,Oct 2016,"48,772",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20429,Easily tired during worst period of anxiety,140,Anxiety,"48,772",Categorical (single),Both sexes,Oct 2016,"48,772",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20421,"Ever felt worried, tense, or anxious for most of a month or longer",140,Anxiety,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20425,Ever worried more than most people would in similar situation,140,Anxiety,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20537,Frequency of difficulty controlling worry during worst period of anxiety,140,Anxiety,"48,772",Categorical (single),Both sexes,Oct 2016,"48,772",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20539,Frequency of inability to stop worrying during worst period of anxiety,140,Anxiety,"48,772",Categorical (single),Both sexes,Oct 2016,"48,772",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20427,Frequent trouble falling or staying asleep during worst period of anxiety,140,Anxiety,"48,772",Categorical (single),Both sexes,Oct 2016,"48,772",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20418,Impact on normal roles during worst period of anxiety,140,Anxiety,"48,772",Categorical (single),Both sexes,Oct 2016,"48,772",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20423,Keyed up or on edge during worst period of anxiety,140,Anxiety,"48,772",Categorical (single),Both sexes,Oct 2016,"48,772",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20420,Longest period spent worried or anxious,140,Anxiety,"39,010",Integer,Both sexes,Oct 2016,"39,010",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20422,More irritable than usual during worst period of anxiety,140,Anxiety,"48,772",Categorical (single),Both sexes,Oct 2016,"48,772",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20540,Multiple worries during worst period of anxiety,140,Anxiety,"48,772",Categorical (single),Both sexes,Oct 2016,"48,772",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20543,Number of things worried about during worst period of anxiety,140,Anxiety,"48,772",Categorical (single),Both sexes,Oct 2016,"48,772",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20428,Professional informed about anxiety,140,Anxiety,"48,772",Categorical (single),Both sexes,Oct 2016,"48,772",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20505,Recent easy annoyance or irritability,140,Anxiety,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20512,Recent feelings of foreboding,140,Anxiety,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20506,Recent feelings or nervousness or anxiety,140,Anxiety,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20509,Recent inability to stop or control worrying,140,Anxiety,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20516,Recent restlessness,140,Anxiety,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20515,Recent trouble relaxing,140,Anxiety,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20520,Recent worrying too much about different things,140,Anxiety,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20426,Restless during period of worst anxiety,140,Anxiety,"48,772",Categorical (single),Both sexes,Oct 2016,"48,772",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20542,Stronger worrying (than other people) during period of worst anxiety,140,Anxiety,"48,772",Categorical (single),Both sexes,Oct 2016,"48,772",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20549,Substances taken for anxiety,140,Anxiety,"26,503",Categorical (multiple),Both sexes,Oct 2016,"32,409",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20417,"Tense, sore, or aching muscles during worst period of anxiety",140,Anxiety,"48,772",Categorical (single),Both sexes,Oct 2016,"48,772",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20538,Worried most days during period of worst anxiety,140,Anxiety,"48,772",Categorical (single),Both sexes,Oct 2016,"48,772",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Anxiety,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20051,Reason for skipping arterial stiffness,100007,Arterial stiffness,931,Categorical (single),Both sexes,Aug 2012,931,Data,Defined (1),Aug 2012,Complete,UK Biobank Assessment Centre,Physical measures,Arterial stiffness,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4204,Absence of notch position in the pulse waveform,100007,Arterial stiffness,"207,275",Categorical (single),Both sexes,Jan 2012,"233,776",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Arterial stiffness,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4136,Arterial pulse-wave stiffness device ID,100007,Arterial stiffness,"212,566",Text,Both sexes,Jan 2012,"241,769",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Arterial stiffness,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4206,Arterial stiffness device ID,100007,Arterial stiffness,"210,357",Text,Both sexes,Jan 2012,"237,848",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Arterial stiffness,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4199,Position of pulse wave notch,100007,Arterial stiffness,"207,275",Integer,Both sexes,Jan 2012,"233,776",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Arterial stiffness,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4198,Position of the pulse wave peak,100007,Arterial stiffness,"207,275",Integer,Both sexes,Jan 2012,"233,776",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Arterial stiffness,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4200,Position of the shoulder on the pulse waveform,100007,Arterial stiffness,"207,275",Integer,Both sexes,Jan 2012,"233,776",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Arterial stiffness,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4194,Pulse rate,100007,Arterial stiffness,"207,275","Integer, bpm",Both sexes,Jan 2012,"233,776",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Arterial stiffness,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21021,Pulse wave Arterial Stiffness index,100007,Arterial stiffness,"206,133",Continuous,Both sexes,Jan 2012,"232,423",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Arterial stiffness,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4196,Pulse wave peak to peak time,100007,Arterial stiffness,"207,161","Integer, milliseconds",Both sexes,Jan 2012,"233,633",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Arterial stiffness,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4205,Pulse wave pressure versus time response curve,100007,Arterial stiffness,"207,275",Compound,Both sexes,Jan 2012,"233,776",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Arterial stiffness,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4195,Pulse wave reflection index,100007,Arterial stiffness,"207,275",Integer,Both sexes,Jan 2012,"233,776",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Arterial stiffness,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4207,Pulse wave velocity (manual entry),100007,Arterial stiffness,330,"Continuous, m/s",Both sexes,Jan 2012,330,Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Arterial stiffness,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4186,Stiffness method,100007,Arterial stiffness,"210,357",Categorical (single),Both sexes,Jan 2012,"237,848",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Arterial stiffness,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42014,Date of asthma report,45,Asthma outcomes,"66,918",Date,Both sexes,Apr 2018,"66,918",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Asthma outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42015,Source of asthma report,45,Asthma outcomes,"66,918",Categorical (single),Both sexes,Apr 2018,"66,918",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Asthma outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20052,Reason for skipping refractometry (left),100014,Autorefraction,"1,520",Categorical (single),Both sexes,Aug 2012,"1,520",Data,Defined (1),Aug 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5193,Duration at which refractometer first shown (left),100014,Autorefraction,"132,134","Integer, seconds",Both sexes,Jan 2012,"136,300",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
20055,Reason for skipping refractometry (right),100014,Autorefraction,"1,399",Categorical (single),Both sexes,Aug 2012,"1,399",Data,Defined (1),Aug 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5190,Duration at which refractometer first shown (right),100014,Autorefraction,"132,140","Integer, seconds",Both sexes,Jan 2012,"136,305",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5191,Auto-refraction method (left),100014,Autorefraction,"132,134",Categorical (single),Both sexes,Jan 2012,"136,300",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5189,Auto-refraction method (right),100014,Autorefraction,"132,140",Categorical (single),Both sexes,Jan 2012,"136,305",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5111,3mm asymmetry angle (left),100014,Autorefraction,"121,700",Integer,Both sexes,Jan 2012,"364,553",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5108,3mm asymmetry angle (right),100014,Autorefraction,"121,930",Integer,Both sexes,Jan 2012,"356,693",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5141,3mm asymmetry index unreliable (left),100014,Autorefraction,"11,661",Categorical (single),Both sexes,Jan 2012,"21,526",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5144,3mm asymmetry index unreliable (right),100014,Autorefraction,"12,011",Categorical (single),Both sexes,Jan 2012,"20,342",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5156,3mm asymmetry index (left),100014,Autorefraction,"121,700",Continuous,Both sexes,Jan 2012,"364,575",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5159,3mm asymmetry index (right),100014,Autorefraction,"121,930",Continuous,Both sexes,Jan 2012,"356,705",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5155,3mm asymmetry index for irregular astigmatism level (left),100014,Autorefraction,"121,700",Categorical (single),Both sexes,Jan 2012,"364,575",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5152,3mm asymmetry index for irregular astigmatism level (right),100014,Autorefraction,"121,930",Categorical (single),Both sexes,Jan 2012,"356,705",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5112,3mm cylindrical power angle (left),100014,Autorefraction,"124,529","Integer, degrees",Both sexes,Jan 2012,"375,549",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5115,3mm cylindrical power angle (right),100014,Autorefraction,"124,515",Integer,Both sexes,Jan 2012,"367,350",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5119,3mm cylindrical power (left),100014,Autorefraction,"124,548","Continuous, diopters",Both sexes,Jan 2012,"376,171",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5116,3mm cylindrical power (right),100014,Autorefraction,"124,527","Continuous, diopters",Both sexes,Jan 2012,"368,000",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5292,3mm index of best keratometry results (left),100014,Autorefraction,"124,548",Integer,Both sexes,Jan 2012,"128,364",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5237,3mm index of best keratometry results (right),100014,Autorefraction,"124,527",Integer,Both sexes,Jan 2012,"128,359",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5136,3mm keratometry result unreliable (left),100014,Autorefraction,"5,886",Categorical (single),Both sexes,Jan 2012,"11,176",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5140,3mm keratometry result unreliable (right),100014,Autorefraction,"6,238",Categorical (single),Both sexes,Jan 2012,"10,738",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5163,3mm regularity index (left),100014,Autorefraction,"121,719",Continuous,Both sexes,Jan 2012,"364,694",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5160,3mm regularity index (right),100014,Autorefraction,"121,968",Continuous,Both sexes,Jan 2012,"356,965",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5148,3mm regularity index unreliable (left),100014,Autorefraction,"11,672",Categorical (single),Both sexes,Jan 2012,"21,542",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5145,3mm regularity index unreliable (right),100014,Autorefraction,"12,032",Categorical (single),Both sexes,Jan 2012,"20,376",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5149,3mm regularity index for irregular astigmatism level (left),100014,Autorefraction,"121,719",Categorical (single),Both sexes,Jan 2012,"364,694",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5164,3mm regularity index for irregular astigmatism level (right),100014,Autorefraction,"121,968",Categorical (single),Both sexes,Jan 2012,"356,965",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5104,3mm strong meridian angle (left),100014,Autorefraction,"124,548","Integer, degrees",Both sexes,Jan 2012,"376,171",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5107,3mm strong meridian angle (right),100014,Autorefraction,"124,527",Integer,Both sexes,Jan 2012,"368,000",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5135,3mm strong meridian (left),100014,Autorefraction,"124,548","Continuous, diopters",Both sexes,Jan 2012,"376,171",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5132,3mm strong meridian (right),100014,Autorefraction,"124,527","Continuous, diopters",Both sexes,Jan 2012,"368,000",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5103,3mm weak meridian angle (left),100014,Autorefraction,"124,548","Integer, degrees",Both sexes,Jan 2012,"376,171",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5100,3mm weak meridian angle (right),100014,Autorefraction,"124,527","Integer, degrees",Both sexes,Jan 2012,"368,000",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5096,3mm weak meridian (left),100014,Autorefraction,"124,548","Continuous, diopters",Both sexes,Jan 2012,"376,171",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5099,3mm weak meridian (right),100014,Autorefraction,"124,527","Continuous, diopters",Both sexes,Jan 2012,"368,000",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5306,6mm index of best keratometry results (left),100014,Autorefraction,"107,705",Integer,Both sexes,Jan 2012,"110,625",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5251,6mm index of best keratometry results (right),100014,Autorefraction,"108,831",Integer,Both sexes,Jan 2012,"111,865",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5138,6mm keratometry result unreliable (left),100014,Autorefraction,"52,810",Categorical (single),Both sexes,Jan 2012,"126,933",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5139,6mm keratometry result unreliable (right),100014,Autorefraction,"54,838",Categorical (single),Both sexes,Jan 2012,"124,688",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5110,6mm asymmetry angle (left),100014,Autorefraction,"66,228",Integer,Both sexes,Jan 2012,"179,742",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5109,6mm asymmetry angle (right),100014,Autorefraction,"67,174",Integer,Both sexes,Jan 2012,"176,210",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5157,6mm asymmetry index (left),100014,Autorefraction,"66,228",Continuous,Both sexes,Jan 2012,"179,742",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5158,6mm asymmetry index (right),100014,Autorefraction,"67,174",Continuous,Both sexes,Jan 2012,"176,210",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5142,6mm asymmetry index unreliable (left),100014,Autorefraction,"34,474",Categorical (single),Both sexes,Jan 2012,"72,678",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5143,6mm asymmetry index unreliable (right),100014,Autorefraction,"35,519",Categorical (single),Both sexes,Jan 2012,"70,652",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5113,6mm cylindrical power angle (left),100014,Autorefraction,"107,674",Integer,Both sexes,Jan 2012,"306,479",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5114,6mm cylindrical power angle (right),100014,Autorefraction,"108,802",Integer,Both sexes,Jan 2012,"301,035",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5118,6mm cylindrical power (left),100014,Autorefraction,"107,705","Continuous, diopters",Both sexes,Jan 2012,"307,022",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5117,6mm cylindrical power (right),100014,Autorefraction,"108,831","Continuous, diopters",Both sexes,Jan 2012,"301,568",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5162,6mm regularity index (left),100014,Autorefraction,"66,266",Continuous,Both sexes,Jan 2012,"179,946",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5161,6mm regularity index (right),100014,Autorefraction,"67,276",Continuous,Both sexes,Jan 2012,"176,704",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5147,6mm regularity index unreliable (left),100014,Autorefraction,"34,508",Categorical (single),Both sexes,Jan 2012,"72,764",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5146,6mm regularity index unreliable (right),100014,Autorefraction,"35,616",Categorical (single),Both sexes,Jan 2012,"70,873",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5105,6mm strong meridian angle (left),100014,Autorefraction,"107,705","Integer, degrees",Both sexes,Jan 2012,"307,022",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5106,6mm strong meridian angle (right),100014,Autorefraction,"108,831","Integer, degrees",Both sexes,Jan 2012,"301,568",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5134,6mm strong meridian (left),100014,Autorefraction,"107,705","Continuous, diopters",Both sexes,Jan 2012,"307,022",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5133,6mm strong meridian (right),100014,Autorefraction,"108,831","Continuous, diopters",Both sexes,Jan 2012,"301,568",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5102,6mm weak meridian angle (left),100014,Autorefraction,"107,705","Integer, degrees",Both sexes,Jan 2012,"307,022",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5101,6mm weak meridian angle (right),100014,Autorefraction,"108,831","Integer, degrees",Both sexes,Jan 2012,"301,568",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5097,6mm weak meridian (left),100014,Autorefraction,"107,705","Continuous, diopters",Both sexes,Jan 2012,"307,022",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5098,6mm weak meridian (right),100014,Autorefraction,"108,831","Continuous, diopters",Both sexes,Jan 2012,"301,568",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5089,Astigmatism angle (left),100014,Autorefraction,"129,265","Integer, degrees",Both sexes,Jan 2012,"399,026",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5088,Astigmatism angle (right),100014,Autorefraction,"129,728","Integer, degrees",Both sexes,Jan 2012,"401,004",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5086,Cylindrical power (left),100014,Autorefraction,"129,265","Continuous, diopters",Both sexes,Jan 2012,"399,125",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5087,Cylindrical power (right),100014,Autorefraction,"129,728","Continuous, diopters",Both sexes,Jan 2012,"401,110",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5085,Spherical power (left),100014,Autorefraction,"129,265","Continuous, diopters",Both sexes,Jan 2012,"399,125",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5084,Spherical power (right),100014,Autorefraction,"129,728","Continuous, diopters",Both sexes,Jan 2012,"401,110",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5274,Vertex distance (left),100014,Autorefraction,"129,265","Continuous, mm",Both sexes,Jan 2012,"133,238",Data,Defined (2),N/A,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5215,Vertex distance (right),100014,Autorefraction,"129,728","Continuous, mm",Both sexes,Jan 2012,"133,735",Data,Defined (2),N/A,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5276,Index of best refractometry result (left),100014,Autorefraction,"129,265",Integer,Both sexes,Jan 2012,"133,238",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5221,Index of best refractometry result (right),100014,Autorefraction,"129,728",Integer,Both sexes,Jan 2012,"133,735",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5090,Refractometry result unreliable (left),100014,Autorefraction,"7,319",Categorical (single),Both sexes,Jan 2012,"16,121",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5091,Refractometry result unreliable (right),100014,Autorefraction,"10,472",Categorical (single),Both sexes,Jan 2012,"23,315",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5273,Auto-refractor device ID (left),100014,Autorefraction,"129,265",Text,Both sexes,Jan 2012,"133,238",Data,Defined (2),N/A,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
5214,Auto-refractor device ID (right),100014,Autorefraction,"129,728",Text,Both sexes,Jan 2012,"133,735",Data,Defined (2),N/A,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Autorefraction,0.0,0.0,0.0,0.0,0.0,0.0
23181,BGI WGS CRAM files,181,BGI WGS pilot,48,Text,Both sexes,Jul 2018,50,Bulk,Singular,Jul 2018,Complete,Genomics,Whole genome sequences,BGI WGS pilot,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23182,BGI WGS CRAM indices,181,BGI WGS pilot,48,Text,Both sexes,Jul 2018,50,Bulk,Singular,Jul 2018,Complete,Genomics,Whole genome sequences,BGI WGS pilot,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21022,Age at recruitment,100094,Baseline characteristics,"502,506","Integer, years",Both sexes,Jul 2014,"502,506",Data,Singular,Jul 2014,Complete,Population characteristics,Baseline characteristics,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
33,Date of birth,100094,Baseline characteristics,"502,506",Date,Both sexes,Jan 2012,"502,506",Data,Singular,Jan 2012,Complete,Population characteristics,Baseline characteristics,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
52,Month of birth,100094,Baseline characteristics,"502,506",Categorical (single),Both sexes,Jan 2012,"502,506",Data,Singular,Jan 2012,Complete,Population characteristics,Baseline characteristics,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
34,Year of birth,100094,Baseline characteristics,"502,506","Integer, years",Both sexes,Jan 2012,"502,506",Data,Singular,Jan 2012,Complete,Population characteristics,Baseline characteristics,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
31,Sex,100094,Baseline characteristics,"502,506",Categorical (single),Both sexes,Jan 2012,"502,506",Data,Singular,Jul 2019,Complete,Population characteristics,Baseline characteristics,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
189,Townsend deprivation index at recruitment,100094,Baseline characteristics,"501,883",Continuous,Both sexes,Jan 2012,"501,883",Data,Singular,Jan 2012,Complete,Population characteristics,Baseline characteristics,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
30620,Alanine aminotransferase,17518,Blood biochemistry,"470,658","Continuous, U/L",Both sexes,May 2018,"487,267",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30600,Albumin,17518,Blood biochemistry,"432,338","Continuous, g/L",Both sexes,May 2018,"445,771",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30610,Alkaline phosphatase,17518,Blood biochemistry,"470,859","Continuous, U/L",Both sexes,May 2018,"487,474",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30630,Apolipoprotein A,17518,Blood biochemistry,"429,790","Continuous, g/L",Both sexes,May 2018,"443,079",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30640,Apolipoprotein B,17518,Blood biochemistry,"468,513","Continuous, g/L",Both sexes,May 2018,"484,997",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30650,Aspartate aminotransferase,17518,Blood biochemistry,"469,109","Continuous, U/L",Both sexes,May 2018,"485,603",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30710,C-reactive protein,17518,Blood biochemistry,"469,857","Continuous, mg/L",Both sexes,May 2018,"486,407",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30680,Calcium,17518,Blood biochemistry,"432,190","Continuous, mmol/L",Both sexes,May 2018,"445,620",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30690,Cholesterol,17518,Blood biochemistry,"470,846","Continuous, mmol/L",Both sexes,May 2018,"487,468",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30700,Creatinine,17518,Blood biochemistry,"470,623","Continuous, umol/L",Both sexes,May 2018,"487,202",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30720,Cystatin C,17518,Blood biochemistry,"470,817","Continuous, mg/L",Both sexes,May 2018,"487,424",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30660,Direct bilirubin,17518,Blood biochemistry,"401,029","Continuous, umol/L",Both sexes,May 2018,"413,663",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30730,Gamma glutamyltransferase,17518,Blood biochemistry,"470,604","Continuous, U/L",Both sexes,May 2018,"487,207",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30740,Glucose,17518,Blood biochemistry,"431,844","Continuous, mmol/L",Both sexes,May 2018,"445,254",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30750,Glycated haemoglobin (HbA1c),17518,Blood biochemistry,"467,912","Continuous, mmol/mol",Both sexes,May 2018,"480,774",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30760,HDL cholesterol,17518,Blood biochemistry,"432,135","Continuous, mmol/L",Both sexes,May 2018,"445,564",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30770,IGF-1,17518,Blood biochemistry,"468,385","Continuous, nmol/L",Both sexes,May 2018,"484,741",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30780,LDL direct,17518,Blood biochemistry,"470,008","Continuous, mmol/L",Both sexes,May 2018,"486,545",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30790,Lipoprotein A,17518,Blood biochemistry,"377,661","Continuous, nmol/L",Both sexes,May 2018,"389,864",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30800,Oestradiol,17518,Blood biochemistry,"77,714","Continuous, pmol/L",Both sexes,May 2018,"78,535",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30810,Phosphate,17518,Blood biochemistry,"431,525","Continuous, mmol/L",Both sexes,May 2018,"444,902",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30820,Rheumatoid factor,17518,Blood biochemistry,"41,989","Continuous, IU/ml",Both sexes,May 2018,"42,998",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30830,SHBG,17518,Blood biochemistry,"428,176","Continuous, nmol/L",Both sexes,May 2018,"441,306",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30850,Testosterone,17518,Blood biochemistry,"427,062","Continuous, nmol/L",Both sexes,May 2018,"441,249",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30840,Total bilirubin,17518,Blood biochemistry,"468,886","Continuous, umol/L",Both sexes,May 2018,"485,337",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30860,Total protein,17518,Blood biochemistry,"431,871","Continuous, g/L",Both sexes,May 2018,"445,290",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30870,Triglycerides,17518,Blood biochemistry,"470,476","Continuous, mmol/L",Both sexes,May 2018,"487,060",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30880,Urate,17518,Blood biochemistry,"470,297","Continuous, umol/L",Both sexes,May 2018,"486,856",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30670,Urea,17518,Blood biochemistry,"470,538","Continuous, mmol/L",Both sexes,May 2018,"487,124",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30890,Vitamin D,17518,Blood biochemistry,"449,954","Continuous, nmol/L",Both sexes,May 2018,"465,390",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,0.0,0.0,0.0,0.0,0.0,0.0
30897,Estimated sample dilution factor,18518,Blood biochemistry processing,"468,487","Continuous, factor",Both sexes,Feb 2019,"485,037",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30622,Alanine aminotransferase aliquot,18518,Blood biochemistry processing,"474,688",Categorical (single),Both sexes,Jun 2018,"492,069",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30621,Alanine aminotransferase assay date,18518,Blood biochemistry processing,"474,897",Date,Both sexes,Jun 2018,"492,290",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30623,Alanine aminotransferase correction level,18518,Blood biochemistry processing,"470,658",Categorical (single),Both sexes,Jun 2018,"487,267",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30624,Alanine aminotransferase correction reason,18518,Blood biochemistry processing,"470,658",Categorical (single),Both sexes,Jun 2018,"487,267",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30625,Alanine aminotransferase missing reason,18518,Blood biochemistry processing,"24,083",Categorical (single),Both sexes,Jun 2018,"24,158",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30626,Alanine aminotransferase reportability,18518,Blood biochemistry processing,"470,724",Categorical (single),Both sexes,Jun 2018,"487,334",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30602,Albumin aliquot,18518,Blood biochemistry processing,"474,572",Categorical (single),Both sexes,Jun 2018,"491,946",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30601,Albumin assay date,18518,Blood biochemistry processing,"474,781",Date,Both sexes,Jun 2018,"492,167",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30603,Albumin correction level,18518,Blood biochemistry processing,"432,338",Categorical (single),Both sexes,Jun 2018,"445,771",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30604,Albumin correction reason,18518,Blood biochemistry processing,"432,338",Categorical (single),Both sexes,Jun 2018,"445,771",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30605,Albumin missing reason,18518,Blood biochemistry processing,"65,190",Categorical (single),Both sexes,Jun 2018,"65,654",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30606,Albumin reportability,18518,Blood biochemistry processing,"432,353",Categorical (single),Both sexes,Jun 2018,"445,787",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30612,Alkaline phosphatase aliquot,18518,Blood biochemistry processing,"474,628",Categorical (single),Both sexes,Jun 2018,"491,979",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30611,Alkaline phosphatase assay date,18518,Blood biochemistry processing,"474,837",Date,Both sexes,Jun 2018,"492,200",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30613,Alkaline phosphatase correction level,18518,Blood biochemistry processing,"470,859",Categorical (single),Both sexes,Jun 2018,"487,474",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30614,Alkaline phosphatase correction reason,18518,Blood biochemistry processing,"470,859",Categorical (single),Both sexes,Jun 2018,"487,474",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30615,Alkaline phosphatase missing reason,18518,Blood biochemistry processing,"23,878",Categorical (single),Both sexes,Jun 2018,"23,951",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30616,Alkaline phosphatase reportability,18518,Blood biochemistry processing,"470,905",Categorical (single),Both sexes,Jun 2018,"487,523",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30632,Apolipoprotein A aliquot,18518,Blood biochemistry processing,"473,942",Categorical (single),Both sexes,Jun 2018,"491,282",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30631,Apolipoprotein A assay date,18518,Blood biochemistry processing,"474,151",Date,Both sexes,Jun 2018,"491,503",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30633,Apolipoprotein A correction level,18518,Blood biochemistry processing,"429,790",Categorical (single),Both sexes,Jun 2018,"443,079",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30634,Apolipoprotein A correction reason,18518,Blood biochemistry processing,"429,790",Categorical (single),Both sexes,Jun 2018,"443,079",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30635,Apolipoprotein A missing reason,18518,Blood biochemistry processing,"67,817",Categorical (single),Both sexes,Jun 2018,"68,346",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30636,Apolipoprotein A reportability,18518,Blood biochemistry processing,"431,522",Categorical (single),Both sexes,Jun 2018,"444,908",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30642,Apolipoprotein B aliquot,18518,Blood biochemistry processing,"474,409",Categorical (single),Both sexes,Jun 2018,"491,759",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30641,Apolipoprotein B assay date,18518,Blood biochemistry processing,"474,617",Date,Both sexes,Jun 2018,"491,979",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30643,Apolipoprotein B correction level,18518,Blood biochemistry processing,"468,513",Categorical (single),Both sexes,Jun 2018,"484,997",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30644,Apolipoprotein B correction reason,18518,Blood biochemistry processing,"468,513",Categorical (single),Both sexes,Jun 2018,"484,997",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30645,Apolipoprotein B missing reason,18518,Blood biochemistry processing,"26,328",Categorical (single),Both sexes,Jun 2018,"26,428",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30646,Apolipoprotein B reportability,18518,Blood biochemistry processing,"469,665",Categorical (single),Both sexes,Jun 2018,"486,207",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30652,Aspartate aminotransferase aliquot,18518,Blood biochemistry processing,"474,669",Categorical (single),Both sexes,Jun 2018,"492,055",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30651,Aspartate aminotransferase assay date,18518,Blood biochemistry processing,"474,878",Date,Both sexes,Jun 2018,"492,276",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30653,Aspartate aminotransferase correction level,18518,Blood biochemistry processing,"469,109",Categorical (single),Both sexes,Jun 2018,"485,603",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30654,Aspartate aminotransferase correction reason,18518,Blood biochemistry processing,"469,109",Categorical (single),Both sexes,Jun 2018,"485,603",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30655,Aspartate aminotransferase missing reason,18518,Blood biochemistry processing,"25,739",Categorical (single),Both sexes,Jun 2018,"25,822",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30656,Aspartate aminotransferase reportability,18518,Blood biochemistry processing,"469,123",Categorical (single),Both sexes,Jun 2018,"485,617",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30712,C-reactive protein aliquot,18518,Blood biochemistry processing,"474,216",Categorical (single),Both sexes,Jun 2018,"491,573",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30711,C-reactive protein assay date,18518,Blood biochemistry processing,"474,425",Date,Both sexes,Jun 2018,"491,794",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30713,C-reactive protein correction level,18518,Blood biochemistry processing,"469,857",Categorical (single),Both sexes,Jun 2018,"486,407",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30714,C-reactive protein correction reason,18518,Blood biochemistry processing,"469,857",Categorical (single),Both sexes,Jun 2018,"486,407",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30715,C-reactive protein missing reason,18518,Blood biochemistry processing,"24,941",Categorical (single),Both sexes,Jun 2018,"25,018",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30716,C-reactive protein reportability,18518,Blood biochemistry processing,"470,263",Categorical (single),Both sexes,Jun 2018,"486,850",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30682,Calcium aliquot,18518,Blood biochemistry processing,"474,198",Categorical (single),Both sexes,Jun 2018,"491,563",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30681,Calcium assay date,18518,Blood biochemistry processing,"474,407",Date,Both sexes,Jun 2018,"491,784",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30683,Calcium correction level,18518,Blood biochemistry processing,"432,190",Categorical (single),Both sexes,Jun 2018,"445,620",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30684,Calcium correction reason,18518,Blood biochemistry processing,"432,190",Categorical (single),Both sexes,Jun 2018,"445,620",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30685,Calcium missing reason,18518,Blood biochemistry processing,"65,340",Categorical (single),Both sexes,Jun 2018,"65,805",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30686,Calcium reportability,18518,Blood biochemistry processing,"432,248",Categorical (single),Both sexes,Jun 2018,"445,681",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30692,Cholesterol aliquot,18518,Blood biochemistry processing,"474,607",Categorical (single),Both sexes,Jun 2018,"491,990",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30691,Cholesterol assay date,18518,Blood biochemistry processing,"474,816",Date,Both sexes,Jun 2018,"492,211",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30693,Cholesterol correction level,18518,Blood biochemistry processing,"470,846",Categorical (single),Both sexes,Jun 2018,"487,468",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30694,Cholesterol correction reason,18518,Blood biochemistry processing,"470,846",Categorical (single),Both sexes,Jun 2018,"487,468",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30695,Cholesterol missing reason,18518,Blood biochemistry processing,"23,884",Categorical (single),Both sexes,Jun 2018,"23,957",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30696,Cholesterol reportability,18518,Blood biochemistry processing,"470,853",Categorical (single),Both sexes,Jun 2018,"487,475",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30702,Creatinine aliquot,18518,Blood biochemistry processing,"474,364",Categorical (single),Both sexes,Jun 2018,"491,704",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30701,Creatinine assay date,18518,Blood biochemistry processing,"474,573",Date,Both sexes,Jun 2018,"491,925",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30703,Creatinine correction level,18518,Blood biochemistry processing,"470,623",Categorical (single),Both sexes,Jun 2018,"487,202",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30704,Creatinine correction reason,18518,Blood biochemistry processing,"470,623",Categorical (single),Both sexes,Jun 2018,"487,202",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30705,Creatinine missing reason,18518,Blood biochemistry processing,"24,149",Categorical (single),Both sexes,Jun 2018,"24,223",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30706,Creatinine reportability,18518,Blood biochemistry processing,"470,623",Categorical (single),Both sexes,Jun 2018,"487,202",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30722,Cystatin C aliquot,18518,Blood biochemistry processing,"474,524",Categorical (single),Both sexes,Jun 2018,"491,888",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30721,Cystatin C assay date,18518,Blood biochemistry processing,"474,734",Date,Both sexes,Jun 2018,"492,110",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30723,Cystatin C correction level,18518,Blood biochemistry processing,"470,817",Categorical (single),Both sexes,Jun 2018,"487,424",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30724,Cystatin C correction reason,18518,Blood biochemistry processing,"470,817",Categorical (single),Both sexes,Jun 2018,"487,424",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30725,Cystatin C missing reason,18518,Blood biochemistry processing,"23,927",Categorical (single),Both sexes,Jun 2018,"24,001",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30726,Cystatin C reportability,18518,Blood biochemistry processing,"470,832",Categorical (single),Both sexes,Jun 2018,"487,439",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30662,Direct bilirubin aliquot,18518,Blood biochemistry processing,"474,188",Categorical (single),Both sexes,Jun 2018,"491,484",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30661,Direct bilirubin assay date,18518,Blood biochemistry processing,"474,397",Date,Both sexes,Jun 2018,"491,705",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30663,Direct bilirubin correction level,18518,Blood biochemistry processing,"401,029",Categorical (single),Both sexes,Jun 2018,"413,663",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30664,Direct bilirubin correction reason,18518,Blood biochemistry processing,"401,029",Categorical (single),Both sexes,Jun 2018,"413,663",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30665,Direct bilirubin missing reason,18518,Blood biochemistry processing,"96,305",Categorical (single),Both sexes,Jun 2018,"97,762",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30666,Direct bilirubin reportability,18518,Blood biochemistry processing,"469,248",Categorical (single),Both sexes,Jun 2018,"485,771",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30732,Gamma glutamyltransferase aliquot,18518,Blood biochemistry processing,"474,506",Categorical (single),Both sexes,Jun 2018,"491,878",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30731,Gamma glutamyltransferase assay date,18518,Blood biochemistry processing,"474,715",Date,Both sexes,Jun 2018,"492,099",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30733,Gamma glutamyltransferase correction level,18518,Blood biochemistry processing,"470,604",Categorical (single),Both sexes,Jun 2018,"487,207",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30734,Gamma glutamyltransferase correction reason,18518,Blood biochemistry processing,"470,604",Categorical (single),Both sexes,Jun 2018,"487,207",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30735,Gamma glutamyltransferase missing reason,18518,Blood biochemistry processing,"24,145",Categorical (single),Both sexes,Jun 2018,"24,218",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30736,Gamma glutamyltransferase reportability,18518,Blood biochemistry processing,"470,698",Categorical (single),Both sexes,Jun 2018,"487,302",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30742,Glucose aliquot,18518,Blood biochemistry processing,"473,937",Categorical (single),Both sexes,Jun 2018,"491,279",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30741,Glucose assay date,18518,Blood biochemistry processing,"474,146",Date,Both sexes,Jun 2018,"491,500",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30743,Glucose correction level,18518,Blood biochemistry processing,"431,844",Categorical (single),Both sexes,Jun 2018,"445,254",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30744,Glucose correction reason,18518,Blood biochemistry processing,"431,844",Categorical (single),Both sexes,Jun 2018,"445,254",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30745,Glucose missing reason,18518,Blood biochemistry processing,"65,704",Categorical (single),Both sexes,Jun 2018,"66,171",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30746,Glucose reportability,18518,Blood biochemistry processing,"431,852",Categorical (single),Both sexes,Jun 2018,"445,262",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30751,Glycated haemoglobin (HbA1c) assay date,18518,Blood biochemistry processing,"483,346",Date,Both sexes,Jun 2018,"497,019",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30753,Glycated haemoglobin (HbA1c) correction level,18518,Blood biochemistry processing,"467,912",Categorical (single),Both sexes,Jun 2018,"480,774",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30754,Glycated haemoglobin (HbA1c) correction reason,18518,Blood biochemistry processing,"467,912",Categorical (single),Both sexes,Jun 2018,"480,774",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30755,Glycated haemoglobin (HbA1c) missing reason,18518,Blood biochemistry processing,"30,398",Categorical (single),Both sexes,Jun 2018,"30,651",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30756,Glycated haemoglobin (HbA1c) reportability,18518,Blood biochemistry processing,"468,107",Categorical (single),Both sexes,Jun 2018,"480,974",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30762,HDL cholesterol aliquot,18518,Blood biochemistry processing,"474,443",Categorical (single),Both sexes,Jun 2018,"491,811",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30761,HDL cholesterol assay date,18518,Blood biochemistry processing,"474,652",Date,Both sexes,Jun 2018,"492,032",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30763,HDL cholesterol correction level,18518,Blood biochemistry processing,"432,135",Categorical (single),Both sexes,Jun 2018,"445,564",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30764,HDL cholesterol correction reason,18518,Blood biochemistry processing,"432,135",Categorical (single),Both sexes,Jun 2018,"445,564",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30765,HDL cholesterol missing reason,18518,Blood biochemistry processing,"65,391",Categorical (single),Both sexes,Jun 2018,"65,861",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30766,HDL cholesterol reportability,18518,Blood biochemistry processing,"432,141",Categorical (single),Both sexes,Jun 2018,"445,570",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30772,IGF-1 aliquot,18518,Blood biochemistry processing,"472,083",Categorical (single),Both sexes,Jun 2018,"489,191",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30771,IGF-1 assay date,18518,Blood biochemistry processing,"472,294",Date,Both sexes,Jun 2018,"489,413",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30773,IGF-1 correction level,18518,Blood biochemistry processing,"468,385",Categorical (single),Both sexes,Jun 2018,"484,741",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30774,IGF-1 correction reason,18518,Blood biochemistry processing,"468,385",Categorical (single),Both sexes,Jun 2018,"484,741",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30775,IGF-1 missing reason,18518,Blood biochemistry processing,"26,595",Categorical (single),Both sexes,Jun 2018,"26,684",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30776,IGF-1 reportability,18518,Blood biochemistry processing,"468,391",Categorical (single),Both sexes,Jun 2018,"484,747",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30782,LDL direct aliquot,18518,Blood biochemistry processing,"473,877",Categorical (single),Both sexes,Jun 2018,"491,178",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30781,LDL direct assay date,18518,Blood biochemistry processing,"474,086",Date,Both sexes,Jun 2018,"491,399",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30783,LDL direct correction level,18518,Blood biochemistry processing,"470,008",Categorical (single),Both sexes,Jun 2018,"486,545",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30784,LDL direct correction reason,18518,Blood biochemistry processing,"470,008",Categorical (single),Both sexes,Jun 2018,"486,545",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30785,LDL direct missing reason,18518,Blood biochemistry processing,"24,801",Categorical (single),Both sexes,Jun 2018,"24,880",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30786,LDL direct reportability,18518,Blood biochemistry processing,"470,015",Categorical (single),Both sexes,Jun 2018,"486,552",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30792,Lipoprotein A aliquot,18518,Blood biochemistry processing,"460,275",Categorical (single),Both sexes,Jun 2018,"476,536",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30791,Lipoprotein A assay date,18518,Blood biochemistry processing,"460,482",Date,Both sexes,Jun 2018,"476,755",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30793,Lipoprotein A correction level,18518,Blood biochemistry processing,"377,661",Categorical (single),Both sexes,Jun 2018,"389,864",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30794,Lipoprotein A correction reason,18518,Blood biochemistry processing,"377,661",Categorical (single),Both sexes,Jun 2018,"389,864",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30795,Lipoprotein A missing reason,18518,Blood biochemistry processing,"118,796",Categorical (single),Both sexes,Jun 2018,"121,561",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30796,Lipoprotein A reportability,18518,Blood biochemistry processing,"456,852",Categorical (single),Both sexes,Jun 2018,"472,413",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30802,Oestradiol aliquot,18518,Blood biochemistry processing,"442,592",Categorical (single),Both sexes,Jun 2018,"457,397",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30801,Oestradiol assay date,18518,Blood biochemistry processing,"442,783",Date,Both sexes,Jun 2018,"457,598",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30803,Oestradiol correction level,18518,Blood biochemistry processing,"77,714",Categorical (single),Both sexes,Jun 2018,"78,535",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30804,Oestradiol correction reason,18518,Blood biochemistry processing,"77,714",Categorical (single),Both sexes,Jun 2018,"78,535",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30805,Oestradiol missing reason,18518,Blood biochemistry processing,"417,440",Categorical (single),Both sexes,Jun 2018,"432,890",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30806,Oestradiol reportability,18518,Blood biochemistry processing,"439,804",Categorical (single),Both sexes,Jun 2018,"454,250",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30812,Phosphate aliquot,18518,Blood biochemistry processing,"473,705",Categorical (single),Both sexes,Jun 2018,"491,014",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30811,Phosphate assay date,18518,Blood biochemistry processing,"473,914",Date,Both sexes,Jun 2018,"491,235",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30813,Phosphate correction level,18518,Blood biochemistry processing,"431,525",Categorical (single),Both sexes,Jun 2018,"444,902",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30814,Phosphate correction reason,18518,Blood biochemistry processing,"431,525",Categorical (single),Both sexes,Jun 2018,"444,902",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30815,Phosphate missing reason,18518,Blood biochemistry processing,"66,048",Categorical (single),Both sexes,Jun 2018,"66,523",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30816,Phosphate reportability,18518,Blood biochemistry processing,"431,537",Categorical (single),Both sexes,Jun 2018,"444,914",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30822,Rheumatoid factor aliquot,18518,Blood biochemistry processing,"473,828",Categorical (single),Both sexes,Jun 2018,"491,169",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30821,Rheumatoid factor assay date,18518,Blood biochemistry processing,"474,037",Date,Both sexes,Jun 2018,"491,390",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30823,Rheumatoid factor correction level,18518,Blood biochemistry processing,"41,989",Categorical (single),Both sexes,Jun 2018,"42,998",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30824,Rheumatoid factor correction reason,18518,Blood biochemistry processing,"41,989",Categorical (single),Both sexes,Jun 2018,"42,998",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30825,Rheumatoid factor missing reason,18518,Blood biochemistry processing,"451,503",Categorical (single),Both sexes,Jun 2018,"468,427",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30826,Rheumatoid factor reportability,18518,Blood biochemistry processing,"470,822",Categorical (single),Both sexes,Jun 2018,"487,498",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30832,SHBG aliquot,18518,Blood biochemistry processing,"470,366",Categorical (single),Both sexes,Jun 2018,"487,065",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30831,SHBG assay date,18518,Blood biochemistry processing,"470,574",Date,Both sexes,Jun 2018,"487,285",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30833,SHBG correction level,18518,Blood biochemistry processing,"428,176",Categorical (single),Both sexes,Jun 2018,"441,306",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30834,SHBG correction reason,18518,Blood biochemistry processing,"428,176",Categorical (single),Both sexes,Jun 2018,"441,306",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30835,SHBG missing reason,18518,Blood biochemistry processing,"69,585",Categorical (single),Both sexes,Jun 2018,"70,119",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30836,SHBG reportability,18518,Blood biochemistry processing,"428,904",Categorical (single),Both sexes,Jun 2018,"442,061",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30852,Testosterone aliquot,18518,Blood biochemistry processing,"470,515",Categorical (single),Both sexes,Jun 2018,"487,204",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30851,Testosterone assay date,18518,Blood biochemistry processing,"470,727",Date,Both sexes,Jun 2018,"487,426",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30853,Testosterone correction level,18518,Blood biochemistry processing,"427,062",Categorical (single),Both sexes,Jun 2018,"441,249",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30854,Testosterone correction reason,18518,Blood biochemistry processing,"427,062",Categorical (single),Both sexes,Jun 2018,"441,249",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30855,Testosterone missing reason,18518,Blood biochemistry processing,"69,060",Categorical (single),Both sexes,Jun 2018,"70,176",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30856,Testosterone reportability,18518,Blood biochemistry processing,"467,043",Categorical (single),Both sexes,Jun 2018,"483,251",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30842,Total bilirubin aliquot,18518,Blood biochemistry processing,"474,313",Categorical (single),Both sexes,Jun 2018,"491,649",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30841,Total bilirubin assay date,18518,Blood biochemistry processing,"474,522",Date,Both sexes,Jun 2018,"491,870",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30843,Total bilirubin correction level,18518,Blood biochemistry processing,"468,886",Categorical (single),Both sexes,Jun 2018,"485,337",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30844,Total bilirubin correction reason,18518,Blood biochemistry processing,"468,886",Categorical (single),Both sexes,Jun 2018,"485,337",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30845,Total bilirubin missing reason,18518,Blood biochemistry processing,"26,006",Categorical (single),Both sexes,Jun 2018,"26,088",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30846,Total bilirubin reportability,18518,Blood biochemistry processing,"468,904",Categorical (single),Both sexes,Jun 2018,"485,355",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30862,Total protein aliquot,18518,Blood biochemistry processing,"474,154",Categorical (single),Both sexes,Jun 2018,"491,489",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30861,Total protein assay date,18518,Blood biochemistry processing,"474,363",Date,Both sexes,Jun 2018,"491,710",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30863,Total protein correction level,18518,Blood biochemistry processing,"431,871",Categorical (single),Both sexes,Jun 2018,"445,290",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30864,Total protein correction reason,18518,Blood biochemistry processing,"431,871",Categorical (single),Both sexes,Jun 2018,"445,290",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30865,Total protein missing reason,18518,Blood biochemistry processing,"65,662",Categorical (single),Both sexes,Jun 2018,"66,135",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30866,Total protein reportability,18518,Blood biochemistry processing,"431,888",Categorical (single),Both sexes,Jun 2018,"445,307",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30872,Triglycerides aliquot,18518,Blood biochemistry processing,"474,328",Categorical (single),Both sexes,Jun 2018,"491,669",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30871,Triglycerides assay date,18518,Blood biochemistry processing,"474,537",Date,Both sexes,Jun 2018,"491,890",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30873,Triglycerides correction level,18518,Blood biochemistry processing,"470,476",Categorical (single),Both sexes,Jun 2018,"487,060",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30874,Triglycerides correction reason,18518,Blood biochemistry processing,"470,476",Categorical (single),Both sexes,Jun 2018,"487,060",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30875,Triglycerides missing reason,18518,Blood biochemistry processing,"24,290",Categorical (single),Both sexes,Jun 2018,"24,365",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30876,Triglycerides reportability,18518,Blood biochemistry processing,"470,615",Categorical (single),Both sexes,Jun 2018,"487,202",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30882,Urate aliquot,18518,Blood biochemistry processing,"474,163",Categorical (single),Both sexes,Jun 2018,"491,483",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30881,Urate assay date,18518,Blood biochemistry processing,"474,372",Date,Both sexes,Jun 2018,"491,704",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30883,Urate correction level,18518,Blood biochemistry processing,"470,297",Categorical (single),Both sexes,Jun 2018,"486,856",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30884,Urate correction reason,18518,Blood biochemistry processing,"470,297",Categorical (single),Both sexes,Jun 2018,"486,856",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30885,Urate missing reason,18518,Blood biochemistry processing,"24,495",Categorical (single),Both sexes,Jun 2018,"24,569",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30886,Urate reportability,18518,Blood biochemistry processing,"470,428",Categorical (single),Both sexes,Jun 2018,"486,991",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30672,Urea aliquot,18518,Blood biochemistry processing,"474,355",Categorical (single),Both sexes,Jun 2018,"491,709",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30671,Urea assay date,18518,Blood biochemistry processing,"474,564",Date,Both sexes,Jun 2018,"491,930",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30673,Urea correction level,18518,Blood biochemistry processing,"470,538",Categorical (single),Both sexes,Jun 2018,"487,124",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30674,Urea correction reason,18518,Blood biochemistry processing,"470,538",Categorical (single),Both sexes,Jun 2018,"487,124",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30675,Urea missing reason,18518,Blood biochemistry processing,"24,227",Categorical (single),Both sexes,Jun 2018,"24,301",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30676,Urea reportability,18518,Blood biochemistry processing,"470,548",Categorical (single),Both sexes,Jun 2018,"487,134",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30892,Vitamin D aliquot,18518,Blood biochemistry processing,"474,357",Categorical (single),Both sexes,Jun 2018,"491,704",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30891,Vitamin D assay date,18518,Blood biochemistry processing,"474,567",Date,Both sexes,Jun 2018,"491,926",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30893,Vitamin D correction level,18518,Blood biochemistry processing,"449,954",Categorical (single),Both sexes,Jun 2018,"465,390",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30894,Vitamin D correction reason,18518,Blood biochemistry processing,"449,954",Categorical (single),Both sexes,Jun 2018,"465,390",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30895,Vitamin D missing reason,18518,Blood biochemistry processing,"45,590",Categorical (single),Both sexes,Jun 2018,"46,035",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30896,Vitamin D reportability,18518,Blood biochemistry processing,"452,518",Categorical (single),Both sexes,Jun 2018,"468,047",Data,Defined (2),Mar 2019,Accruing,Biological samples,Assay results,Blood assays,Blood biochemistry,Blood biochemistry processing,0.0,0.0,0.0,0.0,0.0
30160,Basophill count,100081,Blood count,"478,486","Continuous, 10^9 cells/Litre",Both sexes,Jan 2012,"502,544",Data,Defined (3),Mar 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30220,Basophill percentage,100081,Blood count,"478,491","Continuous, percent",Both sexes,Jan 2012,"502,551",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30150,Eosinophill count,100081,Blood count,"478,486","Continuous, 10^9 cells/Litre",Both sexes,Jan 2012,"502,544",Data,Defined (3),Mar 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30210,Eosinophill percentage,100081,Blood count,"478,491","Continuous, percent",Both sexes,Jan 2012,"502,551",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30030,Haematocrit percentage,100081,Blood count,"479,354","Continuous, percent",Both sexes,Jan 2012,"503,452",Data,Defined (3),Mar 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30020,Haemoglobin concentration,100081,Blood count,"479,353","Continuous, grams/decilitre",Both sexes,Jan 2012,"503,452",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30300,High light scatter reticulocyte count,100081,Blood count,"471,039","Continuous, 10^12 cells/Litre",Both sexes,Jan 2012,"489,146",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30290,High light scatter reticulocyte percentage,100081,Blood count,"471,040","Continuous, percent",Both sexes,Jan 2012,"489,147",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30280,Immature reticulocyte fraction,100081,Blood count,"471,038","Continuous, ratio",Both sexes,Jan 2012,"489,145",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30120,Lymphocyte count,100081,Blood count,"478,486","Continuous, 10^9 cells/Litre",Both sexes,Jan 2012,"502,544",Data,Defined (3),Mar 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30180,Lymphocyte percentage,100081,Blood count,"478,491","Continuous, percent",Both sexes,Jan 2012,"502,551",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30050,Mean corpuscular haemoglobin,100081,Blood count,"479,350","Continuous, picograms",Both sexes,Jan 2012,"503,446",Data,Defined (3),Mar 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30060,Mean corpuscular haemoglobin concentration,100081,Blood count,"479,347","Continuous, grams/decilitre",Both sexes,Jan 2012,"503,442",Data,Defined (3),Mar 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30040,Mean corpuscular volume,100081,Blood count,"479,353","Continuous, femtolitres",Both sexes,Jan 2012,"503,450",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30100,Mean platelet (thrombocyte) volume,100081,Blood count,"479,345","Continuous, femtolitres",Both sexes,Jan 2012,"503,442",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30260,Mean reticulocyte volume,100081,Blood count,"471,299","Continuous, femtolitres",Both sexes,Jan 2012,"494,716",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30270,Mean sphered cell volume,100081,Blood count,"471,040","Continuous, femtolitres",Both sexes,Jan 2012,"489,147",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30130,Monocyte count,100081,Blood count,"478,486","Continuous, 10^9 cells/Litre",Both sexes,Jan 2012,"502,544",Data,Defined (3),Mar 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30190,Monocyte percentage,100081,Blood count,"478,491","Continuous, percent",Both sexes,Jan 2012,"502,551",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30140,Neutrophill count,100081,Blood count,"478,486","Continuous, 10^9 cells/Litre",Both sexes,Jan 2012,"502,544",Data,Defined (3),Mar 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30200,Neutrophill percentage,100081,Blood count,"478,491","Continuous, percent",Both sexes,Jan 2012,"502,551",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30170,Nucleated red blood cell count,100081,Blood count,"478,260","Continuous, 10^9 cells/Litre",Both sexes,Jan 2012,"496,854",Data,Defined (3),Mar 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30230,Nucleated red blood cell percentage,100081,Blood count,"478,256","Continuous, percent",Both sexes,Jan 2012,"496,850",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30080,Platelet count,100081,Blood count,"479,350","Continuous, 10^9 cells/Litre",Both sexes,Jan 2012,"503,449",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30090,Platelet crit,100081,Blood count,"479,136","Continuous, percent",Both sexes,Jan 2012,"497,775",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30110,Platelet distribution width,100081,Blood count,"479,135","Continuous, percent",Both sexes,Jan 2012,"497,774",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30010,Red blood cell (erythrocyte) count,100081,Blood count,"479,354","Continuous, 10^12 cells/Litre",Both sexes,Jan 2012,"503,450",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30070,Red blood cell (erythrocyte) distribution width,100081,Blood count,"479,353","Continuous, percent",Both sexes,Jan 2012,"503,450",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30250,Reticulocyte count,100081,Blood count,"471,300","Continuous, 10^12 cells/Litre",Both sexes,Jan 2012,"494,716",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30240,Reticulocyte percentage,100081,Blood count,"471,300","Continuous, percent",Both sexes,Jan 2012,"494,715",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30000,White blood cell (leukocyte) count,100081,Blood count,"479,349","Continuous, 10^9 cells/Litre",Both sexes,Jan 2012,"503,446",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,0.0,0.0,0.0,0.0,0.0,0.0
30164,Basophill count acquisition route,9081,Blood count processing,"478,486",Categorical (single),Both sexes,Jan 2012,"502,544",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30162,Basophill count acquisition time,9081,Blood count processing,"478,486",Time,Both sexes,Jan 2012,"502,544",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30163,Basophill count device ID,9081,Blood count processing,"478,486",Text,Both sexes,Jan 2012,"502,544",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30161,Basophill count freeze-thaw cycles,9081,Blood count processing,"472,956",Integer,Both sexes,Jan 2012,"472,956",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30224,Basophill percentage acquisition route,9081,Blood count processing,"478,491",Categorical (single),Both sexes,Jan 2012,"502,551",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30222,Basophill percentage acquisition time,9081,Blood count processing,"478,491",Time,Both sexes,Jan 2012,"502,551",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30223,Basophill percentage device ID,9081,Blood count processing,"478,491",Text,Both sexes,Jan 2012,"502,551",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30221,Basophill percentage freeze-thaw cycles,9081,Blood count processing,"474,000",Integer,Both sexes,Jan 2012,"474,000",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30154,Eosinophill count acquisition route,9081,Blood count processing,"478,486",Categorical (single),Both sexes,Jan 2012,"502,544",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30152,Eosinophill count acquisition time,9081,Blood count processing,"478,486",Time,Both sexes,Jan 2012,"502,544",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30153,Eosinophill count device ID,9081,Blood count processing,"478,486",Text,Both sexes,Jan 2012,"502,544",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30151,Eosinophill count freeze-thaw cycles,9081,Blood count processing,"473,910",Integer,Both sexes,Jan 2012,"473,910",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30214,Eosinophill percentage acquisition route,9081,Blood count processing,"478,491",Categorical (single),Both sexes,Jan 2012,"502,551",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30212,Eosinophill percentage acquisition time,9081,Blood count processing,"478,491",Time,Both sexes,Jan 2012,"502,551",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30213,Eosinophill percentage device ID,9081,Blood count processing,"478,491",Text,Both sexes,Jan 2012,"502,551",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30211,Eosinophill percentage freeze-thaw cycles,9081,Blood count processing,"474,016",Integer,Both sexes,Jan 2012,"474,016",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30032,Haematocrit acquisition time,9081,Blood count processing,"479,354",Time,Both sexes,Jan 2012,"503,452",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30031,Haematocrit freeze-thaw cycles,9081,Blood count processing,"474,901",Integer,Both sexes,Jan 2012,"474,901",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30034,Haematocrit percentage acquisition route,9081,Blood count processing,"479,354",Categorical (single),Both sexes,Jan 2012,"503,452",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30033,Haematocrit percentage device ID,9081,Blood count processing,"479,354",Text,Both sexes,Jan 2012,"503,452",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30024,Haemoglobin concentration acquisition route,9081,Blood count processing,"479,353",Categorical (single),Both sexes,Jan 2012,"503,452",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30022,Haemoglobin concentration acquisition time,9081,Blood count processing,"479,353",Time,Both sexes,Jan 2012,"503,452",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30023,Haemoglobin concentration device ID,9081,Blood count processing,"479,353",Text,Both sexes,Jan 2012,"503,452",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30021,Haemoglobin concentration freeze-thaw cycles,9081,Blood count processing,"474,901",Integer,Both sexes,Jan 2012,"474,901",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30304,High light scatter reticulocyte count acquisition route,9081,Blood count processing,"471,039",Categorical (single),Both sexes,Jan 2012,"489,146",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30302,High light scatter reticulocyte count acquisition time,9081,Blood count processing,"471,039",Time,Both sexes,Jan 2012,"489,146",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30303,High light scatter reticulocyte count device ID,9081,Blood count processing,"471,039",Text,Both sexes,Jan 2012,"489,146",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30301,High light scatter reticulocyte count freeze-thaw cycles,9081,Blood count processing,"466,722",Integer,Both sexes,Jan 2012,"466,722",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30294,High light scatter reticulocyte percentage acquisition route,9081,Blood count processing,"471,040",Categorical (single),Both sexes,Jan 2012,"489,147",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30292,High light scatter reticulocyte percentage acquisition time,9081,Blood count processing,"471,040",Time,Both sexes,Jan 2012,"489,147",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30293,High light scatter reticulocyte percentage device ID,9081,Blood count processing,"471,040",Text,Both sexes,Jan 2012,"489,147",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30291,High light scatter reticulocyte percentage freeze-thaw cycles,9081,Blood count processing,"466,723",Integer,Both sexes,Jan 2012,"466,723",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30284,Immature reticulocyte fraction acquisition route,9081,Blood count processing,"471,038",Categorical (single),Both sexes,Jan 2012,"489,145",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30282,Immature reticulocyte fraction acquisition time,9081,Blood count processing,"471,038",Time,Both sexes,Jan 2012,"489,145",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30283,Immature reticulocyte fraction device ID,9081,Blood count processing,"471,038",Text,Both sexes,Jan 2012,"489,145",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30281,Immature reticulocyte fraction freeze-thaw cycles,9081,Blood count processing,"466,721",Integer,Both sexes,Jan 2012,"466,721",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30124,Lymphocyte count acquisition route,9081,Blood count processing,"478,486",Categorical (single),Both sexes,Jan 2012,"502,544",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30122,Lymphocyte count acquisition time,9081,Blood count processing,"478,486",Time,Both sexes,Jan 2012,"502,544",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30123,Lymphocyte count device ID,9081,Blood count processing,"478,486",Text,Both sexes,Jan 2012,"502,544",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30121,Lymphocyte count freeze-thaw cycles,9081,Blood count processing,"474,014",Integer,Both sexes,Jan 2012,"474,014",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30184,Lymphocyte percentage acquisition route,9081,Blood count processing,"478,491",Categorical (single),Both sexes,Jan 2012,"502,551",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30182,Lymphocyte percentage acquisition time,9081,Blood count processing,"478,491",Time,Both sexes,Jan 2012,"502,551",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30183,Lymphocyte percentage device ID,9081,Blood count processing,"478,491",Text,Both sexes,Jan 2012,"502,551",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30181,Lymphocyte percentage freeze-thaw cycles,9081,Blood count processing,"474,020",Integer,Both sexes,Jan 2012,"474,020",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30054,Mean corpuscular haemoglobin acquisition route,9081,Blood count processing,"479,350",Categorical (single),Both sexes,Jan 2012,"503,446",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30052,Mean corpuscular haemoglobin acquisition time,9081,Blood count processing,"479,350",Time,Both sexes,Jan 2012,"503,446",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30064,Mean corpuscular haemoglobin concentration acquisition route,9081,Blood count processing,"479,347",Categorical (single),Both sexes,Jan 2012,"503,442",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30062,Mean corpuscular haemoglobin concentration acquisition time,9081,Blood count processing,"479,347",Time,Both sexes,Jan 2012,"503,442",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30063,Mean corpuscular haemoglobin concentration device ID,9081,Blood count processing,"479,347",Text,Both sexes,Jan 2012,"503,442",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30061,Mean corpuscular haemoglobin concentration freeze-thaw cycles,9081,Blood count processing,"474,894",Integer,Both sexes,Jan 2012,"474,894",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30053,Mean corpuscular haemoglobin device ID,9081,Blood count processing,"479,350",Text,Both sexes,Jan 2012,"503,446",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30051,Mean corpuscular haemoglobin freeze-thaw cycles,9081,Blood count processing,"474,898",Integer,Both sexes,Jan 2012,"474,898",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30044,Mean corpuscular volume acquisition route,9081,Blood count processing,"479,353",Categorical (single),Both sexes,Jan 2012,"503,450",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30042,Mean corpuscular volume acquisition time,9081,Blood count processing,"479,353",Time,Both sexes,Jan 2012,"503,450",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30043,Mean corpuscular volume device ID,9081,Blood count processing,"479,353",Text,Both sexes,Jan 2012,"503,450",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30041,Mean corpuscular volume freeze-thaw cycles,9081,Blood count processing,"474,899",Integer,Both sexes,Jan 2012,"474,899",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30104,Mean platelet (thrombocyte) volume acquisition route,9081,Blood count processing,"479,345",Categorical (single),Both sexes,Jan 2012,"503,442",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30102,Mean platelet (thrombocyte) volume acquisition time,9081,Blood count processing,"479,345",Time,Both sexes,Jan 2012,"503,442",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30103,Mean platelet (thrombocyte) volume device ID,9081,Blood count processing,"479,345",Text,Both sexes,Jan 2012,"503,442",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30101,Mean platelet (thrombocyte) volume freeze-thaw cycles,9081,Blood count processing,"474,893",Integer,Both sexes,Jan 2012,"474,893",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30264,Mean reticulocyte volume acquisition route,9081,Blood count processing,"471,299",Categorical (single),Both sexes,Jan 2012,"494,716",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30262,Mean reticulocyte volume acquisition time,9081,Blood count processing,"471,299",Time,Both sexes,Jan 2012,"494,716",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30263,Mean reticulocyte volume device ID,9081,Blood count processing,"471,299",Text,Both sexes,Jan 2012,"494,716",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30261,Mean reticulocyte volume freeze-thaw cycles,9081,Blood count processing,"466,721",Integer,Both sexes,Jan 2012,"466,721",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30274,Mean sphered cell volume acquisition route,9081,Blood count processing,"471,040",Categorical (single),Both sexes,Jan 2012,"489,147",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30272,Mean sphered cell volume acquisition time,9081,Blood count processing,"471,040",Time,Both sexes,Jan 2012,"489,147",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30273,Mean sphered cell volume device ID,9081,Blood count processing,"471,040",Text,Both sexes,Jan 2012,"489,147",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30271,Mean sphered cell volume freeze-thaw cycles,9081,Blood count processing,"466,723",Integer,Both sexes,Jan 2012,"466,723",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30134,Monocyte count acquisition route,9081,Blood count processing,"478,486",Categorical (single),Both sexes,Jan 2012,"502,544",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30132,Monocyte count acquisition time,9081,Blood count processing,"478,486",Time,Both sexes,Jan 2012,"502,544",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30133,Monocyte count device ID,9081,Blood count processing,"478,486",Text,Both sexes,Jan 2012,"502,544",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30131,Monocyte count freeze-thaw cycles,9081,Blood count processing,"474,008",Integer,Both sexes,Jan 2012,"474,008",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30194,Monocyte percentage acquisition route,9081,Blood count processing,"478,491",Categorical (single),Both sexes,Jan 2012,"502,551",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30192,Monocyte percentage acquisition time,9081,Blood count processing,"478,491",Time,Both sexes,Jan 2012,"502,551",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30193,Monocyte percentage device ID,9081,Blood count processing,"478,491",Text,Both sexes,Jan 2012,"502,551",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30191,Monocyte percentage freeze-thaw cycles,9081,Blood count processing,"474,019",Integer,Both sexes,Jan 2012,"474,019",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30144,Neutrophill count acquisition route,9081,Blood count processing,"478,486",Categorical (single),Both sexes,Jan 2012,"502,544",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30142,Neutrophill count acquisition time,9081,Blood count processing,"478,486",Time,Both sexes,Jan 2012,"502,544",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30143,Neutrophill count device ID,9081,Blood count processing,"478,486",Text,Both sexes,Jan 2012,"502,544",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30141,Neutrophill count freeze-thaw cycles,9081,Blood count processing,"474,014",Integer,Both sexes,Jan 2012,"474,014",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30204,Neutrophill percentage acquisition route,9081,Blood count processing,"478,491",Categorical (single),Both sexes,Jan 2012,"502,551",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30202,Neutrophill percentage acquisition time,9081,Blood count processing,"478,491",Time,Both sexes,Jan 2012,"502,551",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30203,Neutrophill percentage device ID,9081,Blood count processing,"478,491",Text,Both sexes,Jan 2012,"502,551",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30201,Neutrophill percentage freeze-thaw cycles,9081,Blood count processing,"474,020",Integer,Both sexes,Jan 2012,"474,020",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30174,Nucleated red blood cell count acquisition route,9081,Blood count processing,"478,260",Categorical (single),Both sexes,Jan 2012,"496,854",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30172,Nucleated red blood cell count acquisition time,9081,Blood count processing,"478,260",Time,Both sexes,Jan 2012,"496,854",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30173,Nucleated red blood cell count device ID,9081,Blood count processing,"478,260",Text,Both sexes,Jan 2012,"496,854",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30171,Nucleated red blood cell count freeze-thaw cycles,9081,Blood count processing,"472,674",Integer,Both sexes,Jan 2012,"472,674",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30234,Nucleated red blood cell percentage acquisition route,9081,Blood count processing,"478,261",Categorical (single),Both sexes,Jan 2012,"496,855",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30232,Nucleated red blood cell percentage acquisition time,9081,Blood count processing,"478,261",Time,Both sexes,Jan 2012,"496,855",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30233,Nucleated red blood cell percentage device ID,9081,Blood count processing,"478,261",Text,Both sexes,Jan 2012,"496,855",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30231,Nucleated red blood cell percentage freeze-thaw cycles,9081,Blood count processing,"472,675",Integer,Both sexes,Jan 2012,"472,675",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30084,Platelet count acquisition route,9081,Blood count processing,"479,350",Categorical (single),Both sexes,Jan 2012,"503,449",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30082,Platelet count acquisition time,9081,Blood count processing,"479,350",Time,Both sexes,Jan 2012,"503,449",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30083,Platelet count device ID,9081,Blood count processing,"479,350",Text,Both sexes,Jan 2012,"503,449",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30081,Platelet count freeze-thaw cycles,9081,Blood count processing,"474,898",Integer,Both sexes,Jan 2012,"474,898",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30094,Platelet crit acquisition route,9081,Blood count processing,"479,136",Categorical (single),Both sexes,Jan 2012,"497,775",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30092,Platelet crit acquisition time,9081,Blood count processing,"479,136",Time,Both sexes,Jan 2012,"497,775",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30093,Platelet crit device ID,9081,Blood count processing,"479,136",Text,Both sexes,Jan 2012,"497,775",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30091,Platelet crit freeze-thaw cycles,9081,Blood count processing,"474,894",Integer,Both sexes,Jan 2012,"474,894",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30114,Platelet distribution width acquisition route,9081,Blood count processing,"479,135",Categorical (single),Both sexes,Jan 2012,"497,774",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30112,Platelet distribution width acquisition time,9081,Blood count processing,"479,135",Time,Both sexes,Jan 2012,"497,774",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30113,Platelet distribution width device ID,9081,Blood count processing,"479,135",Text,Both sexes,Jan 2012,"497,774",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30111,Platelet distribution width freeze-thaw cycles,9081,Blood count processing,"474,893",Integer,Both sexes,Jan 2012,"474,893",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30014,Red blood cell (erythrocyte) count acquisition route,9081,Blood count processing,"479,354",Categorical (single),Both sexes,Jan 2012,"503,450",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30012,Red blood cell (erythrocyte) count acquisition time,9081,Blood count processing,"479,354",Time,Both sexes,Jan 2012,"503,450",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30013,Red blood cell (erythrocyte) count device ID,9081,Blood count processing,"479,354",Text,Both sexes,Jan 2012,"503,450",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30011,Red blood cell (erythrocyte) count freeze-thaw cycles,9081,Blood count processing,"474,901",Integer,Both sexes,Jan 2012,"474,901",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30074,Red blood cell (erythrocyte) distribution width acquisition route,9081,Blood count processing,"479,353",Categorical (single),Both sexes,Jan 2012,"503,450",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30072,Red blood cell (erythrocyte) distribution width acquisition time,9081,Blood count processing,"479,353",Time,Both sexes,Jan 2012,"503,450",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30073,Red blood cell (erythrocyte) distribution width device ID,9081,Blood count processing,"479,353",Text,Both sexes,Jan 2012,"503,450",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30071,Red blood cell (erythrocyte) distribution width freeze-thaw cycles,9081,Blood count processing,"474,899",Integer,Both sexes,Jan 2012,"474,899",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30254,Reticulocyte count acquisition route,9081,Blood count processing,"471,300",Categorical (single),Both sexes,Jan 2012,"494,716",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30252,Reticulocyte count acquisition time,9081,Blood count processing,"471,300",Time,Both sexes,Jan 2012,"494,716",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30253,Reticulocyte count device ID,9081,Blood count processing,"471,300",Text,Both sexes,Jan 2012,"494,716",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30251,Reticulocyte count freeze-thaw cycles,9081,Blood count processing,"466,722",Integer,Both sexes,Jan 2012,"466,722",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30244,Reticulocyte percentage acquisition route,9081,Blood count processing,"471,300",Categorical (single),Both sexes,Jan 2012,"494,715",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30242,Reticulocyte percentage acquisition time,9081,Blood count processing,"471,300",Time,Both sexes,Jan 2012,"494,715",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30243,Reticulocyte percentage device ID,9081,Blood count processing,"471,300",Text,Both sexes,Jan 2012,"494,715",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30241,Reticulocyte percentage freeze-thaw cycles,9081,Blood count processing,"466,722",Integer,Both sexes,Jan 2012,"466,722",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30004,White blood cell (leukocyte) count acquisition route,9081,Blood count processing,"479,349",Categorical (single),Both sexes,Jan 2012,"503,446",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30002,White blood cell (leukocyte) count acquisition time,9081,Blood count processing,"479,349",Time,Both sexes,Jan 2012,"503,446",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30003,White blood cell (leukocyte) count device ID,9081,Blood count processing,"479,349",Text,Both sexes,Jan 2012,"503,446",Data,Defined (3),Feb 2016,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
30001,White blood cell (leukocyte) count freeze-thaw cycles,9081,Blood count processing,"474,896",Integer,Both sexes,Jan 2012,"474,896",Data,Defined (1),Mar 2012,Complete,Biological samples,Assay results,Blood assays,Blood count,Blood count processing,0.0,0.0,0.0,0.0,0.0
36,Blood pressure device ID,100011,Blood pressure,"498,751",Text,Both sexes,Jan 2012,"562,916",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Blood pressure,0.0,0.0,0.0,0.0,0.0,0.0,0.0
37,Blood pressure manual sphygmomanometer device ID,100011,Blood pressure,"498,751",Text,Both sexes,Jan 2012,"562,916",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Blood pressure,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4079,"Diastolic blood pressure, automated reading",100011,Blood pressure,"475,129","Integer, mmHg",Both sexes,Jan 2012,"1,050,361",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Blood pressure,0.0,0.0,0.0,0.0,0.0,0.0,0.0
94,"Diastolic blood pressure, manual reading",100011,Blood pressure,"48,794","Integer, mmHg",Both sexes,Jan 2012,"80,973",Data,Defined (4),Jan 2020,Complete,UK Biobank Assessment Centre,Physical measures,Blood pressure,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4081,Method of measuring blood pressure,100011,Blood pressure,"501,656",Categorical (single),Both sexes,Jan 2012,"1,132,684",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Blood pressure,0.0,0.0,0.0,0.0,0.0,0.0,0.0
95,Pulse rate (during blood-pressure measurement),100011,Blood pressure,"48,794",Integer,Both sexes,Jan 2012,"80,973",Data,Defined (4),Jan 2020,Complete,UK Biobank Assessment Centre,Physical measures,Blood pressure,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102,"Pulse rate, automated reading",100011,Blood pressure,"475,129","Integer, bpm",Both sexes,Jan 2012,"1,050,361",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Blood pressure,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4080,"Systolic blood pressure, automated reading",100011,Blood pressure,"475,124","Integer, mmHg",Both sexes,Jan 2012,"1,050,331",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Blood pressure,0.0,0.0,0.0,0.0,0.0,0.0,0.0
93,"Systolic blood pressure, manual reading",100011,Blood pressure,"48,794","Integer, mmHg",Both sexes,Jan 2012,"80,973",Data,Defined (4),Jan 2020,Complete,UK Biobank Assessment Centre,Physical measures,Blood pressure,0.0,0.0,0.0,0.0,0.0,0.0,0.0
96,Time since interview start at which blood pressure screen(s) shown,100011,Blood pressure,"501,656","Integer, seconds",Both sexes,Jan 2012,"1,132,684",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Blood pressure,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20049,"Blood sample #, note contents",100002,Blood sample collection,"11,387",Categorical (single),Both sexes,Aug 2012,"34,926",Data,Defined (1),Aug 2012,Complete,UK Biobank Assessment Centre,Biological sampling,Blood sample collection,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20050,Reason blood sampling not attempted,100002,Blood sample collection,"1,583",Categorical (single),Both sexes,Aug 2012,"1,583",Data,Defined (1),Aug 2012,Complete,UK Biobank Assessment Centre,Biological sampling,Blood sample collection,0.0,0.0,0.0,0.0,0.0,0.0,0.0
35,Was blood sampling attempted,100002,Blood sample collection,"501,327",Categorical (single),Both sexes,Jan 2012,"571,519",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Biological sampling,Blood sample collection,0.0,0.0,0.0,0.0,0.0,0.0,0.0
68,Number of blood samples taken,100002,Blood sample collection,"501,327",Integer,Both sexes,Jan 2012,"571,519",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Biological sampling,Blood sample collection,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3166,Time blood sample collected,100002,Blood sample collection,"498,074",Time,Both sexes,Jan 2012,"3,457,580",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Biological sampling,Blood sample collection,0.0,0.0,0.0,0.0,0.0,0.0,0.0
74,Fasting time,100002,Blood sample collection,"501,311","Integer, hours",Both sexes,Jan 2012,"571,495",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Biological sampling,Blood sample collection,0.0,0.0,0.0,0.0,0.0,0.0,0.0
30404,Volume of ACD held by UKB,100085,Blood sample inventory,"483,646","Integer, microlitres",Both sexes,Jan 2012,"498,648",Samples,Defined (2),Jun 2014,Updateable,Biological samples,Sample inventory,Blood sample inventory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
40425,Volume of DNA held by UKB,100085,Blood sample inventory,"171,000","Integer, microlitres",Both sexes,Feb 2014,"171,000",Samples,Defined (2),Jun 2014,Ongoing,Biological samples,Sample inventory,Blood sample inventory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
30334,Volume of EDTA1 buffy held by UKB,100085,Blood sample inventory,"486,021","Integer, microlitres",Both sexes,Jan 2012,"501,261",Samples,Defined (2),Jun 2014,Updateable,Biological samples,Sample inventory,Blood sample inventory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
30314,Volume of EDTA1 plasma held by UKB,100085,Blood sample inventory,"486,309","Integer, microlitres",Both sexes,Jan 2012,"501,551",Samples,Defined (2),Jun 2014,Updateable,Biological samples,Sample inventory,Blood sample inventory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
30324,Volume of EDTA1 red cells held by UKB,100085,Blood sample inventory,"486,090","Integer, microlitres",Both sexes,Jan 2012,"501,322",Samples,Defined (2),Jun 2014,Updateable,Biological samples,Sample inventory,Blood sample inventory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
30354,Volume of EDTA2 buffy held by UKB,100085,Blood sample inventory,"480,198","Integer, microlitres",Both sexes,Jan 2012,"495,200",Samples,Defined (2),Jun 2014,Updateable,Biological samples,Sample inventory,Blood sample inventory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
30344,Volume of EDTA2 plasma held by UKB,100085,Blood sample inventory,"480,366","Integer, microlitres",Both sexes,Jan 2012,"495,399",Samples,Defined (2),Jun 2014,Updateable,Biological samples,Sample inventory,Blood sample inventory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
30364,Volume of EDTA2 red cells held by UKB,100085,Blood sample inventory,"480,177","Integer, microlitres",Both sexes,Jan 2012,"495,177",Samples,Defined (2),Jun 2014,Updateable,Biological samples,Sample inventory,Blood sample inventory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
30374,Volume of Li-Hep plasma held by UKB,100085,Blood sample inventory,"487,674","Integer, microlitres",Both sexes,Jan 2012,"502,807",Samples,Defined (2),Jun 2014,Updateable,Biological samples,Sample inventory,Blood sample inventory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
30414,Volume of RNA held by UKB,100085,Blood sample inventory,"128,007","Integer, microlitres",Both sexes,Jan 2012,"131,336",Samples,Defined (2),Jun 2014,Updateable,Biological samples,Sample inventory,Blood sample inventory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
30384,Volume of serum held by UKB,100085,Blood sample inventory,"485,897","Integer, microlitres",Both sexes,Jan 2012,"501,035",Samples,Defined (2),Jun 2014,Updateable,Biological samples,Sample inventory,Blood sample inventory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130622,Date D50 first reported (iron deficiency anaemia),2403,"Blood, blood-forming organs and certain immune disorders","22,089",Date,Both sexes,Jul 2019,"22,089",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130623,Source of report of D50 (iron deficiency anaemia),2403,"Blood, blood-forming organs and certain immune disorders","22,089",Categorical (single),Both sexes,Jul 2019,"22,089",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130624,Date D51 first reported (vitamin b12 deficiency anaemia),2403,"Blood, blood-forming organs and certain immune disorders","3,272",Date,Both sexes,Jul 2019,"3,272",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130625,Source of report of D51 (vitamin b12 deficiency anaemia),2403,"Blood, blood-forming organs and certain immune disorders","3,272",Categorical (single),Both sexes,Jul 2019,"3,272",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130626,Date D52 first reported (folate deficiency anaemia),2403,"Blood, blood-forming organs and certain immune disorders",510,Date,Both sexes,Jul 2019,510,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130627,Source of report of D52 (folate deficiency anaemia),2403,"Blood, blood-forming organs and certain immune disorders",510,Categorical (single),Both sexes,Jul 2019,510,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130628,Date D53 first reported (other nutritional anaemias),2403,"Blood, blood-forming organs and certain immune disorders",189,Date,Both sexes,Jul 2019,189,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130629,Source of report of D53 (other nutritional anaemias),2403,"Blood, blood-forming organs and certain immune disorders",189,Categorical (single),Both sexes,Jul 2019,189,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130630,Date D55 first reported (anaemia due to enzyme disorders),2403,"Blood, blood-forming organs and certain immune disorders",26,Date,Both sexes,Jul 2019,26,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130631,Source of report of D55 (anaemia due to enzyme disorders),2403,"Blood, blood-forming organs and certain immune disorders",26,Categorical (single),Both sexes,Jul 2019,26,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130632,Date D56 first reported (thalassaemia),2403,"Blood, blood-forming organs and certain immune disorders",633,Date,Both sexes,Jul 2019,633,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130633,Source of report of D56 (thalassaemia),2403,"Blood, blood-forming organs and certain immune disorders",633,Categorical (single),Both sexes,Jul 2019,633,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130634,Date D57 first reported (sickle-cell disorders),2403,"Blood, blood-forming organs and certain immune disorders",570,Date,Both sexes,Jul 2019,570,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130635,Source of report of D57 (sickle-cell disorders),2403,"Blood, blood-forming organs and certain immune disorders",570,Categorical (single),Both sexes,Jul 2019,570,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130636,Date D58 first reported (other hereditary haemolytic anaemias),2403,"Blood, blood-forming organs and certain immune disorders",212,Date,Both sexes,Jul 2019,212,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130637,Source of report of D58 (other hereditary haemolytic anaemias),2403,"Blood, blood-forming organs and certain immune disorders",212,Categorical (single),Both sexes,Jul 2019,212,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130638,Date D59 first reported (acquired haemolytic anaemia),2403,"Blood, blood-forming organs and certain immune disorders",275,Date,Both sexes,Jul 2019,275,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130639,Source of report of D59 (acquired haemolytic anaemia),2403,"Blood, blood-forming organs and certain immune disorders",275,Categorical (single),Both sexes,Jul 2019,275,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130640,Date D60 first reported (acquired pure red cell aplasia [erythroblastopenia]),2403,"Blood, blood-forming organs and certain immune disorders",18,Date,Both sexes,Jul 2019,18,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130641,Source of report of D60 (acquired pure red cell aplasia [erythroblastopenia]),2403,"Blood, blood-forming organs and certain immune disorders",18,Categorical (single),Both sexes,Jul 2019,18,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130642,Date D61 first reported (other aplastic anaemias),2403,"Blood, blood-forming organs and certain immune disorders",984,Date,Both sexes,Jul 2019,984,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130643,Source of report of D61 (other aplastic anaemias),2403,"Blood, blood-forming organs and certain immune disorders",984,Categorical (single),Both sexes,Jul 2019,984,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130644,Date D62 first reported (acute posthaemorrhagic anaemia),2403,"Blood, blood-forming organs and certain immune disorders",371,Date,Both sexes,Jul 2019,371,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130645,Source of report of D62 (acute posthaemorrhagic anaemia),2403,"Blood, blood-forming organs and certain immune disorders",371,Categorical (single),Both sexes,Jul 2019,371,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130646,Date D63 first reported (anaemia in chronic diseases classified elsewhere),2403,"Blood, blood-forming organs and certain immune disorders","1,167",Date,Both sexes,Jul 2019,"1,167",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130647,Source of report of D63 (anaemia in chronic diseases classified elsewhere),2403,"Blood, blood-forming organs and certain immune disorders","1,167",Categorical (single),Both sexes,Jul 2019,"1,167",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130648,Date D64 first reported (other anaemias),2403,"Blood, blood-forming organs and certain immune disorders","22,327",Date,Both sexes,Jul 2019,"22,327",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130649,Source of report of D64 (other anaemias),2403,"Blood, blood-forming organs and certain immune disorders","22,327",Categorical (single),Both sexes,Jul 2019,"22,327",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130650,Date D65 first reported (disseminated intravascular coagulation [defibrination syndrome]),2403,"Blood, blood-forming organs and certain immune disorders",62,Date,Both sexes,Jul 2019,62,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130651,Source of report of D65 (disseminated intravascular coagulation [defibrination syndrome]),2403,"Blood, blood-forming organs and certain immune disorders",62,Categorical (single),Both sexes,Jul 2019,62,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130652,Date D66 first reported (hereditary factor viii deficiency),2403,"Blood, blood-forming organs and certain immune disorders",133,Date,Both sexes,Jul 2019,133,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130653,Source of report of D66 (hereditary factor viii deficiency),2403,"Blood, blood-forming organs and certain immune disorders",133,Categorical (single),Both sexes,Jul 2019,133,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130654,Date D67 first reported (hereditary factor ix deficiency),2403,"Blood, blood-forming organs and certain immune disorders",23,Date,Both sexes,Jul 2019,23,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130655,Source of report of D67 (hereditary factor ix deficiency),2403,"Blood, blood-forming organs and certain immune disorders",23,Categorical (single),Both sexes,Jul 2019,23,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130656,Date D68 first reported (other coagulation defects),2403,"Blood, blood-forming organs and certain immune disorders","2,161",Date,Both sexes,Jul 2019,"2,161",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130657,Source of report of D68 (other coagulation defects),2403,"Blood, blood-forming organs and certain immune disorders","2,161",Categorical (single),Both sexes,Jul 2019,"2,161",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130658,Date D69 first reported (purpura and other haemorrhagic conditions),2403,"Blood, blood-forming organs and certain immune disorders","3,716",Date,Both sexes,Jul 2019,"3,716",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130659,Source of report of D69 (purpura and other haemorrhagic conditions),2403,"Blood, blood-forming organs and certain immune disorders","3,716",Categorical (single),Both sexes,Jul 2019,"3,716",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130660,Date D70 first reported (agranulocytosis),2403,"Blood, blood-forming organs and certain immune disorders","5,380",Date,Both sexes,Jul 2019,"5,380",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130661,Source of report of D70 (agranulocytosis),2403,"Blood, blood-forming organs and certain immune disorders","5,380",Categorical (single),Both sexes,Jul 2019,"5,380",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130662,Date D71 first reported (functional disorders of polymorphonuclear neutrophils),2403,"Blood, blood-forming organs and certain immune disorders",29,Date,Both sexes,Jul 2019,29,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130663,Source of report of D71 (functional disorders of polymorphonuclear neutrophils),2403,"Blood, blood-forming organs and certain immune disorders",29,Categorical (single),Both sexes,Jul 2019,29,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130664,Date D72 first reported (other disorders of white blood cells),2403,"Blood, blood-forming organs and certain immune disorders","1,013",Date,Both sexes,Jul 2019,"1,013",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130665,Source of report of D72 (other disorders of white blood cells),2403,"Blood, blood-forming organs and certain immune disorders","1,013",Categorical (single),Both sexes,Jul 2019,"1,013",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130666,Date D73 first reported (diseases of spleen),2403,"Blood, blood-forming organs and certain immune disorders",808,Date,Both sexes,Jul 2019,808,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130667,Source of report of D73 (diseases of spleen),2403,"Blood, blood-forming organs and certain immune disorders",808,Categorical (single),Both sexes,Jul 2019,808,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130668,Date D74 first reported (methaemoglobinaemia),2403,"Blood, blood-forming organs and certain immune disorders",4,Date,Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130669,Source of report of D74 (methaemoglobinaemia),2403,"Blood, blood-forming organs and certain immune disorders",4,Categorical (single),Both sexes,Jul 2019,4,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130670,Date D75 first reported (other diseases of blood and blood-forming organs),2403,"Blood, blood-forming organs and certain immune disorders","2,014",Date,Both sexes,Jul 2019,"2,014",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130671,Source of report of D75 (other diseases of blood and blood-forming organs),2403,"Blood, blood-forming organs and certain immune disorders","2,014",Categorical (single),Both sexes,Jul 2019,"2,014",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130672,Date D76 first reported (certain diseases involving lymphoreticular tissue and reticulohistiocytic system),2403,"Blood, blood-forming organs and certain immune disorders",109,Date,Both sexes,Jul 2019,109,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130673,Source of report of D76 (certain diseases involving lymphoreticular tissue and reticulohistiocytic system),2403,"Blood, blood-forming organs and certain immune disorders",109,Categorical (single),Both sexes,Jul 2019,109,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130674,Date D77 first reported (other disorders of blood and blood-forming organs in diseases classified elsewhere),2403,"Blood, blood-forming organs and certain immune disorders",5,Date,Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130675,Source of report of D77 (other disorders of blood and blood-forming organs in diseases classified elsewhere),2403,"Blood, blood-forming organs and certain immune disorders",5,Categorical (single),Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130676,Date D80 first reported (immunodeficiency with predominantly antibody defects),2403,"Blood, blood-forming organs and certain immune disorders",290,Date,Both sexes,Jul 2019,290,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130677,Source of report of D80 (immunodeficiency with predominantly antibody defects),2403,"Blood, blood-forming organs and certain immune disorders",290,Categorical (single),Both sexes,Jul 2019,290,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130678,Date D81 first reported (combined immunodeficiencies),2403,"Blood, blood-forming organs and certain immune disorders",14,Date,Both sexes,Jul 2019,14,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130679,Source of report of D81 (combined immunodeficiencies),2403,"Blood, blood-forming organs and certain immune disorders",14,Categorical (single),Both sexes,Jul 2019,14,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130680,Date D82 first reported (immunodeficiency associated with other major defects),2403,"Blood, blood-forming organs and certain immune disorders",40,Date,Both sexes,Jul 2019,40,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130681,Source of report of D82 (immunodeficiency associated with other major defects),2403,"Blood, blood-forming organs and certain immune disorders",40,Categorical (single),Both sexes,Jul 2019,40,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130682,Date D83 first reported (common variable immunodeficiency),2403,"Blood, blood-forming organs and certain immune disorders",43,Date,Both sexes,Jul 2019,43,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130683,Source of report of D83 (common variable immunodeficiency),2403,"Blood, blood-forming organs and certain immune disorders",43,Categorical (single),Both sexes,Jul 2019,43,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130684,Date D84 first reported (other immunodeficiencies),2403,"Blood, blood-forming organs and certain immune disorders",143,Date,Both sexes,Jul 2019,143,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130685,Source of report of D84 (other immunodeficiencies),2403,"Blood, blood-forming organs and certain immune disorders",143,Categorical (single),Both sexes,Jul 2019,143,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130686,Date D86 first reported (sarcoidosis),2403,"Blood, blood-forming organs and certain immune disorders","1,858",Date,Both sexes,Jul 2019,"1,858",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130687,Source of report of D86 (sarcoidosis),2403,"Blood, blood-forming organs and certain immune disorders","1,858",Categorical (single),Both sexes,Jul 2019,"1,858",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130688,"Date D89 first reported (other disorders involving the immune mechanism, not elsewhere classified)",2403,"Blood, blood-forming organs and certain immune disorders",584,Date,Both sexes,Jul 2019,584,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130689,"Source of report of D89 (other disorders involving the immune mechanism, not elsewhere classified)",2403,"Blood, blood-forming organs and certain immune disorders",584,Categorical (single),Both sexes,Jul 2019,584,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Blood, blood-forming organs and certain immune disorders",0.0,0.0,0.0,0.0,0.0,0.0,0.0
23244,Android bone mass,124,Body composition by DXA,"5,170","Integer, g",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23245,Android fat mass,124,Body composition by DXA,"5,170","Integer, g",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23246,Android lean mass,124,Body composition by DXA,"5,170","Integer, g",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23247,Android tissue fat percentage,124,Body composition by DXA,"5,170","Continuous, percent",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23248,Android total mass,124,Body composition by DXA,"5,170","Continuous, kg",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23249,Arm fat mass (left),124,Body composition by DXA,"4,350","Integer, g",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23253,Arm fat mass (right),124,Body composition by DXA,"4,350","Integer, g",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23250,Arm lean mass (left),124,Body composition by DXA,"4,350","Integer, g",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23254,Arm lean mass (right),124,Body composition by DXA,"4,350","Integer, g",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23251,Arm tissue fat percentage (left),124,Body composition by DXA,"4,350","Continuous, percent",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23255,Arm tissue fat percentage (right),124,Body composition by DXA,"4,350","Continuous, percent",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23252,Arm total mass (left),124,Body composition by DXA,"4,350","Continuous, kg",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23256,Arm total mass (right),124,Body composition by DXA,"4,350","Continuous, kg",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23257,Arms fat mass,124,Body composition by DXA,"5,170","Integer, g",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23258,Arms lean mass,124,Body composition by DXA,"5,170","Integer, g",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23259,Arms tissue fat percentage,124,Body composition by DXA,"5,170","Continuous, percent",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23260,Arms total mass,124,Body composition by DXA,"5,170","Continuous, kg",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23261,Gynoid bone mass,124,Body composition by DXA,"5,170","Integer, g",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23262,Gynoid fat mass,124,Body composition by DXA,"5,170","Integer, g",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23263,Gynoid lean mass,124,Body composition by DXA,"5,170","Integer, g",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23264,Gynoid tissue fat percentage,124,Body composition by DXA,"5,170","Continuous, percent",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23265,Gynoid total mass,124,Body composition by DXA,"5,170","Continuous, kg",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23266,Leg fat mass (left),124,Body composition by DXA,"4,350","Integer, g",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23270,Leg fat mass (right),124,Body composition by DXA,"4,350","Integer, g",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23267,Leg lean mass (left),124,Body composition by DXA,"4,350","Integer, g",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23271,Leg lean mass (right),124,Body composition by DXA,"4,350","Integer, g",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23268,Leg tissue fat percentage (left),124,Body composition by DXA,"4,350","Continuous, percent",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23272,Leg tissue fat percentage (right),124,Body composition by DXA,"4,350","Continuous, percent",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23269,Leg total mass (left),124,Body composition by DXA,"4,350","Continuous, kg",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23273,Leg total mass (right),124,Body composition by DXA,"4,350","Continuous, kg",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23274,Legs fat mass,124,Body composition by DXA,"5,170","Integer, g",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23275,Legs lean mass,124,Body composition by DXA,"5,170","Integer, g",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23276,Legs tissue fat percentage,124,Body composition by DXA,"5,170","Continuous, percent",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23277,Legs total mass,124,Body composition by DXA,"5,170","Continuous, kg",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23278,Total fat mass,124,Body composition by DXA,"5,170","Integer, g",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23279,Total fat-free mass,124,Body composition by DXA,"5,170","Integer, g",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23280,Total lean mass,124,Body composition by DXA,"5,170","Integer, g",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23281,Total tissue fat percentage,124,Body composition by DXA,"5,170","Continuous, percent",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23282,Total tissue mass,124,Body composition by DXA,"5,170","Integer, g",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23283,Total mass,124,Body composition by DXA,"5,170","Continuous, kg",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23284,Trunk fat mass,124,Body composition by DXA,"5,170","Integer, g",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23285,Trunk lean mass,124,Body composition by DXA,"5,170","Integer, g",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23286,Trunk tissue fat percentage,124,Body composition by DXA,"5,170","Continuous, percent",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23287,Trunk total mass,124,Body composition by DXA,"5,170","Continuous, kg",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23288,VAT (visceral adipose tissue) mass,124,Body composition by DXA,"5,109","Integer, g",Both sexes,Sep 2015,"5,109",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
23289,VAT (visceral adipose tissue) volume,124,Body composition by DXA,"5,109","Integer, cm3",Both sexes,Sep 2015,"5,109",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,Body composition by DXA,0.0,0.0,0.0,0.0,0.0,0.0
20046,Reason for skipping hip measurement,100010,Body size measures,504,Categorical (single),Both sexes,Aug 2012,504,Data,Defined (1),Oct 2012,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Body size measures,0.0,0.0,0.0,0.0,0.0,0.0
20048,Reason for skipping sitting height,100010,Body size measures,843,Categorical (single),Both sexes,Aug 2012,843,Data,Defined (1),Oct 2012,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Body size measures,0.0,0.0,0.0,0.0,0.0,0.0
20047,Reason for skipping standing height,100010,Body size measures,824,Categorical (single),Both sexes,Aug 2012,824,Data,Defined (1),Oct 2012,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Body size measures,0.0,0.0,0.0,0.0,0.0,0.0
20045,Reason for skipping waist,100010,Body size measures,445,Categorical (single),Both sexes,Aug 2012,445,Data,Defined (1),Oct 2012,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Body size measures,0.0,0.0,0.0,0.0,0.0,0.0
20041,Reason for skipping weight,100010,Body size measures,"1,044",Categorical (single),Both sexes,Aug 2012,"1,044",Data,Defined (1),Oct 2012,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Body size measures,0.0,0.0,0.0,0.0,0.0,0.0
12144,Height,100010,Body size measures,"47,922","Integer, cm",Both sexes,Sep 2015,"50,661",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Physical measures,Anthropometry,Body size measures,0.0,0.0,0.0,0.0,0.0,0.0
12143,Weight (pre-imaging),100010,Body size measures,"47,922","Integer, Kg",Both sexes,Sep 2015,"50,661",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Physical measures,Anthropometry,Body size measures,0.0,0.0,0.0,0.0,0.0,0.0
48,Waist circumference,100010,Body size measures,"500,408","Continuous, cm",Both sexes,Jan 2012,"569,829",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Body size measures,0.0,0.0,0.0,0.0,0.0,0.0
21002,Weight,100010,Body size measures,"499,822","Continuous, Kg",Both sexes,Jan 2012,"569,107",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Body size measures,0.0,0.0,0.0,0.0,0.0,0.0
21001,Body mass index (BMI),100010,Body size measures,"499,506","Continuous, Kg/m2",Both sexes,Jan 2012,"568,679",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Body size measures,0.0,0.0,0.0,0.0,0.0,0.0
49,Hip circumference,100010,Body size measures,"500,346","Continuous, cm",Both sexes,Jan 2012,"569,767",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Body size measures,0.0,0.0,0.0,0.0,0.0,0.0
44,Tape measure device ID,100010,Body size measures,"497,974",Text,Both sexes,Jan 2012,"566,547",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Body size measures,0.0,0.0,0.0,0.0,0.0,0.0
50,Standing height,100010,Body size measures,"500,043","Continuous, cm",Both sexes,Jan 2012,"569,401",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Body size measures,0.0,0.0,0.0,0.0,0.0,0.0
39,Height measure device ID,100010,Body size measures,"497,974",Text,Both sexes,Jan 2012,"566,547",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Body size measures,0.0,0.0,0.0,0.0,0.0,0.0
51,Seated height,100010,Body size measures,"497,178","Continuous, cm",Both sexes,Jan 2012,"565,500",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Body size measures,0.0,0.0,0.0,0.0,0.0,0.0
20015,Sitting height,100010,Body size measures,"497,178","Continuous, cm",Both sexes,Mar 2012,"565,500",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Body size measures,0.0,0.0,0.0,0.0,0.0,0.0
3077,Seating box height,100010,Body size measures,"497,178",Categorical (single),Both sexes,Jan 2012,"565,500",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Body size measures,0.0,0.0,0.0,0.0,0.0,0.0
41,Seating box device ID,100010,Body size measures,"497,974",Text,Both sexes,Jan 2012,"566,547",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Body size measures,0.0,0.0,0.0,0.0,0.0,0.0
3160,"Weight, manual entry",100010,Body size measures,"8,586","Continuous, Kg",Both sexes,Jan 2012,"8,692",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Body size measures,0.0,0.0,0.0,0.0,0.0,0.0
21,Weight method,100010,Body size measures,"500,841",Categorical (single),Both sexes,Jan 2012,"570,293",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Body size measures,0.0,0.0,0.0,0.0,0.0,0.0
40,Manual scales device ID,100010,Body size measures,"497,974",Text,Both sexes,Jan 2012,"566,547",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Body size measures,0.0,0.0,0.0,0.0,0.0,0.0
23220,Arm BMC (bone mineral content) (left),125,"Bone size, mineral and density by DXA","4,350","Continuous, g",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23305,Head bone area,125,"Bone size, mineral and density by DXA","5,170","Continuous, cm2",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23222,Arm BMC (bone mineral content) (right),125,"Bone size, mineral and density by DXA","4,350","Continuous, g",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23317,Arms combined bone area,125,"Bone size, mineral and density by DXA","5,170","Continuous, cm2",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23221,Arm BMD (bone mineral density) (left),125,"Bone size, mineral and density by DXA","4,350","Continuous, g/cm2",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23313,Arm bone area (left),125,"Bone size, mineral and density by DXA","4,350","Continuous, cm2",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23223,Arm BMD (bone mineral density) (right),125,"Bone size, mineral and density by DXA","4,350","Continuous, g/cm2",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23314,Arm bone area (right),125,"Bone size, mineral and density by DXA","4,350","Continuous, cm2",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23224,Arms BMC (bone mineral content),125,"Bone size, mineral and density by DXA","5,170","Continuous, g",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23309,Ribs bone area,125,"Bone size, mineral and density by DXA","5,170","Continuous, cm2",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23225,Arms BMD (bone mineral density),125,"Bone size, mineral and density by DXA","5,170","Continuous, g/cm2",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23311,Spine bone area,125,"Bone size, mineral and density by DXA","5,170","Continuous, cm2",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23302,Femur lower neck BMD (bone mineral density) (left),125,"Bone size, mineral and density by DXA","2,345","Continuous, g/cm2",Both sexes,Sep 2015,"2,345",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23304,Trunk bone area,125,"Bone size, mineral and density by DXA","5,170","Continuous, cm2",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23206,Femur lower neck BMD (bone mineral density) (right),125,"Bone size, mineral and density by DXA","2,344","Continuous, g/cm2",Both sexes,Sep 2015,"2,344",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23307,Pelvis bone area,125,"Bone size, mineral and density by DXA","5,170","Continuous, cm2",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23294,Femur lower neck BMD (bone mineral density) T-score (left),125,"Bone size, mineral and density by DXA",pending,"Continuous, Std.Devs",Both sexes,Sep 2015,pending,Data,Defined (1),N/A,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23318,Legs combined bone area,125,"Bone size, mineral and density by DXA","5,170","Continuous, cm2",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23207,Femur lower neck BMD (bone mineral density) T-score (right),125,"Bone size, mineral and density by DXA",pending,"Continuous, Std.Devs",Both sexes,Sep 2015,pending,Data,Defined (1),N/A,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23315,Leg bone area (left),125,"Bone size, mineral and density by DXA","4,350","Continuous, cm2",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23299,Femur neck BMD (bone mineral density) (left),125,"Bone size, mineral and density by DXA","5,183","Continuous, g/cm2",Both sexes,Sep 2015,"5,183",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23316,Leg bone area (right),125,"Bone size, mineral and density by DXA","4,350","Continuous, cm2",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23208,Femur neck BMD (bone mineral density) (right),125,"Bone size, mineral and density by DXA","5,183","Continuous, g/cm2",Both sexes,Sep 2015,"5,183",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23300,Femur neck BMD (bone mineral density) T-score (left),125,"Bone size, mineral and density by DXA","5,152","Continuous, Std.Devs",Both sexes,Sep 2015,"5,152",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23209,Femur neck BMD (bone mineral density) T-score (right),125,"Bone size, mineral and density by DXA","5,151","Continuous, Std.Devs",Both sexes,Sep 2015,"5,151",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23290,Femur shaft BMD (bone mineral density) (left),125,"Bone size, mineral and density by DXA","5,165","Continuous, g/cm2",Both sexes,Sep 2015,"5,165",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23210,Femur shaft BMD (bone mineral density) (right),125,"Bone size, mineral and density by DXA","5,168","Continuous, g/cm2",Both sexes,Sep 2015,"5,168",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23303,Femur shaft BMD (bone mineral density) T-score (left),125,"Bone size, mineral and density by DXA",pending,"Continuous, Std.Devs",Both sexes,Sep 2015,pending,Data,Defined (1),N/A,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23211,Femur shaft BMD (bone mineral density) T-score (right),125,"Bone size, mineral and density by DXA",pending,"Continuous, Std.Devs",Both sexes,Sep 2015,pending,Data,Defined (1),N/A,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23291,Femur total BMD (bone mineral density) (left),125,"Bone size, mineral and density by DXA","5,165","Continuous, g/cm2",Both sexes,Sep 2015,"5,165",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23212,Femur total BMD (bone mineral density) (right),125,"Bone size, mineral and density by DXA","5,168","Continuous, g/cm2",Both sexes,Sep 2015,"5,168",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23293,Femur total BMD (bone mineral density) T-score (left),125,"Bone size, mineral and density by DXA","5,134","Continuous, Std.Devs",Both sexes,Sep 2015,"5,134",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23213,Femur total BMD (bone mineral density) T-score (right),125,"Bone size, mineral and density by DXA","5,137","Continuous, Std.Devs",Both sexes,Sep 2015,"5,137",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23295,Femur troch BMD (bone mineral density) (left),125,"Bone size, mineral and density by DXA","5,183","Continuous, g/cm2",Both sexes,Sep 2015,"5,183",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23214,Femur troch BMD (bone mineral density) (right),125,"Bone size, mineral and density by DXA","5,183","Continuous, g/cm2",Both sexes,Sep 2015,"5,183",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23298,Femur troch BMD (bone mineral density) T-score (left),125,"Bone size, mineral and density by DXA","5,151","Continuous, Std.Devs",Both sexes,Sep 2015,"5,151",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23215,Femur troch BMD (bone mineral density) T-score (right),125,"Bone size, mineral and density by DXA","5,151","Continuous, Std.Devs",Both sexes,Sep 2015,"5,151",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23200,L1-L4 area,125,"Bone size, mineral and density by DXA","5,151","Continuous, cm2",Both sexes,Sep 2015,"5,151",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23201,L1-L4 average height,125,"Bone size, mineral and density by DXA","5,151","Continuous, cm",Both sexes,Sep 2015,"5,151",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23202,L1-L4 average width,125,"Bone size, mineral and density by DXA","5,151","Continuous, cm",Both sexes,Sep 2015,"5,151",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23292,Femur upper neck BMD (bone mineral density) (left),125,"Bone size, mineral and density by DXA","2,345","Continuous, g/cm2",Both sexes,Sep 2015,"2,345",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23216,Femur upper neck BMD (bone mineral density) (right),125,"Bone size, mineral and density by DXA","2,344","Continuous, g/cm2",Both sexes,Sep 2015,"2,344",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23296,Femur upper neck BMD (bone mineral density) T-score (left),125,"Bone size, mineral and density by DXA","2,335","Continuous, Std.Devs",Both sexes,Sep 2015,"2,335",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23217,Femur upper neck BMD (bone mineral density) T-score (right),125,"Bone size, mineral and density by DXA","2,332","Continuous, Std.Devs",Both sexes,Sep 2015,"2,332",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23297,Femur wards BMD (bone mineral density) (left),125,"Bone size, mineral and density by DXA","5,183","Continuous, g/cm2",Both sexes,Sep 2015,"5,183",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23218,Femur wards BMD (bone mineral density) (right),125,"Bone size, mineral and density by DXA","5,183","Continuous, g/cm2",Both sexes,Sep 2015,"5,183",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23301,Femur wards BMD (bone mineral density) T-score (left),125,"Bone size, mineral and density by DXA","5,151","Continuous, Std.Devs",Both sexes,Sep 2015,"5,151",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23219,Femur wards BMD (bone mineral density) T-score (right),125,"Bone size, mineral and density by DXA","5,150","Continuous, Std.Devs",Both sexes,Sep 2015,"5,150",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23306,Head BMC (bone mineral content),125,"Bone size, mineral and density by DXA","5,170","Continuous, g",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23226,Head BMD (bone mineral density),125,"Bone size, mineral and density by DXA","5,170","Continuous, g/cm2",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23203,L1-L4 BMC (bone mineral content),125,"Bone size, mineral and density by DXA","5,151","Continuous, g",Both sexes,Sep 2015,"5,151",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23204,L1-L4 BMD (bone mineral density),125,"Bone size, mineral and density by DXA","5,151","Continuous, g/cm2",Both sexes,Sep 2015,"5,151",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23205,L1-L4 BMD (bone mineral density) T-score,125,"Bone size, mineral and density by DXA","5,120","Continuous, Std.Devs",Both sexes,Sep 2015,"5,120",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23320,Leg BMC (bone mineral content) (left),125,"Bone size, mineral and density by DXA","4,350","Continuous, g",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23228,Leg BMC (bone mineral content) (right),125,"Bone size, mineral and density by DXA","4,350","Continuous, g",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23227,Leg BMD (bone mineral density) (left),125,"Bone size, mineral and density by DXA","4,350","Continuous, g/cm2",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23229,Leg BMD (bone mineral density) (right),125,"Bone size, mineral and density by DXA","4,350","Continuous, g/cm2",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23230,Legs BMC (bone mineral content),125,"Bone size, mineral and density by DXA","5,170","Continuous, g",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23231,Legs BMD (bone mineral density),125,"Bone size, mineral and density by DXA","5,170","Continuous, g/cm2",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23308,Pelvis BMC (bone mineral content),125,"Bone size, mineral and density by DXA","5,170",Continuous,Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23232,Pelvis BMD (bone mineral density),125,"Bone size, mineral and density by DXA","5,170","Continuous, g/cm2",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23310,Ribs BMC (bone mineral content),125,"Bone size, mineral and density by DXA","5,170","Continuous, g",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23233,Ribs BMD (bone mineral density),125,"Bone size, mineral and density by DXA","5,170","Continuous, g/cm2",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23312,Spine BMC (bone mineral content),125,"Bone size, mineral and density by DXA","5,170","Continuous, g",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23234,Spine BMD (bone mineral density),125,"Bone size, mineral and density by DXA","5,170","Continuous, g/cm2",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23235,Total BMC (bone mineral content),125,"Bone size, mineral and density by DXA","5,170","Continuous, g",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23236,Total BMD (bone mineral density),125,"Bone size, mineral and density by DXA","5,170","Continuous, g/cm2",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23237,Total BMD (bone mineral density) (left),125,"Bone size, mineral and density by DXA","4,350","Continuous, g/cm2",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23238,Total BMD (bone mineral density) (right),125,"Bone size, mineral and density by DXA","4,350","Continuous, g/cm2",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23239,Total BMD (bone mineral density) T-score,125,"Bone size, mineral and density by DXA","5,139","Continuous, Std.Devs",Both sexes,Sep 2015,"5,139",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23240,Trunk BMC (bone mineral content),125,"Bone size, mineral and density by DXA","5,170","Continuous, g",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23241,Trunk BMD (bone mineral density),125,"Bone size, mineral and density by DXA","5,170","Continuous, g/cm2",Both sexes,Sep 2015,"5,170",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23242,Trunk BMD (bone mineral density) (left),125,"Bone size, mineral and density by DXA","4,350","Continuous, g/cm2",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
23243,Trunk BMD (bone mineral density) (right),125,"Bone size, mineral and density by DXA","4,350","Continuous, g/cm2",Both sexes,Sep 2015,"4,350",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,"Bone size, mineral and density by DXA",0.0,0.0,0.0,0.0,0.0,0.0
3082,Fractured heel,100018,Bone-densitometry of heel,"321,838",Categorical (single),Both sexes,Jan 2012,"321,838",Data,Defined (1),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3081,Foot measured for bone density,100018,Bone-densitometry of heel,"321,838",Categorical (single),Both sexes,Jan 2012,"321,838",Data,Defined (1),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
19,Heel ultrasound method,100018,Bone-densitometry of heel,"324,778",Categorical (single),Both sexes,Jan 2012,"324,778",Data,Defined (1),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3146,Speed of sound through heel,100018,Bone-densitometry of heel,"279,094","Continuous, m/s",Both sexes,Jan 2012,"279,094",Data,Defined (1),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3143,Ankle spacing width,100018,Bone-densitometry of heel,"279,094","Continuous, mm",Both sexes,Jan 2012,"279,094",Data,Defined (1),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3144,"Heel Broadband ultrasound attenuation, direct entry",100018,Bone-densitometry of heel,"279,077","Continuous, dB/MHz",Both sexes,Jan 2012,"279,077",Data,Defined (1),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3147,"Heel quantitative ultrasound index (QUI), direct entry",100018,Bone-densitometry of heel,"279,094",Continuous,Both sexes,Jan 2012,"279,094",Data,Defined (1),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3148,Heel bone mineral density (BMD),100018,Bone-densitometry of heel,"278,954","Continuous, g/cm2",Both sexes,Jan 2012,"278,954",Data,Defined (1),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
78,"Heel bone mineral density (BMD) T-score, automated",100018,Bone-densitometry of heel,"279,094","Continuous, Std.Devs",Both sexes,Jan 2012,"279,094",Data,Defined (1),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3086,"Speed of sound through heel, manual entry",100018,Bone-densitometry of heel,"42,731","Continuous, m/s",Both sexes,Jan 2012,"42,731",Data,Defined (1),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3085,"Heel Broadband ultrasound attenuation (BUA), manual entry",100018,Bone-densitometry of heel,"42,731",Continuous,Both sexes,Jan 2012,"42,731",Data,Defined (1),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3083,"Heel quantitative ultrasound index (QUI), manual entry",100018,Bone-densitometry of heel,"42,731",Continuous,Both sexes,Jan 2012,"42,731",Data,Defined (1),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3084,"Heel bone mineral density (BMD), manual entry",100018,Bone-densitometry of heel,"42,731","Continuous, g/cm2",Both sexes,Jan 2012,"42,731",Data,Defined (1),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
77,"Heel bone ultrasound T-score, manual entry",100018,Bone-densitometry of heel,"42,731","Continuous, Std.Devs",Both sexes,Jan 2012,"42,731",Data,Defined (1),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4093,Fractured heel (left),100018,Bone-densitometry of heel,"201,647",Categorical (single),Both sexes,Jan 2012,"224,876",Data,Defined (4),Aug 2019,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4096,Fractured heel (right),100018,Bone-densitometry of heel,"201,904",Categorical (single),Both sexes,Jan 2012,"225,304",Data,Defined (4),Aug 2019,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4092,Heel ultrasound method (left),100018,Bone-densitometry of heel,"212,566",Categorical (single),Both sexes,Jan 2012,"241,769",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4095,Heel ultrasound method (right),100018,Bone-densitometry of heel,"212,566",Categorical (single),Both sexes,Jan 2012,"241,769",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4100,Ankle spacing width (left),100018,Bone-densitometry of heel,"196,792","Continuous, mm",Both sexes,Jan 2012,"218,844",Data,Defined (4),Aug 2019,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4119,Ankle spacing width (right),100018,Bone-densitometry of heel,"196,959","Continuous, mm",Both sexes,Jan 2012,"219,180",Data,Defined (4),Aug 2019,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4103,Speed of sound through heel (left),100018,Bone-densitometry of heel,"196,792","Continuous, m/s",Both sexes,Jan 2012,"218,844",Data,Defined (4),Aug 2019,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4122,Speed of sound through heel (right),100018,Bone-densitometry of heel,"196,959","Continuous, m/s",Both sexes,Jan 2012,"219,180",Data,Defined (4),Aug 2019,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4101,Heel broadband ultrasound attenuation (left),100018,Bone-densitometry of heel,"196,782","Continuous, dB/MHz",Both sexes,Jan 2012,"218,834",Data,Defined (4),Aug 2019,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4120,Heel broadband ultrasound attenuation (right),100018,Bone-densitometry of heel,"196,947","Continuous, dB/MHz",Both sexes,Jan 2012,"219,165",Data,Defined (4),Aug 2019,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4104,"Heel quantitative ultrasound index (QUI), direct entry (left)",100018,Bone-densitometry of heel,"196,792",Continuous,Both sexes,Jan 2012,"218,844",Data,Defined (4),Aug 2019,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4123,"Heel quantitative ultrasound index (QUI), direct entry (right)",100018,Bone-densitometry of heel,"196,959",Continuous,Both sexes,Jan 2012,"219,180",Data,Defined (4),Aug 2019,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4105,Heel bone mineral density (BMD) (left),100018,Bone-densitometry of heel,"196,671","Continuous, g/cm2",Both sexes,Jan 2012,"218,698",Data,Defined (4),Aug 2019,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4124,Heel bone mineral density (BMD) (right),100018,Bone-densitometry of heel,"196,829","Continuous, g/cm2",Both sexes,Jan 2012,"219,031",Data,Defined (4),Aug 2019,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4106,"Heel bone mineral density (BMD) T-score, automated (left)",100018,Bone-densitometry of heel,"196,792","Continuous, Std.Devs",Both sexes,Jan 2012,"218,844",Data,Defined (4),Aug 2019,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4125,"Heel bone mineral density (BMD) T-score, automated (right)",100018,Bone-densitometry of heel,"196,959","Continuous, Std.Devs",Both sexes,Jan 2012,"219,180",Data,Defined (4),Aug 2019,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4142,"Speed of sound through heel, manual entry (left)",100018,Bone-densitometry of heel,"6,008","Continuous, m/s",Both sexes,Jan 2012,"6,015",Data,Defined (4),Aug 2019,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4147,"Speed of sound through heel, manual entry (right)",100018,Bone-densitometry of heel,"6,102","Continuous, m/s",Both sexes,Jan 2012,"6,112",Data,Defined (4),Aug 2019,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4141,"Heel broadband ultrasound attenuation (BUA), manual entry (left)",100018,Bone-densitometry of heel,"6,008","Continuous, dB/MHz",Both sexes,Jan 2012,"6,015",Data,Defined (4),Aug 2019,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4146,"Heel broadband ultrasound attenuation (BUA), manual entry (right)",100018,Bone-densitometry of heel,"6,102","Continuous, dB/MHz",Both sexes,Jan 2012,"6,112",Data,Defined (4),Aug 2019,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4139,"Heel quantitative ultrasound index (QUI), manual entry (left)",100018,Bone-densitometry of heel,"6,008",Continuous,Both sexes,Jan 2012,"6,015",Data,Defined (4),Aug 2019,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4144,"Heel quantitative ultrasound index (QUI), manual entry (right)",100018,Bone-densitometry of heel,"6,102",Continuous,Both sexes,Jan 2012,"6,112",Data,Defined (4),Aug 2019,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4140,"Heel bone mineral density (BMD), manual entry (left)",100018,Bone-densitometry of heel,"6,008","Continuous, g/cm2",Both sexes,Jan 2012,"6,015",Data,Defined (4),Aug 2019,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4145,"Heel bone mineral density (BMD), manual entry (right)",100018,Bone-densitometry of heel,"6,102","Continuous, g/cm2",Both sexes,Jan 2012,"6,112",Data,Defined (4),Aug 2019,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4138,"Heel bone mineral density (BMD) T-score, manual entry (left)",100018,Bone-densitometry of heel,"6,008","Continuous, Std.Devs",Both sexes,Jan 2012,"6,015",Data,Defined (4),Aug 2019,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4143,"Heel bone mineral density (BMD) T-score, manual entry (right)",100018,Bone-densitometry of heel,"6,102","Continuous, Std.Devs",Both sexes,Jan 2012,"6,112",Data,Defined (4),Aug 2019,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
45,Heel ultrasound device id,100018,Bone-densitometry of heel,"497,974",Text,Both sexes,Jan 2012,"566,547",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Bone-densitometry of heel,0.0,0.0,0.0,0.0,0.0,0.0,0.0
25780,Acquisition protocol phase.,100,Brain MRI,"4,522",Categorical (single),Both sexes,Oct 2015,"4,522",Data,Defined (1),Oct 2015,Accruing,Category 112,Category 107,UK Biobank Assessment Centre,Imaging,Brain MRI,0.0,0.0,0.0,0.0,0.0
12139,Believed safe to perform brain MRI scan,100,Brain MRI,"47,922",Categorical (single),Both sexes,Sep 2015,"50,661",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,0.0,0.0,0.0,0.0,0.0,0.0,0.0
12187,Brain MRI measuring method,100,Brain MRI,"47,001",Categorical (single),Both sexes,Sep 2015,"49,735",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,0.0,0.0,0.0,0.0,0.0,0.0,0.0
12188,Operator indicated brain MRI measurement completed,100,Brain MRI,"45,208",Categorical (single),Both sexes,Sep 2015,"47,918",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100940,Bread consumed,100101,Bread/pasta/rice yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100950,Sliced bread intake,100101,Bread/pasta/rice yesterday,"161,012",Categorical (single),Both sexes,Sep 2012,"285,342",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20091,Type of sliced bread eaten,100101,Bread/pasta/rice yesterday,"159,402",Categorical (multiple),Both sexes,Sep 2012,"350,283",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101020,Baguette intake,100101,Bread/pasta/rice yesterday,"36,987",Categorical (single),Both sexes,Sep 2012,"42,456",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20092,Type of baguette eaten,100101,Bread/pasta/rice yesterday,"36,165",Categorical (multiple),Both sexes,Sep 2012,"46,781",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101090,Bap intake,100101,Bread/pasta/rice yesterday,"14,823",Categorical (single),Both sexes,Sep 2012,"16,221",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20093,Type of large bap eaten,100101,Bread/pasta/rice yesterday,"14,403",Categorical (multiple),Both sexes,Sep 2012,"17,351",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101160,Bread roll intake,100101,Bread/pasta/rice yesterday,"55,756",Categorical (single),Both sexes,Sep 2012,"69,769",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20094,Type of bread roll eaten,100101,Bread/pasta/rice yesterday,"54,585",Categorical (multiple),Both sexes,Sep 2012,"79,098",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101230,Naan bread intake,100101,Bread/pasta/rice yesterday,"8,824",Categorical (single),Both sexes,Sep 2012,"9,325",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101240,Garlic bread intake,100101,Bread/pasta/rice yesterday,"8,404",Categorical (single),Both sexes,Sep 2012,"8,822",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101250,Crispbread intake,100101,Bread/pasta/rice yesterday,"43,851",Categorical (single),Both sexes,Sep 2012,"56,469",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101260,Oatcakes intake,100101,Bread/pasta/rice yesterday,"16,767",Categorical (single),Both sexes,Sep 2012,"21,343",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101270,Other bread intake,100101,Bread/pasta/rice yesterday,"25,943",Categorical (single),Both sexes,Sep 2012,"29,722",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101300,Butter/margarine on bread/crackers,100101,Bread/pasta/rice yesterday,"161,204",Categorical (single),Both sexes,Sep 2012,"296,219",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101310,Number of bread slices with butter/margarine,100101,Bread/pasta/rice yesterday,"137,112",Categorical (single),Both sexes,Sep 2012,"232,077",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20098,Thickness of butter/margarine spread on sliced bread,100101,Bread/pasta/rice yesterday,"116,411",Categorical (multiple),Both sexes,Sep 2012,"181,293",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101350,Number of baguettes with butter/margarine,100101,Bread/pasta/rice yesterday,"22,307",Categorical (single),Both sexes,Sep 2012,"24,803",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20099,Thickness of butter/margarine spread on baguettes,100101,Bread/pasta/rice yesterday,"18,459",Categorical (multiple),Both sexes,Sep 2012,"20,319",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101390,Number of baps with  butter/margarine,100101,Bread/pasta/rice yesterday,"6,736",Categorical (single),Both sexes,Sep 2012,"7,157",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20100,Thickness of butter/margarine spread on large baps,100101,Bread/pasta/rice yesterday,"5,630",Categorical (multiple),Both sexes,Sep 2012,"5,977",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101430,Number of bread rolls with  butter/margarine,100101,Bread/pasta/rice yesterday,"38,085",Categorical (single),Both sexes,Sep 2012,"46,155",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20101,Thickness of butter/margarine spread on bread rolls,100101,Bread/pasta/rice yesterday,"32,224",Categorical (multiple),Both sexes,Sep 2012,"38,326",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101470,Number of crackers/crispbreads with butter/margarine,100101,Bread/pasta/rice yesterday,"17,412",Categorical (single),Both sexes,Sep 2012,"21,331",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20102,Thickness of butter/margarine spread on crackers/crispbreads,100101,Bread/pasta/rice yesterday,"14,781",Categorical (multiple),Both sexes,Sep 2012,"17,717",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101510,Number of oatcakes with  butter/margarine,100101,Bread/pasta/rice yesterday,"4,024",Categorical (single),Both sexes,Sep 2012,"4,796",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20103,Thickness of butter/margarine spread on oatcakes,100101,Bread/pasta/rice yesterday,"3,479",Categorical (multiple),Both sexes,Sep 2012,"4,080",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101550,Number of other bread types with  butter/margarine,100101,Bread/pasta/rice yesterday,"12,031",Categorical (single),Both sexes,Sep 2012,"13,336",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20104,Thickness of butter/margarine spread on other bread,100101,Bread/pasta/rice yesterday,"10,031",Categorical (multiple),Both sexes,Sep 2012,"10,954",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20087,Types of spread used on bread/crackers,100101,Bread/pasta/rice yesterday,"161,204",Categorical (multiple),Both sexes,Sep 2012,"617,055",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102700,Starchy food consumers,100101,Bread/pasta/rice yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102710,White pasta intake,100101,Bread/pasta/rice yesterday,"44,654",Categorical (single),Both sexes,Sep 2012,"51,982",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102720,Wholemeal pasta intake,100101,Bread/pasta/rice yesterday,"8,381",Categorical (single),Both sexes,Sep 2012,"9,140",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102730,White rice intake,100101,Bread/pasta/rice yesterday,"43,272",Categorical (single),Both sexes,Sep 2012,"50,737",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102740,Brown rice intake,100101,Bread/pasta/rice yesterday,"9,907",Categorical (single),Both sexes,Sep 2012,"10,965",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102750,Sushi intake,100101,Bread/pasta/rice yesterday,"1,472",Categorical (single),Both sexes,Sep 2012,"1,536",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102760,Snackpot intake,100101,Bread/pasta/rice yesterday,752,Categorical (single),Both sexes,Sep 2012,772,Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102770,Couscous intake,100101,Bread/pasta/rice yesterday,"8,598",Categorical (single),Both sexes,Sep 2012,"9,158",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102780,Other grain intake,100101,Bread/pasta/rice yesterday,"2,659",Categorical (single),Both sexes,Sep 2012,"2,827",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Bread/pasta/rice yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
2316,Wheeze or whistling in the chest in last year,100037,Breathing,"501,602",Categorical (single),Both sexes,Jan 2012,"572,228",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Breathing,0.0,0.0,0.0,0.0,0.0,0.0
4717,Shortness of breath walking on level ground,100037,Breathing,"213,701",Categorical (single),Both sexes,Jan 2012,"243,342",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Breathing,0.0,0.0,0.0,0.0,0.0,0.0
23183,Broad WGS CRAM files,182,Broad WGS pilot,48,Text,Both sexes,Aug 2018,50,Bulk,Singular,Aug 2018,Complete,Genomics,Whole genome sequences,Broad WGS pilot,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23184,Broad WGS CRAM indices,182,Broad WGS pilot,48,Text,Both sexes,Aug 2018,50,Bulk,Singular,Aug 2018,Complete,Genomics,Whole genome sequences,Broad WGS pilot,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42016,Date of chronic obstructive pulmonary disease report,46,COPD outcomes,"19,024",Date,Both sexes,Apr 2018,"19,024",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,COPD outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42017,Source of chronic obstructive pulmonary disease report,46,COPD outcomes,"19,024",Categorical (single),Both sexes,Apr 2018,"19,024",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,COPD outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
40021,Cancer record origin,100092,Cancer register,"89,808",Categorical (single),Both sexes,Mar 2018,"118,822",Data,Defined (17),Aug 2019,Updateable,Health-related outcomes,Cancer register,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
40019,Cancer record format,100092,Cancer register,"89,808",Categorical (single),Both sexes,Mar 2014,"118,822",Data,Variable (17),Aug 2019,Ongoing,Health-related outcomes,Cancer register,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
40009,Reported occurrences of cancer,100092,Cancer register,"89,766",Integer,Both sexes,Aug 2012,"89,766",Data,Variable (1),Aug 2019,Ongoing,Health-related outcomes,Cancer register,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
40005,Date of cancer diagnosis,100092,Cancer register,"89,766",Date,Both sexes,Jul 2012,"118,715",Data,Variable (17),Aug 2019,Accruing,Health-related outcomes,Cancer register,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
40008,Age at cancer diagnosis,100092,Cancer register,"89,766",Continuous,Both sexes,Aug 2012,"118,715",Data,Defined (17),Aug 2019,Accruing,Health-related outcomes,Cancer register,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
40006,Type of cancer: ICD10,100092,Cancer register,"84,723",Categorical (single),Both sexes,Jul 2012,"103,466",Data,Defined (17),Aug 2019,Accruing,Category 100092,Health-related outcomes,Cancer register,0.0,0.0,0.0,0.0,0.0,0.0,0.0
40016,Type of cancer: ICD10 addendum,100092,Cancer register,pending,Text,Both sexes,Feb 2013,pending,Data,Variable (1),N/A,Accruing,Health-related outcomes,Cancer register,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
40013,Type of cancer: ICD9,100092,Cancer register,"11,222",Categorical (single),Both sexes,Jan 2013,"15,241",Data,Defined (15),Mar 2019,Accruing,Health-related outcomes,Cancer register,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
40011,Histology of cancer tumour,100092,Cancer register,"89,177",Categorical (single),Both sexes,Jan 2013,"113,834",Data,Variable (17),Aug 2019,Accruing,Health-related outcomes,Cancer register,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
40017,Type of cancer: ICD9 addendum,100092,Cancer register,pending,Text,Both sexes,Feb 2013,pending,Data,Variable (1),N/A,Accruing,Health-related outcomes,Cancer register,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
40012,Behaviour of cancer tumour,100092,Cancer register,"89,269",Categorical (single),Both sexes,Jan 2013,"114,009",Data,Variable (17),Aug 2019,Accruing,Health-related outcomes,Cancer register,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
2345,Ever had bowel cancer screening,100040,Cancer screening,"501,599",Categorical (single),Both sexes,Jan 2012,"572,225",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Cancer screening,0.0,0.0,0.0,0.0,0.0,0.0
2355,Most recent bowel cancer screening,100040,Cancer screening,"180,035","Integer, years",Both sexes,Jan 2012,"202,611",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Cancer screening,0.0,0.0,0.0,0.0,0.0,0.0
2365,Ever had prostate specific antigen (PSA) test,100040,Cancer screening,"228,662",Categorical (single),Males only,Jan 2012,"262,929",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Cancer screening,0.0,0.0,0.0,0.0,0.0,0.0
3809,Time since last prostate specific antigen (PSA) test,100040,Cancer screening,"72,102","Integer, years",Males only,Jan 2012,"81,240",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Cancer screening,0.0,0.0,0.0,0.0,0.0,0.0
20455,Age when last took cannabis,143,Cannabis use,"34,882",Integer,Both sexes,Oct 2016,"34,882",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Cannabis use,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20453,Ever taken cannabis,143,Cannabis use,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Cannabis use,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20454,Maximum frequency of taking cannabis,143,Cannabis use,"34,882",Categorical (single),Both sexes,Oct 2016,"34,882",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Cannabis use,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22299,Acceleration,347,Cardiac monitoring,pending,Text,Both sexes,Feb 2019,pending,Bulk,Singular,N/A,Accruing,Additional exposures,Cardiac monitoring,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22297,Analysis date,347,Cardiac monitoring,578,Date,Both sexes,Feb 2019,578,Data,Singular,Feb 2019,Accruing,Additional exposures,Cardiac monitoring,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22300,ECG trace,347,Cardiac monitoring,578,Text,Both sexes,Feb 2019,578,Bulk,Singular,Feb 2019,Accruing,Additional exposures,Cardiac monitoring,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22298,Impedance,347,Cardiac monitoring,pending,Text,Both sexes,Feb 2019,pending,Bulk,Singular,N/A,Accruing,Additional exposures,Cardiac monitoring,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
12292,Carotid ultrasound measurement completed,101,Carotid ultrasound,"46,918",Categorical (single),Both sexes,Sep 2015,"49,560",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Physical measures,Carotid ultrasound,0.0,0.0,0.0,0.0,0.0,0.0,0.0
12291,Carotid ultrasound measuring method,101,Carotid ultrasound,"47,717",Categorical (single),Both sexes,Sep 2015,"50,427",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Physical measures,Carotid ultrasound,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22672,Maximum carotid IMT (intima-medial thickness) at 120 degrees ,101,Carotid ultrasound,"44,344","Continuous, micrometres",Both sexes,Sep 2015,"46,458",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Physical measures,Carotid ultrasound,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22675,Maximum carotid IMT (intima-medial thickness) at 150 degrees ,101,Carotid ultrasound,"44,541","Continuous, micrometres",Both sexes,Sep 2015,"46,672",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Physical measures,Carotid ultrasound,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22678,Maximum carotid IMT (intima-medial thickness) at 210 degrees ,101,Carotid ultrasound,"44,459","Continuous, micrometres",Both sexes,Sep 2015,"46,583",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Physical measures,Carotid ultrasound,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22681,Maximum carotid IMT (intima-medial thickness) at 240 degrees ,101,Carotid ultrasound,"44,129","Continuous, micrometres",Both sexes,Sep 2015,"46,244",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Physical measures,Carotid ultrasound,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22671,Mean carotid IMT (intima-medial thickness) at 120 degrees ,101,Carotid ultrasound,"44,344","Continuous, micrometres",Both sexes,Sep 2015,"46,458",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Physical measures,Carotid ultrasound,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22674,Mean carotid IMT (intima-medial thickness) at 150 degrees ,101,Carotid ultrasound,"44,541","Continuous, micrometres",Both sexes,Sep 2015,"46,672",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Physical measures,Carotid ultrasound,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22677,Mean carotid IMT (intima-medial thickness) at 210 degrees ,101,Carotid ultrasound,"44,459","Continuous, micrometres",Both sexes,Sep 2015,"46,583",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Physical measures,Carotid ultrasound,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22680,Mean carotid IMT (intima-medial thickness) at 240 degrees ,101,Carotid ultrasound,"44,129","Continuous, micrometres",Both sexes,Sep 2015,"46,244",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Physical measures,Carotid ultrasound,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22670,Minimum carotid IMT (intima-medial thickness) at 120 degrees ,101,Carotid ultrasound,"44,344","Continuous, micrometres",Both sexes,Sep 2015,"46,458",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Physical measures,Carotid ultrasound,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22673,Minimum carotid IMT (intima-medial thickness) at 150 degrees ,101,Carotid ultrasound,"44,541","Continuous, micrometres",Both sexes,Sep 2015,"46,672",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Physical measures,Carotid ultrasound,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22676,Minimum carotid IMT (intima-medial thickness) at 210 degrees ,101,Carotid ultrasound,"44,459","Continuous, micrometres",Both sexes,Sep 2015,"46,583",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Physical measures,Carotid ultrasound,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22679,Minimum carotid IMT (intima-medial thickness) at 240 degrees ,101,Carotid ultrasound,"44,129","Continuous, micrometres",Both sexes,Sep 2015,"46,244",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Physical measures,Carotid ultrasound,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22682,Quality control indicator for IMT at 120 degrees,101,Carotid ultrasound,"2,579",Categorical (single),Both sexes,Oct 2015,"2,579",Data,Defined (1),Oct 2015,Accruing,UK Biobank Assessment Centre,Physical measures,Carotid ultrasound,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22683,Quality control indicator for IMT at 150 degrees,101,Carotid ultrasound,"2,579",Categorical (single),Both sexes,Oct 2015,"2,579",Data,Defined (1),Oct 2015,Accruing,UK Biobank Assessment Centre,Physical measures,Carotid ultrasound,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22684,Quality control indicator for IMT at 210 degrees,101,Carotid ultrasound,"2,579",Categorical (single),Both sexes,Oct 2015,"2,579",Data,Defined (1),Oct 2015,Accruing,UK Biobank Assessment Centre,Physical measures,Carotid ultrasound,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22685,Quality control indicator for IMT at 240 degrees,101,Carotid ultrasound,"2,579",Categorical (single),Both sexes,Oct 2015,"2,579",Data,Defined (1),Oct 2015,Accruing,UK Biobank Assessment Centre,Physical measures,Carotid ultrasound,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20222,Carotid artery ultrasound image (left),101,Carotid ultrasound,"7,943",Text,Both sexes,Jul 2014,"7,943",Bulk,Defined (1),May 2019,Accruing,UK Biobank Assessment Centre,Physical measures,Carotid ultrasound,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20223,Carotid artery ultrasound image (right),101,Carotid ultrasound,"7,946",Text,Both sexes,Jul 2014,"7,946",Bulk,Defined (1),May 2019,Accruing,UK Biobank Assessment Centre,Physical measures,Carotid ultrasound,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20226,Carotid artery ultrasound report,101,Carotid ultrasound,"7,946",Text,Both sexes,Feb 2015,"7,946",Bulk,Defined (1),May 2019,Accruing,UK Biobank Assessment Centre,Physical measures,Carotid ultrasound,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20241,Raw carotid device data,101,Carotid ultrasound,"44,533",Text,Both sexes,Jan 2020,"46,588",Bulk,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Physical measures,Carotid ultrasound,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100760,Breakfast cereal consumed,100102,Cereal yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Cereal yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100770,Porridge intake,100102,Cereal yesterday,"50,525",Categorical (single),Both sexes,Sep 2012,"76,643",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Cereal yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20105,Liquid used to make porridge,100102,Cereal yesterday,"47,524",Categorical (multiple),Both sexes,Sep 2012,"78,913",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Cereal yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100800,Muesli intake,100102,Cereal yesterday,"46,503",Categorical (single),Both sexes,Sep 2012,"75,559",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Cereal yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100810,Oat crunch intake,100102,Cereal yesterday,"13,646",Categorical (single),Both sexes,Sep 2012,"17,833",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Cereal yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100820,Sweetened cereal intake,100102,Cereal yesterday,"10,625",Categorical (single),Both sexes,Sep 2012,"12,896",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Cereal yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100830,Plain cereal intake,100102,Cereal yesterday,"28,577",Categorical (single),Both sexes,Sep 2012,"39,028",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Cereal yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100840,Bran cereal intake,100102,Cereal yesterday,"29,544",Categorical (single),Both sexes,Sep 2012,"44,237",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Cereal yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100850,Whole-wheat cereal intake,100102,Cereal yesterday,"39,506",Categorical (single),Both sexes,Sep 2012,"58,120",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Cereal yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100860,Other cereal intake,100102,Cereal yesterday,"10,180",Categorical (single),Both sexes,Sep 2012,"12,599",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Cereal yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100880,Dried fruit added to cereal,100102,Cereal yesterday,"82,582",Categorical (single),Both sexes,Sep 2012,"136,535",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Cereal yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100890,Milk added to cereal,100102,Cereal yesterday,"136,548",Categorical (single),Both sexes,Sep 2012,"246,641",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Cereal yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100900,Intake of sugar added to cereal,100102,Cereal yesterday,"41,614",Categorical (single),Both sexes,Sep 2012,"62,076",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Cereal yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100910,Intake of artificial sweetener added to cereal,100102,Cereal yesterday,"7,766",Categorical (single),Both sexes,Sep 2012,"11,207",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Cereal yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132314,Date P00 first reported (foetus and newborn affected by maternal conditions that may be unrelated to present pregnancy),2416,Certain conditions originating in the perinatal period,6,Date,Both sexes,Jul 2019,6,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132315,Source of report of P00 (foetus and newborn affected by maternal conditions that may be unrelated to present pregnancy),2416,Certain conditions originating in the perinatal period,6,Categorical (single),Both sexes,Jul 2019,6,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132316,Date P01 first reported (foetus and newborn affected by maternal complications of pregnancy),2416,Certain conditions originating in the perinatal period,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132317,Source of report of P01 (foetus and newborn affected by maternal complications of pregnancy),2416,Certain conditions originating in the perinatal period,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132318,"Date P02 first reported (foetus and newborn affected by complications of placenta, cord and membranes)",2416,Certain conditions originating in the perinatal period,8,Date,Both sexes,Jul 2019,8,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132319,"Source of report of P02 (foetus and newborn affected by complications of placenta, cord and membranes)",2416,Certain conditions originating in the perinatal period,8,Categorical (single),Both sexes,Jul 2019,8,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132320,Date P03 first reported (foetus and newborn affected by other complications of labour and delivery),2416,Certain conditions originating in the perinatal period,174,Date,Both sexes,Jul 2019,174,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132321,Source of report of P03 (foetus and newborn affected by other complications of labour and delivery),2416,Certain conditions originating in the perinatal period,174,Categorical (single),Both sexes,Jul 2019,174,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132322,Date P04 first reported (foetus and newborn affected by noxious influences transmitted via placenta or breast milk),2416,Certain conditions originating in the perinatal period,1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132323,Source of report of P04 (foetus and newborn affected by noxious influences transmitted via placenta or breast milk),2416,Certain conditions originating in the perinatal period,1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132324,Date P05 first reported (slow foetal growth and foetal malnutrition),2416,Certain conditions originating in the perinatal period,8,Date,Both sexes,Jul 2019,8,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132325,Source of report of P05 (slow foetal growth and foetal malnutrition),2416,Certain conditions originating in the perinatal period,8,Categorical (single),Both sexes,Jul 2019,8,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132326,"Date P07 first reported (disorders related to short gestation and low birth weight, not elsewhere classified)",2416,Certain conditions originating in the perinatal period,29,Date,Both sexes,Jul 2019,29,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132327,"Source of report of P07 (disorders related to short gestation and low birth weight, not elsewhere classified)",2416,Certain conditions originating in the perinatal period,29,Categorical (single),Both sexes,Jul 2019,29,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132328,Date P08 first reported (disorders related to long gestation and high birth weight),2416,Certain conditions originating in the perinatal period,9,Date,Both sexes,Jul 2019,9,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132329,Source of report of P08 (disorders related to long gestation and high birth weight),2416,Certain conditions originating in the perinatal period,9,Categorical (single),Both sexes,Jul 2019,9,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132330,Date P10 first reported (intracranial laceration and haemorrhage due to birth injury),2416,Certain conditions originating in the perinatal period,2,Date,Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132331,Source of report of P10 (intracranial laceration and haemorrhage due to birth injury),2416,Certain conditions originating in the perinatal period,2,Categorical (single),Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132332,Date P11 first reported (other birth injuries to central nervous system),2416,Certain conditions originating in the perinatal period,5,Date,Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132333,Source of report of P11 (other birth injuries to central nervous system),2416,Certain conditions originating in the perinatal period,5,Categorical (single),Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132334,Date P12 first reported (birth injury to scalp),2416,Certain conditions originating in the perinatal period,4,Date,Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132335,Source of report of P12 (birth injury to scalp),2416,Certain conditions originating in the perinatal period,4,Categorical (single),Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132336,Date P13 first reported (birth injury to skeleton),2416,Certain conditions originating in the perinatal period,5,Date,Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132337,Source of report of P13 (birth injury to skeleton),2416,Certain conditions originating in the perinatal period,5,Categorical (single),Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132338,Date P14 first reported (birth injury to peripheral nervous system),2416,Certain conditions originating in the perinatal period,17,Date,Both sexes,Jul 2019,17,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132339,Source of report of P14 (birth injury to peripheral nervous system),2416,Certain conditions originating in the perinatal period,17,Categorical (single),Both sexes,Jul 2019,17,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132340,Date P15 first reported (other birth injuries),2416,Certain conditions originating in the perinatal period,16,Date,Both sexes,Jul 2019,16,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132341,Source of report of P15 (other birth injuries),2416,Certain conditions originating in the perinatal period,16,Categorical (single),Both sexes,Jul 2019,16,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132342,Date P20 first reported (intra-uterine hypoxia),2416,Certain conditions originating in the perinatal period,7,Date,Both sexes,Jul 2019,7,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132343,Source of report of P20 (intra-uterine hypoxia),2416,Certain conditions originating in the perinatal period,7,Categorical (single),Both sexes,Jul 2019,7,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132344,Date P21 first reported (birth asphyxia),2416,Certain conditions originating in the perinatal period,3,Date,Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132345,Source of report of P21 (birth asphyxia),2416,Certain conditions originating in the perinatal period,3,Categorical (single),Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132346,Date P22 first reported (respiratory distress of newborn),2416,Certain conditions originating in the perinatal period,6,Date,Both sexes,Jul 2019,6,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132347,Source of report of P22 (respiratory distress of newborn),2416,Certain conditions originating in the perinatal period,6,Categorical (single),Both sexes,Jul 2019,6,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132348,Date P23 first reported (congenital pneumonia),2416,Certain conditions originating in the perinatal period,3,Date,Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132349,Source of report of P23 (congenital pneumonia),2416,Certain conditions originating in the perinatal period,3,Categorical (single),Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132350,Date P24 first reported (neonatal aspiration syndromes),2416,Certain conditions originating in the perinatal period,4,Date,Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132351,Source of report of P24 (neonatal aspiration syndromes),2416,Certain conditions originating in the perinatal period,4,Categorical (single),Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132352,Date P25 first reported (interstitial emphysema and related conditions originating in the perinatal period),2416,Certain conditions originating in the perinatal period,2,Date,Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132353,Source of report of P25 (interstitial emphysema and related conditions originating in the perinatal period),2416,Certain conditions originating in the perinatal period,2,Categorical (single),Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132354,Date P26 first reported (pulmonary haemorrhage originating in the perinatal period),2416,Certain conditions originating in the perinatal period,1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132355,Source of report of P26 (pulmonary haemorrhage originating in the perinatal period),2416,Certain conditions originating in the perinatal period,1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132356,Date P27 first reported (chronic respiratory disease originating in the perinatal period),2416,Certain conditions originating in the perinatal period,1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132357,Source of report of P27 (chronic respiratory disease originating in the perinatal period),2416,Certain conditions originating in the perinatal period,1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132358,Date P28 first reported (other respiratory conditions originating in the perinatal period),2416,Certain conditions originating in the perinatal period,19,Date,Both sexes,Jul 2019,19,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132359,Source of report of P28 (other respiratory conditions originating in the perinatal period),2416,Certain conditions originating in the perinatal period,19,Categorical (single),Both sexes,Jul 2019,19,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132360,Date P29 first reported (cardiovascular disorders originating in the perinatal period),2416,Certain conditions originating in the perinatal period,12,Date,Both sexes,Jul 2019,12,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132361,Source of report of P29 (cardiovascular disorders originating in the perinatal period),2416,Certain conditions originating in the perinatal period,12,Categorical (single),Both sexes,Jul 2019,12,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132362,Date P35 first reported (congenital viral diseases),2416,Certain conditions originating in the perinatal period,16,Date,Both sexes,Jul 2019,16,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132363,Source of report of P35 (congenital viral diseases),2416,Certain conditions originating in the perinatal period,16,Categorical (single),Both sexes,Jul 2019,16,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132364,Date P36 first reported (bacterial sepsis of newborn),2416,Certain conditions originating in the perinatal period,45,Date,Both sexes,Jul 2019,45,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132365,Source of report of P36 (bacterial sepsis of newborn),2416,Certain conditions originating in the perinatal period,45,Categorical (single),Both sexes,Jul 2019,45,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132366,Date P37 first reported (other congenital infectious and parasitic diseases),2416,Certain conditions originating in the perinatal period,18,Date,Both sexes,Jul 2019,18,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132367,Source of report of P37 (other congenital infectious and parasitic diseases),2416,Certain conditions originating in the perinatal period,18,Categorical (single),Both sexes,Jul 2019,18,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132368,Date P38 first reported (omphalitis of newborn with or without mild haemorrhage),2416,Certain conditions originating in the perinatal period,19,Date,Both sexes,Jul 2019,19,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132369,Source of report of P38 (omphalitis of newborn with or without mild haemorrhage),2416,Certain conditions originating in the perinatal period,19,Categorical (single),Both sexes,Jul 2019,19,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132370,Date P39 first reported (other infections specific to the perinatal period),2416,Certain conditions originating in the perinatal period,15,Date,Both sexes,Jul 2019,15,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132371,Source of report of P39 (other infections specific to the perinatal period),2416,Certain conditions originating in the perinatal period,15,Categorical (single),Both sexes,Jul 2019,15,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132372,Date P50 first reported (foetal blood loss),2416,Certain conditions originating in the perinatal period,1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132373,Source of report of P50 (foetal blood loss),2416,Certain conditions originating in the perinatal period,1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132374,Date P51 first reported (umbilical haemorrhage of newborn),2416,Certain conditions originating in the perinatal period,8,Date,Both sexes,Jul 2019,8,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132375,Source of report of P51 (umbilical haemorrhage of newborn),2416,Certain conditions originating in the perinatal period,8,Categorical (single),Both sexes,Jul 2019,8,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132376,Date P52 first reported (intracranial nontraumatic haemorrhage of foetus and newborn),2416,Certain conditions originating in the perinatal period,1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132377,Source of report of P52 (intracranial nontraumatic haemorrhage of foetus and newborn),2416,Certain conditions originating in the perinatal period,1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132378,Date P53 first reported (haemorrhagic disease of foetus and newborn),2416,Certain conditions originating in the perinatal period,2,Date,Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132379,Source of report of P53 (haemorrhagic disease of foetus and newborn),2416,Certain conditions originating in the perinatal period,2,Categorical (single),Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132380,Date P54 first reported (other neonatal haemorrhages),2416,Certain conditions originating in the perinatal period,9,Date,Both sexes,Jul 2019,9,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132381,Source of report of P54 (other neonatal haemorrhages),2416,Certain conditions originating in the perinatal period,9,Categorical (single),Both sexes,Jul 2019,9,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132382,Date P55 first reported (haemolytic disease of foetus and newborn),2416,Certain conditions originating in the perinatal period,9,Date,Both sexes,Jul 2019,9,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132383,Source of report of P55 (haemolytic disease of foetus and newborn),2416,Certain conditions originating in the perinatal period,9,Categorical (single),Both sexes,Jul 2019,9,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132384,Date P56 first reported (hydrops foetalis due to haemolytic disease),2416,Certain conditions originating in the perinatal period,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132385,Source of report of P56 (hydrops foetalis due to haemolytic disease),2416,Certain conditions originating in the perinatal period,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132386,Date P57 first reported (kernicterus),2416,Certain conditions originating in the perinatal period,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132387,Source of report of P57 (kernicterus),2416,Certain conditions originating in the perinatal period,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132388,Date P58 first reported (neonatal jaundice due to other excessive haemolysis),2416,Certain conditions originating in the perinatal period,4,Date,Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132389,Source of report of P58 (neonatal jaundice due to other excessive haemolysis),2416,Certain conditions originating in the perinatal period,4,Categorical (single),Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132390,Date P59 first reported (neonatal jaundice from other and unspecified causes),2416,Certain conditions originating in the perinatal period,23,Date,Both sexes,Jul 2019,23,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132391,Source of report of P59 (neonatal jaundice from other and unspecified causes),2416,Certain conditions originating in the perinatal period,23,Categorical (single),Both sexes,Jul 2019,23,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132392,Date P60 first reported (disseminated intravascular coagulation of foetus and newborn),2416,Certain conditions originating in the perinatal period,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132393,Source of report of P60 (disseminated intravascular coagulation of foetus and newborn),2416,Certain conditions originating in the perinatal period,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132394,Date P61 first reported (other perinatal haematological disorders),2416,Certain conditions originating in the perinatal period,6,Date,Both sexes,Jul 2019,6,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132395,Source of report of P61 (other perinatal haematological disorders),2416,Certain conditions originating in the perinatal period,6,Categorical (single),Both sexes,Jul 2019,6,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132396,Date P70 first reported (transitory disorders of carbohydrate metabolism specific to foetus and newborn),2416,Certain conditions originating in the perinatal period,2,Date,Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132397,Source of report of P70 (transitory disorders of carbohydrate metabolism specific to foetus and newborn),2416,Certain conditions originating in the perinatal period,2,Categorical (single),Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132398,Date P71 first reported (transitory neonatal disorders of calcium and magnesium metabolism),2416,Certain conditions originating in the perinatal period,1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132399,Source of report of P71 (transitory neonatal disorders of calcium and magnesium metabolism),2416,Certain conditions originating in the perinatal period,1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132400,Date P72 first reported (other transitory neonatal endocrine disorders),2416,Certain conditions originating in the perinatal period,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132401,Source of report of P72 (other transitory neonatal endocrine disorders),2416,Certain conditions originating in the perinatal period,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132402,Date P74 first reported (other transitory neonatal electrolyte and metabolic disturbances),2416,Certain conditions originating in the perinatal period,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132403,Source of report of P74 (other transitory neonatal electrolyte and metabolic disturbances),2416,Certain conditions originating in the perinatal period,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132404,Date P75 first reported (meconium ileus),2416,Certain conditions originating in the perinatal period,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132405,Source of report of P75 (meconium ileus),2416,Certain conditions originating in the perinatal period,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132406,Date P76 first reported (other intestinal obstruction of newborn),2416,Certain conditions originating in the perinatal period,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132407,Source of report of P76 (other intestinal obstruction of newborn),2416,Certain conditions originating in the perinatal period,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132408,Date P77 first reported (necrotising enterocolitis of foetus and newborn),2416,Certain conditions originating in the perinatal period,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132409,Source of report of P77 (necrotising enterocolitis of foetus and newborn),2416,Certain conditions originating in the perinatal period,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132410,Date P78 first reported (other perinatal digestive system disorders),2416,Certain conditions originating in the perinatal period,1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132411,Source of report of P78 (other perinatal digestive system disorders),2416,Certain conditions originating in the perinatal period,1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132412,Date P80 first reported (hypothermia of newborn),2416,Certain conditions originating in the perinatal period,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132413,Source of report of P80 (hypothermia of newborn),2416,Certain conditions originating in the perinatal period,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132414,Date P81 first reported (other disturbances of temperature regulation of newborn),2416,Certain conditions originating in the perinatal period,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132415,Source of report of P81 (other disturbances of temperature regulation of newborn),2416,Certain conditions originating in the perinatal period,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132416,Date P83 first reported (other conditions of integument specific to foetus and newborn),2416,Certain conditions originating in the perinatal period,12,Date,Both sexes,Jul 2019,12,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132417,Source of report of P83 (other conditions of integument specific to foetus and newborn),2416,Certain conditions originating in the perinatal period,12,Categorical (single),Both sexes,Jul 2019,12,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132418,Date P90 first reported (convulsions of newborn),2416,Certain conditions originating in the perinatal period,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132419,Source of report of P90 (convulsions of newborn),2416,Certain conditions originating in the perinatal period,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132420,Date P91 first reported (other disturbances of cerebral status of newborn),2416,Certain conditions originating in the perinatal period,2,Date,Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132421,Source of report of P91 (other disturbances of cerebral status of newborn),2416,Certain conditions originating in the perinatal period,2,Categorical (single),Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132422,Date P92 first reported (feeding problems of newborn),2416,Certain conditions originating in the perinatal period,13,Date,Both sexes,Jul 2019,13,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132423,Source of report of P92 (feeding problems of newborn),2416,Certain conditions originating in the perinatal period,13,Categorical (single),Both sexes,Jul 2019,13,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132424,Date P93 first reported (reactions and intoxications due to drugs administered to foetus and newborn),2416,Certain conditions originating in the perinatal period,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132425,Source of report of P93 (reactions and intoxications due to drugs administered to foetus and newborn),2416,Certain conditions originating in the perinatal period,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132426,Date P94 first reported (disorders of muscle tone of newborn),2416,Certain conditions originating in the perinatal period,4,Date,Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132427,Source of report of P94 (disorders of muscle tone of newborn),2416,Certain conditions originating in the perinatal period,4,Categorical (single),Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132428,Date P95 first reported (foetal death of unspecified cause),2416,Certain conditions originating in the perinatal period,138,Date,Both sexes,Jul 2019,138,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132429,Source of report of P95 (foetal death of unspecified cause),2416,Certain conditions originating in the perinatal period,138,Categorical (single),Both sexes,Jul 2019,138,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132430,Date P96 first reported (other conditions originating in the perinatal period),2416,Certain conditions originating in the perinatal period,206,Date,Both sexes,Jul 2019,206,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132431,Source of report of P96 (other conditions originating in the perinatal period),2416,Certain conditions originating in the perinatal period,206,Categorical (single),Both sexes,Jul 2019,206,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain conditions originating in the perinatal period,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130000,Date A00 first reported (cholera),2401,Certain infectious and parasitic diseases,26,Date,Both sexes,Jul 2019,26,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130001,Source of report of A00 (cholera),2401,Certain infectious and parasitic diseases,26,Categorical (single),Both sexes,Jul 2019,26,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130002,Date A01 first reported (typhoid and paratyphoid fevers),2401,Certain infectious and parasitic diseases,151,Date,Both sexes,Jul 2019,151,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130003,Source of report of A01 (typhoid and paratyphoid fevers),2401,Certain infectious and parasitic diseases,151,Categorical (single),Both sexes,Jul 2019,151,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130004,Date A02 first reported (other salmonella infections),2401,Certain infectious and parasitic diseases,767,Date,Both sexes,Jul 2019,767,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130005,Source of report of A02 (other salmonella infections),2401,Certain infectious and parasitic diseases,767,Categorical (single),Both sexes,Jul 2019,767,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130006,Date A03 first reported (shigellosis),2401,Certain infectious and parasitic diseases,208,Date,Both sexes,Jul 2019,208,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130007,Source of report of A03 (shigellosis),2401,Certain infectious and parasitic diseases,208,Categorical (single),Both sexes,Jul 2019,208,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130008,Date A04 first reported (other bacterial intestinal infections),2401,Certain infectious and parasitic diseases,"7,282",Date,Both sexes,Jul 2019,"7,282",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130009,Source of report of A04 (other bacterial intestinal infections),2401,Certain infectious and parasitic diseases,"7,282",Categorical (single),Both sexes,Jul 2019,"7,282",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130010,Date A05 first reported (other bacterial foodborne intoxications),2401,Certain infectious and parasitic diseases,381,Date,Both sexes,Jul 2019,381,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130011,Source of report of A05 (other bacterial foodborne intoxications),2401,Certain infectious and parasitic diseases,381,Categorical (single),Both sexes,Jul 2019,381,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130012,Date A06 first reported (amoebiasis),2401,Certain infectious and parasitic diseases,114,Date,Both sexes,Jul 2019,114,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130013,Source of report of A06 (amoebiasis),2401,Certain infectious and parasitic diseases,114,Categorical (single),Both sexes,Jul 2019,114,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130014,Date A07 first reported (other protozoal intestinal diseases),2401,Certain infectious and parasitic diseases,484,Date,Both sexes,Jul 2019,484,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130015,Source of report of A07 (other protozoal intestinal diseases),2401,Certain infectious and parasitic diseases,484,Categorical (single),Both sexes,Jul 2019,484,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130016,Date A08 first reported (viral and other specified intestinal infections),2401,Certain infectious and parasitic diseases,"4,927",Date,Both sexes,Jul 2019,"4,927",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130017,Source of report of A08 (viral and other specified intestinal infections),2401,Certain infectious and parasitic diseases,"4,927",Categorical (single),Both sexes,Jul 2019,"4,927",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130018,Date A09 first reported (diarrhoea and gastro-enteritis of presumed infectious origin),2401,Certain infectious and parasitic diseases,"15,167",Date,Both sexes,Jul 2019,"15,167",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130019,Source of report of A09 (diarrhoea and gastro-enteritis of presumed infectious origin),2401,Certain infectious and parasitic diseases,"15,167",Categorical (single),Both sexes,Jul 2019,"15,167",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130020,"Date A15 first reported (respiratory tuberculosis, bacteriologically and histologically confirmed)",2401,Certain infectious and parasitic diseases,"2,666",Date,Both sexes,Jul 2019,"2,666",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130021,"Source of report of A15 (respiratory tuberculosis, bacteriologically and histologically confirmed)",2401,Certain infectious and parasitic diseases,"2,666",Categorical (single),Both sexes,Jul 2019,"2,666",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130022,"Date A16 first reported (respiratory tuberculosis, not confirmed bacteriologically or histologically)",2401,Certain infectious and parasitic diseases,632,Date,Both sexes,Jul 2019,632,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130023,"Source of report of A16 (respiratory tuberculosis, not confirmed bacteriologically or histologically)",2401,Certain infectious and parasitic diseases,632,Categorical (single),Both sexes,Jul 2019,632,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130024,Date A17 first reported (tuberculosis of nervous system),2401,Certain infectious and parasitic diseases,21,Date,Both sexes,Jul 2019,21,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130025,Source of report of A17 (tuberculosis of nervous system),2401,Certain infectious and parasitic diseases,21,Categorical (single),Both sexes,Jul 2019,21,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130026,Date A18 first reported (tuberculosis of other organs),2401,Certain infectious and parasitic diseases,183,Date,Both sexes,Jul 2019,183,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130027,Source of report of A18 (tuberculosis of other organs),2401,Certain infectious and parasitic diseases,183,Categorical (single),Both sexes,Jul 2019,183,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130028,Date A19 first reported (miliary tuberculosis),2401,Certain infectious and parasitic diseases,21,Date,Both sexes,Jul 2019,21,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130029,Source of report of A19 (miliary tuberculosis),2401,Certain infectious and parasitic diseases,21,Categorical (single),Both sexes,Jul 2019,21,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130030,Date A20 first reported (plague),2401,Certain infectious and parasitic diseases,5,Date,Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130031,Source of report of A20 (plague),2401,Certain infectious and parasitic diseases,5,Categorical (single),Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130032,Date A21 first reported (tularaemia),2401,Certain infectious and parasitic diseases,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130033,Source of report of A21 (tularaemia),2401,Certain infectious and parasitic diseases,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130034,Date A22 first reported (anthrax),2401,Certain infectious and parasitic diseases,2,Date,Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130035,Source of report of A22 (anthrax),2401,Certain infectious and parasitic diseases,2,Categorical (single),Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130036,Date A23 first reported (brucellosis),2401,Certain infectious and parasitic diseases,32,Date,Both sexes,Jul 2019,32,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130037,Source of report of A23 (brucellosis),2401,Certain infectious and parasitic diseases,32,Categorical (single),Both sexes,Jul 2019,32,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130038,Date A24 first reported (glanders and melioidosis),2401,Certain infectious and parasitic diseases,1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130039,Source of report of A24 (glanders and melioidosis),2401,Certain infectious and parasitic diseases,1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130040,Date A25 first reported (rat-bite fevers),2401,Certain infectious and parasitic diseases,3,Date,Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130041,Source of report of A25 (rat-bite fevers),2401,Certain infectious and parasitic diseases,3,Categorical (single),Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130042,Date A26 first reported (erysipeloid),2401,Certain infectious and parasitic diseases,12,Date,Both sexes,Jul 2019,12,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130043,Source of report of A26 (erysipeloid),2401,Certain infectious and parasitic diseases,12,Categorical (single),Both sexes,Jul 2019,12,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130044,Date A27 first reported (leptospirosis),2401,Certain infectious and parasitic diseases,27,Date,Both sexes,Jul 2019,27,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130045,Source of report of A27 (leptospirosis),2401,Certain infectious and parasitic diseases,27,Categorical (single),Both sexes,Jul 2019,27,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130046,"Date A28 first reported (other zoonotic bacterial diseases, not elsewhere classified)",2401,Certain infectious and parasitic diseases,51,Date,Both sexes,Jul 2019,51,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130047,"Source of report of A28 (other zoonotic bacterial diseases, not elsewhere classified)",2401,Certain infectious and parasitic diseases,51,Categorical (single),Both sexes,Jul 2019,51,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130048,Date A30 first reported (leprosy [hansen's disease]),2401,Certain infectious and parasitic diseases,3,Date,Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130049,Source of report of A30 (leprosy [hansen's disease]),2401,Certain infectious and parasitic diseases,3,Categorical (single),Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130050,Date A31 first reported (infection due to other mycobacteria),2401,Certain infectious and parasitic diseases,107,Date,Both sexes,Jul 2019,107,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130051,Source of report of A31 (infection due to other mycobacteria),2401,Certain infectious and parasitic diseases,107,Categorical (single),Both sexes,Jul 2019,107,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130052,Date A32 first reported (listeriosis),2401,Certain infectious and parasitic diseases,17,Date,Both sexes,Jul 2019,17,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130053,Source of report of A32 (listeriosis),2401,Certain infectious and parasitic diseases,17,Categorical (single),Both sexes,Jul 2019,17,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130054,Date A33 first reported (tetanus neonatorum),2401,Certain infectious and parasitic diseases,1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130055,Source of report of A33 (tetanus neonatorum),2401,Certain infectious and parasitic diseases,1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130056,Date A34 first reported (obstetrical tetanus),2401,Certain infectious and parasitic diseases,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130057,Source of report of A34 (obstetrical tetanus),2401,Certain infectious and parasitic diseases,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130058,Date A35 first reported (other tetanus),2401,Certain infectious and parasitic diseases,118,Date,Both sexes,Jul 2019,118,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130059,Source of report of A35 (other tetanus),2401,Certain infectious and parasitic diseases,118,Categorical (single),Both sexes,Jul 2019,118,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130060,Date A36 first reported (diphtheria),2401,Certain infectious and parasitic diseases,137,Date,Both sexes,Jul 2019,137,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130061,Source of report of A36 (diphtheria),2401,Certain infectious and parasitic diseases,137,Categorical (single),Both sexes,Jul 2019,137,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130062,Date A37 first reported (whooping cough),2401,Certain infectious and parasitic diseases,"2,121",Date,Both sexes,Jul 2019,"2,121",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130063,Source of report of A37 (whooping cough),2401,Certain infectious and parasitic diseases,"2,121",Categorical (single),Both sexes,Jul 2019,"2,121",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130064,Date A38 first reported (scarlet fever),2401,Certain infectious and parasitic diseases,"1,290",Date,Both sexes,Jul 2019,"1,290",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130065,Source of report of A38 (scarlet fever),2401,Certain infectious and parasitic diseases,"1,290",Categorical (single),Both sexes,Jul 2019,"1,290",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130066,Date A39 first reported (meningococcal infection),2401,Certain infectious and parasitic diseases,107,Date,Both sexes,Jul 2019,107,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130067,Source of report of A39 (meningococcal infection),2401,Certain infectious and parasitic diseases,107,Categorical (single),Both sexes,Jul 2019,107,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130068,Date A40 first reported (streptococcal septicaemia),2401,Certain infectious and parasitic diseases,427,Date,Both sexes,Jul 2019,427,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130069,Source of report of A40 (streptococcal septicaemia),2401,Certain infectious and parasitic diseases,427,Categorical (single),Both sexes,Jul 2019,427,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130070,Date A41 first reported (other septicaemia),2401,Certain infectious and parasitic diseases,"7,492",Date,Both sexes,Jul 2019,"7,492",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130071,Source of report of A41 (other septicaemia),2401,Certain infectious and parasitic diseases,"7,492",Categorical (single),Both sexes,Jul 2019,"7,492",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130072,Date A42 first reported (actinomycosis),2401,Certain infectious and parasitic diseases,211,Date,Both sexes,Jul 2019,211,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130073,Source of report of A42 (actinomycosis),2401,Certain infectious and parasitic diseases,211,Categorical (single),Both sexes,Jul 2019,211,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130074,Date A43 first reported (nocardiosis),2401,Certain infectious and parasitic diseases,3,Date,Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130075,Source of report of A43 (nocardiosis),2401,Certain infectious and parasitic diseases,3,Categorical (single),Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130076,Date A44 first reported (bartonellosis),2401,Certain infectious and parasitic diseases,1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130077,Source of report of A44 (bartonellosis),2401,Certain infectious and parasitic diseases,1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130078,Date A46 first reported (erysipelas),2401,Certain infectious and parasitic diseases,302,Date,Both sexes,Jul 2019,302,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130079,Source of report of A46 (erysipelas),2401,Certain infectious and parasitic diseases,302,Categorical (single),Both sexes,Jul 2019,302,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130080,"Date A48 first reported (other bacterial diseases, not elsewhere classified)",2401,Certain infectious and parasitic diseases,173,Date,Both sexes,Jul 2019,173,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130081,"Source of report of A48 (other bacterial diseases, not elsewhere classified)",2401,Certain infectious and parasitic diseases,173,Categorical (single),Both sexes,Jul 2019,173,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130082,Date A49 first reported (bacterial infection of unspecified site),2401,Certain infectious and parasitic diseases,"1,720",Date,Both sexes,Jul 2019,"1,720",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130083,Source of report of A49 (bacterial infection of unspecified site),2401,Certain infectious and parasitic diseases,"1,720",Categorical (single),Both sexes,Jul 2019,"1,720",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130084,Date A50 first reported (congenital syphilis),2401,Certain infectious and parasitic diseases,9,Date,Both sexes,Jul 2019,9,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130085,Source of report of A50 (congenital syphilis),2401,Certain infectious and parasitic diseases,9,Categorical (single),Both sexes,Jul 2019,9,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130086,Date A51 first reported (early syphilis),2401,Certain infectious and parasitic diseases,20,Date,Both sexes,Jul 2019,20,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130087,Source of report of A51 (early syphilis),2401,Certain infectious and parasitic diseases,20,Categorical (single),Both sexes,Jul 2019,20,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130088,Date A52 first reported (late syphilis),2401,Certain infectious and parasitic diseases,21,Date,Both sexes,Jul 2019,21,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130089,Source of report of A52 (late syphilis),2401,Certain infectious and parasitic diseases,21,Categorical (single),Both sexes,Jul 2019,21,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130090,Date A53 first reported (other and unspecified syphilis),2401,Certain infectious and parasitic diseases,29,Date,Both sexes,Jul 2019,29,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130091,Source of report of A53 (other and unspecified syphilis),2401,Certain infectious and parasitic diseases,29,Categorical (single),Both sexes,Jul 2019,29,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130092,Date A54 first reported (gonococcal infection),2401,Certain infectious and parasitic diseases,282,Date,Both sexes,Jul 2019,282,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130093,Source of report of A54 (gonococcal infection),2401,Certain infectious and parasitic diseases,282,Categorical (single),Both sexes,Jul 2019,282,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130094,Date A55 first reported (chlamydial lymphogranuloma (venereum)),2401,Certain infectious and parasitic diseases,4,Date,Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130095,Source of report of A55 (chlamydial lymphogranuloma (venereum)),2401,Certain infectious and parasitic diseases,4,Categorical (single),Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130096,Date A56 first reported (other sexually transmitted chlamydial diseases),2401,Certain infectious and parasitic diseases,84,Date,Both sexes,Jul 2019,84,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130097,Source of report of A56 (other sexually transmitted chlamydial diseases),2401,Certain infectious and parasitic diseases,84,Categorical (single),Both sexes,Jul 2019,84,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130098,Date A57 first reported (chancroid),2401,Certain infectious and parasitic diseases,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130099,Source of report of A57 (chancroid),2401,Certain infectious and parasitic diseases,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130100,Date A58 first reported (granuloma inguinale),2401,Certain infectious and parasitic diseases,2,Date,Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130101,Source of report of A58 (granuloma inguinale),2401,Certain infectious and parasitic diseases,2,Categorical (single),Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130102,Date A59 first reported (trichomoniasis),2401,Certain infectious and parasitic diseases,90,Date,Both sexes,Jul 2019,90,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130103,Source of report of A59 (trichomoniasis),2401,Certain infectious and parasitic diseases,90,Categorical (single),Both sexes,Jul 2019,90,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130104,Date A60 first reported (anogenital herpesviral [herpes simplex] infections),2401,Certain infectious and parasitic diseases,447,Date,Both sexes,Jul 2019,447,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130105,Source of report of A60 (anogenital herpesviral [herpes simplex] infections),2401,Certain infectious and parasitic diseases,447,Categorical (single),Both sexes,Jul 2019,447,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130106,"Date A63 first reported (other predominantly sexually transmitted diseases, not elsewhere classified)",2401,Certain infectious and parasitic diseases,"1,842",Date,Both sexes,Jul 2019,"1,842",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130107,"Source of report of A63 (other predominantly sexually transmitted diseases, not elsewhere classified)",2401,Certain infectious and parasitic diseases,"1,842",Categorical (single),Both sexes,Jul 2019,"1,842",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130108,Date A64 first reported (unspecified sexually transmitted disease),2401,Certain infectious and parasitic diseases,3,Date,Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130109,Source of report of A64 (unspecified sexually transmitted disease),2401,Certain infectious and parasitic diseases,3,Categorical (single),Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130110,Date A65 first reported (non-venereal syphilis),2401,Certain infectious and parasitic diseases,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130111,Source of report of A65 (non-venereal syphilis),2401,Certain infectious and parasitic diseases,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130112,Date A66 first reported (yaws),2401,Certain infectious and parasitic diseases,22,Date,Both sexes,Jul 2019,22,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130113,Source of report of A66 (yaws),2401,Certain infectious and parasitic diseases,22,Categorical (single),Both sexes,Jul 2019,22,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130114,Date A67 first reported (pinta [carate]),2401,Certain infectious and parasitic diseases,6,Date,Both sexes,Jul 2019,6,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130115,Source of report of A67 (pinta [carate]),2401,Certain infectious and parasitic diseases,6,Categorical (single),Both sexes,Jul 2019,6,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130116,Date A68 first reported (relapsing fevers),2401,Certain infectious and parasitic diseases,2,Date,Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130117,Source of report of A68 (relapsing fevers),2401,Certain infectious and parasitic diseases,2,Categorical (single),Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130118,Date A69 first reported (other spirochaetal infections),2401,Certain infectious and parasitic diseases,280,Date,Both sexes,Jul 2019,280,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130119,Source of report of A69 (other spirochaetal infections),2401,Certain infectious and parasitic diseases,280,Categorical (single),Both sexes,Jul 2019,280,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130120,Date A70 first reported (chlamydia psittaci infection),2401,Certain infectious and parasitic diseases,31,Date,Both sexes,Jul 2019,31,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130121,Source of report of A70 (chlamydia psittaci infection),2401,Certain infectious and parasitic diseases,31,Categorical (single),Both sexes,Jul 2019,31,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130122,Date A71 first reported (trachoma),2401,Certain infectious and parasitic diseases,35,Date,Both sexes,Jul 2019,35,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130123,Source of report of A71 (trachoma),2401,Certain infectious and parasitic diseases,35,Categorical (single),Both sexes,Jul 2019,35,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130124,Date A74 first reported (other diseases caused by chlamydiae),2401,Certain infectious and parasitic diseases,31,Date,Both sexes,Jul 2019,31,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130125,Source of report of A74 (other diseases caused by chlamydiae),2401,Certain infectious and parasitic diseases,31,Categorical (single),Both sexes,Jul 2019,31,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130126,Date A75 first reported (typhus fever),2401,Certain infectious and parasitic diseases,4,Date,Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130127,Source of report of A75 (typhus fever),2401,Certain infectious and parasitic diseases,4,Categorical (single),Both sexes,Jul 2019,4,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130128,Date A77 first reported (spotted fever [tick-borne rickettsioses]),2401,Certain infectious and parasitic diseases,20,Date,Both sexes,Jul 2019,20,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130129,Source of report of A77 (spotted fever [tick-borne rickettsioses]),2401,Certain infectious and parasitic diseases,20,Categorical (single),Both sexes,Jul 2019,20,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130130,Date A78 first reported (q fever),2401,Certain infectious and parasitic diseases,10,Date,Both sexes,Jul 2019,10,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130131,Source of report of A78 (q fever),2401,Certain infectious and parasitic diseases,10,Categorical (single),Both sexes,Jul 2019,10,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130132,Date A79 first reported (other rickettsioses),2401,Certain infectious and parasitic diseases,2,Date,Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130133,Source of report of A79 (other rickettsioses),2401,Certain infectious and parasitic diseases,2,Categorical (single),Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130134,Date A80 first reported (acute poliomyelitis),2401,Certain infectious and parasitic diseases,496,Date,Both sexes,Jul 2019,496,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130135,Source of report of A80 (acute poliomyelitis),2401,Certain infectious and parasitic diseases,496,Categorical (single),Both sexes,Jul 2019,496,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130136,Date A81 first reported (atypical virus infections of central nervous system),2401,Certain infectious and parasitic diseases,47,Date,Both sexes,Jul 2019,47,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130137,Source of report of A81 (atypical virus infections of central nervous system),2401,Certain infectious and parasitic diseases,47,Categorical (single),Both sexes,Jul 2019,47,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130138,Date A82 first reported (rabies),2401,Certain infectious and parasitic diseases,18,Date,Both sexes,Jul 2019,18,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130139,Source of report of A82 (rabies),2401,Certain infectious and parasitic diseases,18,Categorical (single),Both sexes,Jul 2019,18,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130140,Date A83 first reported (mosquito-borne viral encephalitis),2401,Certain infectious and parasitic diseases,33,Date,Both sexes,Jul 2019,33,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130141,Source of report of A83 (mosquito-borne viral encephalitis),2401,Certain infectious and parasitic diseases,33,Categorical (single),Both sexes,Jul 2019,33,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130142,Date A84 first reported (tick-borne viral encephalitis),2401,Certain infectious and parasitic diseases,8,Date,Both sexes,Jul 2019,8,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130143,Source of report of A84 (tick-borne viral encephalitis),2401,Certain infectious and parasitic diseases,8,Categorical (single),Both sexes,Jul 2019,8,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130144,"Date A85 first reported (other viral encephalitis, not elsewhere classified)",2401,Certain infectious and parasitic diseases,12,Date,Both sexes,Jul 2019,12,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130145,"Source of report of A85 (other viral encephalitis, not elsewhere classified)",2401,Certain infectious and parasitic diseases,12,Categorical (single),Both sexes,Jul 2019,12,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130146,Date A86 first reported (unspecified viral encephalitis),2401,Certain infectious and parasitic diseases,90,Date,Both sexes,Jul 2019,90,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130147,Source of report of A86 (unspecified viral encephalitis),2401,Certain infectious and parasitic diseases,90,Categorical (single),Both sexes,Jul 2019,90,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130148,Date A87 first reported (viral meningitis),2401,Certain infectious and parasitic diseases,491,Date,Both sexes,Jul 2019,491,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130149,Source of report of A87 (viral meningitis),2401,Certain infectious and parasitic diseases,491,Categorical (single),Both sexes,Jul 2019,491,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130150,"Date A88 first reported (other viral infections of central nervous system, not elsewhere classified)",2401,Certain infectious and parasitic diseases,22,Date,Both sexes,Jul 2019,22,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130151,"Source of report of A88 (other viral infections of central nervous system, not elsewhere classified)",2401,Certain infectious and parasitic diseases,22,Categorical (single),Both sexes,Jul 2019,22,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130152,Date A89 first reported (unspecified viral infection of central nervous system),2401,Certain infectious and parasitic diseases,37,Date,Both sexes,Jul 2019,37,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130153,Source of report of A89 (unspecified viral infection of central nervous system),2401,Certain infectious and parasitic diseases,37,Categorical (single),Both sexes,Jul 2019,37,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130154,Date A90 first reported (dengue fever [classical dengue]),2401,Certain infectious and parasitic diseases,9,Date,Both sexes,Jul 2019,9,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130155,Source of report of A90 (dengue fever [classical dengue]),2401,Certain infectious and parasitic diseases,9,Categorical (single),Both sexes,Jul 2019,9,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130156,Date A91 first reported (dengue haemorrhagic fever),2401,Certain infectious and parasitic diseases,2,Date,Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130157,Source of report of A91 (dengue haemorrhagic fever),2401,Certain infectious and parasitic diseases,2,Categorical (single),Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130158,Date A92 first reported (other mosquito-borne viral fevers),2401,Certain infectious and parasitic diseases,14,Date,Both sexes,Jul 2019,14,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130159,Source of report of A92 (other mosquito-borne viral fevers),2401,Certain infectious and parasitic diseases,14,Categorical (single),Both sexes,Jul 2019,14,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130160,"Date A93 first reported (other arthropod-borne viral fevers, not elsewhere classified)",2401,Certain infectious and parasitic diseases,9,Date,Both sexes,Jul 2019,9,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130161,"Source of report of A93 (other arthropod-borne viral fevers, not elsewhere classified)",2401,Certain infectious and parasitic diseases,9,Categorical (single),Both sexes,Jul 2019,9,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130162,Date A94 first reported (unspecified arthropod-borne viral fever),2401,Certain infectious and parasitic diseases,4,Date,Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130163,Source of report of A94 (unspecified arthropod-borne viral fever),2401,Certain infectious and parasitic diseases,4,Categorical (single),Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130164,Date A95 first reported (yellow fever),2401,Certain infectious and parasitic diseases,72,Date,Both sexes,Jul 2019,72,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130165,Source of report of A95 (yellow fever),2401,Certain infectious and parasitic diseases,72,Categorical (single),Both sexes,Jul 2019,72,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130166,Date A96 first reported (arenaviral haemorrhagic fever),2401,Certain infectious and parasitic diseases,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130167,Source of report of A96 (arenaviral haemorrhagic fever),2401,Certain infectious and parasitic diseases,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130168,Date A97 first reported (dengue),2401,Certain infectious and parasitic diseases,33,Date,Both sexes,Jul 2019,33,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130169,Source of report of A97 (dengue),2401,Certain infectious and parasitic diseases,33,Categorical (single),Both sexes,Jul 2019,33,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130170,"Date A98 first reported (other viral haemorrhagic fevers, not elsewhere classified)",2401,Certain infectious and parasitic diseases,1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130171,"Source of report of A98 (other viral haemorrhagic fevers, not elsewhere classified)",2401,Certain infectious and parasitic diseases,1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130172,Date A99 first reported (unspecified viral haemorrhagic fever),2401,Certain infectious and parasitic diseases,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130173,Source of report of A99 (unspecified viral haemorrhagic fever),2401,Certain infectious and parasitic diseases,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130174,Date B00 first reported (herpesviral [herpes simplex] infections),2401,Certain infectious and parasitic diseases,"4,624",Date,Both sexes,Jul 2019,"4,624",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130175,Source of report of B00 (herpesviral [herpes simplex] infections),2401,Certain infectious and parasitic diseases,"4,624",Categorical (single),Both sexes,Jul 2019,"4,624",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130176,Date B01 first reported (varicella [chickenpox]),2401,Certain infectious and parasitic diseases,"11,665",Date,Both sexes,Jul 2019,"11,665",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130177,Source of report of B01 (varicella [chickenpox]),2401,Certain infectious and parasitic diseases,"11,665",Categorical (single),Both sexes,Jul 2019,"11,665",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130178,Date B02 first reported (zoster [herpes zoster]),2401,Certain infectious and parasitic diseases,"15,909",Date,Both sexes,Jul 2019,"15,909",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130179,Source of report of B02 (zoster [herpes zoster]),2401,Certain infectious and parasitic diseases,"15,909",Categorical (single),Both sexes,Jul 2019,"15,909",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130180,Date B03 first reported (smallpox),2401,Certain infectious and parasitic diseases,14,Date,Both sexes,Jul 2019,14,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130181,Source of report of B03 (smallpox),2401,Certain infectious and parasitic diseases,14,Categorical (single),Both sexes,Jul 2019,14,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130182,Date B04 first reported (monkeypox),2401,Certain infectious and parasitic diseases,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130183,Source of report of B04 (monkeypox),2401,Certain infectious and parasitic diseases,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130184,Date B05 first reported (measles),2401,Certain infectious and parasitic diseases,"8,342",Date,Both sexes,Jul 2019,"8,342",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130185,Source of report of B05 (measles),2401,Certain infectious and parasitic diseases,"8,342",Categorical (single),Both sexes,Jul 2019,"8,342",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130186,Date B06 first reported (rubella [german measles]),2401,Certain infectious and parasitic diseases,"3,233",Date,Both sexes,Jul 2019,"3,233",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130187,Source of report of B06 (rubella [german measles]),2401,Certain infectious and parasitic diseases,"3,233",Categorical (single),Both sexes,Jul 2019,"3,233",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130188,Date B07 first reported (viral warts),2401,Certain infectious and parasitic diseases,"17,495",Date,Both sexes,Jul 2019,"17,495",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130189,Source of report of B07 (viral warts),2401,Certain infectious and parasitic diseases,"17,495",Categorical (single),Both sexes,Jul 2019,"17,495",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130190,"Date B08 first reported (other viral infections characterised by skin and mucous membrane lesions, not elsewhere classified)",2401,Certain infectious and parasitic diseases,"1,041",Date,Both sexes,Jul 2019,"1,041",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130191,"Source of report of B08 (other viral infections characterised by skin and mucous membrane lesions, not elsewhere classified)",2401,Certain infectious and parasitic diseases,"1,041",Categorical (single),Both sexes,Jul 2019,"1,041",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130192,Date B09 first reported (unspecified viral infection characterised by skin and mucous membrane lesions),2401,Certain infectious and parasitic diseases,23,Date,Both sexes,Jul 2019,23,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130193,Source of report of B09 (unspecified viral infection characterised by skin and mucous membrane lesions),2401,Certain infectious and parasitic diseases,23,Categorical (single),Both sexes,Jul 2019,23,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130194,Date B15 first reported (acute hepatitis a),2401,Certain infectious and parasitic diseases,"1,071",Date,Both sexes,Jul 2019,"1,071",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130195,Source of report of B15 (acute hepatitis a),2401,Certain infectious and parasitic diseases,"1,071",Categorical (single),Both sexes,Jul 2019,"1,071",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130196,Date B16 first reported (acute hepatitis b),2401,Certain infectious and parasitic diseases,245,Date,Both sexes,Jul 2019,245,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130197,Source of report of B16 (acute hepatitis b),2401,Certain infectious and parasitic diseases,245,Categorical (single),Both sexes,Jul 2019,245,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130198,Date B17 first reported (other acute viral hepatitis),2401,Certain infectious and parasitic diseases,263,Date,Both sexes,Jul 2019,263,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130199,Source of report of B17 (other acute viral hepatitis),2401,Certain infectious and parasitic diseases,263,Categorical (single),Both sexes,Jul 2019,263,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130200,Date B18 first reported (chronic viral hepatitis),2401,Certain infectious and parasitic diseases,694,Date,Both sexes,Jul 2019,694,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130201,Source of report of B18 (chronic viral hepatitis),2401,Certain infectious and parasitic diseases,694,Categorical (single),Both sexes,Jul 2019,694,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130202,Date B19 first reported (unspecified viral hepatitis),2401,Certain infectious and parasitic diseases,"1,323",Date,Both sexes,Jul 2019,"1,323",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130203,Source of report of B19 (unspecified viral hepatitis),2401,Certain infectious and parasitic diseases,"1,323",Categorical (single),Both sexes,Jul 2019,"1,323",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130204,Date B20 first reported (human immunodeficiency virus [hiv] disease resulting in infectious and parasitic diseases),2401,Certain infectious and parasitic diseases,67,Date,Both sexes,Jul 2019,67,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130205,Source of report of B20 (human immunodeficiency virus [hiv] disease resulting in infectious and parasitic diseases),2401,Certain infectious and parasitic diseases,67,Categorical (single),Both sexes,Jul 2019,67,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130206,Date B21 first reported (human immunodeficiency virus [hiv] disease resulting in malignant neoplasms),2401,Certain infectious and parasitic diseases,16,Date,Both sexes,Jul 2019,16,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130207,Source of report of B21 (human immunodeficiency virus [hiv] disease resulting in malignant neoplasms),2401,Certain infectious and parasitic diseases,16,Categorical (single),Both sexes,Jul 2019,16,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130208,Date B22 first reported (human immunodeficiency virus [hiv] disease resulting in other specified diseases),2401,Certain infectious and parasitic diseases,12,Date,Both sexes,Jul 2019,12,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130209,Source of report of B22 (human immunodeficiency virus [hiv] disease resulting in other specified diseases),2401,Certain infectious and parasitic diseases,12,Categorical (single),Both sexes,Jul 2019,12,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130210,Date B23 first reported (human immunodeficiency virus [hiv] disease resulting in other conditions),2401,Certain infectious and parasitic diseases,40,Date,Both sexes,Jul 2019,40,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130211,Source of report of B23 (human immunodeficiency virus [hiv] disease resulting in other conditions),2401,Certain infectious and parasitic diseases,40,Categorical (single),Both sexes,Jul 2019,40,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130212,Date B24 first reported (unspecified human immunodeficiency virus [hiv] disease),2401,Certain infectious and parasitic diseases,512,Date,Both sexes,Jul 2019,512,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130213,Source of report of B24 (unspecified human immunodeficiency virus [hiv] disease),2401,Certain infectious and parasitic diseases,512,Categorical (single),Both sexes,Jul 2019,512,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130214,Date B25 first reported (cytomegaloviral disease),2401,Certain infectious and parasitic diseases,230,Date,Both sexes,Jul 2019,230,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130215,Source of report of B25 (cytomegaloviral disease),2401,Certain infectious and parasitic diseases,230,Categorical (single),Both sexes,Jul 2019,230,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130216,Date B26 first reported (mumps),2401,Certain infectious and parasitic diseases,"5,418",Date,Both sexes,Jul 2019,"5,418",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130217,Source of report of B26 (mumps),2401,Certain infectious and parasitic diseases,"5,418",Categorical (single),Both sexes,Jul 2019,"5,418",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130218,Date B27 first reported (infectious mononucleosis),2401,Certain infectious and parasitic diseases,"3,261",Date,Both sexes,Jul 2019,"3,261",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130219,Source of report of B27 (infectious mononucleosis),2401,Certain infectious and parasitic diseases,"3,261",Categorical (single),Both sexes,Jul 2019,"3,261",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130220,Date B30 first reported (viral conjunctivitis),2401,Certain infectious and parasitic diseases,196,Date,Both sexes,Jul 2019,196,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130221,Source of report of B30 (viral conjunctivitis),2401,Certain infectious and parasitic diseases,196,Categorical (single),Both sexes,Jul 2019,196,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130222,"Date B33 first reported (other viral diseases, not elsewhere classified)",2401,Certain infectious and parasitic diseases,230,Date,Both sexes,Jul 2019,230,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130223,"Source of report of B33 (other viral diseases, not elsewhere classified)",2401,Certain infectious and parasitic diseases,230,Categorical (single),Both sexes,Jul 2019,230,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130224,Date B34 first reported (viral infection of unspecified site),2401,Certain infectious and parasitic diseases,"11,209",Date,Both sexes,Jul 2019,"11,209",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130225,Source of report of B34 (viral infection of unspecified site),2401,Certain infectious and parasitic diseases,"11,209",Categorical (single),Both sexes,Jul 2019,"11,209",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130226,Date B35 first reported (dermatophytosis),2401,Certain infectious and parasitic diseases,"32,856",Date,Both sexes,Jul 2019,"32,856",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130227,Source of report of B35 (dermatophytosis),2401,Certain infectious and parasitic diseases,"32,856",Categorical (single),Both sexes,Jul 2019,"32,856",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130228,Date B36 first reported (other superficial mycoses),2401,Certain infectious and parasitic diseases,"5,799",Date,Both sexes,Jul 2019,"5,799",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130229,Source of report of B36 (other superficial mycoses),2401,Certain infectious and parasitic diseases,"5,799",Categorical (single),Both sexes,Jul 2019,"5,799",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130230,Date B37 first reported (candidiasis),2401,Certain infectious and parasitic diseases,"9,690",Date,Both sexes,Jul 2019,"9,690",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130231,Source of report of B37 (candidiasis),2401,Certain infectious and parasitic diseases,"9,690",Categorical (single),Both sexes,Jul 2019,"9,690",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130232,Date B38 first reported (coccidioidomycosis),2401,Certain infectious and parasitic diseases,1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130233,Source of report of B38 (coccidioidomycosis),2401,Certain infectious and parasitic diseases,1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130234,Date B39 first reported (histoplasmosis),2401,Certain infectious and parasitic diseases,9,Date,Both sexes,Jul 2019,9,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130235,Source of report of B39 (histoplasmosis),2401,Certain infectious and parasitic diseases,9,Categorical (single),Both sexes,Jul 2019,9,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130236,Date B40 first reported (blastomycosis),2401,Certain infectious and parasitic diseases,1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130237,Source of report of B40 (blastomycosis),2401,Certain infectious and parasitic diseases,1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130238,Date B41 first reported (paracoccidioidomycosis),2401,Certain infectious and parasitic diseases,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130239,Source of report of B41 (paracoccidioidomycosis),2401,Certain infectious and parasitic diseases,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130240,Date B42 first reported (sporotrichosis),2401,Certain infectious and parasitic diseases,2,Date,Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130241,Source of report of B42 (sporotrichosis),2401,Certain infectious and parasitic diseases,2,Categorical (single),Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130242,Date B43 first reported (chromomycosis and phaeomycotic abscess),2401,Certain infectious and parasitic diseases,3,Date,Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130243,Source of report of B43 (chromomycosis and phaeomycotic abscess),2401,Certain infectious and parasitic diseases,3,Categorical (single),Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130244,Date B44 first reported (aspergillosis),2401,Certain infectious and parasitic diseases,305,Date,Both sexes,Jul 2019,305,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130245,Source of report of B44 (aspergillosis),2401,Certain infectious and parasitic diseases,305,Categorical (single),Both sexes,Jul 2019,305,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130246,Date B45 first reported (cryptococcosis),2401,Certain infectious and parasitic diseases,7,Date,Both sexes,Jul 2019,7,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130247,Source of report of B45 (cryptococcosis),2401,Certain infectious and parasitic diseases,7,Categorical (single),Both sexes,Jul 2019,7,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130248,Date B46 first reported (zygomycosis),2401,Certain infectious and parasitic diseases,3,Date,Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130249,Source of report of B46 (zygomycosis),2401,Certain infectious and parasitic diseases,3,Categorical (single),Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130250,Date B47 first reported (mycetoma),2401,Certain infectious and parasitic diseases,17,Date,Both sexes,Jul 2019,17,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130251,Source of report of B47 (mycetoma),2401,Certain infectious and parasitic diseases,17,Categorical (single),Both sexes,Jul 2019,17,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130252,"Date B48 first reported (other mycoses, not elsewhere classified)",2401,Certain infectious and parasitic diseases,28,Date,Both sexes,Jul 2019,28,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130253,"Source of report of B48 (other mycoses, not elsewhere classified)",2401,Certain infectious and parasitic diseases,28,Categorical (single),Both sexes,Jul 2019,28,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130254,Date B49 first reported (unspecified mycosis),2401,Certain infectious and parasitic diseases,442,Date,Both sexes,Jul 2019,442,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130255,Source of report of B49 (unspecified mycosis),2401,Certain infectious and parasitic diseases,442,Categorical (single),Both sexes,Jul 2019,442,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130256,Date B50 first reported (plasmodium falciparum malaria),2401,Certain infectious and parasitic diseases,170,Date,Both sexes,Jul 2019,170,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130257,Source of report of B50 (plasmodium falciparum malaria),2401,Certain infectious and parasitic diseases,170,Categorical (single),Both sexes,Jul 2019,170,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130258,Date B51 first reported (plasmodium vivax malaria),2401,Certain infectious and parasitic diseases,40,Date,Both sexes,Jul 2019,40,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130259,Source of report of B51 (plasmodium vivax malaria),2401,Certain infectious and parasitic diseases,40,Categorical (single),Both sexes,Jul 2019,40,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130260,Date B52 first reported (plasmodium malariae malaria),2401,Certain infectious and parasitic diseases,5,Date,Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130261,Source of report of B52 (plasmodium malariae malaria),2401,Certain infectious and parasitic diseases,5,Categorical (single),Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130262,Date B53 first reported (other parasitologically confirmed malaria),2401,Certain infectious and parasitic diseases,4,Date,Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130263,Source of report of B53 (other parasitologically confirmed malaria),2401,Certain infectious and parasitic diseases,4,Categorical (single),Both sexes,Jul 2019,4,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130264,Date B54 first reported (unspecified malaria),2401,Certain infectious and parasitic diseases,861,Date,Both sexes,Jul 2019,861,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130265,Source of report of B54 (unspecified malaria),2401,Certain infectious and parasitic diseases,861,Categorical (single),Both sexes,Jul 2019,861,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130266,Date B55 first reported (leishmaniasis),2401,Certain infectious and parasitic diseases,14,Date,Both sexes,Jul 2019,14,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130267,Source of report of B55 (leishmaniasis),2401,Certain infectious and parasitic diseases,14,Categorical (single),Both sexes,Jul 2019,14,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130268,Date B56 first reported (african trypanosomiasis),2401,Certain infectious and parasitic diseases,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130269,Source of report of B56 (african trypanosomiasis),2401,Certain infectious and parasitic diseases,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130270,Date B57 first reported (chagas' disease),2401,Certain infectious and parasitic diseases,1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130271,Source of report of B57 (chagas' disease),2401,Certain infectious and parasitic diseases,1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130272,Date B58 first reported (toxoplasmosis),2401,Certain infectious and parasitic diseases,55,Date,Both sexes,Jul 2019,55,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130273,Source of report of B58 (toxoplasmosis),2401,Certain infectious and parasitic diseases,55,Categorical (single),Both sexes,Jul 2019,55,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130274,Date B59 first reported (pneumocystosis),2401,Certain infectious and parasitic diseases,95,Date,Both sexes,Jul 2019,95,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130275,Source of report of B59 (pneumocystosis),2401,Certain infectious and parasitic diseases,95,Categorical (single),Both sexes,Jul 2019,95,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130276,"Date B60 first reported (other protozoal diseases, not elsewhere classified)",2401,Certain infectious and parasitic diseases,10,Date,Both sexes,Jul 2019,10,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130277,"Source of report of B60 (other protozoal diseases, not elsewhere classified)",2401,Certain infectious and parasitic diseases,10,Categorical (single),Both sexes,Jul 2019,10,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130278,Date B64 first reported (unspecified protozoal disease),2401,Certain infectious and parasitic diseases,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130279,Source of report of B64 (unspecified protozoal disease),2401,Certain infectious and parasitic diseases,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130280,Date B65 first reported (schistosomiasis [bilharziasis]),2401,Certain infectious and parasitic diseases,110,Date,Both sexes,Jul 2019,110,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130281,Source of report of B65 (schistosomiasis [bilharziasis]),2401,Certain infectious and parasitic diseases,110,Categorical (single),Both sexes,Jul 2019,110,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130282,Date B66 first reported (other fluke infections),2401,Certain infectious and parasitic diseases,5,Date,Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130283,Source of report of B66 (other fluke infections),2401,Certain infectious and parasitic diseases,5,Categorical (single),Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130284,Date B67 first reported (echinococcosis),2401,Certain infectious and parasitic diseases,11,Date,Both sexes,Jul 2019,11,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130285,Source of report of B67 (echinococcosis),2401,Certain infectious and parasitic diseases,11,Categorical (single),Both sexes,Jul 2019,11,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130286,Date B68 first reported (taeniasis),2401,Certain infectious and parasitic diseases,11,Date,Both sexes,Jul 2019,11,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130287,Source of report of B68 (taeniasis),2401,Certain infectious and parasitic diseases,11,Categorical (single),Both sexes,Jul 2019,11,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130288,Date B69 first reported (cysticercosis),2401,Certain infectious and parasitic diseases,6,Date,Both sexes,Jul 2019,6,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130289,Source of report of B69 (cysticercosis),2401,Certain infectious and parasitic diseases,6,Categorical (single),Both sexes,Jul 2019,6,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130290,Date B70 first reported (diphyllobothriasis and sparganosis),2401,Certain infectious and parasitic diseases,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130291,Source of report of B70 (diphyllobothriasis and sparganosis),2401,Certain infectious and parasitic diseases,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130292,Date B71 first reported (other cestode infections),2401,Certain infectious and parasitic diseases,13,Date,Both sexes,Jul 2019,13,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130293,Source of report of B71 (other cestode infections),2401,Certain infectious and parasitic diseases,13,Categorical (single),Both sexes,Jul 2019,13,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130294,Date B72 first reported (dracunculiasis),2401,Certain infectious and parasitic diseases,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130295,Source of report of B72 (dracunculiasis),2401,Certain infectious and parasitic diseases,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130296,Date B73 first reported (onchocerciasis),2401,Certain infectious and parasitic diseases,17,Date,Both sexes,Jul 2019,17,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130297,Source of report of B73 (onchocerciasis),2401,Certain infectious and parasitic diseases,17,Categorical (single),Both sexes,Jul 2019,17,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130298,Date B74 first reported (filariasis),2401,Certain infectious and parasitic diseases,4,Date,Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130299,Source of report of B74 (filariasis),2401,Certain infectious and parasitic diseases,4,Categorical (single),Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130300,Date B75 first reported (trichinellosis),2401,Certain infectious and parasitic diseases,1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130301,Source of report of B75 (trichinellosis),2401,Certain infectious and parasitic diseases,1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130302,Date B76 first reported (hookworm diseases),2401,Certain infectious and parasitic diseases,33,Date,Both sexes,Jul 2019,33,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130303,Source of report of B76 (hookworm diseases),2401,Certain infectious and parasitic diseases,33,Categorical (single),Both sexes,Jul 2019,33,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130304,Date B77 first reported (ascariasis),2401,Certain infectious and parasitic diseases,11,Date,Both sexes,Jul 2019,11,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130305,Source of report of B77 (ascariasis),2401,Certain infectious and parasitic diseases,11,Categorical (single),Both sexes,Jul 2019,11,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130306,Date B78 first reported (strongyloidiasis),2401,Certain infectious and parasitic diseases,7,Date,Both sexes,Jul 2019,7,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130307,Source of report of B78 (strongyloidiasis),2401,Certain infectious and parasitic diseases,7,Categorical (single),Both sexes,Jul 2019,7,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130308,Date B79 first reported (trichuriasis),2401,Certain infectious and parasitic diseases,3,Date,Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130309,Source of report of B79 (trichuriasis),2401,Certain infectious and parasitic diseases,3,Categorical (single),Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130310,Date B80 first reported (enterobiasis),2401,Certain infectious and parasitic diseases,726,Date,Both sexes,Jul 2019,726,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130311,Source of report of B80 (enterobiasis),2401,Certain infectious and parasitic diseases,726,Categorical (single),Both sexes,Jul 2019,726,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130312,"Date B81 first reported (other intestinal helminthiases, not elsewhere classified)",2401,Certain infectious and parasitic diseases,17,Date,Both sexes,Jul 2019,17,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130313,"Source of report of B81 (other intestinal helminthiases, not elsewhere classified)",2401,Certain infectious and parasitic diseases,17,Categorical (single),Both sexes,Jul 2019,17,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130314,Date B82 first reported (unspecified intestinal parasitism),2401,Certain infectious and parasitic diseases,83,Date,Both sexes,Jul 2019,83,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130315,Source of report of B82 (unspecified intestinal parasitism),2401,Certain infectious and parasitic diseases,83,Categorical (single),Both sexes,Jul 2019,83,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130316,Date B83 first reported (other helminthiases),2401,Certain infectious and parasitic diseases,81,Date,Both sexes,Jul 2019,81,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130317,Source of report of B83 (other helminthiases),2401,Certain infectious and parasitic diseases,81,Categorical (single),Both sexes,Jul 2019,81,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130318,Date B85 first reported (pediculosis and phthiriasis),2401,Certain infectious and parasitic diseases,330,Date,Both sexes,Jul 2019,330,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130319,Source of report of B85 (pediculosis and phthiriasis),2401,Certain infectious and parasitic diseases,330,Categorical (single),Both sexes,Jul 2019,330,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130320,Date B86 first reported (scabies),2401,Certain infectious and parasitic diseases,"2,429",Date,Both sexes,Jul 2019,"2,429",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130321,Source of report of B86 (scabies),2401,Certain infectious and parasitic diseases,"2,429",Categorical (single),Both sexes,Jul 2019,"2,429",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130322,Date B87 first reported (myiasis),2401,Certain infectious and parasitic diseases,7,Date,Both sexes,Jul 2019,7,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130323,Source of report of B87 (myiasis),2401,Certain infectious and parasitic diseases,7,Categorical (single),Both sexes,Jul 2019,7,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130324,Date B88 first reported (other infestations),2401,Certain infectious and parasitic diseases,181,Date,Both sexes,Jul 2019,181,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130325,Source of report of B88 (other infestations),2401,Certain infectious and parasitic diseases,181,Categorical (single),Both sexes,Jul 2019,181,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130326,Date B89 first reported (unspecified parasitic disease),2401,Certain infectious and parasitic diseases,4,Date,Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130327,Source of report of B89 (unspecified parasitic disease),2401,Certain infectious and parasitic diseases,4,Categorical (single),Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130328,Date B90 first reported (sequelae of tuberculosis),2401,Certain infectious and parasitic diseases,36,Date,Both sexes,Jul 2019,36,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130329,Source of report of B90 (sequelae of tuberculosis),2401,Certain infectious and parasitic diseases,36,Categorical (single),Both sexes,Jul 2019,36,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130330,Date B91 first reported (sequelae of poliomyelitis),2401,Certain infectious and parasitic diseases,193,Date,Both sexes,Jul 2019,193,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130331,Source of report of B91 (sequelae of poliomyelitis),2401,Certain infectious and parasitic diseases,193,Categorical (single),Both sexes,Jul 2019,193,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130332,Date B92 first reported (sequelae of leprosy),2401,Certain infectious and parasitic diseases,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130333,Source of report of B92 (sequelae of leprosy),2401,Certain infectious and parasitic diseases,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130334,Date B94 first reported (sequelae of other and unspecified infectious and parasitic diseases),2401,Certain infectious and parasitic diseases,93,Date,Both sexes,Jul 2019,93,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130335,Source of report of B94 (sequelae of other and unspecified infectious and parasitic diseases),2401,Certain infectious and parasitic diseases,93,Categorical (single),Both sexes,Jul 2019,93,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130336,Date B95 first reported (streptococcus and staphylococcus as the cause of diseases classified to other chapters),2401,Certain infectious and parasitic diseases,"6,168",Date,Both sexes,Jul 2019,"6,168",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130337,Source of report of B95 (streptococcus and staphylococcus as the cause of diseases classified to other chapters),2401,Certain infectious and parasitic diseases,"6,168",Categorical (single),Both sexes,Jul 2019,"6,168",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130338,Date B96 first reported (other bacterial agents as the cause of diseases classified to other chapters),2401,Certain infectious and parasitic diseases,"13,058",Date,Both sexes,Jul 2019,"13,058",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130339,Source of report of B96 (other bacterial agents as the cause of diseases classified to other chapters),2401,Certain infectious and parasitic diseases,"13,058",Categorical (single),Both sexes,Jul 2019,"13,058",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130340,Date B97 first reported (viral agents as the cause of diseases classified to other chapters),2401,Certain infectious and parasitic diseases,810,Date,Both sexes,Jul 2019,810,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130341,Source of report of B97 (viral agents as the cause of diseases classified to other chapters),2401,Certain infectious and parasitic diseases,810,Categorical (single),Both sexes,Jul 2019,810,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130342,Date B98 first reported (other specified infectious agents as the cause of diseases classified to other chapters),2401,Certain infectious and parasitic diseases,"3,507",Date,Both sexes,Jul 2019,"3,507",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130343,Source of report of B98 (other specified infectious agents as the cause of diseases classified to other chapters),2401,Certain infectious and parasitic diseases,"3,507",Categorical (single),Both sexes,Jul 2019,"3,507",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130344,Date B99 first reported (other and unspecified infectious diseases),2401,Certain infectious and parasitic diseases,701,Date,Both sexes,Jul 2019,701,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130345,Source of report of B99 (other and unspecified infectious diseases),2401,Certain infectious and parasitic diseases,701,Categorical (single),Both sexes,Jul 2019,701,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Certain infectious and parasitic diseases,0.0,0.0,0.0,0.0,0.0,0.0,0.0
2335,Chest pain or discomfort,100039,Chest pain,"501,600",Categorical (single),Both sexes,Jan 2012,"572,226",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Chest pain,0.0,0.0,0.0,0.0,0.0,0.0
3606,Chest pain or discomfort walking normally,100039,Chest pain,"85,073",Categorical (single),Both sexes,Jan 2012,"88,833",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Chest pain,0.0,0.0,0.0,0.0,0.0,0.0
3616,Chest pain due to walking ceases when standing still,100039,Chest pain,"33,672",Categorical (single),Both sexes,Jan 2012,"34,653",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Chest pain,0.0,0.0,0.0,0.0,0.0,0.0
3751,Chest pain or discomfort when walking uphill or hurrying,100039,Chest pain,"69,163",Categorical (single),Both sexes,Jan 2012,"72,060",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Chest pain,0.0,0.0,0.0,0.0,0.0,0.0
131270,Date I00 first reported (rheumatic fever without mention of heart involvement),2409,Circulatory system disorders,"1,597",Date,Both sexes,Jul 2019,"1,597",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131271,Source of report of I00 (rheumatic fever without mention of heart involvement),2409,Circulatory system disorders,"1,597",Categorical (single),Both sexes,Jul 2019,"1,597",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131272,Date I01 first reported (rheumatic fever with heart involvement),2409,Circulatory system disorders,28,Date,Both sexes,Jul 2019,28,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131273,Source of report of I01 (rheumatic fever with heart involvement),2409,Circulatory system disorders,28,Categorical (single),Both sexes,Jul 2019,28,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131274,Date I02 first reported (rheumatic chorea),2409,Circulatory system disorders,24,Date,Both sexes,Jul 2019,24,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131275,Source of report of I02 (rheumatic chorea),2409,Circulatory system disorders,24,Categorical (single),Both sexes,Jul 2019,24,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131276,Date I05 first reported (rheumatic mitral valve diseases),2409,Circulatory system disorders,619,Date,Both sexes,Jul 2019,619,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131277,Source of report of I05 (rheumatic mitral valve diseases),2409,Circulatory system disorders,619,Categorical (single),Both sexes,Jul 2019,619,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131278,Date I06 first reported (rheumatic aortic valve diseases),2409,Circulatory system disorders,95,Date,Both sexes,Jul 2019,95,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131279,Source of report of I06 (rheumatic aortic valve diseases),2409,Circulatory system disorders,95,Categorical (single),Both sexes,Jul 2019,95,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131280,Date I07 first reported (rheumatic tricuspid valve diseases),2409,Circulatory system disorders,890,Date,Both sexes,Jul 2019,890,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131281,Source of report of I07 (rheumatic tricuspid valve diseases),2409,Circulatory system disorders,890,Categorical (single),Both sexes,Jul 2019,890,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131282,Date I08 first reported (multiple valve diseases),2409,Circulatory system disorders,"3,159",Date,Both sexes,Jul 2019,"3,159",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131283,Source of report of I08 (multiple valve diseases),2409,Circulatory system disorders,"3,159",Categorical (single),Both sexes,Jul 2019,"3,159",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131284,Date I09 first reported (other rheumatic heart diseases),2409,Circulatory system disorders,101,Date,Both sexes,Jul 2019,101,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131285,Source of report of I09 (other rheumatic heart diseases),2409,Circulatory system disorders,101,Categorical (single),Both sexes,Jul 2019,101,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131286,Date I10 first reported (essential (primary) hypertension),2409,Circulatory system disorders,"125,781",Date,Both sexes,Jul 2019,"125,781",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131287,Source of report of I10 (essential (primary) hypertension),2409,Circulatory system disorders,"125,781",Categorical (single),Both sexes,Jul 2019,"125,781",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131288,Date I11 first reported (hypertensive heart disease),2409,Circulatory system disorders,621,Date,Both sexes,Jul 2019,621,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131289,Source of report of I11 (hypertensive heart disease),2409,Circulatory system disorders,621,Categorical (single),Both sexes,Jul 2019,621,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131290,Date I12 first reported (hypertensive renal disease),2409,Circulatory system disorders,"2,098",Date,Both sexes,Jul 2019,"2,098",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131291,Source of report of I12 (hypertensive renal disease),2409,Circulatory system disorders,"2,098",Categorical (single),Both sexes,Jul 2019,"2,098",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131292,Date I13 first reported (hypertensive heart and renal disease),2409,Circulatory system disorders,62,Date,Both sexes,Jul 2019,62,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131293,Source of report of I13 (hypertensive heart and renal disease),2409,Circulatory system disorders,62,Categorical (single),Both sexes,Jul 2019,62,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131294,Date I15 first reported (secondary hypertension),2409,Circulatory system disorders,238,Date,Both sexes,Jul 2019,238,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131295,Source of report of I15 (secondary hypertension),2409,Circulatory system disorders,238,Categorical (single),Both sexes,Jul 2019,238,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131296,Date I20 first reported (angina pectoris),2409,Circulatory system disorders,"31,055",Date,Both sexes,Jul 2019,"31,055",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131297,Source of report of I20 (angina pectoris),2409,Circulatory system disorders,"31,055",Categorical (single),Both sexes,Jul 2019,"31,055",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131298,Date I21 first reported (acute myocardial infarction),2409,Circulatory system disorders,"18,666",Date,Both sexes,Jul 2019,"18,666",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131299,Source of report of I21 (acute myocardial infarction),2409,Circulatory system disorders,"18,666",Categorical (single),Both sexes,Jul 2019,"18,666",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131300,Date I22 first reported (subsequent myocardial infarction),2409,Circulatory system disorders,902,Date,Both sexes,Jul 2019,902,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131301,Source of report of I22 (subsequent myocardial infarction),2409,Circulatory system disorders,902,Categorical (single),Both sexes,Jul 2019,902,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131302,Date I23 first reported (certain current complications following acute myocardial infarction),2409,Circulatory system disorders,76,Date,Both sexes,Jul 2019,76,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131303,Source of report of I23 (certain current complications following acute myocardial infarction),2409,Circulatory system disorders,76,Categorical (single),Both sexes,Jul 2019,76,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131304,Date I24 first reported (other acute ischaemic heart diseases),2409,Circulatory system disorders,"3,126",Date,Both sexes,Jul 2019,"3,126",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131305,Source of report of I24 (other acute ischaemic heart diseases),2409,Circulatory system disorders,"3,126",Categorical (single),Both sexes,Jul 2019,"3,126",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131306,Date I25 first reported (chronic ischaemic heart disease),2409,Circulatory system disorders,"38,230",Date,Both sexes,Jul 2019,"38,230",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131307,Source of report of I25 (chronic ischaemic heart disease),2409,Circulatory system disorders,"38,230",Categorical (single),Both sexes,Jul 2019,"38,230",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131308,Date I26 first reported (pulmonary embolism),2409,Circulatory system disorders,"8,579",Date,Both sexes,Jul 2019,"8,579",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131309,Source of report of I26 (pulmonary embolism),2409,Circulatory system disorders,"8,579",Categorical (single),Both sexes,Jul 2019,"8,579",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131310,Date I27 first reported (other pulmonary heart diseases),2409,Circulatory system disorders,"1,624",Date,Both sexes,Jul 2019,"1,624",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131311,Source of report of I27 (other pulmonary heart diseases),2409,Circulatory system disorders,"1,624",Categorical (single),Both sexes,Jul 2019,"1,624",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131312,Date I28 first reported (other diseases of pulmonary vessels),2409,Circulatory system disorders,93,Date,Both sexes,Jul 2019,93,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131313,Source of report of I28 (other diseases of pulmonary vessels),2409,Circulatory system disorders,93,Categorical (single),Both sexes,Jul 2019,93,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131314,Date I30 first reported (acute pericarditis),2409,Circulatory system disorders,618,Date,Both sexes,Jul 2019,618,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131315,Source of report of I30 (acute pericarditis),2409,Circulatory system disorders,618,Categorical (single),Both sexes,Jul 2019,618,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131316,Date I31 first reported (other diseases of pericardium),2409,Circulatory system disorders,"2,139",Date,Both sexes,Jul 2019,"2,139",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131317,Source of report of I31 (other diseases of pericardium),2409,Circulatory system disorders,"2,139",Categorical (single),Both sexes,Jul 2019,"2,139",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131318,Date I32 first reported (pericarditis in diseases classified elsewhere),2409,Circulatory system disorders,14,Date,Both sexes,Jul 2019,14,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131319,Source of report of I32 (pericarditis in diseases classified elsewhere),2409,Circulatory system disorders,14,Categorical (single),Both sexes,Jul 2019,14,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131320,Date I33 first reported (acute and subacute endocarditis),2409,Circulatory system disorders,382,Date,Both sexes,Jul 2019,382,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131321,Source of report of I33 (acute and subacute endocarditis),2409,Circulatory system disorders,382,Categorical (single),Both sexes,Jul 2019,382,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131322,Date I34 first reported (nonrheumatic mitral valve disorders),2409,Circulatory system disorders,"4,449",Date,Both sexes,Jul 2019,"4,449",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131323,Source of report of I34 (nonrheumatic mitral valve disorders),2409,Circulatory system disorders,"4,449",Categorical (single),Both sexes,Jul 2019,"4,449",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131324,Date I35 first reported (nonrheumatic aortic valve disorders),2409,Circulatory system disorders,"4,685",Date,Both sexes,Jul 2019,"4,685",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131325,Source of report of I35 (nonrheumatic aortic valve disorders),2409,Circulatory system disorders,"4,685",Categorical (single),Both sexes,Jul 2019,"4,685",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131326,Date I36 first reported (nonrheumatic tricuspid valve disorders),2409,Circulatory system disorders,218,Date,Both sexes,Jul 2019,218,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131327,Source of report of I36 (nonrheumatic tricuspid valve disorders),2409,Circulatory system disorders,218,Categorical (single),Both sexes,Jul 2019,218,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131328,Date I37 first reported (pulmonary valve disorders),2409,Circulatory system disorders,279,Date,Both sexes,Jul 2019,279,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131329,Source of report of I37 (pulmonary valve disorders),2409,Circulatory system disorders,279,Categorical (single),Both sexes,Jul 2019,279,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131330,"Date I38 first reported (endocarditis, valve unspecified)",2409,Circulatory system disorders,743,Date,Both sexes,Jul 2019,743,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131331,"Source of report of I38 (endocarditis, valve unspecified)",2409,Circulatory system disorders,743,Categorical (single),Both sexes,Jul 2019,743,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131332,Date I39 first reported (endocarditis and heart valve disorders in diseases classified elsewhere),2409,Circulatory system disorders,10,Date,Both sexes,Jul 2019,10,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131333,Source of report of I39 (endocarditis and heart valve disorders in diseases classified elsewhere),2409,Circulatory system disorders,10,Categorical (single),Both sexes,Jul 2019,10,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131334,Date I40 first reported (acute myocarditis),2409,Circulatory system disorders,69,Date,Both sexes,Jul 2019,69,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131335,Source of report of I40 (acute myocarditis),2409,Circulatory system disorders,69,Categorical (single),Both sexes,Jul 2019,69,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131336,Date I41 first reported (myocarditis in diseases classified elsewhere),2409,Circulatory system disorders,8,Date,Both sexes,Jul 2019,8,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131337,Source of report of I41 (myocarditis in diseases classified elsewhere),2409,Circulatory system disorders,8,Categorical (single),Both sexes,Jul 2019,8,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131338,Date I42 first reported (cardiomyopathy),2409,Circulatory system disorders,"2,382",Date,Both sexes,Jul 2019,"2,382",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131339,Source of report of I42 (cardiomyopathy),2409,Circulatory system disorders,"2,382",Categorical (single),Both sexes,Jul 2019,"2,382",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131340,Date I43 first reported (cardiomyopathy in diseases classified elsewhere),2409,Circulatory system disorders,55,Date,Both sexes,Jul 2019,55,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131341,Source of report of I43 (cardiomyopathy in diseases classified elsewhere),2409,Circulatory system disorders,55,Categorical (single),Both sexes,Jul 2019,55,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131342,Date I44 first reported (atrioventricular and left bundle-branch block),2409,Circulatory system disorders,"6,568",Date,Both sexes,Jul 2019,"6,568",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131343,Source of report of I44 (atrioventricular and left bundle-branch block),2409,Circulatory system disorders,"6,568",Categorical (single),Both sexes,Jul 2019,"6,568",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131344,Date I45 first reported (other conduction disorders),2409,Circulatory system disorders,"4,177",Date,Both sexes,Jul 2019,"4,177",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131345,Source of report of I45 (other conduction disorders),2409,Circulatory system disorders,"4,177",Categorical (single),Both sexes,Jul 2019,"4,177",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131346,Date I46 first reported (cardiac arrest),2409,Circulatory system disorders,"1,819",Date,Both sexes,Jul 2019,"1,819",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131347,Source of report of I46 (cardiac arrest),2409,Circulatory system disorders,"1,819",Categorical (single),Both sexes,Jul 2019,"1,819",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131348,Date I47 first reported (paroxysmal tachycardia),2409,Circulatory system disorders,"6,047",Date,Both sexes,Jul 2019,"6,047",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131349,Source of report of I47 (paroxysmal tachycardia),2409,Circulatory system disorders,"6,047",Categorical (single),Both sexes,Jul 2019,"6,047",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131350,Date I48 first reported (atrial fibrillation and flutter),2409,Circulatory system disorders,"24,694",Date,Both sexes,Jul 2019,"24,694",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131351,Source of report of I48 (atrial fibrillation and flutter),2409,Circulatory system disorders,"24,694",Categorical (single),Both sexes,Jul 2019,"24,694",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131352,Date I49 first reported (other cardiac arrhythmias),2409,Circulatory system disorders,"9,206",Date,Both sexes,Jul 2019,"9,206",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131353,Source of report of I49 (other cardiac arrhythmias),2409,Circulatory system disorders,"9,206",Categorical (single),Both sexes,Jul 2019,"9,206",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131354,Date I50 first reported (heart failure),2409,Circulatory system disorders,"10,242",Date,Both sexes,Jul 2019,"10,242",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131355,Source of report of I50 (heart failure),2409,Circulatory system disorders,"10,242",Categorical (single),Both sexes,Jul 2019,"10,242",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131356,Date I51 first reported (complications and ill-defined descriptions of heart disease),2409,Circulatory system disorders,"9,133",Date,Both sexes,Jul 2019,"9,133",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131357,Source of report of I51 (complications and ill-defined descriptions of heart disease),2409,Circulatory system disorders,"9,133",Categorical (single),Both sexes,Jul 2019,"9,133",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131358,Date I52 first reported (other heart disorders in diseases classified elsewhere),2409,Circulatory system disorders,4,Date,Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131359,Source of report of I52 (other heart disorders in diseases classified elsewhere),2409,Circulatory system disorders,4,Categorical (single),Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131360,Date I60 first reported (subarachnoid haemorrhage),2409,Circulatory system disorders,"1,547",Date,Both sexes,Jul 2019,"1,547",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131361,Source of report of I60 (subarachnoid haemorrhage),2409,Circulatory system disorders,"1,547",Categorical (single),Both sexes,Jul 2019,"1,547",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131362,Date I61 first reported (intracerebral haemorrhage),2409,Circulatory system disorders,"1,382",Date,Both sexes,Jul 2019,"1,382",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131363,Source of report of I61 (intracerebral haemorrhage),2409,Circulatory system disorders,"1,382",Categorical (single),Both sexes,Jul 2019,"1,382",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131364,Date I62 first reported (other nontraumatic intracranial haemorrhage),2409,Circulatory system disorders,713,Date,Both sexes,Jul 2019,713,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131365,Source of report of I62 (other nontraumatic intracranial haemorrhage),2409,Circulatory system disorders,713,Categorical (single),Both sexes,Jul 2019,713,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131366,Date I63 first reported (cerebral infarction),2409,Circulatory system disorders,"5,771",Date,Both sexes,Jul 2019,"5,771",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131367,Source of report of I63 (cerebral infarction),2409,Circulatory system disorders,"5,771",Categorical (single),Both sexes,Jul 2019,"5,771",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131368,"Date I64 first reported (stroke, not specified as haemorrhage or infarction)",2409,Circulatory system disorders,"8,790",Date,Both sexes,Jul 2019,"8,790",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131369,"Source of report of I64 (stroke, not specified as haemorrhage or infarction)",2409,Circulatory system disorders,"8,790",Categorical (single),Both sexes,Jul 2019,"8,790",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131370,"Date I65 first reported (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",2409,Circulatory system disorders,"1,630",Date,Both sexes,Jul 2019,"1,630",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131371,"Source of report of I65 (occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction)",2409,Circulatory system disorders,"1,630",Categorical (single),Both sexes,Jul 2019,"1,630",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131372,"Date I66 first reported (occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction)",2409,Circulatory system disorders,144,Date,Both sexes,Jul 2019,144,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131373,"Source of report of I66 (occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction)",2409,Circulatory system disorders,144,Categorical (single),Both sexes,Jul 2019,144,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131374,Date I67 first reported (other cerebrovascular diseases),2409,Circulatory system disorders,"5,123",Date,Both sexes,Jul 2019,"5,123",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131375,Source of report of I67 (other cerebrovascular diseases),2409,Circulatory system disorders,"5,123",Categorical (single),Both sexes,Jul 2019,"5,123",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131376,Date I68 first reported (cerebrovascular disorders in diseases classified elsewhere),2409,Circulatory system disorders,54,Date,Both sexes,Jul 2019,54,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131377,Source of report of I68 (cerebrovascular disorders in diseases classified elsewhere),2409,Circulatory system disorders,54,Categorical (single),Both sexes,Jul 2019,54,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131378,Date I69 first reported (sequelae of cerebrovascular disease),2409,Circulatory system disorders,"2,052",Date,Both sexes,Jul 2019,"2,052",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131379,Source of report of I69 (sequelae of cerebrovascular disease),2409,Circulatory system disorders,"2,052",Categorical (single),Both sexes,Jul 2019,"2,052",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131380,Date I70 first reported (atherosclerosis),2409,Circulatory system disorders,"2,186",Date,Both sexes,Jul 2019,"2,186",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131381,Source of report of I70 (atherosclerosis),2409,Circulatory system disorders,"2,186",Categorical (single),Both sexes,Jul 2019,"2,186",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131382,Date I71 first reported (aortic aneurysm and dissection),2409,Circulatory system disorders,"2,836",Date,Both sexes,Jul 2019,"2,836",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131383,Source of report of I71 (aortic aneurysm and dissection),2409,Circulatory system disorders,"2,836",Categorical (single),Both sexes,Jul 2019,"2,836",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131384,Date I72 first reported (other aneurysm),2409,Circulatory system disorders,"1,031",Date,Both sexes,Jul 2019,"1,031",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131385,Source of report of I72 (other aneurysm),2409,Circulatory system disorders,"1,031",Categorical (single),Both sexes,Jul 2019,"1,031",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131386,Date I73 first reported (other peripheral vascular diseases),2409,Circulatory system disorders,"10,529",Date,Both sexes,Jul 2019,"10,529",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131387,Source of report of I73 (other peripheral vascular diseases),2409,Circulatory system disorders,"10,529",Categorical (single),Both sexes,Jul 2019,"10,529",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131388,Date I74 first reported (arterial embolism and thrombosis),2409,Circulatory system disorders,"1,501",Date,Both sexes,Jul 2019,"1,501",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131389,Source of report of I74 (arterial embolism and thrombosis),2409,Circulatory system disorders,"1,501",Categorical (single),Both sexes,Jul 2019,"1,501",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131390,Date I77 first reported (other disorders of arteries and arterioles),2409,Circulatory system disorders,"2,401",Date,Both sexes,Jul 2019,"2,401",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131391,Source of report of I77 (other disorders of arteries and arterioles),2409,Circulatory system disorders,"2,401",Categorical (single),Both sexes,Jul 2019,"2,401",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131392,Date I78 first reported (diseases of capillaries),2409,Circulatory system disorders,"2,644",Date,Both sexes,Jul 2019,"2,644",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131393,Source of report of I78 (diseases of capillaries),2409,Circulatory system disorders,"2,644",Categorical (single),Both sexes,Jul 2019,"2,644",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131394,"Date I79 first reported (disorders of arteries, arterioles and capillaries in diseases classified elsewhere)",2409,Circulatory system disorders,133,Date,Both sexes,Jul 2019,133,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131395,"Source of report of I79 (disorders of arteries, arterioles and capillaries in diseases classified elsewhere)",2409,Circulatory system disorders,133,Categorical (single),Both sexes,Jul 2019,133,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131396,Date I80 first reported (phlebitis and thrombophlebitis),2409,Circulatory system disorders,"16,785",Date,Both sexes,Jul 2019,"16,785",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131397,Source of report of I80 (phlebitis and thrombophlebitis),2409,Circulatory system disorders,"16,785",Categorical (single),Both sexes,Jul 2019,"16,785",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131398,Date I81 first reported (portal vein thrombosis),2409,Circulatory system disorders,264,Date,Both sexes,Jul 2019,264,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131399,Source of report of I81 (portal vein thrombosis),2409,Circulatory system disorders,264,Categorical (single),Both sexes,Jul 2019,264,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131400,Date I82 first reported (other venous embolism and thrombosis),2409,Circulatory system disorders,946,Date,Both sexes,Jul 2019,946,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131401,Source of report of I82 (other venous embolism and thrombosis),2409,Circulatory system disorders,946,Categorical (single),Both sexes,Jul 2019,946,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131402,Date I83 first reported (varicose veins of lower extremities),2409,Circulatory system disorders,"22,247",Date,Both sexes,Jul 2019,"22,247",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131403,Source of report of I83 (varicose veins of lower extremities),2409,Circulatory system disorders,"22,247",Categorical (single),Both sexes,Jul 2019,"22,247",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131404,Date I84 first reported (haemorrhoids),2409,Circulatory system disorders,"31,892",Date,Both sexes,Jul 2019,"31,892",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131405,Source of report of I84 (haemorrhoids),2409,Circulatory system disorders,"31,892",Categorical (single),Both sexes,Jul 2019,"31,892",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131406,Date I85 first reported (oesophageal varices),2409,Circulatory system disorders,845,Date,Both sexes,Jul 2019,845,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131407,Source of report of I85 (oesophageal varices),2409,Circulatory system disorders,845,Categorical (single),Both sexes,Jul 2019,845,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131408,Date I86 first reported (varicose veins of other sites),2409,Circulatory system disorders,"1,960",Date,Both sexes,Jul 2019,"1,960",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131409,Source of report of I86 (varicose veins of other sites),2409,Circulatory system disorders,"1,960",Categorical (single),Both sexes,Jul 2019,"1,960",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131410,Date I87 first reported (other disorders of veins),2409,Circulatory system disorders,"1,421",Date,Both sexes,Jul 2019,"1,421",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131411,Source of report of I87 (other disorders of veins),2409,Circulatory system disorders,"1,421",Categorical (single),Both sexes,Jul 2019,"1,421",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131412,Date I88 first reported (nonspecific lymphadenitis),2409,Circulatory system disorders,426,Date,Both sexes,Jul 2019,426,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131413,Source of report of I88 (nonspecific lymphadenitis),2409,Circulatory system disorders,426,Categorical (single),Both sexes,Jul 2019,426,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131414,Date I89 first reported (other non-infective disorders of lymphatic vessels and lymph nodes),2409,Circulatory system disorders,"1,823",Date,Both sexes,Jul 2019,"1,823",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131415,Source of report of I89 (other non-infective disorders of lymphatic vessels and lymph nodes),2409,Circulatory system disorders,"1,823",Categorical (single),Both sexes,Jul 2019,"1,823",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131416,Date I95 first reported (hypotension),2409,Circulatory system disorders,"10,632",Date,Both sexes,Jul 2019,"10,632",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131417,Source of report of I95 (hypotension),2409,Circulatory system disorders,"10,632",Categorical (single),Both sexes,Jul 2019,"10,632",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131418,"Date I97 first reported (postprocedural disorders of circulatory system, not elsewhere classified)",2409,Circulatory system disorders,336,Date,Both sexes,Jul 2019,336,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131419,"Source of report of I97 (postprocedural disorders of circulatory system, not elsewhere classified)",2409,Circulatory system disorders,336,Categorical (single),Both sexes,Jul 2019,336,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131420,Date I98 first reported (other disorders of circulatory system in diseases classified elsewhere),2409,Circulatory system disorders,415,Date,Both sexes,Jul 2019,415,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131421,Source of report of I98 (other disorders of circulatory system in diseases classified elsewhere),2409,Circulatory system disorders,415,Categorical (single),Both sexes,Jul 2019,415,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131422,Date I99 first reported (other and unspecified disorders of circulatory system),2409,Circulatory system disorders,506,Date,Both sexes,Jul 2019,506,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131423,Source of report of I99 (other and unspecified disorders of circulatory system),2409,Circulatory system disorders,506,Categorical (single),Both sexes,Jul 2019,506,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Circulatory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4728,Leg pain on walking,100038,Claudication and peripheral artery disease,"213,701",Categorical (single),Both sexes,Jan 2012,"243,342",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Claudication and peripheral artery disease,0.0,0.0,0.0,0.0,0.0,0.0
5452,Leg pain when standing still or sitting,100038,Claudication and peripheral artery disease,"50,910",Categorical (single),Both sexes,Jan 2012,"53,409",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Claudication and peripheral artery disease,0.0,0.0,0.0,0.0,0.0,0.0
5463,Leg pain in calf/calves,100038,Claudication and peripheral artery disease,"50,910",Categorical (single),Both sexes,Jan 2012,"53,409",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Claudication and peripheral artery disease,0.0,0.0,0.0,0.0,0.0,0.0
5474,Leg pain when walking uphill or hurrying,100038,Claudication and peripheral artery disease,"50,910",Categorical (single),Both sexes,Jan 2012,"53,409",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Claudication and peripheral artery disease,0.0,0.0,0.0,0.0,0.0,0.0
5485,Leg pain when walking normally,100038,Claudication and peripheral artery disease,"50,910",Categorical (single),Both sexes,Jan 2012,"53,409",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Claudication and peripheral artery disease,0.0,0.0,0.0,0.0,0.0,0.0
5496,Leg pain when walking ever disappears while walking,100038,Claudication and peripheral artery disease,"27,861",Categorical (single),Both sexes,Jan 2012,"28,752",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Claudication and peripheral artery disease,0.0,0.0,0.0,0.0,0.0,0.0
5507,Leg pain on walking : action taken,100038,Claudication and peripheral artery disease,"50,910",Categorical (single),Both sexes,Jan 2012,"53,409",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Claudication and peripheral artery disease,0.0,0.0,0.0,0.0,0.0,0.0
5518,Leg pain on walking : effect of standing still,100038,Claudication and peripheral artery disease,"50,910",Categorical (single),Both sexes,Jan 2012,"53,409",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Claudication and peripheral artery disease,0.0,0.0,0.0,0.0,0.0,0.0
5529,Surgery on leg arteries (other than for varicose veins),100038,Claudication and peripheral artery disease,"50,910",Categorical (single),Both sexes,Jan 2012,"53,409",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Claudication and peripheral artery disease,0.0,0.0,0.0,0.0,0.0,0.0
5540,Surgery/amputation of toe or leg,100038,Claudication and peripheral artery disease,"50,910",Categorical (single),Both sexes,Jan 2012,"53,409",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Claudication and peripheral artery disease,0.0,0.0,0.0,0.0,0.0,0.0
23078,Device used for pointing,116,Cognitive function online,"125,498",Categorical (single),Both sexes,Jan 2020,"131,268",Data,Singular,Jan 2020,Complete,Online follow-up,Cognitive function online,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23077,Device used for typing,116,Cognitive function online,"125,498",Categorical (single),Both sexes,Jan 2020,"131,268",Data,Singular,Jan 2020,Complete,Online follow-up,Cognitive function online,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20140,When device described,116,Cognitive function online,"125,498",Time,Both sexes,Jul 2015,"131,268",Data,Singular,Jan 2020,Complete,Online follow-up,Cognitive function online,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22017,"Invitation to complete online cognitive function questionnaire, date sent",116,Cognitive function online,"339,862",Date,Both sexes,Jul 2015,"339,862",Data,Singular,Jan 2020,Complete,Online follow-up,Cognitive function online,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132432,Date Q00 first reported (anencephaly and similar malformations),2417,Congenital disruptions and chromosomal abnormalities,4,Date,Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132433,Source of report of Q00 (anencephaly and similar malformations),2417,Congenital disruptions and chromosomal abnormalities,4,Categorical (single),Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132434,Date Q01 first reported (encephalocele),2417,Congenital disruptions and chromosomal abnormalities,11,Date,Both sexes,Jul 2019,11,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132435,Source of report of Q01 (encephalocele),2417,Congenital disruptions and chromosomal abnormalities,11,Categorical (single),Both sexes,Jul 2019,11,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132436,Date Q02 first reported (microcephaly),2417,Congenital disruptions and chromosomal abnormalities,2,Date,Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132437,Source of report of Q02 (microcephaly),2417,Congenital disruptions and chromosomal abnormalities,2,Categorical (single),Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132438,Date Q03 first reported (congenital hydrocephalus),2417,Congenital disruptions and chromosomal abnormalities,30,Date,Both sexes,Jul 2019,30,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132439,Source of report of Q03 (congenital hydrocephalus),2417,Congenital disruptions and chromosomal abnormalities,30,Categorical (single),Both sexes,Jul 2019,30,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132440,Date Q04 first reported (other congenital malformations of brain),2417,Congenital disruptions and chromosomal abnormalities,64,Date,Both sexes,Jul 2019,64,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132441,Source of report of Q04 (other congenital malformations of brain),2417,Congenital disruptions and chromosomal abnormalities,64,Categorical (single),Both sexes,Jul 2019,64,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132442,Date Q05 first reported (spina bifida),2417,Congenital disruptions and chromosomal abnormalities,350,Date,Both sexes,Jul 2019,350,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132443,Source of report of Q05 (spina bifida),2417,Congenital disruptions and chromosomal abnormalities,350,Categorical (single),Both sexes,Jul 2019,350,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132444,Date Q06 first reported (other congenital malformations of spinal cord),2417,Congenital disruptions and chromosomal abnormalities,35,Date,Both sexes,Jul 2019,35,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132445,Source of report of Q06 (other congenital malformations of spinal cord),2417,Congenital disruptions and chromosomal abnormalities,35,Categorical (single),Both sexes,Jul 2019,35,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132446,Date Q07 first reported (other congenital malformations of nervous system),2417,Congenital disruptions and chromosomal abnormalities,138,Date,Both sexes,Jul 2019,138,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132447,Source of report of Q07 (other congenital malformations of nervous system),2417,Congenital disruptions and chromosomal abnormalities,138,Categorical (single),Both sexes,Jul 2019,138,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132448,"Date Q10 first reported (congenital malformations of eyelid, lachrymal apparatus and orbit)",2417,Congenital disruptions and chromosomal abnormalities,132,Date,Both sexes,Jul 2019,132,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132449,"Source of report of Q10 (congenital malformations of eyelid, lachrymal apparatus and orbit)",2417,Congenital disruptions and chromosomal abnormalities,132,Categorical (single),Both sexes,Jul 2019,132,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132450,"Date Q11 first reported (anophthalmos, microphthalmos and macrophthalmos)",2417,Congenital disruptions and chromosomal abnormalities,32,Date,Both sexes,Jul 2019,32,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132451,"Source of report of Q11 (anophthalmos, microphthalmos and macrophthalmos)",2417,Congenital disruptions and chromosomal abnormalities,32,Categorical (single),Both sexes,Jul 2019,32,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132452,Date Q12 first reported (congenital lens malformations),2417,Congenital disruptions and chromosomal abnormalities,266,Date,Both sexes,Jul 2019,266,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132453,Source of report of Q12 (congenital lens malformations),2417,Congenital disruptions and chromosomal abnormalities,266,Categorical (single),Both sexes,Jul 2019,266,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132454,Date Q13 first reported (congenital malformations of anterior segment of eye),2417,Congenital disruptions and chromosomal abnormalities,60,Date,Both sexes,Jul 2019,60,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132455,Source of report of Q13 (congenital malformations of anterior segment of eye),2417,Congenital disruptions and chromosomal abnormalities,60,Categorical (single),Both sexes,Jul 2019,60,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132456,Date Q14 first reported (congenital malformations of posterior segment of eye),2417,Congenital disruptions and chromosomal abnormalities,263,Date,Both sexes,Jul 2019,263,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132457,Source of report of Q14 (congenital malformations of posterior segment of eye),2417,Congenital disruptions and chromosomal abnormalities,263,Categorical (single),Both sexes,Jul 2019,263,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132458,Date Q15 first reported (other congenital malformations of eye),2417,Congenital disruptions and chromosomal abnormalities,50,Date,Both sexes,Jul 2019,50,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132459,Source of report of Q15 (other congenital malformations of eye),2417,Congenital disruptions and chromosomal abnormalities,50,Categorical (single),Both sexes,Jul 2019,50,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132460,Date Q16 first reported (congenital malformations of ear causing impairment of hearing),2417,Congenital disruptions and chromosomal abnormalities,63,Date,Both sexes,Jul 2019,63,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132461,Source of report of Q16 (congenital malformations of ear causing impairment of hearing),2417,Congenital disruptions and chromosomal abnormalities,63,Categorical (single),Both sexes,Jul 2019,63,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132462,Date Q17 first reported (other congenital malformations of ear),2417,Congenital disruptions and chromosomal abnormalities,128,Date,Both sexes,Jul 2019,128,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132463,Source of report of Q17 (other congenital malformations of ear),2417,Congenital disruptions and chromosomal abnormalities,128,Categorical (single),Both sexes,Jul 2019,128,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132464,Date Q18 first reported (other congenital malformations of face and neck),2417,Congenital disruptions and chromosomal abnormalities,247,Date,Both sexes,Jul 2019,247,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132465,Source of report of Q18 (other congenital malformations of face and neck),2417,Congenital disruptions and chromosomal abnormalities,247,Categorical (single),Both sexes,Jul 2019,247,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132466,Date Q20 first reported (congenital malformations of cardiac chambers and connexions),2417,Congenital disruptions and chromosomal abnormalities,25,Date,Both sexes,Jul 2019,25,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132467,Source of report of Q20 (congenital malformations of cardiac chambers and connexions),2417,Congenital disruptions and chromosomal abnormalities,25,Categorical (single),Both sexes,Jul 2019,25,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132468,Date Q21 first reported (congenital malformations of cardiac septa),2417,Congenital disruptions and chromosomal abnormalities,"1,069",Date,Both sexes,Jul 2019,"1,069",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132469,Source of report of Q21 (congenital malformations of cardiac septa),2417,Congenital disruptions and chromosomal abnormalities,"1,069",Categorical (single),Both sexes,Jul 2019,"1,069",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132470,Date Q22 first reported (congenital malformations of pulmonary and tricuspid valves),2417,Congenital disruptions and chromosomal abnormalities,57,Date,Both sexes,Jul 2019,57,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132471,Source of report of Q22 (congenital malformations of pulmonary and tricuspid valves),2417,Congenital disruptions and chromosomal abnormalities,57,Categorical (single),Both sexes,Jul 2019,57,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132472,Date Q23 first reported (congenital malformations of aortic and mitral valves),2417,Congenital disruptions and chromosomal abnormalities,476,Date,Both sexes,Jul 2019,476,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132473,Source of report of Q23 (congenital malformations of aortic and mitral valves),2417,Congenital disruptions and chromosomal abnormalities,476,Categorical (single),Both sexes,Jul 2019,476,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132474,Date Q24 first reported (other congenital malformations of heart),2417,Congenital disruptions and chromosomal abnormalities,321,Date,Both sexes,Jul 2019,321,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132475,Source of report of Q24 (other congenital malformations of heart),2417,Congenital disruptions and chromosomal abnormalities,321,Categorical (single),Both sexes,Jul 2019,321,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132476,Date Q25 first reported (congenital malformations of great arteries),2417,Congenital disruptions and chromosomal abnormalities,234,Date,Both sexes,Jul 2019,234,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132477,Source of report of Q25 (congenital malformations of great arteries),2417,Congenital disruptions and chromosomal abnormalities,234,Categorical (single),Both sexes,Jul 2019,234,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132478,Date Q26 first reported (congenital malformations of great veins),2417,Congenital disruptions and chromosomal abnormalities,35,Date,Both sexes,Jul 2019,35,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132479,Source of report of Q26 (congenital malformations of great veins),2417,Congenital disruptions and chromosomal abnormalities,35,Categorical (single),Both sexes,Jul 2019,35,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132480,Date Q27 first reported (other congenital malformations of peripheral vascular system),2417,Congenital disruptions and chromosomal abnormalities,256,Date,Both sexes,Jul 2019,256,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132481,Source of report of Q27 (other congenital malformations of peripheral vascular system),2417,Congenital disruptions and chromosomal abnormalities,256,Categorical (single),Both sexes,Jul 2019,256,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132482,Date Q28 first reported (other congenital malformations of circulatory system),2417,Congenital disruptions and chromosomal abnormalities,222,Date,Both sexes,Jul 2019,222,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132483,Source of report of Q28 (other congenital malformations of circulatory system),2417,Congenital disruptions and chromosomal abnormalities,222,Categorical (single),Both sexes,Jul 2019,222,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132484,Date Q30 first reported (congenital malformations of nose),2417,Congenital disruptions and chromosomal abnormalities,100,Date,Both sexes,Jul 2019,100,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132485,Source of report of Q30 (congenital malformations of nose),2417,Congenital disruptions and chromosomal abnormalities,100,Categorical (single),Both sexes,Jul 2019,100,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132486,Date Q31 first reported (congenital malformations of larynx),2417,Congenital disruptions and chromosomal abnormalities,59,Date,Both sexes,Jul 2019,59,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132487,Source of report of Q31 (congenital malformations of larynx),2417,Congenital disruptions and chromosomal abnormalities,59,Categorical (single),Both sexes,Jul 2019,59,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132488,Date Q32 first reported (congenital malformations of trachea and bronchus),2417,Congenital disruptions and chromosomal abnormalities,11,Date,Both sexes,Jul 2019,11,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132489,Source of report of Q32 (congenital malformations of trachea and bronchus),2417,Congenital disruptions and chromosomal abnormalities,11,Categorical (single),Both sexes,Jul 2019,11,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132490,Date Q33 first reported (congenital malformations of lung),2417,Congenital disruptions and chromosomal abnormalities,57,Date,Both sexes,Jul 2019,57,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132491,Source of report of Q33 (congenital malformations of lung),2417,Congenital disruptions and chromosomal abnormalities,57,Categorical (single),Both sexes,Jul 2019,57,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132492,Date Q34 first reported (other congenital malformations of respiratory system),2417,Congenital disruptions and chromosomal abnormalities,11,Date,Both sexes,Jul 2019,11,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132493,Source of report of Q34 (other congenital malformations of respiratory system),2417,Congenital disruptions and chromosomal abnormalities,11,Categorical (single),Both sexes,Jul 2019,11,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132494,Date Q35 first reported (cleft palate),2417,Congenital disruptions and chromosomal abnormalities,35,Date,Both sexes,Jul 2019,35,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132495,Source of report of Q35 (cleft palate),2417,Congenital disruptions and chromosomal abnormalities,35,Categorical (single),Both sexes,Jul 2019,35,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132496,Date Q36 first reported (cleft lip),2417,Congenital disruptions and chromosomal abnormalities,10,Date,Both sexes,Jul 2019,10,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132497,Source of report of Q36 (cleft lip),2417,Congenital disruptions and chromosomal abnormalities,10,Categorical (single),Both sexes,Jul 2019,10,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132498,Date Q37 first reported (cleft palate with cleft lip),2417,Congenital disruptions and chromosomal abnormalities,41,Date,Both sexes,Jul 2019,41,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132499,Source of report of Q37 (cleft palate with cleft lip),2417,Congenital disruptions and chromosomal abnormalities,41,Categorical (single),Both sexes,Jul 2019,41,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132500,"Date Q38 first reported (other congenital malformations of tongue, mouth and pharynx)",2417,Congenital disruptions and chromosomal abnormalities,493,Date,Both sexes,Jul 2019,493,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132501,"Source of report of Q38 (other congenital malformations of tongue, mouth and pharynx)",2417,Congenital disruptions and chromosomal abnormalities,493,Categorical (single),Both sexes,Jul 2019,493,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132502,Date Q39 first reported (congenital malformations of oesophagus),2417,Congenital disruptions and chromosomal abnormalities,177,Date,Both sexes,Jul 2019,177,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132503,Source of report of Q39 (congenital malformations of oesophagus),2417,Congenital disruptions and chromosomal abnormalities,177,Categorical (single),Both sexes,Jul 2019,177,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132504,Date Q40 first reported (other congenital malformations of upper alimentary tract),2417,Congenital disruptions and chromosomal abnormalities,249,Date,Both sexes,Jul 2019,249,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132505,Source of report of Q40 (other congenital malformations of upper alimentary tract),2417,Congenital disruptions and chromosomal abnormalities,249,Categorical (single),Both sexes,Jul 2019,249,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132506,"Date Q41 first reported (congenital absence, atresia and stenosis of small intestine)",2417,Congenital disruptions and chromosomal abnormalities,5,Date,Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132507,"Source of report of Q41 (congenital absence, atresia and stenosis of small intestine)",2417,Congenital disruptions and chromosomal abnormalities,5,Categorical (single),Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132508,"Date Q42 first reported (congenital absence, atresia and stenosis of large intestine)",2417,Congenital disruptions and chromosomal abnormalities,21,Date,Both sexes,Jul 2019,21,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132509,"Source of report of Q42 (congenital absence, atresia and stenosis of large intestine)",2417,Congenital disruptions and chromosomal abnormalities,21,Categorical (single),Both sexes,Jul 2019,21,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132510,Date Q43 first reported (other congenital malformations of intestine),2417,Congenital disruptions and chromosomal abnormalities,403,Date,Both sexes,Jul 2019,403,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132511,Source of report of Q43 (other congenital malformations of intestine),2417,Congenital disruptions and chromosomal abnormalities,403,Categorical (single),Both sexes,Jul 2019,403,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132512,"Date Q44 first reported (congenital malformations of gallbladder, bile ducts and liver)",2417,Congenital disruptions and chromosomal abnormalities,237,Date,Both sexes,Jul 2019,237,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132513,"Source of report of Q44 (congenital malformations of gallbladder, bile ducts and liver)",2417,Congenital disruptions and chromosomal abnormalities,237,Categorical (single),Both sexes,Jul 2019,237,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132514,Date Q45 first reported (other congenital malformations of digestive system),2417,Congenital disruptions and chromosomal abnormalities,54,Date,Both sexes,Jul 2019,54,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132515,Source of report of Q45 (other congenital malformations of digestive system),2417,Congenital disruptions and chromosomal abnormalities,54,Categorical (single),Both sexes,Jul 2019,54,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132516,"Date Q50 first reported (congenital malformations of ovaries, fallopian tubes and broad ligaments)",2417,Congenital disruptions and chromosomal abnormalities,292,Date,Both sexes,Jul 2019,292,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132517,"Source of report of Q50 (congenital malformations of ovaries, fallopian tubes and broad ligaments)",2417,Congenital disruptions and chromosomal abnormalities,292,Categorical (single),Both sexes,Jul 2019,292,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132518,Date Q51 first reported (congenital malformations of uterus and cervix),2417,Congenital disruptions and chromosomal abnormalities,320,Date,Both sexes,Jul 2019,320,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132519,Source of report of Q51 (congenital malformations of uterus and cervix),2417,Congenital disruptions and chromosomal abnormalities,320,Categorical (single),Both sexes,Jul 2019,320,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132520,Date Q52 first reported (other congenital malformations of female genitalia),2417,Congenital disruptions and chromosomal abnormalities,191,Date,Both sexes,Jul 2019,191,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132521,Source of report of Q52 (other congenital malformations of female genitalia),2417,Congenital disruptions and chromosomal abnormalities,191,Categorical (single),Both sexes,Jul 2019,191,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132522,Date Q53 first reported (undescended testicle),2417,Congenital disruptions and chromosomal abnormalities,581,Date,Both sexes,Jul 2019,581,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132523,Source of report of Q53 (undescended testicle),2417,Congenital disruptions and chromosomal abnormalities,581,Categorical (single),Both sexes,Jul 2019,581,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132524,Date Q54 first reported (hypospadias),2417,Congenital disruptions and chromosomal abnormalities,228,Date,Both sexes,Jul 2019,228,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132525,Source of report of Q54 (hypospadias),2417,Congenital disruptions and chromosomal abnormalities,228,Categorical (single),Both sexes,Jul 2019,228,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132526,Date Q55 first reported (other congenital malformations of male genital organs),2417,Congenital disruptions and chromosomal abnormalities,149,Date,Both sexes,Jul 2019,149,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132527,Source of report of Q55 (other congenital malformations of male genital organs),2417,Congenital disruptions and chromosomal abnormalities,149,Categorical (single),Both sexes,Jul 2019,149,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132528,Date Q56 first reported (indeterminate sex and pseudohermaphroditism),2417,Congenital disruptions and chromosomal abnormalities,2,Date,Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132529,Source of report of Q56 (indeterminate sex and pseudohermaphroditism),2417,Congenital disruptions and chromosomal abnormalities,2,Categorical (single),Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132530,Date Q60 first reported (renal agenesis and other reduction defects of kidney),2417,Congenital disruptions and chromosomal abnormalities,251,Date,Both sexes,Jul 2019,251,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132531,Source of report of Q60 (renal agenesis and other reduction defects of kidney),2417,Congenital disruptions and chromosomal abnormalities,251,Categorical (single),Both sexes,Jul 2019,251,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132532,Date Q61 first reported (cystic kidney disease),2417,Congenital disruptions and chromosomal abnormalities,944,Date,Both sexes,Jul 2019,944,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132533,Source of report of Q61 (cystic kidney disease),2417,Congenital disruptions and chromosomal abnormalities,944,Categorical (single),Both sexes,Jul 2019,944,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132534,Date Q62 first reported (congenital obstructive defects of renal pelvis and congenital malformations of ureter),2417,Congenital disruptions and chromosomal abnormalities,153,Date,Both sexes,Jul 2019,153,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132535,Source of report of Q62 (congenital obstructive defects of renal pelvis and congenital malformations of ureter),2417,Congenital disruptions and chromosomal abnormalities,153,Categorical (single),Both sexes,Jul 2019,153,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132536,Date Q63 first reported (other congenital malformations of kidney),2417,Congenital disruptions and chromosomal abnormalities,571,Date,Both sexes,Jul 2019,571,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132537,Source of report of Q63 (other congenital malformations of kidney),2417,Congenital disruptions and chromosomal abnormalities,571,Categorical (single),Both sexes,Jul 2019,571,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132538,Date Q64 first reported (other congenital malformations of urinary system),2417,Congenital disruptions and chromosomal abnormalities,177,Date,Both sexes,Jul 2019,177,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132539,Source of report of Q64 (other congenital malformations of urinary system),2417,Congenital disruptions and chromosomal abnormalities,177,Categorical (single),Both sexes,Jul 2019,177,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132540,Date Q65 first reported (congenital deformities of hip),2417,Congenital disruptions and chromosomal abnormalities,296,Date,Both sexes,Jul 2019,296,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132541,Source of report of Q65 (congenital deformities of hip),2417,Congenital disruptions and chromosomal abnormalities,296,Categorical (single),Both sexes,Jul 2019,296,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132542,Date Q66 first reported (congenital deformities of feet),2417,Congenital disruptions and chromosomal abnormalities,"1,073",Date,Both sexes,Jul 2019,"1,073",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132543,Source of report of Q66 (congenital deformities of feet),2417,Congenital disruptions and chromosomal abnormalities,"1,073",Categorical (single),Both sexes,Jul 2019,"1,073",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132544,"Date Q67 first reported (congenital musculoskeletal deformities of head, face, spine and chest)",2417,Congenital disruptions and chromosomal abnormalities,272,Date,Both sexes,Jul 2019,272,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132545,"Source of report of Q67 (congenital musculoskeletal deformities of head, face, spine and chest)",2417,Congenital disruptions and chromosomal abnormalities,272,Categorical (single),Both sexes,Jul 2019,272,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132546,Date Q68 first reported (other congenital musculoskeletal deformities),2417,Congenital disruptions and chromosomal abnormalities,104,Date,Both sexes,Jul 2019,104,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132547,Source of report of Q68 (other congenital musculoskeletal deformities),2417,Congenital disruptions and chromosomal abnormalities,104,Categorical (single),Both sexes,Jul 2019,104,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132548,Date Q69 first reported (polydactyly),2417,Congenital disruptions and chromosomal abnormalities,13,Date,Both sexes,Jul 2019,13,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132549,Source of report of Q69 (polydactyly),2417,Congenital disruptions and chromosomal abnormalities,13,Categorical (single),Both sexes,Jul 2019,13,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132550,Date Q70 first reported (syndactyly),2417,Congenital disruptions and chromosomal abnormalities,46,Date,Both sexes,Jul 2019,46,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132551,Source of report of Q70 (syndactyly),2417,Congenital disruptions and chromosomal abnormalities,46,Categorical (single),Both sexes,Jul 2019,46,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132552,Date Q71 first reported (reduction defects of upper limb),2417,Congenital disruptions and chromosomal abnormalities,27,Date,Both sexes,Jul 2019,27,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132553,Source of report of Q71 (reduction defects of upper limb),2417,Congenital disruptions and chromosomal abnormalities,27,Categorical (single),Both sexes,Jul 2019,27,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132554,Date Q72 first reported (reduction defects of lower limb),2417,Congenital disruptions and chromosomal abnormalities,44,Date,Both sexes,Jul 2019,44,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132555,Source of report of Q72 (reduction defects of lower limb),2417,Congenital disruptions and chromosomal abnormalities,44,Categorical (single),Both sexes,Jul 2019,44,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132556,Date Q73 first reported (reduction defects of unspecified limb),2417,Congenital disruptions and chromosomal abnormalities,9,Date,Both sexes,Jul 2019,9,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132557,Source of report of Q73 (reduction defects of unspecified limb),2417,Congenital disruptions and chromosomal abnormalities,9,Categorical (single),Both sexes,Jul 2019,9,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132558,Date Q74 first reported (other congenital malformations of limb(s)),2417,Congenital disruptions and chromosomal abnormalities,240,Date,Both sexes,Jul 2019,240,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132559,Source of report of Q74 (other congenital malformations of limb(s)),2417,Congenital disruptions and chromosomal abnormalities,240,Categorical (single),Both sexes,Jul 2019,240,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132560,Date Q75 first reported (other congenital malformations of skull and face bones),2417,Congenital disruptions and chromosomal abnormalities,41,Date,Both sexes,Jul 2019,41,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132561,Source of report of Q75 (other congenital malformations of skull and face bones),2417,Congenital disruptions and chromosomal abnormalities,41,Categorical (single),Both sexes,Jul 2019,41,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132562,Date Q76 first reported (congenital malformations of spine and bony thorax),2417,Congenital disruptions and chromosomal abnormalities,738,Date,Both sexes,Jul 2019,738,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132563,Source of report of Q76 (congenital malformations of spine and bony thorax),2417,Congenital disruptions and chromosomal abnormalities,738,Categorical (single),Both sexes,Jul 2019,738,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132564,Date Q77 first reported (osteochondrodysplasia with defects of growth of tubular bones and spine),2417,Congenital disruptions and chromosomal abnormalities,39,Date,Both sexes,Jul 2019,39,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132565,Source of report of Q77 (osteochondrodysplasia with defects of growth of tubular bones and spine),2417,Congenital disruptions and chromosomal abnormalities,39,Categorical (single),Both sexes,Jul 2019,39,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132566,Date Q78 first reported (other osteochondrodysplasias),2417,Congenital disruptions and chromosomal abnormalities,162,Date,Both sexes,Jul 2019,162,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132567,Source of report of Q78 (other osteochondrodysplasias),2417,Congenital disruptions and chromosomal abnormalities,162,Categorical (single),Both sexes,Jul 2019,162,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132568,"Date Q79 first reported (congenital malformations of musculoskeletal system, not elsewhere classified)",2417,Congenital disruptions and chromosomal abnormalities,256,Date,Both sexes,Jul 2019,256,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132569,"Source of report of Q79 (congenital malformations of musculoskeletal system, not elsewhere classified)",2417,Congenital disruptions and chromosomal abnormalities,256,Categorical (single),Both sexes,Jul 2019,256,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132570,Date Q80 first reported (congenital ichthyosis),2417,Congenital disruptions and chromosomal abnormalities,125,Date,Both sexes,Jul 2019,125,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132571,Source of report of Q80 (congenital ichthyosis),2417,Congenital disruptions and chromosomal abnormalities,125,Categorical (single),Both sexes,Jul 2019,125,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132572,Date Q81 first reported (epidermolysis bullosa),2417,Congenital disruptions and chromosomal abnormalities,23,Date,Both sexes,Jul 2019,23,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132573,Source of report of Q81 (epidermolysis bullosa),2417,Congenital disruptions and chromosomal abnormalities,23,Categorical (single),Both sexes,Jul 2019,23,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132574,Date Q82 first reported (other congenital malformations of skin),2417,Congenital disruptions and chromosomal abnormalities,"1,597",Date,Both sexes,Jul 2019,"1,597",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132575,Source of report of Q82 (other congenital malformations of skin),2417,Congenital disruptions and chromosomal abnormalities,"1,597",Categorical (single),Both sexes,Jul 2019,"1,597",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132576,Date Q83 first reported (congenital malformations of breast),2417,Congenital disruptions and chromosomal abnormalities,168,Date,Both sexes,Jul 2019,168,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132577,Source of report of Q83 (congenital malformations of breast),2417,Congenital disruptions and chromosomal abnormalities,168,Categorical (single),Both sexes,Jul 2019,168,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132578,Date Q84 first reported (other congenital malformations of integument),2417,Congenital disruptions and chromosomal abnormalities,112,Date,Both sexes,Jul 2019,112,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132579,Source of report of Q84 (other congenital malformations of integument),2417,Congenital disruptions and chromosomal abnormalities,112,Categorical (single),Both sexes,Jul 2019,112,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132580,"Date Q85 first reported (phakomatoses, not elsewhere classified)",2417,Congenital disruptions and chromosomal abnormalities,310,Date,Both sexes,Jul 2019,310,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132581,"Source of report of Q85 (phakomatoses, not elsewhere classified)",2417,Congenital disruptions and chromosomal abnormalities,310,Categorical (single),Both sexes,Jul 2019,310,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132582,"Date Q86 first reported (congenital malformation syndromes due to known exogenous causes, not elsewhere classified)",2417,Congenital disruptions and chromosomal abnormalities,2,Date,Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132583,"Source of report of Q86 (congenital malformation syndromes due to known exogenous causes, not elsewhere classified)",2417,Congenital disruptions and chromosomal abnormalities,2,Categorical (single),Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132584,Date Q87 first reported (other specified congenital malformation syndromes affecting multiple systems),2417,Congenital disruptions and chromosomal abnormalities,280,Date,Both sexes,Jul 2019,280,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132585,Source of report of Q87 (other specified congenital malformation syndromes affecting multiple systems),2417,Congenital disruptions and chromosomal abnormalities,280,Categorical (single),Both sexes,Jul 2019,280,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132586,"Date Q89 first reported (other congenital malformations, not elsewhere classified)",2417,Congenital disruptions and chromosomal abnormalities,346,Date,Both sexes,Jul 2019,346,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132587,"Source of report of Q89 (other congenital malformations, not elsewhere classified)",2417,Congenital disruptions and chromosomal abnormalities,346,Categorical (single),Both sexes,Jul 2019,346,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132588,Date Q90 first reported (down's syndrome),2417,Congenital disruptions and chromosomal abnormalities,40,Date,Both sexes,Jul 2019,40,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132589,Source of report of Q90 (down's syndrome),2417,Congenital disruptions and chromosomal abnormalities,40,Categorical (single),Both sexes,Jul 2019,40,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132590,Date Q91 first reported (edwards' syndrome and patau's syndrome),2417,Congenital disruptions and chromosomal abnormalities,11,Date,Both sexes,Jul 2019,11,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132591,Source of report of Q91 (edwards' syndrome and patau's syndrome),2417,Congenital disruptions and chromosomal abnormalities,11,Categorical (single),Both sexes,Jul 2019,11,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132592,"Date Q92 first reported (other trisomies and partial trisomies of the autosomes, not elsewhere classified)",2417,Congenital disruptions and chromosomal abnormalities,14,Date,Both sexes,Jul 2019,14,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132593,"Source of report of Q92 (other trisomies and partial trisomies of the autosomes, not elsewhere classified)",2417,Congenital disruptions and chromosomal abnormalities,14,Categorical (single),Both sexes,Jul 2019,14,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132594,"Date Q93 first reported (monosomies and deletions from the autosomes, not elsewhere classified)",2417,Congenital disruptions and chromosomal abnormalities,9,Date,Both sexes,Jul 2019,9,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132595,"Source of report of Q93 (monosomies and deletions from the autosomes, not elsewhere classified)",2417,Congenital disruptions and chromosomal abnormalities,9,Categorical (single),Both sexes,Jul 2019,9,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132596,"Date Q95 first reported (balanced rearrangements and structural markers, not elsewhere classified)",2417,Congenital disruptions and chromosomal abnormalities,6,Date,Both sexes,Jul 2019,6,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132597,"Source of report of Q95 (balanced rearrangements and structural markers, not elsewhere classified)",2417,Congenital disruptions and chromosomal abnormalities,6,Categorical (single),Both sexes,Jul 2019,6,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132598,Date Q96 first reported (turner's syndrome),2417,Congenital disruptions and chromosomal abnormalities,52,Date,Both sexes,Jul 2019,52,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132599,Source of report of Q96 (turner's syndrome),2417,Congenital disruptions and chromosomal abnormalities,52,Categorical (single),Both sexes,Jul 2019,52,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132600,"Date Q97 first reported (other sex chromosome abnormalities, female phenotype, not elsewhere classified)",2417,Congenital disruptions and chromosomal abnormalities,9,Date,Both sexes,Jul 2019,9,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132601,"Source of report of Q97 (other sex chromosome abnormalities, female phenotype, not elsewhere classified)",2417,Congenital disruptions and chromosomal abnormalities,9,Categorical (single),Both sexes,Jul 2019,9,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132602,"Date Q98 first reported (other sex chromosome abnormalities, male phenotype, not elsewhere classified)",2417,Congenital disruptions and chromosomal abnormalities,64,Date,Both sexes,Jul 2019,64,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132603,"Source of report of Q98 (other sex chromosome abnormalities, male phenotype, not elsewhere classified)",2417,Congenital disruptions and chromosomal abnormalities,64,Categorical (single),Both sexes,Jul 2019,64,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132604,"Date Q99 first reported (other chromosome abnormalities, not elsewhere classified)",2417,Congenital disruptions and chromosomal abnormalities,53,Date,Both sexes,Jul 2019,53,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132605,"Source of report of Q99 (other chromosome abnormalities, not elsewhere classified)",2417,Congenital disruptions and chromosomal abnormalities,53,Categorical (single),Both sexes,Jul 2019,53,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Congenital disruptions and chromosomal abnormalities,0.0,0.0,0.0,0.0,0.0,0.0,0.0
200,Date of consenting to join UK Biobank,100023,Consent,"502,504",Date,Both sexes,Jan 2012,"502,504",Data,Singular,Jan 2017,Complete,UK Biobank Assessment Centre,Recruitment,Consent,0.0,0.0,0.0,0.0,0.0,0.0,0.0
393,Program (tactus) version ID (compiler timestamp),100023,Consent,"502,504",Categorical (single),Both sexes,Jan 2012,"502,504",Data,Singular,Jan 2012,Complete,UK Biobank Assessment Centre,Recruitment,Consent,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20158,DXA images,103,DXA assessment,"33,824",Text,Both sexes,Sep 2015,"34,815",Bulk,Defined (2),Oct 2019,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,0.0,0.0,0.0,0.0,0.0,0.0,0.0
12254,DXA measurement completed,103,DXA assessment,"46,345",Categorical (single),Both sexes,Sep 2015,"48,843",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,0.0,0.0,0.0,0.0,0.0,0.0,0.0
12253,DXA measuring method,103,DXA assessment,"47,728",Categorical (single),Both sexes,Sep 2015,"50,458",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,0.0,0.0,0.0,0.0,0.0,0.0,0.0
12141,Believed safe to perform DXA scan,103,DXA assessment,"47,922",Categorical (single),Both sexes,Sep 2015,"50,661",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,DXA assessment,0.0,0.0,0.0,0.0,0.0,0.0,0.0
40020,Death record origin,100093,Death register,"20,442",Categorical (single),Both sexes,Mar 2018,"20,502",Data,Defined (2),Aug 2019,Accruing,Health-related outcomes,Death register,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
40018,Death record format,100093,Death register,"20,442",Categorical (single),Both sexes,Mar 2014,"20,502",Data,Defined (2),Aug 2019,Ongoing,Health-related outcomes,Death register,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
40000,Date of death,100093,Death register,"20,442",Date,Both sexes,Jul 2012,"20,502",Data,Defined (2),Aug 2019,Accruing,Health-related outcomes,Death register,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
40007,Age at death,100093,Death register,"20,442","Continuous, years",Both sexes,Aug 2012,"20,502",Data,Defined (2),Jan 2020,Accruing,Health-related outcomes,Death register,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
40001,Underlying (primary) cause of death: ICD10,100093,Death register,"20,432",Categorical (single),Both sexes,Jul 2012,"20,492",Data,Defined (2),Aug 2019,Accruing,Health-related outcomes,Death register,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
40014,Underlying (primary) cause of death: ICD10 addendum,100093,Death register,pending,Text,Both sexes,Feb 2013,pending,Data,Singular,N/A,Accruing,Health-related outcomes,Death register,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
40015,Contributory (secondary) cause of death: ICD10 addendum,100093,Death register,pending,Text,Both sexes,Feb 2013,pending,Data,Singular,N/A,Accruing,Health-related outcomes,Death register,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
40002,Contributory (secondary) causes of death: ICD10,100093,Death register,"12,660",Categorical (single),Both sexes,Jul 2012,"27,182",Data,Defined (2),Aug 2019,Accruing,Health-related outcomes,Death register,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
40010,Description of cause of death,100093,Death register,"17,147",Compound,Both sexes,Aug 2012,"17,147",Data,Variable (1),Aug 2019,Accruing,Health-related outcomes,Death register,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42018,Date of all cause dementia report,47,Dementia outcomes,"2,732",Date,Both sexes,Apr 2018,"2,732",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Dementia outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42019,Source of all cause dementia report,47,Dementia outcomes,"2,732",Categorical (single),Both sexes,Apr 2018,"2,732",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Dementia outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42020,Date of alzheimer's disease report,47,Dementia outcomes,"1,005",Date,Both sexes,Apr 2018,"1,005",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Dementia outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42021,Source of alzheimer's disease report,47,Dementia outcomes,"1,005",Categorical (single),Both sexes,Apr 2018,"1,005",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Dementia outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42022,Date of vascular dementia report,47,Dementia outcomes,541,Date,Both sexes,Apr 2018,541,Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Dementia outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42023,Source of vascular dementia report,47,Dementia outcomes,541,Categorical (single),Both sexes,Apr 2018,541,Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Dementia outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42024,Date of frontotemporal dementia report,47,Dementia outcomes,113,Date,Both sexes,Apr 2018,113,Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Dementia outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42025,Source of frontotemporal dementia report,47,Dementia outcomes,113,Categorical (single),Both sexes,Apr 2018,113,Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Dementia outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20446,Ever had prolonged feelings of sadness or depression,138,Depression,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20441,Ever had prolonged loss of interest in normal activities,138,Depression,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20547,Activities undertaken to treat depression,138,Depression,"40,341",Categorical (multiple),Both sexes,Oct 2016,"47,691",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20433,Age at first episode of depression,138,Depression,"89,035",Integer,Both sexes,Oct 2016,"89,035",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20434,Age at last episode of depression,138,Depression,"89,035",Integer,Both sexes,Oct 2016,"89,035",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20445,Depression possibly related to childbirth,138,Depression,"89,035",Categorical (single),Both sexes,Oct 2016,"89,035",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20447,Depression possibly related to stressful or traumatic event,138,Depression,"89,035",Categorical (single),Both sexes,Oct 2016,"89,035",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20532,Did your sleep change?,138,Depression,"89,035",Categorical (single),Both sexes,Oct 2016,"89,035",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20435,Difficulty concentrating during worst depression,138,Depression,"89,035",Categorical (single),Both sexes,Oct 2016,"89,035",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20438,Duration of worst depression,138,Depression,"89,035",Categorical (single),Both sexes,Oct 2016,"89,035",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20449,Feelings of tiredness during worst episode of depression,138,Depression,"89,035",Categorical (single),Both sexes,Oct 2016,"89,035",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20450,Feelings of worthlessness during worst period of depression,138,Depression,"89,035",Categorical (single),Both sexes,Oct 2016,"89,035",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20436,Fraction of day affected during worst episode of depression,138,Depression,"89,035",Categorical (single),Both sexes,Oct 2016,"89,035",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20439,Frequency of depressed days during worst episode of depression,138,Depression,"89,035",Categorical (single),Both sexes,Oct 2016,"89,035",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20440,Impact on normal roles during worst period of depression,138,Depression,"89,035",Categorical (single),Both sexes,Oct 2016,"89,035",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20442,Lifetime number of depressed periods,138,Depression,"89,035",Integer,Both sexes,Oct 2016,"89,035",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20448,Professional informed about depression,138,Depression,"89,035",Categorical (single),Both sexes,Oct 2016,"89,035",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20518,Recent changes in speed/amount of moving or speaking,138,Depression,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20510,Recent feelings of depression,138,Depression,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20507,Recent feelings of inadequacy,138,Depression,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20519,Recent feelings of tiredness or low energy,138,Depression,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20514,Recent lack of interest or pleasure in doing things,138,Depression,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20511,Recent poor appetite or overeating,138,Depression,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20513,Recent thoughts of suicide or self-harm,138,Depression,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20508,Recent trouble concentrating on things,138,Depression,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20534,Sleeping too much,138,Depression,"60,906",Categorical (single),Both sexes,Oct 2016,"60,906",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20546,Substances taken for depression,138,Depression,"45,715",Categorical (multiple),Both sexes,Oct 2016,"54,587",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20437,Thoughts of death during worst depression,138,Depression,"89,035",Categorical (single),Both sexes,Oct 2016,"89,035",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20533,Trouble falling asleep,138,Depression,"60,906",Categorical (single),Both sexes,Oct 2016,"60,906",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20517,"Trouble falling or staying asleep, or sleeping too much",138,Depression,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20535,Waking too early,138,Depression,"60,906",Categorical (single),Both sexes,Oct 2016,"60,906",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20536,Weight change during worst episode of depression,138,Depression,"89,035",Categorical (single),Both sexes,Oct 2016,"89,035",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Depression,0.0,0.0,0.0,0.0,0.0,0.0,0.0
1289,Cooked vegetable intake,100052,Diet,"501,630","Integer, tablespoons/day",Both sexes,Jan 2012,"572,256",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1299,Salad / raw vegetable intake,100052,Diet,"501,630","Integer, tablespoons/day",Both sexes,Jan 2012,"572,256",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1309,Fresh fruit intake,100052,Diet,"501,630","Integer, pieces/day",Both sexes,Jan 2012,"572,256",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1319,Dried fruit intake,100052,Diet,"501,629","Integer, pieces/day",Both sexes,Jan 2012,"572,255",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1329,Oily fish intake,100052,Diet,"501,629",Categorical (single),Both sexes,Jan 2012,"572,255",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1339,Non-oily fish intake,100052,Diet,"501,629",Categorical (single),Both sexes,Jan 2012,"572,255",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1349,Processed meat intake,100052,Diet,"501,628",Categorical (single),Both sexes,Jan 2012,"572,254",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1359,Poultry intake,100052,Diet,"501,628",Categorical (single),Both sexes,Jan 2012,"572,254",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1369,Beef intake,100052,Diet,"501,628",Categorical (single),Both sexes,Jan 2012,"572,254",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1379,Lamb/mutton intake,100052,Diet,"501,628",Categorical (single),Both sexes,Jan 2012,"572,254",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1389,Pork intake,100052,Diet,"501,626",Categorical (single),Both sexes,Jan 2012,"572,252",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
3680,Age when last ate meat,100052,Diet,"21,142","Integer, years",Both sexes,Jan 2012,"24,552",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
6144,"Never eat eggs, dairy, wheat, sugar",100052,Diet,"498,739",Categorical (multiple),Both sexes,Jan 2012,"589,334",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
10855,"Never eat eggs, dairy, wheat, sugar (pilot)",100052,Diet,"3,770",Categorical (multiple),Both sexes,Jan 2012,"3,938",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1408,Cheese intake,100052,Diet,"490,275",Categorical (single),Both sexes,Jan 2012,"558,765",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1418,Milk type used,100052,Diet,"501,557",Categorical (single),Both sexes,Jan 2012,"572,169",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1428,Spread type,100052,Diet,"498,739",Categorical (single),Both sexes,Jan 2012,"568,482",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
2654,Non-butter spread type details,100052,Diet,"264,354",Categorical (single),Both sexes,Jan 2012,"286,927",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
10767,Spread type (pilot),100052,Diet,"3,770",Categorical (single),Both sexes,Jan 2012,"3,770",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1438,Bread intake,100052,Diet,"498,739","Integer, slices/week",Both sexes,Jan 2012,"568,482",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1448,Bread type,100052,Diet,"483,608",Categorical (single),Both sexes,Jan 2012,"548,894",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
10776,Bread type/intake (pilot),100052,Diet,"3,653",Categorical (single),Both sexes,Jan 2012,"3,653",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1458,Cereal intake,100052,Diet,"501,526","Integer, bowls/week",Both sexes,Jan 2012,"572,135",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1468,Cereal type,100052,Diet,"419,103",Categorical (single),Both sexes,Jan 2012,"472,931",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1478,Salt added to food,100052,Diet,"501,626",Categorical (single),Both sexes,Jan 2012,"572,252",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1488,Tea intake,100052,Diet,"501,626","Integer, cups/day",Both sexes,Jan 2012,"572,252",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1498,Coffee intake,100052,Diet,"501,626","Integer, cups/day",Both sexes,Jan 2012,"572,252",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1508,Coffee type,100052,Diet,"391,175",Categorical (single),Both sexes,Jan 2012,"444,622",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1518,Hot drink temperature,100052,Diet,"501,626",Categorical (single),Both sexes,Jan 2012,"572,252",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1528,Water intake,100052,Diet,"501,626","Integer, glasses/day",Both sexes,Jan 2012,"572,252",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1538,Major dietary changes in the last 5 years,100052,Diet,"501,626",Categorical (single),Both sexes,Jan 2012,"572,252",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
1548,Variation in diet,100052,Diet,"498,739",Categorical (single),Both sexes,Jan 2012,"568,482",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
10912,Variation in diet (pilot),100052,Diet,"3,770",Categorical (single),Both sexes,Jan 2012,"3,770",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Diet,0.0,0.0,0.0,0.0,0.0,0.0
100026,Daily dietary data not credible,100090,Diet by 24-hour recall,"3,171",Categorical (single),Both sexes,Oct 2015,"3,494",Data,Defined (5),Oct 2015,Complete,Online follow-up,Diet by 24-hour recall,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
110001,"Invitation to complete online 24-hour recall dietary questionnaire, acceptance",100090,Diet by 24-hour recall,"330,939",Categorical (single),Both sexes,Jul 2014,"1,265,183",Data,Defined (4),Jul 2014,Complete,Online follow-up,Diet by 24-hour recall,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
110002,"Invitation to complete online 24-hour recall dietary questionnaire, date sent",100090,Diet by 24-hour recall,"330,939",Date,Both sexes,Jul 2014,"1,265,183",Data,Defined (4),Jul 2014,Complete,Online follow-up,Diet by 24-hour recall,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20080,Day-of-week questionnaire completed,100114,Diet questionnaire performance,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Oct 2012,Complete,Online follow-up,Diet by 24-hour recall,Diet questionnaire performance,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20079,Day-of-week questionnaire completion requested,100114,Diet questionnaire performance,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Oct 2012,Complete,Online follow-up,Diet by 24-hour recall,Diet questionnaire performance,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20083,Delay between questionnaire request and completion,100114,Diet questionnaire performance,"211,010","Integer, days",Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Diet questionnaire performance,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20082,Duration of questionnaire,100114,Diet questionnaire performance,"211,010","Integer, minutes",Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Diet questionnaire performance,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20081,Hour-of-day questionnaire completed,100114,Diet questionnaire performance,"211,010","Integer, hours",Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Diet questionnaire performance,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20077,Number of diet questionnaires completed,100114,Diet questionnaire performance,"211,013",Integer,Both sexes,Sep 2012,"211,013",Data,Singular,Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Diet questionnaire performance,0.0,0.0,0.0,0.0,0.0,0.0,0.0
105010,When diet questionnaire completed,100114,Diet questionnaire performance,"211,013",Time,Both sexes,Sep 2012,"458,597",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Diet questionnaire performance,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20078,When diet questionnaire completion requested,100114,Diet questionnaire performance,"211,013",Date,Both sexes,Sep 2012,"458,597",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Diet questionnaire performance,0.0,0.0,0.0,0.0,0.0,0.0,0.0
105030,When diet questionnaire started,100114,Diet questionnaire performance,"211,013",Time,Both sexes,Sep 2012,"458,597",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Diet questionnaire performance,0.0,0.0,0.0,0.0,0.0,0.0,0.0
25921,Increased search space in eddy current estimation used for dMRI,107,Diffusion brain MRI,"39,754",Categorical (single),Both sexes,Dec 2019,"41,181",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25928,Intensity scaling for dMRI,107,Diffusion brain MRI,"38,343","Continuous, units",Both sexes,Dec 2019,"39,762",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25922,Standard deviation of apparent translation in the Y axis as measured by eddy,107,Diffusion brain MRI,"38,055","Continuous, units",Both sexes,Dec 2019,"39,471",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
20250,Multiband diffusion brain images - NIFTI,107,Diffusion brain MRI,"39,026",Text,Both sexes,Oct 2015,"40,519",Bulk,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
20218,Multiband diffusion brain images - DICOM,107,Diffusion brain MRI,"40,674",Text,Both sexes,Jul 2014,"42,395",Bulk,Defined (2),Nov 2019,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25737,Discrepancy between dMRI brain image and T1 brain image,107,Diffusion brain MRI,"38,052","Continuous, AU",Both sexes,Oct 2015,"39,468",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25746,Number of dMRI outlier slices detected and corrected,107,Diffusion brain MRI,"37,525","Integer, slices",Both sexes,Oct 2015,"38,941",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
21027,Abdominal discomfort/pain for 6 months or longer,153,Digestive health,"93,900",Categorical (single),Both sexes,Jul 2018,"93,900",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21044,Average number of times bowels opened per day,153,Digestive health,"174,770","Integer, times/day",Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21075,Bloody diarrhoea when IBS symptoms first began,153,Digestive health,"10,744",Categorical (single),Both sexes,Jul 2018,"10,744",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21066,Born by caesarian section,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21035,Currently (in last 3 months) suffer from abdominal pain,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21038,Currently suffer from abdominal distension,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21048,Degree bothered by back pain in the past 3 months,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21052,Degree bothered by chest pain in the last 3 months,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21053,Degree bothered by dizziness in the last 3 months,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21054,Degree bothered by fainting spells in the last 3 months,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21055,Degree bothered by feeling heart pound/race in the last 3 months,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21060,Degree bothered by feeling tired all the time in the last 3 months,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21051,Degree bothered by headaches in the last 3 months,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21050,Degree bothered by menstrual cramps or other problems with period in the last 3 months,153,Digestive health,"99,286",Categorical (single),Females only,Jul 2018,"99,286",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21059,Degree bothered by nausea in the last 3 months,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21049,Degree bothered by pain in arms/legs/joints in the past 3 months,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21057,Degree bothered by pain/problems during intercourse in the last 3 months,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21056,Degree bothered by shortness of breath in the last 3 months,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21061,Degree bothered by trouble sleeping in the last 3 months,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21058,Degree bothered by urinary frequency/bladder irritability in the last 3 months,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21041,Degree to which abdominal pain/discomfort/altered bowel habits affect/interfere with life in general,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Sep 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21068,Diagnosed with coeliac disease or gluten sensitivity,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21074,Diarrhoea when IBS symptoms first began,153,Digestive health,"21,362",Categorical (single),Both sexes,Jul 2018,"21,362",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21026,Discomfort/pain occurring only during menstrual bleed,153,Digestive health,"61,023",Categorical (single),Females only,Jul 2018,"61,023",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21062,Ever been offered/sought treatment for anxiety,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21063,Ever been offered/sought treatment for depression,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21024,Ever diagnosed with IBS,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21065,Family history of IBS,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21073,Fever when IBS symptoms first began,153,Digestive health,"21,362",Categorical (single),Both sexes,Jul 2018,"21,362",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21028,Frequency of discomfort/pain getting better or stopping after a bowel movement,153,Digestive health,"93,900",Categorical (single),Both sexes,Jul 2018,"93,900",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21025,Frequency of discomfort/pain in abdomen in last 3 months,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21033,Frequency of hard/lumpy stools in the last 3 months,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21032,Frequency of harder stools when abdominal discomfort/pain started,153,Digestive health,"93,900",Categorical (single),Both sexes,Jul 2018,"93,900",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21034,Frequency of loose/mushy/watery stools in the last 3 months,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21042,Greatest number of times bowels opened per day,153,Digestive health,"174,770","Integer, times/day",Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21072,Infection diagnosed alongside IBS when IBS symptoms began,153,Digestive health,"2,118",Categorical (single),Both sexes,Jul 2018,"2,118",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21071,Infectious illness diagnosis status when IBS symptoms first began,153,Digestive health,"21,362",Categorical (single),Both sexes,Jul 2018,"21,362",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21043,Least number of times bowels opened per week,153,Digestive health,"174,770","Integer, times/week",Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21030,Less frequent bowel movements when abdominal discomfort/pain started,153,Digestive health,"93,900",Categorical (single),Both sexes,Jul 2018,"93,900",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21067,Long-term/recurrent antibiotics as child or teenager,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21069,Method of coeliac disease/gluten sensitivity diagnosis,153,Digestive health,"3,262",Categorical (single),Both sexes,Jul 2018,"3,262",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21029,More frequent bowel movements when abdominal discomfort/pain started,153,Digestive health,"93,900",Categorical (single),Both sexes,Jul 2018,"93,900",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21037,Number of days (out of 10) with abdominal pain,153,Digestive health,"50,619",Categorical (single),Both sexes,Jul 2018,"50,619",Data,Singular,Sep 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21047,Number of weeks (in the last year) at work suffering because of IBS,153,Digestive health,"8,370","Integer, weeks",Both sexes,Jul 2018,"8,370",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21045,"Number of weeks absent from work due to IBS, in the last year",153,Digestive health,"21,362","Integer, weeks",Both sexes,Jul 2018,"21,362",Data,Singular,Sep 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21040,Satisfaction with bowel habits,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Sep 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21064,Sensitive stomach,153,Digestive health,"174,770",Categorical (single),Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21039,Severity of current abdominal distension/tightness,153,Digestive health,"40,667",Categorical (single),Both sexes,Jul 2018,"40,667",Data,Singular,Sep 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21036,Severity of current abdominal pain,153,Digestive health,"50,619",Categorical (single),Both sexes,Jul 2018,"50,619",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21070,Speed of onset of IBS symptoms,153,Digestive health,"21,362",Categorical (single),Both sexes,Jul 2018,"21,362",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21031,Stools looser when abdominal discomfort/pain started,153,Digestive health,"93,900",Categorical (single),Both sexes,Jul 2018,"93,900",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21076,Vomiting when IBS symptoms first began,153,Digestive health,"21,362",Categorical (single),Both sexes,Jul 2018,"21,362",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21023,When digestive health questionnaire completed,153,Digestive health,"174,770",Time,Both sexes,Jul 2018,"174,770",Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21046,When gave up work due to IBS,153,Digestive health,150,Date,Both sexes,Jul 2018,150,Data,Singular,Aug 2018,Accruing,Online follow-up,Digestive health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131552,Date K00 first reported (disorders of tooth development and eruption),2411,Digestive system disorders,263,Date,Both sexes,Jul 2019,263,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131553,Source of report of K00 (disorders of tooth development and eruption),2411,Digestive system disorders,263,Categorical (single),Both sexes,Jul 2019,263,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131554,Date K01 first reported (embedded and impacted teeth),2411,Digestive system disorders,"2,575",Date,Both sexes,Jul 2019,"2,575",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131555,Source of report of K01 (embedded and impacted teeth),2411,Digestive system disorders,"2,575",Categorical (single),Both sexes,Jul 2019,"2,575",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131556,Date K02 first reported (dental caries),2411,Digestive system disorders,"4,946",Date,Both sexes,Jul 2019,"4,946",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131557,Source of report of K02 (dental caries),2411,Digestive system disorders,"4,946",Categorical (single),Both sexes,Jul 2019,"4,946",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131558,Date K03 first reported (other diseases of hard tissues of teeth),2411,Digestive system disorders,140,Date,Both sexes,Jul 2019,140,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131559,Source of report of K03 (other diseases of hard tissues of teeth),2411,Digestive system disorders,140,Categorical (single),Both sexes,Jul 2019,140,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131560,Date K04 first reported (diseases of pulp and periapical tissues),2411,Digestive system disorders,"7,764",Date,Both sexes,Jul 2019,"7,764",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131561,Source of report of K04 (diseases of pulp and periapical tissues),2411,Digestive system disorders,"7,764",Categorical (single),Both sexes,Jul 2019,"7,764",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131562,Date K05 first reported (gingivitis and periodontal diseases),2411,Digestive system disorders,"1,888",Date,Both sexes,Jul 2019,"1,888",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131563,Source of report of K05 (gingivitis and periodontal diseases),2411,Digestive system disorders,"1,888",Categorical (single),Both sexes,Jul 2019,"1,888",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131564,Date K06 first reported (other disorders of gingiva and edentulous alveolar ridge),2411,Digestive system disorders,688,Date,Both sexes,Jul 2019,688,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131565,Source of report of K06 (other disorders of gingiva and edentulous alveolar ridge),2411,Digestive system disorders,688,Categorical (single),Both sexes,Jul 2019,688,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131566,Date K07 first reported (dentofacial anomalies [including malocclusion]),2411,Digestive system disorders,"2,525",Date,Both sexes,Jul 2019,"2,525",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131567,Source of report of K07 (dentofacial anomalies [including malocclusion]),2411,Digestive system disorders,"2,525",Categorical (single),Both sexes,Jul 2019,"2,525",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131568,Date K08 first reported (other disorders of teeth and supporting structures),2411,Digestive system disorders,"4,173",Date,Both sexes,Jul 2019,"4,173",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131569,Source of report of K08 (other disorders of teeth and supporting structures),2411,Digestive system disorders,"4,173",Categorical (single),Both sexes,Jul 2019,"4,173",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131570,"Date K09 first reported (cysts of oral region, not elsewhere classified)",2411,Digestive system disorders,830,Date,Both sexes,Jul 2019,830,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131571,"Source of report of K09 (cysts of oral region, not elsewhere classified)",2411,Digestive system disorders,830,Categorical (single),Both sexes,Jul 2019,830,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131572,Date K10 first reported (other diseases of jaws),2411,Digestive system disorders,"1,733",Date,Both sexes,Jul 2019,"1,733",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131573,Source of report of K10 (other diseases of jaws),2411,Digestive system disorders,"1,733",Categorical (single),Both sexes,Jul 2019,"1,733",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131574,Date K11 first reported (diseases of salivary glands),2411,Digestive system disorders,"3,261",Date,Both sexes,Jul 2019,"3,261",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131575,Source of report of K11 (diseases of salivary glands),2411,Digestive system disorders,"3,261",Categorical (single),Both sexes,Jul 2019,"3,261",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131576,Date K12 first reported (stomatitis and related lesions),2411,Digestive system disorders,"3,664",Date,Both sexes,Jul 2019,"3,664",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131577,Source of report of K12 (stomatitis and related lesions),2411,Digestive system disorders,"3,664",Categorical (single),Both sexes,Jul 2019,"3,664",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131578,Date K13 first reported (other diseases of lip and oral mucosa),2411,Digestive system disorders,"6,681",Date,Both sexes,Jul 2019,"6,681",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131579,Source of report of K13 (other diseases of lip and oral mucosa),2411,Digestive system disorders,"6,681",Categorical (single),Both sexes,Jul 2019,"6,681",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131580,Date K14 first reported (diseases of tongue),2411,Digestive system disorders,"3,403",Date,Both sexes,Jul 2019,"3,403",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131581,Source of report of K14 (diseases of tongue),2411,Digestive system disorders,"3,403",Categorical (single),Both sexes,Jul 2019,"3,403",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131582,Date K20 first reported (oesophagitis),2411,Digestive system disorders,"14,641",Date,Both sexes,Jul 2019,"14,641",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131583,Source of report of K20 (oesophagitis),2411,Digestive system disorders,"14,641",Categorical (single),Both sexes,Jul 2019,"14,641",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131584,Date K21 first reported (gastro-oesophageal reflux disease),2411,Digestive system disorders,"60,527",Date,Both sexes,Jul 2019,"60,527",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131585,Source of report of K21 (gastro-oesophageal reflux disease),2411,Digestive system disorders,"60,527",Categorical (single),Both sexes,Jul 2019,"60,527",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131586,Date K22 first reported (other diseases of oesophagus),2411,Digestive system disorders,"16,910",Date,Both sexes,Jul 2019,"16,910",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131587,Source of report of K22 (other diseases of oesophagus),2411,Digestive system disorders,"16,910",Categorical (single),Both sexes,Jul 2019,"16,910",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131588,Date K23 first reported (disorders of oesophagus in diseases classified elsewhere),2411,Digestive system disorders,51,Date,Both sexes,Jul 2019,51,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131589,Source of report of K23 (disorders of oesophagus in diseases classified elsewhere),2411,Digestive system disorders,51,Categorical (single),Both sexes,Jul 2019,51,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131590,Date K25 first reported (gastric ulcer),2411,Digestive system disorders,"10,476",Date,Both sexes,Jul 2019,"10,476",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131591,Source of report of K25 (gastric ulcer),2411,Digestive system disorders,"10,476",Categorical (single),Both sexes,Jul 2019,"10,476",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131592,Date K26 first reported (duodenal ulcer),2411,Digestive system disorders,"8,665",Date,Both sexes,Jul 2019,"8,665",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131593,Source of report of K26 (duodenal ulcer),2411,Digestive system disorders,"8,665",Categorical (single),Both sexes,Jul 2019,"8,665",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131594,"Date K27 first reported (peptic ulcer, site unspecified)",2411,Digestive system disorders,"1,694",Date,Both sexes,Jul 2019,"1,694",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131595,"Source of report of K27 (peptic ulcer, site unspecified)",2411,Digestive system disorders,"1,694",Categorical (single),Both sexes,Jul 2019,"1,694",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131596,Date K28 first reported (gastrojejunal ulcer),2411,Digestive system disorders,110,Date,Both sexes,Jul 2019,110,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131597,Source of report of K28 (gastrojejunal ulcer),2411,Digestive system disorders,110,Categorical (single),Both sexes,Jul 2019,110,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131598,Date K29 first reported (gastritis and duodenitis),2411,Digestive system disorders,"48,356",Date,Both sexes,Jul 2019,"48,356",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131599,Source of report of K29 (gastritis and duodenitis),2411,Digestive system disorders,"48,356",Categorical (single),Both sexes,Jul 2019,"48,356",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131600,Date K30 first reported (dyspepsia),2411,Digestive system disorders,"18,526",Date,Both sexes,Jul 2019,"18,526",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131601,Source of report of K30 (dyspepsia),2411,Digestive system disorders,"18,526",Categorical (single),Both sexes,Jul 2019,"18,526",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131602,Date K31 first reported (other diseases of stomach and duodenum),2411,Digestive system disorders,"13,053",Date,Both sexes,Jul 2019,"13,053",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131603,Source of report of K31 (other diseases of stomach and duodenum),2411,Digestive system disorders,"13,053",Categorical (single),Both sexes,Jul 2019,"13,053",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131604,Date K35 first reported (acute appendicitis),2411,Digestive system disorders,"4,358",Date,Both sexes,Jul 2019,"4,358",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131605,Source of report of K35 (acute appendicitis),2411,Digestive system disorders,"4,358",Categorical (single),Both sexes,Jul 2019,"4,358",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131606,Date K36 first reported (other appendicitis),2411,Digestive system disorders,168,Date,Both sexes,Jul 2019,168,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131607,Source of report of K36 (other appendicitis),2411,Digestive system disorders,168,Categorical (single),Both sexes,Jul 2019,168,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131608,Date K37 first reported (unspecified appendicitis),2411,Digestive system disorders,"5,968",Date,Both sexes,Jul 2019,"5,968",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131609,Source of report of K37 (unspecified appendicitis),2411,Digestive system disorders,"5,968",Categorical (single),Both sexes,Jul 2019,"5,968",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131610,Date K38 first reported (other diseases of appendix),2411,Digestive system disorders,419,Date,Both sexes,Jul 2019,419,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131611,Source of report of K38 (other diseases of appendix),2411,Digestive system disorders,419,Categorical (single),Both sexes,Jul 2019,419,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131612,Date K40 first reported (inguinal hernia),2411,Digestive system disorders,"26,789",Date,Both sexes,Jul 2019,"26,789",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131613,Source of report of K40 (inguinal hernia),2411,Digestive system disorders,"26,789",Categorical (single),Both sexes,Jul 2019,"26,789",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131614,Date K41 first reported (femoral hernia),2411,Digestive system disorders,"1,219",Date,Both sexes,Jul 2019,"1,219",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131615,Source of report of K41 (femoral hernia),2411,Digestive system disorders,"1,219",Categorical (single),Both sexes,Jul 2019,"1,219",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131616,Date K42 first reported (umbilical hernia),2411,Digestive system disorders,"7,173",Date,Both sexes,Jul 2019,"7,173",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131617,Source of report of K42 (umbilical hernia),2411,Digestive system disorders,"7,173",Categorical (single),Both sexes,Jul 2019,"7,173",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131618,Date K43 first reported (ventral hernia),2411,Digestive system disorders,"6,103",Date,Both sexes,Jul 2019,"6,103",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131619,Source of report of K43 (ventral hernia),2411,Digestive system disorders,"6,103",Categorical (single),Both sexes,Jul 2019,"6,103",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131620,Date K44 first reported (diaphragmatic hernia),2411,Digestive system disorders,"45,056",Date,Both sexes,Jul 2019,"45,056",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131621,Source of report of K44 (diaphragmatic hernia),2411,Digestive system disorders,"45,056",Categorical (single),Both sexes,Jul 2019,"45,056",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131622,Date K45 first reported (other abdominal hernia),2411,Digestive system disorders,214,Date,Both sexes,Jul 2019,214,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131623,Source of report of K45 (other abdominal hernia),2411,Digestive system disorders,214,Categorical (single),Both sexes,Jul 2019,214,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131624,Date K46 first reported (unspecified abdominal hernia),2411,Digestive system disorders,"1,855",Date,Both sexes,Jul 2019,"1,855",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131625,Source of report of K46 (unspecified abdominal hernia),2411,Digestive system disorders,"1,855",Categorical (single),Both sexes,Jul 2019,"1,855",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131626,Date K50 first reported (crohn's disease [regional enteritis]),2411,Digestive system disorders,"2,907",Date,Both sexes,Jul 2019,"2,907",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131627,Source of report of K50 (crohn's disease [regional enteritis]),2411,Digestive system disorders,"2,907",Categorical (single),Both sexes,Jul 2019,"2,907",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131628,Date K51 first reported (ulcerative colitis),2411,Digestive system disorders,"5,614",Date,Both sexes,Jul 2019,"5,614",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131629,Source of report of K51 (ulcerative colitis),2411,Digestive system disorders,"5,614",Categorical (single),Both sexes,Jul 2019,"5,614",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131630,Date K52 first reported (other non-infective gastro-enteritis and colitis),2411,Digestive system disorders,"25,127",Date,Both sexes,Jul 2019,"25,127",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131631,Source of report of K52 (other non-infective gastro-enteritis and colitis),2411,Digestive system disorders,"25,127",Categorical (single),Both sexes,Jul 2019,"25,127",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131632,Date K55 first reported (vascular disorders of intestine),2411,Digestive system disorders,"1,848",Date,Both sexes,Jul 2019,"1,848",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131633,Source of report of K55 (vascular disorders of intestine),2411,Digestive system disorders,"1,848",Categorical (single),Both sexes,Jul 2019,"1,848",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131634,Date K56 first reported (paralytic ileus and intestinal obstruction without hernia),2411,Digestive system disorders,"6,670",Date,Both sexes,Jul 2019,"6,670",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131635,Source of report of K56 (paralytic ileus and intestinal obstruction without hernia),2411,Digestive system disorders,"6,670",Categorical (single),Both sexes,Jul 2019,"6,670",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131636,Date K57 first reported (diverticular disease of intestine),2411,Digestive system disorders,"46,816",Date,Both sexes,Jul 2019,"46,816",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131637,Source of report of K57 (diverticular disease of intestine),2411,Digestive system disorders,"46,816",Categorical (single),Both sexes,Jul 2019,"46,816",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131638,Date K58 first reported (irritable bowel syndrome),2411,Digestive system disorders,"32,015",Date,Both sexes,Jul 2019,"32,015",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131639,Source of report of K58 (irritable bowel syndrome),2411,Digestive system disorders,"32,015",Categorical (single),Both sexes,Jul 2019,"32,015",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131640,Date K59 first reported (other functional intestinal disorders),2411,Digestive system disorders,"23,103",Date,Both sexes,Jul 2019,"23,103",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131641,Source of report of K59 (other functional intestinal disorders),2411,Digestive system disorders,"23,103",Categorical (single),Both sexes,Jul 2019,"23,103",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131642,Date K60 first reported (fissure and fistula of anal and rectal regions),2411,Digestive system disorders,"6,340",Date,Both sexes,Jul 2019,"6,340",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131643,Source of report of K60 (fissure and fistula of anal and rectal regions),2411,Digestive system disorders,"6,340",Categorical (single),Both sexes,Jul 2019,"6,340",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131644,Date K61 first reported (abscess of anal and rectal regions),2411,Digestive system disorders,"2,972",Date,Both sexes,Jul 2019,"2,972",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131645,Source of report of K61 (abscess of anal and rectal regions),2411,Digestive system disorders,"2,972",Categorical (single),Both sexes,Jul 2019,"2,972",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131646,Date K62 first reported (other diseases of anus and rectum),2411,Digestive system disorders,"39,818",Date,Both sexes,Jul 2019,"39,818",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131647,Source of report of K62 (other diseases of anus and rectum),2411,Digestive system disorders,"39,818",Categorical (single),Both sexes,Jul 2019,"39,818",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131648,Date K63 first reported (other diseases of intestine),2411,Digestive system disorders,"24,527",Date,Both sexes,Jul 2019,"24,527",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131649,Source of report of K63 (other diseases of intestine),2411,Digestive system disorders,"24,527",Categorical (single),Both sexes,Jul 2019,"24,527",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131650,Date K64 first reported (haemorrhoids and perianal venous thrombosis),2411,Digestive system disorders,"33,736",Date,Both sexes,Jul 2019,"33,736",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131651,Source of report of K64 (haemorrhoids and perianal venous thrombosis),2411,Digestive system disorders,"33,736",Categorical (single),Both sexes,Jul 2019,"33,736",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131652,Date K65 first reported (peritonitis),2411,Digestive system disorders,"3,010",Date,Both sexes,Jul 2019,"3,010",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131653,Source of report of K65 (peritonitis),2411,Digestive system disorders,"3,010",Categorical (single),Both sexes,Jul 2019,"3,010",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131654,Date K66 first reported (other disorders of peritoneum),2411,Digestive system disorders,"5,188",Date,Both sexes,Jul 2019,"5,188",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131655,Source of report of K66 (other disorders of peritoneum),2411,Digestive system disorders,"5,188",Categorical (single),Both sexes,Jul 2019,"5,188",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131656,Date K67 first reported (disorders of peritoneum in infectious diseases classified elsewhere),2411,Digestive system disorders,9,Date,Both sexes,Jul 2019,9,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131657,Source of report of K67 (disorders of peritoneum in infectious diseases classified elsewhere),2411,Digestive system disorders,9,Categorical (single),Both sexes,Jul 2019,9,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131658,Date K70 first reported (alcoholic liver disease),2411,Digestive system disorders,"1,658",Date,Both sexes,Jul 2019,"1,658",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131659,Source of report of K70 (alcoholic liver disease),2411,Digestive system disorders,"1,658",Categorical (single),Both sexes,Jul 2019,"1,658",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131660,Date K71 first reported (toxic liver disease),2411,Digestive system disorders,143,Date,Both sexes,Jul 2019,143,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131661,Source of report of K71 (toxic liver disease),2411,Digestive system disorders,143,Categorical (single),Both sexes,Jul 2019,143,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131662,"Date K72 first reported (hepatic failure, not elsewhere classified)",2411,Digestive system disorders,741,Date,Both sexes,Jul 2019,741,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131663,"Source of report of K72 (hepatic failure, not elsewhere classified)",2411,Digestive system disorders,741,Categorical (single),Both sexes,Jul 2019,741,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131664,"Date K73 first reported (chronic hepatitis, not elsewhere classified)",2411,Digestive system disorders,301,Date,Both sexes,Jul 2019,301,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131665,"Source of report of K73 (chronic hepatitis, not elsewhere classified)",2411,Digestive system disorders,301,Categorical (single),Both sexes,Jul 2019,301,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131666,Date K74 first reported (fibrosis and cirrhosis of liver),2411,Digestive system disorders,"1,838",Date,Both sexes,Jul 2019,"1,838",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131667,Source of report of K74 (fibrosis and cirrhosis of liver),2411,Digestive system disorders,"1,838",Categorical (single),Both sexes,Jul 2019,"1,838",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131668,Date K75 first reported (other inflammatory liver diseases),2411,Digestive system disorders,"2,028",Date,Both sexes,Jul 2019,"2,028",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131669,Source of report of K75 (other inflammatory liver diseases),2411,Digestive system disorders,"2,028",Categorical (single),Both sexes,Jul 2019,"2,028",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131670,Date K76 first reported (other diseases of liver),2411,Digestive system disorders,"9,010",Date,Both sexes,Jul 2019,"9,010",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131671,Source of report of K76 (other diseases of liver),2411,Digestive system disorders,"9,010",Categorical (single),Both sexes,Jul 2019,"9,010",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131672,Date K77 first reported (liver disorders in diseases classified elsewhere),2411,Digestive system disorders,32,Date,Both sexes,Jul 2019,32,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131673,Source of report of K77 (liver disorders in diseases classified elsewhere),2411,Digestive system disorders,32,Categorical (single),Both sexes,Jul 2019,32,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131674,Date K80 first reported (cholelithiasis),2411,Digestive system disorders,"27,611",Date,Both sexes,Jul 2019,"27,611",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131675,Source of report of K80 (cholelithiasis),2411,Digestive system disorders,"27,611",Categorical (single),Both sexes,Jul 2019,"27,611",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131676,Date K81 first reported (cholecystitis),2411,Digestive system disorders,"5,204",Date,Both sexes,Jul 2019,"5,204",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131677,Source of report of K81 (cholecystitis),2411,Digestive system disorders,"5,204",Categorical (single),Both sexes,Jul 2019,"5,204",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131678,Date K82 first reported (other diseases of gallbladder),2411,Digestive system disorders,"3,191",Date,Both sexes,Jul 2019,"3,191",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131679,Source of report of K82 (other diseases of gallbladder),2411,Digestive system disorders,"3,191",Categorical (single),Both sexes,Jul 2019,"3,191",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131680,Date K83 first reported (other diseases of biliary tract),2411,Digestive system disorders,"3,354",Date,Both sexes,Jul 2019,"3,354",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131681,Source of report of K83 (other diseases of biliary tract),2411,Digestive system disorders,"3,354",Categorical (single),Both sexes,Jul 2019,"3,354",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131682,Date K85 first reported (acute pancreatitis),2411,Digestive system disorders,"3,606",Date,Both sexes,Jul 2019,"3,606",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131683,Source of report of K85 (acute pancreatitis),2411,Digestive system disorders,"3,606",Categorical (single),Both sexes,Jul 2019,"3,606",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131684,Date K86 first reported (other diseases of pancreas),2411,Digestive system disorders,"2,033",Date,Both sexes,Jul 2019,"2,033",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131685,Source of report of K86 (other diseases of pancreas),2411,Digestive system disorders,"2,033",Categorical (single),Both sexes,Jul 2019,"2,033",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131686,"Date K87 first reported (disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere)",2411,Digestive system disorders,5,Date,Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131687,"Source of report of K87 (disorders of gallbladder, biliary tract and pancreas in diseases classified elsewhere)",2411,Digestive system disorders,5,Categorical (single),Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131688,Date K90 first reported (intestinal malabsorption),2411,Digestive system disorders,"4,099",Date,Both sexes,Jul 2019,"4,099",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131689,Source of report of K90 (intestinal malabsorption),2411,Digestive system disorders,"4,099",Categorical (single),Both sexes,Jul 2019,"4,099",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131690,"Date K91 first reported (postprocedural disorders of digestive system, not elsewhere classified)",2411,Digestive system disorders,"2,484",Date,Both sexes,Jul 2019,"2,484",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131691,"Source of report of K91 (postprocedural disorders of digestive system, not elsewhere classified)",2411,Digestive system disorders,"2,484",Categorical (single),Both sexes,Jul 2019,"2,484",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131692,Date K92 first reported (other diseases of digestive system),2411,Digestive system disorders,"16,803",Date,Both sexes,Jul 2019,"16,803",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131693,Source of report of K92 (other diseases of digestive system),2411,Digestive system disorders,"16,803",Categorical (single),Both sexes,Jul 2019,"16,803",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131694,Date K93 first reported (disorders of other digestive organs in diseases classified elsewhere),2411,Digestive system disorders,20,Date,Both sexes,Jul 2019,20,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131695,Source of report of K93 (disorders of other digestive organs in diseases classified elsewhere),2411,Digestive system disorders,20,Categorical (single),Both sexes,Jul 2019,20,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Digestive system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
12323,12-lead ECG measuring method,104,"ECG at rest, 12-lead","47,600",Categorical (single),Both sexes,Sep 2015,"50,187",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Physical measures,"ECG at rest, 12-lead",0.0,0.0,0.0,0.0,0.0,0.0,0.0
12657,Suspicious flag for 12-lead ECG,104,"ECG at rest, 12-lead","1,876",Integer,Both sexes,Sep 2015,"1,876",Data,Defined (1),Sep 2015,Accruing,UK Biobank Assessment Centre,Physical measures,"ECG at rest, 12-lead",0.0,0.0,0.0,0.0,0.0,0.0,0.0
12653,ECG automated diagnoses,104,"ECG at rest, 12-lead","41,642",Text,Both sexes,Sep 2015,"245,926",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Physical measures,"ECG at rest, 12-lead",0.0,0.0,0.0,0.0,0.0,0.0,0.0
20205,ECG datasets,104,"ECG at rest, 12-lead","41,683",Text,Both sexes,Jul 2014,"43,467",Bulk,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Physical measures,"ECG at rest, 12-lead",0.0,0.0,0.0,0.0,0.0,0.0,0.0
12654,Number of automated diagnostic comments recorded during 12-lead ECG,104,"ECG at rest, 12-lead","41,642",Integer,Both sexes,Sep 2015,"43,366",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Physical measures,"ECG at rest, 12-lead",0.0,0.0,0.0,0.0,0.0,0.0,0.0
12336,Ventricular rate,104,"ECG at rest, 12-lead","41,736","Integer, bpm",Both sexes,Sep 2015,"43,525",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Physical measures,"ECG at rest, 12-lead",0.0,0.0,0.0,0.0,0.0,0.0,0.0
12338,P duration,104,"ECG at rest, 12-lead","39,531","Integer, ms",Both sexes,Sep 2015,"41,241",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Physical measures,"ECG at rest, 12-lead",0.0,0.0,0.0,0.0,0.0,0.0,0.0
22334,PP interval,104,"ECG at rest, 12-lead","24,924","Integer, ms",Both sexes,Sep 2018,"24,924",Data,Defined (1),Sep 2018,Accruing,UK Biobank Assessment Centre,Physical measures,"ECG at rest, 12-lead",0.0,0.0,0.0,0.0,0.0,0.0,0.0
22330,PQ interval,104,"ECG at rest, 12-lead","23,679","Integer, ms",Both sexes,Sep 2018,"23,679",Data,Defined (1),Sep 2018,Accruing,UK Biobank Assessment Centre,Physical measures,"ECG at rest, 12-lead",0.0,0.0,0.0,0.0,0.0,0.0,0.0
22338,QRS num,104,"ECG at rest, 12-lead","24,924","Integer, units",Both sexes,Sep 2018,"24,924",Data,Defined (1),Sep 2018,Accruing,UK Biobank Assessment Centre,Physical measures,"ECG at rest, 12-lead",0.0,0.0,0.0,0.0,0.0,0.0,0.0
12340,QRS duration,104,"ECG at rest, 12-lead","41,731","Integer, ms",Both sexes,Sep 2015,"43,520",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Physical measures,"ECG at rest, 12-lead",0.0,0.0,0.0,0.0,0.0,0.0,0.0
22331,QT interval,104,"ECG at rest, 12-lead","24,924","Integer, ms",Both sexes,Sep 2018,"24,924",Data,Defined (1),Sep 2018,Accruing,UK Biobank Assessment Centre,Physical measures,"ECG at rest, 12-lead",0.0,0.0,0.0,0.0,0.0,0.0,0.0
22332,QTC interval,104,"ECG at rest, 12-lead","24,924","Integer, ms",Both sexes,Sep 2018,"24,924",Data,Defined (1),Sep 2018,Accruing,UK Biobank Assessment Centre,Physical measures,"ECG at rest, 12-lead",0.0,0.0,0.0,0.0,0.0,0.0,0.0
22333,RR interval,104,"ECG at rest, 12-lead","24,924","Integer, ms",Both sexes,Sep 2018,"24,924",Data,Defined (1),Sep 2018,Accruing,UK Biobank Assessment Centre,Physical measures,"ECG at rest, 12-lead",0.0,0.0,0.0,0.0,0.0,0.0,0.0
22335,P axis,104,"ECG at rest, 12-lead","23,722","Integer, degrees",Both sexes,Sep 2018,"23,722",Data,Defined (1),Sep 2018,Accruing,UK Biobank Assessment Centre,Physical measures,"ECG at rest, 12-lead",0.0,0.0,0.0,0.0,0.0,0.0,0.0
22336,R axis,104,"ECG at rest, 12-lead","24,924","Integer, degrees",Both sexes,Sep 2018,"24,924",Data,Defined (1),Sep 2018,Accruing,UK Biobank Assessment Centre,Physical measures,"ECG at rest, 12-lead",0.0,0.0,0.0,0.0,0.0,0.0,0.0
22337,T axis,104,"ECG at rest, 12-lead","24,924","Integer, degrees",Both sexes,Sep 2018,"24,924",Data,Defined (1),Sep 2018,Accruing,UK Biobank Assessment Centre,Physical measures,"ECG at rest, 12-lead",0.0,0.0,0.0,0.0,0.0,0.0,0.0
12658,Identifier for 12-lead ECG device,104,"ECG at rest, 12-lead","47,569",Text,Both sexes,Sep 2015,"50,156",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Physical measures,"ECG at rest, 12-lead",0.0,0.0,0.0,0.0,0.0,0.0,0.0
20059,Reason ECG not completed,100012,ECG during exercise,262,Categorical (single),Both sexes,Aug 2012,262,Data,Defined (1),Aug 2012,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20060,Reason at-rest ECG performed without bicycle,100012,ECG during exercise,942,Categorical (single),Both sexes,Aug 2012,942,Data,Defined (1),Aug 2012,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20058,Reason for skipping ECG,100012,ECG during exercise,358,Categorical (single),Both sexes,Aug 2012,358,Data,Defined (1),Aug 2012,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6014,Doctor restricts physical activity due to heart condition,100012,ECG during exercise,"96,548",Categorical (single),Both sexes,Jan 2012,"99,519",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6015,Chest pain felt during physical activity,100012,ECG during exercise,"96,548",Categorical (single),Both sexes,Jan 2012,"99,519",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6016,Chest pain felt outside physical activity,100012,ECG during exercise,"96,548",Categorical (single),Both sexes,Jan 2012,"99,519",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6017,Able to walk or cycle unaided for 10 minutes,100012,ECG during exercise,"96,548",Categorical (single),Both sexes,Jan 2012,"99,519",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6023,Description of exercise protocol recommended,100012,ECG during exercise,"95,152",Text,Both sexes,Jan 2012,"98,040",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6019,ECG/bike method for fitness test,100012,ECG during exercise,"96,208",Categorical (single),Both sexes,Jan 2012,"99,167",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6024,Program category,100012,ECG during exercise,"96,550",Categorical (single),Both sexes,Jan 2012,"99,521",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6038,Number of trend entries,100012,ECG during exercise,"95,142",Integer,Both sexes,Jan 2012,"98,030",Data,Defined (2),N/A,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
5985,Bicycle speed,100012,ECG during exercise,"94,946","Integer, revolutions/minute",Both sexes,Jan 2012,"5,745,470",Data,Defined (2),N/A,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
5991,"ECG, phase name",100012,ECG during exercise,"95,142",Text,Both sexes,Jan 2012,"294,090",Data,Defined (2),N/A,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
5987,"ECG, trend phase name",100012,ECG during exercise,"95,136",Text,Both sexes,Jan 2012,"5,758,636",Data,Defined (2),N/A,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
5992,"ECG, phase duration",100012,ECG during exercise,"95,142",Integer,Both sexes,Jan 2012,"294,090",Data,Defined (2),N/A,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
5986,"ECG, phase time",100012,ECG during exercise,"95,142","Integer, seconds",Both sexes,Jan 2012,"5,758,642",Data,Defined (2),N/A,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
5988,"ECG, stage name",100012,ECG during exercise,"95,136",Text,Both sexes,Jan 2012,"5,758,636",Data,Defined (2),N/A,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
5993,"ECG, number of stages in a phase",100012,ECG during exercise,"95,142",Integer,Both sexes,Jan 2012,"294,090",Data,Defined (2),N/A,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
5990,"ECG, stage duration",100012,ECG during exercise,pending,Integer,Both sexes,Jan 2012,pending,Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
5984,"ECG, load",100012,ECG during exercise,"94,946","Integer, Watts",Both sexes,Jan 2012,"5,745,470",Data,Defined (2),N/A,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
5983,"ECG, heart rate",100012,ECG during exercise,"94,847",Integer,Both sexes,Jan 2012,"5,728,242",Data,Defined (2),N/A,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6033,Maximum heart rate during fitness test,100012,ECG during exercise,"95,121","Integer, bpm",Both sexes,Jan 2012,"98,007",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6032,Maximum workload during fitness test,100012,ECG during exercise,"95,141","Integer, Watts",Both sexes,Jan 2012,"98,029",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6034,Target heart rate achieved,100012,ECG during exercise,"95,142",Categorical (single),Both sexes,Jan 2012,"98,030",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6025,"Fitness test results, including ECG data",100012,ECG during exercise,"95,052",Text,Both sexes,Jan 2012,"97,928",Bulk,Defined (2),Mar 2013,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6039,Duration of fitness test,100012,ECG during exercise,"95,142","Integer, seconds",Both sexes,Jan 2012,"98,030",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6020,Completion status of test,100012,ECG during exercise,"95,154",Categorical (single),Both sexes,Jan 2012,"98,043",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,ECG during exercise,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131222,Date H60 first reported (otitis externa),2408,Ear and mastoid process disorders,"21,898",Date,Both sexes,Jul 2019,"21,898",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131223,Source of report of H60 (otitis externa),2408,Ear and mastoid process disorders,"21,898",Categorical (single),Both sexes,Jul 2019,"21,898",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131224,Date H61 first reported (other disorders of external ear),2408,Ear and mastoid process disorders,"29,835",Date,Both sexes,Jul 2019,"29,835",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131225,Source of report of H61 (other disorders of external ear),2408,Ear and mastoid process disorders,"29,835",Categorical (single),Both sexes,Jul 2019,"29,835",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131226,Date H62 first reported (disorders of external ear in diseases classified elsewhere),2408,Ear and mastoid process disorders,55,Date,Both sexes,Jul 2019,55,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131227,Source of report of H62 (disorders of external ear in diseases classified elsewhere),2408,Ear and mastoid process disorders,55,Categorical (single),Both sexes,Jul 2019,55,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131228,Date H65 first reported (nonsuppurative otitis media),2408,Ear and mastoid process disorders,"5,883",Date,Both sexes,Jul 2019,"5,883",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131229,Source of report of H65 (nonsuppurative otitis media),2408,Ear and mastoid process disorders,"5,883",Categorical (single),Both sexes,Jul 2019,"5,883",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131230,Date H66 first reported (suppurative and unspecified otitis media),2408,Ear and mastoid process disorders,"10,082",Date,Both sexes,Jul 2019,"10,082",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131231,Source of report of H66 (suppurative and unspecified otitis media),2408,Ear and mastoid process disorders,"10,082",Categorical (single),Both sexes,Jul 2019,"10,082",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131232,Date H67 first reported (otitis media in diseases classified elsewhere),2408,Ear and mastoid process disorders,11,Date,Both sexes,Jul 2019,11,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131233,Source of report of H67 (otitis media in diseases classified elsewhere),2408,Ear and mastoid process disorders,11,Categorical (single),Both sexes,Jul 2019,11,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131234,Date H68 first reported (eustachian salpingitis and obstruction),2408,Ear and mastoid process disorders,"2,493",Date,Both sexes,Jul 2019,"2,493",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131235,Source of report of H68 (eustachian salpingitis and obstruction),2408,Ear and mastoid process disorders,"2,493",Categorical (single),Both sexes,Jul 2019,"2,493",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131236,Date H69 first reported (other disorders of eustachian tube),2408,Ear and mastoid process disorders,"2,643",Date,Both sexes,Jul 2019,"2,643",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131237,Source of report of H69 (other disorders of eustachian tube),2408,Ear and mastoid process disorders,"2,643",Categorical (single),Both sexes,Jul 2019,"2,643",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131238,Date H70 first reported (mastoiditis and related conditions),2408,Ear and mastoid process disorders,255,Date,Both sexes,Jul 2019,255,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131239,Source of report of H70 (mastoiditis and related conditions),2408,Ear and mastoid process disorders,255,Categorical (single),Both sexes,Jul 2019,255,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131240,Date H71 first reported (cholesteatoma of middle ear),2408,Ear and mastoid process disorders,655,Date,Both sexes,Jul 2019,655,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131241,Source of report of H71 (cholesteatoma of middle ear),2408,Ear and mastoid process disorders,655,Categorical (single),Both sexes,Jul 2019,655,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131242,Date H72 first reported (perforation of tympanic membrane),2408,Ear and mastoid process disorders,"2,054",Date,Both sexes,Jul 2019,"2,054",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131243,Source of report of H72 (perforation of tympanic membrane),2408,Ear and mastoid process disorders,"2,054",Categorical (single),Both sexes,Jul 2019,"2,054",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131244,Date H73 first reported (other disorders of tympanic membrane),2408,Ear and mastoid process disorders,720,Date,Both sexes,Jul 2019,720,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131245,Source of report of H73 (other disorders of tympanic membrane),2408,Ear and mastoid process disorders,720,Categorical (single),Both sexes,Jul 2019,720,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131246,Date H74 first reported (other disorders of middle ear and mastoid),2408,Ear and mastoid process disorders,864,Date,Both sexes,Jul 2019,864,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131247,Source of report of H74 (other disorders of middle ear and mastoid),2408,Ear and mastoid process disorders,864,Categorical (single),Both sexes,Jul 2019,864,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131248,Date H75 first reported (other disorders of middle ear and mastoid in diseases classified elsewhere),2408,Ear and mastoid process disorders,3,Date,Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131249,Source of report of H75 (other disorders of middle ear and mastoid in diseases classified elsewhere),2408,Ear and mastoid process disorders,3,Categorical (single),Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131250,Date H80 first reported (otosclerosis),2408,Ear and mastoid process disorders,"1,066",Date,Both sexes,Jul 2019,"1,066",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131251,Source of report of H80 (otosclerosis),2408,Ear and mastoid process disorders,"1,066",Categorical (single),Both sexes,Jul 2019,"1,066",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131252,Date H81 first reported (disorders of vestibular function),2408,Ear and mastoid process disorders,"11,846",Date,Both sexes,Jul 2019,"11,846",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131253,Source of report of H81 (disorders of vestibular function),2408,Ear and mastoid process disorders,"11,846",Categorical (single),Both sexes,Jul 2019,"11,846",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131254,Date H82 first reported (vertiginous syndromes in diseases classified elsewhere),2408,Ear and mastoid process disorders,1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131255,Source of report of H82 (vertiginous syndromes in diseases classified elsewhere),2408,Ear and mastoid process disorders,1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131256,Date H83 first reported (other diseases of inner ear),2408,Ear and mastoid process disorders,"11,833",Date,Both sexes,Jul 2019,"11,833",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131257,Source of report of H83 (other diseases of inner ear),2408,Ear and mastoid process disorders,"11,833",Categorical (single),Both sexes,Jul 2019,"11,833",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131258,Date H90 first reported (conductive and sensorineural hearing loss),2408,Ear and mastoid process disorders,"7,304",Date,Both sexes,Jul 2019,"7,304",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131259,Source of report of H90 (conductive and sensorineural hearing loss),2408,Ear and mastoid process disorders,"7,304",Categorical (single),Both sexes,Jul 2019,"7,304",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131260,Date H91 first reported (other hearing loss),2408,Ear and mastoid process disorders,"13,202",Date,Both sexes,Jul 2019,"13,202",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131261,Source of report of H91 (other hearing loss),2408,Ear and mastoid process disorders,"13,202",Categorical (single),Both sexes,Jul 2019,"13,202",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131262,Date H92 first reported (otalgia and effusion of ear),2408,Ear and mastoid process disorders,"16,230",Date,Both sexes,Jul 2019,"16,230",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131263,Source of report of H92 (otalgia and effusion of ear),2408,Ear and mastoid process disorders,"16,230",Categorical (single),Both sexes,Jul 2019,"16,230",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131264,"Date H93 first reported (other disorders of ear, not elsewhere classified)",2408,Ear and mastoid process disorders,"13,922",Date,Both sexes,Jul 2019,"13,922",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131265,"Source of report of H93 (other disorders of ear, not elsewhere classified)",2408,Ear and mastoid process disorders,"13,922",Categorical (single),Both sexes,Jul 2019,"13,922",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131266,Date H94 first reported (other disorders of ear in diseases classified elsewhere),2408,Ear and mastoid process disorders,16,Date,Both sexes,Jul 2019,16,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131267,Source of report of H94 (other disorders of ear in diseases classified elsewhere),2408,Ear and mastoid process disorders,16,Categorical (single),Both sexes,Jul 2019,16,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131268,"Date H95 first reported (postprocedural disorders of ear and mastoid process, not elsewhere classified)",2408,Ear and mastoid process disorders,151,Date,Both sexes,Jul 2019,151,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131269,"Source of report of H95 (postprocedural disorders of ear and mastoid process, not elsewhere classified)",2408,Ear and mastoid process disorders,151,Categorical (single),Both sexes,Jul 2019,151,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Ear and mastoid process disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
1647,Country of birth (UK/elsewhere),100033,Early life factors,"501,614",Categorical (single),Both sexes,Jan 2012,"533,614",Data,Defined (3),Nov 2016,Complete,UK Biobank Assessment Centre,Touchscreen,Early life factors,0.0,0.0,0.0,0.0,0.0,0.0,0.0
1677,Breastfed as a baby,100033,Early life factors,"501,614",Categorical (single),Both sexes,Jan 2012,"533,614",Data,Defined (3),Nov 2016,Complete,UK Biobank Assessment Centre,Touchscreen,Early life factors,0.0,0.0,0.0,0.0,0.0,0.0,0.0
1687,Comparative body size at age 10,100033,Early life factors,"501,614",Categorical (single),Both sexes,Jan 2012,"533,614",Data,Defined (3),Nov 2016,Complete,UK Biobank Assessment Centre,Touchscreen,Early life factors,0.0,0.0,0.0,0.0,0.0,0.0,0.0
1697,Comparative height size at age 10,100033,Early life factors,"501,614",Categorical (single),Both sexes,Jan 2012,"533,614",Data,Defined (3),Nov 2016,Complete,UK Biobank Assessment Centre,Touchscreen,Early life factors,0.0,0.0,0.0,0.0,0.0,0.0,0.0
1707,Handedness (chirality/laterality),100033,Early life factors,"501,614",Categorical (single),Both sexes,Jan 2012,"533,614",Data,Defined (3),Nov 2016,Complete,UK Biobank Assessment Centre,Touchscreen,Early life factors,0.0,0.0,0.0,0.0,0.0,0.0,0.0
1767,Adopted as a child,100033,Early life factors,"501,623",Categorical (single),Both sexes,Jan 2012,"572,249",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Early life factors,0.0,0.0,0.0,0.0,0.0,0.0,0.0
1777,Part of a multiple birth,100033,Early life factors,"494,270",Categorical (single),Both sexes,Jan 2012,"525,799",Data,Defined (3),Nov 2016,Complete,UK Biobank Assessment Centre,Touchscreen,Early life factors,0.0,0.0,0.0,0.0,0.0,0.0,0.0
1787,Maternal smoking around birth,100033,Early life factors,"494,270",Categorical (single),Both sexes,Jan 2012,"525,799",Data,Defined (3),Nov 2016,Complete,UK Biobank Assessment Centre,Touchscreen,Early life factors,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20022,Birth weight,100072,Early life factors,"280,255","Continuous, Kg",Both sexes,Aug 2012,"293,434",Data,Defined (3),Nov 2016,Complete,UK Biobank Assessment Centre,Verbal interview,Early life factors,0.0,0.0,0.0,0.0,0.0,0.0,0.0
120,Birth weight known,100072,Early life factors,"501,648",Categorical (single),Both sexes,Jan 2012,"533,687",Data,Defined (3),Nov 2016,Complete,UK Biobank Assessment Centre,Verbal interview,Early life factors,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20115,Country of Birth (non-UK origin),100072,Early life factors,"40,577",Categorical (single),Both sexes,Mar 2013,"40,577",Data,Defined (1),Mar 2013,Complete,UK Biobank Assessment Centre,Verbal interview,Early life factors,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130,Place of birth in UK - east co-ordinate,100072,Early life factors,"452,292","Integer, metre-grid",Both sexes,Jan 2012,"481,102",Data,Defined (3),Nov 2017,Complete,UK Biobank Assessment Centre,Verbal interview,Early life factors,0.0,0.0,0.0,0.0,0.0,0.0,0.0
129,Place of birth in UK - north co-ordinate,100072,Early life factors,"452,292","Integer, metre-grid",Both sexes,Jan 2012,"481,102",Data,Defined (3),Nov 2017,Complete,UK Biobank Assessment Centre,Verbal interview,Early life factors,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6138,Qualifications,100063,Education,"498,766",Categorical (multiple),Both sexes,Jan 2012,"1,045,887",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Education,0.0,0.0,0.0,0.0,0.0,0.0
10722,Qualifications (pilot),100063,Education,"3,770",Categorical (multiple),Both sexes,Jan 2012,"6,195",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Education,0.0,0.0,0.0,0.0,0.0,0.0
845,Age completed full time education,100063,Education,"337,413","Integer, years",Both sexes,Jan 2012,"354,358",Data,Defined (3),Nov 2016,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Education,0.0,0.0,0.0,0.0,0.0,0.0
1110,Length of mobile phone use,100053,Electronic device use,"501,639",Categorical (single),Both sexes,Jan 2012,"572,265",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Electronic device use,0.0,0.0,0.0,0.0,0.0,0.0
1120,Weekly usage of mobile phone in last 3 months,100053,Electronic device use,"428,783",Categorical (single),Both sexes,Jan 2012,"487,215",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Electronic device use,0.0,0.0,0.0,0.0,0.0,0.0
10749,Time using mobile phone in last 3 months (pilot),100053,Electronic device use,"2,949",Categorical (single),Both sexes,Jan 2012,"2,949",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Electronic device use,0.0,0.0,0.0,0.0,0.0,0.0
10016,Regular use of hands-free device/speakerphone with mobile phone (pilot),100053,Electronic device use,"2,949",Categorical (single),Both sexes,Jan 2012,"2,949",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Electronic device use,0.0,0.0,0.0,0.0,0.0,0.0
1130,Hands-free device/speakerphone use with mobile phone in last 3 month,100053,Electronic device use,"428,783",Categorical (single),Both sexes,Jan 2012,"487,215",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Electronic device use,0.0,0.0,0.0,0.0,0.0,0.0
1140,Difference in mobile phone use compared to two years previously,100053,Electronic device use,"428,783",Categorical (single),Both sexes,Jan 2012,"487,215",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Electronic device use,0.0,0.0,0.0,0.0,0.0,0.0
10886,Difference in mobile phone use compared to one year previously (pilot),100053,Electronic device use,"2,949",Categorical (single),Both sexes,Jan 2012,"2,949",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Electronic device use,0.0,0.0,0.0,0.0,0.0,0.0
1150,Usual side of head for mobile phone use,100053,Electronic device use,"428,781",Categorical (single),Both sexes,Jan 2012,"487,213",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Electronic device use,0.0,0.0,0.0,0.0,0.0,0.0
2237,Plays computer games,100053,Electronic device use,"501,604",Categorical (single),Both sexes,Jan 2012,"572,230",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Electronic device use,0.0,0.0,0.0,0.0,0.0,0.0
10105,Internet user (pilot),100053,Electronic device use,"3,770",Categorical (single),Both sexes,Jan 2012,"3,770",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Electronic device use,0.0,0.0,0.0,0.0,0.0,0.0
10114,Willing to be contacted by email (pilot),100053,Electronic device use,"3,770",Categorical (single),Both sexes,Jan 2012,"3,770",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Electronic device use,0.0,0.0,0.0,0.0,0.0,0.0
20119,Current employment status - corrected,100064,Employment,"3,364",Categorical (single),Both sexes,Jun 2013,"3,364",Data,Defined (1),Jun 2013,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Employment,0.0,0.0,0.0,0.0,0.0,0.0
796,Distance between home and job workplace,100064,Employment,"267,669","Integer, miles",Both sexes,Jan 2012,"290,328",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Employment,0.0,0.0,0.0,0.0,0.0,0.0
6142,Current employment status,100064,Employment,"501,653",Categorical (multiple),Both sexes,Jan 2012,"625,423",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Employment,0.0,0.0,0.0,0.0,0.0,0.0
757,Time employed in main current job,100064,Employment,"288,413","Integer, years",Both sexes,Jan 2012,"314,653",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Employment,0.0,0.0,0.0,0.0,0.0,0.0
767,Length of working week for main job,100064,Employment,"288,414","Integer, hours",Both sexes,Jan 2012,"314,655",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Employment,0.0,0.0,0.0,0.0,0.0,0.0
777,Frequency of travelling from home to job workplace,100064,Employment,"286,437","Integer, times",Both sexes,Jan 2012,"312,320",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Employment,0.0,0.0,0.0,0.0,0.0,0.0
6143,Transport type for commuting to job workplace,100064,Employment,"267,669",Categorical (multiple),Both sexes,Jan 2012,"361,902",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Employment,0.0,0.0,0.0,0.0,0.0,0.0
806,Job involves mainly walking or standing,100064,Employment,"288,414",Categorical (single),Both sexes,Jan 2012,"314,655",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Employment,0.0,0.0,0.0,0.0,0.0,0.0
816,Job involves heavy manual or physical work,100064,Employment,"288,414",Categorical (single),Both sexes,Jan 2012,"314,655",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Employment,0.0,0.0,0.0,0.0,0.0,0.0
826,Job involves shift work,100064,Employment,"288,414",Categorical (single),Both sexes,Jan 2012,"314,655",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Employment,0.0,0.0,0.0,0.0,0.0,0.0
3426,Job involves night shift work,100064,Employment,"51,645",Categorical (single),Both sexes,Jan 2012,"54,250",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Employment,0.0,0.0,0.0,0.0,0.0,0.0
20121,Cascot confidence score,100073,Employment,"14,552","Integer, percent",Both sexes,Jun 2013,"14,552",Data,Defined (1),Jun 2013,Complete,UK Biobank Assessment Centre,Verbal interview,Employment,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20277,Job code at visit,100073,Employment,"338,993",Categorical (single),Both sexes,Jan 2020,"384,584",Data,Defined (4),Feb 2020,Accruing,UK Biobank Assessment Centre,Verbal interview,Employment,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132,Job code at visit - entered,100073,Employment,"343,134",Categorical (single),Both sexes,Jan 2012,"391,639",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Verbal interview,Employment,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22661,Number of gap periods,130,Employment history,"118,680",Integer,Both sexes,Jul 2015,"118,680",Data,Singular,Sep 2016,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22599,Number of jobs held,130,Employment history,"118,680","Integer, jobs",Both sexes,Jul 2015,"118,680",Data,Singular,Sep 2016,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22200,Year of birth,130,Employment history,"121,277","Integer, calendar year",Both sexes,Jul 2015,"121,277",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22660,Gap coding,130,Employment history,"95,577",Categorical (single),Both sexes,Jul 2015,"179,341",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22662,Title for other gap,130,Employment history,"6,600",Text,Both sexes,Jul 2015,"8,394",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22663,Year gap started,130,Employment history,"95,577","Integer, calendar year",Both sexes,Jul 2015,"179,341",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22664,Year gap ended,130,Employment history,"95,577","Integer, calendar year",Both sexes,Jul 2015,"179,341",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22601,Job coding,130,Employment history,"120,300",Categorical (single),Both sexes,Jul 2015,"402,691",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22617,Job code - historical,130,Employment history,"120,300",Categorical (single),Both sexes,Jul 2015,"402,691",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22602,Year job started,130,Employment history,"120,300","Integer, calendar year",Both sexes,Jul 2015,"402,691",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22603,Year job ended,130,Employment history,"120,300","Integer, calendar year",Both sexes,Jul 2015,"402,691",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22604,Work hours - lumped category,130,Employment history,"99,383",Categorical (single),Both sexes,Jul 2015,"287,578",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22605,Work hours per week - exact value,130,Employment history,"44,327","Continuous, hours/week",Both sexes,Jul 2015,"115,113",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22620,Job involved shift work,130,Employment history,"120,300",Categorical (single),Both sexes,Jul 2015,"402,691",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22630,Day shifts worked,130,Employment history,"34,413",Categorical (single),Both sexes,Jul 2015,"53,944",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22631,Period spent working day shifts,130,Employment history,"2,314","Continuous, years",Both sexes,Jul 2015,"2,461",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22640,Mixture of day and night shifts worked,130,Employment history,"34,413",Categorical (single),Both sexes,Jul 2015,"53,944",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22641,Period spent working mix of day and night shifts,130,Employment history,"12,140","Continuous, years",Both sexes,Jul 2015,"13,297",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22642,Usual length of each night shift during mixed shift periods,130,Employment history,"26,665","Integer, hours",Both sexes,Jul 2015,"38,006",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22643,Number of night shifts worked monthly during mixed shift periods,130,Employment history,"26,665","Integer, shifts",Both sexes,Jul 2015,"38,006",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22644,Consecutive night shifts during mixed shift periods,130,Employment history,"26,665","Integer, shifts",Both sexes,Jul 2015,"38,006",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22645,Rest days during mixed shift periods,130,Employment history,"23,434","Integer, days",Both sexes,Jul 2015,"32,519",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22650,Night shifts worked,130,Employment history,"34,413",Categorical (single),Both sexes,Jul 2015,"53,944",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22651,Period spent working night shifts,130,Employment history,"1,084",Continuous,Both sexes,Jul 2015,"1,145",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22652,Usual length of each night shift during night shift periods,130,Employment history,"2,822","Integer, hours",Both sexes,Jul 2015,"3,192",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22653,Number of night shifts worked monthly during night shift periods,130,Employment history,"2,822","Integer, shifts",Both sexes,Jul 2015,"3,192",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22654,Consecutive night shifts during night shift periods,130,Employment history,"2,822","Integer, shifts",Both sexes,Jul 2015,"3,192",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22655,Rest days during night shift periods,130,Employment history,"2,690","Integer, days",Both sexes,Jul 2015,"3,043",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22606,Workplace very noisy,130,Employment history,"120,088",Categorical (single),Both sexes,Jul 2015,"400,666",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22607,Workplace very cold,130,Employment history,"119,955",Categorical (single),Both sexes,Jul 2015,"399,503",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22608,Workplace very hot,130,Employment history,"119,972",Categorical (single),Both sexes,Jul 2015,"399,292",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22609,Workplace very dusty,130,Employment history,"119,903",Categorical (single),Both sexes,Jul 2015,"398,587",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22610,Workplace full of chemical or other fumes,130,Employment history,"119,916",Categorical (single),Both sexes,Jul 2015,"398,984",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22611,Workplace had a lot of cigarette smoke from other people smoking,130,Employment history,"119,966",Categorical (single),Both sexes,Jul 2015,"399,149",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22612,Worked with materials containing asbestos,130,Employment history,"119,861",Categorical (single),Both sexes,Jul 2015,"398,056",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22613,"Worked with paints, thinners or glues",130,Employment history,"119,916",Categorical (single),Both sexes,Jul 2015,"398,707",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22614,Worked with pesticides,130,Employment history,"119,840",Categorical (single),Both sexes,Jul 2015,"397,660",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22615,Workplace had a lot of diesel exhaust,130,Employment history,"119,819",Categorical (single),Both sexes,Jul 2015,"396,899",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22616,Breathing problems during period of job,130,Employment history,"120,300",Categorical (single),Both sexes,Jul 2015,"402,691",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22618,Breathing problems improved/stopped away from workplace or on holiday,130,Employment history,"8,911",Categorical (single),Both sexes,Jul 2015,"15,241",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22619,Breathing problems responsible for leaving job,130,Employment history,"7,525",Categorical (single),Both sexes,Jul 2015,"12,774",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Employment history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42026,Date of end stage renal disease report,48,End stage renal disease outcomes,"1,191",Date,Both sexes,Apr 2018,"1,191",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,End stage renal disease outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42027,Source of end stage renal disease report,48,End stage renal disease outcomes,"1,191",Categorical (single),Both sexes,Apr 2018,"1,191",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,End stage renal disease outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130690,Date E00 first reported (congenital iodine-deficiency syndrome),2404,"Endocrine, nutritional and metabolic diseases",pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130691,Source of report of E00 (congenital iodine-deficiency syndrome),2404,"Endocrine, nutritional and metabolic diseases",pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130692,Date E01 first reported (iodine-deficiency-related thyroid disorders and allied conditions),2404,"Endocrine, nutritional and metabolic diseases",94,Date,Both sexes,Jul 2019,94,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130693,Source of report of E01 (iodine-deficiency-related thyroid disorders and allied conditions),2404,"Endocrine, nutritional and metabolic diseases",94,Categorical (single),Both sexes,Jul 2019,94,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130694,Date E02 first reported (subclinical iodine-deficiency hypothyroidism),2404,"Endocrine, nutritional and metabolic diseases",88,Date,Both sexes,Jul 2019,88,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130695,Source of report of E02 (subclinical iodine-deficiency hypothyroidism),2404,"Endocrine, nutritional and metabolic diseases",88,Categorical (single),Both sexes,Jul 2019,88,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130696,Date E03 first reported (other hypothyroidism),2404,"Endocrine, nutritional and metabolic diseases","34,201",Date,Both sexes,Jul 2019,"34,201",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130697,Source of report of E03 (other hypothyroidism),2404,"Endocrine, nutritional and metabolic diseases","34,201",Categorical (single),Both sexes,Jul 2019,"34,201",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130698,Date E04 first reported (other non-toxic goitre),2404,"Endocrine, nutritional and metabolic diseases","4,657",Date,Both sexes,Jul 2019,"4,657",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130699,Source of report of E04 (other non-toxic goitre),2404,"Endocrine, nutritional and metabolic diseases","4,657",Categorical (single),Both sexes,Jul 2019,"4,657",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130700,Date E05 first reported (thyrotoxicosis [hyperthyroidism]),2404,"Endocrine, nutritional and metabolic diseases","7,123",Date,Both sexes,Jul 2019,"7,123",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130701,Source of report of E05 (thyrotoxicosis [hyperthyroidism]),2404,"Endocrine, nutritional and metabolic diseases","7,123",Categorical (single),Both sexes,Jul 2019,"7,123",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130702,Date E06 first reported (thyroiditis),2404,"Endocrine, nutritional and metabolic diseases","1,203",Date,Both sexes,Jul 2019,"1,203",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130703,Source of report of E06 (thyroiditis),2404,"Endocrine, nutritional and metabolic diseases","1,203",Categorical (single),Both sexes,Jul 2019,"1,203",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130704,Date E07 first reported (other disorders of thyroid),2404,"Endocrine, nutritional and metabolic diseases","2,132",Date,Both sexes,Jul 2019,"2,132",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130705,Source of report of E07 (other disorders of thyroid),2404,"Endocrine, nutritional and metabolic diseases","2,132",Categorical (single),Both sexes,Jul 2019,"2,132",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130706,Date E10 first reported (insulin-dependent diabetes mellitus),2404,"Endocrine, nutritional and metabolic diseases","4,425",Date,Both sexes,Jul 2019,"4,425",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130707,Source of report of E10 (insulin-dependent diabetes mellitus),2404,"Endocrine, nutritional and metabolic diseases","4,425",Categorical (single),Both sexes,Jul 2019,"4,425",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130708,Date E11 first reported (non-insulin-dependent diabetes mellitus),2404,"Endocrine, nutritional and metabolic diseases","33,242",Date,Both sexes,Jul 2019,"33,242",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130709,Source of report of E11 (non-insulin-dependent diabetes mellitus),2404,"Endocrine, nutritional and metabolic diseases","33,242",Categorical (single),Both sexes,Jul 2019,"33,242",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130710,Date E12 first reported (malnutrition-related diabetes mellitus),2404,"Endocrine, nutritional and metabolic diseases",4,Date,Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130711,Source of report of E12 (malnutrition-related diabetes mellitus),2404,"Endocrine, nutritional and metabolic diseases",4,Categorical (single),Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130712,Date E13 first reported (other specified diabetes mellitus),2404,"Endocrine, nutritional and metabolic diseases",340,Date,Both sexes,Jul 2019,340,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130713,Source of report of E13 (other specified diabetes mellitus),2404,"Endocrine, nutritional and metabolic diseases",340,Categorical (single),Both sexes,Jul 2019,340,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130714,Date E14 first reported (unspecified diabetes mellitus),2404,"Endocrine, nutritional and metabolic diseases","24,109",Date,Both sexes,Jul 2019,"24,109",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130715,Source of report of E14 (unspecified diabetes mellitus),2404,"Endocrine, nutritional and metabolic diseases","24,109",Categorical (single),Both sexes,Jul 2019,"24,109",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130716,Date E15 first reported (nondiabetic hypoglycaemic coma),2404,"Endocrine, nutritional and metabolic diseases",35,Date,Both sexes,Jul 2019,35,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130717,Source of report of E15 (nondiabetic hypoglycaemic coma),2404,"Endocrine, nutritional and metabolic diseases",35,Categorical (single),Both sexes,Jul 2019,35,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130718,Date E16 first reported (other disorders of pancreatic internal secretion),2404,"Endocrine, nutritional and metabolic diseases","3,015",Date,Both sexes,Jul 2019,"3,015",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130719,Source of report of E16 (other disorders of pancreatic internal secretion),2404,"Endocrine, nutritional and metabolic diseases","3,015",Categorical (single),Both sexes,Jul 2019,"3,015",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130720,Date E20 first reported (hypoparathyroidism),2404,"Endocrine, nutritional and metabolic diseases",194,Date,Both sexes,Jul 2019,194,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130721,Source of report of E20 (hypoparathyroidism),2404,"Endocrine, nutritional and metabolic diseases",194,Categorical (single),Both sexes,Jul 2019,194,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130722,Date E21 first reported (hyperparathyroidism and other disorders of parathyroid gland),2404,"Endocrine, nutritional and metabolic diseases","1,759",Date,Both sexes,Jul 2019,"1,759",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130723,Source of report of E21 (hyperparathyroidism and other disorders of parathyroid gland),2404,"Endocrine, nutritional and metabolic diseases","1,759",Categorical (single),Both sexes,Jul 2019,"1,759",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130724,Date E22 first reported (hyperfunction of pituitary gland),2404,"Endocrine, nutritional and metabolic diseases",782,Date,Both sexes,Jul 2019,782,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130725,Source of report of E22 (hyperfunction of pituitary gland),2404,"Endocrine, nutritional and metabolic diseases",782,Categorical (single),Both sexes,Jul 2019,782,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130726,Date E23 first reported (hypofunction and other disorders of pituitary gland),2404,"Endocrine, nutritional and metabolic diseases","1,064",Date,Both sexes,Jul 2019,"1,064",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130727,Source of report of E23 (hypofunction and other disorders of pituitary gland),2404,"Endocrine, nutritional and metabolic diseases","1,064",Categorical (single),Both sexes,Jul 2019,"1,064",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130728,Date E24 first reported (cushing's syndrome),2404,"Endocrine, nutritional and metabolic diseases",190,Date,Both sexes,Jul 2019,190,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130729,Source of report of E24 (cushing's syndrome),2404,"Endocrine, nutritional and metabolic diseases",190,Categorical (single),Both sexes,Jul 2019,190,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130730,Date E25 first reported (adrenogenital disorders),2404,"Endocrine, nutritional and metabolic diseases",31,Date,Both sexes,Jul 2019,31,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130731,Source of report of E25 (adrenogenital disorders),2404,"Endocrine, nutritional and metabolic diseases",31,Categorical (single),Both sexes,Jul 2019,31,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130732,Date E26 first reported (hyperaldosteronism),2404,"Endocrine, nutritional and metabolic diseases",156,Date,Both sexes,Jul 2019,156,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130733,Source of report of E26 (hyperaldosteronism),2404,"Endocrine, nutritional and metabolic diseases",156,Categorical (single),Both sexes,Jul 2019,156,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130734,Date E27 first reported (other disorders of adrenal gland),2404,"Endocrine, nutritional and metabolic diseases",961,Date,Both sexes,Jul 2019,961,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130735,Source of report of E27 (other disorders of adrenal gland),2404,"Endocrine, nutritional and metabolic diseases",961,Categorical (single),Both sexes,Jul 2019,961,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130736,Date E28 first reported (ovarian dysfunction),2404,"Endocrine, nutritional and metabolic diseases","2,264",Date,Both sexes,Jul 2019,"2,264",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130737,Source of report of E28 (ovarian dysfunction),2404,"Endocrine, nutritional and metabolic diseases","2,264",Categorical (single),Both sexes,Jul 2019,"2,264",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130738,Date E29 first reported (testicular dysfunction),2404,"Endocrine, nutritional and metabolic diseases",497,Date,Both sexes,Jul 2019,497,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130739,Source of report of E29 (testicular dysfunction),2404,"Endocrine, nutritional and metabolic diseases",497,Categorical (single),Both sexes,Jul 2019,497,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130740,"Date E30 first reported (disorders of puberty, not elsewhere classified)",2404,"Endocrine, nutritional and metabolic diseases",21,Date,Both sexes,Jul 2019,21,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130741,"Source of report of E30 (disorders of puberty, not elsewhere classified)",2404,"Endocrine, nutritional and metabolic diseases",21,Categorical (single),Both sexes,Jul 2019,21,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130742,Date E31 first reported (polyglandular dysfunction),2404,"Endocrine, nutritional and metabolic diseases",18,Date,Both sexes,Jul 2019,18,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130743,Source of report of E31 (polyglandular dysfunction),2404,"Endocrine, nutritional and metabolic diseases",18,Categorical (single),Both sexes,Jul 2019,18,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130744,Date E32 first reported (diseases of thymus),2404,"Endocrine, nutritional and metabolic diseases",25,Date,Both sexes,Jul 2019,25,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130745,Source of report of E32 (diseases of thymus),2404,"Endocrine, nutritional and metabolic diseases",25,Categorical (single),Both sexes,Jul 2019,25,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130746,Date E34 first reported (other endocrine disorders),2404,"Endocrine, nutritional and metabolic diseases",372,Date,Both sexes,Jul 2019,372,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130747,Source of report of E34 (other endocrine disorders),2404,"Endocrine, nutritional and metabolic diseases",372,Categorical (single),Both sexes,Jul 2019,372,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130748,Date E35 first reported (disorders of endocrine glands in diseases classified elsewhere),2404,"Endocrine, nutritional and metabolic diseases",3,Date,Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130749,Source of report of E35 (disorders of endocrine glands in diseases classified elsewhere),2404,"Endocrine, nutritional and metabolic diseases",3,Categorical (single),Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130750,Date E40 first reported (kwashiorkor),2404,"Endocrine, nutritional and metabolic diseases",pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130751,Source of report of E40 (kwashiorkor),2404,"Endocrine, nutritional and metabolic diseases",pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130752,Date E41 first reported (nutritional marasmus),2404,"Endocrine, nutritional and metabolic diseases",12,Date,Both sexes,Jul 2019,12,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130753,Source of report of E41 (nutritional marasmus),2404,"Endocrine, nutritional and metabolic diseases",12,Categorical (single),Both sexes,Jul 2019,12,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130754,Date E42 first reported (marasmic kwashiorkor),2404,"Endocrine, nutritional and metabolic diseases",pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130755,Source of report of E42 (marasmic kwashiorkor),2404,"Endocrine, nutritional and metabolic diseases",pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130756,Date E43 first reported (unspecified severe protein-energy malnutrition),2404,"Endocrine, nutritional and metabolic diseases",12,Date,Both sexes,Jul 2019,12,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130757,Source of report of E43 (unspecified severe protein-energy malnutrition),2404,"Endocrine, nutritional and metabolic diseases",12,Categorical (single),Both sexes,Jul 2019,12,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130758,Date E44 first reported (protein-energy malnutrition of moderate and mild degree),2404,"Endocrine, nutritional and metabolic diseases",5,Date,Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130759,Source of report of E44 (protein-energy malnutrition of moderate and mild degree),2404,"Endocrine, nutritional and metabolic diseases",5,Categorical (single),Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130760,Date E45 first reported (retarded development following protein-energy malnutrition),2404,"Endocrine, nutritional and metabolic diseases",1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130761,Source of report of E45 (retarded development following protein-energy malnutrition),2404,"Endocrine, nutritional and metabolic diseases",1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130762,Date E46 first reported (unspecified protein-energy malnutrition),2404,"Endocrine, nutritional and metabolic diseases",326,Date,Both sexes,Jul 2019,326,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130763,Source of report of E46 (unspecified protein-energy malnutrition),2404,"Endocrine, nutritional and metabolic diseases",326,Categorical (single),Both sexes,Jul 2019,326,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130764,Date E50 first reported (vitamin a deficiency),2404,"Endocrine, nutritional and metabolic diseases",6,Date,Both sexes,Jul 2019,6,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130765,Source of report of E50 (vitamin a deficiency),2404,"Endocrine, nutritional and metabolic diseases",6,Categorical (single),Both sexes,Jul 2019,6,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130766,Date E51 first reported (thiamine deficiency),2404,"Endocrine, nutritional and metabolic diseases",38,Date,Both sexes,Jul 2019,38,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130767,Source of report of E51 (thiamine deficiency),2404,"Endocrine, nutritional and metabolic diseases",38,Categorical (single),Both sexes,Jul 2019,38,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130768,Date E52 first reported (niacin deficiency [pellagra]),2404,"Endocrine, nutritional and metabolic diseases",3,Date,Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130769,Source of report of E52 (niacin deficiency [pellagra]),2404,"Endocrine, nutritional and metabolic diseases",3,Categorical (single),Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130770,Date E53 first reported (deficiency of other b group vitamins),2404,"Endocrine, nutritional and metabolic diseases","2,462",Date,Both sexes,Jul 2019,"2,462",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130771,Source of report of E53 (deficiency of other b group vitamins),2404,"Endocrine, nutritional and metabolic diseases","2,462",Categorical (single),Both sexes,Jul 2019,"2,462",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130772,Date E54 first reported (ascorbic acid deficiency),2404,"Endocrine, nutritional and metabolic diseases",19,Date,Both sexes,Jul 2019,19,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130773,Source of report of E54 (ascorbic acid deficiency),2404,"Endocrine, nutritional and metabolic diseases",19,Categorical (single),Both sexes,Jul 2019,19,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130774,Date E55 first reported (vitamin d deficiency),2404,"Endocrine, nutritional and metabolic diseases","2,312",Date,Both sexes,Jul 2019,"2,312",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130775,Source of report of E55 (vitamin d deficiency),2404,"Endocrine, nutritional and metabolic diseases","2,312",Categorical (single),Both sexes,Jul 2019,"2,312",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130776,Date E56 first reported (other vitamin deficiencies),2404,"Endocrine, nutritional and metabolic diseases",299,Date,Both sexes,Jul 2019,299,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130777,Source of report of E56 (other vitamin deficiencies),2404,"Endocrine, nutritional and metabolic diseases",299,Categorical (single),Both sexes,Jul 2019,299,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130778,Date E58 first reported (dietary calcium deficiency),2404,"Endocrine, nutritional and metabolic diseases",33,Date,Both sexes,Jul 2019,33,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130779,Source of report of E58 (dietary calcium deficiency),2404,"Endocrine, nutritional and metabolic diseases",33,Categorical (single),Both sexes,Jul 2019,33,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130780,Date E59 first reported (dietary selenium deficiency),2404,"Endocrine, nutritional and metabolic diseases",2,Date,Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130781,Source of report of E59 (dietary selenium deficiency),2404,"Endocrine, nutritional and metabolic diseases",2,Categorical (single),Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130782,Date E60 first reported (dietary zinc deficiency),2404,"Endocrine, nutritional and metabolic diseases",21,Date,Both sexes,Jul 2019,21,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130783,Source of report of E60 (dietary zinc deficiency),2404,"Endocrine, nutritional and metabolic diseases",21,Categorical (single),Both sexes,Jul 2019,21,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130784,Date E61 first reported (deficiency of other nutrient elements),2404,"Endocrine, nutritional and metabolic diseases",832,Date,Both sexes,Jul 2019,832,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130785,Source of report of E61 (deficiency of other nutrient elements),2404,"Endocrine, nutritional and metabolic diseases",832,Categorical (single),Both sexes,Jul 2019,832,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130786,Date E63 first reported (other nutritional deficiencies),2404,"Endocrine, nutritional and metabolic diseases",44,Date,Both sexes,Jul 2019,44,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130787,Source of report of E63 (other nutritional deficiencies),2404,"Endocrine, nutritional and metabolic diseases",44,Categorical (single),Both sexes,Jul 2019,44,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130788,Date E64 first reported (sequelae of malnutrition and other nutritional deficiencies),2404,"Endocrine, nutritional and metabolic diseases",3,Date,Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130789,Source of report of E64 (sequelae of malnutrition and other nutritional deficiencies),2404,"Endocrine, nutritional and metabolic diseases",3,Categorical (single),Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130790,Date E65 first reported (localised adiposity),2404,"Endocrine, nutritional and metabolic diseases",130,Date,Both sexes,Jul 2019,130,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130791,Source of report of E65 (localised adiposity),2404,"Endocrine, nutritional and metabolic diseases",130,Categorical (single),Both sexes,Jul 2019,130,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130792,Date E66 first reported (obesity),2404,"Endocrine, nutritional and metabolic diseases","33,912",Date,Both sexes,Jul 2019,"33,912",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130793,Source of report of E66 (obesity),2404,"Endocrine, nutritional and metabolic diseases","33,912",Categorical (single),Both sexes,Jul 2019,"33,912",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130794,Date E67 first reported (other hyperalimentation),2404,"Endocrine, nutritional and metabolic diseases",10,Date,Both sexes,Jul 2019,10,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130795,Source of report of E67 (other hyperalimentation),2404,"Endocrine, nutritional and metabolic diseases",10,Categorical (single),Both sexes,Jul 2019,10,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130796,Date E68 first reported (sequelae of hyperalimentation),2404,"Endocrine, nutritional and metabolic diseases",1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130797,Source of report of E68 (sequelae of hyperalimentation),2404,"Endocrine, nutritional and metabolic diseases",1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130798,Date E70 first reported (disorders of aromatic amino-acid metabolism),2404,"Endocrine, nutritional and metabolic diseases",61,Date,Both sexes,Jul 2019,61,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130799,Source of report of E70 (disorders of aromatic amino-acid metabolism),2404,"Endocrine, nutritional and metabolic diseases",61,Categorical (single),Both sexes,Jul 2019,61,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130800,Date E71 first reported (disorders of branched-chain amino-acid metabolism and fatty-acid metabolism),2404,"Endocrine, nutritional and metabolic diseases",10,Date,Both sexes,Jul 2019,10,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130801,Source of report of E71 (disorders of branched-chain amino-acid metabolism and fatty-acid metabolism),2404,"Endocrine, nutritional and metabolic diseases",10,Categorical (single),Both sexes,Jul 2019,10,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130802,Date E72 first reported (other disorders of amino-acid metabolism),2404,"Endocrine, nutritional and metabolic diseases",86,Date,Both sexes,Jul 2019,86,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130803,Source of report of E72 (other disorders of amino-acid metabolism),2404,"Endocrine, nutritional and metabolic diseases",86,Categorical (single),Both sexes,Jul 2019,86,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130804,Date E73 first reported (lactose intolerance),2404,"Endocrine, nutritional and metabolic diseases",380,Date,Both sexes,Jul 2019,380,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130805,Source of report of E73 (lactose intolerance),2404,"Endocrine, nutritional and metabolic diseases",380,Categorical (single),Both sexes,Jul 2019,380,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130806,Date E74 first reported (other disorders of carbohydrate metabolism),2404,"Endocrine, nutritional and metabolic diseases",400,Date,Both sexes,Jul 2019,400,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130807,Source of report of E74 (other disorders of carbohydrate metabolism),2404,"Endocrine, nutritional and metabolic diseases",400,Categorical (single),Both sexes,Jul 2019,400,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130808,Date E75 first reported (disorders of sphingolipid metabolism and other lipid storage disorders),2404,"Endocrine, nutritional and metabolic diseases",103,Date,Both sexes,Jul 2019,103,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130809,Source of report of E75 (disorders of sphingolipid metabolism and other lipid storage disorders),2404,"Endocrine, nutritional and metabolic diseases",103,Categorical (single),Both sexes,Jul 2019,103,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130810,Date E76 first reported (disorders of glycosaminoglycan metabolism),2404,"Endocrine, nutritional and metabolic diseases",8,Date,Both sexes,Jul 2019,8,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130811,Source of report of E76 (disorders of glycosaminoglycan metabolism),2404,"Endocrine, nutritional and metabolic diseases",8,Categorical (single),Both sexes,Jul 2019,8,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130812,Date E77 first reported (disorders of glycoprotein metabolism),2404,"Endocrine, nutritional and metabolic diseases",19,Date,Both sexes,Jul 2019,19,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130813,Source of report of E77 (disorders of glycoprotein metabolism),2404,"Endocrine, nutritional and metabolic diseases",19,Categorical (single),Both sexes,Jul 2019,19,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130814,Date E78 first reported (disorders of lipoprotein metabolism and other lipidaemias),2404,"Endocrine, nutritional and metabolic diseases","104,305",Date,Both sexes,Jul 2019,"104,305",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130815,Source of report of E78 (disorders of lipoprotein metabolism and other lipidaemias),2404,"Endocrine, nutritional and metabolic diseases","104,305",Categorical (single),Both sexes,Jul 2019,"104,305",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130816,Date E79 first reported (disorders of purine and pyrimidine metabolism),2404,"Endocrine, nutritional and metabolic diseases",519,Date,Both sexes,Jul 2019,519,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130817,Source of report of E79 (disorders of purine and pyrimidine metabolism),2404,"Endocrine, nutritional and metabolic diseases",519,Categorical (single),Both sexes,Jul 2019,519,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130818,Date E80 first reported (disorders of porphyrin and bilirubin metabolism),2404,"Endocrine, nutritional and metabolic diseases","1,536",Date,Both sexes,Jul 2019,"1,536",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130819,Source of report of E80 (disorders of porphyrin and bilirubin metabolism),2404,"Endocrine, nutritional and metabolic diseases","1,536",Categorical (single),Both sexes,Jul 2019,"1,536",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130820,Date E83 first reported (disorders of mineral metabolism),2404,"Endocrine, nutritional and metabolic diseases","4,417",Date,Both sexes,Jul 2019,"4,417",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130821,Source of report of E83 (disorders of mineral metabolism),2404,"Endocrine, nutritional and metabolic diseases","4,417",Categorical (single),Both sexes,Jul 2019,"4,417",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130822,Date E84 first reported (cystic fibrosis),2404,"Endocrine, nutritional and metabolic diseases",130,Date,Both sexes,Jul 2019,130,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130823,Source of report of E84 (cystic fibrosis),2404,"Endocrine, nutritional and metabolic diseases",130,Categorical (single),Both sexes,Jul 2019,130,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130824,Date E85 first reported (amyloidosis),2404,"Endocrine, nutritional and metabolic diseases",230,Date,Both sexes,Jul 2019,230,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130825,Source of report of E85 (amyloidosis),2404,"Endocrine, nutritional and metabolic diseases",230,Categorical (single),Both sexes,Jul 2019,230,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130826,Date E86 first reported (volume depletion),2404,"Endocrine, nutritional and metabolic diseases","5,067",Date,Both sexes,Jul 2019,"5,067",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130827,Source of report of E86 (volume depletion),2404,"Endocrine, nutritional and metabolic diseases","5,067",Categorical (single),Both sexes,Jul 2019,"5,067",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130828,"Date E87 first reported (other disorders of fluid, electrolyte and acid-base balance)",2404,"Endocrine, nutritional and metabolic diseases","11,724",Date,Both sexes,Jul 2019,"11,724",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130829,"Source of report of E87 (other disorders of fluid, electrolyte and acid-base balance)",2404,"Endocrine, nutritional and metabolic diseases","11,724",Categorical (single),Both sexes,Jul 2019,"11,724",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130830,Date E88 first reported (other metabolic disorders),2404,"Endocrine, nutritional and metabolic diseases",961,Date,Both sexes,Jul 2019,961,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130831,Source of report of E88 (other metabolic disorders),2404,"Endocrine, nutritional and metabolic diseases",961,Categorical (single),Both sexes,Jul 2019,961,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130832,"Date E89 first reported (postprocedural endocrine and metabolic disorders, not elsewhere classified)",2404,"Endocrine, nutritional and metabolic diseases","2,291",Date,Both sexes,Jul 2019,"2,291",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130833,"Source of report of E89 (postprocedural endocrine and metabolic disorders, not elsewhere classified)",2404,"Endocrine, nutritional and metabolic diseases","2,291",Categorical (single),Both sexes,Jul 2019,"2,291",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130834,Date E90 first reported (nutritional and metabolic disorders in diseases classified elsewhere),2404,"Endocrine, nutritional and metabolic diseases",pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
130835,Source of report of E90 (nutritional and metabolic disorders in diseases classified elsewhere),2404,"Endocrine, nutritional and metabolic diseases",pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,"Endocrine, nutritional and metabolic diseases",0.0,0.0,0.0,0.0,0.0,0.0,0.0
100022,Alcohol,100098,Estimated nutrients yesterday,"211,025","Continuous, g",Both sexes,Sep 2012,"458,661",Data,Defined (5),Apr 2014,Complete,Online follow-up,Diet by 24-hour recall,Estimated nutrients yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100024,Calcium,100098,Estimated nutrients yesterday,"211,025","Continuous, mg",Both sexes,Sep 2012,"458,661",Data,Defined (5),Apr 2014,Complete,Online follow-up,Diet by 24-hour recall,Estimated nutrients yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100005,Carbohydrate,100098,Estimated nutrients yesterday,"211,025","Continuous, g",Both sexes,Sep 2012,"458,661",Data,Defined (5),Apr 2014,Complete,Online follow-up,Diet by 24-hour recall,Estimated nutrients yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100019,Carotene,100098,Estimated nutrients yesterday,"211,025","Continuous, ug",Both sexes,Sep 2012,"458,661",Data,Defined (5),Apr 2014,Complete,Online follow-up,Diet by 24-hour recall,Estimated nutrients yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100002,Energy,100098,Estimated nutrients yesterday,"211,025","Continuous, KJ",Both sexes,Sep 2012,"458,661",Data,Defined (5),Apr 2014,Complete,Online follow-up,Diet by 24-hour recall,Estimated nutrients yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100009,Englyst dietary fibre,100098,Estimated nutrients yesterday,"211,025","Continuous, g",Both sexes,Sep 2012,"458,661",Data,Defined (5),Apr 2014,Complete,Online follow-up,Diet by 24-hour recall,Estimated nutrients yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100004,Fat,100098,Estimated nutrients yesterday,"211,025","Continuous, g",Both sexes,Sep 2012,"458,661",Data,Defined (5),Apr 2014,Complete,Online follow-up,Diet by 24-hour recall,Estimated nutrients yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100014,Folate,100098,Estimated nutrients yesterday,"211,025","Continuous, ug",Both sexes,Sep 2012,"458,661",Data,Defined (5),Apr 2014,Complete,Online follow-up,Diet by 24-hour recall,Estimated nutrients yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100001,Food weight,100098,Estimated nutrients yesterday,"211,025","Continuous, g",Both sexes,Sep 2012,"458,661",Data,Defined (5),Apr 2014,Complete,Online follow-up,Diet by 24-hour recall,Estimated nutrients yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100011,Iron,100098,Estimated nutrients yesterday,"211,025","Continuous, mg",Both sexes,Sep 2012,"458,661",Data,Defined (5),Apr 2014,Complete,Online follow-up,Diet by 24-hour recall,Estimated nutrients yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100017,Magnesium,100098,Estimated nutrients yesterday,"211,025","Continuous, mg",Both sexes,Sep 2012,"458,661",Data,Defined (5),Apr 2014,Complete,Online follow-up,Diet by 24-hour recall,Estimated nutrients yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100007,Polyunsaturated fat,100098,Estimated nutrients yesterday,"211,025","Continuous, g",Both sexes,Sep 2012,"458,661",Data,Defined (5),Apr 2014,Complete,Online follow-up,Diet by 24-hour recall,Estimated nutrients yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100016,Potassium,100098,Estimated nutrients yesterday,"211,025","Continuous, mg",Both sexes,Sep 2012,"458,661",Data,Defined (5),Apr 2014,Complete,Online follow-up,Diet by 24-hour recall,Estimated nutrients yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100003,Protein,100098,Estimated nutrients yesterday,"211,025","Continuous, g",Both sexes,Sep 2012,"458,661",Data,Defined (5),Apr 2014,Complete,Online follow-up,Diet by 24-hour recall,Estimated nutrients yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100018,Retinol,100098,Estimated nutrients yesterday,"208,082","Continuous, ug",Both sexes,Sep 2012,"442,710",Data,Defined (5),Apr 2014,Complete,Online follow-up,Diet by 24-hour recall,Estimated nutrients yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100006,Saturated fat,100098,Estimated nutrients yesterday,"211,025","Continuous, g",Both sexes,Sep 2012,"458,661",Data,Defined (5),Apr 2014,Complete,Online follow-up,Diet by 24-hour recall,Estimated nutrients yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100023,Starch,100098,Estimated nutrients yesterday,"211,025","Continuous, g",Both sexes,Sep 2012,"458,661",Data,Defined (5),Apr 2014,Complete,Online follow-up,Diet by 24-hour recall,Estimated nutrients yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100008,Total sugars,100098,Estimated nutrients yesterday,"211,025","Continuous, g",Both sexes,Sep 2012,"458,661",Data,Defined (5),Apr 2014,Complete,Online follow-up,Diet by 24-hour recall,Estimated nutrients yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100013,Vitamin B12,100098,Estimated nutrients yesterday,"211,025","Continuous, ug",Both sexes,Sep 2012,"458,661",Data,Defined (5),Apr 2014,Complete,Online follow-up,Diet by 24-hour recall,Estimated nutrients yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100012,Vitamin B6,100098,Estimated nutrients yesterday,"211,025","Continuous, mg",Both sexes,Sep 2012,"458,661",Data,Defined (5),Apr 2014,Complete,Online follow-up,Diet by 24-hour recall,Estimated nutrients yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100015,Vitamin C,100098,Estimated nutrients yesterday,"211,025","Continuous, mg",Both sexes,Sep 2012,"458,661",Data,Defined (5),Apr 2014,Complete,Online follow-up,Diet by 24-hour recall,Estimated nutrients yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100021,Vitamin D,100098,Estimated nutrients yesterday,"211,025","Continuous, ug",Both sexes,Sep 2012,"458,661",Data,Defined (5),Apr 2014,Complete,Online follow-up,Diet by 24-hour recall,Estimated nutrients yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100025,Vitamin E,100098,Estimated nutrients yesterday,"211,025","Continuous, mg",Both sexes,Sep 2012,"458,661",Data,Defined (5),Apr 2014,Complete,Online follow-up,Diet by 24-hour recall,Estimated nutrients yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3659,Year immigrated to UK (United Kingdom),100065,Ethnicity,"44,562",Integer,Both sexes,Jan 2012,"46,085",Data,Defined (3),Nov 2016,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Ethnicity,0.0,0.0,0.0,0.0,0.0,0.0
21000,Ethnic background,100065,Ethnicity,"501,614",Categorical (single),Both sexes,Jan 2012,"533,614",Data,Defined (3),Nov 2016,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Ethnicity,0.0,0.0,0.0,0.0,0.0,0.0
23160,"Population-level FE variants, PLINK format",170,Exome sequences,"49,991",Text,Both sexes,Mar 2019,"49,991",Bulk,Singular,Mar 2019,Accruing,Genomics,Exome sequences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23161,Exome FE variant call files (VCFs),170,Exome sequences,"49,991",Text,Both sexes,Mar 2019,"49,991",Bulk,Singular,Mar 2019,Accruing,Genomics,Exome sequences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23162,Exome FE variant calls indices,170,Exome sequences,"49,991",Text,Both sexes,Mar 2019,"49,991",Bulk,Singular,Mar 2019,Accruing,Genomics,Exome sequences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23163,Exome FE CRAM files,170,Exome sequences,"49,991",Text,Both sexes,Mar 2019,"49,991",Bulk,Singular,Mar 2019,Accruing,Genomics,Exome sequences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23164,Exome FE CRAM indices,170,Exome sequences,"49,991",Text,Both sexes,Mar 2019,"49,991",Bulk,Singular,Mar 2019,Accruing,Genomics,Exome sequences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23176,Exome SPB variant call files (VCFs),170,Exome sequences,"49,953",Text,Both sexes,Dec 2019,"49,953",Bulk,Singular,N/A,Accruing,Genomics,Exome sequences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23177,Exome SPB variant calls indices,170,Exome sequences,"49,953",Text,Both sexes,Dec 2019,"49,953",Bulk,Singular,N/A,Accruing,Genomics,Exome sequences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23178,Exome SPB CRAM files,170,Exome sequences,"49,953",Text,Both sexes,Dec 2019,"49,953",Bulk,Singular,N/A,Accruing,Genomics,Exome sequences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23179,Exome SPB CRAM indices,170,Exome sequences,"49,953",Text,Both sexes,Dec 2019,"49,953",Bulk,Singular,N/A,Accruing,Genomics,Exome sequences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23170,"INVALID Population-level SPB variants, PLINK format",170,Exome sequences,"49,991",Text,Both sexes,Feb 2019,"49,991",Bulk,Singular,Mar 2019,Accruing,Genomics,Exome sequences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23171,INVALID Exome SPB variant call files (VCFs),170,Exome sequences,"49,991",Text,Both sexes,Jul 2018,"49,991",Bulk,Singular,Jul 2018,Accruing,Genomics,Exome sequences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23172,INVALID Exome SPB variant calls indices,170,Exome sequences,"49,991",Text,Both sexes,Jul 2018,"49,991",Bulk,Singular,Jul 2018,Accruing,Genomics,Exome sequences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23173,INVALID Exome SPB CRAM files,170,Exome sequences,"49,991",Text,Both sexes,Jul 2018,"49,991",Bulk,Singular,Jul 2018,Accruing,Genomics,Exome sequences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23174,INVALID Exome SPB CRAM indices,170,Exome sequences,"49,991",Text,Both sexes,Jul 2018,"49,991",Bulk,Singular,Jul 2018,Accruing,Genomics,Exome sequences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131128,Date H00 first reported (hordeolum and chalazion),2407,Eye and adnexa disorders,"12,628",Date,Both sexes,Jul 2019,"12,628",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131129,Source of report of H00 (hordeolum and chalazion),2407,Eye and adnexa disorders,"12,628",Categorical (single),Both sexes,Jul 2019,"12,628",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131130,Date H01 first reported (other inflammation of eyelid),2407,Eye and adnexa disorders,"5,019",Date,Both sexes,Jul 2019,"5,019",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131131,Source of report of H01 (other inflammation of eyelid),2407,Eye and adnexa disorders,"5,019",Categorical (single),Both sexes,Jul 2019,"5,019",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131132,Date H02 first reported (other disorders of eyelid),2407,Eye and adnexa disorders,"11,339",Date,Both sexes,Jul 2019,"11,339",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131133,Source of report of H02 (other disorders of eyelid),2407,Eye and adnexa disorders,"11,339",Categorical (single),Both sexes,Jul 2019,"11,339",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131134,Date H03 first reported (disorders of eyelid in diseases classified elsewhere),2407,Eye and adnexa disorders,80,Date,Both sexes,Jul 2019,80,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131135,Source of report of H03 (disorders of eyelid in diseases classified elsewhere),2407,Eye and adnexa disorders,80,Categorical (single),Both sexes,Jul 2019,80,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131136,Date H04 first reported (disorders of lachrymal system),2407,Eye and adnexa disorders,"14,345",Date,Both sexes,Jul 2019,"14,345",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131137,Source of report of H04 (disorders of lachrymal system),2407,Eye and adnexa disorders,"14,345",Categorical (single),Both sexes,Jul 2019,"14,345",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131138,Date H05 first reported (disorders of orbit),2407,Eye and adnexa disorders,"1,059",Date,Both sexes,Jul 2019,"1,059",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131139,Source of report of H05 (disorders of orbit),2407,Eye and adnexa disorders,"1,059",Categorical (single),Both sexes,Jul 2019,"1,059",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131140,Date H06 first reported (disorders of lachrymal system and orbit in diseases classified elsewhere),2407,Eye and adnexa disorders,184,Date,Both sexes,Jul 2019,184,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131141,Source of report of H06 (disorders of lachrymal system and orbit in diseases classified elsewhere),2407,Eye and adnexa disorders,184,Categorical (single),Both sexes,Jul 2019,184,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131142,Date H10 first reported (conjunctivitis),2407,Eye and adnexa disorders,"23,583",Date,Both sexes,Jul 2019,"23,583",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131143,Source of report of H10 (conjunctivitis),2407,Eye and adnexa disorders,"23,583",Categorical (single),Both sexes,Jul 2019,"23,583",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131144,Date H11 first reported (other disorders of conjunctiva),2407,Eye and adnexa disorders,"8,290",Date,Both sexes,Jul 2019,"8,290",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131145,Source of report of H11 (other disorders of conjunctiva),2407,Eye and adnexa disorders,"8,290",Categorical (single),Both sexes,Jul 2019,"8,290",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131146,Date H13 first reported (disorders of conjunctiva in diseases classified elsewhere),2407,Eye and adnexa disorders,134,Date,Both sexes,Jul 2019,134,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131147,Source of report of H13 (disorders of conjunctiva in diseases classified elsewhere),2407,Eye and adnexa disorders,134,Categorical (single),Both sexes,Jul 2019,134,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131148,Date H15 first reported (disorders of sclera),2407,Eye and adnexa disorders,"1,277",Date,Both sexes,Jul 2019,"1,277",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131149,Source of report of H15 (disorders of sclera),2407,Eye and adnexa disorders,"1,277",Categorical (single),Both sexes,Jul 2019,"1,277",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131150,Date H16 first reported (keratitis),2407,Eye and adnexa disorders,"1,561",Date,Both sexes,Jul 2019,"1,561",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131151,Source of report of H16 (keratitis),2407,Eye and adnexa disorders,"1,561",Categorical (single),Both sexes,Jul 2019,"1,561",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131152,Date H17 first reported (corneal scars and opacities),2407,Eye and adnexa disorders,348,Date,Both sexes,Jul 2019,348,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131153,Source of report of H17 (corneal scars and opacities),2407,Eye and adnexa disorders,348,Categorical (single),Both sexes,Jul 2019,348,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131154,Date H18 first reported (other disorders of cornea),2407,Eye and adnexa disorders,"2,342",Date,Both sexes,Jul 2019,"2,342",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131155,Source of report of H18 (other disorders of cornea),2407,Eye and adnexa disorders,"2,342",Categorical (single),Both sexes,Jul 2019,"2,342",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131156,Date H19 first reported (disorders of sclera and cornea in diseases classified elsewhere),2407,Eye and adnexa disorders,146,Date,Both sexes,Jul 2019,146,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131157,Source of report of H19 (disorders of sclera and cornea in diseases classified elsewhere),2407,Eye and adnexa disorders,146,Categorical (single),Both sexes,Jul 2019,146,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131158,Date H20 first reported (iridocyclitis),2407,Eye and adnexa disorders,"2,688",Date,Both sexes,Jul 2019,"2,688",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131159,Source of report of H20 (iridocyclitis),2407,Eye and adnexa disorders,"2,688",Categorical (single),Both sexes,Jul 2019,"2,688",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131160,Date H21 first reported (other disorders of iris and ciliary body),2407,Eye and adnexa disorders,770,Date,Both sexes,Jul 2019,770,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131161,Source of report of H21 (other disorders of iris and ciliary body),2407,Eye and adnexa disorders,770,Categorical (single),Both sexes,Jul 2019,770,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131162,Date H22 first reported (disorders of iris and ciliary body in diseases classified elsewhere),2407,Eye and adnexa disorders,42,Date,Both sexes,Jul 2019,42,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131163,Source of report of H22 (disorders of iris and ciliary body in diseases classified elsewhere),2407,Eye and adnexa disorders,42,Categorical (single),Both sexes,Jul 2019,42,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131164,Date H25 first reported (senile cataract),2407,Eye and adnexa disorders,"15,182",Date,Both sexes,Jul 2019,"15,182",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131165,Source of report of H25 (senile cataract),2407,Eye and adnexa disorders,"15,182",Categorical (single),Both sexes,Jul 2019,"15,182",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131166,Date H26 first reported (other cataract),2407,Eye and adnexa disorders,"31,426",Date,Both sexes,Jul 2019,"31,426",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131167,Source of report of H26 (other cataract),2407,Eye and adnexa disorders,"31,426",Categorical (single),Both sexes,Jul 2019,"31,426",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131168,Date H27 first reported (other disorders of lens),2407,Eye and adnexa disorders,420,Date,Both sexes,Jul 2019,420,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131169,Source of report of H27 (other disorders of lens),2407,Eye and adnexa disorders,420,Categorical (single),Both sexes,Jul 2019,420,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131170,Date H28 first reported (cataract and other disorders of lens in diseases classified elsewhere),2407,Eye and adnexa disorders,46,Date,Both sexes,Jul 2019,46,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131171,Source of report of H28 (cataract and other disorders of lens in diseases classified elsewhere),2407,Eye and adnexa disorders,46,Categorical (single),Both sexes,Jul 2019,46,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131172,Date H30 first reported (chorioretinal inflammation),2407,Eye and adnexa disorders,226,Date,Both sexes,Jul 2019,226,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131173,Source of report of H30 (chorioretinal inflammation),2407,Eye and adnexa disorders,226,Categorical (single),Both sexes,Jul 2019,226,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131174,Date H31 first reported (other disorders of choroid),2407,Eye and adnexa disorders,633,Date,Both sexes,Jul 2019,633,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131175,Source of report of H31 (other disorders of choroid),2407,Eye and adnexa disorders,633,Categorical (single),Both sexes,Jul 2019,633,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131176,Date H32 first reported (chorioretinal disorders in diseases classified elsewhere),2407,Eye and adnexa disorders,13,Date,Both sexes,Jul 2019,13,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131177,Source of report of H32 (chorioretinal disorders in diseases classified elsewhere),2407,Eye and adnexa disorders,13,Categorical (single),Both sexes,Jul 2019,13,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131178,Date H33 first reported (retinal detachments and breaks),2407,Eye and adnexa disorders,"6,225",Date,Both sexes,Jul 2019,"6,225",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131179,Source of report of H33 (retinal detachments and breaks),2407,Eye and adnexa disorders,"6,225",Categorical (single),Both sexes,Jul 2019,"6,225",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131180,Date H34 first reported (retinal vascular occlusions),2407,Eye and adnexa disorders,"1,947",Date,Both sexes,Jul 2019,"1,947",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131181,Source of report of H34 (retinal vascular occlusions),2407,Eye and adnexa disorders,"1,947",Categorical (single),Both sexes,Jul 2019,"1,947",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131182,Date H35 first reported (other retinal disorders),2407,Eye and adnexa disorders,"11,527",Date,Both sexes,Jul 2019,"11,527",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131183,Source of report of H35 (other retinal disorders),2407,Eye and adnexa disorders,"11,527",Categorical (single),Both sexes,Jul 2019,"11,527",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131184,Date H36 first reported (retinal disorders in diseases classified elsewhere),2407,Eye and adnexa disorders,"3,189",Date,Both sexes,Jul 2019,"3,189",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131185,Source of report of H36 (retinal disorders in diseases classified elsewhere),2407,Eye and adnexa disorders,"3,189",Categorical (single),Both sexes,Jul 2019,"3,189",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131186,Date H40 first reported (glaucoma),2407,Eye and adnexa disorders,"14,831",Date,Both sexes,Jul 2019,"14,831",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131187,Source of report of H40 (glaucoma),2407,Eye and adnexa disorders,"14,831",Categorical (single),Both sexes,Jul 2019,"14,831",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131188,Date H42 first reported (glaucoma in diseases classified elsewhere),2407,Eye and adnexa disorders,7,Date,Both sexes,Jul 2019,7,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131189,Source of report of H42 (glaucoma in diseases classified elsewhere),2407,Eye and adnexa disorders,7,Categorical (single),Both sexes,Jul 2019,7,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131190,Date H43 first reported (disorders of vitreous body),2407,Eye and adnexa disorders,"9,892",Date,Both sexes,Jul 2019,"9,892",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131191,Source of report of H43 (disorders of vitreous body),2407,Eye and adnexa disorders,"9,892",Categorical (single),Both sexes,Jul 2019,"9,892",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131192,Date H44 first reported (disorders of globe),2407,Eye and adnexa disorders,"1,818",Date,Both sexes,Jul 2019,"1,818",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131193,Source of report of H44 (disorders of globe),2407,Eye and adnexa disorders,"1,818",Categorical (single),Both sexes,Jul 2019,"1,818",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131194,Date H45 first reported (disorders of vitreous body and globe in diseases classified elsewhere),2407,Eye and adnexa disorders,17,Date,Both sexes,Jul 2019,17,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131195,Source of report of H45 (disorders of vitreous body and globe in diseases classified elsewhere),2407,Eye and adnexa disorders,17,Categorical (single),Both sexes,Jul 2019,17,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131196,Date H46 first reported (optic neuritis),2407,Eye and adnexa disorders,474,Date,Both sexes,Jul 2019,474,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131197,Source of report of H46 (optic neuritis),2407,Eye and adnexa disorders,474,Categorical (single),Both sexes,Jul 2019,474,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131198,Date H47 first reported (other disorders of optic [2nd] nerve and visual pathways),2407,Eye and adnexa disorders,"1,248",Date,Both sexes,Jul 2019,"1,248",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131199,Source of report of H47 (other disorders of optic [2nd] nerve and visual pathways),2407,Eye and adnexa disorders,"1,248",Categorical (single),Both sexes,Jul 2019,"1,248",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131200,Date H48 first reported (disorders of optic [2nd] nerve and visual pathways in diseases classified elsewhere),2407,Eye and adnexa disorders,12,Date,Both sexes,Jul 2019,12,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131201,Source of report of H48 (disorders of optic [2nd] nerve and visual pathways in diseases classified elsewhere),2407,Eye and adnexa disorders,12,Categorical (single),Both sexes,Jul 2019,12,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131202,Date H49 first reported (paralytic strabismus),2407,Eye and adnexa disorders,621,Date,Both sexes,Jul 2019,621,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131203,Source of report of H49 (paralytic strabismus),2407,Eye and adnexa disorders,621,Categorical (single),Both sexes,Jul 2019,621,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131204,Date H50 first reported (other strabismus),2407,Eye and adnexa disorders,"2,313",Date,Both sexes,Jul 2019,"2,313",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131205,Source of report of H50 (other strabismus),2407,Eye and adnexa disorders,"2,313",Categorical (single),Both sexes,Jul 2019,"2,313",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131206,Date H51 first reported (other disorders of binocular movement),2407,Eye and adnexa disorders,231,Date,Both sexes,Jul 2019,231,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131207,Source of report of H51 (other disorders of binocular movement),2407,Eye and adnexa disorders,231,Categorical (single),Both sexes,Jul 2019,231,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131208,Date H52 first reported (disorders of refraction and accommodation),2407,Eye and adnexa disorders,"5,215",Date,Both sexes,Jul 2019,"5,215",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131209,Source of report of H52 (disorders of refraction and accommodation),2407,Eye and adnexa disorders,"5,215",Categorical (single),Both sexes,Jul 2019,"5,215",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131210,Date H53 first reported (visual disturbances),2407,Eye and adnexa disorders,"10,480",Date,Both sexes,Jul 2019,"10,480",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131211,Source of report of H53 (visual disturbances),2407,Eye and adnexa disorders,"10,480",Categorical (single),Both sexes,Jul 2019,"10,480",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131212,Date H54 first reported (blindness and low vision),2407,Eye and adnexa disorders,"2,710",Date,Both sexes,Jul 2019,"2,710",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131213,Source of report of H54 (blindness and low vision),2407,Eye and adnexa disorders,"2,710",Categorical (single),Both sexes,Jul 2019,"2,710",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131214,Date H55 first reported (nystagmus and other irregular eye movements),2407,Eye and adnexa disorders,456,Date,Both sexes,Jul 2019,456,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131215,Source of report of H55 (nystagmus and other irregular eye movements),2407,Eye and adnexa disorders,456,Categorical (single),Both sexes,Jul 2019,456,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131216,Date H57 first reported (other disorders of eye and adnexa),2407,Eye and adnexa disorders,"7,735",Date,Both sexes,Jul 2019,"7,735",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131217,Source of report of H57 (other disorders of eye and adnexa),2407,Eye and adnexa disorders,"7,735",Categorical (single),Both sexes,Jul 2019,"7,735",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131218,Date H58 first reported (other disorders of eye and adnexa in diseases classified elsewhere),2407,Eye and adnexa disorders,142,Date,Both sexes,Jul 2019,142,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131219,Source of report of H58 (other disorders of eye and adnexa in diseases classified elsewhere),2407,Eye and adnexa disorders,142,Categorical (single),Both sexes,Jul 2019,142,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131220,"Date H59 first reported (postprocedural disorders of eye and adnexa, not elsewhere classified)",2407,Eye and adnexa disorders,322,Date,Both sexes,Jul 2019,322,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131221,"Source of report of H59 (postprocedural disorders of eye and adnexa, not elsewhere classified)",2407,Eye and adnexa disorders,322,Categorical (single),Both sexes,Jul 2019,322,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Eye and adnexa disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
5181,Ever had eye surgery,100099,Eye surgery/complications,"133,926",Categorical (single),Both sexes,Jan 2012,"138,194",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Eye surgery/complications,0.0,0.0,0.0,0.0,0.0,0.0
5324,Ever had cataract surgery,100099,Eye surgery/complications,"10,626",Categorical (single),Both sexes,Jan 2012,"10,878",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Eye surgery/complications,0.0,0.0,0.0,0.0,0.0,0.0
5325,Ever had refractive laser eye surgery,100099,Eye surgery/complications,"10,626",Categorical (single),Both sexes,Jan 2012,"10,878",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Eye surgery/complications,0.0,0.0,0.0,0.0,0.0,0.0
5326,Ever had surgery for glaucoma or high eye pressure,100099,Eye surgery/complications,"10,626",Categorical (single),Both sexes,Jan 2012,"10,878",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Eye surgery/complications,0.0,0.0,0.0,0.0,0.0,0.0
5327,Ever had laser treatment for glaucoma or high eye pressure,100099,Eye surgery/complications,"10,626",Categorical (single),Both sexes,Jan 2012,"10,878",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Eye surgery/complications,0.0,0.0,0.0,0.0,0.0,0.0
5328,Ever had corneal graft surgery,100099,Eye surgery/complications,"10,626",Categorical (single),Both sexes,Jan 2012,"10,878",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Eye surgery/complications,0.0,0.0,0.0,0.0,0.0,0.0
5182,Both eyes present,100099,Eye surgery/complications,"133,926",Categorical (single),Both sexes,Jan 2012,"138,194",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Eye surgery/complications,0.0,0.0,0.0,0.0,0.0,0.0
5183,Current eye infection,100099,Eye surgery/complications,"133,919",Categorical (single),Both sexes,Jan 2012,"138,187",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Eye surgery/complications,0.0,0.0,0.0,0.0,0.0,0.0
2207,Wears glasses or contact lenses,100041,Eyesight,"501,605",Categorical (single),Both sexes,Jan 2012,"572,231",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Eyesight,0.0,0.0,0.0,0.0,0.0,0.0
2217,Age started wearing glasses or contact lenses,100041,Eyesight,"445,516",Integer,Both sexes,Jan 2012,"506,507",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Eyesight,0.0,0.0,0.0,0.0,0.0,0.0
6147,Reason for glasses/contact lenses,100041,Eyesight,"151,205",Categorical (multiple),Both sexes,Jan 2012,"218,669",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Eyesight,0.0,0.0,0.0,0.0,0.0,0.0
5843,Which eye(s) affected by myopia (short sight),100041,Eyesight,"61,925",Categorical (single),Both sexes,Jan 2012,"70,342",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Eyesight,0.0,0.0,0.0,0.0,0.0,0.0
5832,Which eye(s) affected by hypermetropia (long sight),100041,Eyesight,"33,792",Categorical (single),Both sexes,Jan 2012,"36,135",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Eyesight,0.0,0.0,0.0,0.0,0.0,0.0
5610,Which eye(s) affected by presbyopia,100041,Eyesight,"66,261",Categorical (single),Both sexes,Jan 2012,"73,013",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Eyesight,0.0,0.0,0.0,0.0,0.0,0.0
5855,Which eye(s) affected by astigmatism,100041,Eyesight,"20,709",Categorical (single),Both sexes,Jan 2012,"23,299",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Eyesight,0.0,0.0,0.0,0.0,0.0,0.0
6205,Which eye(s) affected by strabismus (squint),100041,Eyesight,"3,035",Categorical (single),Both sexes,Jan 2012,"3,333",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Eyesight,0.0,0.0,0.0,0.0,0.0,0.0
5408,Which eye(s) affected by amblyopia (lazy eye),100041,Eyesight,"5,885",Categorical (single),Both sexes,Jan 2012,"6,469",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Eyesight,0.0,0.0,0.0,0.0,0.0,0.0
5877,Which eye(s) affected by other eye condition,100041,Eyesight,"2,783",Categorical (single),Both sexes,Jan 2012,"2,885",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Eyesight,0.0,0.0,0.0,0.0,0.0,0.0
5934,Which eye(s) affected by other serious eye condition,100041,Eyesight,"3,884",Categorical (single),Both sexes,Jan 2012,"4,103",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Eyesight,0.0,0.0,0.0,0.0,0.0,0.0
2227,Other eye problems,100041,Eyesight,"501,604",Categorical (single),Both sexes,Jan 2012,"572,230",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Eyesight,0.0,0.0,0.0,0.0,0.0,0.0
6148,Eye problems/disorders,100041,Eyesight,"214,897",Categorical (multiple),Both sexes,Jan 2012,"252,799",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Eyesight,0.0,0.0,0.0,0.0,0.0,0.0
5890,Which eye(s) affected by diabetes-related eye disease,100041,Eyesight,"2,060",Categorical (single),Both sexes,Jan 2012,"2,147",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Eyesight,0.0,0.0,0.0,0.0,0.0,0.0
6119,Which eye(s) affected by glaucoma,100041,Eyesight,"3,633",Categorical (single),Both sexes,Jan 2012,"3,970",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Eyesight,0.0,0.0,0.0,0.0,0.0,0.0
5419,Which eye(s) affected by injury or trauma resulting in loss of vision,100041,Eyesight,"1,178",Categorical (single),Both sexes,Jan 2012,"1,238",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Eyesight,0.0,0.0,0.0,0.0,0.0,0.0
5441,Which eye(s) are affected by cataract,100041,Eyesight,"13,646",Categorical (single),Both sexes,Jan 2012,"14,737",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Eyesight,0.0,0.0,0.0,0.0,0.0,0.0
5912,Which eye(s) affected by macular degeneration,100041,Eyesight,"2,585",Categorical (single),Both sexes,Jan 2012,"2,769",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Eyesight,0.0,0.0,0.0,0.0,0.0,0.0
5901,Age when diabetes-related eye disease diagnosed,100041,Eyesight,"2,368","Integer, years",Both sexes,Jan 2012,"2,462",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Eyesight,0.0,0.0,0.0,0.0,0.0,0.0
4689,Age glaucoma diagnosed,100041,Eyesight,"4,308","Integer, years",Both sexes,Jan 2012,"4,683",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Eyesight,0.0,0.0,0.0,0.0,0.0,0.0
5430,Age when loss of vision due to injury or trauma diagnosed,100041,Eyesight,"1,178","Integer, years",Both sexes,Jan 2012,"1,238",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Eyesight,0.0,0.0,0.0,0.0,0.0,0.0
4700,Age cataract diagnosed,100041,Eyesight,"14,981","Integer, years",Both sexes,Jan 2012,"16,146",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Eyesight,0.0,0.0,0.0,0.0,0.0,0.0
5923,Age macular degeneration diagnosed,100041,Eyesight,"2,585","Integer, years",Both sexes,Jan 2012,"2,769",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Eyesight,0.0,0.0,0.0,0.0,0.0,0.0
5945,Age other serious eye condition diagnosed,100041,Eyesight,"3,884","Integer, years",Both sexes,Jan 2012,"4,103",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Eyesight,0.0,0.0,0.0,0.0,0.0,0.0
20112,Illnesses of adopted father,100034,Family history,"5,295",Categorical (single),Both sexes,Oct 2012,"12,490",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Family history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20113,Illnesses of adopted mother,100034,Family history,"5,630",Categorical (single),Both sexes,Oct 2012,"13,446",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Family history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20114,Illnesses of adopted siblings,100034,Family history,"3,831",Categorical (single),Both sexes,Oct 2012,"8,808",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Family history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20107,Illnesses of father,100034,Family history,"488,082",Categorical (single),Both sexes,Oct 2012,"1,239,224",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Family history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20110,Illnesses of mother,100034,Family history,"492,995",Categorical (single),Both sexes,Oct 2012,"1,248,372",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Family history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20111,Illnesses of siblings,100034,Family history,"434,184",Categorical (single),Both sexes,Oct 2012,"1,057,159",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Family history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
1797,Father still alive,100034,Family history,"494,294",Categorical (single),Both sexes,Jan 2012,"563,954",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Family history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3912,Adopted father still alive,100034,Family history,"7,407",Categorical (single),Both sexes,Jan 2012,"8,230",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Family history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
2946,Father's age,100034,Family history,"114,724","Integer, years",Both sexes,Jan 2012,"124,362",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Family history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
1807,Father's age at death,100034,Family history,"385,925","Integer, years",Both sexes,Jan 2012,"438,263",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Family history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
1835,Mother still alive,100034,Family history,"494,294",Categorical (single),Both sexes,Jan 2012,"563,954",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Family history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3942,Adopted mother still alive,100034,Family history,"7,407",Categorical (single),Both sexes,Jan 2012,"8,230",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Family history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
1845,Mother's age,100034,Family history,"199,420","Integer, years",Both sexes,Jan 2012,"218,016",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Family history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3526,Mother's age at death,100034,Family history,"309,621","Integer, years",Both sexes,Jan 2012,"350,111",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Family history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
1873,Number of full brothers,100034,Family history,"494,291",Integer,Both sexes,Jan 2012,"563,951",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Family history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3972,Number of adopted brothers,100034,Family history,"7,407",Integer,Both sexes,Jan 2012,"8,230",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Family history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
1883,Number of full sisters,100034,Family history,"494,291",Integer,Both sexes,Jan 2012,"563,951",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Family history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3982,Number of adopted sisters,100034,Family history,"7,407",Integer,Both sexes,Jan 2012,"8,230",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Family history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
5057,Number of older siblings,100034,Family history,"186,944",Integer,Both sexes,Jan 2012,"212,865",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Family history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4501,Non-accidental death in close genetic family,100034,Family history,"210,503",Categorical (single),Both sexes,Jan 2012,"239,655",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Family history,0.0,0.0,0.0,0.0,0.0,0.0,0.0
2674,Ever had breast cancer screening / mammogram,100069,Female-specific factors,"272,921",Categorical (single),Females only,Jan 2012,"309,271",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
2684,Years since last breast cancer screening / mammogram,100069,Female-specific factors,"223,188","Integer, years",Females only,Jan 2012,"252,179",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
2694,Ever had cervical smear test,100069,Female-specific factors,"272,921",Categorical (single),Females only,Jan 2012,"309,271",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
2704,Years since last cervical smear test,100069,Female-specific factors,"265,921","Integer, years",Females only,Jan 2012,"301,295",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
2714,Age when periods started (menarche),100069,Female-specific factors,"272,921","Integer, years",Females only,Jan 2012,"309,271",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
2724,Had menopause,100069,Female-specific factors,"272,921",Categorical (single),Females only,Jan 2012,"309,271",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
3581,Age at menopause (last menstrual period),100069,Female-specific factors,"173,248","Integer, years",Females only,Jan 2012,"194,232",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
3700,Time since last menstrual period,100069,Female-specific factors,"64,175","Integer, days",Females only,Jan 2012,"66,440",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
3710,Length of menstrual cycle,100069,Female-specific factors,"64,175","Integer, days",Females only,Jan 2012,"66,440",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
3720,Menstruating today,100069,Female-specific factors,"76,489",Categorical (single),Females only,Jan 2012,"80,069",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
2734,Number of live births,100069,Female-specific factors,"272,919","Integer, children",Females only,Jan 2012,"309,269",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
2744,Birth weight of first child,100069,Female-specific factors,"221,497","Integer, pounds",Females only,Jan 2012,"250,073",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
3872,Age of primiparous women at birth of child,100069,Female-specific factors,"36,520","Integer, years",Females only,Jan 2012,"41,108",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
2754,Age at first live birth,100069,Female-specific factors,"185,028","Integer, years",Females only,Jan 2012,"208,965",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
2764,Age at last live birth,100069,Female-specific factors,"185,028","Integer, years",Females only,Jan 2012,"208,965",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
2774,"Ever had stillbirth, spontaneous miscarriage or termination",100069,Female-specific factors,"272,918",Categorical (single),Females only,Jan 2012,"309,268",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
3829,Number of stillbirths,100069,Female-specific factors,"87,822",Integer,Females only,Jan 2012,"98,277",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
3839,Number of spontaneous miscarriages,100069,Female-specific factors,"87,822",Integer,Females only,Jan 2012,"98,277",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
3849,Number of pregnancy terminations,100069,Female-specific factors,"87,822",Integer,Females only,Jan 2012,"98,277",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
2784,Ever taken oral contraceptive pill,100069,Female-specific factors,"272,918",Categorical (single),Females only,Jan 2012,"309,268",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
10132,Type of progestan-only oral contraceptive used (pilot),100069,Female-specific factors,44,Categorical (single),Females only,Jan 2012,44,Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
2794,Age started oral contraceptive pill,100069,Female-specific factors,"220,791","Integer, years",Females only,Jan 2012,"251,031",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
2804,Age when last used oral contraceptive pill,100069,Female-specific factors,"220,473","Integer, years",Females only,Jan 2012,"250,590",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
2814,Ever used hormone-replacement therapy (HRT),100069,Female-specific factors,"272,918",Categorical (single),Females only,Jan 2012,"309,268",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
3536,Age started hormone-replacement therapy (HRT),100069,Female-specific factors,"105,766","Integer, years",Females only,Jan 2012,"117,809",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
3546,Age last used hormone-replacement therapy (HRT),100069,Female-specific factors,"105,766","Integer, years",Females only,Jan 2012,"117,809",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
3591,Ever had hysterectomy (womb removed),100069,Female-specific factors,"242,678",Categorical (single),Females only,Jan 2012,"274,349",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
2824,Age at hysterectomy,100069,Female-specific factors,"51,876","Integer, years",Females only,Jan 2012,"57,663",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
2834,Bilateral oophorectomy (both ovaries removed),100069,Female-specific factors,"272,918",Categorical (single),Females only,Jan 2012,"309,268",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
3882,Age at bilateral oophorectomy (both ovaries removed),100069,Female-specific factors,"22,507","Integer, years",Females only,Jan 2012,"24,980",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Female-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
20242,Fluid intelligence completion status,118,Fluid intelligence / reasoning,"123,621",Categorical (single),Both sexes,Jul 2015,"123,621",Data,Singular,Jul 2015,Complete,Online follow-up,Cognitive function online,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20135,When fluid intelligence test completed,118,Fluid intelligence / reasoning,"123,621",Time,Both sexes,Jul 2015,"123,621",Data,Singular,Jul 2015,Complete,Online follow-up,Cognitive function online,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20191,Fluid intelligence score,118,Fluid intelligence / reasoning,"123,621","Integer, correct-answers",Both sexes,Mar 2012,"123,621",Data,Defined (1),Jan 2020,Complete,Online follow-up,Cognitive function online,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20192,Number of fluid intelligence questions attempted within time limit,118,Fluid intelligence / reasoning,"123,621","Integer, questions",Both sexes,Jul 2015,"123,621",Data,Singular,Jan 2020,Complete,Online follow-up,Cognitive function online,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20165,FI1 : numeric addition test,118,Fluid intelligence / reasoning,"123,159",Categorical (single),Both sexes,Jan 2012,"123,159",Data,Defined (1),Jul 2015,Complete,Online follow-up,Cognitive function online,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20167,FI2 : identify largest number,118,Fluid intelligence / reasoning,"123,183",Categorical (single),Both sexes,Jan 2012,"123,183",Data,Defined (1),Jul 2015,Complete,Online follow-up,Cognitive function online,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20169,FI3 : word interpolation,118,Fluid intelligence / reasoning,"123,149",Categorical (single),Both sexes,Jan 2012,"123,149",Data,Defined (1),Jul 2015,Complete,Online follow-up,Cognitive function online,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20171,FI4 : positional arithmetic,118,Fluid intelligence / reasoning,"122,509",Categorical (single),Both sexes,Jan 2012,"122,509",Data,Defined (1),Jul 2015,Complete,Online follow-up,Cognitive function online,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20173,FI5 : family relationship calculation,118,Fluid intelligence / reasoning,"119,916",Categorical (single),Both sexes,Jan 2012,"119,916",Data,Defined (1),Jul 2015,Complete,Online follow-up,Cognitive function online,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20175,FI6 : conditional arithmetic,118,Fluid intelligence / reasoning,"107,549",Categorical (single),Both sexes,Jan 2012,"107,549",Data,Defined (1),Jul 2015,Complete,Online follow-up,Cognitive function online,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20177,FI7 : synonym,118,Fluid intelligence / reasoning,"87,420",Categorical (single),Both sexes,Jan 2012,"87,420",Data,Defined (1),Jul 2015,Complete,Online follow-up,Cognitive function online,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20179,FI8 : chained arithmetic,118,Fluid intelligence / reasoning,"79,520",Categorical (single),Both sexes,Jan 2012,"79,520",Data,Defined (1),Jul 2015,Complete,Online follow-up,Cognitive function online,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20181,FI9 : concept interpolation,118,Fluid intelligence / reasoning,"32,426",Categorical (single),Both sexes,Jan 2012,"32,426",Data,Defined (1),Jul 2015,Complete,Online follow-up,Cognitive function online,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20183,FI10 : arithmetic sequence recognition,118,Fluid intelligence / reasoning,"21,571",Categorical (single),Both sexes,Jan 2012,"21,571",Data,Defined (1),Jul 2015,Complete,Online follow-up,Cognitive function online,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20185,FI11 : antonym,118,Fluid intelligence / reasoning,"10,008",Categorical (single),Both sexes,Jan 2012,"10,008",Data,Defined (1),Jul 2015,Complete,Online follow-up,Cognitive function online,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20187,FI12 : square sequence recognition,118,Fluid intelligence / reasoning,"6,424",Categorical (single),Both sexes,Jan 2012,"6,424",Data,Defined (1),Jul 2015,Complete,Online follow-up,Cognitive function online,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20189,FI13 : subset inclusion logic,118,Fluid intelligence / reasoning,"1,444",Categorical (single),Both sexes,Jan 2012,"1,444",Data,Defined (1),Jul 2015,Complete,Online follow-up,Cognitive function online,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20193,FI14 : alphanumeric substitution,118,Fluid intelligence / reasoning,525,Categorical (single),Both sexes,Jul 2015,525,Data,Singular,Jul 2015,Complete,Online follow-up,Cognitive function online,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20016,Fluid intelligence score,100027,Fluid intelligence / reasoning,"204,713","Integer, correct-answers",Both sexes,Mar 2012,"232,255",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20128,Number of fluid intelligence questions attempted within time limit,100027,Fluid intelligence / reasoning,"204,713","Integer, questions",Both sexes,Jul 2015,"232,255",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4924,Attempted fluid intelligence (FI) test.,100027,Fluid intelligence / reasoning,"207,945",Categorical (single),Both sexes,Jan 2012,"235,832",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4935,FI1 : numeric addition test,100027,Fluid intelligence / reasoning,"204,713",Categorical (single),Both sexes,Jan 2012,"232,255",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4946,FI2 : identify largest number,100027,Fluid intelligence / reasoning,"204,263",Categorical (single),Both sexes,Jan 2012,"231,756",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4957,FI3 : word interpolation,100027,Fluid intelligence / reasoning,"204,143",Categorical (single),Both sexes,Jan 2012,"231,615",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4968,FI4 : positional arithmetic,100027,Fluid intelligence / reasoning,"203,762",Categorical (single),Both sexes,Jan 2012,"231,200",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4979,FI5 : family relationship calculation,100027,Fluid intelligence / reasoning,"198,668",Categorical (single),Both sexes,Jan 2012,"225,642",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4990,FI6 : conditional arithmetic,100027,Fluid intelligence / reasoning,"178,863",Categorical (single),Both sexes,Jan 2012,"202,822",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
5001,FI7 : synonym,100027,Fluid intelligence / reasoning,"146,798",Categorical (single),Both sexes,Jan 2012,"165,969",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
5012,FI8 : chained arithmetic,100027,Fluid intelligence / reasoning,"133,705",Categorical (single),Both sexes,Jan 2012,"150,938",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
5556,FI9 : concept interpolation,100027,Fluid intelligence / reasoning,"63,783",Categorical (single),Both sexes,Jan 2012,"70,330",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
5699,FI10 : arithmetic sequence recognition,100027,Fluid intelligence / reasoning,"44,527",Categorical (single),Both sexes,Jan 2012,"48,690",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
5779,FI11 : antonym,100027,Fluid intelligence / reasoning,"23,532",Categorical (single),Both sexes,Jan 2012,"25,473",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
5790,FI12 : square sequence recognition,100027,Fluid intelligence / reasoning,"16,610",Categorical (single),Both sexes,Jan 2012,"17,871",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
5866,FI13 : subset inclusion logic,100027,Fluid intelligence / reasoning,"6,035",Categorical (single),Both sexes,Jan 2012,"6,312",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Fluid intelligence / reasoning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20599,Order of asking questions,1039,Food (and other) preferences,"182,220",Compound,Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20600,Liking for adding salt to foods,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20601,Liking for aniseed,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20602,Liking for apple juice,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20603,Liking for apples,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20604,Liking for asparagus,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20605,Liking for aubergine,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20606,Liking for avocados,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20607,Liking for bacon,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20608,Liking for baked/steamed fish,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20609,Liking for bananas,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20610,Liking for barbequed or grilled meat,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20611,Liking for beef steak,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20612,Liking for beetroot,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20613,Liking for bell pepper,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20614,Liking for bicycling,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20615,Liking for biscuits,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20616,Liking for bitter foods,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20617,Liking for bitter/ale,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20618,Liking for black olives,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20619,Liking for black pepper,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20620,Liking for blue cheese,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20621,Liking for bolognese sauce,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20622,Liking for broad beans,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20623,Liking for broccoli,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20624,Liking for brown rice,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20625,Liking for brussel sprouts,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20626,Liking for burgers (meat),1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20627,Liking for burn of spicy foods,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20628,Liking for butter on bread,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20629,Liking for butternut squash,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20630,Liking for cabbage,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20631,Liking for cake,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20632,Liking for cake icing,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20633,Liking for capers,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20634,Liking for cauliflower,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20635,Liking for cereal/granola bar,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20636,Liking for cheesecake,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20637,Liking for cherries,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20638,Liking for chicken,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20639,Liking for chilli pepper,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20640,Liking for chips/french fries,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20641,Liking for cigarette smoking,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20642,Liking for cod,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20643,Liking for coffee with sugar,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20644,Liking for coffee without sugar ,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20645,Liking for coriander,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20646,Liking for corn flakes,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20647,Liking for cream,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20648,Liking for croissant,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20649,Liking for cucumber,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20650,Liking for curry,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20651,Liking for dairy products,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20652,Liking for dark chocolate,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20653,Liking for diet fizzy drinks,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20654,Liking for dried fruit,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20655,Liking for eggs,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20656,Liking for exercising alone,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20657,Liking for exercising with others,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20658,Liking for extra virgin olive oil,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20659,Liking for fatty foods,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20660,Liking for fresh tomatoes,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20661,Liking for fried chicken,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20662,Liking for fried/battered fish,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20663,Liking for fruit,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20664,Liking for garlic,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20665,Liking for gherkins,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20666,Liking for globe artichoke,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20667,Liking for goat's cheese,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20668,Liking for going to a cafe,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20669,Liking for going to the gym,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20670,Liking for going to the pub,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20671,Liking for grapefruit,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20672,Liking for green olives,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20673,Liking for haddock,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20674,Liking for ham,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20675,Liking for hard cheese,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20676,Liking for herring,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20677,Liking for honey,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20678,Liking for horseradish/wasabi,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20679,Liking for ice cream,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20680,Liking for jam,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20681,Liking for kiwi fruit,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20682,Liking for lager,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20683,Liking for lamb,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20684,Liking for lemons,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20685,Liking for lentils/beans,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20686,Liking for liver,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20687,Liking for mackerel,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20688,Liking for marzipan,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20689,Liking for mayonnaise,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20690,Liking for melon,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20691,Liking for milk chocolate,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20692,Liking for mushrooms,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20693,Liking for onions,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20694,Liking for orange juice,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20695,Liking for oranges,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20696,Liking for pasta,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20697,Liking for pears,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20698,Liking for pizza,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20699,Liking for plain yogurt,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20700,Liking for plums,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20701,Liking for pollock,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20702,Liking for pork chop,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20703,Liking for porridge,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20704,Liking for potato crisps,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20705,Liking for potatoes,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20706,Liking for prawns,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20707,Liking for raw carrots,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20708,Liking for red meat,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20709,Liking for red wine,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20710,Liking for regular (non-diet) fizzy drinks,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20711,Liking for roast chicken,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20712,Liking for salad dressing,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20713,Liking for salad leaves,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20714,Liking for salami,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20715,Liking for salmon,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20716,Liking for salty foods,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20717,Liking for salty pretzels,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20718,Liking for sardines,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20719,Liking for sausages (meat),1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20720,Liking for savoury biscuits,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20721,Liking for shellfish (other than prawns),1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20722,Liking for skimmed milk,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20723,Liking for smoked fish,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20724,Liking for soft cheese,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20725,Liking for soy sauce,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20726,Liking for soya milk,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20727,Liking for spicy foods,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20728,Liking for spinach,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20729,Liking for spirits,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20730,Liking for strawberries,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20731,Liking for sweet coffee house drinks,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20732,Liking for sweet foods,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20733,Liking for taking the stairs,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20734,Liking for tea with sugar,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20735,Liking for tea without sugar,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20737,Liking for tinned tuna,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20736,Liking for tomato ketchup,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20738,Liking for turnip (white),1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20739,Liking for vegetables,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20740,Liking for vinegar,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20741,Liking for watching television,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20742,Liking for whisky,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20743,Liking for white bread,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20744,Liking for white rice,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20745,Liking for white wine,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20746,Liking for whole grain breakfast cereal,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20747,Liking for whole milk,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20748,Liking for wholemeal bread,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20749,Liking for working up a sweat,1039,Food (and other) preferences,"182,220",Categorical (single),Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20750,When food preferences questionnaire completed,1039,Food (and other) preferences,"182,220",Time,Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20751,Duration of questionnaire,1039,Food (and other) preferences,"182,220","Integer, minutes",Both sexes,Jan 2020,"182,220",Data,Singular,Jan 2020,Accruing,Online follow-up,Food (and other) preferences,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26501,Mean intensity of 3rd-Ventricle (whole brain),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26502,Mean intensity of 4th-Ventricle (whole brain),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26503,Mean intensity of 5th-Ventricle (whole brain),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26548,Mean intensity of Accumbens-area (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26579,Mean intensity of Accumbens-area (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26547,Mean intensity of Amygdala (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26578,Mean intensity of Amygdala (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26504,Mean intensity of Brain-Stem (whole brain),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26513,Mean intensity of CC-Anterior (whole brain),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26511,Mean intensity of CC-Central (whole brain),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26512,Mean intensity of CC-Mid-Anterior (whole brain),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26510,Mean intensity of CC-Mid-Posterior (whole brain),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26509,Mean intensity of CC-Posterior (whole brain),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26505,Mean intensity of CSF (whole brain),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26543,Mean intensity of Caudate (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26574,Mean intensity of Caudate (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26541,Mean intensity of Cerebellum-Cortex (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26572,Mean intensity of Cerebellum-Cortex (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26540,Mean intensity of Cerebellum-White-Matter (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26571,Mean intensity of Cerebellum-White-Matter (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26546,Mean intensity of Hippocampus (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26577,Mean intensity of Hippocampus (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26539,Mean intensity of Inf-Lat-Vent (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26570,Mean intensity of Inf-Lat-Vent (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26538,Mean intensity of Lateral-Ventricle (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26569,Mean intensity of Lateral-Ventricle (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26508,Mean intensity of Optic-Chiasm (whole brain),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26545,Mean intensity of Pallidum (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26576,Mean intensity of Pallidum (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26544,Mean intensity of Putamen (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26575,Mean intensity of Putamen (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26542,Mean intensity of Thalamus-Proper (left hemisphere),190,Freesurfer ASEG,"40,097","Continuous, AU",Both sexes,Apr 2019,"41,469",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26573,Mean intensity of Thalamus-Proper (right hemisphere),190,Freesurfer ASEG,"40,097","Continuous, AU",Both sexes,Apr 2019,"41,469",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26549,Mean intensity of VentralDC (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26580,Mean intensity of VentralDC (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26506,Mean intensity of WM-hypointensities (whole brain),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26551,Mean intensity of choroid-plexus (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26582,Mean intensity of choroid-plexus (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26507,Mean intensity of non-WM-hypointensities (whole brain),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26550,Mean intensity of vessel (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26581,Mean intensity of vessel (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26568,Number of HolesBeforeFixing (left hemisphere),190,Freesurfer ASEG,"40,098","Integer, count",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26599,Number of HolesBeforeFixing (right hemisphere),190,Freesurfer ASEG,"40,098","Integer, count",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26523,Volume of 3rd-Ventricle (whole brain),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26524,Volume of 4th-Ventricle (whole brain),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26525,Volume of 5th-Ventricle (whole brain),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26564,Volume of Accumbens-area (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26595,Volume of Accumbens-area (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26563,Volume of Amygdala (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26594,Volume of Amygdala (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26526,Volume of Brain-Stem (whole brain),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26514,Volume of BrainSeg (whole brain),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26515,Volume of BrainSegNotVent (whole brain),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26516,Volume of BrainSegNotVentSurf (whole brain),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26535,Volume of CC-Anterior (whole brain),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26533,Volume of CC-Central (whole brain),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26534,Volume of CC-Mid-Anterior (whole brain),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26532,Volume of CC-Mid-Posterior (whole brain),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26531,Volume of CC-Posterior (whole brain),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26527,Volume of CSF (whole brain),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26559,Volume of Caudate (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26590,Volume of Caudate (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26557,Volume of Cerebellum-Cortex (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26588,Volume of Cerebellum-Cortex (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26556,Volume of Cerebellum-White-Matter (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26587,Volume of Cerebellum-White-Matter (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26553,Volume of CerebralWhiteMatter (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26584,Volume of CerebralWhiteMatter (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26552,Volume of Cortex (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26583,Volume of Cortex (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26521,Volume of EstimatedTotalIntraCranial (whole brain),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26562,Volume of Hippocampus (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26593,Volume of Hippocampus (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26555,Volume of Inf-Lat-Vent (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26586,Volume of Inf-Lat-Vent (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26554,Volume of Lateral-Ventricle (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26585,Volume of Lateral-Ventricle (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26530,Volume of Optic-Chiasm (whole brain),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26561,Volume of Pallidum (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26592,Volume of Pallidum (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26560,Volume of Putamen (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26591,Volume of Putamen (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26517,Volume of SubCortGray (whole brain),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26519,Volume of SupraTentorial (whole brain),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26520,Volume of SupraTentorialNotVent (whole brain),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26558,Volume of Thalamus-Proper (left hemisphere),190,Freesurfer ASEG,"40,097","Continuous, mm3",Both sexes,Apr 2019,"41,469",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26589,Volume of Thalamus-Proper (right hemisphere),190,Freesurfer ASEG,"40,097","Continuous, mm3",Both sexes,Apr 2019,"41,469",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26518,Volume of TotalGray (whole brain),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26565,Volume of VentralDC (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26596,Volume of VentralDC (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26522,Volume of VentricleChoroid (whole brain),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26528,Volume of WM-hypointensities (whole brain),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26567,Volume of choroid-plexus (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26598,Volume of choroid-plexus (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26529,Volume of non-WM-hypointensities (whole brain),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26566,Volume of vessel (left hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26597,Volume of vessel (right hemisphere),190,Freesurfer ASEG,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26536,Volume-ratio of BrainSegVol-to-eTIV (whole brain),190,Freesurfer ASEG,"40,098","Continuous, ratio",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
26537,Volume-ratio of MaskVol-to-eTIV (whole brain),190,Freesurfer ASEG,"40,098","Continuous, ratio",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer ASEG,0.0,0.0,0.0,0.0,0.0
27059,Area of BA1 (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27101,Area of BA1 (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27060,Area of BA2 (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27102,Area of BA2 (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27061,Area of BA3a (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27103,Area of BA3a (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27062,Area of BA3b (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27104,Area of BA3b (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27066,Area of BA44 (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27108,Area of BA44 (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27067,Area of BA45 (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27109,Area of BA45 (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27063,Area of BA4a (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27105,Area of BA4a (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27064,Area of BA4p (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27106,Area of BA4p (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27065,Area of BA6 (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27107,Area of BA6 (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27070,Area of MT (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27112,Area of MT (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27068,Area of V1 (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27110,Area of V1 (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27069,Area of V2 (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27111,Area of V2 (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27072,Area of entorhinal (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27114,Area of entorhinal (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27071,Area of perirhinal (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27113,Area of perirhinal (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27073,Mean thickness of BA1 (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27115,Mean thickness of BA1 (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27074,Mean thickness of BA2 (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27116,Mean thickness of BA2 (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27075,Mean thickness of BA3a (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27117,Mean thickness of BA3a (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27076,Mean thickness of BA3b (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27118,Mean thickness of BA3b (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27080,Mean thickness of BA44 (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27122,Mean thickness of BA44 (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27081,Mean thickness of BA45 (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27123,Mean thickness of BA45 (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27077,Mean thickness of BA4a (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27119,Mean thickness of BA4a (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27078,Mean thickness of BA4p (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27120,Mean thickness of BA4p (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27079,Mean thickness of BA6 (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27121,Mean thickness of BA6 (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27084,Mean thickness of MT (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27126,Mean thickness of MT (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27082,Mean thickness of V1 (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27124,Mean thickness of V1 (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27083,Mean thickness of V2 (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27125,Mean thickness of V2 (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27086,Mean thickness of entorhinal (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27128,Mean thickness of entorhinal (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27085,Mean thickness of perirhinal (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27127,Mean thickness of perirhinal (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27087,Volume of BA1 (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27129,Volume of BA1 (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27088,Volume of BA2 (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27130,Volume of BA2 (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27089,Volume of BA3a (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27131,Volume of BA3a (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27090,Volume of BA3b (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27132,Volume of BA3b (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27094,Volume of BA44 (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27136,Volume of BA44 (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27095,Volume of BA45 (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27137,Volume of BA45 (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27091,Volume of BA4a (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27133,Volume of BA4a (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27092,Volume of BA4p (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27134,Volume of BA4p (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27093,Volume of BA6 (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27135,Volume of BA6 (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27098,Volume of MT (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27140,Volume of MT (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27096,Volume of V1 (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27138,Volume of V1 (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27097,Volume of V2 (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27139,Volume of V2 (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27100,Volume of entorhinal (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27142,Volume of entorhinal (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27099,Volume of perirhinal (left hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27141,Volume of perirhinal (right hemisphere),195,Freesurfer BA exvivo,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer BA exvivo,0.0,0.0,0.0,0.0,0.0
27143,Area of caudalanteriorcingulate (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27236,Area of caudalanteriorcingulate (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27144,Area of caudalmiddlefrontal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27237,Area of caudalmiddlefrontal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27145,Area of cuneus (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27238,Area of cuneus (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27146,Area of entorhinal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27239,Area of entorhinal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27147,Area of fusiform (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27240,Area of fusiform (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27148,Area of inferiorparietal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27241,Area of inferiorparietal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27149,Area of inferiortemporal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27242,Area of inferiortemporal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27173,Area of insula (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27266,Area of insula (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27150,Area of isthmuscingulate (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27243,Area of isthmuscingulate (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27151,Area of lateraloccipital (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27244,Area of lateraloccipital (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27152,Area of lateralorbitofrontal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27245,Area of lateralorbitofrontal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27153,Area of lingual (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27246,Area of lingual (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27154,Area of medialorbitofrontal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27247,Area of medialorbitofrontal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27155,Area of middletemporal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27248,Area of middletemporal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27157,Area of paracentral (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27250,Area of paracentral (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27156,Area of parahippocampal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27249,Area of parahippocampal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27158,Area of parsopercularis (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27251,Area of parsopercularis (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27159,Area of parsorbitalis (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27252,Area of parsorbitalis (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27160,Area of parstriangularis (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27253,Area of parstriangularis (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27161,Area of pericalcarine (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27254,Area of pericalcarine (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27162,Area of postcentral (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27255,Area of postcentral (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27163,Area of posteriorcingulate (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27256,Area of posteriorcingulate (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27164,Area of precentral (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27257,Area of precentral (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27165,Area of precuneus (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27258,Area of precuneus (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27166,Area of rostralanteriorcingulate (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27259,Area of rostralanteriorcingulate (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27167,Area of rostralmiddlefrontal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27260,Area of rostralmiddlefrontal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27168,Area of superiorfrontal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27261,Area of superiorfrontal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27169,Area of superiorparietal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27262,Area of superiorparietal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27170,Area of superiortemporal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27263,Area of superiortemporal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27171,Area of supramarginal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27264,Area of supramarginal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27172,Area of transversetemporal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27265,Area of transversetemporal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27174,Mean thickness of caudalanteriorcingulate (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27267,Mean thickness of caudalanteriorcingulate (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27175,Mean thickness of caudalmiddlefrontal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27268,Mean thickness of caudalmiddlefrontal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27176,Mean thickness of cuneus (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27269,Mean thickness of cuneus (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27177,Mean thickness of entorhinal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27270,Mean thickness of entorhinal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27178,Mean thickness of fusiform (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27271,Mean thickness of fusiform (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27179,Mean thickness of inferiorparietal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27272,Mean thickness of inferiorparietal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27180,Mean thickness of inferiortemporal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27273,Mean thickness of inferiortemporal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27204,Mean thickness of insula (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27297,Mean thickness of insula (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27181,Mean thickness of isthmuscingulate (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27274,Mean thickness of isthmuscingulate (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27182,Mean thickness of lateraloccipital (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27275,Mean thickness of lateraloccipital (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27183,Mean thickness of lateralorbitofrontal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27276,Mean thickness of lateralorbitofrontal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27184,Mean thickness of lingual (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27277,Mean thickness of lingual (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27185,Mean thickness of medialorbitofrontal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27278,Mean thickness of medialorbitofrontal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27186,Mean thickness of middletemporal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27279,Mean thickness of middletemporal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27188,Mean thickness of paracentral (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27281,Mean thickness of paracentral (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27187,Mean thickness of parahippocampal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27280,Mean thickness of parahippocampal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27189,Mean thickness of parsopercularis (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27282,Mean thickness of parsopercularis (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27190,Mean thickness of parsorbitalis (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27283,Mean thickness of parsorbitalis (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27191,Mean thickness of parstriangularis (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27284,Mean thickness of parstriangularis (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27192,Mean thickness of pericalcarine (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27285,Mean thickness of pericalcarine (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27193,Mean thickness of postcentral (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27286,Mean thickness of postcentral (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27194,Mean thickness of posteriorcingulate (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27287,Mean thickness of posteriorcingulate (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27195,Mean thickness of precentral (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27288,Mean thickness of precentral (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27196,Mean thickness of precuneus (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27289,Mean thickness of precuneus (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27197,Mean thickness of rostralanteriorcingulate (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27290,Mean thickness of rostralanteriorcingulate (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27198,Mean thickness of rostralmiddlefrontal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27291,Mean thickness of rostralmiddlefrontal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27199,Mean thickness of superiorfrontal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27292,Mean thickness of superiorfrontal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27200,Mean thickness of superiorparietal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27293,Mean thickness of superiorparietal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27201,Mean thickness of superiortemporal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27294,Mean thickness of superiortemporal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27202,Mean thickness of supramarginal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27295,Mean thickness of supramarginal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27203,Mean thickness of transversetemporal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27296,Mean thickness of transversetemporal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27205,Volume of caudalanteriorcingulate (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27298,Volume of caudalanteriorcingulate (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27206,Volume of caudalmiddlefrontal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27299,Volume of caudalmiddlefrontal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27207,Volume of cuneus (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27300,Volume of cuneus (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27208,Volume of entorhinal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27301,Volume of entorhinal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27209,Volume of fusiform (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27302,Volume of fusiform (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27210,Volume of inferiorparietal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27303,Volume of inferiorparietal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27211,Volume of inferiortemporal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27304,Volume of inferiortemporal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27235,Volume of insula (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27328,Volume of insula (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27212,Volume of isthmuscingulate (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27305,Volume of isthmuscingulate (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27213,Volume of lateraloccipital (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27306,Volume of lateraloccipital (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27214,Volume of lateralorbitofrontal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27307,Volume of lateralorbitofrontal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27215,Volume of lingual (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27308,Volume of lingual (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27216,Volume of medialorbitofrontal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27309,Volume of medialorbitofrontal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27217,Volume of middletemporal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27310,Volume of middletemporal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27219,Volume of paracentral (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27312,Volume of paracentral (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27218,Volume of parahippocampal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27311,Volume of parahippocampal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27220,Volume of parsopercularis (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27313,Volume of parsopercularis (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27221,Volume of parsorbitalis (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27314,Volume of parsorbitalis (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27222,Volume of parstriangularis (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27315,Volume of parstriangularis (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27223,Volume of pericalcarine (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27316,Volume of pericalcarine (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27224,Volume of postcentral (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27317,Volume of postcentral (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27225,Volume of posteriorcingulate (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27318,Volume of posteriorcingulate (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27226,Volume of precentral (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27319,Volume of precentral (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27227,Volume of precuneus (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27320,Volume of precuneus (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27228,Volume of rostralanteriorcingulate (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27321,Volume of rostralanteriorcingulate (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27229,Volume of rostralmiddlefrontal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27322,Volume of rostralmiddlefrontal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27230,Volume of superiorfrontal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27323,Volume of superiorfrontal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27231,Volume of superiorparietal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27324,Volume of superiorparietal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27232,Volume of superiortemporal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27325,Volume of superiortemporal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27233,Volume of supramarginal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27326,Volume of supramarginal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27234,Volume of transversetemporal (left hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27327,Volume of transversetemporal (right hemisphere),196,Freesurfer DKT,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer DKT,0.0,0.0,0.0,0.0,0.0
27334,Area of G+S-cingul-Ant (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27556,Area of G+S-cingul-Ant (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27335,Area of G+S-cingul-Mid-Ant (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27557,Area of G+S-cingul-Mid-Ant (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27336,Area of G+S-cingul-Mid-Post (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27558,Area of G+S-cingul-Mid-Post (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27329,Area of G+S-frontomargin (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27551,Area of G+S-frontomargin (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27330,Area of G+S-occipital-inf (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27552,Area of G+S-occipital-inf (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27331,Area of G+S-paracentral (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27553,Area of G+S-paracentral (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27332,Area of G+S-subcentral (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27554,Area of G+S-subcentral (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27333,Area of G+S-transv-frontopol (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27555,Area of G+S-transv-frontopol (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27345,Area of G-Ins-lg+S-cent-ins (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27567,Area of G-Ins-lg+S-cent-ins (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27337,Area of G-cingul-Post-dorsal (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27559,Area of G-cingul-Post-dorsal (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27338,Area of G-cingul-Post-ventral (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27560,Area of G-cingul-Post-ventral (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27339,Area of G-cuneus (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27561,Area of G-cuneus (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27340,Area of G-front-inf-Opercular (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27562,Area of G-front-inf-Opercular (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27341,Area of G-front-inf-Orbital (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27563,Area of G-front-inf-Orbital (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27342,Area of G-front-inf-Triangul (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27564,Area of G-front-inf-Triangul (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27343,Area of G-front-middle (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27565,Area of G-front-middle (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27344,Area of G-front-sup (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27566,Area of G-front-sup (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27346,Area of G-insular-short (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27568,Area of G-insular-short (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27349,Area of G-oc-temp-lat-fusifor (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27571,Area of G-oc-temp-lat-fusifor (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27350,Area of G-oc-temp-med-Lingual (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27572,Area of G-oc-temp-med-Lingual (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27351,Area of G-oc-temp-med-Parahip (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27573,Area of G-oc-temp-med-Parahip (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27347,Area of G-occipital-middle (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27569,Area of G-occipital-middle (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27348,Area of G-occipital-sup (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27570,Area of G-occipital-sup (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27352,Area of G-orbital (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27574,Area of G-orbital (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27353,Area of G-pariet-inf-Angular (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27575,Area of G-pariet-inf-Angular (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27354,Area of G-pariet-inf-Supramar (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27576,Area of G-pariet-inf-Supramar (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27355,Area of G-parietal-sup (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27577,Area of G-parietal-sup (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27356,Area of G-postcentral (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27578,Area of G-postcentral (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27357,Area of G-precentral (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27579,Area of G-precentral (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27358,Area of G-precuneus (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27580,Area of G-precuneus (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27359,Area of G-rectus (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27581,Area of G-rectus (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27360,Area of G-subcallosal (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27582,Area of G-subcallosal (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27361,Area of G-temp-sup-G-T-transv (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27583,Area of G-temp-sup-G-T-transv (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27362,Area of G-temp-sup-Lateral (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27584,Area of G-temp-sup-Lateral (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27363,Area of G-temp-sup-Plan-polar (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27585,Area of G-temp-sup-Plan-polar (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27364,Area of G-temp-sup-Plan-tempo (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27586,Area of G-temp-sup-Plan-tempo (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27365,Area of G-temporal-inf (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27587,Area of G-temporal-inf (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27366,Area of G-temporal-middle (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27588,Area of G-temporal-middle (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27367,Area of Lat-Fis-ant-Horizont (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27589,Area of Lat-Fis-ant-Horizont (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27368,Area of Lat-Fis-ant-Vertical (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27590,Area of Lat-Fis-ant-Vertical (right hemisphere),197,Freesurfer a2009s,"40,092","Continuous, mm2",Both sexes,Apr 2019,"41,463",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27369,Area of Lat-Fis-post (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27591,Area of Lat-Fis-post (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27370,Area of Pole-occipital (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27592,Area of Pole-occipital (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27371,Area of Pole-temporal (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27593,Area of Pole-temporal (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27372,Area of S-calcarine (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27594,Area of S-calcarine (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27373,Area of S-central (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27595,Area of S-central (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27374,Area of S-cingul-Marginalis (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27596,Area of S-cingul-Marginalis (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27375,Area of S-circular-insula-ant (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27597,Area of S-circular-insula-ant (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27376,Area of S-circular-insula-inf (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27598,Area of S-circular-insula-inf (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27377,Area of S-circular-insula-sup (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27599,Area of S-circular-insula-sup (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27378,Area of S-collat-transv-ant (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27600,Area of S-collat-transv-ant (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27379,Area of S-collat-transv-post (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27601,Area of S-collat-transv-post (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27380,Area of S-front-inf (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27602,Area of S-front-inf (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27381,Area of S-front-middle (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27603,Area of S-front-middle (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27382,Area of S-front-sup (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27604,Area of S-front-sup (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27383,Area of S-interm-prim-Jensen (left hemisphere),197,Freesurfer a2009s,"40,078","Continuous, mm2",Both sexes,Apr 2019,"41,449",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27605,Area of S-interm-prim-Jensen (right hemisphere),197,Freesurfer a2009s,"40,094","Continuous, mm2",Both sexes,Apr 2019,"41,466",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27384,Area of S-intrapariet+P-trans (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27606,Area of S-intrapariet+P-trans (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27385,Area of S-oc-middle+Lunatus (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27607,Area of S-oc-middle+Lunatus (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27386,Area of S-oc-sup+transversal (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27608,Area of S-oc-sup+transversal (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27388,Area of S-oc-temp-lat (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27610,Area of S-oc-temp-lat (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27389,Area of S-oc-temp-med+Lingual (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27611,Area of S-oc-temp-med+Lingual (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27387,Area of S-occipital-ant (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27609,Area of S-occipital-ant (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27392,Area of S-orbital-H-Shaped (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27614,Area of S-orbital-H-Shaped (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27390,Area of S-orbital-lateral (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27612,Area of S-orbital-lateral (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27391,Area of S-orbital-med-olfact (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27613,Area of S-orbital-med-olfact (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27393,Area of S-parieto-occipital (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27615,Area of S-parieto-occipital (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27394,Area of S-pericallosal (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27616,Area of S-pericallosal (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27395,Area of S-postcentral (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27617,Area of S-postcentral (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27396,Area of S-precentral-inf-part (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27618,Area of S-precentral-inf-part (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27397,Area of S-precentral-sup-part (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27619,Area of S-precentral-sup-part (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27398,Area of S-suborbital (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27620,Area of S-suborbital (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27399,Area of S-subparietal (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27621,Area of S-subparietal (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27400,Area of S-temporal-inf (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27622,Area of S-temporal-inf (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27401,Area of S-temporal-sup (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27623,Area of S-temporal-sup (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27402,Area of S-temporal-transverse (left hemisphere),197,Freesurfer a2009s,"40,095","Continuous, mm2",Both sexes,Apr 2019,"41,467",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27624,Area of S-temporal-transverse (right hemisphere),197,Freesurfer a2009s,"40,097","Continuous, mm2",Both sexes,Apr 2019,"41,469",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27408,Mean thickness of G+S-cingul-Ant (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27630,Mean thickness of G+S-cingul-Ant (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27409,Mean thickness of G+S-cingul-Mid-Ant (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27631,Mean thickness of G+S-cingul-Mid-Ant (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27410,Mean thickness of G+S-cingul-Mid-Post (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27632,Mean thickness of G+S-cingul-Mid-Post (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27403,Mean thickness of G+S-frontomargin (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27625,Mean thickness of G+S-frontomargin (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27404,Mean thickness of G+S-occipital-inf (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27626,Mean thickness of G+S-occipital-inf (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27405,Mean thickness of G+S-paracentral (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27627,Mean thickness of G+S-paracentral (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27406,Mean thickness of G+S-subcentral (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27628,Mean thickness of G+S-subcentral (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27407,Mean thickness of G+S-transv-frontopol (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27629,Mean thickness of G+S-transv-frontopol (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27419,Mean thickness of G-Ins-lg+S-cent-ins (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27641,Mean thickness of G-Ins-lg+S-cent-ins (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27411,Mean thickness of G-cingul-Post-dorsal (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27633,Mean thickness of G-cingul-Post-dorsal (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27412,Mean thickness of G-cingul-Post-ventral (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27634,Mean thickness of G-cingul-Post-ventral (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27413,Mean thickness of G-cuneus (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27635,Mean thickness of G-cuneus (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27414,Mean thickness of G-front-inf-Opercular (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27636,Mean thickness of G-front-inf-Opercular (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27415,Mean thickness of G-front-inf-Orbital (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27637,Mean thickness of G-front-inf-Orbital (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27416,Mean thickness of G-front-inf-Triangul (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27638,Mean thickness of G-front-inf-Triangul (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27417,Mean thickness of G-front-middle (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27639,Mean thickness of G-front-middle (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27418,Mean thickness of G-front-sup (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27640,Mean thickness of G-front-sup (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27420,Mean thickness of G-insular-short (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27642,Mean thickness of G-insular-short (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27423,Mean thickness of G-oc-temp-lat-fusifor (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27645,Mean thickness of G-oc-temp-lat-fusifor (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27424,Mean thickness of G-oc-temp-med-Lingual (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27646,Mean thickness of G-oc-temp-med-Lingual (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27425,Mean thickness of G-oc-temp-med-Parahip (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27647,Mean thickness of G-oc-temp-med-Parahip (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27421,Mean thickness of G-occipital-middle (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27643,Mean thickness of G-occipital-middle (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27422,Mean thickness of G-occipital-sup (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27644,Mean thickness of G-occipital-sup (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27426,Mean thickness of G-orbital (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27648,Mean thickness of G-orbital (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27427,Mean thickness of G-pariet-inf-Angular (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27649,Mean thickness of G-pariet-inf-Angular (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27428,Mean thickness of G-pariet-inf-Supramar (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27650,Mean thickness of G-pariet-inf-Supramar (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27429,Mean thickness of G-parietal-sup (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27651,Mean thickness of G-parietal-sup (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27430,Mean thickness of G-postcentral (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27652,Mean thickness of G-postcentral (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27431,Mean thickness of G-precentral (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27653,Mean thickness of G-precentral (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27432,Mean thickness of G-precuneus (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27654,Mean thickness of G-precuneus (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27433,Mean thickness of G-rectus (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27655,Mean thickness of G-rectus (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27434,Mean thickness of G-subcallosal (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27656,Mean thickness of G-subcallosal (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27435,Mean thickness of G-temp-sup-G-T-transv (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27657,Mean thickness of G-temp-sup-G-T-transv (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27436,Mean thickness of G-temp-sup-Lateral (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27658,Mean thickness of G-temp-sup-Lateral (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27437,Mean thickness of G-temp-sup-Plan-polar (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27659,Mean thickness of G-temp-sup-Plan-polar (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27438,Mean thickness of G-temp-sup-Plan-tempo (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27660,Mean thickness of G-temp-sup-Plan-tempo (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27439,Mean thickness of G-temporal-inf (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27661,Mean thickness of G-temporal-inf (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27440,Mean thickness of G-temporal-middle (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27662,Mean thickness of G-temporal-middle (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27441,Mean thickness of Lat-Fis-ant-Horizont (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27663,Mean thickness of Lat-Fis-ant-Horizont (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27442,Mean thickness of Lat-Fis-ant-Vertical (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27664,Mean thickness of Lat-Fis-ant-Vertical (right hemisphere),197,Freesurfer a2009s,"40,092","Continuous, mm",Both sexes,Apr 2019,"41,463",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27443,Mean thickness of Lat-Fis-post (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27665,Mean thickness of Lat-Fis-post (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27444,Mean thickness of Pole-occipital (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27666,Mean thickness of Pole-occipital (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27445,Mean thickness of Pole-temporal (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27667,Mean thickness of Pole-temporal (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27446,Mean thickness of S-calcarine (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27668,Mean thickness of S-calcarine (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27447,Mean thickness of S-central (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27669,Mean thickness of S-central (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27448,Mean thickness of S-cingul-Marginalis (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27670,Mean thickness of S-cingul-Marginalis (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27449,Mean thickness of S-circular-insula-ant (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27671,Mean thickness of S-circular-insula-ant (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27450,Mean thickness of S-circular-insula-inf (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27672,Mean thickness of S-circular-insula-inf (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27451,Mean thickness of S-circular-insula-sup (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27673,Mean thickness of S-circular-insula-sup (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27452,Mean thickness of S-collat-transv-ant (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27674,Mean thickness of S-collat-transv-ant (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27453,Mean thickness of S-collat-transv-post (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27675,Mean thickness of S-collat-transv-post (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27454,Mean thickness of S-front-inf (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27676,Mean thickness of S-front-inf (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27455,Mean thickness of S-front-middle (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27677,Mean thickness of S-front-middle (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27456,Mean thickness of S-front-sup (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27678,Mean thickness of S-front-sup (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27457,Mean thickness of S-interm-prim-Jensen (left hemisphere),197,Freesurfer a2009s,"40,078","Continuous, mm",Both sexes,Apr 2019,"41,449",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27679,Mean thickness of S-interm-prim-Jensen (right hemisphere),197,Freesurfer a2009s,"40,094","Continuous, mm",Both sexes,Apr 2019,"41,466",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27458,Mean thickness of S-intrapariet+P-trans (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27680,Mean thickness of S-intrapariet+P-trans (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27459,Mean thickness of S-oc-middle+Lunatus (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27681,Mean thickness of S-oc-middle+Lunatus (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27460,Mean thickness of S-oc-sup+transversal (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27682,Mean thickness of S-oc-sup+transversal (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27462,Mean thickness of S-oc-temp-lat (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27684,Mean thickness of S-oc-temp-lat (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27463,Mean thickness of S-oc-temp-med+Lingual (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27685,Mean thickness of S-oc-temp-med+Lingual (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27461,Mean thickness of S-occipital-ant (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27683,Mean thickness of S-occipital-ant (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27466,Mean thickness of S-orbital-H-Shaped (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27688,Mean thickness of S-orbital-H-Shaped (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27464,Mean thickness of S-orbital-lateral (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27686,Mean thickness of S-orbital-lateral (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27465,Mean thickness of S-orbital-med-olfact (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27687,Mean thickness of S-orbital-med-olfact (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27467,Mean thickness of S-parieto-occipital (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27689,Mean thickness of S-parieto-occipital (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27468,Mean thickness of S-pericallosal (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27690,Mean thickness of S-pericallosal (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27469,Mean thickness of S-postcentral (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27691,Mean thickness of S-postcentral (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27470,Mean thickness of S-precentral-inf-part (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27692,Mean thickness of S-precentral-inf-part (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27471,Mean thickness of S-precentral-sup-part (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27693,Mean thickness of S-precentral-sup-part (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27472,Mean thickness of S-suborbital (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27694,Mean thickness of S-suborbital (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27473,Mean thickness of S-subparietal (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27695,Mean thickness of S-subparietal (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27474,Mean thickness of S-temporal-inf (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27696,Mean thickness of S-temporal-inf (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27475,Mean thickness of S-temporal-sup (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27697,Mean thickness of S-temporal-sup (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27476,Mean thickness of S-temporal-transverse (left hemisphere),197,Freesurfer a2009s,"40,095","Continuous, mm",Both sexes,Apr 2019,"41,467",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27698,Mean thickness of S-temporal-transverse (right hemisphere),197,Freesurfer a2009s,"40,097","Continuous, mm",Both sexes,Apr 2019,"41,469",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27482,Volume of G+S-cingul-Ant (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27704,Volume of G+S-cingul-Ant (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27483,Volume of G+S-cingul-Mid-Ant (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27705,Volume of G+S-cingul-Mid-Ant (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27484,Volume of G+S-cingul-Mid-Post (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27706,Volume of G+S-cingul-Mid-Post (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27477,Volume of G+S-frontomargin (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27699,Volume of G+S-frontomargin (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27478,Volume of G+S-occipital-inf (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27700,Volume of G+S-occipital-inf (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27479,Volume of G+S-paracentral (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27701,Volume of G+S-paracentral (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27480,Volume of G+S-subcentral (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27702,Volume of G+S-subcentral (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27481,Volume of G+S-transv-frontopol (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27703,Volume of G+S-transv-frontopol (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27493,Volume of G-Ins-lg+S-cent-ins (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27715,Volume of G-Ins-lg+S-cent-ins (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27485,Volume of G-cingul-Post-dorsal (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27707,Volume of G-cingul-Post-dorsal (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27486,Volume of G-cingul-Post-ventral (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27708,Volume of G-cingul-Post-ventral (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27487,Volume of G-cuneus (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27709,Volume of G-cuneus (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27488,Volume of G-front-inf-Opercular (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27710,Volume of G-front-inf-Opercular (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27489,Volume of G-front-inf-Orbital (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27711,Volume of G-front-inf-Orbital (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27490,Volume of G-front-inf-Triangul (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27712,Volume of G-front-inf-Triangul (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27491,Volume of G-front-middle (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27713,Volume of G-front-middle (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27492,Volume of G-front-sup (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27714,Volume of G-front-sup (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27494,Volume of G-insular-short (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27716,Volume of G-insular-short (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27497,Volume of G-oc-temp-lat-fusifor (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27719,Volume of G-oc-temp-lat-fusifor (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27498,Volume of G-oc-temp-med-Lingual (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27720,Volume of G-oc-temp-med-Lingual (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27499,Volume of G-oc-temp-med-Parahip (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27721,Volume of G-oc-temp-med-Parahip (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27495,Volume of G-occipital-middle (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27717,Volume of G-occipital-middle (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27496,Volume of G-occipital-sup (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27718,Volume of G-occipital-sup (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27500,Volume of G-orbital (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27722,Volume of G-orbital (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27501,Volume of G-pariet-inf-Angular (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27723,Volume of G-pariet-inf-Angular (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27502,Volume of G-pariet-inf-Supramar (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27724,Volume of G-pariet-inf-Supramar (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27503,Volume of G-parietal-sup (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27725,Volume of G-parietal-sup (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27504,Volume of G-postcentral (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27726,Volume of G-postcentral (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27505,Volume of G-precentral (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27727,Volume of G-precentral (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27506,Volume of G-precuneus (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27728,Volume of G-precuneus (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27507,Volume of G-rectus (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27729,Volume of G-rectus (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27508,Volume of G-subcallosal (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27730,Volume of G-subcallosal (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27509,Volume of G-temp-sup-G-T-transv (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27731,Volume of G-temp-sup-G-T-transv (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27510,Volume of G-temp-sup-Lateral (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27732,Volume of G-temp-sup-Lateral (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27511,Volume of G-temp-sup-Plan-polar (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27733,Volume of G-temp-sup-Plan-polar (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27512,Volume of G-temp-sup-Plan-tempo (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27734,Volume of G-temp-sup-Plan-tempo (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27513,Volume of G-temporal-inf (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27735,Volume of G-temporal-inf (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27514,Volume of G-temporal-middle (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27736,Volume of G-temporal-middle (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27515,Volume of Lat-Fis-ant-Horizont (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27737,Volume of Lat-Fis-ant-Horizont (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27516,Volume of Lat-Fis-ant-Vertical (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27738,Volume of Lat-Fis-ant-Vertical (right hemisphere),197,Freesurfer a2009s,"40,092","Continuous, mm3",Both sexes,Apr 2019,"41,463",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27517,Volume of Lat-Fis-post (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27739,Volume of Lat-Fis-post (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27518,Volume of Pole-occipital (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27740,Volume of Pole-occipital (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27519,Volume of Pole-temporal (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27741,Volume of Pole-temporal (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27520,Volume of S-calcarine (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27742,Volume of S-calcarine (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27521,Volume of S-central (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27743,Volume of S-central (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27522,Volume of S-cingul-Marginalis (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27744,Volume of S-cingul-Marginalis (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27523,Volume of S-circular-insula-ant (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27745,Volume of S-circular-insula-ant (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27524,Volume of S-circular-insula-inf (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27746,Volume of S-circular-insula-inf (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27525,Volume of S-circular-insula-sup (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27747,Volume of S-circular-insula-sup (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27526,Volume of S-collat-transv-ant (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27748,Volume of S-collat-transv-ant (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27527,Volume of S-collat-transv-post (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27749,Volume of S-collat-transv-post (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27528,Volume of S-front-inf (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27750,Volume of S-front-inf (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27529,Volume of S-front-middle (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27751,Volume of S-front-middle (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27530,Volume of S-front-sup (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27752,Volume of S-front-sup (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27531,Volume of S-interm-prim-Jensen (left hemisphere),197,Freesurfer a2009s,"40,078","Continuous, mm3",Both sexes,Apr 2019,"41,449",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27753,Volume of S-interm-prim-Jensen (right hemisphere),197,Freesurfer a2009s,"40,094","Continuous, mm3",Both sexes,Apr 2019,"41,466",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27532,Volume of S-intrapariet+P-trans (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27754,Volume of S-intrapariet+P-trans (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27533,Volume of S-oc-middle+Lunatus (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27755,Volume of S-oc-middle+Lunatus (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27534,Volume of S-oc-sup+transversal (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27756,Volume of S-oc-sup+transversal (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27536,Volume of S-oc-temp-lat (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27758,Volume of S-oc-temp-lat (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27537,Volume of S-oc-temp-med+Lingual (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27759,Volume of S-oc-temp-med+Lingual (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27535,Volume of S-occipital-ant (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27757,Volume of S-occipital-ant (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27540,Volume of S-orbital-H-Shaped (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27762,Volume of S-orbital-H-Shaped (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27538,Volume of S-orbital-lateral (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27760,Volume of S-orbital-lateral (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27539,Volume of S-orbital-med-olfact (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27761,Volume of S-orbital-med-olfact (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27541,Volume of S-parieto-occipital (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27763,Volume of S-parieto-occipital (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27542,Volume of S-pericallosal (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27764,Volume of S-pericallosal (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27543,Volume of S-postcentral (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27765,Volume of S-postcentral (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27544,Volume of S-precentral-inf-part (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27766,Volume of S-precentral-inf-part (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27545,Volume of S-precentral-sup-part (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27767,Volume of S-precentral-sup-part (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27546,Volume of S-suborbital (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27768,Volume of S-suborbital (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27547,Volume of S-subparietal (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27769,Volume of S-subparietal (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27548,Volume of S-temporal-inf (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27770,Volume of S-temporal-inf (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27549,Volume of S-temporal-sup (left hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27771,Volume of S-temporal-sup (right hemisphere),197,Freesurfer a2009s,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27550,Volume of S-temporal-transverse (left hemisphere),197,Freesurfer a2009s,"40,095","Continuous, mm3",Both sexes,Apr 2019,"41,467",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
27772,Volume of S-temporal-transverse (right hemisphere),197,Freesurfer a2009s,"40,097","Continuous, mm3",Both sexes,Apr 2019,"41,469",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer a2009s,0.0,0.0,0.0,0.0,0.0
26990,Grey-white contrast in bankssts (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27025,Grey-white contrast in bankssts (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
26991,Grey-white contrast in caudalanteriorcingulate (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27026,Grey-white contrast in caudalanteriorcingulate (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
26992,Grey-white contrast in caudalmiddlefrontal (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27027,Grey-white contrast in caudalmiddlefrontal (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
26993,Grey-white contrast in cuneus (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27028,Grey-white contrast in cuneus (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
26994,Grey-white contrast in entorhinal (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27029,Grey-white contrast in entorhinal (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27020,Grey-white contrast in frontalpole (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27055,Grey-white contrast in frontalpole (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
26995,Grey-white contrast in fusiform (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27030,Grey-white contrast in fusiform (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
26996,Grey-white contrast in inferiorparietal (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27031,Grey-white contrast in inferiorparietal (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
26997,Grey-white contrast in inferiortemporal (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27032,Grey-white contrast in inferiortemporal (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27023,Grey-white contrast in insula (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27058,Grey-white contrast in insula (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
26998,Grey-white contrast in isthmuscingulate (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27033,Grey-white contrast in isthmuscingulate (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
26999,Grey-white contrast in lateraloccipital (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27034,Grey-white contrast in lateraloccipital (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27000,Grey-white contrast in lateralorbitofrontal (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27035,Grey-white contrast in lateralorbitofrontal (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27001,Grey-white contrast in lingual (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27036,Grey-white contrast in lingual (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27002,Grey-white contrast in medialorbitofrontal (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27037,Grey-white contrast in medialorbitofrontal (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27003,Grey-white contrast in middletemporal (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27038,Grey-white contrast in middletemporal (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27005,Grey-white contrast in paracentral (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27040,Grey-white contrast in paracentral (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27004,Grey-white contrast in parahippocampal (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27039,Grey-white contrast in parahippocampal (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27006,Grey-white contrast in parsopercularis (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27041,Grey-white contrast in parsopercularis (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27007,Grey-white contrast in parsorbitalis (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27042,Grey-white contrast in parsorbitalis (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27008,Grey-white contrast in parstriangularis (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27043,Grey-white contrast in parstriangularis (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27009,Grey-white contrast in pericalcarine (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27044,Grey-white contrast in pericalcarine (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27010,Grey-white contrast in postcentral (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27045,Grey-white contrast in postcentral (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27011,Grey-white contrast in posteriorcingulate (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27046,Grey-white contrast in posteriorcingulate (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27012,Grey-white contrast in precentral (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27047,Grey-white contrast in precentral (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27013,Grey-white contrast in precuneus (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27048,Grey-white contrast in precuneus (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27014,Grey-white contrast in rostralanteriorcingulate (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27049,Grey-white contrast in rostralanteriorcingulate (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27015,Grey-white contrast in rostralmiddlefrontal (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27050,Grey-white contrast in rostralmiddlefrontal (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27016,Grey-white contrast in superiorfrontal (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27051,Grey-white contrast in superiorfrontal (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27017,Grey-white contrast in superiorparietal (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27052,Grey-white contrast in superiorparietal (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27018,Grey-white contrast in superiortemporal (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27053,Grey-white contrast in superiortemporal (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27019,Grey-white contrast in supramarginal (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27054,Grey-white contrast in supramarginal (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27021,Grey-white contrast in temporalpole (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27056,Grey-white contrast in temporalpole (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27022,Grey-white contrast in transversetemporal (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27057,Grey-white contrast in transversetemporal (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
26989,Grey-white contrast in unknown (left hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
27024,Grey-white contrast in unknown (right hemisphere),194,Freesurfer desikan gw,"40,098","Continuous, AU",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan gw,0.0,0.0,0.0,0.0,0.0
26923,Area of TotalSurface (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26956,Area of TotalSurface (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26924,Area of bankssts (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26957,Area of bankssts (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26925,Area of caudalanteriorcingulate (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26958,Area of caudalanteriorcingulate (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26926,Area of caudalmiddlefrontal (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26959,Area of caudalmiddlefrontal (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26927,Area of cuneus (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26960,Area of cuneus (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26928,Area of entorhinal (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26961,Area of entorhinal (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26954,Area of frontalpole (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26987,Area of frontalpole (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26929,Area of fusiform (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26962,Area of fusiform (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26930,Area of inferiorparietal (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26963,Area of inferiorparietal (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26931,Area of inferiortemporal (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26964,Area of inferiortemporal (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26932,Area of isthmuscingulate (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26965,Area of isthmuscingulate (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26933,Area of lateraloccipital (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26966,Area of lateraloccipital (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26934,Area of lateralorbitofrontal (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26967,Area of lateralorbitofrontal (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26935,Area of lingual (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26968,Area of lingual (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26936,Area of medialorbitofrontal (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26969,Area of medialorbitofrontal (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26937,Area of middletemporal (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26970,Area of middletemporal (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26939,Area of paracentral (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26972,Area of paracentral (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26938,Area of parahippocampal (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26971,Area of parahippocampal (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26940,Area of parsopercularis (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26973,Area of parsopercularis (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26941,Area of parsorbitalis (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26974,Area of parsorbitalis (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26942,Area of parstriangularis (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26975,Area of parstriangularis (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26943,Area of pericalcarine (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26976,Area of pericalcarine (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26944,Area of postcentral (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26977,Area of postcentral (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26945,Area of posteriorcingulate (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26978,Area of posteriorcingulate (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26946,Area of precentral (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26979,Area of precentral (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26947,Area of precuneus (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26980,Area of precuneus (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26948,Area of rostralanteriorcingulate (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26981,Area of rostralanteriorcingulate (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26949,Area of rostralmiddlefrontal (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26982,Area of rostralmiddlefrontal (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26950,Area of superiorfrontal (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26983,Area of superiorfrontal (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26951,Area of superiorparietal (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26984,Area of superiorparietal (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26952,Area of superiortemporal (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26985,Area of superiortemporal (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26953,Area of supramarginal (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26986,Area of supramarginal (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26955,Area of transversetemporal (left hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26988,Area of transversetemporal (right hemisphere),193,Freesurfer desikan pial,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan pial,0.0,0.0,0.0,0.0,0.0
26721,Area of TotalSurface (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26822,Area of TotalSurface (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26722,Area of bankssts (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26823,Area of bankssts (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26723,Area of caudalanteriorcingulate (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26824,Area of caudalanteriorcingulate (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26724,Area of caudalmiddlefrontal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26825,Area of caudalmiddlefrontal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26725,Area of cuneus (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26826,Area of cuneus (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26726,Area of entorhinal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26827,Area of entorhinal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26752,Area of frontalpole (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26853,Area of frontalpole (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26727,Area of fusiform (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26828,Area of fusiform (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26728,Area of inferiorparietal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26829,Area of inferiorparietal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26729,Area of inferiortemporal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26830,Area of inferiortemporal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26754,Area of insula (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26855,Area of insula (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26730,Area of isthmuscingulate (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26831,Area of isthmuscingulate (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26731,Area of lateraloccipital (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26832,Area of lateraloccipital (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26732,Area of lateralorbitofrontal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26833,Area of lateralorbitofrontal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26733,Area of lingual (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26834,Area of lingual (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26734,Area of medialorbitofrontal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26835,Area of medialorbitofrontal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26735,Area of middletemporal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26836,Area of middletemporal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26737,Area of paracentral (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26838,Area of paracentral (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26736,Area of parahippocampal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26837,Area of parahippocampal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26738,Area of parsopercularis (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26839,Area of parsopercularis (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26739,Area of parsorbitalis (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26840,Area of parsorbitalis (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26740,Area of parstriangularis (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26841,Area of parstriangularis (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26741,Area of pericalcarine (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26842,Area of pericalcarine (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26742,Area of postcentral (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26843,Area of postcentral (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26743,Area of posteriorcingulate (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26844,Area of posteriorcingulate (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26744,Area of precentral (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26845,Area of precentral (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26745,Area of precuneus (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26846,Area of precuneus (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26746,Area of rostralanteriorcingulate (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26847,Area of rostralanteriorcingulate (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26747,Area of rostralmiddlefrontal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26848,Area of rostralmiddlefrontal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26748,Area of superiorfrontal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26849,Area of superiorfrontal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26749,Area of superiorparietal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26850,Area of superiorparietal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26750,Area of superiortemporal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26851,Area of superiortemporal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26751,Area of supramarginal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26852,Area of supramarginal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26753,Area of transversetemporal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26854,Area of transversetemporal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm2",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26755,Mean thickness of GlobalMeanMean thickness (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26856,Mean thickness of GlobalMeanMean thickness (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26756,Mean thickness of bankssts (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26857,Mean thickness of bankssts (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26757,Mean thickness of caudalanteriorcingulate (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26858,Mean thickness of caudalanteriorcingulate (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26758,Mean thickness of caudalmiddlefrontal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26859,Mean thickness of caudalmiddlefrontal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26759,Mean thickness of cuneus (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26860,Mean thickness of cuneus (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26760,Mean thickness of entorhinal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26861,Mean thickness of entorhinal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26786,Mean thickness of frontalpole (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26887,Mean thickness of frontalpole (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26761,Mean thickness of fusiform (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26862,Mean thickness of fusiform (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26762,Mean thickness of inferiorparietal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26863,Mean thickness of inferiorparietal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26763,Mean thickness of inferiortemporal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26864,Mean thickness of inferiortemporal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26788,Mean thickness of insula (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26889,Mean thickness of insula (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26764,Mean thickness of isthmuscingulate (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26865,Mean thickness of isthmuscingulate (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26765,Mean thickness of lateraloccipital (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26866,Mean thickness of lateraloccipital (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26766,Mean thickness of lateralorbitofrontal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26867,Mean thickness of lateralorbitofrontal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26767,Mean thickness of lingual (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26868,Mean thickness of lingual (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26768,Mean thickness of medialorbitofrontal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26869,Mean thickness of medialorbitofrontal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26769,Mean thickness of middletemporal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26870,Mean thickness of middletemporal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26771,Mean thickness of paracentral (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26872,Mean thickness of paracentral (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26770,Mean thickness of parahippocampal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26871,Mean thickness of parahippocampal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26772,Mean thickness of parsopercularis (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26873,Mean thickness of parsopercularis (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26773,Mean thickness of parsorbitalis (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26874,Mean thickness of parsorbitalis (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26774,Mean thickness of parstriangularis (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26875,Mean thickness of parstriangularis (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26775,Mean thickness of pericalcarine (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26876,Mean thickness of pericalcarine (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26776,Mean thickness of postcentral (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26877,Mean thickness of postcentral (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26777,Mean thickness of posteriorcingulate (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26878,Mean thickness of posteriorcingulate (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26778,Mean thickness of precentral (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26879,Mean thickness of precentral (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26779,Mean thickness of precuneus (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26880,Mean thickness of precuneus (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26780,Mean thickness of rostralanteriorcingulate (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26881,Mean thickness of rostralanteriorcingulate (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26781,Mean thickness of rostralmiddlefrontal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26882,Mean thickness of rostralmiddlefrontal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26782,Mean thickness of superiorfrontal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26883,Mean thickness of superiorfrontal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26783,Mean thickness of superiorparietal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26884,Mean thickness of superiorparietal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26784,Mean thickness of superiortemporal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26885,Mean thickness of superiortemporal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26785,Mean thickness of supramarginal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26886,Mean thickness of supramarginal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26787,Mean thickness of transversetemporal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26888,Mean thickness of transversetemporal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26789,Volume of bankssts (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26890,Volume of bankssts (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26790,Volume of caudalanteriorcingulate (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26891,Volume of caudalanteriorcingulate (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26791,Volume of caudalmiddlefrontal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26892,Volume of caudalmiddlefrontal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26792,Volume of cuneus (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26893,Volume of cuneus (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26793,Volume of entorhinal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26894,Volume of entorhinal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26819,Volume of frontalpole (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26920,Volume of frontalpole (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26794,Volume of fusiform (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26895,Volume of fusiform (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26795,Volume of inferiorparietal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26896,Volume of inferiorparietal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26796,Volume of inferiortemporal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26897,Volume of inferiortemporal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26821,Volume of insula (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26922,Volume of insula (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26797,Volume of isthmuscingulate (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26898,Volume of isthmuscingulate (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26798,Volume of lateraloccipital (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26899,Volume of lateraloccipital (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26799,Volume of lateralorbitofrontal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26900,Volume of lateralorbitofrontal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26800,Volume of lingual (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26901,Volume of lingual (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26801,Volume of medialorbitofrontal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26902,Volume of medialorbitofrontal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26802,Volume of middletemporal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26903,Volume of middletemporal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26804,Volume of paracentral (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26905,Volume of paracentral (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26803,Volume of parahippocampal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26904,Volume of parahippocampal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26805,Volume of parsopercularis (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26906,Volume of parsopercularis (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26806,Volume of parsorbitalis (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26907,Volume of parsorbitalis (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26807,Volume of parstriangularis (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26908,Volume of parstriangularis (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26808,Volume of pericalcarine (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26909,Volume of pericalcarine (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26809,Volume of postcentral (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26910,Volume of postcentral (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26810,Volume of posteriorcingulate (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26911,Volume of posteriorcingulate (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26811,Volume of precentral (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26912,Volume of precentral (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26812,Volume of precuneus (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26913,Volume of precuneus (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26813,Volume of rostralanteriorcingulate (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26914,Volume of rostralanteriorcingulate (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26814,Volume of rostralmiddlefrontal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26915,Volume of rostralmiddlefrontal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26815,Volume of superiorfrontal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26916,Volume of superiorfrontal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26816,Volume of superiorparietal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26917,Volume of superiorparietal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26817,Volume of superiortemporal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26918,Volume of superiortemporal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26818,Volume of supramarginal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26919,Volume of supramarginal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26820,Volume of transversetemporal (left hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26921,Volume of transversetemporal (right hemisphere),192,Freesurfer desikan white,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer desikan white,0.0,0.0,0.0,0.0,0.0
26684,Volume of AV (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26710,Volume of AV (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26602,Volume of Accessory-Basal-nucleus (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26612,Volume of Accessory-Basal-nucleus (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26603,Volume of Anterior-amygdaloid-area-AAA (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26613,Volume of Anterior-amygdaloid-area-AAA (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26601,Volume of Basal-nucleus (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26611,Volume of Basal-nucleus (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26622,Volume of CA1-body (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26644,Volume of CA1-body (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26626,Volume of CA1-head (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26648,Volume of CA1-head (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26632,Volume of CA3-body (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26654,Volume of CA3-body (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26637,Volume of CA3-head (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26659,Volume of CA3-head (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26635,Volume of CA4-body (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26657,Volume of CA4-body (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26634,Volume of CA4-head (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26656,Volume of CA4-head (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26681,Volume of CL (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26706,Volume of CL (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26670,Volume of CM (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26694,Volume of CM (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26677,Volume of CeM (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26703,Volume of CeM (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26604,Volume of Central-nucleus (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26614,Volume of Central-nucleus (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26606,Volume of Cortical-nucleus (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26616,Volume of Cortical-nucleus (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26607,Volume of Corticoamygdaloid-transitio (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26617,Volume of Corticoamygdaloid-transitio (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26633,Volume of GC-ML-DG-body (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26655,Volume of GC-ML-DG-body (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26631,Volume of GC-ML-DG-head (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26653,Volume of GC-ML-DG-head (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26638,Volume of HATA (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26660,Volume of HATA (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26620,Volume of Hippocampal-tail (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26642,Volume of Hippocampal-tail (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26668,Volume of L-Sg (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26692,Volume of L-Sg (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26712,Volume of LD (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26713,Volume of LD (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26665,Volume of LGN (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26688,Volume of LGN (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26687,Volume of LP (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26711,Volume of LP (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26600,Volume of Lateral-nucleus (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26610,Volume of Lateral-nucleus (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26676,Volume of MDl (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26700,Volume of MDl (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26673,Volume of MDm (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26697,Volume of MDm (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26664,Volume of MGN (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26689,Volume of MGN (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26679,Volume of MV(Re) (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26702,Volume of MV(Re) (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26605,Volume of Medial-nucleus (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26615,Volume of Medial-nucleus (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26716,Volume of Medulla (whole brain),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26719,Volume of Midbrain (whole brain),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26608,Volume of Paralaminar-nucleus (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26618,Volume of Paralaminar-nucleus (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26685,Volume of Pc (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26708,Volume of Pc (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26674,Volume of Pf (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26698,Volume of Pf (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26717,Volume of Pons (whole brain),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26683,Volume of Pt (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26709,Volume of Pt (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26672,Volume of PuA (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26696,Volume of PuA (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26666,Volume of PuI (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26690,Volume of PuI (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26682,Volume of PuL (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26705,Volume of PuL (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26667,Volume of PuM (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26691,Volume of PuM (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26718,Volume of SCP (whole brain),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26678,Volume of VA (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26701,Volume of VA (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26675,Volume of VAmc (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26699,Volume of VAmc (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26671,Volume of VLa (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26695,Volume of VLa (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26686,Volume of VLp (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26707,Volume of VLp (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26680,Volume of VM (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26704,Volume of VM (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26669,Volume of VPL (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26693,Volume of VPL (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26609,Volume of Whole-amygdala (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26619,Volume of Whole-amygdala (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26720,Volume of Whole-brainstem (whole brain),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26639,Volume of Whole-hippocampal-body (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26661,Volume of Whole-hippocampal-body (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26640,Volume of Whole-hippocampal-head (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26662,Volume of Whole-hippocampal-head (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26641,Volume of Whole-hippocampus (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26663,Volume of Whole-hippocampus (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26714,Volume of Whole-thalamus (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26715,Volume of Whole-thalamus (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26636,Volume of fimbria (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26658,Volume of fimbria (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26624,Volume of hippocampal-fissure (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26646,Volume of hippocampal-fissure (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26630,Volume of molecular-layer-HP-body (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26652,Volume of molecular-layer-HP-body (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26629,Volume of molecular-layer-HP-head (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26651,Volume of molecular-layer-HP-head (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26628,Volume of parasubiculum (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26650,Volume of parasubiculum (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26627,Volume of presubiculum-body (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26649,Volume of presubiculum-body (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26625,Volume of presubiculum-head (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26647,Volume of presubiculum-head (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26621,Volume of subiculum-body (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26643,Volume of subiculum-body (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26623,Volume of subiculum-head (left hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
26645,Volume of subiculum-head (right hemisphere),191,Freesurfer subsegmentation,"40,098","Continuous, mm3",Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Freesurfer subsegmentation,0.0,0.0,0.0,0.0,0.0
103990,Vegetable consumers,100103,Fruit/vegetables yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104000,Baked bean intake,100103,Fruit/vegetables yesterday,"29,672",Categorical (single),Both sexes,Sep 2012,"33,531",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104010,Pulses intake,100103,Fruit/vegetables yesterday,"35,362",Categorical (single),Both sexes,Sep 2012,"41,756",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104020,Fried potatoes intake,100103,Fruit/vegetables yesterday,"67,187",Categorical (single),Both sexes,Sep 2012,"82,485",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104030,Boiled/baked potatoes intake,100103,Fruit/vegetables yesterday,"89,559",Categorical (single),Both sexes,Sep 2012,"119,113",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104040,Butter/margarine added to potatoes,100103,Fruit/vegetables yesterday,"16,701",Categorical (single),Both sexes,Sep 2012,"18,363",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104050,Mashed potato intake,100103,Fruit/vegetables yesterday,"41,122",Categorical (single),Both sexes,Sep 2012,"47,213",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104060,Mixed vegetable intake,100103,Fruit/vegetables yesterday,"34,403",Categorical (single),Both sexes,Sep 2012,"39,820",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104070,Vegetable pieces intake,100103,Fruit/vegetables yesterday,"48,138",Categorical (single),Both sexes,Sep 2012,"56,694",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104080,Coleslaw intake,100103,Fruit/vegetables yesterday,"23,152",Categorical (single),Both sexes,Sep 2012,"26,258",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104090,Side salad intake,100103,Fruit/vegetables yesterday,"79,096",Categorical (single),Both sexes,Sep 2012,"105,014",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104100,Avocado intake,100103,Fruit/vegetables yesterday,"13,476",Categorical (single),Both sexes,Sep 2012,"15,920",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104110,Broad bean intake,100103,Fruit/vegetables yesterday,"10,005",Categorical (single),Both sexes,Sep 2012,"10,657",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104120,Green bean intake,100103,Fruit/vegetables yesterday,"39,282",Categorical (single),Both sexes,Sep 2012,"45,977",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104130,Beetroot intake,100103,Fruit/vegetables yesterday,"25,929",Categorical (single),Both sexes,Sep 2012,"30,641",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104140,Broccoli intake,100103,Fruit/vegetables yesterday,"56,725",Categorical (single),Both sexes,Sep 2012,"71,349",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104150,Butternut squash intake,100103,Fruit/vegetables yesterday,"8,699",Categorical (single),Both sexes,Sep 2012,"9,462",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104160,Cabbage/kale intake,100103,Fruit/vegetables yesterday,"34,118",Categorical (single),Both sexes,Sep 2012,"39,561",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104170,Carrot intake,100103,Fruit/vegetables yesterday,"93,429",Categorical (single),Both sexes,Sep 2012,"128,853",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104180,Cauliflower intake,100103,Fruit/vegetables yesterday,"31,851",Categorical (single),Both sexes,Sep 2012,"37,060",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104190,Celery intake,100103,Fruit/vegetables yesterday,"28,586",Categorical (single),Both sexes,Sep 2012,"35,027",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104200,Courgette intake,100103,Fruit/vegetables yesterday,"22,736",Categorical (single),Both sexes,Sep 2012,"26,023",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104210,Cucumber intake,100103,Fruit/vegetables yesterday,"49,888",Categorical (single),Both sexes,Sep 2012,"63,122",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104220,Garlic intake,100103,Fruit/vegetables yesterday,"39,517",Categorical (single),Both sexes,Sep 2012,"50,634",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104230,Leek intake,100103,Fruit/vegetables yesterday,"19,304",Categorical (single),Both sexes,Sep 2012,"21,430",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104240,Lettuce intake,100103,Fruit/vegetables yesterday,"71,366",Categorical (single),Both sexes,Sep 2012,"92,851",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104250,Mushroom intake,100103,Fruit/vegetables yesterday,"51,549",Categorical (single),Both sexes,Sep 2012,"63,552",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104260,Onion intake,100103,Fruit/vegetables yesterday,"84,459",Categorical (single),Both sexes,Sep 2012,"115,142",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104270,Parsnip intake,100103,Fruit/vegetables yesterday,"16,063",Categorical (single),Both sexes,Sep 2012,"17,448",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104280,Pea intake,100103,Fruit/vegetables yesterday,"51,155",Categorical (single),Both sexes,Sep 2012,"61,190",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104290,Sweet pepper intake,100103,Fruit/vegetables yesterday,"58,217",Categorical (single),Both sexes,Sep 2012,"74,080",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104300,Spinach intake,100103,Fruit/vegetables yesterday,"20,046",Categorical (single),Both sexes,Sep 2012,"23,009",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104310,Sprouts intake,100103,Fruit/vegetables yesterday,"11,560",Categorical (single),Both sexes,Sep 2012,"12,305",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104320,Sweetcorn intake,100103,Fruit/vegetables yesterday,"19,467",Categorical (single),Both sexes,Sep 2012,"21,552",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104330,Sweet potato intake,100103,Fruit/vegetables yesterday,"8,640",Categorical (single),Both sexes,Sep 2012,"9,387",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104340,Fresh tomato intake,100103,Fruit/vegetables yesterday,"100,855",Categorical (single),Both sexes,Sep 2012,"146,157",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104350,Tinned tomato intake,100103,Fruit/vegetables yesterday,"38,217",Categorical (single),Both sexes,Sep 2012,"44,187",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104360,Turnip/swede intake,100103,Fruit/vegetables yesterday,"11,318",Categorical (single),Both sexes,Sep 2012,"12,237",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104370,Watercress intake,100103,Fruit/vegetables yesterday,"14,714",Categorical (single),Both sexes,Sep 2012,"17,239",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104380,Other vegetables intake,100103,Fruit/vegetables yesterday,"22,802",Categorical (single),Both sexes,Sep 2012,"26,104",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104400,Fruit consumers,100103,Fruit/vegetables yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104410,Stewed fruit intake,100103,Fruit/vegetables yesterday,"24,145",Categorical (single),Both sexes,Sep 2012,"29,348",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104420,Prune intake,100103,Fruit/vegetables yesterday,"13,294",Categorical (single),Both sexes,Sep 2012,"18,603",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104430,Dried fruit intake,100103,Fruit/vegetables yesterday,"36,091",Categorical (single),Both sexes,Sep 2012,"47,785",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104440,Mixed fruit intake,100103,Fruit/vegetables yesterday,"20,088",Categorical (single),Both sexes,Sep 2012,"23,443",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104450,Apple intake,100103,Fruit/vegetables yesterday,"98,718",Categorical (single),Both sexes,Sep 2012,"157,389",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104460,Banana intake,100103,Fruit/vegetables yesterday,"118,319",Categorical (single),Both sexes,Sep 2012,"197,629",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104470,Berry intake,100103,Fruit/vegetables yesterday,"58,724",Categorical (single),Both sexes,Sep 2012,"79,583",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104480,Cherry intake,100103,Fruit/vegetables yesterday,"11,335",Categorical (single),Both sexes,Sep 2012,"11,949",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104490,Grapefruit intake,100103,Fruit/vegetables yesterday,"10,471",Categorical (single),Both sexes,Sep 2012,"14,415",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104500,Grape intake,100103,Fruit/vegetables yesterday,"57,301",Categorical (single),Both sexes,Sep 2012,"79,296",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104510,Mango intake,100103,Fruit/vegetables yesterday,"9,202",Categorical (single),Both sexes,Sep 2012,"10,437",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104520,Melon intake,100103,Fruit/vegetables yesterday,"17,149",Categorical (single),Both sexes,Sep 2012,"19,825",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104530,Orange intake,100103,Fruit/vegetables yesterday,"38,792",Categorical (single),Both sexes,Sep 2012,"52,576",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104540,Satsuma intake,100103,Fruit/vegetables yesterday,"49,818",Categorical (single),Both sexes,Sep 2012,"67,200",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104550,Peach/nectarine intake,100103,Fruit/vegetables yesterday,"23,569",Categorical (single),Both sexes,Sep 2012,"25,875",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104560,Pear intake,100103,Fruit/vegetables yesterday,"38,405",Categorical (single),Both sexes,Sep 2012,"50,421",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104570,Pineapple intake,100103,Fruit/vegetables yesterday,"16,781",Categorical (single),Both sexes,Sep 2012,"19,421",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104580,Plum intake,100103,Fruit/vegetables yesterday,"20,397",Categorical (single),Both sexes,Sep 2012,"23,491",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104590,Other fruit intake,100103,Fruit/vegetables yesterday,"18,371",Categorical (single),Both sexes,Sep 2012,"21,908",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Fruit/vegetables yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
2178,Overall health rating,100042,General health,"501,605",Categorical (single),Both sexes,Jan 2012,"572,231",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,General health,0.0,0.0,0.0,0.0,0.0,0.0
2188,"Long-standing illness, disability or infirmity",100042,General health,"501,605",Categorical (single),Both sexes,Jan 2012,"572,231",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,General health,0.0,0.0,0.0,0.0,0.0,0.0
2296,Falls in the last year,100042,General health,"501,604",Categorical (single),Both sexes,Jan 2012,"572,230",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,General health,0.0,0.0,0.0,0.0,0.0,0.0
2306,Weight change compared with 1 year ago,100042,General health,"501,603",Categorical (single),Both sexes,Jan 2012,"572,229",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,General health,0.0,0.0,0.0,0.0,0.0,0.0
131998,Date N00 first reported (acute nephritic syndrome),2414,Genitourinary system disorders,278,Date,Both sexes,Jul 2019,278,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131999,Source of report of N00 (acute nephritic syndrome),2414,Genitourinary system disorders,278,Categorical (single),Both sexes,Jul 2019,278,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132000,Date N01 first reported (rapidly progressive nephritic syndrome),2414,Genitourinary system disorders,13,Date,Both sexes,Jul 2019,13,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132001,Source of report of N01 (rapidly progressive nephritic syndrome),2414,Genitourinary system disorders,13,Categorical (single),Both sexes,Jul 2019,13,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132002,Date N02 first reported (recurrent and persistent haematuria),2414,Genitourinary system disorders,"1,348",Date,Both sexes,Jul 2019,"1,348",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132003,Source of report of N02 (recurrent and persistent haematuria),2414,Genitourinary system disorders,"1,348",Categorical (single),Both sexes,Jul 2019,"1,348",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132004,Date N03 first reported (chronic nephritic syndrome),2414,Genitourinary system disorders,"1,248",Date,Both sexes,Jul 2019,"1,248",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132005,Source of report of N03 (chronic nephritic syndrome),2414,Genitourinary system disorders,"1,248",Categorical (single),Both sexes,Jul 2019,"1,248",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132006,Date N04 first reported (nephrotic syndrome),2414,Genitourinary system disorders,334,Date,Both sexes,Jul 2019,334,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132007,Source of report of N04 (nephrotic syndrome),2414,Genitourinary system disorders,334,Categorical (single),Both sexes,Jul 2019,334,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132008,Date N05 first reported (unspecified nephritic syndrome),2414,Genitourinary system disorders,694,Date,Both sexes,Jul 2019,694,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132009,Source of report of N05 (unspecified nephritic syndrome),2414,Genitourinary system disorders,694,Categorical (single),Both sexes,Jul 2019,694,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132010,Date N06 first reported (isolated proteinuria with specified morphological lesion),2414,Genitourinary system disorders,17,Date,Both sexes,Jul 2019,17,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132011,Source of report of N06 (isolated proteinuria with specified morphological lesion),2414,Genitourinary system disorders,17,Categorical (single),Both sexes,Jul 2019,17,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132012,"Date N07 first reported (hereditary nephropathy, not elsewhere classified)",2414,Genitourinary system disorders,12,Date,Both sexes,Jul 2019,12,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132013,"Source of report of N07 (hereditary nephropathy, not elsewhere classified)",2414,Genitourinary system disorders,12,Categorical (single),Both sexes,Jul 2019,12,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132014,Date N08 first reported (glomerular disorders in diseases classified elsewhere),2414,Genitourinary system disorders,766,Date,Both sexes,Jul 2019,766,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132015,Source of report of N08 (glomerular disorders in diseases classified elsewhere),2414,Genitourinary system disorders,766,Categorical (single),Both sexes,Jul 2019,766,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132016,Date N10 first reported (acute tubulo-interstitial nephritis),2414,Genitourinary system disorders,"1,466",Date,Both sexes,Jul 2019,"1,466",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132017,Source of report of N10 (acute tubulo-interstitial nephritis),2414,Genitourinary system disorders,"1,466",Categorical (single),Both sexes,Jul 2019,"1,466",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132018,Date N11 first reported (chronic tubulo-interstitial nephritis),2414,Genitourinary system disorders,289,Date,Both sexes,Jul 2019,289,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132019,Source of report of N11 (chronic tubulo-interstitial nephritis),2414,Genitourinary system disorders,289,Categorical (single),Both sexes,Jul 2019,289,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132020,"Date N12 first reported (tubulo-interstitial nephritis, not specified as acute or chronic)",2414,Genitourinary system disorders,"1,825",Date,Both sexes,Jul 2019,"1,825",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132021,"Source of report of N12 (tubulo-interstitial nephritis, not specified as acute or chronic)",2414,Genitourinary system disorders,"1,825",Categorical (single),Both sexes,Jul 2019,"1,825",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132022,Date N13 first reported (obstructive and reflux uropathy),2414,Genitourinary system disorders,"4,378",Date,Both sexes,Jul 2019,"4,378",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132023,Source of report of N13 (obstructive and reflux uropathy),2414,Genitourinary system disorders,"4,378",Categorical (single),Both sexes,Jul 2019,"4,378",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132024,Date N14 first reported (drug- and heavy-metal-induced tubulo-interstitial and tubular conditions),2414,Genitourinary system disorders,59,Date,Both sexes,Jul 2019,59,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132025,Source of report of N14 (drug- and heavy-metal-induced tubulo-interstitial and tubular conditions),2414,Genitourinary system disorders,59,Categorical (single),Both sexes,Jul 2019,59,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132026,Date N15 first reported (other renal tubulo-interstitial diseases),2414,Genitourinary system disorders,168,Date,Both sexes,Jul 2019,168,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132027,Source of report of N15 (other renal tubulo-interstitial diseases),2414,Genitourinary system disorders,168,Categorical (single),Both sexes,Jul 2019,168,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132028,Date N16 first reported (renal tubulo-interstitial disorders in diseases classified elsewhere),2414,Genitourinary system disorders,43,Date,Both sexes,Jul 2019,43,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132029,Source of report of N16 (renal tubulo-interstitial disorders in diseases classified elsewhere),2414,Genitourinary system disorders,43,Categorical (single),Both sexes,Jul 2019,43,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132030,Date N17 first reported (acute renal failure),2414,Genitourinary system disorders,"9,513",Date,Both sexes,Jul 2019,"9,513",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132031,Source of report of N17 (acute renal failure),2414,Genitourinary system disorders,"9,513",Categorical (single),Both sexes,Jul 2019,"9,513",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132032,Date N18 first reported (chronic renal failure),2414,Genitourinary system disorders,"17,999",Date,Both sexes,Jul 2019,"17,999",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132033,Source of report of N18 (chronic renal failure),2414,Genitourinary system disorders,"17,999",Categorical (single),Both sexes,Jul 2019,"17,999",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132034,Date N19 first reported (unspecified renal failure),2414,Genitourinary system disorders,"3,118",Date,Both sexes,Jul 2019,"3,118",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132035,Source of report of N19 (unspecified renal failure),2414,Genitourinary system disorders,"3,118",Categorical (single),Both sexes,Jul 2019,"3,118",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132036,Date N20 first reported (calculus of kidney and ureter),2414,Genitourinary system disorders,"7,566",Date,Both sexes,Jul 2019,"7,566",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132037,Source of report of N20 (calculus of kidney and ureter),2414,Genitourinary system disorders,"7,566",Categorical (single),Both sexes,Jul 2019,"7,566",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132038,Date N21 first reported (calculus of lower urinary tract),2414,Genitourinary system disorders,"1,189",Date,Both sexes,Jul 2019,"1,189",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132039,Source of report of N21 (calculus of lower urinary tract),2414,Genitourinary system disorders,"1,189",Categorical (single),Both sexes,Jul 2019,"1,189",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132040,Date N22 first reported (calculus of urinary tract in diseases classified elsewhere),2414,Genitourinary system disorders,1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132041,Source of report of N22 (calculus of urinary tract in diseases classified elsewhere),2414,Genitourinary system disorders,1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132042,Date N23 first reported (unspecified renal colic),2414,Genitourinary system disorders,"5,478",Date,Both sexes,Jul 2019,"5,478",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132043,Source of report of N23 (unspecified renal colic),2414,Genitourinary system disorders,"5,478",Categorical (single),Both sexes,Jul 2019,"5,478",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132044,Date N25 first reported (disorders resulting from impaired renal tubular function),2414,Genitourinary system disorders,212,Date,Both sexes,Jul 2019,212,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132045,Source of report of N25 (disorders resulting from impaired renal tubular function),2414,Genitourinary system disorders,212,Categorical (single),Both sexes,Jul 2019,212,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132046,Date N26 first reported (unspecified contracted kidney),2414,Genitourinary system disorders,246,Date,Both sexes,Jul 2019,246,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132047,Source of report of N26 (unspecified contracted kidney),2414,Genitourinary system disorders,246,Categorical (single),Both sexes,Jul 2019,246,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132048,Date N27 first reported (small kidney of unknown cause),2414,Genitourinary system disorders,120,Date,Both sexes,Jul 2019,120,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132049,Source of report of N27 (small kidney of unknown cause),2414,Genitourinary system disorders,120,Categorical (single),Both sexes,Jul 2019,120,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132050,"Date N28 first reported (other disorders of kidney and ureter, not elsewhere classified)",2414,Genitourinary system disorders,"6,720",Date,Both sexes,Jul 2019,"6,720",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132051,"Source of report of N28 (other disorders of kidney and ureter, not elsewhere classified)",2414,Genitourinary system disorders,"6,720",Categorical (single),Both sexes,Jul 2019,"6,720",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132052,Date N29 first reported (other disorders of kidney and ureter in diseases classified elsewhere),2414,Genitourinary system disorders,37,Date,Both sexes,Jul 2019,37,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132053,Source of report of N29 (other disorders of kidney and ureter in diseases classified elsewhere),2414,Genitourinary system disorders,37,Categorical (single),Both sexes,Jul 2019,37,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132054,Date N30 first reported (cystitis),2414,Genitourinary system disorders,"17,401",Date,Both sexes,Jul 2019,"17,401",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132055,Source of report of N30 (cystitis),2414,Genitourinary system disorders,"17,401",Categorical (single),Both sexes,Jul 2019,"17,401",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132056,"Date N31 first reported (neuromuscular dysfunction of bladder, not elsewhere classified)",2414,Genitourinary system disorders,"4,870",Date,Both sexes,Jul 2019,"4,870",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132057,"Source of report of N31 (neuromuscular dysfunction of bladder, not elsewhere classified)",2414,Genitourinary system disorders,"4,870",Categorical (single),Both sexes,Jul 2019,"4,870",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132058,Date N32 first reported (other disorders of bladder),2414,Genitourinary system disorders,"16,661",Date,Both sexes,Jul 2019,"16,661",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132059,Source of report of N32 (other disorders of bladder),2414,Genitourinary system disorders,"16,661",Categorical (single),Both sexes,Jul 2019,"16,661",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132060,Date N33 first reported (bladder disorders in diseases classified elsewhere),2414,Genitourinary system disorders,7,Date,Both sexes,Jul 2019,7,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132061,Source of report of N33 (bladder disorders in diseases classified elsewhere),2414,Genitourinary system disorders,7,Categorical (single),Both sexes,Jul 2019,7,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132062,Date N34 first reported (urethritis and urethral syndrome),2414,Genitourinary system disorders,"1,111",Date,Both sexes,Jul 2019,"1,111",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132063,Source of report of N34 (urethritis and urethral syndrome),2414,Genitourinary system disorders,"1,111",Categorical (single),Both sexes,Jul 2019,"1,111",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132064,Date N35 first reported (urethral stricture),2414,Genitourinary system disorders,"4,734",Date,Both sexes,Jul 2019,"4,734",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132065,Source of report of N35 (urethral stricture),2414,Genitourinary system disorders,"4,734",Categorical (single),Both sexes,Jul 2019,"4,734",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132066,Date N36 first reported (other disorders of urethra),2414,Genitourinary system disorders,"1,417",Date,Both sexes,Jul 2019,"1,417",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132067,Source of report of N36 (other disorders of urethra),2414,Genitourinary system disorders,"1,417",Categorical (single),Both sexes,Jul 2019,"1,417",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132068,Date N37 first reported (urethral disorders in diseases classified elsewhere),2414,Genitourinary system disorders,6,Date,Both sexes,Jul 2019,6,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132069,Source of report of N37 (urethral disorders in diseases classified elsewhere),2414,Genitourinary system disorders,6,Categorical (single),Both sexes,Jul 2019,6,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132070,Date N39 first reported (other disorders of urinary system),2414,Genitourinary system disorders,"44,832",Date,Both sexes,Jul 2019,"44,832",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132071,Source of report of N39 (other disorders of urinary system),2414,Genitourinary system disorders,"44,832",Categorical (single),Both sexes,Jul 2019,"44,832",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132072,Date N40 first reported (hyperplasia of prostate),2414,Genitourinary system disorders,"25,843",Date,Both sexes,Jul 2019,"25,843",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132073,Source of report of N40 (hyperplasia of prostate),2414,Genitourinary system disorders,"25,843",Categorical (single),Both sexes,Jul 2019,"25,843",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132074,Date N41 first reported (inflammatory diseases of prostate),2414,Genitourinary system disorders,"4,102",Date,Both sexes,Jul 2019,"4,102",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132075,Source of report of N41 (inflammatory diseases of prostate),2414,Genitourinary system disorders,"4,102",Categorical (single),Both sexes,Jul 2019,"4,102",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132076,Date N42 first reported (other disorders of prostate),2414,Genitourinary system disorders,"2,926",Date,Both sexes,Jul 2019,"2,926",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132077,Source of report of N42 (other disorders of prostate),2414,Genitourinary system disorders,"2,926",Categorical (single),Both sexes,Jul 2019,"2,926",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132078,Date N43 first reported (hydrocele and spermatocele),2414,Genitourinary system disorders,"2,281",Date,Both sexes,Jul 2019,"2,281",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132079,Source of report of N43 (hydrocele and spermatocele),2414,Genitourinary system disorders,"2,281",Categorical (single),Both sexes,Jul 2019,"2,281",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132080,Date N44 first reported (torsion of testis),2414,Genitourinary system disorders,231,Date,Both sexes,Jul 2019,231,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132081,Source of report of N44 (torsion of testis),2414,Genitourinary system disorders,231,Categorical (single),Both sexes,Jul 2019,231,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132082,Date N45 first reported (orchitis and epididymitis),2414,Genitourinary system disorders,"2,655",Date,Both sexes,Jul 2019,"2,655",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132083,Source of report of N45 (orchitis and epididymitis),2414,Genitourinary system disorders,"2,655",Categorical (single),Both sexes,Jul 2019,"2,655",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132084,Date N46 first reported (male infertility),2414,Genitourinary system disorders,593,Date,Both sexes,Jul 2019,593,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132085,Source of report of N46 (male infertility),2414,Genitourinary system disorders,593,Categorical (single),Both sexes,Jul 2019,593,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132086,"Date N47 first reported (redundant prepuce, phimosis and paraphimosis)",2414,Genitourinary system disorders,"3,321",Date,Both sexes,Jul 2019,"3,321",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132087,"Source of report of N47 (redundant prepuce, phimosis and paraphimosis)",2414,Genitourinary system disorders,"3,321",Categorical (single),Both sexes,Jul 2019,"3,321",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132088,Date N48 first reported (other disorders of penis),2414,Genitourinary system disorders,"6,316",Date,Both sexes,Jul 2019,"6,316",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132089,Source of report of N48 (other disorders of penis),2414,Genitourinary system disorders,"6,316",Categorical (single),Both sexes,Jul 2019,"6,316",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132090,"Date N49 first reported (inflammatory disorders of male genital organs, not elsewhere classified)",2414,Genitourinary system disorders,457,Date,Both sexes,Jul 2019,457,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132091,"Source of report of N49 (inflammatory disorders of male genital organs, not elsewhere classified)",2414,Genitourinary system disorders,457,Categorical (single),Both sexes,Jul 2019,457,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132092,Date N50 first reported (other disorders of male genital organs),2414,Genitourinary system disorders,"11,179",Date,Both sexes,Jul 2019,"11,179",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132093,Source of report of N50 (other disorders of male genital organs),2414,Genitourinary system disorders,"11,179",Categorical (single),Both sexes,Jul 2019,"11,179",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132094,Date N51 first reported (disorders of male genital organs in diseases classified elsewhere),2414,Genitourinary system disorders,37,Date,Both sexes,Jul 2019,37,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132095,Source of report of N51 (disorders of male genital organs in diseases classified elsewhere),2414,Genitourinary system disorders,37,Categorical (single),Both sexes,Jul 2019,37,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132096,Date N60 first reported (benign mammary dysplasia),2414,Genitourinary system disorders,"12,186",Date,Both sexes,Jul 2019,"12,186",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132097,Source of report of N60 (benign mammary dysplasia),2414,Genitourinary system disorders,"12,186",Categorical (single),Both sexes,Jul 2019,"12,186",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132098,Date N61 first reported (inflammatory disorders of breast),2414,Genitourinary system disorders,"1,953",Date,Both sexes,Jul 2019,"1,953",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132099,Source of report of N61 (inflammatory disorders of breast),2414,Genitourinary system disorders,"1,953",Categorical (single),Both sexes,Jul 2019,"1,953",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132100,Date N62 first reported (hypertrophy of breast),2414,Genitourinary system disorders,"2,047",Date,Both sexes,Jul 2019,"2,047",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132101,Source of report of N62 (hypertrophy of breast),2414,Genitourinary system disorders,"2,047",Categorical (single),Both sexes,Jul 2019,"2,047",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132102,Date N63 first reported (unspecified lump in breast),2414,Genitourinary system disorders,"15,946",Date,Both sexes,Jul 2019,"15,946",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132103,Source of report of N63 (unspecified lump in breast),2414,Genitourinary system disorders,"15,946",Categorical (single),Both sexes,Jul 2019,"15,946",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132104,Date N64 first reported (other disorders of breast),2414,Genitourinary system disorders,"13,331",Date,Both sexes,Jul 2019,"13,331",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132105,Source of report of N64 (other disorders of breast),2414,Genitourinary system disorders,"13,331",Categorical (single),Both sexes,Jul 2019,"13,331",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132106,Date N70 first reported (salpingitis and oophoritis),2414,Genitourinary system disorders,"1,070",Date,Both sexes,Jul 2019,"1,070",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132107,Source of report of N70 (salpingitis and oophoritis),2414,Genitourinary system disorders,"1,070",Categorical (single),Both sexes,Jul 2019,"1,070",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132108,"Date N71 first reported (inflammatory disease of uterus, except cervix)",2414,Genitourinary system disorders,524,Date,Both sexes,Jul 2019,524,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132109,"Source of report of N71 (inflammatory disease of uterus, except cervix)",2414,Genitourinary system disorders,524,Categorical (single),Both sexes,Jul 2019,524,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132110,Date N72 first reported (inflammatory disease of cervix uteri),2414,Genitourinary system disorders,"2,056",Date,Both sexes,Jul 2019,"2,056",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132111,Source of report of N72 (inflammatory disease of cervix uteri),2414,Genitourinary system disorders,"2,056",Categorical (single),Both sexes,Jul 2019,"2,056",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132112,Date N73 first reported (other female pelvic inflammatory diseases),2414,Genitourinary system disorders,"4,730",Date,Both sexes,Jul 2019,"4,730",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132113,Source of report of N73 (other female pelvic inflammatory diseases),2414,Genitourinary system disorders,"4,730",Categorical (single),Both sexes,Jul 2019,"4,730",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132114,Date N74 first reported (female pelvic inflammatory disorders in diseases classified elsewhere),2414,Genitourinary system disorders,24,Date,Both sexes,Jul 2019,24,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132115,Source of report of N74 (female pelvic inflammatory disorders in diseases classified elsewhere),2414,Genitourinary system disorders,24,Categorical (single),Both sexes,Jul 2019,24,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132116,Date N75 first reported (diseases of bartholin's gland),2414,Genitourinary system disorders,"2,377",Date,Both sexes,Jul 2019,"2,377",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132117,Source of report of N75 (diseases of bartholin's gland),2414,Genitourinary system disorders,"2,377",Categorical (single),Both sexes,Jul 2019,"2,377",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132118,Date N76 first reported (other inflammation of vagina and vulva),2414,Genitourinary system disorders,"4,936",Date,Both sexes,Jul 2019,"4,936",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132119,Source of report of N76 (other inflammation of vagina and vulva),2414,Genitourinary system disorders,"4,936",Categorical (single),Both sexes,Jul 2019,"4,936",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132120,Date N77 first reported (vulvovaginal ulceration and inflammation in diseases classified elsewhere),2414,Genitourinary system disorders,339,Date,Both sexes,Jul 2019,339,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132121,Source of report of N77 (vulvovaginal ulceration and inflammation in diseases classified elsewhere),2414,Genitourinary system disorders,339,Categorical (single),Both sexes,Jul 2019,339,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132122,Date N80 first reported (endometriosis),2414,Genitourinary system disorders,"9,612",Date,Both sexes,Jul 2019,"9,612",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132123,Source of report of N80 (endometriosis),2414,Genitourinary system disorders,"9,612",Categorical (single),Both sexes,Jul 2019,"9,612",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132124,Date N81 first reported (female genital prolapse),2414,Genitourinary system disorders,"17,801",Date,Both sexes,Jul 2019,"17,801",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132125,Source of report of N81 (female genital prolapse),2414,Genitourinary system disorders,"17,801",Categorical (single),Both sexes,Jul 2019,"17,801",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132126,Date N82 first reported (fistulae involving female genital tract),2414,Genitourinary system disorders,276,Date,Both sexes,Jul 2019,276,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132127,Source of report of N82 (fistulae involving female genital tract),2414,Genitourinary system disorders,276,Categorical (single),Both sexes,Jul 2019,276,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132128,"Date N83 first reported (noninflammatory disorders of ovary, fallopian tube and broad ligament)",2414,Genitourinary system disorders,"12,319",Date,Both sexes,Jul 2019,"12,319",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132129,"Source of report of N83 (noninflammatory disorders of ovary, fallopian tube and broad ligament)",2414,Genitourinary system disorders,"12,319",Categorical (single),Both sexes,Jul 2019,"12,319",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132130,Date N84 first reported (polyp of female genital tract),2414,Genitourinary system disorders,"17,395",Date,Both sexes,Jul 2019,"17,395",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132131,Source of report of N84 (polyp of female genital tract),2414,Genitourinary system disorders,"17,395",Categorical (single),Both sexes,Jul 2019,"17,395",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132132,"Date N85 first reported (other noninflammatory disorders of uterus, except cervix)",2414,Genitourinary system disorders,"7,711",Date,Both sexes,Jul 2019,"7,711",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132133,"Source of report of N85 (other noninflammatory disorders of uterus, except cervix)",2414,Genitourinary system disorders,"7,711",Categorical (single),Both sexes,Jul 2019,"7,711",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132134,Date N86 first reported (erosion and ectropion of cervix uteri),2414,Genitourinary system disorders,"2,031",Date,Both sexes,Jul 2019,"2,031",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132135,Source of report of N86 (erosion and ectropion of cervix uteri),2414,Genitourinary system disorders,"2,031",Categorical (single),Both sexes,Jul 2019,"2,031",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132136,Date N87 first reported (dysplasia of cervix uteri),2414,Genitourinary system disorders,"7,495",Date,Both sexes,Jul 2019,"7,495",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132137,Source of report of N87 (dysplasia of cervix uteri),2414,Genitourinary system disorders,"7,495",Categorical (single),Both sexes,Jul 2019,"7,495",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132138,Date N88 first reported (other noninflammatory disorders of cervix uteri),2414,Genitourinary system disorders,"2,894",Date,Both sexes,Jul 2019,"2,894",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132139,Source of report of N88 (other noninflammatory disorders of cervix uteri),2414,Genitourinary system disorders,"2,894",Categorical (single),Both sexes,Jul 2019,"2,894",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132140,Date N89 first reported (other noninflammatory disorders of vagina),2414,Genitourinary system disorders,"12,409",Date,Both sexes,Jul 2019,"12,409",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132141,Source of report of N89 (other noninflammatory disorders of vagina),2414,Genitourinary system disorders,"12,409",Categorical (single),Both sexes,Jul 2019,"12,409",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132142,Date N90 first reported (other noninflammatory disorders of vulva and perineum),2414,Genitourinary system disorders,"6,175",Date,Both sexes,Jul 2019,"6,175",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132143,Source of report of N90 (other noninflammatory disorders of vulva and perineum),2414,Genitourinary system disorders,"6,175",Categorical (single),Both sexes,Jul 2019,"6,175",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132144,"Date N91 first reported (absent, scanty and rare menstruation)",2414,Genitourinary system disorders,"2,455",Date,Both sexes,Jul 2019,"2,455",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132145,"Source of report of N91 (absent, scanty and rare menstruation)",2414,Genitourinary system disorders,"2,455",Categorical (single),Both sexes,Jul 2019,"2,455",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132146,"Date N92 first reported (excessive, frequent and irregular menstruation)",2414,Genitourinary system disorders,"29,539",Date,Both sexes,Jul 2019,"29,539",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132147,"Source of report of N92 (excessive, frequent and irregular menstruation)",2414,Genitourinary system disorders,"29,539",Categorical (single),Both sexes,Jul 2019,"29,539",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132148,Date N93 first reported (other abnormal uterine and vaginal bleeding),2414,Genitourinary system disorders,"10,912",Date,Both sexes,Jul 2019,"10,912",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132149,Source of report of N93 (other abnormal uterine and vaginal bleeding),2414,Genitourinary system disorders,"10,912",Categorical (single),Both sexes,Jul 2019,"10,912",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132150,Date N94 first reported (pain and other conditions associated with female genital organs and menstrual cycle),2414,Genitourinary system disorders,"12,083",Date,Both sexes,Jul 2019,"12,083",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132151,Source of report of N94 (pain and other conditions associated with female genital organs and menstrual cycle),2414,Genitourinary system disorders,"12,083",Categorical (single),Both sexes,Jul 2019,"12,083",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132152,Date N95 first reported (menopausal and other perimenopausal disorders),2414,Genitourinary system disorders,"36,760",Date,Both sexes,Jul 2019,"36,760",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132153,Source of report of N95 (menopausal and other perimenopausal disorders),2414,Genitourinary system disorders,"36,760",Categorical (single),Both sexes,Jul 2019,"36,760",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132154,Date N96 first reported (habitual aborter),2414,Genitourinary system disorders,33,Date,Both sexes,Jul 2019,33,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132155,Source of report of N96 (habitual aborter),2414,Genitourinary system disorders,33,Categorical (single),Both sexes,Jul 2019,33,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132156,Date N97 first reported (female infertility),2414,Genitourinary system disorders,"4,102",Date,Both sexes,Jul 2019,"4,102",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132157,Source of report of N97 (female infertility),2414,Genitourinary system disorders,"4,102",Categorical (single),Both sexes,Jul 2019,"4,102",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132158,Date N98 first reported (complications associated with artificial fertilisation),2414,Genitourinary system disorders,63,Date,Both sexes,Jul 2019,63,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132159,Source of report of N98 (complications associated with artificial fertilisation),2414,Genitourinary system disorders,63,Categorical (single),Both sexes,Jul 2019,63,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132160,"Date N99 first reported (postprocedural disorders of genito-urinary system, not elsewhere classified)",2414,Genitourinary system disorders,"1,616",Date,Both sexes,Jul 2019,"1,616",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132161,"Source of report of N99 (postprocedural disorders of genito-urinary system, not elsewhere classified)",2414,Genitourinary system disorders,"1,616",Categorical (single),Both sexes,Jul 2019,"1,616",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Genitourinary system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22101,Chromosome 1 genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22102,Chromosome 2 genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22103,Chromosome 3 genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22104,Chromosome 4 genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22105,Chromosome 5 genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22106,Chromosome 6 genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22107,Chromosome 7 genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22108,Chromosome 8 genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22109,Chromosome 9 genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22110,Chromosome 10 genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22111,Chromosome 11 genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22112,Chromosome 12 genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22113,Chromosome 13 genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22114,Chromosome 14 genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22115,Chromosome 15 genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22116,Chromosome 16 genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22117,Chromosome 17 genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22118,Chromosome 18 genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22119,Chromosome 19 genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22120,Chromosome 20 genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22121,Chromosome 21 genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22122,Chromosome 22 genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22123,Chromosome X genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22124,Chromosome Y genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22100,Chromosome XY genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Apr 2017,"488,265",Bulk,Singular,Jul 2017,Complete,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22125,Mitochondrial genotype results,100315,Genotype Results,"488,265",Text,Both sexes,Aug 2014,"488,265",Bulk,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotype Results,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22201,Chromosome 1 genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22202,Chromosome 2 genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22203,Chromosome 3 genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22204,Chromosome 4 genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22205,Chromosome 5 genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22206,Chromosome 6 genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22207,Chromosome 7 genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22208,Chromosome 8 genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22209,Chromosome 9 genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22210,Chromosome 10 genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22211,Chromosome 11 genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22212,Chromosome 12 genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22213,Chromosome 13 genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22214,Chromosome 14 genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22215,Chromosome 15 genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22216,Chromosome 16 genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22217,Chromosome 17 genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22218,Chromosome 18 genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22219,Chromosome 19 genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22220,Chromosome 20 genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22221,Chromosome 21 genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22222,Chromosome 22 genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22223,Chromosome X genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22224,Chromosome Y genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22225,Mitochondrial genotype probabilities,100316,Genotype confidences,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotype confidences,0.0,0.0,0.0,0.0,0.0,0.0
22301,Chromosome 1 genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22302,Chromosome 2 genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22303,Chromosome 3 genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22304,Chromosome 4 genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22305,Chromosome 5 genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22306,Chromosome 6 genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22307,Chromosome 7 genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22308,Chromosome 8 genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22309,Chromosome 9 genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22310,Chromosome 10 genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22311,Chromosome 11 genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22312,Chromosome 12 genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22313,Chromosome 13 genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22314,Chromosome 14 genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22315,Chromosome 15 genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22316,Chromosome 16 genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22317,Chromosome 17 genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22318,Chromosome 18 genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22319,Chromosome 19 genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22320,Chromosome 20 genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22321,Chromosome 21 genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22322,Chromosome 22 genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22323,Chromosome X genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22324,Chromosome Y genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22325,Mitochondrial genotype intensities,100317,Genotyping intensities,"152,682",Text,Both sexes,Aug 2014,"152,682",Bulk,Singular,Apr 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22014,Average X chromosome intensities for determining sex,100317,Genotyping intensities,"152,682","Continuous, Units",Both sexes,May 2015,"152,682",Data,Singular,May 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22015,Average Y chromosome intensities for determining sex,100317,Genotyping intensities,"152,682","Continuous, units",Both sexes,May 2015,"152,682",Data,Singular,May 2015,Accruing,Genomics,Genotypes,Interim genotype release,Genotyping intensities,0.0,0.0,0.0,0.0,0.0,0.0
22000,Genotype measurement batch,100313,Genotyping process and sample QC,"488,265",Categorical (single),Both sexes,Jul 2014,"488,265",Data,Singular,Apr 2017,Accruing,Genomics,Genotypes,Genotyping process and sample QC,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22007,Genotype measurement plate,100313,Genotyping process and sample QC,"488,265",Text,Both sexes,Feb 2015,"488,265",Data,Singular,Apr 2017,Accruing,Genomics,Genotypes,Genotyping process and sample QC,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22008,Genotype measurement well,100313,Genotyping process and sample QC,"488,265",Text,Both sexes,Feb 2015,"488,265",Data,Singular,Apr 2017,Accruing,Genomics,Genotypes,Genotyping process and sample QC,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22001,Genetic sex,100313,Genotyping process and sample QC,"488,265",Categorical (single),Both sexes,Aug 2014,"488,265",Data,Singular,May 2017,Complete,Genomics,Genotypes,Genotyping process and sample QC,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22021,Genetic kinship to other participants,100313,Genotyping process and sample QC,"488,265",Categorical (single),Both sexes,May 2017,"488,265",Data,Singular,May 2017,Complete,Genomics,Genotypes,Genotyping process and sample QC,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22006,Genetic ethnic grouping,100313,Genotyping process and sample QC,"409,616",Categorical (single),Both sexes,Jan 2015,"409,616",Data,Singular,May 2017,Accruing,Genomics,Genotypes,Genotyping process and sample QC,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22019,Sex chromosome aneuploidy,100313,Genotyping process and sample QC,651,Categorical (single),Both sexes,May 2017,651,Data,Singular,May 2017,Complete,Genomics,Genotypes,Genotyping process and sample QC,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22027,Outliers for heterozygosity or missing rate,100313,Genotyping process and sample QC,968,Categorical (single),Both sexes,May 2017,968,Data,Singular,May 2017,Complete,Genomics,Genotypes,Genotyping process and sample QC,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22003,Heterozygosity,100313,Genotyping process and sample QC,"488,265","Continuous, Fraction",Both sexes,Jan 2015,"488,265",Data,Singular,May 2017,Accruing,Genomics,Genotypes,Genotyping process and sample QC,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22004,"Heterozygosity, PCA corrected",100313,Genotyping process and sample QC,"488,265","Continuous, Fraction",Both sexes,Jan 2015,"488,265",Data,Singular,May 2017,Ongoing,Genomics,Genotypes,Genotyping process and sample QC,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22005,Missingness,100313,Genotyping process and sample QC,"488,265","Continuous, Fraction",Both sexes,Jan 2015,"488,265",Data,Singular,May 2017,Accruing,Genomics,Genotypes,Genotyping process and sample QC,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22009,Genetic principal components,100313,Genotyping process and sample QC,"488,265","Continuous, Units",Both sexes,Feb 2015,"19,530,600",Data,Singular,Jul 2017,Accruing,Genomics,Genotypes,Genotyping process and sample QC,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22020,Used in genetic principal components,100313,Genotyping process and sample QC,"407,128",Categorical (single),Both sexes,May 2017,"407,128",Data,Singular,May 2017,Complete,Genomics,Genotypes,Genotyping process and sample QC,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22022,Sex inference X probe-intensity,100313,Genotyping process and sample QC,"488,265",Continuous,Both sexes,May 2017,"488,265",Data,Singular,May 2017,Complete,Genomics,Genotypes,Genotyping process and sample QC,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22023,Sex inference Y probe-intensity,100313,Genotyping process and sample QC,"488,265",Continuous,Both sexes,May 2017,"488,265",Data,Singular,May 2017,Complete,Genomics,Genotypes,Genotyping process and sample QC,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22025,"Affymetrix quality control metric ""Cluster.CR""",100313,Genotyping process and sample QC,"488,265",Continuous,Both sexes,May 2017,"488,265",Data,Singular,May 2017,Complete,Genomics,Genotypes,Genotyping process and sample QC,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22026,"Affymetrix quality control metric ""dQC""",100313,Genotyping process and sample QC,"488,265",Continuous,Both sexes,May 2017,"488,265",Data,Singular,May 2017,Complete,Genomics,Genotypes,Genotyping process and sample QC,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22024,DNA concentration,100313,Genotyping process and sample QC,"488,265","Continuous, ng/micro-l",Both sexes,May 2017,"488,265",Data,Singular,May 2017,Complete,Genomics,Genotypes,Genotyping process and sample QC,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22028,Use in phasing Chromosomes 1-22,100313,Genotyping process and sample QC,"488,265",Categorical (single),Both sexes,Jul 2017,"488,265",Data,Singular,Jul 2017,Complete,Genomics,Genotypes,Genotyping process and sample QC,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22029,Use in phasing Chromosome X,100313,Genotyping process and sample QC,"488,265",Categorical (single),Both sexes,Jul 2017,"488,265",Data,Singular,Jul 2017,Complete,Genomics,Genotypes,Genotyping process and sample QC,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22030,Use in phasing Chromosome XY,100313,Genotyping process and sample QC,"488,265",Categorical (single),Both sexes,Jul 2017,"488,265",Data,Singular,Jul 2017,Complete,Genomics,Genotypes,Genotyping process and sample QC,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22002,CEL files,100313,Genotyping process and sample QC,"488,265",Text,Both sexes,Sep 2014,"488,265",Bulk,Singular,Jun 2017,Accruing,Genomics,Genotypes,Genotyping process and sample QC,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24506,"Natural environment percentage, buffer 1000m",151,Greenspace and coastal proximity,"497,690","Continuous, percent",Both sexes,Sep 2017,"517,871",Data,Defined (2),Oct 2017,Complete,Additional exposures,Local environment,Greenspace and coastal proximity,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24507,"Natural environment percentage, buffer 300m",151,Greenspace and coastal proximity,"497,690","Continuous, percent",Both sexes,Sep 2017,"517,871",Data,Defined (2),Oct 2017,Complete,Additional exposures,Local environment,Greenspace and coastal proximity,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24500,"Greenspace percentage, buffer 1000m",151,Greenspace and coastal proximity,"441,029","Continuous, percent",Both sexes,Sep 2017,"461,200",Data,Defined (2),Oct 2017,Complete,Additional exposures,Local environment,Greenspace and coastal proximity,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24503,"Greenspace percentage, buffer 300m",151,Greenspace and coastal proximity,"441,029","Continuous, percent",Both sexes,Sep 2017,"461,200",Data,Defined (2),Oct 2017,Complete,Additional exposures,Local environment,Greenspace and coastal proximity,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24501,"Domestic garden percentage, buffer 1000m",151,Greenspace and coastal proximity,"441,029","Continuous, percent",Both sexes,Sep 2017,"461,200",Data,Defined (2),Oct 2017,Complete,Additional exposures,Local environment,Greenspace and coastal proximity,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24504,"Domestic garden percentage, buffer 300m",151,Greenspace and coastal proximity,"441,029","Continuous, percent",Both sexes,Sep 2017,"461,200",Data,Defined (2),Oct 2017,Complete,Additional exposures,Local environment,Greenspace and coastal proximity,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24502,"Water percentage, buffer 1000m",151,Greenspace and coastal proximity,"441,029","Continuous, percent",Both sexes,Sep 2017,"461,200",Data,Defined (2),Oct 2017,Complete,Additional exposures,Local environment,Greenspace and coastal proximity,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24505,"Water percentage, buffer 300m",151,Greenspace and coastal proximity,"441,029","Continuous, percent",Both sexes,Sep 2017,"461,200",Data,Defined (2),Oct 2017,Complete,Additional exposures,Local environment,Greenspace and coastal proximity,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24508,Distance (Euclidean) to coast,151,Greenspace and coastal proximity,"497,690","Continuous, Kilometres",Both sexes,Sep 2017,"517,871",Data,Defined (2),Oct 2017,Complete,Additional exposures,Local environment,Greenspace and coastal proximity,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22182,HLA imputation values,100035,HLA,"488,265",Compound,Both sexes,Mar 2016,"488,265",Data,Singular,May 2017,Accruing,Genomics,Genotypes,HLA,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20044,Reason for skipping grip strength (left),100019,Hand grip strength,"1,695",Categorical (single),Both sexes,Aug 2012,"1,695",Data,Defined (1),Oct 2012,Complete,UK Biobank Assessment Centre,Physical measures,Hand grip strength,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20043,Reason for skipping grip strength (right),100019,Hand grip strength,"1,628",Categorical (single),Both sexes,Aug 2012,"1,628",Data,Defined (1),May 2013,Complete,UK Biobank Assessment Centre,Physical measures,Hand grip strength,0.0,0.0,0.0,0.0,0.0,0.0,0.0
46,Hand grip strength (left),100019,Hand grip strength,"499,266","Integer, Kg",Both sexes,Jan 2012,"568,255",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hand grip strength,0.0,0.0,0.0,0.0,0.0,0.0,0.0
47,Hand grip strength (right),100019,Hand grip strength,"499,341","Integer, Kg",Both sexes,Jan 2012,"568,338",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hand grip strength,0.0,0.0,0.0,0.0,0.0,0.0,0.0
38,Hand grip dynamometer device ID,100019,Hand grip strength,"497,974",Text,Both sexes,Jan 2012,"566,547",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hand grip strength,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20458,General happiness,147,Happiness and subjective well-being,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Happiness and subjective well-being,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20459,General happiness with own health,147,Happiness and subjective well-being,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Happiness and subjective well-being,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20460,Belief that own life is meaningful,147,Happiness and subjective well-being,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Happiness and subjective well-being,0.0,0.0,0.0,0.0,0.0,0.0,0.0
2247,Hearing difficulty/problems,100043,Hearing,"498,717",Categorical (single),Both sexes,Jan 2012,"568,460",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Hearing,0.0,0.0,0.0,0.0,0.0,0.0
10793,Hearing difficulty/problems (pilot),100043,Hearing,"3,770",Categorical (single),Both sexes,Jan 2012,"3,770",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Hearing,0.0,0.0,0.0,0.0,0.0,0.0
2257,Hearing difficulty/problems with background noise,100043,Hearing,"501,474",Categorical (single),Both sexes,Jan 2012,"572,086",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Hearing,0.0,0.0,0.0,0.0,0.0,0.0
3393,Hearing aid user,100043,Hearing,"331,808",Categorical (single),Both sexes,Jan 2012,"378,260",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Hearing,0.0,0.0,0.0,0.0,0.0,0.0
4792,Cochlear implant,100043,Hearing,"213,561",Categorical (single),Both sexes,Jan 2012,"243,198",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Hearing,0.0,0.0,0.0,0.0,0.0,0.0
4803,Tinnitus,100043,Hearing,"213,561",Categorical (single),Both sexes,Jan 2012,"243,198",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Hearing,0.0,0.0,0.0,0.0,0.0,0.0
4814,Tinnitus severity/nuisance,100043,Hearing,"64,727",Categorical (single),Both sexes,Jan 2012,"71,197",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Hearing,0.0,0.0,0.0,0.0,0.0,0.0
4825,Noisy workplace,100043,Hearing,"213,561",Categorical (single),Both sexes,Jan 2012,"243,198",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Hearing,0.0,0.0,0.0,0.0,0.0,0.0
4836,Loud music exposure frequency,100043,Hearing,"213,561",Categorical (single),Both sexes,Jan 2012,"243,198",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Hearing,0.0,0.0,0.0,0.0,0.0,0.0
4268,Completion status (left),100049,Hearing test,"208,445",Categorical (single),Both sexes,Jan 2012,"237,471",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4272,Duration of hearing test (left),100049,Hearing test,"208,445","Integer, deciseconds",Both sexes,Jan 2012,"237,471",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4849,Hearing test done,100049,Hearing test,"212,779",Categorical (single),Both sexes,Jan 2012,"242,352",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4238,Keystroke history (left),100049,Hearing test,"206,772",Text,Both sexes,Jan 2012,"3,486,638",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4233,"Mean signal-to-noise ratio (SNR), (left)",100049,Hearing test,"206,358",Continuous,Both sexes,Jan 2012,"3,483,875",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4239,Number of times 'clear' was pressed (left),100049,Hearing test,"206,772",Integer,Both sexes,Jan 2012,"3,486,638",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4269,Number of triplets attempted (left),100049,Hearing test,"208,445",Integer,Both sexes,Jan 2012,"237,471",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4230,Signal-to-noise-ratio (SNR) of triplet (left),100049,Hearing test,"206,772",Integer,Both sexes,Jan 2012,"3,486,638",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20019,Speech-reception-threshold (SRT) estimate (left),100049,Hearing test,"203,414",Continuous,Both sexes,Aug 2012,"231,336",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20021,Speech-reception-threshold (SRT) estimate (right),100049,Hearing test,"203,414",Continuous,Both sexes,Aug 2012,"231,351",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4237,Time to press 'next' (left),100049,Hearing test,"206,358","Integer, deciseconds",Both sexes,Jan 2012,"3,483,875",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4234,Time to press first digit (left),100049,Hearing test,"206,358","Integer, deciseconds",Both sexes,Jan 2012,"3,483,875",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4235,Time to press last digit (left),100049,Hearing test,"206,358","Integer, deciseconds",Both sexes,Jan 2012,"3,483,875",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4232,Triplet correct (left),100049,Hearing test,"206,358",Categorical (single),Both sexes,Jan 2012,"3,483,875",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4236,Triplet entered (left),100049,Hearing test,"206,358",Text,Both sexes,Jan 2012,"3,483,875",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4229,Triplet played (left),100049,Hearing test,"206,772",Text,Both sexes,Jan 2012,"3,486,638",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4270,Volume level set by participant (left),100049,Hearing test,"206,772",Categorical (single),Both sexes,Jan 2012,"235,511",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4275,Completion status (right),100049,Hearing test,"208,572",Categorical (single),Both sexes,Jan 2012,"237,627",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4279,Duration of hearing test (right),100049,Hearing test,"208,572",Integer,Both sexes,Jan 2012,"237,627",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4248,Keystroke history (right),100049,Hearing test,"206,850",Text,Both sexes,Jan 2012,"3,487,502",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4244,"Mean signal-to-noise ratio (SNR), (right)",100049,Hearing test,"206,441",Continuous,Both sexes,Jan 2012,"3,484,759",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4249,Number of times 'clear' was pressed (right),100049,Hearing test,"206,850",Integer,Both sexes,Jan 2012,"3,487,502",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4276,Number of triplets attempted (right),100049,Hearing test,"208,572",Integer,Both sexes,Jan 2012,"237,627",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4241,Signal-to-noise-ratio (SNR) of triplet (right),100049,Hearing test,"206,850",Integer,Both sexes,Jan 2012,"3,487,502",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4247,Time to press 'next' (right),100049,Hearing test,"206,441","Integer, deciseconds",Both sexes,Jan 2012,"3,484,759",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4245,Time to press first digit (right),100049,Hearing test,"206,441","Integer, deciseconds",Both sexes,Jan 2012,"3,484,759",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4246,Time to press last digit (right),100049,Hearing test,"206,441","Integer, deciseconds",Both sexes,Jan 2012,"3,484,759",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4243,Triplet correct (right),100049,Hearing test,"206,441",Categorical (single),Both sexes,Jan 2012,"3,484,759",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4242,Triplet entered (right),100049,Hearing test,"206,441",Text,Both sexes,Jan 2012,"3,484,759",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4240,Triplet played (right),100049,Hearing test,"206,850",Text,Both sexes,Jan 2012,"3,487,502",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4277,Volume level set by participant (right),100049,Hearing test,"206,850",Categorical (single),Both sexes,Jan 2012,"235,603",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Hearing test,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20210,Aortic distensibilty images - DICOM,102,Heart MRI,"38,676",Text,Both sexes,Jul 2014,"39,559",Bulk,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20213,Blood flow images - DICOM,102,Heart MRI,"38,403",Text,Both sexes,Jul 2014,"39,274",Bulk,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20211,Cine tagging images - DICOM,102,Heart MRI,"38,520",Text,Both sexes,Jul 2014,"39,396",Bulk,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20214,Experimental shMOLLI sequence images - DICOM,102,Heart MRI,"38,640",Text,Both sexes,Jul 2014,"39,512",Bulk,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20212,Left ventricular outflow tract images - DICOM,102,Heart MRI,"38,623",Text,Both sexes,Jul 2014,"39,501",Bulk,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20208,Long axis heart images - DICOM,102,Heart MRI,"40,587",Text,Both sexes,Jul 2014,"41,512",Bulk,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20207,Scout images for heart MRI - DICOM,102,Heart MRI,"40,674",Text,Both sexes,Jul 2014,"41,601",Bulk,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20209,Short axis heart images - DICOM,102,Heart MRI,"40,433",Text,Both sexes,Jul 2014,"41,348",Bulk,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,0.0,0.0,0.0,0.0,0.0,0.0,0.0
12624,Identifier for blood pressure device,102,Heart MRI,"47,135",Text,Both sexes,Sep 2015,"49,869",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22700,Date first recorded at location,150,Home locations,"502,496",Date,Both sexes,Jan 2017,"774,933",Data,Singular,Jan 2017,Ongoing,Additional exposures,Local environment,Home locations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22701,Home location - east co-ordinate,150,Home locations,"502,496","Integer, metre-grid",Both sexes,Jan 2017,"774,933",Data,Singular,Jan 2017,Ongoing,Additional exposures,Local environment,Home locations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22702,Home location - east co-ordinate (rounded),150,Home locations,"502,496","Integer, metre-grid",Both sexes,Jan 2017,"774,933",Data,Singular,Jan 2017,Ongoing,Additional exposures,Local environment,Home locations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22703,Home location - north co-ordinate,150,Home locations,"502,496","Integer, metre-grid",Both sexes,Jan 2017,"774,933",Data,Singular,Jan 2017,Ongoing,Additional exposures,Local environment,Home locations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22704,Home location - north co-ordinate (rounded),150,Home locations,"502,496","Integer, metre-grid",Both sexes,Jan 2017,"774,933",Data,Singular,Jan 2017,Ongoing,Additional exposures,Local environment,Home locations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100150,Drinking water intake,100104,Hot/cold beverages yesterday,"186,982",Categorical (single),Both sexes,Sep 2012,"377,561",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100160,Low calorie drink intake,100104,Hot/cold beverages yesterday,"43,601",Categorical (single),Both sexes,Sep 2012,"62,226",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100170,Fizzy drink intake,100104,Hot/cold beverages yesterday,"33,879",Categorical (single),Both sexes,Sep 2012,"41,451",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100180,Squash intake,100104,Hot/cold beverages yesterday,"44,612",Categorical (single),Both sexes,Sep 2012,"57,776",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100190,Orange juice intake,100104,Hot/cold beverages yesterday,"76,235",Categorical (single),Both sexes,Sep 2012,"124,235",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100200,Grapefruit juice intake,100104,Hot/cold beverages yesterday,"9,434",Categorical (single),Both sexes,Sep 2012,"13,387",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100210,Pure fruit/vegetable juice intake,100104,Hot/cold beverages yesterday,"44,626",Categorical (single),Both sexes,Sep 2012,"64,979",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100220,Fruit smoothie intake,100104,Hot/cold beverages yesterday,"9,731",Categorical (single),Both sexes,Sep 2012,"12,415",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100230,Dairy smoothie intake,100104,Hot/cold beverages yesterday,"16,482",Categorical (single),Both sexes,Sep 2012,"19,330",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100240,Coffee consumed,100104,Hot/cold beverages yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100250,Instant coffee intake,100104,Hot/cold beverages yesterday,"117,067",Categorical (single),Both sexes,Sep 2012,"217,402",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100270,Filtered coffee intake,100104,Hot/cold beverages yesterday,"61,849",Categorical (single),Both sexes,Sep 2012,"107,793",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100290,Cappuccino intake,100104,Hot/cold beverages yesterday,"19,232",Categorical (single),Both sexes,Sep 2012,"26,164",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100300,Latte intake,100104,Hot/cold beverages yesterday,"18,282",Categorical (single),Both sexes,Sep 2012,"24,689",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100310,Espresso intake,100104,Hot/cold beverages yesterday,"8,113",Categorical (single),Both sexes,Sep 2012,"11,896",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100330,Other coffee type,100104,Hot/cold beverages yesterday,"3,919",Categorical (single),Both sexes,Sep 2012,"4,366",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100260,Added milk to instant coffee,100104,Hot/cold beverages yesterday,"98,404",Categorical (single),Both sexes,Sep 2012,"179,612",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100280,Added milk to filtered coffee,100104,Hot/cold beverages yesterday,"43,447",Categorical (single),Both sexes,Sep 2012,"72,418",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100320,Added milk to espresso,100104,Hot/cold beverages yesterday,"2,434",Categorical (single),Both sexes,Sep 2012,"3,108",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100350,Added milk to other coffee type,100104,Hot/cold beverages yesterday,"2,336",Categorical (single),Both sexes,Sep 2012,"2,541",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100360,Decaffeinated coffee,100104,Hot/cold beverages yesterday,"39,188",Categorical (single),Both sexes,Sep 2012,"67,064",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100370,Intake of sugar added to coffee,100104,Hot/cold beverages yesterday,"36,334",Categorical (single),Both sexes,Sep 2012,"62,900",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100380,Intake of artificial sweetener added to coffee,100104,Hot/cold beverages yesterday,"17,416",Categorical (single),Both sexes,Sep 2012,"31,262",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100390,Tea consumed,100104,Hot/cold beverages yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100400,Standard tea intake,100104,Hot/cold beverages yesterday,"157,832",Categorical (single),Both sexes,Sep 2012,"320,162",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100410,Rooibos tea intake,100104,Hot/cold beverages yesterday,"11,460",Categorical (single),Both sexes,Sep 2012,"19,442",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100420,Green tea intake,100104,Hot/cold beverages yesterday,"19,127",Categorical (single),Both sexes,Sep 2012,"30,629",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100430,Herbal tea intake,100104,Hot/cold beverages yesterday,"30,030",Categorical (single),Both sexes,Sep 2012,"47,781",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100440,Other tea intake,100104,Hot/cold beverages yesterday,"12,267",Categorical (single),Both sexes,Sep 2012,"15,890",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100460,Added milk to standard tea,100104,Hot/cold beverages yesterday,"142,916",Categorical (single),Both sexes,Sep 2012,"288,095",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100470,Decaffeinated tea,100104,Hot/cold beverages yesterday,"16,740",Categorical (single),Both sexes,Sep 2012,"26,103",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100480,Added milk to rooibos tea,100104,Hot/cold beverages yesterday,"5,656",Categorical (single),Both sexes,Sep 2012,"9,683",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100490,Intake of sugar added to tea,100104,Hot/cold beverages yesterday,"25,899",Categorical (single),Both sexes,Sep 2012,"45,914",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100500,Intake of artificial sweetener added to tea,100104,Hot/cold beverages yesterday,"14,075",Categorical (single),Both sexes,Sep 2012,"25,466",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100510,Other non-alcoholic drinks,100104,Hot/cold beverages yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100520,Milk intake,100104,Hot/cold beverages yesterday,"15,164",Categorical (single),Both sexes,Sep 2012,"19,865",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100530,Flavoured milk intake,100104,Hot/cold beverages yesterday,"7,906",Categorical (single),Both sexes,Sep 2012,"9,391",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100540,Low calorie hot chocolate intake,100104,Hot/cold beverages yesterday,"5,149",Categorical (single),Both sexes,Sep 2012,"6,349",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100550,Hot chocolate intake,100104,Hot/cold beverages yesterday,"16,115",Categorical (single),Both sexes,Sep 2012,"20,979",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100560,Other drink intake,100104,Hot/cold beverages yesterday,"8,875",Categorical (single),Both sexes,Sep 2012,"10,112",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Hot/cold beverages yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
670,Type of accommodation lived in,100066,Household,"501,660",Categorical (single),Both sexes,Jan 2012,"572,286",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Household,0.0,0.0,0.0,0.0,0.0,0.0
680,Own or rent accommodation lived in,100066,Household,"500,281",Categorical (single),Both sexes,Jan 2012,"570,804",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Household,0.0,0.0,0.0,0.0,0.0,0.0
6139,Gas or solid-fuel cooking/heating,100066,Household,"498,769",Categorical (multiple),Both sexes,Jan 2012,"769,957",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Household,0.0,0.0,0.0,0.0,0.0,0.0
10860,Gas or solid-fuel cooking/heating (pilot),100066,Household,"3,770",Categorical (multiple),Both sexes,Jan 2012,"4,379",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Household,0.0,0.0,0.0,0.0,0.0,0.0
6140,Heating type(s) in home,100066,Household,"213,701",Categorical (multiple),Both sexes,Jan 2012,"245,430",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Household,0.0,0.0,0.0,0.0,0.0,0.0
699,Length of time at current address,100066,Household,"501,656","Integer, years",Both sexes,Jan 2012,"572,282",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Household,0.0,0.0,0.0,0.0,0.0,0.0
709,Number in household,100066,Household,"500,277","Integer, people",Both sexes,Jan 2012,"570,800",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Household,0.0,0.0,0.0,0.0,0.0,0.0
6141,How are people in household related to participant,100066,Household,"409,395",Categorical (multiple),Both sexes,Jan 2012,"642,068",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Household,0.0,0.0,0.0,0.0,0.0,0.0
728,Number of vehicles in household,100066,Household,"500,277",Categorical (single),Both sexes,Jan 2012,"570,800",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Household,0.0,0.0,0.0,0.0,0.0,0.0
738,Average total household income before tax,100066,Household,"497,405",Categorical (single),Both sexes,Jan 2012,"567,047",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Household,0.0,0.0,0.0,0.0,0.0,0.0
10877,Average total household income before tax (pilot),100066,Household,"3,751",Categorical (single),Both sexes,Jan 2012,"3,751",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Household,0.0,0.0,0.0,0.0,0.0,0.0
23098,Weight,100009,Impedance measures,"493,082","Continuous, Kg",Both sexes,Jan 2012,"560,415",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23104,Body mass index (BMI),100009,Impedance measures,"493,076","Continuous, Kg/m2",Both sexes,Jan 2012,"560,407",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23113,Leg fat-free mass (right),100009,Impedance measures,"493,031","Continuous, Kg",Both sexes,Jan 2012,"560,355",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23118,Leg predicted mass (left),100009,Impedance measures,"492,997","Continuous, Kg",Both sexes,Jan 2012,"560,314",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23114,Leg predicted mass (right),100009,Impedance measures,"493,030","Continuous, Kg",Both sexes,Jan 2012,"560,354",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23123,Arm fat percentage (left),100009,Impedance measures,"492,925","Continuous, percent",Both sexes,Jan 2012,"560,233",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23119,Arm fat percentage (right),100009,Impedance measures,"492,987","Continuous, percent",Both sexes,Jan 2012,"560,302",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23124,Arm fat mass (left),100009,Impedance measures,"492,887","Continuous, Kg",Both sexes,Jan 2012,"560,189",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23120,Arm fat mass (right),100009,Impedance measures,"492,955","Continuous, Kg",Both sexes,Jan 2012,"560,267",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23121,Arm fat-free mass (right),100009,Impedance measures,"492,954","Continuous, Kg",Both sexes,Jan 2012,"560,264",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23125,Arm fat-free mass (left),100009,Impedance measures,"492,872","Continuous, Kg",Both sexes,Jan 2012,"560,175",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23126,Arm predicted mass (left),100009,Impedance measures,"492,855","Continuous, Kg",Both sexes,Jan 2012,"560,156",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23122,Arm predicted mass (right),100009,Impedance measures,"492,946","Continuous, Kg",Both sexes,Jan 2012,"560,256",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23127,Trunk fat percentage,100009,Impedance measures,"492,825","Continuous, percent",Both sexes,Jan 2012,"560,113",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23128,Trunk fat mass,100009,Impedance measures,"492,803","Continuous, Kg",Both sexes,Jan 2012,"560,086",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23129,Trunk fat-free mass,100009,Impedance measures,"492,732","Continuous, Kg",Both sexes,Jan 2012,"560,002",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23130,Trunk predicted mass,100009,Impedance measures,"492,690","Continuous, Kg",Both sexes,Jan 2012,"559,948",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23105,Basal metabolic rate,100009,Impedance measures,"493,066","Continuous, KJ",Both sexes,Jan 2012,"560,396",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23099,Body fat percentage,100009,Impedance measures,"492,828","Continuous, percent",Both sexes,Jan 2012,"560,112",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23100,Whole body fat mass,100009,Impedance measures,"492,298","Continuous, Kg",Both sexes,Jan 2012,"559,505",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23101,Whole body fat-free mass,100009,Impedance measures,"493,035","Continuous, Kg",Both sexes,Jan 2012,"560,364",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23102,Whole body water mass,100009,Impedance measures,"493,079","Continuous, Kg",Both sexes,Jan 2012,"560,410",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23115,Leg fat percentage (left),100009,Impedance measures,"493,021","Continuous, percent",Both sexes,Jan 2012,"560,344",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23111,Leg fat percentage (right),100009,Impedance measures,"493,048","Continuous, percent",Both sexes,Jan 2012,"560,376",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23116,Leg fat mass (left),100009,Impedance measures,"493,016","Continuous, Kg",Both sexes,Jan 2012,"560,339",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23112,Leg fat mass (right),100009,Impedance measures,"493,040","Continuous, Kg",Both sexes,Jan 2012,"560,367",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23117,Leg fat-free mass (left),100009,Impedance measures,"493,003","Continuous, Kg",Both sexes,Jan 2012,"560,320",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
43,Impedance device ID,100009,Impedance measures,"497,974",Text,Both sexes,Jan 2012,"566,547",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23106,Impedance of whole body,100009,Impedance measures,"493,028","Continuous, ohms",Both sexes,Jan 2012,"560,352",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23110,Impedance of arm (left),100009,Impedance measures,"493,044","Continuous, ohms",Both sexes,Jan 2012,"560,371",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23109,Impedance of arm (right),100009,Impedance measures,"493,022","Continuous, ohms",Both sexes,Jan 2012,"560,347",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23108,Impedance of leg (left),100009,Impedance measures,"493,051","Continuous, ohms",Both sexes,Jan 2012,"560,379",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
23107,Impedance of leg (right),100009,Impedance measures,"493,055","Continuous, ohms",Both sexes,Jan 2012,"560,385",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
6218,"Impedance of whole body, manual entry",100009,Impedance measures,28,"Integer, ohm",Both sexes,Oct 2012,28,Data,Defined (3),Aug 2015,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
6222,"Impedance of arm, manual entry (left)",100009,Impedance measures,28,"Integer, ohm",Both sexes,Oct 2012,28,Data,Defined (3),Aug 2015,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
6221,"Impedance of arm, manual entry (right)",100009,Impedance measures,28,"Integer, ohm",Both sexes,Oct 2012,28,Data,Defined (3),Aug 2015,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
6220,"Impedance of leg, manual entry (left)",100009,Impedance measures,28,"Integer, ohm",Both sexes,Oct 2012,28,Data,Defined (3),Aug 2015,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
6219,"Impedance of leg, manual entry (right)",100009,Impedance measures,28,"Integer, ohm",Both sexes,Oct 2012,28,Data,Defined (3),Aug 2015,Complete,UK Biobank Assessment Centre,Physical measures,Anthropometry,Impedance measures,0.0,0.0,0.0,0.0,0.0,0.0
22801,Chromosome 1 imputation and haplotype results,100319,Imputation,"487,297",Text,Both sexes,Aug 2014,"487,297",Bulk,Singular,Jul 2017,Updateable,Genomics,Genotypes,Imputation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22802,Chromosome 2 imputation and haplotype results,100319,Imputation,"487,297",Text,Both sexes,Aug 2014,"487,297",Bulk,Singular,Jul 2017,Updateable,Genomics,Genotypes,Imputation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22803,Chromosome 3 imputation and haplotype results,100319,Imputation,"487,297",Text,Both sexes,Aug 2014,"487,297",Bulk,Singular,Jul 2017,Updateable,Genomics,Genotypes,Imputation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22804,Chromosome 4 imputation and haplotype results,100319,Imputation,"487,297",Text,Both sexes,Aug 2014,"487,297",Bulk,Singular,Jul 2017,Updateable,Genomics,Genotypes,Imputation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22805,Chromosome 5 imputation and haplotype results,100319,Imputation,"487,297",Text,Both sexes,Aug 2014,"487,297",Bulk,Singular,Jul 2017,Updateable,Genomics,Genotypes,Imputation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22806,Chromosome 6 imputation and haplotype results,100319,Imputation,"487,297",Text,Both sexes,Aug 2014,"487,297",Bulk,Singular,Jul 2017,Updateable,Genomics,Genotypes,Imputation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22807,Chromosome 7 imputation and haplotype results,100319,Imputation,"487,297",Text,Both sexes,Aug 2014,"487,297",Bulk,Singular,Jul 2017,Updateable,Genomics,Genotypes,Imputation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22808,Chromosome 8 imputation and haplotype results,100319,Imputation,"487,297",Text,Both sexes,Aug 2014,"487,297",Bulk,Singular,Jul 2017,Updateable,Genomics,Genotypes,Imputation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22809,Chromosome 9 imputation and haplotype results,100319,Imputation,"487,297",Text,Both sexes,Aug 2014,"487,297",Bulk,Singular,Jul 2017,Updateable,Genomics,Genotypes,Imputation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22810,Chromosome 10 imputation and haplotype results,100319,Imputation,"487,297",Text,Both sexes,Aug 2014,"487,297",Bulk,Singular,Jul 2017,Updateable,Genomics,Genotypes,Imputation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22811,Chromosome 11 imputation and haplotype results,100319,Imputation,"487,297",Text,Both sexes,Aug 2014,"487,297",Bulk,Singular,Jul 2017,Updateable,Genomics,Genotypes,Imputation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22812,Chromosome 12 imputation and haplotype results,100319,Imputation,"487,297",Text,Both sexes,Aug 2014,"487,297",Bulk,Singular,Jul 2017,Updateable,Genomics,Genotypes,Imputation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22813,Chromosome 13 imputation and haplotype results,100319,Imputation,"487,297",Text,Both sexes,Aug 2014,"487,297",Bulk,Singular,Jul 2017,Updateable,Genomics,Genotypes,Imputation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22814,Chromosome 14 imputation and haplotype results,100319,Imputation,"487,297",Text,Both sexes,Aug 2014,"487,297",Bulk,Singular,Jul 2017,Updateable,Genomics,Genotypes,Imputation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22815,Chromosome 15 imputation and haplotype results,100319,Imputation,"487,297",Text,Both sexes,Aug 2014,"487,297",Bulk,Singular,Jul 2017,Updateable,Genomics,Genotypes,Imputation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22816,Chromosome 16 imputation and haplotype results,100319,Imputation,"487,297",Text,Both sexes,Aug 2014,"487,297",Bulk,Singular,Jul 2017,Updateable,Genomics,Genotypes,Imputation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22817,Chromosome 17 imputation and haplotype results,100319,Imputation,"487,297",Text,Both sexes,Aug 2014,"487,297",Bulk,Singular,Jul 2017,Updateable,Genomics,Genotypes,Imputation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22818,Chromosome 18 imputation and haplotype results,100319,Imputation,"487,297",Text,Both sexes,Aug 2014,"487,297",Bulk,Singular,Jul 2017,Updateable,Genomics,Genotypes,Imputation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22819,Chromosome 19 imputation and haplotype results,100319,Imputation,"487,297",Text,Both sexes,Aug 2014,"487,297",Bulk,Singular,Jul 2017,Updateable,Genomics,Genotypes,Imputation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22820,Chromosome 20 imputation and haplotype results,100319,Imputation,"487,297",Text,Both sexes,Aug 2014,"487,297",Bulk,Singular,Jul 2017,Updateable,Genomics,Genotypes,Imputation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22821,Chromosome 21 imputation and haplotype results,100319,Imputation,"487,297",Text,Both sexes,Aug 2014,"487,297",Bulk,Singular,Jul 2017,Updateable,Genomics,Genotypes,Imputation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22822,Chromosome 22 imputation and haplotype results,100319,Imputation,"487,297",Text,Both sexes,Aug 2014,"487,297",Bulk,Singular,Jul 2017,Updateable,Genomics,Genotypes,Imputation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22823,Chromosome X imputation and haplotype results,100319,Imputation,"486,646",Text,Both sexes,Aug 2014,"486,646",Bulk,Singular,Nov 2017,Updateable,Genomics,Genotypes,Imputation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22800,Chromosome XY imputation and haplotype results,100319,Imputation,"486,332",Text,Both sexes,Apr 2017,"486,332",Bulk,Singular,Nov 2017,Updateable,Genomics,Genotypes,Imputation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26433,Access to services score (Scotland),76,Indices of Multiple Deprivation,"35,849",Continuous,Both sexes,May 2018,"35,849",Data,Singular,Jul 2018,Complete,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26422,Access to services score (Wales),76,Indices of Multiple Deprivation,"21,187",Continuous,Both sexes,May 2018,"21,187",Data,Singular,May 2018,Complete,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26425,Community safety score (Wales),76,Indices of Multiple Deprivation,"21,187",Continuous,Both sexes,May 2018,"21,187",Data,Singular,May 2018,Complete,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26416,Crime score (England),76,Indices of Multiple Deprivation,"432,733",Continuous,Both sexes,May 2018,"432,733",Data,Singular,May 2018,Complete,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26434,Crime score (Scotland),76,Indices of Multiple Deprivation,"33,489",Continuous,Both sexes,May 2018,"33,489",Data,Singular,May 2018,Ongoing,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26414,Education score (England),76,Indices of Multiple Deprivation,"432,733",Continuous,Both sexes,May 2018,"432,733",Data,Singular,May 2018,Complete,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26431,Education score (Scotland),76,Indices of Multiple Deprivation,"35,849",Continuous,Both sexes,May 2018,"35,849",Data,Singular,May 2018,Complete,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26421,Education score (Wales),76,Indices of Multiple Deprivation,"21,187",Continuous,Both sexes,May 2018,"21,187",Data,Singular,May 2018,Complete,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26412,Employment score (England),76,Indices of Multiple Deprivation,"432,733",Continuous,Both sexes,May 2018,"432,733",Data,Singular,May 2018,Complete,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26429,Employment score (Scotland),76,Indices of Multiple Deprivation,"35,849",Continuous,Both sexes,May 2018,"35,849",Data,Singular,May 2018,Complete,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26419,Employment score (Wales),76,Indices of Multiple Deprivation,"21,187",Continuous,Both sexes,May 2018,"21,187",Data,Singular,May 2018,Complete,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26413,Health score (England),76,Indices of Multiple Deprivation,"432,733",Continuous,Both sexes,May 2018,"432,733",Data,Singular,May 2018,Complete,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26430,Health score (Scotland),76,Indices of Multiple Deprivation,"35,849",Continuous,Both sexes,May 2018,"35,849",Data,Singular,Jul 2018,Complete,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26420,Health score (Wales),76,Indices of Multiple Deprivation,"21,187",Continuous,Both sexes,May 2018,"21,187",Data,Singular,May 2018,Complete,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26415,Housing score (England),76,Indices of Multiple Deprivation,"432,733",Continuous,Both sexes,May 2018,"432,733",Data,Singular,May 2018,Complete,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26432,Housing score (Scotland),76,Indices of Multiple Deprivation,"35,849",Continuous,Both sexes,May 2018,"35,849",Data,Singular,Jul 2018,Complete,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26423,Housing score (Wales),76,Indices of Multiple Deprivation,"21,187",Continuous,Both sexes,May 2018,"21,187",Data,Singular,May 2018,Complete,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26411,Income score (England),76,Indices of Multiple Deprivation,"432,733",Continuous,Both sexes,May 2018,"432,733",Data,Singular,May 2018,Complete,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26428,Income score (Scotland),76,Indices of Multiple Deprivation,"35,849",Continuous,Both sexes,May 2018,"35,849",Data,Singular,May 2018,Complete,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26418,Income score (Wales),76,Indices of Multiple Deprivation,"21,187",Continuous,Both sexes,May 2018,"21,187",Data,Singular,May 2018,Complete,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26410,Index of Multiple Deprivation (England),76,Indices of Multiple Deprivation,"432,733",Continuous,Both sexes,May 2018,"432,733",Data,Singular,May 2018,Complete,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26427,Index of Multiple Deprivation (Scotland),76,Indices of Multiple Deprivation,"35,849",Continuous,Both sexes,May 2018,"35,849",Data,Singular,Jul 2018,Complete,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26426,Index of Multiple Deprivation (Wales),76,Indices of Multiple Deprivation,"21,187",Continuous,Both sexes,May 2018,"21,187",Data,Singular,May 2018,Complete,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26417,Living environment score (England),76,Indices of Multiple Deprivation,"432,733",Continuous,Both sexes,May 2018,"432,733",Data,Singular,May 2018,Complete,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
26424,Physical environment score (Wales),76,Indices of Multiple Deprivation,"21,187",Continuous,Both sexes,May 2018,"21,187",Data,Singular,May 2018,Complete,Population characteristics,Baseline characteristics,Indices of Multiple Deprivation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23000,1gG antigen for Herpes Simplex virus-1,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23001,2mgG unique antigen for Herpes Simplex virus-2,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23049,Antigen assay QC indicator,1307,Infectious Disease Antigens,"1,586",Categorical (single),Both sexes,Jun 2018,"1,605",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23048,Antigen assay date,1307,Infectious Disease Antigens,"9,691",Date,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23026,BK VP1 antigen for Human Polyomavirus BKV,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23039,CagA antigen for Helicobacter pylori,1307,Infectious Disease Antigens,"4,898",Integer,Both sexes,Jun 2018,"5,075",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23043,Catalase antigen for Helicobacter pylori,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23018,Core antigen for Hepatitis C Virus,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23030,E6 antigen for Human Papillomavirus type-16,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23031,E7 antigen for Human Papillomavirus type-16,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23006,EA-D antigen for Epstein-Barr Virus,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23004,EBNA-1 antigen for Epstein-Barr Virus,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23042,GroEL antigen for Helicobacter pylori,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23016,HBc antigen for Hepatitis B Virus,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23017,HBe antigen for Hepatitis B Virus,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23025,HIV-1 env antigen for Human Immunodeficiency Virus,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23024,HIV-1 gag antigen for Human Immunodeficiency Virus,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23023,HTLV-1 env antigen for Human T-Lymphotropic Virus 1,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23022,HTLV-1 gag antigen for Human T-Lymphotropic Virus 1,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23010,IE1A antigen for Human Herpesvirus-6,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23011,IE1B antigen for Human Herpesvirus-6,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23027,JC VP1 antigen for Human Polyomavirus JCV,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23015,K8.1 antigen for Kaposi's Sarcoma-Associated Herpesvirus,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23029,L1 antigen for Human Papillomavirus type-16,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23032,L1 antigen for Human Papillomavirus type-18,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23014,LANA antigen for Kaposi's Sarcoma-Associated Herpesvirus,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23028,MC VP1 antigen for Merkel Cell Polyomavirus,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23019,NS3 antigen for Hepatitis C Virus,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23041,OMP antigen for Helicobacter pylori,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23037,PorB antigen for Chlamydia trachomatis,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23013,U14 antigen for Human Herpesvirus-7,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23044,UreA antigen for Helicobacter pylori,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23003,VCA p18 antigen for Epstein-Barr Virus,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23040,VacA antigen for Helicobacter pylori,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23005,ZEBRA antigen for Epstein-Barr Virus,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23002,gE / gI antigen for Varicella Zoster Virus ,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23034,momp A antigen for Chlamydia trachomatis,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23033,momp D antigen for Chlamydia trachomatis,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23012,p101 k antigen for Human Herpesvirus-6,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23020,p22 antigen for Toxoplasma gondii,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23038,pGP3 antigen for Chlamydia trachomatis,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23009,pp 28 antigen for Human Cytomegalovirus,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23008,pp 52 antigen for Human Cytomegalovirus,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23007,pp150 Nter antigen for Human Cytomegalovirus,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23021,sag1 antigen for Toxoplasma gondii,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23035,tarp-D F1 antigen for Chlamydia trachomatis,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23036,tarp-D F2 antigen for Chlamydia trachomatis,1307,Infectious Disease Antigens,"9,691",Integer,Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,Infectious Disease Antigens,0.0,0.0,0.0,0.0,0.0
23050,HSV-1 seropositivity for Herpes Simplex virus-1,51428,Infectious Diseases,"9,691",Categorical (single),Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
23051,HSV-2 seropositivity for Herpes Simplex virus-2,51428,Infectious Diseases,"9,691",Categorical (single),Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
23052,VZV seropositivity for Varicella Zoster Virus ,51428,Infectious Diseases,"9,691",Categorical (single),Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
23053,EBV seropositivity for Epstein-Barr Virus,51428,Infectious Diseases,"9,691",Categorical (single),Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
23054,CMV seropositivity for Human Cytomegalovirus,51428,Infectious Diseases,"9,691",Categorical (single),Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
23055,HHV-6 overall seropositivity for Human Herpesvirus-6,51428,Infectious Diseases,"9,691",Categorical (single),Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
23056,HHV-6A seropositivity for Human Herpesvirus-6,51428,Infectious Diseases,"9,691",Categorical (single),Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
23057,HHV-6B seropositivity for Human Herpesvirus-6,51428,Infectious Diseases,"9,691",Categorical (single),Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
23058,HHV-7 seropositivity for Human Herpesvirus-7,51428,Infectious Diseases,"9,691",Categorical (single),Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
23059,KSHV seropositivity for Kaposi's Sarcoma-Associated Herpesvirus,51428,Infectious Diseases,"9,691",Categorical (single),Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
23060,HBV seropositivity for Hepatitis B Virus,51428,Infectious Diseases,"9,691",Categorical (single),Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
23061,HCV seropositivity for Hepatitis C Virus,51428,Infectious Diseases,"9,691",Categorical (single),Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
23062,T. gondii seropositivity for Toxoplasma gondii,51428,Infectious Diseases,"9,691",Categorical (single),Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
23063,HTLV-1 seropositivity for Human T-Lymphotropic Virus 1,51428,Infectious Diseases,"9,691",Categorical (single),Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
23064,HIV-1 seropositivity for Human Immunodeficiency Virus,51428,Infectious Diseases,"9,691",Categorical (single),Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
23065,BKV seropositivity for Human Polyomavirus BKV,51428,Infectious Diseases,"9,691",Categorical (single),Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
23066,JCV seropositivity for Human Polyomavirus JCV,51428,Infectious Diseases,"9,691",Categorical (single),Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
23067,MCV seropositivity for Merkel Cell Polyomavirus,51428,Infectious Diseases,"9,691",Categorical (single),Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
23068,HPV 16 Definition I seropositivity for Human Papillomavirus type-16,51428,Infectious Diseases,"9,691",Categorical (single),Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
23075,HPV 16 Definition II seropositivity for Human Papillomavirus type-16,51428,Infectious Diseases,"9,691",Categorical (single),Both sexes,Jan 2019,"9,968",Data,Defined (2),Feb 2019,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
23069,HPV 18 seropositivity for Human Papillomavirus type-18,51428,Infectious Diseases,"9,691",Categorical (single),Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
23070,C. trachomatis Definition I seropositivity for Chlamydia trachomatis,51428,Infectious Diseases,"9,691",Categorical (single),Both sexes,Jun 2018,"9,968",Data,Defined (2),Feb 2019,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
23071,C. trachomatis Definition II seropositivity for Chlamydia trachomatis,51428,Infectious Diseases,"7,620",Categorical (single),Both sexes,Jun 2018,"7,851",Data,Defined (2),Feb 2019,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
23073,H. pylori Definition I seropositivity for Helicobacter pylori,51428,Infectious Diseases,"4,898",Categorical (single),Both sexes,Jun 2018,"5,075",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
23074,H. pylori Definition II seropositivity for Helicobacter pylori,51428,Infectious Diseases,"9,691",Categorical (single),Both sexes,Jun 2018,"9,968",Data,Defined (2),Jun 2018,Accruing,Biological samples,Assay results,Blood assays,Infectious Diseases,0.0,0.0,0.0,0.0,0.0,0.0
22050,UKBiLEVE Affymetrix quality control for samples,199001,Interim genotype release,"49,992",Categorical (single),Both sexes,Mar 2015,"49,992",Data,Singular,Mar 2015,Complete,Genomics,Genotypes,Interim genotype release,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22051,UKBiLEVE genotype quality control for samples,199001,Interim genotype release,"49,992",Categorical (single),Both sexes,Mar 2015,"49,992",Data,Singular,Mar 2015,Complete,Genomics,Genotypes,Interim genotype release,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22011,Genetic relatedness pairing,199001,Interim genotype release,"17,302",Integer,Both sexes,Mar 2015,"19,377",Data,Singular,Mar 2015,Accruing,Genomics,Genotypes,Interim genotype release,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22018,Genetic relatedness exclusions,199001,Interim genotype release,"1,532",Categorical (single),Both sexes,Feb 2016,"1,532",Data,Singular,Feb 2016,Accruing,Genomics,Genotypes,Interim genotype release,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22012,Genetic relatedness factor,199001,Interim genotype release,"17,302",Continuous,Both sexes,Mar 2015,"19,377",Data,Singular,Mar 2015,Accruing,Genomics,Genotypes,Interim genotype release,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22013,Genetic relatedness IBS0,199001,Interim genotype release,"17,302",Continuous,Both sexes,Mar 2015,"19,377",Data,Singular,Mar 2015,Accruing,Genomics,Genotypes,Interim genotype release,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22010,Recommended genomic analysis exclusions,199001,Interim genotype release,480,Categorical (single),Both sexes,Feb 2015,480,Data,Singular,Feb 2015,Accruing,Genomics,Genotypes,Interim genotype release,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22052,UKBiLEVE unrelatedness indicator,199001,Interim genotype release,"49,992",Categorical (single),Both sexes,Mar 2015,"49,992",Data,Singular,Mar 2015,Complete,Genomics,Genotypes,Interim genotype release,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20054,Reason for skipping IOP (left),100015,Intraocular pressure,"2,596",Categorical (single),Both sexes,Aug 2012,"2,596",Data,Defined (1),Aug 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Intraocular pressure,0.0,0.0,0.0,0.0,0.0,0.0
20053,Reason for skipping IOP (right),100015,Intraocular pressure,"2,403",Categorical (single),Both sexes,Aug 2012,"2,403",Data,Defined (1),Aug 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Intraocular pressure,0.0,0.0,0.0,0.0,0.0,0.0
5196,Intra-ocular pressure (IOP) method (left),100015,Intraocular pressure,"132,134",Categorical (single),Both sexes,Jan 2012,"136,300",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Intraocular pressure,0.0,0.0,0.0,0.0,0.0,0.0
5194,Intra-ocular pressure (IOP) method (right),100015,Intraocular pressure,"132,140",Categorical (single),Both sexes,Jan 2012,"136,305",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Intraocular pressure,0.0,0.0,0.0,0.0,0.0,0.0
5264,Corneal hysteresis (left),100015,Intraocular pressure,"127,442",Continuous,Both sexes,Jan 2012,"131,385",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Intraocular pressure,0.0,0.0,0.0,0.0,0.0,0.0
5256,Corneal hysteresis (right),100015,Intraocular pressure,"127,812",Continuous,Both sexes,Jan 2012,"131,772",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Intraocular pressure,0.0,0.0,0.0,0.0,0.0,0.0
5265,Corneal resistance factor (left),100015,Intraocular pressure,"127,442",Continuous,Both sexes,Jan 2012,"131,385",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Intraocular pressure,0.0,0.0,0.0,0.0,0.0,0.0
5257,Corneal resistance factor (right),100015,Intraocular pressure,"127,812",Continuous,Both sexes,Jan 2012,"131,772",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Intraocular pressure,0.0,0.0,0.0,0.0,0.0,0.0
5262,"Intra-ocular pressure, corneal-compensated (left)",100015,Intraocular pressure,"127,442","Continuous, mmHg",Both sexes,Jan 2012,"131,385",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Intraocular pressure,0.0,0.0,0.0,0.0,0.0,0.0
5254,"Intra-ocular pressure, corneal-compensated (right)",100015,Intraocular pressure,"127,812","Continuous, mmHg",Both sexes,Jan 2012,"131,772",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Intraocular pressure,0.0,0.0,0.0,0.0,0.0,0.0
5263,"Intra-ocular pressure, Goldmann-correlated (left)",100015,Intraocular pressure,"127,442","Continuous, mmHg",Both sexes,Jan 2012,"131,385",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Intraocular pressure,0.0,0.0,0.0,0.0,0.0,0.0
5255,"Intra-ocular pressure, Goldmann-correlated (right)",100015,Intraocular pressure,"127,812","Continuous, mmHg",Both sexes,Jan 2012,"131,772",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Intraocular pressure,0.0,0.0,0.0,0.0,0.0,0.0
5266,Applanation curve (left),100015,Intraocular pressure,"127,442",Compound,Both sexes,Jan 2012,"131,385",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Intraocular pressure,0.0,0.0,0.0,0.0,0.0,0.0
5258,Applanation curve (right),100015,Intraocular pressure,"127,812",Compound,Both sexes,Jan 2012,"131,772",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Intraocular pressure,0.0,0.0,0.0,0.0,0.0,0.0
5267,Pressure curve (left),100015,Intraocular pressure,"127,442",Compound,Both sexes,Jan 2012,"131,385",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Intraocular pressure,0.0,0.0,0.0,0.0,0.0,0.0
5259,Pressure curve (right),100015,Intraocular pressure,"127,812",Compound,Both sexes,Jan 2012,"131,772",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Intraocular pressure,0.0,0.0,0.0,0.0,0.0,0.0
5261,Intra-ocular pressure device ID (left),100015,Intraocular pressure,"68,045",Text,Both sexes,Jan 2012,"68,045",Data,Defined (1),Aug 2014,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Intraocular pressure,0.0,0.0,0.0,0.0,0.0,0.0
5253,Intra-ocular pressure device ID (right),100015,Intraocular pressure,"68,189",Text,Both sexes,Jan 2012,"68,189",Data,Defined (1),Aug 2014,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Intraocular pressure,0.0,0.0,0.0,0.0,0.0,0.0
22426,Average heart rate,133,Left ventricular size and function,"39,705","Integer, bpm",Both sexes,Sep 2015,"40,608",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Left ventricular size and function,0.0,0.0,0.0,0.0,0.0,0.0
22427,Body surface area,133,Left ventricular size and function,"39,698","Continuous, m2",Both sexes,Sep 2015,"40,601",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Left ventricular size and function,0.0,0.0,0.0,0.0,0.0,0.0
22425,Cardiac index,133,Left ventricular size and function,"39,698","Continuous, litres/min/m2",Both sexes,Sep 2015,"40,601",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Left ventricular size and function,0.0,0.0,0.0,0.0,0.0,0.0
22424,Cardiac output,133,Left ventricular size and function,"39,705","Continuous, litres/min",Both sexes,Sep 2015,"40,608",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Left ventricular size and function,0.0,0.0,0.0,0.0,0.0,0.0
22420,LV ejection fraction,133,Left ventricular size and function,"39,705","Integer, percent",Both sexes,Sep 2015,"40,608",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Left ventricular size and function,0.0,0.0,0.0,0.0,0.0,0.0
22421,LV end diastolic volume,133,Left ventricular size and function,"39,705","Integer, mL",Both sexes,Sep 2015,"40,608",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Left ventricular size and function,0.0,0.0,0.0,0.0,0.0,0.0
22422,LV end systolic volume,133,Left ventricular size and function,"39,705","Integer, mL",Both sexes,Sep 2015,"40,608",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Left ventricular size and function,0.0,0.0,0.0,0.0,0.0,0.0
22423,LV stroke volume,133,Left ventricular size and function,"39,705","Integer, mL",Both sexes,Sep 2015,"40,608",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Left ventricular size and function,0.0,0.0,0.0,0.0,0.0,0.0
10142,Number of columns displayed (pilot),100028,Lights pattern memory,"3,714",Integer,Both sexes,Jan 2012,"11,142",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Cognitive function,Lights pattern memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10143,Number of rows displayed (pilot),100028,Lights pattern memory,"3,714",Integer,Both sexes,Jan 2012,"11,142",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Cognitive function,Lights pattern memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10145,Pattern of lights displayed (pilot),100028,Lights pattern memory,"3,714",Text,Both sexes,Jan 2012,"11,142",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Cognitive function,Lights pattern memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10146,Pattern of lights as remembered (pilot),100028,Lights pattern memory,"3,714",Text,Both sexes,Jan 2012,"11,142",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Cognitive function,Lights pattern memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10144,Time taken to complete lights test (pilot),100028,Lights pattern memory,"3,714","Integer, deciseconds",Both sexes,Jan 2012,"11,142",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Cognitive function,Lights pattern memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20204,Liver Imaging - T1 ShMoLLI - DICOM,126,Liver MRI,"39,968",Text,Both sexes,Jul 2014,"41,093",Bulk,Defined (2),Oct 2019,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Liver MRI,0.0,0.0,0.0,0.0,0.0,0.0
20254,Liver images - IDEAL protocol - DICOM,126,Liver MRI,"31,548",Text,Both sexes,Feb 2018,"32,675",Bulk,Defined (2),Oct 2019,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Liver MRI,0.0,0.0,0.0,0.0,0.0,0.0
20203,Liver images - gradient echo - DICOM,126,Liver MRI,"10,091",Text,Both sexes,Jul 2014,"10,091",Bulk,Defined (1),Jul 2017,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Liver MRI,0.0,0.0,0.0,0.0,0.0,0.0
22402,Proton density fat fraction (PDFF),126,Liver MRI,"4,617","Continuous, percent",Both sexes,Sep 2015,"4,617",Data,Defined (1),Apr 2018,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Liver MRI,0.0,0.0,0.0,0.0,0.0,0.0
22401,Liver inflammation factor (LIF),126,Liver MRI,"1,095","Continuous, units",Both sexes,Sep 2015,"1,095",Data,Defined (1),Oct 2015,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Liver MRI,0.0,0.0,0.0,0.0,0.0,0.0
22417,Liver iron corrected T1 (ct1),126,Liver MRI,"2,816","Continuous, msec",Both sexes,Jan 2020,"2,816",Data,Defined (1),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Liver MRI,0.0,0.0,0.0,0.0,0.0,0.0
22400,Liver iron (Fe),126,Liver MRI,"1,112","Continuous, mg/g",Both sexes,Sep 2015,"1,112",Data,Defined (1),Oct 2015,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Liver MRI,0.0,0.0,0.0,0.0,0.0,0.0
24025,Included in pollution study,113,Local environment,pending,Categorical (single),Both sexes,Mar 2015,pending,Data,Singular,N/A,Complete,Additional exposures,Local environment,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22035,Above moderate/vigorous recommendation,54,MET Scores,"402,381",Categorical (single),Both sexes,Jan 2018,"402,381",Data,Defined (1),May 2018,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,MET Scores,0.0,0.0,0.0,0.0,0.0
22036,Above moderate/vigorous/walking recommendation,54,MET Scores,"402,269",Categorical (single),Both sexes,Jan 2018,"402,269",Data,Defined (1),May 2018,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,MET Scores,0.0,0.0,0.0,0.0,0.0
22032,IPAQ activity group,54,MET Scores,"402,381",Categorical (single),Both sexes,Jan 2018,"402,381",Data,Defined (1),May 2018,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,MET Scores,0.0,0.0,0.0,0.0,0.0
22038,MET minutes per week for moderate activity,54,MET Scores,"402,381","Continuous, minutes/week",Both sexes,Jan 2018,"402,381",Data,Defined (1),May 2018,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,MET Scores,0.0,0.0,0.0,0.0,0.0
22039,MET minutes per week for vigorous activity,54,MET Scores,"402,381","Continuous, minutes/week",Both sexes,Jan 2018,"402,381",Data,Defined (1),May 2018,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,MET Scores,0.0,0.0,0.0,0.0,0.0
22037,MET minutes per week for walking,54,MET Scores,"402,381","Continuous, minutes/week",Both sexes,Jan 2018,"402,381",Data,Defined (1),May 2018,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,MET Scores,0.0,0.0,0.0,0.0,0.0
22040,Summed MET minutes per week for all activity,54,MET Scores,"402,381","Continuous, minutes/week",Both sexes,Jan 2018,"402,381",Data,Defined (1),May 2018,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,MET Scores,0.0,0.0,0.0,0.0,0.0
22033,Summed days activity,54,MET Scores,"414,038","Integer, days",Both sexes,Jan 2018,"414,038",Data,Defined (1),May 2018,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,MET Scores,0.0,0.0,0.0,0.0,0.0
22034,Summed minutes activity,54,MET Scores,"402,381","Integer, minutes",Both sexes,Jan 2018,"402,381",Data,Defined (1),May 2018,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,MET Scores,0.0,0.0,0.0,0.0,0.0
2375,Relative age of first facial hair,100070,Male-specific factors,"227,213",Categorical (single),Males only,Jan 2012,"242,529",Data,Defined (3),Nov 2016,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Male-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
2385,Relative age voice broke,100070,Male-specific factors,"227,213",Categorical (single),Males only,Jan 2012,"242,529",Data,Defined (3),Nov 2016,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Male-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
2395,Hair/balding pattern,100070,Male-specific factors,"227,360",Categorical (single),Males only,Jan 2012,"261,212",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Male-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
2405,Number of children fathered,100070,Male-specific factors,"227,360",Integer,Males only,Jan 2012,"261,212",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sex-specific factors,Male-specific factors,0.0,0.0,0.0,0.0,0.0,0.0
20502,Ever had period extreme irritability,139,Mania,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Mania,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20501,Ever had period of mania / excitability,139,Mania,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Mania,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20492,Longest period of mania or irritability,139,Mania,"42,499",Categorical (single),Both sexes,Oct 2016,"42,499",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Mania,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20548,Manifestations of mania or irritability,139,Mania,"29,053",Categorical (multiple),Both sexes,Oct 2016,"74,866",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Mania,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20493,Severity of problems due to mania or irritability,139,Mania,"42,499",Categorical (single),Both sexes,Oct 2016,"42,499",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Mania,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6373,Number of puzzles correctly solved,501,Matrix pattern completion,"32,468","Integer, correct-answers",Both sexes,Jun 2017,"34,653",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Matrix pattern completion,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6374,Number of puzzles viewed,501,Matrix pattern completion,"32,468","Integer, attempts",Both sexes,Jun 2017,"34,653",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Matrix pattern completion,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6332,Item selected for each puzzle,501,Matrix pattern completion,"32,466",Categorical (multiple),Both sexes,Jun 2017,"453,267",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Matrix pattern completion,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6333,Duration spent answering each puzzle,501,Matrix pattern completion,"32,466","Integer, deciseconds",Both sexes,Jun 2017,"453,267",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Matrix pattern completion,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20089,Type of meals eaten,100105,Meal type yesterday,"204,931",Categorical (multiple),Both sexes,Sep 2012,"523,815",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Meal type yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103000,Meat consumers,100106,Meat/fish yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Meat/fish yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103010,Sausage intake,100106,Meat/fish yesterday,"32,220",Categorical (single),Both sexes,Sep 2012,"36,038",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Meat/fish yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103020,Beef intake,100106,Meat/fish yesterday,"69,703",Categorical (single),Both sexes,Sep 2012,"85,874",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Meat/fish yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103030,Pork intake,100106,Meat/fish yesterday,"28,891",Categorical (single),Both sexes,Sep 2012,"32,034",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Meat/fish yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103040,Lamb intake,100106,Meat/fish yesterday,"22,840",Categorical (single),Both sexes,Sep 2012,"24,910",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Meat/fish yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103050,Crumbed or deep-fried poultry intake,100106,Meat/fish yesterday,"13,767",Categorical (single),Both sexes,Sep 2012,"14,480",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Meat/fish yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103060,Poultry intake,100106,Meat/fish yesterday,"83,166",Categorical (single),Both sexes,Sep 2012,"107,299",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Meat/fish yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103070,Bacon intake,100106,Meat/fish yesterday,"37,288",Categorical (single),Both sexes,Sep 2012,"43,197",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Meat/fish yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103080,Ham intake,100106,Meat/fish yesterday,"57,078",Categorical (single),Both sexes,Sep 2012,"71,336",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Meat/fish yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103090,Liver intake,100106,Meat/fish yesterday,"9,132",Categorical (single),Both sexes,Sep 2012,"9,773",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Meat/fish yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103100,Other meat intake,100106,Meat/fish yesterday,"8,736",Categorical (single),Both sexes,Sep 2012,"9,156",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Meat/fish yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103130,Skin removed from poultry,100106,Meat/fish yesterday,"82,033",Categorical (single),Both sexes,Sep 2012,"106,206",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Meat/fish yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103120,Fat removed from meat,100106,Meat/fish yesterday,"105,587",Categorical (single),Both sexes,Sep 2012,"152,696",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Meat/fish yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103140,Fish consumer,100106,Meat/fish yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Meat/fish yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103150,Tinned tuna intake,100106,Meat/fish yesterday,"20,556",Categorical (single),Both sexes,Sep 2012,"22,801",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Meat/fish yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103160,Oily fish intake,100106,Meat/fish yesterday,"44,523",Categorical (single),Both sexes,Sep 2012,"53,766",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Meat/fish yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103170,Breaded fish intake,100106,Meat/fish yesterday,"9,728",Categorical (single),Both sexes,Sep 2012,"10,222",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Meat/fish yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103180,Battered fish intake,100106,Meat/fish yesterday,"8,841",Categorical (single),Both sexes,Sep 2012,"9,166",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Meat/fish yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103190,White fish intake,100106,Meat/fish yesterday,"21,712",Categorical (single),Both sexes,Sep 2012,"23,583",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Meat/fish yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103200,Prawns intake,100106,Meat/fish yesterday,"19,118",Categorical (single),Both sexes,Sep 2012,"21,019",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Meat/fish yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103210,Lobster/crab intake,100106,Meat/fish yesterday,"2,276",Categorical (single),Both sexes,Sep 2012,"2,345",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Meat/fish yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103220,Shellfish intake,100106,Meat/fish yesterday,"4,830",Categorical (single),Both sexes,Sep 2012,"5,056",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Meat/fish yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103230,Other fish intake,100106,Meat/fish yesterday,"8,119",Categorical (single),Both sexes,Sep 2012,"8,530",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Meat/fish yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6150,Vascular/heart problems diagnosed by doctor,100044,Medical conditions,"501,583",Categorical (multiple),Both sexes,Jan 2012,"556,738",Data,Defined (3),Nov 2016,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0
3894,Age heart attack diagnosed,100044,Medical conditions,"12,211","Integer, years",Both sexes,Jan 2012,"13,156",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0
3627,Age angina diagnosed,100044,Medical conditions,"16,775","Integer, years",Both sexes,Jan 2012,"17,869",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0
4056,Age stroke diagnosed,100044,Medical conditions,"8,199","Integer, years",Both sexes,Jan 2012,"8,683",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0
2966,Age high blood pressure diagnosed,100044,Medical conditions,"140,495","Integer, years",Both sexes,Jan 2012,"153,599",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0
6152,"Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",100044,Medical conditions,"501,592",Categorical (multiple),Both sexes,Jan 2012,"612,295",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0
4012,"Age deep-vein thrombosis (DVT, blood clot in leg) diagnosed",100044,Medical conditions,"10,458","Integer, years",Both sexes,Jan 2012,"11,184",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0
4022,Age pulmonary embolism (blood clot in lung) diagnosed,100044,Medical conditions,"4,345","Integer, years",Both sexes,Jan 2012,"4,673",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0
3992,Age emphysema/chronic bronchitis diagnosed,100044,Medical conditions,"8,808","Integer, years",Both sexes,Jan 2012,"9,101",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0
3786,Age asthma diagnosed,100044,Medical conditions,"59,139","Integer, years",Both sexes,Jan 2012,"65,631",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0
3761,"Age hay fever, rhinitis or eczema diagnosed",100044,Medical conditions,"118,295","Integer, years",Both sexes,Jan 2012,"131,906",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0
2443,Diabetes diagnosed by doctor,100044,Medical conditions,"501,592",Categorical (single),Both sexes,Jan 2012,"572,218",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0
4041,Gestational diabetes only,100044,Medical conditions,"10,922",Categorical (single),Females only,Jan 2012,"11,709",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0
10844,Gestational diabetes only (pilot),100044,Medical conditions,63,Categorical (single),Females only,Jan 2012,63,Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0
2976,Age diabetes diagnosed,100044,Medical conditions,"26,945","Integer, years",Both sexes,Jan 2012,"29,109",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0
2986,Started insulin within one year diagnosis of diabetes,100044,Medical conditions,"26,970",Categorical (single),Both sexes,Jan 2012,"29,135",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0
2453,Cancer diagnosed by doctor,100044,Medical conditions,"501,592",Categorical (single),Both sexes,Jan 2012,"572,218",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0
2463,Fractured/broken bones in last 5 years,100044,Medical conditions,"501,592",Categorical (single),Both sexes,Jan 2012,"572,218",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0
6151,Fractured bone site(s),100044,Medical conditions,"52,059",Categorical (multiple),Both sexes,Jan 2012,"59,609",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0
3005,Fracture resulting from simple fall,100044,Medical conditions,"52,059",Categorical (single),Both sexes,Jan 2012,"53,927",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0
2473,Other serious medical condition/disability diagnosed by doctor,100044,Medical conditions,"501,592",Categorical (single),Both sexes,Jan 2012,"572,218",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0
20001,"Cancer code, self-reported",100074,Medical conditions,"45,525",Categorical (multiple),Both sexes,Jan 2012,"53,149",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Verbal interview,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
84,Cancer year/age first occurred,100074,Medical conditions,"45,525",Integer,Both sexes,Jan 2012,"53,149",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Verbal interview,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20007,Interpolated Age of participant when cancer first diagnosed,100074,Medical conditions,"45,525","Continuous, years",Both sexes,Feb 2012,"53,149",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Verbal interview,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20009,Interpolated Age of participant when non-cancer illness first diagnosed,100074,Medical conditions,"385,696","Continuous, years",Both sexes,Feb 2012,"1,121,517",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Verbal interview,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20006,Interpolated Year when cancer first diagnosed,100074,Medical conditions,"45,525","Continuous, years",Both sexes,Feb 2012,"53,149",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Verbal interview,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20008,Interpolated Year when non-cancer illness first diagnosed,100074,Medical conditions,"385,696","Continuous, years",Both sexes,Feb 2012,"1,121,517",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Verbal interview,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20012,Method of recording time when cancer first diagnosed,100074,Medical conditions,"45,525",Categorical (single),Both sexes,Feb 2012,"53,149",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Verbal interview,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20013,Method of recording time when non-cancer illness first diagnosed,100074,Medical conditions,"385,697",Categorical (single),Both sexes,Feb 2012,"1,121,528",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Verbal interview,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20002,"Non-cancer illness code, self-reported",100074,Medical conditions,"385,697",Categorical (multiple),Both sexes,Jan 2012,"1,121,528",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Verbal interview,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
87,Non-cancer illness year/age first occurred,100074,Medical conditions,"385,697",Integer,Both sexes,Jan 2012,"1,121,528",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Verbal interview,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
134,Number of self-reported cancers,100074,Medical conditions,"501,656",Integer,Both sexes,Jan 2012,"566,685",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Verbal interview,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
135,Number of self-reported non-cancer illnesses,100074,Medical conditions,"501,656",Integer,Both sexes,Jan 2012,"566,685",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Verbal interview,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3140,Pregnant,100074,Medical conditions,"272,567",Categorical (single),Females only,Jan 2012,"308,282",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Verbal interview,Medical conditions,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22502,Cough on most days,132,Medical information,"121,277",Categorical (single),Both sexes,Jul 2015,"121,277",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22504,Bring up phlegm/sputum/mucus on most days,132,Medical information,"121,277",Categorical (single),Both sexes,Jul 2015,"121,277",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22503,Years of cough on most days,132,Medical information,"16,497","Integer, years",Both sexes,Jul 2015,"16,497",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22505,Years of bringing up phlegm/sputum/mucus on most days,132,Medical information,"10,481","Integer, years",Both sexes,Jul 2015,"10,481",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22506,Tobacco smoking,132,Medical information,"121,277",Categorical (single),Both sexes,Jul 2015,"121,277",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22507,Age of stopping smoking,132,Medical information,"44,009","Integer, years",Both sexes,Jul 2015,"44,009",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22508,Amount of tobacco currently smoked,132,Medical information,"2,873",Integer,Both sexes,Jul 2015,"2,873",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22132,Doctor diagnosed alpha-1 antitrypsin deficiency,132,Medical information,"121,277",Categorical (single),Both sexes,Jul 2015,"121,277",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22139,Doctor diagnosed asbestosis,132,Medical information,"121,277",Categorical (single),Both sexes,Jul 2015,"121,277",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22127,Doctor diagnosed asthma,132,Medical information,"121,277",Categorical (single),Both sexes,Jul 2015,"121,277",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22134,Doctor diagnosed bronchiectasis,132,Medical information,"121,277",Categorical (single),Both sexes,Jul 2015,"121,277",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22129,Doctor diagnosed chronic bronchitis,132,Medical information,"121,277",Categorical (single),Both sexes,Jul 2015,"121,277",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22130,Doctor diagnosed COPD (chronic obstructive pulmonary disease),132,Medical information,"121,277",Categorical (single),Both sexes,Jul 2015,"121,277",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22131,Doctor diagnosed cystic fibrosis,132,Medical information,"121,277",Categorical (single),Both sexes,Jul 2015,"121,277",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22128,Doctor diagnosed emphysema,132,Medical information,"121,277",Categorical (single),Both sexes,Jul 2015,"121,277",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22136,Doctor diagnosed fibrosing alveolitis/unspecified alveolitis,132,Medical information,"121,277",Categorical (single),Both sexes,Jul 2015,"121,277",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22126,Doctor diagnosed hayfever or allergic rhinitis,132,Medical information,"121,277",Categorical (single),Both sexes,Jul 2015,"121,277",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22135,Doctor diagnosed idiopathic pulmonary fibrosis,132,Medical information,"121,277",Categorical (single),Both sexes,Jul 2015,"121,277",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22140,Doctor diagnosed lung cancer (not mesothelioma),132,Medical information,"121,277",Categorical (single),Both sexes,Jul 2015,"121,277",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22141,Doctor diagnosed mesothelioma of the lung,132,Medical information,"121,277",Categorical (single),Both sexes,Jul 2015,"121,277",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22133,Doctor diagnosed sarcoidosis,132,Medical information,"121,277",Categorical (single),Both sexes,Jul 2015,"121,277",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22138,Doctor diagnosed silicosis,132,Medical information,"121,277",Categorical (single),Both sexes,Jul 2015,"121,277",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22137,Doctor diagnosed tuberculosis,132,Medical information,"121,277",Categorical (single),Both sexes,Jul 2015,"121,277",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22152,Age alpha-1 antitrypsin deficiency diagnosed by doctor,132,Medical information,48,Integer,Both sexes,Jul 2015,48,Data,Singular,Nov 2015,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22159,Age asbestosis diagnosed by doctor,132,Medical information,85,Integer,Both sexes,Jul 2015,85,Data,Singular,Sep 2016,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22147,Age asthma diagnosed by doctor,132,Medical information,"15,492",Integer,Both sexes,Jul 2015,"15,492",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22154,Age bronchiectasis diagnosed by doctor,132,Medical information,"1,073",Integer,Both sexes,Jul 2015,"1,073",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22149,Age chronic bronchitis diagnosed by doctor,132,Medical information,"1,383",Integer,Both sexes,Jul 2015,"1,383",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22150,Age COPD (Chronic Obstructive Pulmonary Disease) diagnosed by doctor,132,Medical information,"1,768",Integer,Both sexes,Jul 2015,"1,768",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22151,Age cystic fibrosis diagnosed by doctor,132,Medical information,9,Integer,Both sexes,Jul 2015,9,Data,Singular,Jan 2016,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22148,Age emphysema diagnosed by doctor,132,Medical information,365,Integer,Both sexes,Jul 2015,365,Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22156,Age fibrosing alveolitis/unspecified alveolitis diagnosed by doctor,132,Medical information,46,Integer,Both sexes,Jul 2015,46,Data,Singular,Jan 2016,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22146,Age hayfever or allergic rhinitis diagnosed by doctor,132,Medical information,"27,704",Integer,Both sexes,Jul 2015,"27,704",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22155,Age idiopathic pulmonary fibrosis diagnosed by doctor,132,Medical information,108,Integer,Both sexes,Jul 2015,108,Data,Singular,Feb 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22160,Age lung cancer (not mesothelioma) diagnosed by doctor,132,Medical information,156,Integer,Both sexes,Jul 2015,156,Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22161,Age mesothelioma of the lung diagnosed by doctor,132,Medical information,14,Integer,Both sexes,Jul 2015,14,Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22153,Age sarcoidosis diagnosed by doctor,132,Medical information,529,Integer,Both sexes,Jul 2015,529,Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22158,Age silicosis diagnosed by doctor,132,Medical information,8,Integer,Both sexes,Jul 2015,8,Data,Singular,Sep 2015,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22157,Age tuberculosis diagnosed by doctor,132,Medical information,654,Integer,Both sexes,Jul 2015,654,Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22172,Recent medication for alpha-1 antitrypsin deficiency,132,Medical information,48,Categorical (single),Both sexes,Jul 2015,48,Data,Singular,Nov 2015,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22179,Recent medication for asbestosis,132,Medical information,85,Categorical (single),Both sexes,Jul 2015,85,Data,Singular,Sep 2016,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22167,Recent medication for asthma,132,Medical information,"15,492",Categorical (single),Both sexes,Jul 2015,"15,492",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22174,Recent medication for bronchiectasis,132,Medical information,"1,073",Categorical (single),Both sexes,Jul 2015,"1,073",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22169,Recent medication for chronic bronchitis,132,Medical information,"1,383",Categorical (single),Both sexes,Jul 2015,"1,383",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22170,Recent medication for COPD (Chronic Obstructive Pulmonary Disease),132,Medical information,"1,768",Categorical (single),Both sexes,Jul 2015,"1,768",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22171,Recent medication for cystic fibrosis,132,Medical information,9,Categorical (single),Both sexes,Jul 2015,9,Data,Singular,Jan 2016,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22168,Recent medication for emphysema,132,Medical information,365,Categorical (single),Both sexes,Jul 2015,365,Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22176,Recent medication for fibrosing alveolitis/unspecified alveolitis,132,Medical information,46,Categorical (single),Both sexes,Jul 2015,46,Data,Singular,Jan 2016,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22166,Recent medication for hayfever or allergic rhinitis,132,Medical information,"27,704",Categorical (single),Both sexes,Jul 2015,"27,704",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22175,Recent medication for idiopathic pulmonary fibrosis,132,Medical information,108,Categorical (single),Both sexes,Jul 2015,108,Data,Singular,Feb 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22180,Recent medication for lung cancer (not mesothelioma),132,Medical information,156,Categorical (single),Both sexes,Jul 2015,156,Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22181,Recent medication for mesothelioma of the lung,132,Medical information,14,Categorical (single),Both sexes,Jul 2015,14,Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22173,Recent medication for sarcoidosis,132,Medical information,529,Categorical (single),Both sexes,Jul 2015,529,Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22178,Recent medication for silicosis,132,Medical information,8,Categorical (single),Both sexes,Jul 2015,8,Data,Singular,Sep 2015,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22177,Recent medication for tuberculosis,132,Medical information,654,Categorical (single),Both sexes,Jul 2015,654,Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,Medical information,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6177,"Medication for cholesterol, blood pressure or diabetes",100045,Medication,"227,358",Categorical (multiple),Males only,Jan 2012,"304,429",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medication,0.0,0.0,0.0,0.0,0.0,0.0
6153,"Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones",100045,Medication,"271,334",Categorical (multiple),Females only,Jan 2012,"338,045",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medication,0.0,0.0,0.0,0.0,0.0,0.0
2492,Taking other prescription medications,100045,Medication,"501,592",Categorical (single),Both sexes,Jan 2012,"572,218",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medication,0.0,0.0,0.0,0.0,0.0,0.0
6154,"Medication for pain relief, constipation, heartburn",100045,Medication,"498,704",Categorical (multiple),Both sexes,Jan 2012,"666,126",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medication,0.0,0.0,0.0,0.0,0.0,0.0
10004,"Medication for pain relief, constipation, heartburn (pilot)",100045,Medication,"3,770",Categorical (multiple),Both sexes,Jan 2012,"4,460",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medication,0.0,0.0,0.0,0.0,0.0,0.0
10005,"Medication for smoking cessation, constipation, heartburn, allergies (pilot)",100045,Medication,"3,770",Categorical (multiple),Both sexes,Jan 2012,"3,824",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medication,0.0,0.0,0.0,0.0,0.0,0.0
6155,Vitamin and mineral supplements,100045,Medication,"498,704",Categorical (multiple),Both sexes,Jan 2012,"651,677",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medication,0.0,0.0,0.0,0.0,0.0,0.0
10007,Vitamin and mineral supplements (pilot),100045,Medication,"3,770",Categorical (multiple),Both sexes,Jan 2012,"4,917",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medication,0.0,0.0,0.0,0.0,0.0,0.0
6179,Mineral and other dietary supplements,100045,Medication,"498,703",Categorical (multiple),Both sexes,Jan 2012,"702,807",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medication,0.0,0.0,0.0,0.0,0.0,0.0
10723,Vitamin supplements (pilot),100045,Medication,"3,770",Categorical (multiple),Both sexes,Jan 2012,"4,471",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medication,0.0,0.0,0.0,0.0,0.0,0.0
10854,Other dietary supplements (pilot),100045,Medication,"3,770",Categorical (multiple),Both sexes,Jan 2012,"4,183",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Medication,0.0,0.0,0.0,0.0,0.0,0.0
137,Number of treatments/medications taken,100075,Medications,"501,656",Integer,Both sexes,Jan 2012,"566,685",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Verbal interview,Medications,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20076,Treatment/medication READ-code,100075,Medications,pending,Text,Both sexes,Jun 2015,pending,Data,Defined (1),N/A,Accruing,UK Biobank Assessment Centre,Verbal interview,Medications,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20003,Treatment/medication code,100075,Medications,"372,746",Categorical (multiple),Both sexes,Jan 2012,"1,377,803",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Verbal interview,Medications,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6671,Number of antibiotics taken in last 3 months,100075,Medications,"29,630",Integer,Both sexes,Nov 2018,"32,081",Data,Defined (2),Feb 2020,Ongoing,UK Biobank Assessment Centre,Verbal interview,Medications,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20199,Antibiotic codes for last 3 months,100075,Medications,"2,079",Categorical (multiple),Both sexes,Nov 2018,"2,294",Data,Defined (2),Feb 2020,Ongoing,UK Biobank Assessment Centre,Verbal interview,Medications,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130836,Date F00 first reported (dementia in alzheimer's disease),2405,Mental and behavioural disorders,586,Date,Both sexes,Jul 2019,586,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130837,Source of report of F00 (dementia in alzheimer's disease),2405,Mental and behavioural disorders,586,Categorical (single),Both sexes,Jul 2019,586,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130838,Date F01 first reported (vascular dementia),2405,Mental and behavioural disorders,686,Date,Both sexes,Jul 2019,686,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130839,Source of report of F01 (vascular dementia),2405,Mental and behavioural disorders,686,Categorical (single),Both sexes,Jul 2019,686,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130840,Date F02 first reported (dementia in other diseases classified elsewhere),2405,Mental and behavioural disorders,296,Date,Both sexes,Jul 2019,296,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130841,Source of report of F02 (dementia in other diseases classified elsewhere),2405,Mental and behavioural disorders,296,Categorical (single),Both sexes,Jul 2019,296,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130842,Date F03 first reported (unspecified dementia),2405,Mental and behavioural disorders,"1,405",Date,Both sexes,Jul 2019,"1,405",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130843,Source of report of F03 (unspecified dementia),2405,Mental and behavioural disorders,"1,405",Categorical (single),Both sexes,Jul 2019,"1,405",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130844,"Date F04 first reported (organic amnesic syndrome, not induced by alcohol and other psychoactive substances)",2405,Mental and behavioural disorders,21,Date,Both sexes,Jul 2019,21,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130845,"Source of report of F04 (organic amnesic syndrome, not induced by alcohol and other psychoactive substances)",2405,Mental and behavioural disorders,21,Categorical (single),Both sexes,Jul 2019,21,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130846,"Date F05 first reported (delirium, not induced by alcohol and other psychoactive substances)",2405,Mental and behavioural disorders,"1,592",Date,Both sexes,Jul 2019,"1,592",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130847,"Source of report of F05 (delirium, not induced by alcohol and other psychoactive substances)",2405,Mental and behavioural disorders,"1,592",Categorical (single),Both sexes,Jul 2019,"1,592",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130848,Date F06 first reported (other mental disorders due to brain damage and dysfunction and to physical disease),2405,Mental and behavioural disorders,773,Date,Both sexes,Jul 2019,773,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130849,Source of report of F06 (other mental disorders due to brain damage and dysfunction and to physical disease),2405,Mental and behavioural disorders,773,Categorical (single),Both sexes,Jul 2019,773,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130850,"Date F07 first reported (personality and behavioural disorders due to brain disease, damage and dysfunction)",2405,Mental and behavioural disorders,198,Date,Both sexes,Jul 2019,198,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130851,"Source of report of F07 (personality and behavioural disorders due to brain disease, damage and dysfunction)",2405,Mental and behavioural disorders,198,Categorical (single),Both sexes,Jul 2019,198,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130852,Date F09 first reported (unspecified organic or symptomatic mental disorder),2405,Mental and behavioural disorders,502,Date,Both sexes,Jul 2019,502,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130853,Source of report of F09 (unspecified organic or symptomatic mental disorder),2405,Mental and behavioural disorders,502,Categorical (single),Both sexes,Jul 2019,502,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130854,Date F10 first reported (mental and behavioural disorders due to use of alcohol),2405,Mental and behavioural disorders,"9,794",Date,Both sexes,Jul 2019,"9,794",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130855,Source of report of F10 (mental and behavioural disorders due to use of alcohol),2405,Mental and behavioural disorders,"9,794",Categorical (single),Both sexes,Jul 2019,"9,794",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130856,Date F11 first reported (mental and behavioural disorders due to use of opioids),2405,Mental and behavioural disorders,280,Date,Both sexes,Jul 2019,280,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130857,Source of report of F11 (mental and behavioural disorders due to use of opioids),2405,Mental and behavioural disorders,280,Categorical (single),Both sexes,Jul 2019,280,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130858,Date F12 first reported (mental and behavioural disorders due to use of cannabinoids),2405,Mental and behavioural disorders,312,Date,Both sexes,Jul 2019,312,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130859,Source of report of F12 (mental and behavioural disorders due to use of cannabinoids),2405,Mental and behavioural disorders,312,Categorical (single),Both sexes,Jul 2019,312,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130860,Date F13 first reported (mental and behavioural disorders due to use of sedatives or hypnotics),2405,Mental and behavioural disorders,262,Date,Both sexes,Jul 2019,262,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130861,Source of report of F13 (mental and behavioural disorders due to use of sedatives or hypnotics),2405,Mental and behavioural disorders,262,Categorical (single),Both sexes,Jul 2019,262,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130862,Date F14 first reported (mental and behavioural disorders due to use of cocaine),2405,Mental and behavioural disorders,62,Date,Both sexes,Jul 2019,62,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130863,Source of report of F14 (mental and behavioural disorders due to use of cocaine),2405,Mental and behavioural disorders,62,Categorical (single),Both sexes,Jul 2019,62,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130864,"Date F15 first reported (mental and behavioural disorders due to use of other stimulants, including caffeine)",2405,Mental and behavioural disorders,67,Date,Both sexes,Jul 2019,67,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130865,"Source of report of F15 (mental and behavioural disorders due to use of other stimulants, including caffeine)",2405,Mental and behavioural disorders,67,Categorical (single),Both sexes,Jul 2019,67,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130866,Date F16 first reported (mental and behavioural disorders due to use of hallucinogens),2405,Mental and behavioural disorders,38,Date,Both sexes,Jul 2019,38,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130867,Source of report of F16 (mental and behavioural disorders due to use of hallucinogens),2405,Mental and behavioural disorders,38,Categorical (single),Both sexes,Jul 2019,38,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130868,Date F17 first reported (mental and behavioural disorders due to use of tobacco),2405,Mental and behavioural disorders,"39,286",Date,Both sexes,Jul 2019,"39,286",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130869,Source of report of F17 (mental and behavioural disorders due to use of tobacco),2405,Mental and behavioural disorders,"39,286",Categorical (single),Both sexes,Jul 2019,"39,286",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130870,Date F18 first reported (mental and behavioural disorders due to use of volatile solvents),2405,Mental and behavioural disorders,9,Date,Both sexes,Jul 2019,9,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130871,Source of report of F18 (mental and behavioural disorders due to use of volatile solvents),2405,Mental and behavioural disorders,9,Categorical (single),Both sexes,Jul 2019,9,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130872,Date F19 first reported (mental and behavioural disorders due to multiple drug use and use of other psychoactive substances),2405,Mental and behavioural disorders,261,Date,Both sexes,Jul 2019,261,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130873,Source of report of F19 (mental and behavioural disorders due to multiple drug use and use of other psychoactive substances),2405,Mental and behavioural disorders,261,Categorical (single),Both sexes,Jul 2019,261,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130874,Date F20 first reported (schizophrenia),2405,Mental and behavioural disorders,"1,200",Date,Both sexes,Jul 2019,"1,200",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130875,Source of report of F20 (schizophrenia),2405,Mental and behavioural disorders,"1,200",Categorical (single),Both sexes,Jul 2019,"1,200",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130876,Date F21 first reported (schizotypal disorder),2405,Mental and behavioural disorders,21,Date,Both sexes,Jul 2019,21,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130877,Source of report of F21 (schizotypal disorder),2405,Mental and behavioural disorders,21,Categorical (single),Both sexes,Jul 2019,21,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130878,Date F22 first reported (persistent delusional disorders),2405,Mental and behavioural disorders,439,Date,Both sexes,Jul 2019,439,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130879,Source of report of F22 (persistent delusional disorders),2405,Mental and behavioural disorders,439,Categorical (single),Both sexes,Jul 2019,439,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130880,Date F23 first reported (acute and transient psychotic disorders),2405,Mental and behavioural disorders,265,Date,Both sexes,Jul 2019,265,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130881,Source of report of F23 (acute and transient psychotic disorders),2405,Mental and behavioural disorders,265,Categorical (single),Both sexes,Jul 2019,265,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130882,Date F24 first reported (induced delusional disorder),2405,Mental and behavioural disorders,5,Date,Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130883,Source of report of F24 (induced delusional disorder),2405,Mental and behavioural disorders,5,Categorical (single),Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130884,Date F25 first reported (schizoaffective disorders),2405,Mental and behavioural disorders,310,Date,Both sexes,Jul 2019,310,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130885,Source of report of F25 (schizoaffective disorders),2405,Mental and behavioural disorders,310,Categorical (single),Both sexes,Jul 2019,310,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130886,Date F28 first reported (other nonorganic psychotic disorders),2405,Mental and behavioural disorders,11,Date,Both sexes,Jul 2019,11,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130887,Source of report of F28 (other nonorganic psychotic disorders),2405,Mental and behavioural disorders,11,Categorical (single),Both sexes,Jul 2019,11,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130888,Date F29 first reported (unspecified nonorganic psychosis),2405,Mental and behavioural disorders,441,Date,Both sexes,Jul 2019,441,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130889,Source of report of F29 (unspecified nonorganic psychosis),2405,Mental and behavioural disorders,441,Categorical (single),Both sexes,Jul 2019,441,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130890,Date F30 first reported (manic episode),2405,Mental and behavioural disorders,456,Date,Both sexes,Jul 2019,456,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130891,Source of report of F30 (manic episode),2405,Mental and behavioural disorders,456,Categorical (single),Both sexes,Jul 2019,456,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130892,Date F31 first reported (bipolar affective disorder),2405,Mental and behavioural disorders,"1,705",Date,Both sexes,Jul 2019,"1,705",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130893,Source of report of F31 (bipolar affective disorder),2405,Mental and behavioural disorders,"1,705",Categorical (single),Both sexes,Jul 2019,"1,705",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130894,Date F32 first reported (depressive episode),2405,Mental and behavioural disorders,"52,319",Date,Both sexes,Jul 2019,"52,319",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130895,Source of report of F32 (depressive episode),2405,Mental and behavioural disorders,"52,319",Categorical (single),Both sexes,Jul 2019,"52,319",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130896,Date F33 first reported (recurrent depressive disorder),2405,Mental and behavioural disorders,"3,652",Date,Both sexes,Jul 2019,"3,652",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130897,Source of report of F33 (recurrent depressive disorder),2405,Mental and behavioural disorders,"3,652",Categorical (single),Both sexes,Jul 2019,"3,652",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130898,Date F34 first reported (persistent mood [affective] disorders),2405,Mental and behavioural disorders,879,Date,Both sexes,Jul 2019,879,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130899,Source of report of F34 (persistent mood [affective] disorders),2405,Mental and behavioural disorders,879,Categorical (single),Both sexes,Jul 2019,879,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130900,Date F38 first reported (other mood [affective] disorders),2405,Mental and behavioural disorders,156,Date,Both sexes,Jul 2019,156,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130901,Source of report of F38 (other mood [affective] disorders),2405,Mental and behavioural disorders,156,Categorical (single),Both sexes,Jul 2019,156,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130902,Date F39 first reported (unspecified mood [affective] disorder),2405,Mental and behavioural disorders,888,Date,Both sexes,Jul 2019,888,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130903,Source of report of F39 (unspecified mood [affective] disorder),2405,Mental and behavioural disorders,888,Categorical (single),Both sexes,Jul 2019,888,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130904,Date F40 first reported (phobic anxiety disorders),2405,Mental and behavioural disorders,"3,059",Date,Both sexes,Jul 2019,"3,059",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130905,Source of report of F40 (phobic anxiety disorders),2405,Mental and behavioural disorders,"3,059",Categorical (single),Both sexes,Jul 2019,"3,059",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130906,Date F41 first reported (other anxiety disorders),2405,Mental and behavioural disorders,"22,990",Date,Both sexes,Jul 2019,"22,990",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130907,Source of report of F41 (other anxiety disorders),2405,Mental and behavioural disorders,"22,990",Categorical (single),Both sexes,Jul 2019,"22,990",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130908,Date F42 first reported (obsessive-compulsive disorder),2405,Mental and behavioural disorders,814,Date,Both sexes,Jul 2019,814,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130909,Source of report of F42 (obsessive-compulsive disorder),2405,Mental and behavioural disorders,814,Categorical (single),Both sexes,Jul 2019,814,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130910,"Date F43 first reported (reaction to severe stress, and adjustment disorders)",2405,Mental and behavioural disorders,"14,330",Date,Both sexes,Jul 2019,"14,330",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130911,"Source of report of F43 (reaction to severe stress, and adjustment disorders)",2405,Mental and behavioural disorders,"14,330",Categorical (single),Both sexes,Jul 2019,"14,330",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130912,Date F44 first reported (dissociative [conversion] disorders),2405,Mental and behavioural disorders,280,Date,Both sexes,Jul 2019,280,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130913,Source of report of F44 (dissociative [conversion] disorders),2405,Mental and behavioural disorders,280,Categorical (single),Both sexes,Jul 2019,280,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130914,Date F45 first reported (somatoform disorders),2405,Mental and behavioural disorders,"2,965",Date,Both sexes,Jul 2019,"2,965",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130915,Source of report of F45 (somatoform disorders),2405,Mental and behavioural disorders,"2,965",Categorical (single),Both sexes,Jul 2019,"2,965",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130916,Date F48 first reported (other neurotic disorders),2405,Mental and behavioural disorders,354,Date,Both sexes,Jul 2019,354,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130917,Source of report of F48 (other neurotic disorders),2405,Mental and behavioural disorders,354,Categorical (single),Both sexes,Jul 2019,354,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130918,Date F50 first reported (eating disorders),2405,Mental and behavioural disorders,908,Date,Both sexes,Jul 2019,908,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130919,Source of report of F50 (eating disorders),2405,Mental and behavioural disorders,908,Categorical (single),Both sexes,Jul 2019,908,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130920,Date F51 first reported (nonorganic sleep disorders),2405,Mental and behavioural disorders,536,Date,Both sexes,Jul 2019,536,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130921,Source of report of F51 (nonorganic sleep disorders),2405,Mental and behavioural disorders,536,Categorical (single),Both sexes,Jul 2019,536,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130922,"Date F52 first reported (sexual dysfunction, not caused by organic disorder or disease)",2405,Mental and behavioural disorders,"2,147",Date,Both sexes,Jul 2019,"2,147",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130923,"Source of report of F52 (sexual dysfunction, not caused by organic disorder or disease)",2405,Mental and behavioural disorders,"2,147",Categorical (single),Both sexes,Jul 2019,"2,147",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130924,"Date F53 first reported (mental and behavioural disorders associated with the puerperium, not elsewhere classified)",2405,Mental and behavioural disorders,"1,259",Date,Both sexes,Jul 2019,"1,259",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130925,"Source of report of F53 (mental and behavioural disorders associated with the puerperium, not elsewhere classified)",2405,Mental and behavioural disorders,"1,259",Categorical (single),Both sexes,Jul 2019,"1,259",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130926,Date F54 first reported (psychological and behavioural factors associated with disorders or diseases classified elsewhere),2405,Mental and behavioural disorders,8,Date,Both sexes,Jul 2019,8,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130927,Source of report of F54 (psychological and behavioural factors associated with disorders or diseases classified elsewhere),2405,Mental and behavioural disorders,8,Categorical (single),Both sexes,Jul 2019,8,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130928,Date F55 first reported (abuse of non-dependence-producing substances),2405,Mental and behavioural disorders,20,Date,Both sexes,Jul 2019,20,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130929,Source of report of F55 (abuse of non-dependence-producing substances),2405,Mental and behavioural disorders,20,Categorical (single),Both sexes,Jul 2019,20,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130930,Date F59 first reported (unspecified behavioural syndromes associated with physiological disturbances and physical factors),2405,Mental and behavioural disorders,3,Date,Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130931,Source of report of F59 (unspecified behavioural syndromes associated with physiological disturbances and physical factors),2405,Mental and behavioural disorders,3,Categorical (single),Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130932,Date F60 first reported (specific personality disorders),2405,Mental and behavioural disorders,688,Date,Both sexes,Jul 2019,688,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130933,Source of report of F60 (specific personality disorders),2405,Mental and behavioural disorders,688,Categorical (single),Both sexes,Jul 2019,688,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130934,Date F61 first reported (mixed and other personality disorders),2405,Mental and behavioural disorders,29,Date,Both sexes,Jul 2019,29,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130935,Source of report of F61 (mixed and other personality disorders),2405,Mental and behavioural disorders,29,Categorical (single),Both sexes,Jul 2019,29,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130936,"Date F62 first reported (enduring personality changes, not attributable to brain damage and disease)",2405,Mental and behavioural disorders,42,Date,Both sexes,Jul 2019,42,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130937,"Source of report of F62 (enduring personality changes, not attributable to brain damage and disease)",2405,Mental and behavioural disorders,42,Categorical (single),Both sexes,Jul 2019,42,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130938,Date F63 first reported (habit and impulse disorders),2405,Mental and behavioural disorders,47,Date,Both sexes,Jul 2019,47,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130939,Source of report of F63 (habit and impulse disorders),2405,Mental and behavioural disorders,47,Categorical (single),Both sexes,Jul 2019,47,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130940,Date F64 first reported (gender identity disorders),2405,Mental and behavioural disorders,90,Date,Both sexes,Jul 2019,90,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130941,Source of report of F64 (gender identity disorders),2405,Mental and behavioural disorders,90,Categorical (single),Both sexes,Jul 2019,90,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130942,Date F65 first reported (disorders of sexual preference),2405,Mental and behavioural disorders,29,Date,Both sexes,Jul 2019,29,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130943,Source of report of F65 (disorders of sexual preference),2405,Mental and behavioural disorders,29,Categorical (single),Both sexes,Jul 2019,29,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130944,Date F66 first reported (psychological and behavioural disorders associated with sexual development and orientation),2405,Mental and behavioural disorders,382,Date,Both sexes,Jul 2019,382,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130945,Source of report of F66 (psychological and behavioural disorders associated with sexual development and orientation),2405,Mental and behavioural disorders,382,Categorical (single),Both sexes,Jul 2019,382,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130946,Date F68 first reported (other disorders of adult personality and behaviour),2405,Mental and behavioural disorders,20,Date,Both sexes,Jul 2019,20,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130947,Source of report of F68 (other disorders of adult personality and behaviour),2405,Mental and behavioural disorders,20,Categorical (single),Both sexes,Jul 2019,20,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130948,Date F69 first reported (unspecified disorder of adult personality and behaviour),2405,Mental and behavioural disorders,151,Date,Both sexes,Jul 2019,151,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130949,Source of report of F69 (unspecified disorder of adult personality and behaviour),2405,Mental and behavioural disorders,151,Categorical (single),Both sexes,Jul 2019,151,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130950,Date F70 first reported (mild mental retardation),2405,Mental and behavioural disorders,45,Date,Both sexes,Jul 2019,45,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130951,Source of report of F70 (mild mental retardation),2405,Mental and behavioural disorders,45,Categorical (single),Both sexes,Jul 2019,45,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130952,Date F71 first reported (moderate mental retardation),2405,Mental and behavioural disorders,12,Date,Both sexes,Jul 2019,12,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130953,Source of report of F71 (moderate mental retardation),2405,Mental and behavioural disorders,12,Categorical (single),Both sexes,Jul 2019,12,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130954,Date F72 first reported (severe mental retardation),2405,Mental and behavioural disorders,3,Date,Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130955,Source of report of F72 (severe mental retardation),2405,Mental and behavioural disorders,3,Categorical (single),Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130956,Date F73 first reported (profound mental retardation),2405,Mental and behavioural disorders,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130957,Source of report of F73 (profound mental retardation),2405,Mental and behavioural disorders,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130958,Date F78 first reported (other mental retardation),2405,Mental and behavioural disorders,3,Date,Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130959,Source of report of F78 (other mental retardation),2405,Mental and behavioural disorders,3,Categorical (single),Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130960,Date F79 first reported (unspecified mental retardation),2405,Mental and behavioural disorders,83,Date,Both sexes,Jul 2019,83,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130961,Source of report of F79 (unspecified mental retardation),2405,Mental and behavioural disorders,83,Categorical (single),Both sexes,Jul 2019,83,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130962,Date F80 first reported (specific developmental disorders of speech and language),2405,Mental and behavioural disorders,233,Date,Both sexes,Jul 2019,233,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130963,Source of report of F80 (specific developmental disorders of speech and language),2405,Mental and behavioural disorders,233,Categorical (single),Both sexes,Jul 2019,233,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130964,Date F81 first reported (specific developmental disorders of scholastic skills),2405,Mental and behavioural disorders,372,Date,Both sexes,Jul 2019,372,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130965,Source of report of F81 (specific developmental disorders of scholastic skills),2405,Mental and behavioural disorders,372,Categorical (single),Both sexes,Jul 2019,372,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130966,Date F82 first reported (specific developmental disorder of motor function),2405,Mental and behavioural disorders,16,Date,Both sexes,Jul 2019,16,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130967,Source of report of F82 (specific developmental disorder of motor function),2405,Mental and behavioural disorders,16,Categorical (single),Both sexes,Jul 2019,16,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130968,Date F83 first reported (mixed specific developmental disorders),2405,Mental and behavioural disorders,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130969,Source of report of F83 (mixed specific developmental disorders),2405,Mental and behavioural disorders,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130970,Date F84 first reported (pervasive developmental disorders),2405,Mental and behavioural disorders,191,Date,Both sexes,Jul 2019,191,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130971,Source of report of F84 (pervasive developmental disorders),2405,Mental and behavioural disorders,191,Categorical (single),Both sexes,Jul 2019,191,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130972,Date F88 first reported (other disorders of psychological development),2405,Mental and behavioural disorders,3,Date,Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130973,Source of report of F88 (other disorders of psychological development),2405,Mental and behavioural disorders,3,Categorical (single),Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130974,Date F89 first reported (unspecified disorder of psychological development),2405,Mental and behavioural disorders,5,Date,Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130975,Source of report of F89 (unspecified disorder of psychological development),2405,Mental and behavioural disorders,5,Categorical (single),Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130976,Date F90 first reported (hyperkinetic disorders),2405,Mental and behavioural disorders,43,Date,Both sexes,Jul 2019,43,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130977,Source of report of F90 (hyperkinetic disorders),2405,Mental and behavioural disorders,43,Categorical (single),Both sexes,Jul 2019,43,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130978,Date F91 first reported (conduct disorders),2405,Mental and behavioural disorders,143,Date,Both sexes,Jul 2019,143,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130979,Source of report of F91 (conduct disorders),2405,Mental and behavioural disorders,143,Categorical (single),Both sexes,Jul 2019,143,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130980,Date F92 first reported (mixed disorders of conduct and emotions),2405,Mental and behavioural disorders,5,Date,Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130981,Source of report of F92 (mixed disorders of conduct and emotions),2405,Mental and behavioural disorders,5,Categorical (single),Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130982,Date F93 first reported (emotional disorders with onset specific to childhood),2405,Mental and behavioural disorders,23,Date,Both sexes,Jul 2019,23,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130983,Source of report of F93 (emotional disorders with onset specific to childhood),2405,Mental and behavioural disorders,23,Categorical (single),Both sexes,Jul 2019,23,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130984,Date F94 first reported (disorders of social functioning with onset specific to childhood and adolescence),2405,Mental and behavioural disorders,3,Date,Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130985,Source of report of F94 (disorders of social functioning with onset specific to childhood and adolescence),2405,Mental and behavioural disorders,3,Categorical (single),Both sexes,Jul 2019,3,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130986,Date F95 first reported (tic disorders),2405,Mental and behavioural disorders,39,Date,Both sexes,Jul 2019,39,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130987,Source of report of F95 (tic disorders),2405,Mental and behavioural disorders,39,Categorical (single),Both sexes,Jul 2019,39,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130988,Date F98 first reported (other behavioural and emotional disorders with onset usually occurring in childhood and adolescence),2405,Mental and behavioural disorders,151,Date,Both sexes,Jul 2019,151,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130989,Source of report of F98 (other behavioural and emotional disorders with onset usually occurring in childhood and adolescence),2405,Mental and behavioural disorders,151,Categorical (single),Both sexes,Jul 2019,151,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130990,"Date F99 first reported (mental disorder, not otherwise specified)",2405,Mental and behavioural disorders,364,Date,Both sexes,Jul 2019,364,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130991,"Source of report of F99 (mental disorder, not otherwise specified)",2405,Mental and behavioural disorders,364,Categorical (single),Both sexes,Jul 2019,364,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Mental and behavioural disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20499,Ever sought or received professional help for mental distress,137,Mental distress,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Mental distress,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20500,Ever suffered mental distress preventing usual activities,137,Mental distress,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Mental distress,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20544,Mental health problems ever diagnosed by a professional,137,Mental distress,"50,096",Categorical (multiple),Both sexes,Oct 2016,"74,886",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Mental distress,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20400,Date of completing mental health questionnaire,136,Mental health,"157,380",Date,Both sexes,Dec 2016,"157,380",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20126,Bipolar and major depression status,100060,Mental health,"122,976",Categorical (single),Both sexes,Jan 2015,"122,976",Data,Defined (1),Apr 2015,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
20122,Bipolar disorder status,100060,Mental health,"1,615",Categorical (single),Both sexes,Jan 2015,"1,615",Data,Defined (1),Apr 2015,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
20127,Neuroticism score,100060,Mental health,"401,576",Integer,Both sexes,Jan 2015,"401,576",Data,Defined (1),Apr 2015,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
20124,Probable recurrent major depression (moderate),100060,Mental health,"15,245",Categorical (single),Both sexes,Jan 2015,"15,245",Data,Defined (1),Apr 2015,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
20125,Probable recurrent major depression (severe),100060,Mental health,"9,398",Categorical (single),Both sexes,Jan 2015,"9,398",Data,Defined (1),Apr 2015,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
20123,Single episode of probable major depression,100060,Mental health,"9,754",Categorical (single),Both sexes,Jan 2015,"9,754",Data,Defined (1),Apr 2015,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
1920,Mood swings,100060,Mental health,"501,619",Categorical (single),Both sexes,Jan 2012,"572,245",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
1930,Miserableness,100060,Mental health,"501,619",Categorical (single),Both sexes,Jan 2012,"572,245",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
1940,Irritability,100060,Mental health,"501,619",Categorical (single),Both sexes,Jan 2012,"572,245",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
1950,Sensitivity / hurt feelings,100060,Mental health,"501,618",Categorical (single),Both sexes,Jan 2012,"572,244",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
1960,Fed-up feelings,100060,Mental health,"501,618",Categorical (single),Both sexes,Jan 2012,"572,244",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
1970,Nervous feelings,100060,Mental health,"501,618",Categorical (single),Both sexes,Jan 2012,"572,244",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
1980,Worrier / anxious feelings,100060,Mental health,"501,617",Categorical (single),Both sexes,Jan 2012,"572,243",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
1990,Tense / 'highly strung',100060,Mental health,"501,617",Categorical (single),Both sexes,Jan 2012,"572,243",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
2000,Worry too long after embarrassment,100060,Mental health,"501,617",Categorical (single),Both sexes,Jan 2012,"572,243",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
2010,Suffer from 'nerves',100060,Mental health,"501,617",Categorical (single),Both sexes,Jan 2012,"572,243",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
2020,"Loneliness, isolation",100060,Mental health,"501,616",Categorical (single),Both sexes,Jan 2012,"572,242",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
2030,Guilty feelings,100060,Mental health,"501,616",Categorical (single),Both sexes,Jan 2012,"572,242",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
2040,Risk taking,100060,Mental health,"501,616",Categorical (single),Both sexes,Jan 2012,"572,242",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
4526,Happiness,100060,Mental health,"213,701",Categorical (single),Both sexes,Jan 2012,"243,342",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
4537,Work/job satisfaction,100060,Mental health,"213,701",Categorical (single),Both sexes,Jan 2012,"243,342",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
4548,Health satisfaction,100060,Mental health,"213,701",Categorical (single),Both sexes,Jan 2012,"243,342",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
4559,Family relationship satisfaction,100060,Mental health,"213,701",Categorical (single),Both sexes,Jan 2012,"243,342",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
4570,Friendships satisfaction,100060,Mental health,"213,701",Categorical (single),Both sexes,Jan 2012,"243,342",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
4581,Financial situation satisfaction,100060,Mental health,"213,701",Categorical (single),Both sexes,Jan 2012,"243,342",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
2050,Frequency of depressed mood in last 2 weeks,100060,Mental health,"501,616",Categorical (single),Both sexes,Jan 2012,"572,242",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
2060,Frequency of unenthusiasm / disinterest in last 2 weeks,100060,Mental health,"501,615",Categorical (single),Both sexes,Jan 2012,"572,241",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
2070,Frequency of tenseness / restlessness in last 2 weeks,100060,Mental health,"501,614",Categorical (single),Both sexes,Jan 2012,"572,240",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
2080,Frequency of tiredness / lethargy in last 2 weeks,100060,Mental health,"501,613",Categorical (single),Both sexes,Jan 2012,"572,239",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
2090,"Seen doctor (GP) for nerves, anxiety, tension or depression",100060,Mental health,"501,612",Categorical (single),Both sexes,Jan 2012,"572,238",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
2100,"Seen a psychiatrist for nerves, anxiety, tension or depression",100060,Mental health,"501,612",Categorical (single),Both sexes,Jan 2012,"572,238",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
4598,Ever depressed for a whole week,100060,Mental health,"213,701",Categorical (single),Both sexes,Jan 2012,"243,342",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
4609,Longest period of depression,100060,Mental health,"112,622","Integer, weeks",Both sexes,Jan 2012,"124,654",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
4620,Number of depression episodes,100060,Mental health,"112,622","Integer, periods",Both sexes,Jan 2012,"124,654",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
4631,Ever unenthusiastic/disinterested for a whole week,100060,Mental health,"213,701",Categorical (single),Both sexes,Jan 2012,"243,342",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
5375,Longest period of unenthusiasm / disinterest,100060,Mental health,"75,741","Integer, weeks",Both sexes,Jan 2012,"82,273",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
5386,Number of unenthusiastic/disinterested episodes,100060,Mental health,"75,738","Integer, periods",Both sexes,Jan 2012,"82,269",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
4642,Ever manic/hyper for 2 days,100060,Mental health,"213,701",Categorical (single),Both sexes,Jan 2012,"243,342",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
4653,Ever highly irritable/argumentative for 2 days,100060,Mental health,"213,701",Categorical (single),Both sexes,Jan 2012,"243,342",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
6156,Manic/hyper symptoms,100060,Mental health,"43,449",Categorical (multiple),Both sexes,Jan 2012,"53,771",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
5663,Length of longest manic/irritable episode,100060,Mental health,"43,449",Categorical (single),Both sexes,Jan 2012,"45,743",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
5674,Severity of manic/irritable episodes,100060,Mental health,"43,449",Categorical (single),Both sexes,Jan 2012,"45,743",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
6145,"Illness, injury, bereavement, stress in last 2 years",100060,Mental health,"498,723",Categorical (multiple),Both sexes,Jan 2012,"648,839",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
10721,"Illness, injury, bereavement, stress in last 2 years (pilot)",100060,Mental health,"3,770",Categorical (multiple),Both sexes,Jan 2012,"4,342",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Mental health,0.0,0.0,0.0,0.0,0.0,0.0
100920,Type milk consumed,100107,Milk/eggs/cheese yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Milk/eggs/cheese yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102800,Cheese consumers,100107,Milk/eggs/cheese yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Milk/eggs/cheese yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102810,Low fat hard cheese intake,100107,Milk/eggs/cheese yesterday,"20,012",Categorical (single),Both sexes,Sep 2012,"23,377",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Milk/eggs/cheese yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102820,Hard cheese intake,100107,Milk/eggs/cheese yesterday,"91,915",Categorical (single),Both sexes,Sep 2012,"130,105",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Milk/eggs/cheese yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102830,Soft cheese intake,100107,Milk/eggs/cheese yesterday,"17,486",Categorical (single),Both sexes,Sep 2012,"20,070",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Milk/eggs/cheese yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102840,Blue cheese intake,100107,Milk/eggs/cheese yesterday,"12,939",Categorical (single),Both sexes,Sep 2012,"14,753",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Milk/eggs/cheese yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102850,Low fat cheese spread intake,100107,Milk/eggs/cheese yesterday,"7,428",Categorical (single),Both sexes,Sep 2012,"8,412",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Milk/eggs/cheese yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102860,Cheese spread intake,100107,Milk/eggs/cheese yesterday,"7,750",Categorical (single),Both sexes,Sep 2012,"8,333",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Milk/eggs/cheese yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102870,Cottage cheese intake,100107,Milk/eggs/cheese yesterday,"5,608",Categorical (single),Both sexes,Sep 2012,"6,627",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Milk/eggs/cheese yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102880,Feta intake,100107,Milk/eggs/cheese yesterday,"5,485",Categorical (single),Both sexes,Sep 2012,"5,834",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Milk/eggs/cheese yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102890,Mozzarella intake,100107,Milk/eggs/cheese yesterday,"7,148",Categorical (single),Both sexes,Sep 2012,"7,511",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Milk/eggs/cheese yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102900,Goat's cheese intake,100107,Milk/eggs/cheese yesterday,"6,773",Categorical (single),Both sexes,Sep 2012,"7,677",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Milk/eggs/cheese yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102910,Other cheese intake,100107,Milk/eggs/cheese yesterday,"8,428",Categorical (single),Both sexes,Sep 2012,"8,967",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Milk/eggs/cheese yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102930,Egg consumers,100107,Milk/eggs/cheese yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Milk/eggs/cheese yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102940,Whole egg intake,100107,Milk/eggs/cheese yesterday,"52,149",Categorical (single),Both sexes,Sep 2012,"64,946",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Milk/eggs/cheese yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102950,Omelette intake,100107,Milk/eggs/cheese yesterday,"20,385",Categorical (single),Both sexes,Sep 2012,"22,376",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Milk/eggs/cheese yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102960,Eggs in sandwiches intake,100107,Milk/eggs/cheese yesterday,"10,307",Categorical (single),Both sexes,Sep 2012,"10,919",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Milk/eggs/cheese yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102970,Scotch egg intake,100107,Milk/eggs/cheese yesterday,989,Categorical (single),Both sexes,Sep 2012,"1,016",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Milk/eggs/cheese yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102980,Other egg intake,100107,Milk/eggs/cheese yesterday,"6,463",Categorical (single),Both sexes,Sep 2012,"6,747",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Milk/eggs/cheese yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23079,When mood described,155,Mood,"125,498",Time,Both sexes,Jan 2020,"131,268",Data,Singular,Jan 2020,Complete,Online follow-up,Cognitive function online,Mood,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23045,Very nervous mood over last week,155,Mood,"120,808",Categorical (single),Both sexes,Jan 2020,"122,665",Data,Singular,Jan 2020,Complete,Online follow-up,Cognitive function online,Mood,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23046,Down in dumps over last week,155,Mood,"120,808",Categorical (single),Both sexes,Jan 2020,"122,665",Data,Singular,Jan 2020,Complete,Online follow-up,Cognitive function online,Mood,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23047,Felt calm over last week,155,Mood,"120,808",Categorical (single),Both sexes,Jan 2020,"122,665",Data,Singular,Jan 2020,Complete,Online follow-up,Cognitive function online,Mood,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23072,Downhearted and depressed over last week,155,Mood,"120,808",Categorical (single),Both sexes,Jan 2020,"122,665",Data,Singular,Jan 2020,Complete,Online follow-up,Cognitive function online,Mood,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23076,Happy over last week,155,Mood,"120,808",Categorical (single),Both sexes,Jan 2020,"122,665",Data,Singular,Jan 2020,Complete,Online follow-up,Cognitive function online,Mood,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42028,Date of motor neurone disease report,49,Motor neurone disease outcomes,423,Date,Both sexes,Apr 2018,423,Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Motor neurone disease outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42029,Source of motor neurone disease report,49,Motor neurone disease outcomes,423,Categorical (single),Both sexes,Apr 2018,423,Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Motor neurone disease outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6149,Mouth/teeth dental problems,100046,Mouth,"498,717",Categorical (multiple),Both sexes,Jan 2012,"636,688",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Mouth,0.0,0.0,0.0,0.0,0.0,0.0
10006,Mouth/teeth dental problems (pilot),100046,Mouth,"3,770",Categorical (multiple),Both sexes,Jan 2012,"4,337",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Mouth,0.0,0.0,0.0,0.0,0.0,0.0
131840,Date M00 first reported (pyogenic arthritis),2413,Musculoskeletal system and connective tissue disorders,687,Date,Both sexes,Jul 2019,687,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131841,Source of report of M00 (pyogenic arthritis),2413,Musculoskeletal system and connective tissue disorders,687,Categorical (single),Both sexes,Jul 2019,687,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131842,Date M01 first reported (direct infections of joint in infectious and parasitic diseases classified elsewhere),2413,Musculoskeletal system and connective tissue disorders,36,Date,Both sexes,Jul 2019,36,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131843,Source of report of M01 (direct infections of joint in infectious and parasitic diseases classified elsewhere),2413,Musculoskeletal system and connective tissue disorders,36,Categorical (single),Both sexes,Jul 2019,36,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131844,Date M02 first reported (reactive arthropathies),2413,Musculoskeletal system and connective tissue disorders,236,Date,Both sexes,Jul 2019,236,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131845,Source of report of M02 (reactive arthropathies),2413,Musculoskeletal system and connective tissue disorders,236,Categorical (single),Both sexes,Jul 2019,236,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131846,Date M03 first reported (postinfective and reactive arthropathies in diseases classified elsewhere),2413,Musculoskeletal system and connective tissue disorders,7,Date,Both sexes,Jul 2019,7,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131847,Source of report of M03 (postinfective and reactive arthropathies in diseases classified elsewhere),2413,Musculoskeletal system and connective tissue disorders,7,Categorical (single),Both sexes,Jul 2019,7,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131848,Date M05 first reported (seropositive rheumatoid arthritis),2413,Musculoskeletal system and connective tissue disorders,962,Date,Both sexes,Jul 2019,962,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131849,Source of report of M05 (seropositive rheumatoid arthritis),2413,Musculoskeletal system and connective tissue disorders,962,Categorical (single),Both sexes,Jul 2019,962,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131850,Date M06 first reported (other rheumatoid arthritis),2413,Musculoskeletal system and connective tissue disorders,"10,021",Date,Both sexes,Jul 2019,"10,021",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131851,Source of report of M06 (other rheumatoid arthritis),2413,Musculoskeletal system and connective tissue disorders,"10,021",Categorical (single),Both sexes,Jul 2019,"10,021",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131852,Date M07 first reported (psoriatic and enteropathic arthropathies),2413,Musculoskeletal system and connective tissue disorders,"1,040",Date,Both sexes,Jul 2019,"1,040",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131853,Source of report of M07 (psoriatic and enteropathic arthropathies),2413,Musculoskeletal system and connective tissue disorders,"1,040",Categorical (single),Both sexes,Jul 2019,"1,040",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131854,Date M08 first reported (juvenile arthritis),2413,Musculoskeletal system and connective tissue disorders,88,Date,Both sexes,Jul 2019,88,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131855,Source of report of M08 (juvenile arthritis),2413,Musculoskeletal system and connective tissue disorders,88,Categorical (single),Both sexes,Jul 2019,88,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131856,Date M09 first reported (juvenile arthritis in diseases classified elsewhere),2413,Musculoskeletal system and connective tissue disorders,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131857,Source of report of M09 (juvenile arthritis in diseases classified elsewhere),2413,Musculoskeletal system and connective tissue disorders,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131858,Date M10 first reported (gout),2413,Musculoskeletal system and connective tissue disorders,"17,015",Date,Both sexes,Jul 2019,"17,015",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131859,Source of report of M10 (gout),2413,Musculoskeletal system and connective tissue disorders,"17,015",Categorical (single),Both sexes,Jul 2019,"17,015",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131860,Date M11 first reported (other crystal arthropathies),2413,Musculoskeletal system and connective tissue disorders,841,Date,Both sexes,Jul 2019,841,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131861,Source of report of M11 (other crystal arthropathies),2413,Musculoskeletal system and connective tissue disorders,841,Categorical (single),Both sexes,Jul 2019,841,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131862,Date M12 first reported (other specific arthropathies),2413,Musculoskeletal system and connective tissue disorders,679,Date,Both sexes,Jul 2019,679,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131863,Source of report of M12 (other specific arthropathies),2413,Musculoskeletal system and connective tissue disorders,679,Categorical (single),Both sexes,Jul 2019,679,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131864,Date M13 first reported (other arthritis),2413,Musculoskeletal system and connective tissue disorders,"31,094",Date,Both sexes,Jul 2019,"31,094",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131865,Source of report of M13 (other arthritis),2413,Musculoskeletal system and connective tissue disorders,"31,094",Categorical (single),Both sexes,Jul 2019,"31,094",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131866,Date M14 first reported (arthropathies in other diseases classified elsewhere),2413,Musculoskeletal system and connective tissue disorders,209,Date,Both sexes,Jul 2019,209,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131867,Source of report of M14 (arthropathies in other diseases classified elsewhere),2413,Musculoskeletal system and connective tissue disorders,209,Categorical (single),Both sexes,Jul 2019,209,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131868,Date M15 first reported (polyarthrosis),2413,Musculoskeletal system and connective tissue disorders,"10,289",Date,Both sexes,Jul 2019,"10,289",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131869,Source of report of M15 (polyarthrosis),2413,Musculoskeletal system and connective tissue disorders,"10,289",Categorical (single),Both sexes,Jul 2019,"10,289",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131870,Date M16 first reported (coxarthrosis [arthrosis of hip]),2413,Musculoskeletal system and connective tissue disorders,"19,281",Date,Both sexes,Jul 2019,"19,281",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131871,Source of report of M16 (coxarthrosis [arthrosis of hip]),2413,Musculoskeletal system and connective tissue disorders,"19,281",Categorical (single),Both sexes,Jul 2019,"19,281",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131872,Date M17 first reported (gonarthrosis [arthrosis of knee]),2413,Musculoskeletal system and connective tissue disorders,"35,579",Date,Both sexes,Jul 2019,"35,579",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131873,Source of report of M17 (gonarthrosis [arthrosis of knee]),2413,Musculoskeletal system and connective tissue disorders,"35,579",Categorical (single),Both sexes,Jul 2019,"35,579",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131874,Date M18 first reported (arthrosis of first carpometacarpal joint),2413,Musculoskeletal system and connective tissue disorders,"2,053",Date,Both sexes,Jul 2019,"2,053",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131875,Source of report of M18 (arthrosis of first carpometacarpal joint),2413,Musculoskeletal system and connective tissue disorders,"2,053",Categorical (single),Both sexes,Jul 2019,"2,053",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131876,Date M19 first reported (other arthrosis),2413,Musculoskeletal system and connective tissue disorders,"73,655",Date,Both sexes,Jul 2019,"73,655",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131877,Source of report of M19 (other arthrosis),2413,Musculoskeletal system and connective tissue disorders,"73,655",Categorical (single),Both sexes,Jul 2019,"73,655",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131878,Date M20 first reported (acquired deformities of fingers and toes),2413,Musculoskeletal system and connective tissue disorders,"20,188",Date,Both sexes,Jul 2019,"20,188",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131879,Source of report of M20 (acquired deformities of fingers and toes),2413,Musculoskeletal system and connective tissue disorders,"20,188",Categorical (single),Both sexes,Jul 2019,"20,188",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131880,Date M21 first reported (other acquired deformities of limbs),2413,Musculoskeletal system and connective tissue disorders,"4,122",Date,Both sexes,Jul 2019,"4,122",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131881,Source of report of M21 (other acquired deformities of limbs),2413,Musculoskeletal system and connective tissue disorders,"4,122",Categorical (single),Both sexes,Jul 2019,"4,122",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131882,Date M22 first reported (disorders of patella),2413,Musculoskeletal system and connective tissue disorders,"3,174",Date,Both sexes,Jul 2019,"3,174",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131883,Source of report of M22 (disorders of patella),2413,Musculoskeletal system and connective tissue disorders,"3,174",Categorical (single),Both sexes,Jul 2019,"3,174",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131884,Date M23 first reported (internal derangement of knee),2413,Musculoskeletal system and connective tissue disorders,"21,830",Date,Both sexes,Jul 2019,"21,830",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131885,Source of report of M23 (internal derangement of knee),2413,Musculoskeletal system and connective tissue disorders,"21,830",Categorical (single),Both sexes,Jul 2019,"21,830",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131886,Date M24 first reported (other specific joint derangements),2413,Musculoskeletal system and connective tissue disorders,"4,341",Date,Both sexes,Jul 2019,"4,341",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131887,Source of report of M24 (other specific joint derangements),2413,Musculoskeletal system and connective tissue disorders,"4,341",Categorical (single),Both sexes,Jul 2019,"4,341",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131888,"Date M25 first reported (other joint disorders, not elsewhere classified)",2413,Musculoskeletal system and connective tissue disorders,"85,555",Date,Both sexes,Jul 2019,"85,555",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131889,"Source of report of M25 (other joint disorders, not elsewhere classified)",2413,Musculoskeletal system and connective tissue disorders,"85,555",Categorical (single),Both sexes,Jul 2019,"85,555",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131890,Date M30 first reported (polyarteritis nodosa and related conditions),2413,Musculoskeletal system and connective tissue disorders,170,Date,Both sexes,Jul 2019,170,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131891,Source of report of M30 (polyarteritis nodosa and related conditions),2413,Musculoskeletal system and connective tissue disorders,170,Categorical (single),Both sexes,Jul 2019,170,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131892,Date M31 first reported (other necrotising vasculopathies),2413,Musculoskeletal system and connective tissue disorders,"1,423",Date,Both sexes,Jul 2019,"1,423",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131893,Source of report of M31 (other necrotising vasculopathies),2413,Musculoskeletal system and connective tissue disorders,"1,423",Categorical (single),Both sexes,Jul 2019,"1,423",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131894,Date M32 first reported (systemic lupus erythematosus),2413,Musculoskeletal system and connective tissue disorders,928,Date,Both sexes,Jul 2019,928,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131895,Source of report of M32 (systemic lupus erythematosus),2413,Musculoskeletal system and connective tissue disorders,928,Categorical (single),Both sexes,Jul 2019,928,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131896,Date M33 first reported (dermatopolymyositis),2413,Musculoskeletal system and connective tissue disorders,226,Date,Both sexes,Jul 2019,226,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131897,Source of report of M33 (dermatopolymyositis),2413,Musculoskeletal system and connective tissue disorders,226,Categorical (single),Both sexes,Jul 2019,226,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131898,Date M34 first reported (systemic sclerosis),2413,Musculoskeletal system and connective tissue disorders,382,Date,Both sexes,Jul 2019,382,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131899,Source of report of M34 (systemic sclerosis),2413,Musculoskeletal system and connective tissue disorders,382,Categorical (single),Both sexes,Jul 2019,382,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131900,Date M35 first reported (other systemic involvement of connective tissue),2413,Musculoskeletal system and connective tissue disorders,"4,922",Date,Both sexes,Jul 2019,"4,922",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131901,Source of report of M35 (other systemic involvement of connective tissue),2413,Musculoskeletal system and connective tissue disorders,"4,922",Categorical (single),Both sexes,Jul 2019,"4,922",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131902,Date M36 first reported (systemic disorders of connective tissue in diseases classified elsewhere),2413,Musculoskeletal system and connective tissue disorders,41,Date,Both sexes,Jul 2019,41,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131903,Source of report of M36 (systemic disorders of connective tissue in diseases classified elsewhere),2413,Musculoskeletal system and connective tissue disorders,41,Categorical (single),Both sexes,Jul 2019,41,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131904,Date M40 first reported (kyphosis and lordosis),2413,Musculoskeletal system and connective tissue disorders,562,Date,Both sexes,Jul 2019,562,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131905,Source of report of M40 (kyphosis and lordosis),2413,Musculoskeletal system and connective tissue disorders,562,Categorical (single),Both sexes,Jul 2019,562,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131906,Date M41 first reported (scoliosis),2413,Musculoskeletal system and connective tissue disorders,"2,985",Date,Both sexes,Jul 2019,"2,985",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131907,Source of report of M41 (scoliosis),2413,Musculoskeletal system and connective tissue disorders,"2,985",Categorical (single),Both sexes,Jul 2019,"2,985",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131908,Date M42 first reported (spinal osteochondrosis),2413,Musculoskeletal system and connective tissue disorders,169,Date,Both sexes,Jul 2019,169,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131909,Source of report of M42 (spinal osteochondrosis),2413,Musculoskeletal system and connective tissue disorders,169,Categorical (single),Both sexes,Jul 2019,169,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131910,Date M43 first reported (other deforming dorsopathies),2413,Musculoskeletal system and connective tissue disorders,"5,101",Date,Both sexes,Jul 2019,"5,101",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131911,Source of report of M43 (other deforming dorsopathies),2413,Musculoskeletal system and connective tissue disorders,"5,101",Categorical (single),Both sexes,Jul 2019,"5,101",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131912,Date M45 first reported (ankylosing spondylitis),2413,Musculoskeletal system and connective tissue disorders,"1,886",Date,Both sexes,Jul 2019,"1,886",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131913,Source of report of M45 (ankylosing spondylitis),2413,Musculoskeletal system and connective tissue disorders,"1,886",Categorical (single),Both sexes,Jul 2019,"1,886",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131914,Date M46 first reported (other inflammatory spondylopathies),2413,Musculoskeletal system and connective tissue disorders,"3,475",Date,Both sexes,Jul 2019,"3,475",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131915,Source of report of M46 (other inflammatory spondylopathies),2413,Musculoskeletal system and connective tissue disorders,"3,475",Categorical (single),Both sexes,Jul 2019,"3,475",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131916,Date M47 first reported (spondylosis),2413,Musculoskeletal system and connective tissue disorders,"28,721",Date,Both sexes,Jul 2019,"28,721",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131917,Source of report of M47 (spondylosis),2413,Musculoskeletal system and connective tissue disorders,"28,721",Categorical (single),Both sexes,Jul 2019,"28,721",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131918,Date M48 first reported (other spondylopathies),2413,Musculoskeletal system and connective tissue disorders,"12,172",Date,Both sexes,Jul 2019,"12,172",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131919,Source of report of M48 (other spondylopathies),2413,Musculoskeletal system and connective tissue disorders,"12,172",Categorical (single),Both sexes,Jul 2019,"12,172",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131920,Date M49 first reported (spondylopathies in diseases classified elsewhere),2413,Musculoskeletal system and connective tissue disorders,223,Date,Both sexes,Jul 2019,223,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131921,Source of report of M49 (spondylopathies in diseases classified elsewhere),2413,Musculoskeletal system and connective tissue disorders,223,Categorical (single),Both sexes,Jul 2019,223,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131922,Date M50 first reported (cervical disk disorders),2413,Musculoskeletal system and connective tissue disorders,"3,797",Date,Both sexes,Jul 2019,"3,797",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131923,Source of report of M50 (cervical disk disorders),2413,Musculoskeletal system and connective tissue disorders,"3,797",Categorical (single),Both sexes,Jul 2019,"3,797",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131924,Date M51 first reported (other intervertebral disk disorders),2413,Musculoskeletal system and connective tissue disorders,"22,960",Date,Both sexes,Jul 2019,"22,960",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131925,Source of report of M51 (other intervertebral disk disorders),2413,Musculoskeletal system and connective tissue disorders,"22,960",Categorical (single),Both sexes,Jul 2019,"22,960",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131926,"Date M53 first reported (other dorsopathies, not elsewhere classified)",2413,Musculoskeletal system and connective tissue disorders,"6,235",Date,Both sexes,Jul 2019,"6,235",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131927,"Source of report of M53 (other dorsopathies, not elsewhere classified)",2413,Musculoskeletal system and connective tissue disorders,"6,235",Categorical (single),Both sexes,Jul 2019,"6,235",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131928,Date M54 first reported (dorsalgia),2413,Musculoskeletal system and connective tissue disorders,"70,952",Date,Both sexes,Jul 2019,"70,952",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131929,Source of report of M54 (dorsalgia),2413,Musculoskeletal system and connective tissue disorders,"70,952",Categorical (single),Both sexes,Jul 2019,"70,952",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131930,Date M60 first reported (myositis),2413,Musculoskeletal system and connective tissue disorders,450,Date,Both sexes,Jul 2019,450,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131931,Source of report of M60 (myositis),2413,Musculoskeletal system and connective tissue disorders,450,Categorical (single),Both sexes,Jul 2019,450,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131932,Date M61 first reported (calcification and ossification of muscle),2413,Musculoskeletal system and connective tissue disorders,73,Date,Both sexes,Jul 2019,73,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131933,Source of report of M61 (calcification and ossification of muscle),2413,Musculoskeletal system and connective tissue disorders,73,Categorical (single),Both sexes,Jul 2019,73,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131934,Date M62 first reported (other disorders of muscle),2413,Musculoskeletal system and connective tissue disorders,"4,344",Date,Both sexes,Jul 2019,"4,344",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131935,Source of report of M62 (other disorders of muscle),2413,Musculoskeletal system and connective tissue disorders,"4,344",Categorical (single),Both sexes,Jul 2019,"4,344",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131936,Date M63 first reported (disorders of muscle in diseases classified elsewhere),2413,Musculoskeletal system and connective tissue disorders,2,Date,Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131937,Source of report of M63 (disorders of muscle in diseases classified elsewhere),2413,Musculoskeletal system and connective tissue disorders,2,Categorical (single),Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131938,Date M65 first reported (synovitis and tenosynovitis),2413,Musculoskeletal system and connective tissue disorders,"18,009",Date,Both sexes,Jul 2019,"18,009",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131939,Source of report of M65 (synovitis and tenosynovitis),2413,Musculoskeletal system and connective tissue disorders,"18,009",Categorical (single),Both sexes,Jul 2019,"18,009",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131940,Date M66 first reported (spontaneous rupture of synovium and tendon),2413,Musculoskeletal system and connective tissue disorders,"1,253",Date,Both sexes,Jul 2019,"1,253",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131941,Source of report of M66 (spontaneous rupture of synovium and tendon),2413,Musculoskeletal system and connective tissue disorders,"1,253",Categorical (single),Both sexes,Jul 2019,"1,253",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131942,Date M67 first reported (other disorders of synovium and tendon),2413,Musculoskeletal system and connective tissue disorders,"11,362",Date,Both sexes,Jul 2019,"11,362",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131943,Source of report of M67 (other disorders of synovium and tendon),2413,Musculoskeletal system and connective tissue disorders,"11,362",Categorical (single),Both sexes,Jul 2019,"11,362",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131944,Date M68 first reported (disorders of synovium and tendon in diseases classified elsewhere),2413,Musculoskeletal system and connective tissue disorders,5,Date,Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131945,Source of report of M68 (disorders of synovium and tendon in diseases classified elsewhere),2413,Musculoskeletal system and connective tissue disorders,5,Categorical (single),Both sexes,Jul 2019,5,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131946,"Date M70 first reported (soft tissue disorders related to use, overuse and pressure)",2413,Musculoskeletal system and connective tissue disorders,"16,192",Date,Both sexes,Jul 2019,"16,192",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131947,"Source of report of M70 (soft tissue disorders related to use, overuse and pressure)",2413,Musculoskeletal system and connective tissue disorders,"16,192",Categorical (single),Both sexes,Jul 2019,"16,192",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131948,Date M71 first reported (other bursopathies),2413,Musculoskeletal system and connective tissue disorders,"3,087",Date,Both sexes,Jul 2019,"3,087",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131949,Source of report of M71 (other bursopathies),2413,Musculoskeletal system and connective tissue disorders,"3,087",Categorical (single),Both sexes,Jul 2019,"3,087",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131950,Date M72 first reported (fibroblastic disorders),2413,Musculoskeletal system and connective tissue disorders,"23,578",Date,Both sexes,Jul 2019,"23,578",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131951,Source of report of M72 (fibroblastic disorders),2413,Musculoskeletal system and connective tissue disorders,"23,578",Categorical (single),Both sexes,Jul 2019,"23,578",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131952,Date M73 first reported (soft tissue disorders in diseases classified elsewhere),2413,Musculoskeletal system and connective tissue disorders,1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131953,Source of report of M73 (soft tissue disorders in diseases classified elsewhere),2413,Musculoskeletal system and connective tissue disorders,1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131954,Date M75 first reported (shoulder lesions),2413,Musculoskeletal system and connective tissue disorders,"32,489",Date,Both sexes,Jul 2019,"32,489",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131955,Source of report of M75 (shoulder lesions),2413,Musculoskeletal system and connective tissue disorders,"32,489",Categorical (single),Both sexes,Jul 2019,"32,489",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131956,"Date M76 first reported (enthesopathies of lower limb, excluding foot)",2413,Musculoskeletal system and connective tissue disorders,"7,957",Date,Both sexes,Jul 2019,"7,957",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131957,"Source of report of M76 (enthesopathies of lower limb, excluding foot)",2413,Musculoskeletal system and connective tissue disorders,"7,957",Categorical (single),Both sexes,Jul 2019,"7,957",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131958,Date M77 first reported (other enthesopathies),2413,Musculoskeletal system and connective tissue disorders,"32,675",Date,Both sexes,Jul 2019,"32,675",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131959,Source of report of M77 (other enthesopathies),2413,Musculoskeletal system and connective tissue disorders,"32,675",Categorical (single),Both sexes,Jul 2019,"32,675",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131960,"Date M79 first reported (other soft tissue disorders, not elsewhere classified)",2413,Musculoskeletal system and connective tissue disorders,"82,150",Date,Both sexes,Jul 2019,"82,150",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131961,"Source of report of M79 (other soft tissue disorders, not elsewhere classified)",2413,Musculoskeletal system and connective tissue disorders,"82,150",Categorical (single),Both sexes,Jul 2019,"82,150",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131962,Date M80 first reported (osteoporosis with pathological fracture),2413,Musculoskeletal system and connective tissue disorders,"1,590",Date,Both sexes,Jul 2019,"1,590",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131963,Source of report of M80 (osteoporosis with pathological fracture),2413,Musculoskeletal system and connective tissue disorders,"1,590",Categorical (single),Both sexes,Jul 2019,"1,590",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131964,Date M81 first reported (osteoporosis without pathological fracture),2413,Musculoskeletal system and connective tissue disorders,"17,856",Date,Both sexes,Jul 2019,"17,856",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131965,Source of report of M81 (osteoporosis without pathological fracture),2413,Musculoskeletal system and connective tissue disorders,"17,856",Categorical (single),Both sexes,Jul 2019,"17,856",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131966,Date M82 first reported (osteoporosis in diseases classified elsewhere),2413,Musculoskeletal system and connective tissue disorders,168,Date,Both sexes,Jul 2019,168,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131967,Source of report of M82 (osteoporosis in diseases classified elsewhere),2413,Musculoskeletal system and connective tissue disorders,168,Categorical (single),Both sexes,Jul 2019,168,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131968,Date M83 first reported (adult osteomalacia),2413,Musculoskeletal system and connective tissue disorders,105,Date,Both sexes,Jul 2019,105,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131969,Source of report of M83 (adult osteomalacia),2413,Musculoskeletal system and connective tissue disorders,105,Categorical (single),Both sexes,Jul 2019,105,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131970,Date M84 first reported (disorders of continuity of bone),2413,Musculoskeletal system and connective tissue disorders,"3,436",Date,Both sexes,Jul 2019,"3,436",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131971,Source of report of M84 (disorders of continuity of bone),2413,Musculoskeletal system and connective tissue disorders,"3,436",Categorical (single),Both sexes,Jul 2019,"3,436",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131972,Date M85 first reported (other disorders of bone density and structure),2413,Musculoskeletal system and connective tissue disorders,"12,486",Date,Both sexes,Jul 2019,"12,486",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131973,Source of report of M85 (other disorders of bone density and structure),2413,Musculoskeletal system and connective tissue disorders,"12,486",Categorical (single),Both sexes,Jul 2019,"12,486",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131974,Date M86 first reported (osteomyelitis),2413,Musculoskeletal system and connective tissue disorders,"2,289",Date,Both sexes,Jul 2019,"2,289",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131975,Source of report of M86 (osteomyelitis),2413,Musculoskeletal system and connective tissue disorders,"2,289",Categorical (single),Both sexes,Jul 2019,"2,289",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131976,Date M87 first reported (osteonecrosis),2413,Musculoskeletal system and connective tissue disorders,907,Date,Both sexes,Jul 2019,907,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131977,Source of report of M87 (osteonecrosis),2413,Musculoskeletal system and connective tissue disorders,907,Categorical (single),Both sexes,Jul 2019,907,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131978,Date M88 first reported (paget's disease of bone [osteitis deformans]),2413,Musculoskeletal system and connective tissue disorders,502,Date,Both sexes,Jul 2019,502,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131979,Source of report of M88 (paget's disease of bone [osteitis deformans]),2413,Musculoskeletal system and connective tissue disorders,502,Categorical (single),Both sexes,Jul 2019,502,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131980,Date M89 first reported (other disorders of bone),2413,Musculoskeletal system and connective tissue disorders,"4,931",Date,Both sexes,Jul 2019,"4,931",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131981,Source of report of M89 (other disorders of bone),2413,Musculoskeletal system and connective tissue disorders,"4,931",Categorical (single),Both sexes,Jul 2019,"4,931",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131982,Date M90 first reported (osteopathies in diseases classified elsewhere),2413,Musculoskeletal system and connective tissue disorders,526,Date,Both sexes,Jul 2019,526,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131983,Source of report of M90 (osteopathies in diseases classified elsewhere),2413,Musculoskeletal system and connective tissue disorders,526,Categorical (single),Both sexes,Jul 2019,526,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131984,Date M91 first reported (juvenile osteochondrosis of hip and pelvis),2413,Musculoskeletal system and connective tissue disorders,201,Date,Both sexes,Jul 2019,201,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131985,Source of report of M91 (juvenile osteochondrosis of hip and pelvis),2413,Musculoskeletal system and connective tissue disorders,201,Categorical (single),Both sexes,Jul 2019,201,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131986,Date M92 first reported (other juvenile osteochondrosis),2413,Musculoskeletal system and connective tissue disorders,671,Date,Both sexes,Jul 2019,671,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131987,Source of report of M92 (other juvenile osteochondrosis),2413,Musculoskeletal system and connective tissue disorders,671,Categorical (single),Both sexes,Jul 2019,671,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131988,Date M93 first reported (other osteochondropathies),2413,Musculoskeletal system and connective tissue disorders,807,Date,Both sexes,Jul 2019,807,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131989,Source of report of M93 (other osteochondropathies),2413,Musculoskeletal system and connective tissue disorders,807,Categorical (single),Both sexes,Jul 2019,807,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131990,Date M94 first reported (other disorders of cartilage),2413,Musculoskeletal system and connective tissue disorders,"2,521",Date,Both sexes,Jul 2019,"2,521",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131991,Source of report of M94 (other disorders of cartilage),2413,Musculoskeletal system and connective tissue disorders,"2,521",Categorical (single),Both sexes,Jul 2019,"2,521",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131992,Date M95 first reported (other acquired deformities of musculoskeletal system and connective tissue),2413,Musculoskeletal system and connective tissue disorders,"2,213",Date,Both sexes,Jul 2019,"2,213",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131993,Source of report of M95 (other acquired deformities of musculoskeletal system and connective tissue),2413,Musculoskeletal system and connective tissue disorders,"2,213",Categorical (single),Both sexes,Jul 2019,"2,213",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131994,"Date M96 first reported (postprocedural musculoskeletal disorders, not elsewhere classified)",2413,Musculoskeletal system and connective tissue disorders,699,Date,Both sexes,Jul 2019,699,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131995,"Source of report of M96 (postprocedural musculoskeletal disorders, not elsewhere classified)",2413,Musculoskeletal system and connective tissue disorders,699,Categorical (single),Both sexes,Jul 2019,699,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131996,"Date M99 first reported (biomechanical lesions, not elsewhere classified)",2413,Musculoskeletal system and connective tissue disorders,275,Date,Both sexes,Jul 2019,275,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131997,"Source of report of M99 (biomechanical lesions, not elsewhere classified)",2413,Musculoskeletal system and connective tissue disorders,275,Categorical (single),Both sexes,Jul 2019,275,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Musculoskeletal system and connective tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42000,Date of myocardial infarction,44,Myocardial infarction outcomes,"20,815",Date,Both sexes,Nov 2016,"20,815",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Myocardial infarction outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42001,Source of myocardial infarction report,44,Myocardial infarction outcomes,"20,815",Categorical (single),Both sexes,Nov 2016,"20,815",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Myocardial infarction outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42002,Date of STEMI,44,Myocardial infarction outcomes,"5,711",Date,Both sexes,Nov 2016,"5,711",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Myocardial infarction outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42003,Source of STEMI report,44,Myocardial infarction outcomes,"5,711",Categorical (single),Both sexes,Nov 2016,"5,711",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Myocardial infarction outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42004,Date of NSTEMI,44,Myocardial infarction outcomes,"7,084",Date,Both sexes,Nov 2016,"7,084",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Myocardial infarction outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42005,Source of NSTEMI report,44,Myocardial infarction outcomes,"7,084",Categorical (single),Both sexes,Nov 2016,"7,084",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Myocardial infarction outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130992,"Date G00 first reported (bacterial meningitis, not elsewhere classified)",2406,Nervous system disorders,193,Date,Both sexes,Jul 2019,193,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130993,"Source of report of G00 (bacterial meningitis, not elsewhere classified)",2406,Nervous system disorders,193,Categorical (single),Both sexes,Jul 2019,193,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130994,Date G01 first reported (meningitis in bacterial diseases classified elsewhere),2406,Nervous system disorders,55,Date,Both sexes,Jul 2019,55,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130995,Source of report of G01 (meningitis in bacterial diseases classified elsewhere),2406,Nervous system disorders,55,Categorical (single),Both sexes,Jul 2019,55,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130996,Date G02 first reported (meningitis in other infectious and parasitic diseases classified elsewhere),2406,Nervous system disorders,86,Date,Both sexes,Jul 2019,86,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130997,Source of report of G02 (meningitis in other infectious and parasitic diseases classified elsewhere),2406,Nervous system disorders,86,Categorical (single),Both sexes,Jul 2019,86,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130998,Date G03 first reported (meningitis due to other and unspecified causes),2406,Nervous system disorders,"2,344",Date,Both sexes,Jul 2019,"2,344",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
130999,Source of report of G03 (meningitis due to other and unspecified causes),2406,Nervous system disorders,"2,344",Categorical (single),Both sexes,Jul 2019,"2,344",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131000,"Date G04 first reported (encephalitis, myelitis and encephalomyelitis)",2406,Nervous system disorders,687,Date,Both sexes,Jul 2019,687,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131001,"Source of report of G04 (encephalitis, myelitis and encephalomyelitis)",2406,Nervous system disorders,687,Categorical (single),Both sexes,Jul 2019,687,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131002,"Date G05 first reported (encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere)",2406,Nervous system disorders,81,Date,Both sexes,Jul 2019,81,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131003,"Source of report of G05 (encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere)",2406,Nervous system disorders,81,Categorical (single),Both sexes,Jul 2019,81,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131004,Date G06 first reported (intracranial and intraspinal abscess and granuloma),2406,Nervous system disorders,292,Date,Both sexes,Jul 2019,292,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131005,Source of report of G06 (intracranial and intraspinal abscess and granuloma),2406,Nervous system disorders,292,Categorical (single),Both sexes,Jul 2019,292,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131006,Date G07 first reported (intracranial and intraspinal abscess and granuloma in diseases classified elsewhere),2406,Nervous system disorders,6,Date,Both sexes,Jul 2019,6,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131007,Source of report of G07 (intracranial and intraspinal abscess and granuloma in diseases classified elsewhere),2406,Nervous system disorders,6,Categorical (single),Both sexes,Jul 2019,6,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131008,Date G08 first reported (intracranial and intraspinal phlebitis and thrombophlebitis),2406,Nervous system disorders,81,Date,Both sexes,Jul 2019,81,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131009,Source of report of G08 (intracranial and intraspinal phlebitis and thrombophlebitis),2406,Nervous system disorders,81,Categorical (single),Both sexes,Jul 2019,81,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131010,Date G09 first reported (sequelae of inflammatory diseases of central nervous system),2406,Nervous system disorders,73,Date,Both sexes,Jul 2019,73,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131011,Source of report of G09 (sequelae of inflammatory diseases of central nervous system),2406,Nervous system disorders,73,Categorical (single),Both sexes,Jul 2019,73,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131012,Date G10 first reported (huntington's disease),2406,Nervous system disorders,44,Date,Both sexes,Jul 2019,44,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131013,Source of report of G10 (huntington's disease),2406,Nervous system disorders,44,Categorical (single),Both sexes,Jul 2019,44,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131014,Date G11 first reported (hereditary ataxia),2406,Nervous system disorders,313,Date,Both sexes,Jul 2019,313,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131015,Source of report of G11 (hereditary ataxia),2406,Nervous system disorders,313,Categorical (single),Both sexes,Jul 2019,313,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131016,Date G12 first reported (spinal muscular atrophy and related syndromes),2406,Nervous system disorders,504,Date,Both sexes,Jul 2019,504,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131017,Source of report of G12 (spinal muscular atrophy and related syndromes),2406,Nervous system disorders,504,Categorical (single),Both sexes,Jul 2019,504,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131018,Date G13 first reported (systemic atrophies primarily affecting central nervous system in diseases classified elsewhere),2406,Nervous system disorders,24,Date,Both sexes,Jul 2019,24,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131019,Source of report of G13 (systemic atrophies primarily affecting central nervous system in diseases classified elsewhere),2406,Nervous system disorders,24,Categorical (single),Both sexes,Jul 2019,24,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131020,Date G14 first reported (postpolio syndrome),2406,Nervous system disorders,38,Date,Both sexes,Jul 2019,38,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131021,Source of report of G14 (postpolio syndrome),2406,Nervous system disorders,38,Categorical (single),Both sexes,Jul 2019,38,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131022,Date G20 first reported (parkinson's disease),2406,Nervous system disorders,"2,364",Date,Both sexes,Jul 2019,"2,364",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131023,Source of report of G20 (parkinson's disease),2406,Nervous system disorders,"2,364",Categorical (single),Both sexes,Jul 2019,"2,364",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131024,Date G21 first reported (secondary parkinsonism),2406,Nervous system disorders,117,Date,Both sexes,Jul 2019,117,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131025,Source of report of G21 (secondary parkinsonism),2406,Nervous system disorders,117,Categorical (single),Both sexes,Jul 2019,117,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131026,Date G22 first reported (parkinsonism in diseases classified elsewhere),2406,Nervous system disorders,4,Date,Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131027,Source of report of G22 (parkinsonism in diseases classified elsewhere),2406,Nervous system disorders,4,Categorical (single),Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131028,Date G23 first reported (other degenerative diseases of basal ganglia),2406,Nervous system disorders,150,Date,Both sexes,Jul 2019,150,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131029,Source of report of G23 (other degenerative diseases of basal ganglia),2406,Nervous system disorders,150,Categorical (single),Both sexes,Jul 2019,150,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131030,Date G24 first reported (dystonia),2406,Nervous system disorders,"1,089",Date,Both sexes,Jul 2019,"1,089",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131031,Source of report of G24 (dystonia),2406,Nervous system disorders,"1,089",Categorical (single),Both sexes,Jul 2019,"1,089",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131032,Date G25 first reported (other extrapyramidal and movement disorders),2406,Nervous system disorders,"4,476",Date,Both sexes,Jul 2019,"4,476",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131033,Source of report of G25 (other extrapyramidal and movement disorders),2406,Nervous system disorders,"4,476",Categorical (single),Both sexes,Jul 2019,"4,476",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131034,Date G26 first reported (extrapyramidal and movement disorders in diseases classified elsewhere),2406,Nervous system disorders,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131035,Source of report of G26 (extrapyramidal and movement disorders in diseases classified elsewhere),2406,Nervous system disorders,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131036,Date G30 first reported (alzheimer's disease),2406,Nervous system disorders,"1,125",Date,Both sexes,Jul 2019,"1,125",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131037,Source of report of G30 (alzheimer's disease),2406,Nervous system disorders,"1,125",Categorical (single),Both sexes,Jul 2019,"1,125",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131038,"Date G31 first reported (other degenerative diseases of nervous system, not elsewhere classified)",2406,Nervous system disorders,"1,382",Date,Both sexes,Jul 2019,"1,382",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131039,"Source of report of G31 (other degenerative diseases of nervous system, not elsewhere classified)",2406,Nervous system disorders,"1,382",Categorical (single),Both sexes,Jul 2019,"1,382",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131040,Date G32 first reported (other degenerative disorders of nervous system in diseases classified elsewhere),2406,Nervous system disorders,28,Date,Both sexes,Jul 2019,28,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131041,Source of report of G32 (other degenerative disorders of nervous system in diseases classified elsewhere),2406,Nervous system disorders,28,Categorical (single),Both sexes,Jul 2019,28,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131042,Date G35 first reported (multiple sclerosis),2406,Nervous system disorders,"2,370",Date,Both sexes,Jul 2019,"2,370",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131043,Source of report of G35 (multiple sclerosis),2406,Nervous system disorders,"2,370",Categorical (single),Both sexes,Jul 2019,"2,370",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131044,Date G36 first reported (other acute disseminated demyelination),2406,Nervous system disorders,34,Date,Both sexes,Jul 2019,34,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131045,Source of report of G36 (other acute disseminated demyelination),2406,Nervous system disorders,34,Categorical (single),Both sexes,Jul 2019,34,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131046,Date G37 first reported (other demyelinating diseases of central nervous system),2406,Nervous system disorders,596,Date,Both sexes,Jul 2019,596,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131047,Source of report of G37 (other demyelinating diseases of central nervous system),2406,Nervous system disorders,596,Categorical (single),Both sexes,Jul 2019,596,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131048,Date G40 first reported (epilepsy),2406,Nervous system disorders,"7,272",Date,Both sexes,Jul 2019,"7,272",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131049,Source of report of G40 (epilepsy),2406,Nervous system disorders,"7,272",Categorical (single),Both sexes,Jul 2019,"7,272",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131050,Date G41 first reported (status epilepticus),2406,Nervous system disorders,254,Date,Both sexes,Jul 2019,254,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131051,Source of report of G41 (status epilepticus),2406,Nervous system disorders,254,Categorical (single),Both sexes,Jul 2019,254,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131052,Date G43 first reported (migraine),2406,Nervous system disorders,"24,307",Date,Both sexes,Jul 2019,"24,307",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131053,Source of report of G43 (migraine),2406,Nervous system disorders,"24,307",Categorical (single),Both sexes,Jul 2019,"24,307",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131054,Date G44 first reported (other headache syndromes),2406,Nervous system disorders,"5,667",Date,Both sexes,Jul 2019,"5,667",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131055,Source of report of G44 (other headache syndromes),2406,Nervous system disorders,"5,667",Categorical (single),Both sexes,Jul 2019,"5,667",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131056,Date G45 first reported (transient cerebral ischaemic attacks and related syndromes),2406,Nervous system disorders,"8,250",Date,Both sexes,Jul 2019,"8,250",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131057,Source of report of G45 (transient cerebral ischaemic attacks and related syndromes),2406,Nervous system disorders,"8,250",Categorical (single),Both sexes,Jul 2019,"8,250",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131058,Date G46 first reported (vascular syndromes of brain in cerebrovascular diseases),2406,Nervous system disorders,201,Date,Both sexes,Jul 2019,201,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131059,Source of report of G46 (vascular syndromes of brain in cerebrovascular diseases),2406,Nervous system disorders,201,Categorical (single),Both sexes,Jul 2019,201,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131060,Date G47 first reported (sleep disorders),2406,Nervous system disorders,"16,710",Date,Both sexes,Jul 2019,"16,710",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131061,Source of report of G47 (sleep disorders),2406,Nervous system disorders,"16,710",Categorical (single),Both sexes,Jul 2019,"16,710",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131062,Date G50 first reported (disorders of trigeminal nerve),2406,Nervous system disorders,"2,976",Date,Both sexes,Jul 2019,"2,976",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131063,Source of report of G50 (disorders of trigeminal nerve),2406,Nervous system disorders,"2,976",Categorical (single),Both sexes,Jul 2019,"2,976",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131064,Date G51 first reported (facial nerve disorders),2406,Nervous system disorders,"3,156",Date,Both sexes,Jul 2019,"3,156",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131065,Source of report of G51 (facial nerve disorders),2406,Nervous system disorders,"3,156",Categorical (single),Both sexes,Jul 2019,"3,156",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131066,Date G52 first reported (disorders of other cranial nerves),2406,Nervous system disorders,449,Date,Both sexes,Jul 2019,449,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131067,Source of report of G52 (disorders of other cranial nerves),2406,Nervous system disorders,449,Categorical (single),Both sexes,Jul 2019,449,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131068,Date G53 first reported (cranial nerve disorders in diseases classified elsewhere),2406,Nervous system disorders,145,Date,Both sexes,Jul 2019,145,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131069,Source of report of G53 (cranial nerve disorders in diseases classified elsewhere),2406,Nervous system disorders,145,Categorical (single),Both sexes,Jul 2019,145,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131070,Date G54 first reported (nerve root and plexus disorders),2406,Nervous system disorders,"1,205",Date,Both sexes,Jul 2019,"1,205",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131071,Source of report of G54 (nerve root and plexus disorders),2406,Nervous system disorders,"1,205",Categorical (single),Both sexes,Jul 2019,"1,205",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131072,Date G55 first reported (nerve root and plexus compressions in diseases classified elsewhere),2406,Nervous system disorders,"6,181",Date,Both sexes,Jul 2019,"6,181",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131073,Source of report of G55 (nerve root and plexus compressions in diseases classified elsewhere),2406,Nervous system disorders,"6,181",Categorical (single),Both sexes,Jul 2019,"6,181",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131074,Date G56 first reported (mononeuropathies of upper limb),2406,Nervous system disorders,"22,737",Date,Both sexes,Jul 2019,"22,737",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131075,Source of report of G56 (mononeuropathies of upper limb),2406,Nervous system disorders,"22,737",Categorical (single),Both sexes,Jul 2019,"22,737",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131076,Date G57 first reported (mononeuropathies of lower limb),2406,Nervous system disorders,"4,818",Date,Both sexes,Jul 2019,"4,818",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131077,Source of report of G57 (mononeuropathies of lower limb),2406,Nervous system disorders,"4,818",Categorical (single),Both sexes,Jul 2019,"4,818",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131078,Date G58 first reported (other mononeuropathies),2406,Nervous system disorders,844,Date,Both sexes,Jul 2019,844,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131079,Source of report of G58 (other mononeuropathies),2406,Nervous system disorders,844,Categorical (single),Both sexes,Jul 2019,844,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131080,Date G59 first reported (mononeuropathy in diseases classified elsewhere),2406,Nervous system disorders,331,Date,Both sexes,Jul 2019,331,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131081,Source of report of G59 (mononeuropathy in diseases classified elsewhere),2406,Nervous system disorders,331,Categorical (single),Both sexes,Jul 2019,331,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131082,Date G60 first reported (hereditary and idiopathic neuropathy),2406,Nervous system disorders,431,Date,Both sexes,Jul 2019,431,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131083,Source of report of G60 (hereditary and idiopathic neuropathy),2406,Nervous system disorders,431,Categorical (single),Both sexes,Jul 2019,431,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131084,Date G61 first reported (inflammatory polyneuropathy),2406,Nervous system disorders,574,Date,Both sexes,Jul 2019,574,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131085,Source of report of G61 (inflammatory polyneuropathy),2406,Nervous system disorders,574,Categorical (single),Both sexes,Jul 2019,574,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131086,Date G62 first reported (other polyneuropathies),2406,Nervous system disorders,"3,385",Date,Both sexes,Jul 2019,"3,385",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131087,Source of report of G62 (other polyneuropathies),2406,Nervous system disorders,"3,385",Categorical (single),Both sexes,Jul 2019,"3,385",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131088,Date G63 first reported (polyneuropathy in diseases classified elsewhere),2406,Nervous system disorders,729,Date,Both sexes,Jul 2019,729,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131089,Source of report of G63 (polyneuropathy in diseases classified elsewhere),2406,Nervous system disorders,729,Categorical (single),Both sexes,Jul 2019,729,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131090,Date G64 first reported (other disorders of peripheral nervous system),2406,Nervous system disorders,283,Date,Both sexes,Jul 2019,283,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131091,Source of report of G64 (other disorders of peripheral nervous system),2406,Nervous system disorders,283,Categorical (single),Both sexes,Jul 2019,283,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131092,Date G70 first reported (myasthenia gravis and other myoneural disorders),2406,Nervous system disorders,417,Date,Both sexes,Jul 2019,417,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131093,Source of report of G70 (myasthenia gravis and other myoneural disorders),2406,Nervous system disorders,417,Categorical (single),Both sexes,Jul 2019,417,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131094,Date G71 first reported (primary disorders of muscles),2406,Nervous system disorders,268,Date,Both sexes,Jul 2019,268,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131095,Source of report of G71 (primary disorders of muscles),2406,Nervous system disorders,268,Categorical (single),Both sexes,Jul 2019,268,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131096,Date G72 first reported (other myopathies),2406,Nervous system disorders,342,Date,Both sexes,Jul 2019,342,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131097,Source of report of G72 (other myopathies),2406,Nervous system disorders,342,Categorical (single),Both sexes,Jul 2019,342,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131098,Date G73 first reported (disorders of myoneural junction and muscle in diseases classified elsewhere),2406,Nervous system disorders,29,Date,Both sexes,Jul 2019,29,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131099,Source of report of G73 (disorders of myoneural junction and muscle in diseases classified elsewhere),2406,Nervous system disorders,29,Categorical (single),Both sexes,Jul 2019,29,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131100,Date G80 first reported (infantile cerebral palsy),2406,Nervous system disorders,289,Date,Both sexes,Jul 2019,289,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131101,Source of report of G80 (infantile cerebral palsy),2406,Nervous system disorders,289,Categorical (single),Both sexes,Jul 2019,289,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131102,Date G81 first reported (hemiplegia),2406,Nervous system disorders,"2,653",Date,Both sexes,Jul 2019,"2,653",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131103,Source of report of G81 (hemiplegia),2406,Nervous system disorders,"2,653",Categorical (single),Both sexes,Jul 2019,"2,653",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131104,Date G82 first reported (paraplegia and tetraplegia),2406,Nervous system disorders,514,Date,Both sexes,Jul 2019,514,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131105,Source of report of G82 (paraplegia and tetraplegia),2406,Nervous system disorders,514,Categorical (single),Both sexes,Jul 2019,514,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131106,Date G83 first reported (other paralytic syndromes),2406,Nervous system disorders,"1,148",Date,Both sexes,Jul 2019,"1,148",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131107,Source of report of G83 (other paralytic syndromes),2406,Nervous system disorders,"1,148",Categorical (single),Both sexes,Jul 2019,"1,148",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131108,Date G90 first reported (disorders of autonomic nervous system),2406,Nervous system disorders,556,Date,Both sexes,Jul 2019,556,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131109,Source of report of G90 (disorders of autonomic nervous system),2406,Nervous system disorders,556,Categorical (single),Both sexes,Jul 2019,556,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131110,Date G91 first reported (hydrocephalus),2406,Nervous system disorders,717,Date,Both sexes,Jul 2019,717,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131111,Source of report of G91 (hydrocephalus),2406,Nervous system disorders,717,Categorical (single),Both sexes,Jul 2019,717,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131112,Date G92 first reported (toxic encephalopathy),2406,Nervous system disorders,12,Date,Both sexes,Jul 2019,12,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131113,Source of report of G92 (toxic encephalopathy),2406,Nervous system disorders,12,Categorical (single),Both sexes,Jul 2019,12,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131114,Date G93 first reported (other disorders of brain),2406,Nervous system disorders,"3,956",Date,Both sexes,Jul 2019,"3,956",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131115,Source of report of G93 (other disorders of brain),2406,Nervous system disorders,"3,956",Categorical (single),Both sexes,Jul 2019,"3,956",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131116,Date G94 first reported (other disorders of brain in diseases classified elsewhere),2406,Nervous system disorders,108,Date,Both sexes,Jul 2019,108,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131117,Source of report of G94 (other disorders of brain in diseases classified elsewhere),2406,Nervous system disorders,108,Categorical (single),Both sexes,Jul 2019,108,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131118,Date G95 first reported (other diseases of spinal cord),2406,Nervous system disorders,"1,550",Date,Both sexes,Jul 2019,"1,550",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131119,Source of report of G95 (other diseases of spinal cord),2406,Nervous system disorders,"1,550",Categorical (single),Both sexes,Jul 2019,"1,550",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131120,Date G96 first reported (other disorders of central nervous system),2406,Nervous system disorders,414,Date,Both sexes,Jul 2019,414,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131121,Source of report of G96 (other disorders of central nervous system),2406,Nervous system disorders,414,Categorical (single),Both sexes,Jul 2019,414,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131122,"Date G97 first reported (postprocedural disorders of nervous system, not elsewhere classified)",2406,Nervous system disorders,314,Date,Both sexes,Jul 2019,314,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131123,"Source of report of G97 (postprocedural disorders of nervous system, not elsewhere classified)",2406,Nervous system disorders,314,Categorical (single),Both sexes,Jul 2019,314,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131124,"Date G98 first reported (other disorders of nervous system, not elsewhere classified)",2406,Nervous system disorders,"2,073",Date,Both sexes,Jul 2019,"2,073",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131125,"Source of report of G98 (other disorders of nervous system, not elsewhere classified)",2406,Nervous system disorders,"2,073",Categorical (single),Both sexes,Jul 2019,"2,073",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131126,Date G99 first reported (other disorders of nervous system in diseases classified elsewhere),2406,Nervous system disorders,"1,664",Date,Both sexes,Jul 2019,"1,664",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131127,Source of report of G99 (other disorders of nervous system in diseases classified elsewhere),2406,Nervous system disorders,"1,664",Categorical (single),Both sexes,Jul 2019,"1,664",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Nervous system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20138,When numeric memory test completed,120,Numeric memory,"111,068",Time,Both sexes,Jul 2015,"111,068",Data,Singular,Oct 2015,Complete,Online follow-up,Cognitive function online,Numeric memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20240,Maximum digits remembered correctly,120,Numeric memory,"111,068",Integer,Both sexes,Jan 2012,"111,068",Data,Singular,Oct 2015,Complete,Online follow-up,Cognitive function online,Numeric memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4281,Completion status of numeric memory test,100029,Numeric memory,"81,789",Categorical (single),Both sexes,Jan 2012,"87,733",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Numeric memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4283,Number of rounds of numeric memory test performed,100029,Numeric memory,"81,789","Integer, rounds",Both sexes,Jan 2012,"87,733",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Numeric memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4260,Round of numeric memory test,100029,Numeric memory,"81,499",Integer,Both sexes,Jan 2012,"713,694",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Numeric memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4250,Number of digits to be memorised/recalled,100029,Numeric memory,"81,499",Integer,Both sexes,Jan 2012,"713,694",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Numeric memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4251,Target number to be memorised,100029,Numeric memory,"81,495",Text,Both sexes,Jan 2012,"713,688",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Numeric memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4252,Target number to be entered,100029,Numeric memory,"81,495",Text,Both sexes,Jan 2012,"713,688",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Numeric memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4258,Number entered by participant,100029,Numeric memory,"81,480",Text,Both sexes,Jan 2012,"713,603",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Numeric memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4253,Time number displayed for,100029,Numeric memory,"81,495","Integer, milliseconds",Both sexes,Jan 2012,"713,688",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Numeric memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4259,Digits entered correctly,100029,Numeric memory,"81,480",Categorical (single),Both sexes,Jan 2012,"713,603",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Numeric memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4282,Maximum digits remembered correctly,100029,Numeric memory,"81,789",Integer,Both sexes,Jan 2012,"87,733",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Numeric memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4254,Time first key touched,100029,Numeric memory,"81,480","Integer, milliseconds",Both sexes,Jan 2012,"713,603",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Numeric memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4255,Time last key touched,100029,Numeric memory,"81,480","Integer, milliseconds",Both sexes,Jan 2012,"713,603",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Numeric memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4256,Time elapsed,100029,Numeric memory,"81,480","Integer, milliseconds",Both sexes,Jan 2012,"713,603",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Numeric memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4257,Keystroke history,100029,Numeric memory,"81,499",Text,Both sexes,Jan 2012,"713,694",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Numeric memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4285,Time to complete test,100029,Numeric memory,"81,789","Integer, deciseconds",Both sexes,Jan 2012,"87,733",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Numeric memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
190,Reason lost to follow-up,2,Ongoing characteristics,"1,298",Categorical (single),Both sexes,May 2017,"1,298",Data,Singular,May 2017,Ongoing,Population characteristics,Ongoing characteristics,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
191,Date lost to follow-up,2,Ongoing characteristics,"1,298",Date,Both sexes,May 2017,"1,298",Data,Singular,May 2017,Ongoing,Population characteristics,Ongoing characteristics,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20005,Email access,2,Ongoing characteristics,"317,738",Categorical (single),Both sexes,Feb 2012,"317,738",Data,Singular,Feb 2012,Ongoing,Population characteristics,Ongoing characteristics,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
110007,"Newsletter communications, date sent",2,Ongoing characteristics,pending,Date,Both sexes,Jul 2014,pending,Data,Singular,N/A,Ongoing,Population characteristics,Ongoing characteristics,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
2415,Had major operations,100047,Operations,"228,661",Categorical (single),Males only,Jan 2012,"262,928",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Operations,0.0,0.0,0.0,0.0,0.0,0.0
2844,Had other major operations,100047,Operations,"272,918",Categorical (single),Females only,Jan 2012,"309,268",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Operations,0.0,0.0,0.0,0.0,0.0,0.0
20011,Interpolated Age of participant when operation took place,100076,Operations,"398,514","Continuous, years",Both sexes,Feb 2012,"991,164",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Verbal interview,Operations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20010,Interpolated Year when operation took place,100076,Operations,"398,514","Continuous, years",Both sexes,Feb 2012,"991,164",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Verbal interview,Operations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20014,Method of recording time when operation occurred,100076,Operations,"398,516",Categorical (single),Both sexes,Feb 2012,"991,168",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Verbal interview,Operations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
136,"Number of operations, self-reported",100076,Operations,"501,656",Integer,Both sexes,Jan 2012,"566,685",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Verbal interview,Operations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20004,Operation code,100076,Operations,"398,516",Categorical (multiple),Both sexes,Jan 2012,"991,168",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Verbal interview,Operations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
92,Operation year/age first occurred,100076,Operations,"398,516",Integer,Both sexes,Jan 2012,"991,168",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Verbal interview,Operations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3079,Pace-maker,100076,Operations,"500,841",Categorical (single),Both sexes,Jan 2012,"570,293",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Verbal interview,Operations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6146,Attendance/disability/mobility allowance,100067,Other sociodemographic factors,"501,605",Categorical (multiple),Both sexes,Jan 2012,"587,584",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Other sociodemographic factors,0.0,0.0,0.0,0.0,0.0,0.0
4674,Private healthcare,100067,Other sociodemographic factors,"213,701",Categorical (single),Both sexes,Jan 2012,"243,342",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Sociodemographics,Other sociodemographic factors,0.0,0.0,0.0,0.0,0.0,0.0
6159,Pain type(s) experienced in last month,100048,Pain,"501,601",Categorical (multiple),Both sexes,Jan 2012,"870,811",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Pain,0.0,0.0,0.0,0.0,0.0,0.0
3799,Headaches for 3+ months,100048,Pain,"106,242",Categorical (single),Both sexes,Jan 2012,"111,251",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Pain,0.0,0.0,0.0,0.0,0.0,0.0
4067,Facial pains for 3+ months,100048,Pain,"9,931",Categorical (single),Both sexes,Jan 2012,"10,138",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Pain,0.0,0.0,0.0,0.0,0.0,0.0
3404,Neck/shoulder pain for 3+ months,100048,Pain,"123,651",Categorical (single),Both sexes,Jan 2012,"129,097",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Pain,0.0,0.0,0.0,0.0,0.0,0.0
3571,Back pain for 3+ months,100048,Pain,"137,266",Categorical (single),Both sexes,Jan 2012,"144,105",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Pain,0.0,0.0,0.0,0.0,0.0,0.0
3741,Stomach/abdominal pain for 3+ months,100048,Pain,"46,443",Categorical (single),Both sexes,Jan 2012,"47,656",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Pain,0.0,0.0,0.0,0.0,0.0,0.0
3414,Hip pain for 3+ months,100048,Pain,"61,446",Categorical (single),Both sexes,Jan 2012,"63,790",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Pain,0.0,0.0,0.0,0.0,0.0,0.0
3773,Knee pain for 3+ months,100048,Pain,"116,003",Categorical (single),Both sexes,Jan 2012,"121,929",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Pain,0.0,0.0,0.0,0.0,0.0,0.0
2956,General pain for 3+ months,100048,Pain,"9,343",Categorical (single),Both sexes,Jan 2012,"9,537",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Health and medical history,Pain,0.0,0.0,0.0,0.0,0.0,0.0
20197,Number of word pairs correctly associated,506,Paired associate learning,"32,832",Integer,Both sexes,Jun 2017,"35,054",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Paired associate learning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6448,"Word associated with ""huge""",506,Paired associate learning,"32,832",Categorical (single),Both sexes,Jun 2017,"35,054",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Paired associate learning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6459,"Word associated with ""happy""",506,Paired associate learning,"32,832",Categorical (single),Both sexes,Jun 2017,"35,054",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Paired associate learning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6470,"Word associated with ""tattered""",506,Paired associate learning,"32,832",Categorical (single),Both sexes,Jun 2017,"35,054",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Paired associate learning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6481,"Word associated with ""old""",506,Paired associate learning,"32,832",Categorical (single),Both sexes,Jun 2017,"35,054",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Paired associate learning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6492,"Word associated with ""long""",506,Paired associate learning,"32,832",Categorical (single),Both sexes,Jun 2017,"35,054",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Paired associate learning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6503,"Word associated with ""red""",506,Paired associate learning,"32,832",Categorical (single),Both sexes,Jun 2017,"35,054",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Paired associate learning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6514,"Word associated with ""sulking""",506,Paired associate learning,"32,832",Categorical (single),Both sexes,Jun 2017,"35,054",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Paired associate learning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6525,"Word associated with ""pretty""",506,Paired associate learning,"32,832",Categorical (single),Both sexes,Jun 2017,"35,054",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Paired associate learning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6536,"Word associated with ""tiny""",506,Paired associate learning,"32,832",Categorical (single),Both sexes,Jun 2017,"35,054",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Paired associate learning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6547,"Word associated with ""new""",506,Paired associate learning,"32,832",Categorical (single),Both sexes,Jun 2017,"35,054",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Paired associate learning,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20244,Pairs matching completion status,117,Pairs matching,"118,535",Categorical (single),Both sexes,Jul 2015,"118,535",Data,Singular,Jul 2015,Complete,Online follow-up,Cognitive function online,Pairs matching,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20134,When pairs test completed,117,Pairs matching,"118,535",Time,Both sexes,Jul 2015,"118,535",Data,Singular,Jul 2015,Complete,Online follow-up,Cognitive function online,Pairs matching,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20129,Number of columns displayed in round,117,Pairs matching,"118,535",Integer,Both sexes,Jan 2012,"252,034",Data,Defined (1),Jul 2015,Complete,Online follow-up,Cognitive function online,Pairs matching,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20130,Number of rows displayed in round,117,Pairs matching,"118,535",Integer,Both sexes,Jan 2012,"252,034",Data,Defined (1),Jul 2015,Complete,Online follow-up,Cognitive function online,Pairs matching,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20131,Number of correct matches in round,117,Pairs matching,"118,535",Integer,Both sexes,Jan 2012,"252,034",Data,Defined (1),Jul 2015,Complete,Online follow-up,Cognitive function online,Pairs matching,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20132,Number of incorrect matches in round,117,Pairs matching,"118,535",Integer,Both sexes,Jan 2012,"252,034",Data,Defined (1),Jul 2015,Complete,Online follow-up,Cognitive function online,Pairs matching,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20133,Time to complete round,117,Pairs matching,"118,535","Integer, deciseconds",Both sexes,Jan 2012,"252,034",Data,Defined (1),Aug 2015,Complete,Online follow-up,Cognitive function online,Pairs matching,0.0,0.0,0.0,0.0,0.0,0.0,0.0
399,Number of incorrect matches in round,100030,Pairs matching,"498,751",Integer,Both sexes,Jan 2012,"1,164,328",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Pairs matching,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10137,Number of incorrect matches in round (pilot),100030,Pairs matching,"3,714",Integer,Both sexes,Jan 2012,"11,142",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Cognitive function,Pairs matching,0.0,0.0,0.0,0.0,0.0,0.0,0.0
400,Time to complete round,100030,Pairs matching,"498,751","Integer, deciseconds",Both sexes,Jan 2012,"1,164,328",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Pairs matching,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10138,Time to complete round (pilot),100030,Pairs matching,"3,714","Integer, deciseconds",Both sexes,Jan 2012,"11,142",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Cognitive function,Pairs matching,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6334,Screen layout,100030,Pairs matching,"32,832",Text,Both sexes,Jun 2017,"91,667",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Pairs matching,0.0,0.0,0.0,0.0,0.0,0.0,0.0
396,Number of columns displayed in round,100030,Pairs matching,"498,751",Integer,Both sexes,Jan 2012,"1,164,328",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Pairs matching,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10133,Number of columns displayed in round (pilot),100030,Pairs matching,"3,714",Integer,Both sexes,Jan 2012,"11,142",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Cognitive function,Pairs matching,0.0,0.0,0.0,0.0,0.0,0.0,0.0
397,Number of rows displayed in round,100030,Pairs matching,"498,751",Integer,Both sexes,Jan 2012,"1,131,630",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Pairs matching,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10134,Number of rows displayed in round (pilot),100030,Pairs matching,"3,714",Integer,Both sexes,Jan 2012,"11,142",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Cognitive function,Pairs matching,0.0,0.0,0.0,0.0,0.0,0.0,0.0
398,Number of correct matches in round,100030,Pairs matching,"498,751",Integer,Both sexes,Jan 2012,"1,164,328",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Pairs matching,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10136,Number of correct matches in round (pilot),100030,Pairs matching,"3,714",Integer,Both sexes,Jan 2012,"11,142",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Cognitive function,Pairs matching,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20259,Pancreas Images - ShMoLLI - DICOM,131,Pancreas MRI,"32,169",Text,Both sexes,May 2018,"33,254",Bulk,Defined (2),Oct 2019,Ongoing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Pancreas MRI,0.0,0.0,0.0,0.0,0.0,0.0
20260,Pancreas Images - gradient echo - DICOM,131,Pancreas MRI,"32,300",Text,Both sexes,May 2018,"33,385",Bulk,Defined (2),Oct 2019,Ongoing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Pancreas MRI,0.0,0.0,0.0,0.0,0.0,0.0
20202,Pancreatic fat - DICOM,131,Pancreas MRI,"38,645",Text,Both sexes,Jul 2014,"39,737",Bulk,Defined (2),Oct 2019,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Pancreas MRI,0.0,0.0,0.0,0.0,0.0,0.0
20206,Measurements of pancreas volume - DICOM,131,Pancreas MRI,"21,704",Text,Both sexes,Jul 2014,"21,704",Bulk,Defined (1),Dec 2018,Accruing,UK Biobank Assessment Centre,Imaging,Abdominal MRI,Pancreas MRI,0.0,0.0,0.0,0.0,0.0,0.0
42030,Date of all cause parkinsonism report,50,Parkinson's disease outcomes,"2,268",Date,Both sexes,Apr 2018,"2,268",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Parkinson's disease outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42031,Source of all cause parkinsonism report,50,Parkinson's disease outcomes,"2,268",Categorical (single),Both sexes,Apr 2018,"2,268",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Parkinson's disease outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42032,Date of parkinson's disease report,50,Parkinson's disease outcomes,"2,087",Date,Both sexes,Apr 2018,"2,087",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Parkinson's disease outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42033,Source of parkinson's disease report,50,Parkinson's disease outcomes,"2,087",Categorical (single),Both sexes,Apr 2018,"2,087",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Parkinson's disease outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42034,Date of progressive supranuclear palsy report,50,Parkinson's disease outcomes,60,Date,Both sexes,Apr 2018,60,Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Parkinson's disease outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42035,Source of progressive supranuclear palsy report,50,Parkinson's disease outcomes,60,Categorical (single),Both sexes,Apr 2018,60,Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Parkinson's disease outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42036,Date of multiple system atrophy report,50,Parkinson's disease outcomes,74,Date,Both sexes,Apr 2018,74,Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Parkinson's disease outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42037,Source of multiple system atrophy report,50,Parkinson's disease outcomes,74,Categorical (single),Both sexes,Apr 2018,74,Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Parkinson's disease outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
1100,Drive faster than motorway speed limit,100054,Physical activity,"501,424",Categorical (single),Both sexes,Jan 2012,"572,023",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
2634,Duration of heavy DIY,100054,Physical activity,"215,477",Categorical (single),Both sexes,Jan 2012,"237,557",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
1021,Duration of light DIY,100054,Physical activity,"260,646",Categorical (single),Both sexes,Jan 2012,"288,887",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
894,Duration of moderate activity,100054,Physical activity,"418,013","Integer, minutes/day",Both sexes,Jan 2012,"474,174",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
10962,Duration of moderate physical activity (pilot),100054,Physical activity,"3,045",Categorical (single),Both sexes,Jan 2012,"3,045",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
3647,Duration of other exercises,100054,Physical activity,"245,608",Categorical (single),Both sexes,Jan 2012,"274,343",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
1001,Duration of strenuous sports,100054,Physical activity,"53,621",Categorical (single),Both sexes,Jan 2012,"58,573",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
914,Duration of vigorous activity,100054,Physical activity,"304,461","Integer, minutes/day",Both sexes,Jan 2012,"341,973",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
10971,Duration of vigorous physical activity (pilot),100054,Physical activity,"1,980",Categorical (single),Both sexes,Jan 2012,"1,980",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
874,Duration of walks,100054,Physical activity,"480,084","Integer, minutes/day",Both sexes,Jan 2012,"547,065",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
10953,Duration of walks (pilot),100054,Physical activity,"3,634",Categorical (single),Both sexes,Jan 2012,"3,634",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
981,Duration walking for pleasure,100054,Physical activity,"359,685",Categorical (single),Both sexes,Jan 2012,"406,732",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
2624,Frequency of heavy DIY in last 4 weeks,100054,Physical activity,"215,477",Categorical (single),Both sexes,Jan 2012,"237,557",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
1011,Frequency of light DIY in last 4 weeks,100054,Physical activity,"260,646",Categorical (single),Both sexes,Jan 2012,"288,887",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
3637,Frequency of other exercises in last 4 weeks,100054,Physical activity,"245,608",Categorical (single),Both sexes,Jan 2012,"274,343",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
943,Frequency of stair climbing in last 4 weeks,100054,Physical activity,"496,882",Categorical (single),Both sexes,Jan 2012,"566,490",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
991,Frequency of strenuous sports in last 4 weeks,100054,Physical activity,"53,621",Categorical (single),Both sexes,Jan 2012,"58,573",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
971,Frequency of walking for pleasure in last 4 weeks,100054,Physical activity,"359,685",Categorical (single),Both sexes,Jan 2012,"406,732",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
884,Number of days/week of moderate physical activity 10+ minutes,100054,Physical activity,"501,645","Integer, days/week",Both sexes,Jan 2012,"572,271",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
904,Number of days/week of vigorous physical activity 10+ minutes,100054,Physical activity,"501,645","Integer, days/week",Both sexes,Jan 2012,"572,271",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
864,Number of days/week walked 10+ minutes,100054,Physical activity,"501,649","Integer, days/week",Both sexes,Jan 2012,"572,275",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
1090,Time spent driving,100054,Physical activity,"501,424","Integer, hours/day",Both sexes,Jan 2012,"572,023",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
1080,Time spent using computer,100054,Physical activity,"498,752","Integer, hours/day",Both sexes,Jan 2012,"568,495",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
1070,Time spent watching television (TV),100054,Physical activity,"501,640","Integer, hours/day",Both sexes,Jan 2012,"572,266",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
6164,Types of physical activity in last 4 weeks,100054,Physical activity,"497,134",Categorical (multiple),Both sexes,Jan 2012,"1,302,117",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
6162,Types of transport used (excluding work),100054,Physical activity,"496,881",Categorical (multiple),Both sexes,Jan 2012,"939,198",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
924,Usual walking pace,100054,Physical activity,"499,753",Categorical (single),Both sexes,Jan 2012,"570,241",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Physical activity,0.0,0.0,0.0,0.0,0.0,0.0
90001,Acceleration data - cwa format,1008,Physical activity measurement,"103,688",Text,Both sexes,Jun 2013,"115,464",Bulk,Defined (5),Feb 2019,Accruing,Additional exposures,Physical activity measurement,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90004,Acceleration intensity time-series,1008,Physical activity measurement,"103,687",Text,Both sexes,Mar 2016,"103,687",Bulk,Singular,Apr 2016,Complete,Additional exposures,Physical activity measurement,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
110005,"Invitation to physical activity study, acceptance",1008,Physical activity measurement,"236,466",Categorical (single),Both sexes,Jul 2014,"236,466",Data,Singular,Jan 2016,Ongoing,Additional exposures,Physical activity measurement,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
110006,"Invitation to physical activity study, date sent",1008,Physical activity measurement,"233,444",Date,Both sexes,Jul 2014,"233,444",Data,Singular,Dec 2015,Ongoing,Additional exposures,Physical activity measurement,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104900,Time spent doing vigorous physical activity,100108,Physical activity yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Physical activity yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104910,Time spent doing moderate physical activity,100108,Physical activity yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Physical activity yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104920,Time spent doing light physical activity,100108,Physical activity yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Physical activity yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6364,Vocabulary level,504,Picture vocabulary,"32,431",Continuous,Both sexes,Jun 2017,"34,586",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Picture vocabulary,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6365,Uncertainty in vocabulary level,504,Picture vocabulary,"32,431",Continuous,Both sexes,Jun 2017,"34,586",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Picture vocabulary,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6314,Word/picture group used for each round,504,Picture vocabulary,"32,561",Categorical (multiple),Both sexes,Jun 2017,"867,934",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Picture vocabulary,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6315,Picture selected for each round,504,Picture vocabulary,"32,613",Categorical (multiple),Both sexes,Jun 2017,"869,198",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Picture vocabulary,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6317,Duration of selection in each round,504,Picture vocabulary,"32,561","Integer, milliseconds",Both sexes,Jun 2017,"867,934",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Picture vocabulary,0.0,0.0,0.0,0.0,0.0,0.0,0.0
132162,Date O00 first reported (ectopic pregnancy),2415,"Pregnancy, childbirth and the puerperium","1,013",Date,Both sexes,Jul 2019,"1,013",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132163,Source of report of O00 (ectopic pregnancy),2415,"Pregnancy, childbirth and the puerperium","1,013",Categorical (single),Both sexes,Jul 2019,"1,013",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132164,Date O01 first reported (hydatidiform mole),2415,"Pregnancy, childbirth and the puerperium",227,Date,Both sexes,Jul 2019,227,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132165,Source of report of O01 (hydatidiform mole),2415,"Pregnancy, childbirth and the puerperium",227,Categorical (single),Both sexes,Jul 2019,227,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132166,Date O02 first reported (other abnormal products of conception),2415,"Pregnancy, childbirth and the puerperium","2,285",Date,Both sexes,Jul 2019,"2,285",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132167,Source of report of O02 (other abnormal products of conception),2415,"Pregnancy, childbirth and the puerperium","2,285",Categorical (single),Both sexes,Jul 2019,"2,285",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132168,Date O03 first reported (spontaneous abortion),2415,"Pregnancy, childbirth and the puerperium","5,817",Date,Both sexes,Jul 2019,"5,817",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132169,Source of report of O03 (spontaneous abortion),2415,"Pregnancy, childbirth and the puerperium","5,817",Categorical (single),Both sexes,Jul 2019,"5,817",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132170,Date O04 first reported (medical abortion),2415,"Pregnancy, childbirth and the puerperium","4,009",Date,Both sexes,Jul 2019,"4,009",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132171,Source of report of O04 (medical abortion),2415,"Pregnancy, childbirth and the puerperium","4,009",Categorical (single),Both sexes,Jul 2019,"4,009",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132172,Date O05 first reported (other abortion),2415,"Pregnancy, childbirth and the puerperium",6,Date,Both sexes,Jul 2019,6,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132173,Source of report of O05 (other abortion),2415,"Pregnancy, childbirth and the puerperium",6,Categorical (single),Both sexes,Jul 2019,6,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132174,Date O06 first reported (unspecified abortion),2415,"Pregnancy, childbirth and the puerperium",512,Date,Both sexes,Jul 2019,512,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132175,Source of report of O06 (unspecified abortion),2415,"Pregnancy, childbirth and the puerperium",512,Categorical (single),Both sexes,Jul 2019,512,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132176,Date O07 first reported (failed attempted abortion),2415,"Pregnancy, childbirth and the puerperium",23,Date,Both sexes,Jul 2019,23,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132177,Source of report of O07 (failed attempted abortion),2415,"Pregnancy, childbirth and the puerperium",23,Categorical (single),Both sexes,Jul 2019,23,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132178,Date O08 first reported (complications following abortion and ectopic and molar pregnancy),2415,"Pregnancy, childbirth and the puerperium",85,Date,Both sexes,Jul 2019,85,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132179,Source of report of O08 (complications following abortion and ectopic and molar pregnancy),2415,"Pregnancy, childbirth and the puerperium",85,Categorical (single),Both sexes,Jul 2019,85,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132180,"Date O10 first reported (pre-existing hypertension complicating pregnancy, childbirth and the puerperium)",2415,"Pregnancy, childbirth and the puerperium",129,Date,Both sexes,Jul 2019,129,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132181,"Source of report of O10 (pre-existing hypertension complicating pregnancy, childbirth and the puerperium)",2415,"Pregnancy, childbirth and the puerperium",129,Categorical (single),Both sexes,Jul 2019,129,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132182,Date O11 first reported (pre-existing hypertensive disorder with superimposed proteinuria),2415,"Pregnancy, childbirth and the puerperium",32,Date,Both sexes,Jul 2019,32,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132183,Source of report of O11 (pre-existing hypertensive disorder with superimposed proteinuria),2415,"Pregnancy, childbirth and the puerperium",32,Categorical (single),Both sexes,Jul 2019,32,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132184,Date O12 first reported (gestational [pregnancy-induced] oedema and proteinuria without hypertension),2415,"Pregnancy, childbirth and the puerperium",224,Date,Both sexes,Jul 2019,224,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132185,Source of report of O12 (gestational [pregnancy-induced] oedema and proteinuria without hypertension),2415,"Pregnancy, childbirth and the puerperium",224,Categorical (single),Both sexes,Jul 2019,224,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132186,Date O13 first reported (gestational [pregnancy-induced] hypertension without significant proteinuria),2415,"Pregnancy, childbirth and the puerperium",836,Date,Both sexes,Jul 2019,836,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132187,Source of report of O13 (gestational [pregnancy-induced] hypertension without significant proteinuria),2415,"Pregnancy, childbirth and the puerperium",836,Categorical (single),Both sexes,Jul 2019,836,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132188,Date O14 first reported (gestational [pregnancy-induced] hypertension with significant proteinuria),2415,"Pregnancy, childbirth and the puerperium",577,Date,Both sexes,Jul 2019,577,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132189,Source of report of O14 (gestational [pregnancy-induced] hypertension with significant proteinuria),2415,"Pregnancy, childbirth and the puerperium",577,Categorical (single),Both sexes,Jul 2019,577,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132190,Date O15 first reported (eclampsia),2415,"Pregnancy, childbirth and the puerperium",108,Date,Both sexes,Jul 2019,108,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132191,Source of report of O15 (eclampsia),2415,"Pregnancy, childbirth and the puerperium",108,Categorical (single),Both sexes,Jul 2019,108,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132192,Date O16 first reported (unspecified maternal hypertension),2415,"Pregnancy, childbirth and the puerperium",862,Date,Both sexes,Jul 2019,862,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132193,Source of report of O16 (unspecified maternal hypertension),2415,"Pregnancy, childbirth and the puerperium",862,Categorical (single),Both sexes,Jul 2019,862,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132194,Date O20 first reported (haemorrhage in early pregnancy),2415,"Pregnancy, childbirth and the puerperium","1,552",Date,Both sexes,Jul 2019,"1,552",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132195,Source of report of O20 (haemorrhage in early pregnancy),2415,"Pregnancy, childbirth and the puerperium","1,552",Categorical (single),Both sexes,Jul 2019,"1,552",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132196,Date O21 first reported (excessive vomiting in pregnancy),2415,"Pregnancy, childbirth and the puerperium",406,Date,Both sexes,Jul 2019,406,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132197,Source of report of O21 (excessive vomiting in pregnancy),2415,"Pregnancy, childbirth and the puerperium",406,Categorical (single),Both sexes,Jul 2019,406,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132198,Date O22 first reported (venous complications in pregnancy),2415,"Pregnancy, childbirth and the puerperium",142,Date,Both sexes,Jul 2019,142,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132199,Source of report of O22 (venous complications in pregnancy),2415,"Pregnancy, childbirth and the puerperium",142,Categorical (single),Both sexes,Jul 2019,142,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132200,Date O23 first reported (infections of genito-urinary tract in pregnancy),2415,"Pregnancy, childbirth and the puerperium",338,Date,Both sexes,Jul 2019,338,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132201,Source of report of O23 (infections of genito-urinary tract in pregnancy),2415,"Pregnancy, childbirth and the puerperium",338,Categorical (single),Both sexes,Jul 2019,338,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132202,Date O24 first reported (diabetes mellitus in pregnancy),2415,"Pregnancy, childbirth and the puerperium",781,Date,Both sexes,Jul 2019,781,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132203,Source of report of O24 (diabetes mellitus in pregnancy),2415,"Pregnancy, childbirth and the puerperium",781,Categorical (single),Both sexes,Jul 2019,781,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132204,Date O25 first reported (malnutrition in pregnancy),2415,"Pregnancy, childbirth and the puerperium",1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132205,Source of report of O25 (malnutrition in pregnancy),2415,"Pregnancy, childbirth and the puerperium",1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132206,Date O26 first reported (maternal care for other conditions predominantly related to pregnancy),2415,"Pregnancy, childbirth and the puerperium","2,519",Date,Both sexes,Jul 2019,"2,519",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132207,Source of report of O26 (maternal care for other conditions predominantly related to pregnancy),2415,"Pregnancy, childbirth and the puerperium","2,519",Categorical (single),Both sexes,Jul 2019,"2,519",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132208,Date O28 first reported (abnormal findings on antenatal screening of mother),2415,"Pregnancy, childbirth and the puerperium",146,Date,Both sexes,Jul 2019,146,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132209,Source of report of O28 (abnormal findings on antenatal screening of mother),2415,"Pregnancy, childbirth and the puerperium",146,Categorical (single),Both sexes,Jul 2019,146,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132210,Date O29 first reported (complications of anaesthesia during pregnancy),2415,"Pregnancy, childbirth and the puerperium",2,Date,Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132211,Source of report of O29 (complications of anaesthesia during pregnancy),2415,"Pregnancy, childbirth and the puerperium",2,Categorical (single),Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132212,Date O30 first reported (multiple gestation),2415,"Pregnancy, childbirth and the puerperium",641,Date,Both sexes,Jul 2019,641,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132213,Source of report of O30 (multiple gestation),2415,"Pregnancy, childbirth and the puerperium",641,Categorical (single),Both sexes,Jul 2019,641,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132214,Date O31 first reported (complications specific to multiple gestation),2415,"Pregnancy, childbirth and the puerperium",35,Date,Both sexes,Jul 2019,35,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132215,Source of report of O31 (complications specific to multiple gestation),2415,"Pregnancy, childbirth and the puerperium",35,Categorical (single),Both sexes,Jul 2019,35,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132216,Date O32 first reported (maternal care for known or suspected malpresentation of foetus),2415,"Pregnancy, childbirth and the puerperium","1,555",Date,Both sexes,Jul 2019,"1,555",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132217,Source of report of O32 (maternal care for known or suspected malpresentation of foetus),2415,"Pregnancy, childbirth and the puerperium","1,555",Categorical (single),Both sexes,Jul 2019,"1,555",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132218,Date O33 first reported (maternal care for known or suspected disproportion),2415,"Pregnancy, childbirth and the puerperium",100,Date,Both sexes,Jul 2019,100,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132219,Source of report of O33 (maternal care for known or suspected disproportion),2415,"Pregnancy, childbirth and the puerperium",100,Categorical (single),Both sexes,Jul 2019,100,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132220,Date O34 first reported (maternal care for known or suspected abnormality of pelvic organs),2415,"Pregnancy, childbirth and the puerperium","2,059",Date,Both sexes,Jul 2019,"2,059",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132221,Source of report of O34 (maternal care for known or suspected abnormality of pelvic organs),2415,"Pregnancy, childbirth and the puerperium","2,059",Categorical (single),Both sexes,Jul 2019,"2,059",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132222,Date O35 first reported (maternal care for known or suspected foetal abnormality and damage),2415,"Pregnancy, childbirth and the puerperium",345,Date,Both sexes,Jul 2019,345,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132223,Source of report of O35 (maternal care for known or suspected foetal abnormality and damage),2415,"Pregnancy, childbirth and the puerperium",345,Categorical (single),Both sexes,Jul 2019,345,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132224,Date O36 first reported (maternal care for other known or suspected foetal problems),2415,"Pregnancy, childbirth and the puerperium","2,497",Date,Both sexes,Jul 2019,"2,497",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132225,Source of report of O36 (maternal care for other known or suspected foetal problems),2415,"Pregnancy, childbirth and the puerperium","2,497",Categorical (single),Both sexes,Jul 2019,"2,497",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132226,Date O40 first reported (polyhydramnios),2415,"Pregnancy, childbirth and the puerperium",155,Date,Both sexes,Jul 2019,155,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132227,Source of report of O40 (polyhydramnios),2415,"Pregnancy, childbirth and the puerperium",155,Categorical (single),Both sexes,Jul 2019,155,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132228,Date O41 first reported (other disorders of amniotic fluid and membranes),2415,"Pregnancy, childbirth and the puerperium",331,Date,Both sexes,Jul 2019,331,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132229,Source of report of O41 (other disorders of amniotic fluid and membranes),2415,"Pregnancy, childbirth and the puerperium",331,Categorical (single),Both sexes,Jul 2019,331,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132230,Date O42 first reported (premature rupture of membranes),2415,"Pregnancy, childbirth and the puerperium","1,421",Date,Both sexes,Jul 2019,"1,421",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132231,Source of report of O42 (premature rupture of membranes),2415,"Pregnancy, childbirth and the puerperium","1,421",Categorical (single),Both sexes,Jul 2019,"1,421",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132232,Date O43 first reported (placental disorders),2415,"Pregnancy, childbirth and the puerperium",301,Date,Both sexes,Jul 2019,301,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132233,Source of report of O43 (placental disorders),2415,"Pregnancy, childbirth and the puerperium",301,Categorical (single),Both sexes,Jul 2019,301,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132234,Date O44 first reported (placenta praevia),2415,"Pregnancy, childbirth and the puerperium",249,Date,Both sexes,Jul 2019,249,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132235,Source of report of O44 (placenta praevia),2415,"Pregnancy, childbirth and the puerperium",249,Categorical (single),Both sexes,Jul 2019,249,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132236,Date O45 first reported (premature separation of placenta [abruptio placentae]),2415,"Pregnancy, childbirth and the puerperium",67,Date,Both sexes,Jul 2019,67,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132237,Source of report of O45 (premature separation of placenta [abruptio placentae]),2415,"Pregnancy, childbirth and the puerperium",67,Categorical (single),Both sexes,Jul 2019,67,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132238,"Date O46 first reported (antepartum haemorrhage, not elsewhere classified)",2415,"Pregnancy, childbirth and the puerperium",837,Date,Both sexes,Jul 2019,837,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132239,"Source of report of O46 (antepartum haemorrhage, not elsewhere classified)",2415,"Pregnancy, childbirth and the puerperium",837,Categorical (single),Both sexes,Jul 2019,837,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132240,Date O47 first reported (false labour),2415,"Pregnancy, childbirth and the puerperium","1,368",Date,Both sexes,Jul 2019,"1,368",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132241,Source of report of O47 (false labour),2415,"Pregnancy, childbirth and the puerperium","1,368",Categorical (single),Both sexes,Jul 2019,"1,368",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132242,Date O48 first reported (prolonged pregnancy),2415,"Pregnancy, childbirth and the puerperium","1,478",Date,Both sexes,Jul 2019,"1,478",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132243,Source of report of O48 (prolonged pregnancy),2415,"Pregnancy, childbirth and the puerperium","1,478",Categorical (single),Both sexes,Jul 2019,"1,478",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132244,Date O60 first reported (preterm delivery),2415,"Pregnancy, childbirth and the puerperium",994,Date,Both sexes,Jul 2019,994,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132245,Source of report of O60 (preterm delivery),2415,"Pregnancy, childbirth and the puerperium",994,Categorical (single),Both sexes,Jul 2019,994,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132246,Date O61 first reported (failed induction of labour),2415,"Pregnancy, childbirth and the puerperium",203,Date,Both sexes,Jul 2019,203,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132247,Source of report of O61 (failed induction of labour),2415,"Pregnancy, childbirth and the puerperium",203,Categorical (single),Both sexes,Jul 2019,203,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132248,Date O62 first reported (abnormalities of forces of labour),2415,"Pregnancy, childbirth and the puerperium",574,Date,Both sexes,Jul 2019,574,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132249,Source of report of O62 (abnormalities of forces of labour),2415,"Pregnancy, childbirth and the puerperium",574,Categorical (single),Both sexes,Jul 2019,574,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132250,Date O63 first reported (long labour),2415,"Pregnancy, childbirth and the puerperium","2,444",Date,Both sexes,Jul 2019,"2,444",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132251,Source of report of O63 (long labour),2415,"Pregnancy, childbirth and the puerperium","2,444",Categorical (single),Both sexes,Jul 2019,"2,444",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132252,Date O64 first reported (obstructed labour due to malposition and malpresentation of foetus),2415,"Pregnancy, childbirth and the puerperium",543,Date,Both sexes,Jul 2019,543,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132253,Source of report of O64 (obstructed labour due to malposition and malpresentation of foetus),2415,"Pregnancy, childbirth and the puerperium",543,Categorical (single),Both sexes,Jul 2019,543,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132254,Date O65 first reported (obstructed labour due to maternal pelvic abnormality),2415,"Pregnancy, childbirth and the puerperium",62,Date,Both sexes,Jul 2019,62,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132255,Source of report of O65 (obstructed labour due to maternal pelvic abnormality),2415,"Pregnancy, childbirth and the puerperium",62,Categorical (single),Both sexes,Jul 2019,62,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132256,Date O66 first reported (other obstructed labour),2415,"Pregnancy, childbirth and the puerperium",425,Date,Both sexes,Jul 2019,425,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132257,Source of report of O66 (other obstructed labour),2415,"Pregnancy, childbirth and the puerperium",425,Categorical (single),Both sexes,Jul 2019,425,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132258,"Date O67 first reported (labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified)",2415,"Pregnancy, childbirth and the puerperium",136,Date,Both sexes,Jul 2019,136,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132259,"Source of report of O67 (labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified)",2415,"Pregnancy, childbirth and the puerperium",136,Categorical (single),Both sexes,Jul 2019,136,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132260,Date O68 first reported (labour and delivery complicated by foetal stress [distress]),2415,"Pregnancy, childbirth and the puerperium","4,334",Date,Both sexes,Jul 2019,"4,334",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132261,Source of report of O68 (labour and delivery complicated by foetal stress [distress]),2415,"Pregnancy, childbirth and the puerperium","4,334",Categorical (single),Both sexes,Jul 2019,"4,334",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132262,Date O69 first reported (labour and delivery complicated by umbilical cord complications),2415,"Pregnancy, childbirth and the puerperium",808,Date,Both sexes,Jul 2019,808,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132263,Source of report of O69 (labour and delivery complicated by umbilical cord complications),2415,"Pregnancy, childbirth and the puerperium",808,Categorical (single),Both sexes,Jul 2019,808,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132264,Date O70 first reported (perineal laceration during delivery),2415,"Pregnancy, childbirth and the puerperium","6,890",Date,Both sexes,Jul 2019,"6,890",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132265,Source of report of O70 (perineal laceration during delivery),2415,"Pregnancy, childbirth and the puerperium","6,890",Categorical (single),Both sexes,Jul 2019,"6,890",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132266,Date O71 first reported (other obstetric trauma),2415,"Pregnancy, childbirth and the puerperium",292,Date,Both sexes,Jul 2019,292,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132267,Source of report of O71 (other obstetric trauma),2415,"Pregnancy, childbirth and the puerperium",292,Categorical (single),Both sexes,Jul 2019,292,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132268,Date O72 first reported (postpartum haemorrhage),2415,"Pregnancy, childbirth and the puerperium","2,077",Date,Both sexes,Jul 2019,"2,077",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132269,Source of report of O72 (postpartum haemorrhage),2415,"Pregnancy, childbirth and the puerperium","2,077",Categorical (single),Both sexes,Jul 2019,"2,077",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132270,"Date O73 first reported (retained placenta and membranes, without haemorrhage)",2415,"Pregnancy, childbirth and the puerperium",308,Date,Both sexes,Jul 2019,308,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132271,"Source of report of O73 (retained placenta and membranes, without haemorrhage)",2415,"Pregnancy, childbirth and the puerperium",308,Categorical (single),Both sexes,Jul 2019,308,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132272,Date O74 first reported (complications of anaesthesia during labour and delivery),2415,"Pregnancy, childbirth and the puerperium",35,Date,Both sexes,Jul 2019,35,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132273,Source of report of O74 (complications of anaesthesia during labour and delivery),2415,"Pregnancy, childbirth and the puerperium",35,Categorical (single),Both sexes,Jul 2019,35,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132274,"Date O75 first reported (other complications of labour and delivery, not elsewhere classified)",2415,"Pregnancy, childbirth and the puerperium","1,012",Date,Both sexes,Jul 2019,"1,012",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132275,"Source of report of O75 (other complications of labour and delivery, not elsewhere classified)",2415,"Pregnancy, childbirth and the puerperium","1,012",Categorical (single),Both sexes,Jul 2019,"1,012",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132276,Date O80 first reported (single spontaneous delivery),2415,"Pregnancy, childbirth and the puerperium","15,316",Date,Both sexes,Jul 2019,"15,316",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132277,Source of report of O80 (single spontaneous delivery),2415,"Pregnancy, childbirth and the puerperium","15,316",Categorical (single),Both sexes,Jul 2019,"15,316",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132278,Date O81 first reported (single delivery by forceps and vacuum extractor),2415,"Pregnancy, childbirth and the puerperium","1,949",Date,Both sexes,Jul 2019,"1,949",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132279,Source of report of O81 (single delivery by forceps and vacuum extractor),2415,"Pregnancy, childbirth and the puerperium","1,949",Categorical (single),Both sexes,Jul 2019,"1,949",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132280,Date O82 first reported (single delivery by caesarean section),2415,"Pregnancy, childbirth and the puerperium","2,814",Date,Both sexes,Jul 2019,"2,814",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132281,Source of report of O82 (single delivery by caesarean section),2415,"Pregnancy, childbirth and the puerperium","2,814",Categorical (single),Both sexes,Jul 2019,"2,814",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132282,Date O83 first reported (other assisted single delivery),2415,"Pregnancy, childbirth and the puerperium",27,Date,Both sexes,Jul 2019,27,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132283,Source of report of O83 (other assisted single delivery),2415,"Pregnancy, childbirth and the puerperium",27,Categorical (single),Both sexes,Jul 2019,27,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132284,Date O84 first reported (multiple delivery),2415,"Pregnancy, childbirth and the puerperium",34,Date,Both sexes,Jul 2019,34,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132285,Source of report of O84 (multiple delivery),2415,"Pregnancy, childbirth and the puerperium",34,Categorical (single),Both sexes,Jul 2019,34,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132286,Date O85 first reported (puerperal sepsis),2415,"Pregnancy, childbirth and the puerperium",82,Date,Both sexes,Jul 2019,82,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132287,Source of report of O85 (puerperal sepsis),2415,"Pregnancy, childbirth and the puerperium",82,Categorical (single),Both sexes,Jul 2019,82,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132288,Date O86 first reported (other puerperal infections),2415,"Pregnancy, childbirth and the puerperium",318,Date,Both sexes,Jul 2019,318,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132289,Source of report of O86 (other puerperal infections),2415,"Pregnancy, childbirth and the puerperium",318,Categorical (single),Both sexes,Jul 2019,318,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132290,Date O87 first reported (venous complications in the puerperium),2415,"Pregnancy, childbirth and the puerperium",149,Date,Both sexes,Jul 2019,149,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132291,Source of report of O87 (venous complications in the puerperium),2415,"Pregnancy, childbirth and the puerperium",149,Categorical (single),Both sexes,Jul 2019,149,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132292,Date O88 first reported (obstetric embolism),2415,"Pregnancy, childbirth and the puerperium",16,Date,Both sexes,Jul 2019,16,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132293,Source of report of O88 (obstetric embolism),2415,"Pregnancy, childbirth and the puerperium",16,Categorical (single),Both sexes,Jul 2019,16,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132294,Date O89 first reported (complications of anaesthesia during the puerperium),2415,"Pregnancy, childbirth and the puerperium",26,Date,Both sexes,Jul 2019,26,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132295,Source of report of O89 (complications of anaesthesia during the puerperium),2415,"Pregnancy, childbirth and the puerperium",26,Categorical (single),Both sexes,Jul 2019,26,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132296,"Date O90 first reported (complications of the puerperium, not elsewhere classified)",2415,"Pregnancy, childbirth and the puerperium",323,Date,Both sexes,Jul 2019,323,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132297,"Source of report of O90 (complications of the puerperium, not elsewhere classified)",2415,"Pregnancy, childbirth and the puerperium",323,Categorical (single),Both sexes,Jul 2019,323,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132298,Date O91 first reported (infections of breast associated with childbirth),2415,"Pregnancy, childbirth and the puerperium",327,Date,Both sexes,Jul 2019,327,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132299,Source of report of O91 (infections of breast associated with childbirth),2415,"Pregnancy, childbirth and the puerperium",327,Categorical (single),Both sexes,Jul 2019,327,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132300,Date O92 first reported (other disorders of breast and lactation associated with childbirth),2415,"Pregnancy, childbirth and the puerperium",228,Date,Both sexes,Jul 2019,228,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132301,Source of report of O92 (other disorders of breast and lactation associated with childbirth),2415,"Pregnancy, childbirth and the puerperium",228,Categorical (single),Both sexes,Jul 2019,228,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132302,"Date O94 first reported (sequelae of complication of pregnancy, childbirth and the puerperium)",2415,"Pregnancy, childbirth and the puerperium",6,Date,Both sexes,Jul 2019,6,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132303,"Source of report of O94 (sequelae of complication of pregnancy, childbirth and the puerperium)",2415,"Pregnancy, childbirth and the puerperium",6,Categorical (single),Both sexes,Jul 2019,6,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132304,Date O95 first reported (obstetric death of unspecified cause),2415,"Pregnancy, childbirth and the puerperium",pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132305,Source of report of O95 (obstetric death of unspecified cause),2415,"Pregnancy, childbirth and the puerperium",pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132306,Date O96 first reported (death from any obstetric cause occurring more than 42 days but less than one year after delivery),2415,"Pregnancy, childbirth and the puerperium",1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132307,Source of report of O96 (death from any obstetric cause occurring more than 42 days but less than one year after delivery),2415,"Pregnancy, childbirth and the puerperium",1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132308,Date O97 first reported (death from sequelae of direct obstetric causes),2415,"Pregnancy, childbirth and the puerperium",pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132309,Source of report of O97 (death from sequelae of direct obstetric causes),2415,"Pregnancy, childbirth and the puerperium",pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132310,"Date O98 first reported (maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium)",2415,"Pregnancy, childbirth and the puerperium",91,Date,Both sexes,Jul 2019,91,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132311,"Source of report of O98 (maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium)",2415,"Pregnancy, childbirth and the puerperium",91,Categorical (single),Both sexes,Jul 2019,91,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132312,"Date O99 first reported (other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium)",2415,"Pregnancy, childbirth and the puerperium","2,581",Date,Both sexes,Jul 2019,"2,581",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
132313,"Source of report of O99 (other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium)",2415,"Pregnancy, childbirth and the puerperium","2,581",Categorical (single),Both sexes,Jul 2019,"2,581",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,"Pregnancy, childbirth and the puerperium",0.0,0.0,0.0,0.0,0.0,0.0,0.0
111,Aide-memoire completed,100004,Procedural metrics,"501,648",Categorical (single),Both sexes,Jan 2012,"521,979",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Procedural metrics,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
12148,Number of imaging stages blocked at screening,100004,Procedural metrics,"47,922",Integer,Both sexes,Sep 2015,"50,661",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
62,Willing to attempt cognitive tests,100004,Procedural metrics,"498,377",Categorical (single),Both sexes,Jan 2012,"529,807",Data,Defined (3),Nov 2016,Complete,UK Biobank Assessment Centre,Procedural metrics,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21734,Biometrics authorisation,127,Process authorisation,"497,976",Categorical (single),Both sexes,Jan 2018,"566,549",Data,Defined (4),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process authorisation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21762,Brain MRI authorisation,127,Process authorisation,"47,115",Categorical (single),Both sexes,Jan 2018,"49,849",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process authorisation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21771,Cardiac monitor authorisation,127,Process authorisation,"21,446",Categorical (single),Both sexes,Jan 2018,"22,735",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process authorisation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21765,Carotid ultrasound authorisation,127,Process authorisation,"47,717",Categorical (single),Both sexes,Jan 2018,"50,427",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process authorisation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21763,Chest MRI authorisation,127,Process authorisation,"47,163",Categorical (single),Both sexes,Jan 2018,"49,897",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process authorisation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21751,Conclusion authorisation,127,Process authorisation,"501,840",Categorical (single),Both sexes,Jan 2018,"572,773",Data,Defined (4),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process authorisation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21721,Consent authorisation,127,Process authorisation,"502,506",Categorical (single),Both sexes,Jan 2018,"553,177",Data,Defined (4),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process authorisation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21764,DXA assessment authorisation,127,Process authorisation,"47,730",Categorical (single),Both sexes,Jan 2018,"50,461",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process authorisation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21766,ECG at rest authorisation,127,Process authorisation,"47,600",Categorical (single),Both sexes,Jan 2018,"50,187",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process authorisation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21738,ECG during exercise authorisation,127,Process authorisation,"96,551",Categorical (single),Both sexes,Jan 2018,"99,522",Data,Defined (2),Jan 2018,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process authorisation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21736,Eye measures authorisation,127,Process authorisation,"133,929",Categorical (single),Both sexes,Jan 2018,"138,197",Data,Defined (2),Jan 2018,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process authorisation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21761,Imaging screening authorisation,127,Process authorisation,"47,922",Categorical (single),Both sexes,Jan 2018,"50,661",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process authorisation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21733,Measurement/Impedance authorisation (pilot),127,Process authorisation,"3,746",Categorical (single),Both sexes,Jan 2018,"3,746",Data,Defined (1),Jan 2018,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process authorisation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21732,Pilot Spirometry authorisation,127,Process authorisation,"3,736",Categorical (single),Both sexes,Jan 2018,"3,736",Data,Defined (1),Jan 2018,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process authorisation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21711,Reception authorisation,127,Process authorisation,"502,405",Categorical (single),Both sexes,Jan 2018,"573,417",Data,Defined (4),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process authorisation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21742,Sample collection authorisation,127,Process authorisation,"501,330",Categorical (single),Both sexes,Jan 2018,"571,522",Data,Defined (4),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process authorisation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21722,Touchscreen authorisation,127,Process authorisation,"501,575",Categorical (single),Both sexes,Jan 2018,"572,200",Data,Defined (4),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process authorisation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21725,Touchscreen cognitive authorisation,127,Process authorisation,"33,704",Categorical (single),Both sexes,Jan 2018,"35,926",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process authorisation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21723,Touchscreen cognitive authorisation (pilot),127,Process authorisation,"3,714",Categorical (single),Both sexes,Jan 2018,"3,714",Data,Defined (1),Jan 2018,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process authorisation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21741,Urine collection authorisation,127,Process authorisation,"3,711",Categorical (single),Both sexes,Jan 2018,"3,711",Data,Defined (1),Jan 2018,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process authorisation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21731,Verbal interview authorisation,127,Process authorisation,"501,658",Categorical (single),Both sexes,Jan 2018,"566,697",Data,Defined (4),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process authorisation,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21834,Biometrics sign-off timestamp,129,Process completion times,"497,976",Time,Both sexes,Jan 2018,"566,549",Data,Defined (4),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process completion times,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21862,Brain MRI sign-off timestamp,129,Process completion times,"47,115",Time,Both sexes,Jan 2018,"49,849",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process completion times,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21871,Cardiac monitor sign-off timestamp,129,Process completion times,"21,446",Time,Both sexes,Jan 2018,"22,735",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process completion times,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21865,Carotid ultrasound sign-off timestamp,129,Process completion times,"47,717",Time,Both sexes,Jan 2018,"50,427",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process completion times,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21863,Chest MRI sign-off timestamp,129,Process completion times,"47,163",Time,Both sexes,Jan 2018,"49,897",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process completion times,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21851,Conclusion sign-off timestamp,129,Process completion times,"501,840",Time,Both sexes,Jan 2018,"572,773",Data,Defined (4),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process completion times,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21821,Consent sign-off timestamp,129,Process completion times,"502,506",Time,Both sexes,Jan 2018,"553,177",Data,Defined (4),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process completion times,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21864,DXA assessment sign-off timestamp,129,Process completion times,"47,730",Time,Both sexes,Jan 2018,"50,461",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process completion times,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21866,ECG at rest sign-off timestamp,129,Process completion times,"47,600",Time,Both sexes,Jan 2018,"50,187",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process completion times,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21838,ECG during exercise sign-off timestamp,129,Process completion times,"96,551",Time,Both sexes,Jan 2018,"99,522",Data,Defined (2),Jan 2018,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process completion times,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21836,Eye measures sign-off timestamp,129,Process completion times,"133,929",Time,Both sexes,Jan 2018,"138,197",Data,Defined (2),Jan 2018,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process completion times,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21861,Imaging screening sign-off timestamp,129,Process completion times,"47,922",Time,Both sexes,Jan 2018,"50,661",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process completion times,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21833,Measurement/Impedance sign-off timestamp (pilot),129,Process completion times,"3,746",Time,Both sexes,Jan 2018,"3,746",Data,Defined (1),Jan 2018,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process completion times,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21832,Pilot Spirometry sign-off timestamp,129,Process completion times,"3,736",Time,Both sexes,Jan 2018,"3,736",Data,Defined (1),Jan 2018,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process completion times,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21811,Reception sign-off timestamp,129,Process completion times,"502,405",Time,Both sexes,Jan 2018,"573,417",Data,Defined (4),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process completion times,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21842,Sample collection sign-off timestamp,129,Process completion times,"501,330",Time,Both sexes,Jan 2018,"571,522",Data,Defined (4),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process completion times,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21825,Touchscreen cognitive sign-off timestamp,129,Process completion times,"33,704",Time,Both sexes,Jan 2018,"35,926",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process completion times,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21823,Touchscreen cognitive sign-off timestamp (pilot),129,Process completion times,"3,714",Time,Both sexes,Jan 2018,"3,714",Data,Defined (1),Jan 2018,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process completion times,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21822,Touchscreen sign-off timestamp,129,Process completion times,"501,575",Time,Both sexes,Jan 2018,"572,200",Data,Defined (4),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process completion times,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21841,Urine collection sign-off timestamp,129,Process completion times,"3,711",Time,Both sexes,Jan 2018,"3,711",Data,Defined (1),Jan 2018,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process completion times,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21831,Verbal nterview sign-off timestamp,129,Process completion times,"501,658",Time,Both sexes,Jan 2018,"566,697",Data,Defined (4),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process completion times,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4,Biometrics duration,152,Process durations,"497,973","Integer, seconds",Both sexes,Jan 2012,"566,546",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21634,Biometrics duration,152,Process durations,"14,715","Integer, seconds",Both sexes,Apr 2019,"14,715",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21662,Brain MRI duration,152,Process durations,"15,214","Integer, seconds",Both sexes,Apr 2019,"15,214",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21671,Cardiac monitor duration,152,Process durations,"8,871","Integer, seconds",Both sexes,Apr 2019,"8,871",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21665,Carotid ultrasound duration,152,Process durations,"15,355","Integer, seconds",Both sexes,Apr 2019,"15,355",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21663,Chest MRI duration,152,Process durations,"15,223","Integer, seconds",Both sexes,Apr 2019,"15,223",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6,Conclusion duration,152,Process durations,"499,027","Integer, seconds",Both sexes,Jan 2012,"569,096",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21651,Conclusion duration,152,Process durations,"15,389","Integer, seconds",Both sexes,Apr 2019,"15,389",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21621,Consent duration,152,Process durations,"15,405","Integer, seconds",Both sexes,Apr 2019,"15,405",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21664,DXA assessment duration,152,Process durations,"15,325","Integer, seconds",Both sexes,Apr 2019,"15,325",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21666,ECG at rest duration,152,Process durations,"15,342","Integer, seconds",Both sexes,Apr 2019,"15,342",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6022,ECG during exercise duration,152,Process durations,"96,550","Integer, seconds",Both sexes,Jan 2012,"99,521",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21638,ECG during exercise duration,152,Process durations,pending,"Integer, seconds",Both sexes,Apr 2019,pending,Data,Defined (1),N/A,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
5198,Eye measures duration,152,Process durations,"133,926","Integer, seconds",Both sexes,Jan 2012,"138,194",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21636,Eye measures duration,152,Process durations,pending,"Integer, seconds",Both sexes,Apr 2019,pending,Data,Defined (1),N/A,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21661,Imaging screening duration,152,Process durations,"15,404","Integer, seconds",Both sexes,Apr 2019,"15,404",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21633,Measurement/Impedance duration (pilot),152,Process durations,pending,"Integer, seconds",Both sexes,Apr 2019,pending,Data,Defined (1),N/A,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21632,Pilot Spirometry duration,152,Process durations,pending,"Integer, seconds",Both sexes,Apr 2019,pending,Data,Defined (1),N/A,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21611,Reception duration,152,Process durations,"15,410","Integer, seconds",Both sexes,Apr 2019,"15,410",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
5,Sample collection duration,152,Process durations,"501,327","Integer, seconds",Both sexes,Jan 2012,"571,519",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21642,Sample collection duration,152,Process durations,"14,916","Integer, seconds",Both sexes,Apr 2019,"14,916",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21625,Touchscreen cognitive duration,152,Process durations,"14,808","Integer, seconds",Both sexes,Apr 2019,"14,808",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21623,Touchscreen cognitive duration (pilot),152,Process durations,pending,"Integer, seconds",Both sexes,Apr 2019,pending,Data,Defined (1),N/A,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
630,Touchscreen duration,152,Process durations,"501,670","Integer, deciseconds",Both sexes,Jan 2012,"572,296",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21622,Touchscreen duration,152,Process durations,"15,322","Integer, seconds",Both sexes,Apr 2019,"15,322",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10241,Touchscreen duration (pilot),152,Process durations,"3,714","Integer, deciseconds",Both sexes,Jan 2012,"3,714",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21641,Urine collection duration,152,Process durations,pending,"Integer, seconds",Both sexes,Apr 2019,pending,Data,Defined (1),N/A,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3,Verbal interview duration,152,Process durations,"501,656","Integer, seconds",Both sexes,Jan 2012,"566,685",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21631,Verbal interview duration,152,Process durations,"12,501","Integer, seconds",Both sexes,Apr 2019,"12,501",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Procedural metrics,Process durations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20018,Prospective memory result,100031,Prospective memory,"211,307",Categorical (single),Both sexes,Jul 2012,"239,452",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Prospective memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4287,Test completion status,100031,Prospective memory,"211,307",Categorical (single),Both sexes,Jan 2012,"239,452",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Prospective memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4292,PM: initial answer,100031,Prospective memory,"211,307",Categorical (single),Both sexes,Jan 2012,"239,452",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Prospective memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4293,PM: final answer,100031,Prospective memory,"211,307",Categorical (single),Both sexes,Jan 2012,"239,452",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Prospective memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4294,Final attempt correct,100031,Prospective memory,"211,307",Categorical (single),Both sexes,Jan 2012,"239,452",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Prospective memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4291,Number of attempts,100031,Prospective memory,"211,307",Integer,Both sexes,Jan 2012,"239,451",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Prospective memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4295,History of attempts,100031,Prospective memory,"211,307",Text,Both sexes,Jan 2012,"239,452",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Prospective memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4290,Duration screen displayed,100031,Prospective memory,"211,307","Integer, deciseconds",Both sexes,Jan 2012,"239,452",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Prospective memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4286,Time when initial screen shown,100031,Prospective memory,"211,307",Time,Both sexes,Jan 2012,"239,452",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Prospective memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4288,Time to answer,100031,Prospective memory,"211,307","Integer, seconds",Both sexes,Jan 2012,"239,452",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Prospective memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
4289,Time screen exited,100031,Prospective memory,"211,307",Time,Both sexes,Jan 2012,"239,452",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Prospective memory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
12681,Augmentation index for PWA,128,Pulse wave analysis,"40,177","Continuous, percent",Both sexes,Sep 2015,"84,026",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Pulse wave analysis,0.0,0.0,0.0,0.0,0.0,0.0
12695,Blood pressure test start time,128,Pulse wave analysis,"40,309",Text,Both sexes,Sep 2015,"42,374",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Pulse wave analysis,0.0,0.0,0.0,0.0,0.0,0.0
12702,Cardiac index during PWA,128,Pulse wave analysis,"37,836","Continuous, litres/min/m2",Both sexes,Sep 2015,"76,883",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Pulse wave analysis,0.0,0.0,0.0,0.0,0.0,0.0
12682,Cardiac output during PWA,128,Pulse wave analysis,"39,321","Continuous, litres/min",Both sexes,Sep 2015,"79,797",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Pulse wave analysis,0.0,0.0,0.0,0.0,0.0,0.0
12680,Central augmentation pressure during PWA,128,Pulse wave analysis,"39,934","Continuous, mmHg",Both sexes,Sep 2015,"82,629",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Pulse wave analysis,0.0,0.0,0.0,0.0,0.0,0.0
12678,Central pulse pressure during PWA,128,Pulse wave analysis,"39,939","Integer, mmHg",Both sexes,Sep 2015,"82,743",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Pulse wave analysis,0.0,0.0,0.0,0.0,0.0,0.0
12677,Central systolic blood pressure during PWA,128,Pulse wave analysis,"39,942","Integer, mmHg",Both sexes,Sep 2015,"82,752",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Pulse wave analysis,0.0,0.0,0.0,0.0,0.0,0.0
12698,Diastolic brachial blood pressure,128,Pulse wave analysis,"40,306","Integer, mmHg",Both sexes,Sep 2015,"42,370",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Pulse wave analysis,0.0,0.0,0.0,0.0,0.0,0.0
12675,Diastolic brachial blood pressure during PWA,128,Pulse wave analysis,"39,944","Integer, mmHg",Both sexes,Sep 2015,"82,778",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Pulse wave analysis,0.0,0.0,0.0,0.0,0.0,0.0
12683,End systolic pressure during PWA,128,Pulse wave analysis,"39,862","Continuous, mmHg",Both sexes,Sep 2015,"82,575",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Pulse wave analysis,0.0,0.0,0.0,0.0,0.0,0.0
12684,End systolic pressure index during PWA,128,Pulse wave analysis,"39,289",Continuous,Both sexes,Sep 2015,"79,797",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Pulse wave analysis,0.0,0.0,0.0,0.0,0.0,0.0
12673,Heart rate during PWA,128,Pulse wave analysis,"40,177","Integer, bpm",Both sexes,Sep 2015,"84,054",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Pulse wave analysis,0.0,0.0,0.0,0.0,0.0,0.0
12687,Mean arterial pressure during PWA,128,Pulse wave analysis,"39,942","Integer, mmHg",Both sexes,Sep 2015,"82,752",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Pulse wave analysis,0.0,0.0,0.0,0.0,0.0,0.0
12679,Number of beats in waveform average for PWA,128,Pulse wave analysis,"40,182","Continuous, beats",Both sexes,Sep 2015,"84,142",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Pulse wave analysis,0.0,0.0,0.0,0.0,0.0,0.0
12676,Peripheral pulse pressure during PWA,128,Pulse wave analysis,"39,939","Integer, mmHg",Both sexes,Sep 2015,"82,743",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Pulse wave analysis,0.0,0.0,0.0,0.0,0.0,0.0
12686,Stroke volume during PWA,128,Pulse wave analysis,"39,327","Integer, mL",Both sexes,Sep 2015,"79,858",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Pulse wave analysis,0.0,0.0,0.0,0.0,0.0,0.0
12697,Systolic brachial blood pressure,128,Pulse wave analysis,"40,304","Integer, mmHg",Both sexes,Sep 2015,"42,368",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Pulse wave analysis,0.0,0.0,0.0,0.0,0.0,0.0
12674,Systolic brachial blood pressure during PWA,128,Pulse wave analysis,"39,944","Integer, mmHg",Both sexes,Sep 2015,"82,778",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Pulse wave analysis,0.0,0.0,0.0,0.0,0.0,0.0
12685,Total peripheral resistance during PWA,128,Pulse wave analysis,"39,861","Continuous, PRU",Both sexes,Sep 2015,"82,545",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Pulse wave analysis,0.0,0.0,0.0,0.0,0.0,0.0
12671,PWA start time,128,Pulse wave analysis,"40,184",Text,Both sexes,Sep 2015,"84,170",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Pulse wave analysis,0.0,0.0,0.0,0.0,0.0,0.0
12699,Number of PWA tests performed,128,Pulse wave analysis,"40,428","Integer, tests",Both sexes,Sep 2015,"42,499",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Pulse wave analysis,0.0,0.0,0.0,0.0,0.0,0.0
12700,Vicorder results plausible,128,Pulse wave analysis,"40,428",Categorical (single),Both sexes,Sep 2015,"42,499",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Pulse wave analysis,0.0,0.0,0.0,0.0,0.0,0.0
12688,Vicorder trace,128,Pulse wave analysis,"40,428",Compound,Both sexes,May 2018,"42,499",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Heart MRI,Pulse wave analysis,0.0,0.0,0.0,0.0,0.0,0.0
90002,Data problem indicator,1013,Raw accelerometer statistics,"4,695",Categorical (single),Both sexes,Nov 2013,"4,695",Data,Singular,Feb 2016,Updateable,Additional exposures,Physical activity measurement,Raw accelerometer statistics,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90182,Data recording errors,1013,Raw accelerometer statistics,"103,687",Integer,Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Raw accelerometer statistics,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90179,Device ID,1013,Raw accelerometer statistics,"103,687",Integer,Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Raw accelerometer statistics,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90187,Total data readings,1013,Raw accelerometer statistics,"103,687","Integer, readings",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Raw accelerometer statistics,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90188,Sample rate average,1013,Raw accelerometer statistics,"103,687","Continuous, Hz",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Raw accelerometer statistics,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90189,Sample rate standard deviation,1013,Raw accelerometer statistics,"103,687","Continuous, Hz",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Raw accelerometer statistics,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90190,Sample rate minimum,1013,Raw accelerometer statistics,"103,687","Continuous, Hz",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Raw accelerometer statistics,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90191,Sample rate maximum,1013,Raw accelerometer statistics,"103,687","Continuous, Hz",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Raw accelerometer statistics,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90180,Interrupted recording periods,1013,Raw accelerometer statistics,"103,687",Integer,Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Raw accelerometer statistics,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90181,Duration of interrupted recording periods,1013,Raw accelerometer statistics,"103,687","Continuous, minutes",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Raw accelerometer statistics,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90183,Readings exceeding +/-8 gravities before calibration,1013,Raw accelerometer statistics,"103,687",Integer,Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Raw accelerometer statistics,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90185,Readings exceeding +/-8 gravities after calibration,1013,Raw accelerometer statistics,"103,687",Integer,Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Raw accelerometer statistics,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90184,Maximum readings exceeding +/-8 gravities before calibration in a 5 second epoch,1013,Raw accelerometer statistics,"103,687","Integer, readings",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Raw accelerometer statistics,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90186,Maximum readings exceeding +/-8 gravities after calibration in a 5 second epoch,1013,Raw accelerometer statistics,"103,687","Integer, readings",Both sexes,Nov 2015,"103,687",Data,Singular,Feb 2016,Accruing,Additional exposures,Physical activity measurement,Raw accelerometer statistics,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90192,Temperature average,1013,Raw accelerometer statistics,"103,687","Continuous, Celsius",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Raw accelerometer statistics,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90193,Temperature standard deviation,1013,Raw accelerometer statistics,"103,687","Continuous, Celsius",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Raw accelerometer statistics,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90194,Temperature minimum,1013,Raw accelerometer statistics,"103,687","Continuous, Celsius",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Raw accelerometer statistics,0.0,0.0,0.0,0.0,0.0,0.0,0.0
90195,Temperature maximum,1013,Raw accelerometer statistics,"103,687","Continuous, Celsius",Both sexes,Nov 2015,"103,687",Data,Singular,Jan 2016,Accruing,Additional exposures,Physical activity measurement,Raw accelerometer statistics,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20023,Mean time to correctly identify matches,100032,Reaction time,"496,850","Integer, milliseconds",Both sexes,Jun 2013,"564,184",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Reaction time,0.0,0.0,0.0,0.0,0.0,0.0,0.0
401,Index for card A in round,100032,Reaction time,"496,614",Categorical (single),Both sexes,Jan 2012,"6,763,056",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Reaction time,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10139,Index for card A in round (pilot),100032,Reaction time,"3,714",Categorical (single),Both sexes,Jan 2012,"74,280",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Cognitive function,Reaction time,0.0,0.0,0.0,0.0,0.0,0.0,0.0
402,Index for card B in round,100032,Reaction time,"496,614",Categorical (single),Both sexes,Jan 2012,"6,763,056",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Reaction time,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10140,Index for card B in round (pilot),100032,Reaction time,"3,714",Categorical (single),Both sexes,Jan 2012,"74,280",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Cognitive function,Reaction time,0.0,0.0,0.0,0.0,0.0,0.0,0.0
403,Number of times snap-button pressed,100032,Reaction time,"496,614",Integer,Both sexes,Jan 2012,"6,763,056",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Reaction time,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10141,Number of times snap-button pressed (pilot),100032,Reaction time,"3,714",Integer,Both sexes,Jan 2012,"74,280",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Cognitive function,Reaction time,0.0,0.0,0.0,0.0,0.0,0.0,0.0
404,Duration to first press of snap-button in each round,100032,Reaction time,"494,253","Integer, milliseconds",Both sexes,Jan 2012,"3,396,561",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Cognitive function,Reaction time,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10147,Duration to first press of snap-button in each round (pilot),100032,Reaction time,"3,701","Integer, milliseconds",Both sexes,Jan 2012,"30,021",Data,Defined (1),Jul 2012,Complete,UK Biobank Assessment Centre,Cognitive function,Reaction time,0.0,0.0,0.0,0.0,0.0,0.0,0.0
54,UK Biobank assessment centre,100024,Reception,"502,506",Categorical (single),Both sexes,Jan 2012,"573,520",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Recruitment,Reception,0.0,0.0,0.0,0.0,0.0,0.0,0.0
53,Date of attending assessment centre,100024,Reception,"502,506",Date,Both sexes,Jan 2012,"573,525",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Recruitment,Reception,0.0,0.0,0.0,0.0,0.0,0.0,0.0
55,Month of attending assessment centre,100024,Reception,"502,506",Categorical (single),Both sexes,Jan 2012,"573,525",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Recruitment,Reception,0.0,0.0,0.0,0.0,0.0,0.0,0.0
21003,Age when attended assessment centre,100024,Reception,"502,506","Integer, years",Both sexes,Jan 2012,"573,525",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Recruitment,Reception,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20033,Home location at assessment - east co-ordinate,100024,Reception,"497,874","Integer, metre-grid",Both sexes,Aug 2012,"544,128",Data,Defined (3),Aug 2018,Complete,UK Biobank Assessment Centre,Recruitment,Reception,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20074,Home location at assessment - east co-ordinate (rounded),100024,Reception,"497,874","Integer, metre-grid",Both sexes,Aug 2012,"544,128",Data,Defined (3),Aug 2018,Complete,UK Biobank Assessment Centre,Recruitment,Reception,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20034,Home location at assessment - north co-ordinate,100024,Reception,"497,874","Integer, metre-grid",Both sexes,Aug 2012,"544,128",Data,Defined (3),Aug 2018,Complete,UK Biobank Assessment Centre,Recruitment,Reception,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20075,Home location at assessment - north co-ordinate (rounded),100024,Reception,"497,874","Integer, metre-grid",Both sexes,Aug 2012,"544,128",Data,Defined (3),Aug 2018,Complete,UK Biobank Assessment Centre,Recruitment,Reception,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20118,Home area population density - urban or rural,100024,Reception,"497,455",Categorical (single),Both sexes,Mar 2013,"497,455",Data,Defined (1),Mar 2013,Complete,UK Biobank Assessment Centre,Recruitment,Reception,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20270,Home location - census output area (2001 Census),100024,Reception,pending,Text,Both sexes,Apr 2019,pending,Data,Singular,N/A,Accruing,UK Biobank Assessment Centre,Recruitment,Reception,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20273,Home location - census output area (2011 Census),100024,Reception,pending,Text,Both sexes,Apr 2019,pending,Data,Singular,N/A,Accruing,UK Biobank Assessment Centre,Recruitment,Reception,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20272,Home location - local authority district (2001 boundaries),100024,Reception,pending,Text,Both sexes,Apr 2019,pending,Data,Singular,N/A,Accruing,UK Biobank Assessment Centre,Recruitment,Reception,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20276,Home location - local authority district (2011 boundaries),100024,Reception,pending,Text,Both sexes,Apr 2019,pending,Data,Singular,N/A,Accruing,UK Biobank Assessment Centre,Recruitment,Reception,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20275,Home location - middle layer super output area (2011 Census),100024,Reception,pending,Text,Both sexes,Apr 2019,pending,Data,Singular,N/A,Accruing,UK Biobank Assessment Centre,Recruitment,Reception,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20271,Home location - lower layer super output area (2001 Census),100024,Reception,pending,Text,Both sexes,Apr 2019,pending,Data,Singular,N/A,Accruing,UK Biobank Assessment Centre,Recruitment,Reception,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20274,Home location - lower layer super output area (2011 Census),100024,Reception,pending,Text,Both sexes,Apr 2019,pending,Data,Singular,N/A,Accruing,UK Biobank Assessment Centre,Recruitment,Reception,0.0,0.0,0.0,0.0,0.0,0.0,0.0
41259,Records in HES inpatient main dataset,2006,Record-level access,"413,688",Integer,Both sexes,May 2019,"413,688",Records,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Record-level access,0.0,0.0,0.0,0.0,0.0,0.0
41234,Records in HES inpatient diagnoses dataset,2006,Record-level access,"413,574",Integer,Both sexes,May 2019,"413,574",Records,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Record-level access,0.0,0.0,0.0,0.0,0.0,0.0
41149,Records in HES inpatient operations dataset,2006,Record-level access,"411,615",Integer,Both sexes,May 2019,"411,615",Records,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Record-level access,0.0,0.0,0.0,0.0,0.0,0.0
41261,Records in HES inpatient maternity dataset,2006,Record-level access,"16,624",Integer,Both sexes,May 2019,"16,624",Records,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Record-level access,0.0,0.0,0.0,0.0,0.0,0.0
41264,Records in HES inpatient delivery dataset,2006,Record-level access,"16,624",Integer,Both sexes,May 2019,"16,624",Records,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Record-level access,0.0,0.0,0.0,0.0,0.0,0.0
41265,Records in HES inpatient birth dataset,2006,Record-level access,"16,624",Integer,Both sexes,May 2019,"16,624",Records,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Record-level access,0.0,0.0,0.0,0.0,0.0,0.0
41289,Records in HES inpatient psychiatric dataset,2006,Record-level access,"366,424","Integer, records",Both sexes,Jun 2019,"366,424",Records,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Record-level access,0.0,0.0,0.0,0.0,0.0,0.0
42040,GP clinical event records,3001,Record-level access,"230,097","Integer, records",Both sexes,Jun 2019,"230,097",Records,Singular,Sep 2019,Ongoing,Health-related outcomes,Primary care,Record-level access,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42039,GP prescription records,3001,Record-level access,"222,114","Integer, records",Both sexes,Jun 2019,"222,114",Records,Singular,Sep 2019,Ongoing,Health-related outcomes,Primary care,Record-level access,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42038,GP registration records,3001,Record-level access,"228,949","Integer, records",Both sexes,Jun 2019,"228,949",Records,Singular,Sep 2019,Ongoing,Health-related outcomes,Primary care,Record-level access,0.0,0.0,0.0,0.0,0.0,0.0,0.0
110003,"Invitation to assessment centre, acceptance",100021,Recruitment,pending,Categorical (single),Both sexes,Sep 2014,pending,Data,Defined (1),N/A,Ongoing,UK Biobank Assessment Centre,Recruitment,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
110008,"Invitation to assessment centre, date sent",100021,Recruitment,"103,516",Date,Both sexes,Sep 2014,"107,361",Data,Defined (2),Sep 2014,Complete,UK Biobank Assessment Centre,Recruitment,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
25888,Volume of grey matter in Amygdala (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25889,Volume of grey matter in Amygdala (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25822,Volume of grey matter in Angular Gyrus (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25823,Volume of grey matter in Angular Gyrus (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25892,Volume of grey matter in Brain-Stem,1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25880,Volume of grey matter in Caudate (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25881,Volume of grey matter in Caudate (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25864,Volume of grey matter in Central Opercular Cortex (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25865,Volume of grey matter in Central Opercular Cortex (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25838,"Volume of grey matter in Cingulate Gyrus, anterior division (left)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25839,"Volume of grey matter in Cingulate Gyrus, anterior division (right)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25840,"Volume of grey matter in Cingulate Gyrus, posterior division (left)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25841,"Volume of grey matter in Cingulate Gyrus, posterior division (right)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25900,Volume of grey matter in Crus I Cerebellum (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25902,Volume of grey matter in Crus I Cerebellum (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25901,Volume of grey matter in Crus I Cerebellum (vermis),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25903,Volume of grey matter in Crus II Cerebellum (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25905,Volume of grey matter in Crus II Cerebellum (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25904,Volume of grey matter in Crus II Cerebellum (vermis),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25844,Volume of grey matter in Cuneal Cortex (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25845,Volume of grey matter in Cuneal Cortex (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25830,Volume of grey matter in Frontal Medial Cortex (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25831,Volume of grey matter in Frontal Medial Cortex (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25862,Volume of grey matter in Frontal Operculum Cortex (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25863,Volume of grey matter in Frontal Operculum Cortex (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25846,Volume of grey matter in Frontal Orbital Cortex (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25847,Volume of grey matter in Frontal Orbital Cortex (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25782,Volume of grey matter in Frontal Pole (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25783,Volume of grey matter in Frontal Pole (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25870,Volume of grey matter in Heschl's Gyrus (includes H1 and H2) (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25871,Volume of grey matter in Heschl's Gyrus (includes H1 and H2) (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25886,Volume of grey matter in Hippocampus (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25887,Volume of grey matter in Hippocampus (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25893,Volume of grey matter in I-IV Cerebellum (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25894,Volume of grey matter in I-IV Cerebellum (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25915,Volume of grey matter in IX Cerebellum (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25917,Volume of grey matter in IX Cerebellum (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25916,Volume of grey matter in IX Cerebellum (vermis),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25792,"Volume of grey matter in Inferior Frontal Gyrus, pars opercularis (left)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25793,"Volume of grey matter in Inferior Frontal Gyrus, pars opercularis (right)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25790,"Volume of grey matter in Inferior Frontal Gyrus, pars triangularis (left)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25791,"Volume of grey matter in Inferior Frontal Gyrus, pars triangularis (right)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25808,"Volume of grey matter in Inferior Temporal Gyrus, anterior division (left)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25809,"Volume of grey matter in Inferior Temporal Gyrus, anterior division (right)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25810,"Volume of grey matter in Inferior Temporal Gyrus, posterior division (left)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25811,"Volume of grey matter in Inferior Temporal Gyrus, posterior division (right)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25812,"Volume of grey matter in Inferior Temporal Gyrus, temporooccipital part (left)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25813,"Volume of grey matter in Inferior Temporal Gyrus, temporooccipital part (right)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25784,Volume of grey matter in Insular Cortex (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25785,Volume of grey matter in Insular Cortex (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25828,Volume of grey matter in Intracalcarine Cortex (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25829,Volume of grey matter in Intracalcarine Cortex (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25832,Volume of grey matter in Juxtapositional Lobule Cortex (formerly Supplementary Motor Cortex) (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25833,Volume of grey matter in Juxtapositional Lobule Cortex (formerly Supplementary Motor Cortex) (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25826,"Volume of grey matter in Lateral Occipital Cortex, inferior division (left)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25827,"Volume of grey matter in Lateral Occipital Cortex, inferior division (right)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25824,"Volume of grey matter in Lateral Occipital Cortex, superior division (left)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25825,"Volume of grey matter in Lateral Occipital Cortex, superior division (right)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25852,Volume of grey matter in Lingual Gyrus (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25853,Volume of grey matter in Lingual Gyrus (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25788,Volume of grey matter in Middle Frontal Gyrus (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25789,Volume of grey matter in Middle Frontal Gyrus (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25802,"Volume of grey matter in Middle Temporal Gyrus, anterior division (left)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25803,"Volume of grey matter in Middle Temporal Gyrus, anterior division (right)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25804,"Volume of grey matter in Middle Temporal Gyrus, posterior division (left)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25805,"Volume of grey matter in Middle Temporal Gyrus, posterior division (right)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25806,"Volume of grey matter in Middle Temporal Gyrus, temporooccipital part (left)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25807,"Volume of grey matter in Middle Temporal Gyrus, temporooccipital part (right)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25860,Volume of grey matter in Occipital Fusiform Gyrus (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25861,Volume of grey matter in Occipital Fusiform Gyrus (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25876,Volume of grey matter in Occipital Pole (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25877,Volume of grey matter in Occipital Pole (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25884,Volume of grey matter in Pallidum (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25885,Volume of grey matter in Pallidum (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25836,Volume of grey matter in Paracingulate Gyrus (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25837,Volume of grey matter in Paracingulate Gyrus (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25848,"Volume of grey matter in Parahippocampal Gyrus, anterior division (left)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25849,"Volume of grey matter in Parahippocampal Gyrus, anterior division (right)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25850,"Volume of grey matter in Parahippocampal Gyrus, posterior division (left)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25851,"Volume of grey matter in Parahippocampal Gyrus, posterior division (right)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25866,Volume of grey matter in Parietal Operculum Cortex (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25867,Volume of grey matter in Parietal Operculum Cortex (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25868,Volume of grey matter in Planum Polare (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25869,Volume of grey matter in Planum Polare (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25872,Volume of grey matter in Planum Temporale (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25873,Volume of grey matter in Planum Temporale (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25814,Volume of grey matter in Postcentral Gyrus (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25815,Volume of grey matter in Postcentral Gyrus (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25794,Volume of grey matter in Precentral Gyrus (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25795,Volume of grey matter in Precentral Gyrus (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25842,Volume of grey matter in Precuneous Cortex (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25843,Volume of grey matter in Precuneous Cortex (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25882,Volume of grey matter in Putamen (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25883,Volume of grey matter in Putamen (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25834,Volume of grey matter in Subcallosal Cortex (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25835,Volume of grey matter in Subcallosal Cortex (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25786,Volume of grey matter in Superior Frontal Gyrus (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25787,Volume of grey matter in Superior Frontal Gyrus (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25816,Volume of grey matter in Superior Parietal Lobule (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25817,Volume of grey matter in Superior Parietal Lobule (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25798,"Volume of grey matter in Superior Temporal Gyrus, anterior division (left)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25799,"Volume of grey matter in Superior Temporal Gyrus, anterior division (right)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25800,"Volume of grey matter in Superior Temporal Gyrus, posterior division (left)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25801,"Volume of grey matter in Superior Temporal Gyrus, posterior division (right)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25874,Volume of grey matter in Supracalcarine Cortex (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25875,Volume of grey matter in Supracalcarine Cortex (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25818,"Volume of grey matter in Supramarginal Gyrus, anterior division (left)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25819,"Volume of grey matter in Supramarginal Gyrus, anterior division (right)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25820,"Volume of grey matter in Supramarginal Gyrus, posterior division (left)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25821,"Volume of grey matter in Supramarginal Gyrus, posterior division (right)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25854,"Volume of grey matter in Temporal Fusiform Cortex, anterior division (left)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25855,"Volume of grey matter in Temporal Fusiform Cortex, anterior division (right)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25856,"Volume of grey matter in Temporal Fusiform Cortex, posterior division (left)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25857,"Volume of grey matter in Temporal Fusiform Cortex, posterior division (right)",1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25858,Volume of grey matter in Temporal Occipital Fusiform Cortex (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25859,Volume of grey matter in Temporal Occipital Fusiform Cortex (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25796,Volume of grey matter in Temporal Pole (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25797,Volume of grey matter in Temporal Pole (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25878,Volume of grey matter in Thalamus (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25879,Volume of grey matter in Thalamus (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25895,Volume of grey matter in V Cerebellum (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25896,Volume of grey matter in V Cerebellum (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25897,Volume of grey matter in VI Cerebellum (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25899,Volume of grey matter in VI Cerebellum (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25898,Volume of grey matter in VI Cerebellum (vermis),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25909,Volume of grey matter in VIIIa Cerebellum (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25911,Volume of grey matter in VIIIa Cerebellum (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25910,Volume of grey matter in VIIIa Cerebellum (vermis),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25912,Volume of grey matter in VIIIb Cerebellum (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25914,Volume of grey matter in VIIIb Cerebellum (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25913,Volume of grey matter in VIIIb Cerebellum (vermis),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25906,Volume of grey matter in VIIb Cerebellum (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25908,Volume of grey matter in VIIb Cerebellum (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25907,Volume of grey matter in VIIb Cerebellum (vermis),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25890,Volume of grey matter in Ventral Striatum (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25891,Volume of grey matter in Ventral Striatum (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25918,Volume of grey matter in X Cerebellum (left),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25919,Volume of grey matter in X Cerebellum (vermis),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
25920,Volume of grey matter in X Cerebellum (right),1101,Regional grey matter volumes (FAST),"39,767","Continuous, mm3",Both sexes,Jan 2017,"41,194",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Regional grey matter volumes (FAST),0.0,0.0,0.0,0.0,0.0
24014,Close to major road,114,Residential air pollution,"495,126",Categorical (single),Both sexes,Mar 2015,"495,126",Data,Singular,Apr 2015,Complete,Additional exposures,Local environment,Residential air pollution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24012,Inverse distance to the nearest major road,114,Residential air pollution,"495,126","Continuous, 1/metres",Both sexes,Mar 2015,"495,126",Data,Singular,Apr 2015,Complete,Additional exposures,Local environment,Residential air pollution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24010,Inverse distance to the nearest road,114,Residential air pollution,"495,126","Continuous, 1/metres",Both sexes,Mar 2015,"495,126",Data,Singular,Apr 2015,Complete,Additional exposures,Local environment,Residential air pollution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24016,Nitrogen dioxide air pollution; 2005,114,Residential air pollution,"495,126","Continuous, micro-g/m3",Both sexes,Mar 2015,"495,126",Data,Singular,Apr 2015,Complete,Additional exposures,Local environment,Residential air pollution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24017,Nitrogen dioxide air pollution; 2006,114,Residential air pollution,"495,126","Continuous, micro-g/m3",Both sexes,Mar 2015,"495,126",Data,Singular,Apr 2015,Complete,Additional exposures,Local environment,Residential air pollution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24018,Nitrogen dioxide air pollution; 2007,114,Residential air pollution,"495,126","Continuous, micro-g/m3",Both sexes,Mar 2015,"495,126",Data,Singular,Apr 2015,Complete,Additional exposures,Local environment,Residential air pollution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24003,Nitrogen dioxide air pollution; 2010,114,Residential air pollution,"495,126","Continuous, micro-g/m3",Both sexes,Mar 2015,"495,126",Data,Singular,Apr 2015,Complete,Additional exposures,Local environment,Residential air pollution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24004,Nitrogen oxides air pollution; 2010,114,Residential air pollution,"495,126","Continuous, micro-g/m3",Both sexes,Mar 2015,"495,126",Data,Singular,Apr 2015,Complete,Additional exposures,Local environment,Residential air pollution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24019,Particulate matter air pollution (pm10); 2007,114,Residential air pollution,"494,028","Continuous, micro-g/m3",Both sexes,Mar 2015,"494,028",Data,Singular,Apr 2015,Complete,Additional exposures,Local environment,Residential air pollution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24005,Particulate matter air pollution (pm10); 2010,114,Residential air pollution,"461,203","Continuous, micro-g/m3",Both sexes,Mar 2015,"461,203",Data,Singular,Apr 2015,Complete,Additional exposures,Local environment,Residential air pollution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24007,Particulate matter air pollution (pm2.5) absorbance; 2010,114,Residential air pollution,"461,203","Continuous, per-metre",Both sexes,Mar 2015,"461,203",Data,Singular,Apr 2015,Complete,Additional exposures,Local environment,Residential air pollution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24006,Particulate matter air pollution (pm2.5); 2010,114,Residential air pollution,"461,203","Continuous, micro-g/m3",Both sexes,Mar 2015,"461,203",Data,Singular,Apr 2015,Complete,Additional exposures,Local environment,Residential air pollution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24008,Particulate matter air pollution 2.5-10um; 2010,114,Residential air pollution,"461,203","Continuous, micro-g/m3",Both sexes,Mar 2015,"461,203",Data,Singular,Apr 2015,Complete,Additional exposures,Local environment,Residential air pollution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24015,Sum of road length of major roads within 100m,114,Residential air pollution,"495,126","Continuous, metres",Both sexes,Mar 2015,"495,126",Data,Singular,Apr 2015,Complete,Additional exposures,Local environment,Residential air pollution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24013,Total traffic load on major roads,114,Residential air pollution,"495,126","Integer, vehicles/day",Both sexes,Mar 2015,"495,126",Data,Singular,Apr 2015,Complete,Additional exposures,Local environment,Residential air pollution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24011,Traffic intensity on the nearest major road,114,Residential air pollution,"495,126","Integer, vehicles/day",Both sexes,Mar 2015,"495,126",Data,Singular,Apr 2015,Complete,Additional exposures,Local environment,Residential air pollution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24009,Traffic intensity on the nearest road,114,Residential air pollution,"495,126","Integer, vehicles/day",Both sexes,Mar 2015,"495,126",Data,Singular,Apr 2015,Complete,Additional exposures,Local environment,Residential air pollution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24023,Average 16-hour sound level of noise pollution,115,Residential noise pollution,"495,126","Continuous, dB",Both sexes,Mar 2015,"495,126",Data,Singular,Apr 2015,Complete,Additional exposures,Local environment,Residential noise pollution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24024,Average 24-hour sound level of noise pollution,115,Residential noise pollution,"495,126","Continuous, dB",Both sexes,Mar 2015,"495,126",Data,Singular,Apr 2015,Complete,Additional exposures,Local environment,Residential noise pollution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24020,Average daytime sound level of noise pollution,115,Residential noise pollution,"495,126","Continuous, dB",Both sexes,Mar 2015,"495,126",Data,Singular,Apr 2015,Complete,Additional exposures,Local environment,Residential noise pollution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24021,Average evening sound level of noise pollution,115,Residential noise pollution,"495,126","Continuous, dB",Both sexes,Mar 2015,"495,126",Data,Singular,Apr 2015,Complete,Additional exposures,Local environment,Residential noise pollution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
24022,Average night-time sound level of noise pollution,115,Residential noise pollution,"495,126","Continuous, dB",Both sexes,Mar 2015,"495,126",Data,Singular,Apr 2015,Complete,Additional exposures,Local environment,Residential noise pollution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131424,Date J00 first reported (acute nasopharyngitis [common cold]),2410,Respiratory system disorders,"5,403",Date,Both sexes,Jul 2019,"5,403",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131425,Source of report of J00 (acute nasopharyngitis [common cold]),2410,Respiratory system disorders,"5,403",Categorical (single),Both sexes,Jul 2019,"5,403",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131426,Date J01 first reported (acute sinusitis),2410,Respiratory system disorders,"24,561",Date,Both sexes,Jul 2019,"24,561",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131427,Source of report of J01 (acute sinusitis),2410,Respiratory system disorders,"24,561",Categorical (single),Both sexes,Jul 2019,"24,561",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131428,Date J02 first reported (acute pharyngitis),2410,Respiratory system disorders,"23,798",Date,Both sexes,Jul 2019,"23,798",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131429,Source of report of J02 (acute pharyngitis),2410,Respiratory system disorders,"23,798",Categorical (single),Both sexes,Jul 2019,"23,798",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131430,Date J03 first reported (acute tonsillitis),2410,Respiratory system disorders,"16,333",Date,Both sexes,Jul 2019,"16,333",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131431,Source of report of J03 (acute tonsillitis),2410,Respiratory system disorders,"16,333",Categorical (single),Both sexes,Jul 2019,"16,333",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131432,Date J04 first reported (acute laryngitis and tracheitis),2410,Respiratory system disorders,"4,564",Date,Both sexes,Jul 2019,"4,564",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131433,Source of report of J04 (acute laryngitis and tracheitis),2410,Respiratory system disorders,"4,564",Categorical (single),Both sexes,Jul 2019,"4,564",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131434,Date J05 first reported (acute obstructive laryngitis [croup] and epiglottitis),2410,Respiratory system disorders,150,Date,Both sexes,Jul 2019,150,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131435,Source of report of J05 (acute obstructive laryngitis [croup] and epiglottitis),2410,Respiratory system disorders,150,Categorical (single),Both sexes,Jul 2019,150,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131436,Date J06 first reported (acute upper respiratory infections of multiple and unspecified sites),2410,Respiratory system disorders,"51,927",Date,Both sexes,Jul 2019,"51,927",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131437,Source of report of J06 (acute upper respiratory infections of multiple and unspecified sites),2410,Respiratory system disorders,"51,927",Categorical (single),Both sexes,Jul 2019,"51,927",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131438,Date J09 first reported (influenza due to certain identified influenza virus),2410,Respiratory system disorders,19,Date,Both sexes,Jul 2019,19,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131439,Source of report of J09 (influenza due to certain identified influenza virus),2410,Respiratory system disorders,19,Categorical (single),Both sexes,Jul 2019,19,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131440,Date J10 first reported (influenza due to identified influenza virus),2410,Respiratory system disorders,609,Date,Both sexes,Jul 2019,609,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131441,Source of report of J10 (influenza due to identified influenza virus),2410,Respiratory system disorders,609,Categorical (single),Both sexes,Jul 2019,609,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131442,"Date J11 first reported (influenza, virus not identified)",2410,Respiratory system disorders,"10,896",Date,Both sexes,Jul 2019,"10,896",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131443,"Source of report of J11 (influenza, virus not identified)",2410,Respiratory system disorders,"10,896",Categorical (single),Both sexes,Jul 2019,"10,896",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131444,"Date J12 first reported (viral pneumonia, not elsewhere classified)",2410,Respiratory system disorders,207,Date,Both sexes,Jul 2019,207,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131445,"Source of report of J12 (viral pneumonia, not elsewhere classified)",2410,Respiratory system disorders,207,Categorical (single),Both sexes,Jul 2019,207,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131446,Date J13 first reported (pneumonia due to streptococcus pneumoniae),2410,Respiratory system disorders,886,Date,Both sexes,Jul 2019,886,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131447,Source of report of J13 (pneumonia due to streptococcus pneumoniae),2410,Respiratory system disorders,886,Categorical (single),Both sexes,Jul 2019,886,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131448,Date J14 first reported (pneumonia due to haemophilus influenzae),2410,Respiratory system disorders,164,Date,Both sexes,Jul 2019,164,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131449,Source of report of J14 (pneumonia due to haemophilus influenzae),2410,Respiratory system disorders,164,Categorical (single),Both sexes,Jul 2019,164,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131450,"Date J15 first reported (bacterial pneumonia, not elsewhere classified)",2410,Respiratory system disorders,"1,025",Date,Both sexes,Jul 2019,"1,025",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131451,"Source of report of J15 (bacterial pneumonia, not elsewhere classified)",2410,Respiratory system disorders,"1,025",Categorical (single),Both sexes,Jul 2019,"1,025",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131452,"Date J16 first reported (pneumonia due to other infectious organisms, not elsewhere classified)",2410,Respiratory system disorders,80,Date,Both sexes,Jul 2019,80,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131453,"Source of report of J16 (pneumonia due to other infectious organisms, not elsewhere classified)",2410,Respiratory system disorders,80,Categorical (single),Both sexes,Jul 2019,80,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131454,Date J17 first reported (pneumonia in diseases classified elsewhere),2410,Respiratory system disorders,238,Date,Both sexes,Jul 2019,238,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131455,Source of report of J17 (pneumonia in diseases classified elsewhere),2410,Respiratory system disorders,238,Categorical (single),Both sexes,Jul 2019,238,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131456,"Date J18 first reported (pneumonia, organism unspecified)",2410,Respiratory system disorders,"24,038",Date,Both sexes,Jul 2019,"24,038",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131457,"Source of report of J18 (pneumonia, organism unspecified)",2410,Respiratory system disorders,"24,038",Categorical (single),Both sexes,Jul 2019,"24,038",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131458,Date J20 first reported (acute bronchitis),2410,Respiratory system disorders,"5,372",Date,Both sexes,Jul 2019,"5,372",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131459,Source of report of J20 (acute bronchitis),2410,Respiratory system disorders,"5,372",Categorical (single),Both sexes,Jul 2019,"5,372",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131460,Date J21 first reported (acute bronchiolitis),2410,Respiratory system disorders,130,Date,Both sexes,Jul 2019,130,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131461,Source of report of J21 (acute bronchiolitis),2410,Respiratory system disorders,130,Categorical (single),Both sexes,Jul 2019,130,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131462,Date J22 first reported (unspecified acute lower respiratory infection),2410,Respiratory system disorders,"59,381",Date,Both sexes,Jul 2019,"59,381",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131463,Source of report of J22 (unspecified acute lower respiratory infection),2410,Respiratory system disorders,"59,381",Categorical (single),Both sexes,Jul 2019,"59,381",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131464,Date J30 first reported (vasomotor and allergic rhinitis),2410,Respiratory system disorders,"48,063",Date,Both sexes,Jul 2019,"48,063",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131465,Source of report of J30 (vasomotor and allergic rhinitis),2410,Respiratory system disorders,"48,063",Categorical (single),Both sexes,Jul 2019,"48,063",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131466,"Date J31 first reported (chronic rhinitis, nasopharyngitis and pharyngitis)",2410,Respiratory system disorders,"6,510",Date,Both sexes,Jul 2019,"6,510",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131467,"Source of report of J31 (chronic rhinitis, nasopharyngitis and pharyngitis)",2410,Respiratory system disorders,"6,510",Categorical (single),Both sexes,Jul 2019,"6,510",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131468,Date J32 first reported (chronic sinusitis),2410,Respiratory system disorders,"12,674",Date,Both sexes,Jul 2019,"12,674",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131469,Source of report of J32 (chronic sinusitis),2410,Respiratory system disorders,"12,674",Categorical (single),Both sexes,Jul 2019,"12,674",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131470,Date J33 first reported (nasal polyp),2410,Respiratory system disorders,"7,318",Date,Both sexes,Jul 2019,"7,318",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131471,Source of report of J33 (nasal polyp),2410,Respiratory system disorders,"7,318",Categorical (single),Both sexes,Jul 2019,"7,318",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131472,Date J34 first reported (other disorders of nose and nasal sinuses),2410,Respiratory system disorders,"17,073",Date,Both sexes,Jul 2019,"17,073",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131473,Source of report of J34 (other disorders of nose and nasal sinuses),2410,Respiratory system disorders,"17,073",Categorical (single),Both sexes,Jul 2019,"17,073",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131474,Date J35 first reported (chronic diseases of tonsils and adenoids),2410,Respiratory system disorders,"1,760",Date,Both sexes,Jul 2019,"1,760",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131475,Source of report of J35 (chronic diseases of tonsils and adenoids),2410,Respiratory system disorders,"1,760",Categorical (single),Both sexes,Jul 2019,"1,760",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131476,Date J36 first reported (peritonsillar abscess),2410,Respiratory system disorders,858,Date,Both sexes,Jul 2019,858,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131477,Source of report of J36 (peritonsillar abscess),2410,Respiratory system disorders,858,Categorical (single),Both sexes,Jul 2019,858,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131478,Date J37 first reported (chronic laryngitis and laryngotracheitis),2410,Respiratory system disorders,569,Date,Both sexes,Jul 2019,569,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131479,Source of report of J37 (chronic laryngitis and laryngotracheitis),2410,Respiratory system disorders,569,Categorical (single),Both sexes,Jul 2019,569,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131480,"Date J38 first reported (diseases of vocal cords and larynx, not elsewhere classified)",2410,Respiratory system disorders,"3,071",Date,Both sexes,Jul 2019,"3,071",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131481,"Source of report of J38 (diseases of vocal cords and larynx, not elsewhere classified)",2410,Respiratory system disorders,"3,071",Categorical (single),Both sexes,Jul 2019,"3,071",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131482,Date J39 first reported (other diseases of upper respiratory tract),2410,Respiratory system disorders,"1,620",Date,Both sexes,Jul 2019,"1,620",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131483,Source of report of J39 (other diseases of upper respiratory tract),2410,Respiratory system disorders,"1,620",Categorical (single),Both sexes,Jul 2019,"1,620",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131484,"Date J40 first reported (bronchitis, not specified as acute or chronic)",2410,Respiratory system disorders,"9,273",Date,Both sexes,Jul 2019,"9,273",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131485,"Source of report of J40 (bronchitis, not specified as acute or chronic)",2410,Respiratory system disorders,"9,273",Categorical (single),Both sexes,Jul 2019,"9,273",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131486,Date J41 first reported (simple and mucopurulent chronic bronchitis),2410,Respiratory system disorders,106,Date,Both sexes,Jul 2019,106,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131487,Source of report of J41 (simple and mucopurulent chronic bronchitis),2410,Respiratory system disorders,106,Categorical (single),Both sexes,Jul 2019,106,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131488,Date J42 first reported (unspecified chronic bronchitis),2410,Respiratory system disorders,544,Date,Both sexes,Jul 2019,544,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131489,Source of report of J42 (unspecified chronic bronchitis),2410,Respiratory system disorders,544,Categorical (single),Both sexes,Jul 2019,544,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131490,Date J43 first reported (emphysema),2410,Respiratory system disorders,"3,141",Date,Both sexes,Jul 2019,"3,141",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131491,Source of report of J43 (emphysema),2410,Respiratory system disorders,"3,141",Categorical (single),Both sexes,Jul 2019,"3,141",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131492,Date J44 first reported (other chronic obstructive pulmonary disease),2410,Respiratory system disorders,"15,993",Date,Both sexes,Jul 2019,"15,993",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131493,Source of report of J44 (other chronic obstructive pulmonary disease),2410,Respiratory system disorders,"15,993",Categorical (single),Both sexes,Jul 2019,"15,993",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131494,Date J45 first reported (asthma),2410,Respiratory system disorders,"67,876",Date,Both sexes,Jul 2019,"67,876",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131495,Source of report of J45 (asthma),2410,Respiratory system disorders,"67,876",Categorical (single),Both sexes,Jul 2019,"67,876",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131496,Date J46 first reported (status asthmaticus),2410,Respiratory system disorders,494,Date,Both sexes,Jul 2019,494,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131497,Source of report of J46 (status asthmaticus),2410,Respiratory system disorders,494,Categorical (single),Both sexes,Jul 2019,494,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131498,Date J47 first reported (bronchiectasis),2410,Respiratory system disorders,"4,100",Date,Both sexes,Jul 2019,"4,100",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131499,Source of report of J47 (bronchiectasis),2410,Respiratory system disorders,"4,100",Categorical (single),Both sexes,Jul 2019,"4,100",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131500,Date J60 first reported (coalworker's pneumoconiosis),2410,Respiratory system disorders,32,Date,Both sexes,Jul 2019,32,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131501,Source of report of J60 (coalworker's pneumoconiosis),2410,Respiratory system disorders,32,Categorical (single),Both sexes,Jul 2019,32,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131502,Date J61 first reported (pneumoconiosis due to asbestos and other mineral fibres),2410,Respiratory system disorders,510,Date,Both sexes,Jul 2019,510,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131503,Source of report of J61 (pneumoconiosis due to asbestos and other mineral fibres),2410,Respiratory system disorders,510,Categorical (single),Both sexes,Jul 2019,510,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131504,Date J62 first reported (pneumoconiosis due to dust containing silica),2410,Respiratory system disorders,18,Date,Both sexes,Jul 2019,18,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131505,Source of report of J62 (pneumoconiosis due to dust containing silica),2410,Respiratory system disorders,18,Categorical (single),Both sexes,Jul 2019,18,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131506,Date J63 first reported (pneumoconiosis due to other inorganic dusts),2410,Respiratory system disorders,27,Date,Both sexes,Jul 2019,27,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131507,Source of report of J63 (pneumoconiosis due to other inorganic dusts),2410,Respiratory system disorders,27,Categorical (single),Both sexes,Jul 2019,27,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131508,Date J64 first reported (unspecified pneumoconiosis),2410,Respiratory system disorders,39,Date,Both sexes,Jul 2019,39,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131509,Source of report of J64 (unspecified pneumoconiosis),2410,Respiratory system disorders,39,Categorical (single),Both sexes,Jul 2019,39,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131510,Date J65 first reported (pneumoconiosis associated with tuberculosis),2410,Respiratory system disorders,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131511,Source of report of J65 (pneumoconiosis associated with tuberculosis),2410,Respiratory system disorders,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131512,Date J66 first reported (airway disease due to specific organic dust),2410,Respiratory system disorders,4,Date,Both sexes,Jul 2019,4,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131513,Source of report of J66 (airway disease due to specific organic dust),2410,Respiratory system disorders,4,Categorical (single),Both sexes,Jul 2019,4,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131514,Date J67 first reported (hypersensitivity pneumonitis due to organic dust),2410,Respiratory system disorders,191,Date,Both sexes,Jul 2019,191,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131515,Source of report of J67 (hypersensitivity pneumonitis due to organic dust),2410,Respiratory system disorders,191,Categorical (single),Both sexes,Jul 2019,191,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131516,"Date J68 first reported (respiratory conditions due to inhalation of chemicals, gases, fumes and vapours)",2410,Respiratory system disorders,27,Date,Both sexes,Jul 2019,27,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131517,"Source of report of J68 (respiratory conditions due to inhalation of chemicals, gases, fumes and vapours)",2410,Respiratory system disorders,27,Categorical (single),Both sexes,Jul 2019,27,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131518,Date J69 first reported (pneumonitis due to solids and liquids),2410,Respiratory system disorders,"1,333",Date,Both sexes,Jul 2019,"1,333",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131519,Source of report of J69 (pneumonitis due to solids and liquids),2410,Respiratory system disorders,"1,333",Categorical (single),Both sexes,Jul 2019,"1,333",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131520,Date J70 first reported (respiratory conditions due to other external agents),2410,Respiratory system disorders,115,Date,Both sexes,Jul 2019,115,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131521,Source of report of J70 (respiratory conditions due to other external agents),2410,Respiratory system disorders,115,Categorical (single),Both sexes,Jul 2019,115,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131522,Date J80 first reported (adult respiratory distress syndrome),2410,Respiratory system disorders,268,Date,Both sexes,Jul 2019,268,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131523,Source of report of J80 (adult respiratory distress syndrome),2410,Respiratory system disorders,268,Categorical (single),Both sexes,Jul 2019,268,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131524,Date J81 first reported (pulmonary oedema),2410,Respiratory system disorders,969,Date,Both sexes,Jul 2019,969,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131525,Source of report of J81 (pulmonary oedema),2410,Respiratory system disorders,969,Categorical (single),Both sexes,Jul 2019,969,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131526,"Date J82 first reported (pulmonary eosinophilia, not elsewhere classified)",2410,Respiratory system disorders,102,Date,Both sexes,Jul 2019,102,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131527,"Source of report of J82 (pulmonary eosinophilia, not elsewhere classified)",2410,Respiratory system disorders,102,Categorical (single),Both sexes,Jul 2019,102,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131528,Date J84 first reported (other interstitial pulmonary diseases),2410,Respiratory system disorders,"2,285",Date,Both sexes,Jul 2019,"2,285",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131529,Source of report of J84 (other interstitial pulmonary diseases),2410,Respiratory system disorders,"2,285",Categorical (single),Both sexes,Jul 2019,"2,285",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131530,Date J85 first reported (abscess of lung and mediastinum),2410,Respiratory system disorders,192,Date,Both sexes,Jul 2019,192,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131531,Source of report of J85 (abscess of lung and mediastinum),2410,Respiratory system disorders,192,Categorical (single),Both sexes,Jul 2019,192,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131532,Date J86 first reported (pyothorax),2410,Respiratory system disorders,563,Date,Both sexes,Jul 2019,563,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131533,Source of report of J86 (pyothorax),2410,Respiratory system disorders,563,Categorical (single),Both sexes,Jul 2019,563,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131534,"Date J90 first reported (pleural effusion, not elsewhere classified)",2410,Respiratory system disorders,"8,738",Date,Both sexes,Jul 2019,"8,738",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131535,"Source of report of J90 (pleural effusion, not elsewhere classified)",2410,Respiratory system disorders,"8,738",Categorical (single),Both sexes,Jul 2019,"8,738",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131536,Date J91 first reported (pleural effusion in conditions classified elsewhere),2410,Respiratory system disorders,350,Date,Both sexes,Jul 2019,350,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131537,Source of report of J91 (pleural effusion in conditions classified elsewhere),2410,Respiratory system disorders,350,Categorical (single),Both sexes,Jul 2019,350,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131538,Date J92 first reported (pleural plaque),2410,Respiratory system disorders,"1,658",Date,Both sexes,Jul 2019,"1,658",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131539,Source of report of J92 (pleural plaque),2410,Respiratory system disorders,"1,658",Categorical (single),Both sexes,Jul 2019,"1,658",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131540,Date J93 first reported (pneumothorax),2410,Respiratory system disorders,"2,711",Date,Both sexes,Jul 2019,"2,711",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131541,Source of report of J93 (pneumothorax),2410,Respiratory system disorders,"2,711",Categorical (single),Both sexes,Jul 2019,"2,711",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131542,Date J94 first reported (other pleural conditions),2410,Respiratory system disorders,557,Date,Both sexes,Jul 2019,557,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131543,Source of report of J94 (other pleural conditions),2410,Respiratory system disorders,557,Categorical (single),Both sexes,Jul 2019,557,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131544,"Date J95 first reported (postprocedural respiratory disorders, not elsewhere classified)",2410,Respiratory system disorders,629,Date,Both sexes,Jul 2019,629,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131545,"Source of report of J95 (postprocedural respiratory disorders, not elsewhere classified)",2410,Respiratory system disorders,629,Categorical (single),Both sexes,Jul 2019,629,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131546,"Date J96 first reported (respiratory failure, not elsewhere classified)",2410,Respiratory system disorders,"3,826",Date,Both sexes,Jul 2019,"3,826",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131547,"Source of report of J96 (respiratory failure, not elsewhere classified)",2410,Respiratory system disorders,"3,826",Categorical (single),Both sexes,Jul 2019,"3,826",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131548,Date J98 first reported (other respiratory disorders),2410,Respiratory system disorders,"15,040",Date,Both sexes,Jul 2019,"15,040",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131549,Source of report of J98 (other respiratory disorders),2410,Respiratory system disorders,"15,040",Categorical (single),Both sexes,Jul 2019,"15,040",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131550,Date J99 first reported (respiratory disorders in diseases classified elsewhere),2410,Respiratory system disorders,339,Date,Both sexes,Jul 2019,339,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131551,Source of report of J99 (respiratory disorders in diseases classified elsewhere),2410,Respiratory system disorders,339,Categorical (single),Both sexes,Jul 2019,339,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Respiratory system disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
25923,Echo Time for rfMRI,111,Resting functional brain MRI,"39,645","Continuous, milliseconds",Both sexes,Dec 2019,"41,071",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Resting functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25929,Intensity scaling for rfMRI,111,Resting functional brain MRI,"39,645","Continuous, units",Both sexes,Dec 2019,"41,071",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Resting functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
20227,Functional brain images - resting - NIFTI,111,Resting functional brain MRI,"40,597",Text,Both sexes,Oct 2015,"42,098",Bulk,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Resting functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
20225,Functional brain images - resting - DICOM,111,Resting functional brain MRI,"42,139",Text,Both sexes,Feb 2015,"43,869",Bulk,Defined (2),Nov 2019,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Resting functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25739,Discrepancy between rfMRI brain image and T1 brain image,111,Resting functional brain MRI,"37,967","Continuous, AU",Both sexes,Oct 2015,"39,380",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Resting functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25750,"rfMRI full correlation matrix, dimension 25",111,Resting functional brain MRI,"37,928",Text,Both sexes,Oct 2015,"39,341",Bulk,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Resting functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25752,"rfMRI partial correlation matrix, dimension 25",111,Resting functional brain MRI,"37,928",Text,Both sexes,Oct 2015,"39,341",Bulk,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Resting functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25754,"rfMRI component amplitudes, dimension 25",111,Resting functional brain MRI,"37,927",Text,Both sexes,Sep 2016,"39,340",Bulk,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Resting functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25751,"rfMRI full correlation matrix, dimension 100",111,Resting functional brain MRI,"37,928",Text,Both sexes,Oct 2015,"39,341",Bulk,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Resting functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25753,"rfMRI partial correlation matrix, dimension 100",111,Resting functional brain MRI,"37,928",Text,Both sexes,Oct 2015,"39,341",Bulk,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Resting functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25755,"rfMRI component amplitudes, dimension 100",111,Resting functional brain MRI,"37,927",Text,Both sexes,Sep 2016,"39,340",Bulk,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Resting functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25741,"Mean rfMRI head motion, averaged across space and time points",111,Resting functional brain MRI,"37,967","Continuous, mm",Both sexes,Oct 2015,"39,380",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Resting functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25744,Inverted temporal signal-to-noise ratio in artefact-cleaned pre-processed rfMRI,111,Resting functional brain MRI,"37,965","Continuous, ratio",Both sexes,Oct 2015,"39,378",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Resting functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25743,Inverted temporal signal-to-noise ratio in pre-processed rfMRI,111,Resting functional brain MRI,"37,967","Continuous, ratio",Both sexes,Oct 2015,"39,380",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Resting functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
21015,Fundus retinal eye image (left),100016,Retinal optical coherence tomography,"84,760",Text,Both sexes,Aug 2012,"87,562",Bulk,Defined (2),Nov 2017,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Retinal optical coherence tomography,0.0,0.0,0.0,0.0,0.0,0.0
21016,Fundus retinal eye image (right),100016,Retinal optical coherence tomography,"85,239",Text,Both sexes,Aug 2012,"88,259",Bulk,Defined (2),Nov 2017,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Retinal optical coherence tomography,0.0,0.0,0.0,0.0,0.0,0.0
21017,OCT image slices (left),100016,Retinal optical coherence tomography,"84,793",Text,Both sexes,Nov 2018,"87,595",Bulk,Defined (2),Nov 2018,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Retinal optical coherence tomography,0.0,0.0,0.0,0.0,0.0,0.0
21018,OCT image slices (right),100016,Retinal optical coherence tomography,"85,262",Text,Both sexes,Nov 2018,"88,282",Bulk,Defined (2),Nov 2018,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Retinal optical coherence tomography,0.0,0.0,0.0,0.0,0.0,0.0
20062,Reason for skipping OCT (left),100016,Retinal optical coherence tomography,"3,360",Categorical (single),Both sexes,Aug 2012,"3,360",Data,Defined (1),Aug 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Retinal optical coherence tomography,0.0,0.0,0.0,0.0,0.0,0.0
20061,Reason for skipping OCT (right),100016,Retinal optical coherence tomography,"3,164",Categorical (single),Both sexes,Aug 2012,"3,164",Data,Defined (1),Aug 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Retinal optical coherence tomography,0.0,0.0,0.0,0.0,0.0,0.0
6072,OCT measured (left),100016,Retinal optical coherence tomography,"95,951",Categorical (single),Both sexes,Jan 2012,"98,855",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Retinal optical coherence tomography,0.0,0.0,0.0,0.0,0.0,0.0
6070,OCT measured (right),100016,Retinal optical coherence tomography,"95,946",Categorical (single),Both sexes,Jan 2012,"98,849",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Retinal optical coherence tomography,0.0,0.0,0.0,0.0,0.0,0.0
21011,FDA data file (left),100016,Retinal optical coherence tomography,"84,793",Text,Both sexes,Jan 2012,"87,595",Bulk,Defined (2),Aug 2013,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Retinal optical coherence tomography,0.0,0.0,0.0,0.0,0.0,0.0
21013,FDA data file (right),100016,Retinal optical coherence tomography,"85,264",Text,Both sexes,Jan 2012,"88,285",Bulk,Defined (2),Aug 2013,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Retinal optical coherence tomography,0.0,0.0,0.0,0.0,0.0,0.0
21012,FDS data file (left),100016,Retinal optical coherence tomography,"83,448",Text,Both sexes,Jan 2012,"86,065",Bulk,Defined (2),Aug 2013,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Retinal optical coherence tomography,0.0,0.0,0.0,0.0,0.0,0.0
21014,FDS data file (right),100016,Retinal optical coherence tomography,"83,927",Text,Both sexes,Jan 2012,"86,750",Bulk,Defined (2),Aug 2013,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Retinal optical coherence tomography,0.0,0.0,0.0,0.0,0.0,0.0
6073,Duration at which OCT screen shown (left),100016,Retinal optical coherence tomography,"95,951","Integer, seconds",Both sexes,Jan 2012,"98,855",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Retinal optical coherence tomography,0.0,0.0,0.0,0.0,0.0,0.0
6071,Duration at which OCT screen shown (right),100016,Retinal optical coherence tomography,"95,946","Integer, seconds",Both sexes,Jan 2012,"98,849",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Retinal optical coherence tomography,0.0,0.0,0.0,0.0,0.0,0.0
5270,Optical-coherence tomography device ID,100016,Retinal optical coherence tomography,"133,926",Text,Both sexes,Jan 2012,"138,194",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Retinal optical coherence tomography,0.0,0.0,0.0,0.0,0.0,0.0
20071,Reason no saliva sample collected,100096,Saliva sample collection,783,Categorical (single),Both sexes,Aug 2012,783,Data,Defined (1),Aug 2012,Complete,UK Biobank Assessment Centre,Biological sampling,Saliva sample collection,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20025,Time saliva sample collected,100096,Saliva sample collection,"120,138",Time,Both sexes,Jan 2012,"120,138",Data,Defined (1),Mar 2012,Complete,UK Biobank Assessment Centre,Biological sampling,Saliva sample collection,0.0,0.0,0.0,0.0,0.0,0.0,0.0
30424,Total volume of saliva samples held by UKB,100086,Saliva sample inventory,"96,318","Integer, microlitres",Both sexes,Jan 2012,"98,664",Samples,Defined (2),Jun 2014,Updateable,Biological samples,Sample inventory,Saliva sample inventory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20215,Scout images for brain scans - DICOM,108,Scout images and configuration for brain MRI,"42,260",Text,Both sexes,Jul 2014,"43,991",Bulk,Defined (2),Nov 2019,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Scout images and configuration for brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
20224,Phoenix - DICOM,108,Scout images and configuration for brain MRI,"41,864",Text,Both sexes,Feb 2015,"43,408",Bulk,Defined (2),Nov 2019,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Scout images and configuration for brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
20479,Ever thought that life not worth living,146,Self-harm behaviours,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Self-harm behaviours,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20485,Ever contemplated self-harm,146,Self-harm behaviours,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Self-harm behaviours,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20486,Contemplated self-harm in past year,146,Self-harm behaviours,"23,188",Categorical (single),Both sexes,Oct 2016,"23,188",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Self-harm behaviours,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20480,Ever self-harmed,146,Self-harm behaviours,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Self-harm behaviours,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20482,Number of times self-harmed,146,Self-harm behaviours,"6,870",Categorical (single),Both sexes,Oct 2016,"6,870",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Self-harm behaviours,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20481,Self-harmed in past year,146,Self-harm behaviours,"6,870",Categorical (single),Both sexes,Oct 2016,"6,870",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Self-harm behaviours,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20553,Methods of self-harm used,146,Self-harm behaviours,"6,870",Categorical (multiple),Both sexes,Oct 2016,"9,540",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Self-harm behaviours,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20554,Actions taken following self-harm,146,Self-harm behaviours,"4,336",Categorical (multiple),Both sexes,Oct 2016,"9,436",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Self-harm behaviours,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20483,Ever attempted suicide,146,Self-harm behaviours,"6,870",Categorical (single),Both sexes,Oct 2016,"6,870",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Self-harm behaviours,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20484,Attempted suicide in past year,146,Self-harm behaviours,"3,561",Categorical (single),Both sexes,Oct 2016,"3,561",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Self-harm behaviours,0.0,0.0,0.0,0.0,0.0,0.0,0.0
2129,Answered sexual history questions,100056,Sexual factors,"501,609",Categorical (single),Both sexes,Jan 2012,"572,235",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Sexual factors,0.0,0.0,0.0,0.0,0.0,0.0
2139,Age first had sexual intercourse,100056,Sexual factors,"456,560","Integer, years",Both sexes,Jan 2012,"519,823",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Sexual factors,0.0,0.0,0.0,0.0,0.0,0.0
2149,Lifetime number of sexual partners,100056,Sexual factors,"452,365",Integer,Both sexes,Jan 2012,"515,019",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Sexual factors,0.0,0.0,0.0,0.0,0.0,0.0
2159,Ever had same-sex intercourse,100056,Sexual factors,"452,365",Categorical (single),Both sexes,Jan 2012,"515,019",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Sexual factors,0.0,0.0,0.0,0.0,0.0,0.0
3669,Lifetime number of same-sex sexual partners,100056,Sexual factors,"16,325",Integer,Both sexes,Jan 2012,"18,492",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Sexual factors,0.0,0.0,0.0,0.0,0.0,0.0
131696,Date L00 first reported (staphylococcal scalded skin syndrome),2412,Skin and subcutaneous tissue disorders,10,Date,Both sexes,Jul 2019,10,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131697,Source of report of L00 (staphylococcal scalded skin syndrome),2412,Skin and subcutaneous tissue disorders,10,Categorical (single),Both sexes,Jul 2019,10,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131698,Date L01 first reported (impetigo),2412,Skin and subcutaneous tissue disorders,"1,462",Date,Both sexes,Jul 2019,"1,462",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131699,Source of report of L01 (impetigo),2412,Skin and subcutaneous tissue disorders,"1,462",Categorical (single),Both sexes,Jul 2019,"1,462",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131700,"Date L02 first reported (cutaneous abscess, furuncle and carbuncle)",2412,Skin and subcutaneous tissue disorders,"11,974",Date,Both sexes,Jul 2019,"11,974",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131701,"Source of report of L02 (cutaneous abscess, furuncle and carbuncle)",2412,Skin and subcutaneous tissue disorders,"11,974",Categorical (single),Both sexes,Jul 2019,"11,974",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131702,Date L03 first reported (cellulitis),2412,Skin and subcutaneous tissue disorders,"28,675",Date,Both sexes,Jul 2019,"28,675",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131703,Source of report of L03 (cellulitis),2412,Skin and subcutaneous tissue disorders,"28,675",Categorical (single),Both sexes,Jul 2019,"28,675",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131704,Date L04 first reported (acute lymphadenitis),2412,Skin and subcutaneous tissue disorders,754,Date,Both sexes,Jul 2019,754,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131705,Source of report of L04 (acute lymphadenitis),2412,Skin and subcutaneous tissue disorders,754,Categorical (single),Both sexes,Jul 2019,754,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131706,Date L05 first reported (pilonidal cyst),2412,Skin and subcutaneous tissue disorders,"1,559",Date,Both sexes,Jul 2019,"1,559",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131707,Source of report of L05 (pilonidal cyst),2412,Skin and subcutaneous tissue disorders,"1,559",Categorical (single),Both sexes,Jul 2019,"1,559",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131708,Date L08 first reported (other local infections of skin and subcutaneous tissue),2412,Skin and subcutaneous tissue disorders,"14,438",Date,Both sexes,Jul 2019,"14,438",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131709,Source of report of L08 (other local infections of skin and subcutaneous tissue),2412,Skin and subcutaneous tissue disorders,"14,438",Categorical (single),Both sexes,Jul 2019,"14,438",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131710,Date L10 first reported (pemphigus),2412,Skin and subcutaneous tissue disorders,75,Date,Both sexes,Jul 2019,75,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131711,Source of report of L10 (pemphigus),2412,Skin and subcutaneous tissue disorders,75,Categorical (single),Both sexes,Jul 2019,75,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131712,Date L11 first reported (other acantholytic disorders),2412,Skin and subcutaneous tissue disorders,97,Date,Both sexes,Jul 2019,97,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131713,Source of report of L11 (other acantholytic disorders),2412,Skin and subcutaneous tissue disorders,97,Categorical (single),Both sexes,Jul 2019,97,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131714,Date L12 first reported (pemphigoid),2412,Skin and subcutaneous tissue disorders,170,Date,Both sexes,Jul 2019,170,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131715,Source of report of L12 (pemphigoid),2412,Skin and subcutaneous tissue disorders,170,Categorical (single),Both sexes,Jul 2019,170,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131716,Date L13 first reported (other bullous disorders),2412,Skin and subcutaneous tissue disorders,130,Date,Both sexes,Jul 2019,130,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131717,Source of report of L13 (other bullous disorders),2412,Skin and subcutaneous tissue disorders,130,Categorical (single),Both sexes,Jul 2019,130,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131718,Date L14 first reported (bullous disorders in diseases classified elsewhere),2412,Skin and subcutaneous tissue disorders,1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131719,Source of report of L14 (bullous disorders in diseases classified elsewhere),2412,Skin and subcutaneous tissue disorders,1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131720,Date L20 first reported (atopic dermatitis),2412,Skin and subcutaneous tissue disorders,"13,823",Date,Both sexes,Jul 2019,"13,823",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131721,Source of report of L20 (atopic dermatitis),2412,Skin and subcutaneous tissue disorders,"13,823",Categorical (single),Both sexes,Jul 2019,"13,823",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131722,Date L21 first reported (seborrhoeic dermatitis),2412,Skin and subcutaneous tissue disorders,"9,982",Date,Both sexes,Jul 2019,"9,982",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131723,Source of report of L21 (seborrhoeic dermatitis),2412,Skin and subcutaneous tissue disorders,"9,982",Categorical (single),Both sexes,Jul 2019,"9,982",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131724,Date L22 first reported (diaper [napkin] dermatitis),2412,Skin and subcutaneous tissue disorders,34,Date,Both sexes,Jul 2019,34,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131725,Source of report of L22 (diaper [napkin] dermatitis),2412,Skin and subcutaneous tissue disorders,34,Categorical (single),Both sexes,Jul 2019,34,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131726,Date L23 first reported (allergic contact dermatitis),2412,Skin and subcutaneous tissue disorders,894,Date,Both sexes,Jul 2019,894,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131727,Source of report of L23 (allergic contact dermatitis),2412,Skin and subcutaneous tissue disorders,894,Categorical (single),Both sexes,Jul 2019,894,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131728,Date L24 first reported (irritant contact dermatitis),2412,Skin and subcutaneous tissue disorders,502,Date,Both sexes,Jul 2019,502,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131729,Source of report of L24 (irritant contact dermatitis),2412,Skin and subcutaneous tissue disorders,502,Categorical (single),Both sexes,Jul 2019,502,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131730,Date L25 first reported (unspecified contact dermatitis),2412,Skin and subcutaneous tissue disorders,"3,169",Date,Both sexes,Jul 2019,"3,169",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131731,Source of report of L25 (unspecified contact dermatitis),2412,Skin and subcutaneous tissue disorders,"3,169",Categorical (single),Both sexes,Jul 2019,"3,169",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131732,Date L26 first reported (exfoliative dermatitis),2412,Skin and subcutaneous tissue disorders,16,Date,Both sexes,Jul 2019,16,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131733,Source of report of L26 (exfoliative dermatitis),2412,Skin and subcutaneous tissue disorders,16,Categorical (single),Both sexes,Jul 2019,16,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131734,Date L27 first reported (dermatitis due to substances taken internally),2412,Skin and subcutaneous tissue disorders,"1,009",Date,Both sexes,Jul 2019,"1,009",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131735,Source of report of L27 (dermatitis due to substances taken internally),2412,Skin and subcutaneous tissue disorders,"1,009",Categorical (single),Both sexes,Jul 2019,"1,009",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131736,Date L28 first reported (lichen simplex chronicus and prurigo),2412,Skin and subcutaneous tissue disorders,"1,583",Date,Both sexes,Jul 2019,"1,583",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131737,Source of report of L28 (lichen simplex chronicus and prurigo),2412,Skin and subcutaneous tissue disorders,"1,583",Categorical (single),Both sexes,Jul 2019,"1,583",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131738,Date L29 first reported (pruritus),2412,Skin and subcutaneous tissue disorders,"12,385",Date,Both sexes,Jul 2019,"12,385",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131739,Source of report of L29 (pruritus),2412,Skin and subcutaneous tissue disorders,"12,385",Categorical (single),Both sexes,Jul 2019,"12,385",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131740,Date L30 first reported (other dermatitis),2412,Skin and subcutaneous tissue disorders,"47,082",Date,Both sexes,Jul 2019,"47,082",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131741,Source of report of L30 (other dermatitis),2412,Skin and subcutaneous tissue disorders,"47,082",Categorical (single),Both sexes,Jul 2019,"47,082",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131742,Date L40 first reported (psoriasis),2412,Skin and subcutaneous tissue disorders,"14,075",Date,Both sexes,Jul 2019,"14,075",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131743,Source of report of L40 (psoriasis),2412,Skin and subcutaneous tissue disorders,"14,075",Categorical (single),Both sexes,Jul 2019,"14,075",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131744,Date L41 first reported (parapsoriasis),2412,Skin and subcutaneous tissue disorders,120,Date,Both sexes,Jul 2019,120,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131745,Source of report of L41 (parapsoriasis),2412,Skin and subcutaneous tissue disorders,120,Categorical (single),Both sexes,Jul 2019,120,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131746,Date L42 first reported (pityriasis rosea),2412,Skin and subcutaneous tissue disorders,"1,617",Date,Both sexes,Jul 2019,"1,617",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131747,Source of report of L42 (pityriasis rosea),2412,Skin and subcutaneous tissue disorders,"1,617",Categorical (single),Both sexes,Jul 2019,"1,617",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131748,Date L43 first reported (lichen planus),2412,Skin and subcutaneous tissue disorders,"2,272",Date,Both sexes,Jul 2019,"2,272",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131749,Source of report of L43 (lichen planus),2412,Skin and subcutaneous tissue disorders,"2,272",Categorical (single),Both sexes,Jul 2019,"2,272",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131750,Date L44 first reported (other papulosquamous disorders),2412,Skin and subcutaneous tissue disorders,68,Date,Both sexes,Jul 2019,68,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131751,Source of report of L44 (other papulosquamous disorders),2412,Skin and subcutaneous tissue disorders,68,Categorical (single),Both sexes,Jul 2019,68,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131752,Date L45 first reported (papulosquamous disorders in diseases classified elsewhere),2412,Skin and subcutaneous tissue disorders,pending,Date,Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131753,Source of report of L45 (papulosquamous disorders in diseases classified elsewhere),2412,Skin and subcutaneous tissue disorders,pending,Categorical (single),Both sexes,Jul 2019,pending,Data,Singular,N/A,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131754,Date L50 first reported (urticaria),2412,Skin and subcutaneous tissue disorders,"10,944",Date,Both sexes,Jul 2019,"10,944",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131755,Source of report of L50 (urticaria),2412,Skin and subcutaneous tissue disorders,"10,944",Categorical (single),Both sexes,Jul 2019,"10,944",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131756,Date L51 first reported (erythema multiforme),2412,Skin and subcutaneous tissue disorders,302,Date,Both sexes,Jul 2019,302,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131757,Source of report of L51 (erythema multiforme),2412,Skin and subcutaneous tissue disorders,302,Categorical (single),Both sexes,Jul 2019,302,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131758,Date L52 first reported (erythema nodosum),2412,Skin and subcutaneous tissue disorders,296,Date,Both sexes,Jul 2019,296,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131759,Source of report of L52 (erythema nodosum),2412,Skin and subcutaneous tissue disorders,296,Categorical (single),Both sexes,Jul 2019,296,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131760,Date L53 first reported (other erythematous conditions),2412,Skin and subcutaneous tissue disorders,"1,171",Date,Both sexes,Jul 2019,"1,171",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131761,Source of report of L53 (other erythematous conditions),2412,Skin and subcutaneous tissue disorders,"1,171",Categorical (single),Both sexes,Jul 2019,"1,171",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131762,Date L54 first reported (erythema in diseases classified elsewhere),2412,Skin and subcutaneous tissue disorders,2,Date,Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131763,Source of report of L54 (erythema in diseases classified elsewhere),2412,Skin and subcutaneous tissue disorders,2,Categorical (single),Both sexes,Jul 2019,2,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131764,Date L55 first reported (sunburn),2412,Skin and subcutaneous tissue disorders,403,Date,Both sexes,Jul 2019,403,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131765,Source of report of L55 (sunburn),2412,Skin and subcutaneous tissue disorders,403,Categorical (single),Both sexes,Jul 2019,403,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131766,Date L56 first reported (other acute skin changes due to ultraviolet radiation),2412,Skin and subcutaneous tissue disorders,630,Date,Both sexes,Jul 2019,630,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131767,Source of report of L56 (other acute skin changes due to ultraviolet radiation),2412,Skin and subcutaneous tissue disorders,630,Categorical (single),Both sexes,Jul 2019,630,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131768,Date L57 first reported (skin changes due to chronic exposure to nonionising radiation),2412,Skin and subcutaneous tissue disorders,"18,783",Date,Both sexes,Jul 2019,"18,783",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131769,Source of report of L57 (skin changes due to chronic exposure to nonionising radiation),2412,Skin and subcutaneous tissue disorders,"18,783",Categorical (single),Both sexes,Jul 2019,"18,783",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131770,Date L58 first reported (radiodermatitis),2412,Skin and subcutaneous tissue disorders,23,Date,Both sexes,Jul 2019,23,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131771,Source of report of L58 (radiodermatitis),2412,Skin and subcutaneous tissue disorders,23,Categorical (single),Both sexes,Jul 2019,23,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131772,Date L59 first reported (other disorders of skin and subcutaneous tissue related to radiation),2412,Skin and subcutaneous tissue disorders,64,Date,Both sexes,Jul 2019,64,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131773,Source of report of L59 (other disorders of skin and subcutaneous tissue related to radiation),2412,Skin and subcutaneous tissue disorders,64,Categorical (single),Both sexes,Jul 2019,64,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131774,Date L60 first reported (nail disorders),2412,Skin and subcutaneous tissue disorders,"11,187",Date,Both sexes,Jul 2019,"11,187",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131775,Source of report of L60 (nail disorders),2412,Skin and subcutaneous tissue disorders,"11,187",Categorical (single),Both sexes,Jul 2019,"11,187",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131776,Date L62 first reported (nail disorders in diseases classified elsewhere),2412,Skin and subcutaneous tissue disorders,1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131777,Source of report of L62 (nail disorders in diseases classified elsewhere),2412,Skin and subcutaneous tissue disorders,1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131778,Date L63 first reported (alopecia areata),2412,Skin and subcutaneous tissue disorders,913,Date,Both sexes,Jul 2019,913,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131779,Source of report of L63 (alopecia areata),2412,Skin and subcutaneous tissue disorders,913,Categorical (single),Both sexes,Jul 2019,913,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131780,Date L64 first reported (androgenic alopecia),2412,Skin and subcutaneous tissue disorders,157,Date,Both sexes,Jul 2019,157,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131781,Source of report of L64 (androgenic alopecia),2412,Skin and subcutaneous tissue disorders,157,Categorical (single),Both sexes,Jul 2019,157,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131782,Date L65 first reported (other nonscarring hair loss),2412,Skin and subcutaneous tissue disorders,"3,298",Date,Both sexes,Jul 2019,"3,298",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131783,Source of report of L65 (other nonscarring hair loss),2412,Skin and subcutaneous tissue disorders,"3,298",Categorical (single),Both sexes,Jul 2019,"3,298",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131784,Date L66 first reported (cicatricial alopecia [scarring hair loss]),2412,Skin and subcutaneous tissue disorders,213,Date,Both sexes,Jul 2019,213,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131785,Source of report of L66 (cicatricial alopecia [scarring hair loss]),2412,Skin and subcutaneous tissue disorders,213,Categorical (single),Both sexes,Jul 2019,213,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131786,Date L67 first reported (hair colour and hair shaft abnormalities),2412,Skin and subcutaneous tissue disorders,42,Date,Both sexes,Jul 2019,42,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131787,Source of report of L67 (hair colour and hair shaft abnormalities),2412,Skin and subcutaneous tissue disorders,42,Categorical (single),Both sexes,Jul 2019,42,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131788,Date L68 first reported (hypertrichosis),2412,Skin and subcutaneous tissue disorders,535,Date,Both sexes,Jul 2019,535,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131789,Source of report of L68 (hypertrichosis),2412,Skin and subcutaneous tissue disorders,535,Categorical (single),Both sexes,Jul 2019,535,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131790,Date L70 first reported (acne),2412,Skin and subcutaneous tissue disorders,"5,802",Date,Both sexes,Jul 2019,"5,802",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131791,Source of report of L70 (acne),2412,Skin and subcutaneous tissue disorders,"5,802",Categorical (single),Both sexes,Jul 2019,"5,802",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131792,Date L71 first reported (rosacea),2412,Skin and subcutaneous tissue disorders,"5,731",Date,Both sexes,Jul 2019,"5,731",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131793,Source of report of L71 (rosacea),2412,Skin and subcutaneous tissue disorders,"5,731",Categorical (single),Both sexes,Jul 2019,"5,731",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131794,Date L72 first reported (follicular cysts of skin and subcutaneous tissue),2412,Skin and subcutaneous tissue disorders,"14,699",Date,Both sexes,Jul 2019,"14,699",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131795,Source of report of L72 (follicular cysts of skin and subcutaneous tissue),2412,Skin and subcutaneous tissue disorders,"14,699",Categorical (single),Both sexes,Jul 2019,"14,699",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131796,Date L73 first reported (other follicular disorders),2412,Skin and subcutaneous tissue disorders,"3,730",Date,Both sexes,Jul 2019,"3,730",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131797,Source of report of L73 (other follicular disorders),2412,Skin and subcutaneous tissue disorders,"3,730",Categorical (single),Both sexes,Jul 2019,"3,730",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131798,Date L74 first reported (eccrine sweat disorders),2412,Skin and subcutaneous tissue disorders,"1,118",Date,Both sexes,Jul 2019,"1,118",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131799,Source of report of L74 (eccrine sweat disorders),2412,Skin and subcutaneous tissue disorders,"1,118",Categorical (single),Both sexes,Jul 2019,"1,118",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131800,Date L75 first reported (apocrine sweat disorders),2412,Skin and subcutaneous tissue disorders,19,Date,Both sexes,Jul 2019,19,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131801,Source of report of L75 (apocrine sweat disorders),2412,Skin and subcutaneous tissue disorders,19,Categorical (single),Both sexes,Jul 2019,19,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131802,Date L80 first reported (vitiligo),2412,Skin and subcutaneous tissue disorders,"1,121",Date,Both sexes,Jul 2019,"1,121",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131803,Source of report of L80 (vitiligo),2412,Skin and subcutaneous tissue disorders,"1,121",Categorical (single),Both sexes,Jul 2019,"1,121",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131804,Date L81 first reported (other disorders of pigmentation),2412,Skin and subcutaneous tissue disorders,"4,408",Date,Both sexes,Jul 2019,"4,408",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131805,Source of report of L81 (other disorders of pigmentation),2412,Skin and subcutaneous tissue disorders,"4,408",Categorical (single),Both sexes,Jul 2019,"4,408",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131806,Date L82 first reported (seborrhoeic keratosis),2412,Skin and subcutaneous tissue disorders,"29,862",Date,Both sexes,Jul 2019,"29,862",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131807,Source of report of L82 (seborrhoeic keratosis),2412,Skin and subcutaneous tissue disorders,"29,862",Categorical (single),Both sexes,Jul 2019,"29,862",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131808,Date L83 first reported (acanthosis nigricans),2412,Skin and subcutaneous tissue disorders,168,Date,Both sexes,Jul 2019,168,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131809,Source of report of L83 (acanthosis nigricans),2412,Skin and subcutaneous tissue disorders,168,Categorical (single),Both sexes,Jul 2019,168,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131810,Date L84 first reported (corns and callosities),2412,Skin and subcutaneous tissue disorders,"3,756",Date,Both sexes,Jul 2019,"3,756",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131811,Source of report of L84 (corns and callosities),2412,Skin and subcutaneous tissue disorders,"3,756",Categorical (single),Both sexes,Jul 2019,"3,756",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131812,Date L85 first reported (other epidermal thickening),2412,Skin and subcutaneous tissue disorders,"3,439",Date,Both sexes,Jul 2019,"3,439",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131813,Source of report of L85 (other epidermal thickening),2412,Skin and subcutaneous tissue disorders,"3,439",Categorical (single),Both sexes,Jul 2019,"3,439",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131814,Date L86 first reported (keratoderma in diseases classified elsewhere),2412,Skin and subcutaneous tissue disorders,1,Date,Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131815,Source of report of L86 (keratoderma in diseases classified elsewhere),2412,Skin and subcutaneous tissue disorders,1,Categorical (single),Both sexes,Jul 2019,1,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131816,Date L87 first reported (transepidermal elimination disorders),2412,Skin and subcutaneous tissue disorders,17,Date,Both sexes,Jul 2019,17,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131817,Source of report of L87 (transepidermal elimination disorders),2412,Skin and subcutaneous tissue disorders,17,Categorical (single),Both sexes,Jul 2019,17,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131818,Date L88 first reported (pyoderma gangrenosum),2412,Skin and subcutaneous tissue disorders,67,Date,Both sexes,Jul 2019,67,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131819,Source of report of L88 (pyoderma gangrenosum),2412,Skin and subcutaneous tissue disorders,67,Categorical (single),Both sexes,Jul 2019,67,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131820,Date L89 first reported (decubitus ulcer),2412,Skin and subcutaneous tissue disorders,"2,216",Date,Both sexes,Jul 2019,"2,216",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131821,Source of report of L89 (decubitus ulcer),2412,Skin and subcutaneous tissue disorders,"2,216",Categorical (single),Both sexes,Jul 2019,"2,216",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131822,Date L90 first reported (atrophic disorders of skin),2412,Skin and subcutaneous tissue disorders,"5,402",Date,Both sexes,Jul 2019,"5,402",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131823,Source of report of L90 (atrophic disorders of skin),2412,Skin and subcutaneous tissue disorders,"5,402",Categorical (single),Both sexes,Jul 2019,"5,402",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131824,Date L91 first reported (hypertrophic disorders of skin),2412,Skin and subcutaneous tissue disorders,"5,074",Date,Both sexes,Jul 2019,"5,074",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131825,Source of report of L91 (hypertrophic disorders of skin),2412,Skin and subcutaneous tissue disorders,"5,074",Categorical (single),Both sexes,Jul 2019,"5,074",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131826,Date L92 first reported (granulomatous disorders of skin and subcutaneous tissue),2412,Skin and subcutaneous tissue disorders,"1,758",Date,Both sexes,Jul 2019,"1,758",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131827,Source of report of L92 (granulomatous disorders of skin and subcutaneous tissue),2412,Skin and subcutaneous tissue disorders,"1,758",Categorical (single),Both sexes,Jul 2019,"1,758",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131828,Date L93 first reported (lupus erythematosus),2412,Skin and subcutaneous tissue disorders,427,Date,Both sexes,Jul 2019,427,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131829,Source of report of L93 (lupus erythematosus),2412,Skin and subcutaneous tissue disorders,427,Categorical (single),Both sexes,Jul 2019,427,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131830,Date L94 first reported (other localised connective tissue disorders),2412,Skin and subcutaneous tissue disorders,578,Date,Both sexes,Jul 2019,578,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131831,Source of report of L94 (other localised connective tissue disorders),2412,Skin and subcutaneous tissue disorders,578,Categorical (single),Both sexes,Jul 2019,578,Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131832,"Date L95 first reported (vasculitis limited to skin, not elsewhere classified)",2412,Skin and subcutaneous tissue disorders,257,Date,Both sexes,Jul 2019,257,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131833,"Source of report of L95 (vasculitis limited to skin, not elsewhere classified)",2412,Skin and subcutaneous tissue disorders,257,Categorical (single),Both sexes,Jul 2019,257,Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131834,"Date L97 first reported (ulcer of lower limb, not elsewhere classified)",2412,Skin and subcutaneous tissue disorders,"2,202",Date,Both sexes,Jul 2019,"2,202",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131835,"Source of report of L97 (ulcer of lower limb, not elsewhere classified)",2412,Skin and subcutaneous tissue disorders,"2,202",Categorical (single),Both sexes,Jul 2019,"2,202",Data,Singular,Sep 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131836,"Date L98 first reported (other disorders of skin and subcutaneous tissue, not elsewhere classified)",2412,Skin and subcutaneous tissue disorders,"45,203",Date,Both sexes,Jul 2019,"45,203",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131837,"Source of report of L98 (other disorders of skin and subcutaneous tissue, not elsewhere classified)",2412,Skin and subcutaneous tissue disorders,"45,203",Categorical (single),Both sexes,Jul 2019,"45,203",Data,Singular,Feb 2020,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131838,Date L99 first reported (other disorders of skin and subcutaneous tissue in diseases classified elsewhere),2412,Skin and subcutaneous tissue disorders,17,Date,Both sexes,Jul 2019,17,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131839,Source of report of L99 (other disorders of skin and subcutaneous tissue in diseases classified elsewhere),2412,Skin and subcutaneous tissue disorders,17,Categorical (single),Both sexes,Jul 2019,17,Data,Singular,Aug 2019,Ongoing,Health-related outcomes,First occurrences,Skin and subcutaneous tissue disorders,0.0,0.0,0.0,0.0,0.0,0.0,0.0
1160,Sleep duration,100057,Sleep,"501,636","Integer, hours/day",Both sexes,Jan 2012,"572,262",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Sleep,0.0,0.0,0.0,0.0,0.0,0.0
1170,Getting up in morning,100057,Sleep,"498,749",Categorical (single),Both sexes,Jan 2012,"568,492",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Sleep,0.0,0.0,0.0,0.0,0.0,0.0
1180,Morning/evening person (chronotype),100057,Sleep,"498,747",Categorical (single),Both sexes,Jan 2012,"568,490",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Sleep,0.0,0.0,0.0,0.0,0.0,0.0
1190,Nap during day,100057,Sleep,"501,633",Categorical (single),Both sexes,Jan 2012,"572,259",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Sleep,0.0,0.0,0.0,0.0,0.0,0.0
1200,Sleeplessness / insomnia,100057,Sleep,"501,632",Categorical (single),Both sexes,Jan 2012,"572,258",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Sleep,0.0,0.0,0.0,0.0,0.0,0.0
1210,Snoring,100057,Sleep,"501,632",Categorical (single),Both sexes,Jan 2012,"572,258",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Sleep,0.0,0.0,0.0,0.0,0.0,0.0
1220,Daytime dozing / sleeping (narcolepsy),100057,Sleep,"501,632",Categorical (single),Both sexes,Jan 2012,"572,258",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Sleep,0.0,0.0,0.0,0.0,0.0,0.0
20160,Ever smoked,100058,Smoking,"499,746",Categorical (single),Both sexes,Mar 2015,"570,058",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
20162,Pack years adult smoking as proportion of life span exposed to smoking,100058,Smoking,"152,617","Continuous, Units",Both sexes,Mar 2015,"168,225",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
20161,Pack years of smoking,100058,Smoking,"152,617","Continuous, years",Both sexes,Mar 2015,"168,225",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
10895,"Light smokers, at least 100 smokes in lifetime (pilot)",100058,Smoking,934,Categorical (single),Both sexes,Jan 2012,934,Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
20116,Smoking status,100058,Smoking,"501,632",Categorical (single),Both sexes,Mar 2013,"572,258",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
1239,Current tobacco smoking,100058,Smoking,"501,632",Categorical (single),Both sexes,Jan 2012,"572,258",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
1249,Past tobacco smoking,100058,Smoking,"463,710",Categorical (single),Both sexes,Jan 2012,"531,342",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
2644,"Light smokers, at least 100 smokes in lifetime",100058,Smoking,"141,669",Categorical (single),Both sexes,Jan 2012,"157,463",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
3436,Age started smoking in current smokers,100058,Smoking,"39,514","Integer, years",Both sexes,Jan 2012,"40,916",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
3446,Type of tobacco currently smoked,100058,Smoking,"39,514",Categorical (single),Both sexes,Jan 2012,"40,916",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
5959,Previously smoked cigarettes on most/all days,100058,Smoking,"2,673",Categorical (single),Both sexes,Jan 2012,"2,784",Data,Defined (4),Jan 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
3456,Number of cigarettes currently smoked daily (current cigarette smokers),100058,Smoking,"36,725","Integer, cigarettes/day",Both sexes,Jan 2012,"37,998",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
6194,Age stopped smoking cigarettes (current cigar/pipe or previous cigarette smoker),100058,Smoking,"1,813","Integer, years",Both sexes,Jan 2012,"1,875",Data,Defined (4),Jan 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
6183,Number of cigarettes previously smoked daily (current cigar/pipe smokers),100058,Smoking,"1,813",Integer,Both sexes,Jan 2012,"1,875",Data,Defined (4),Jan 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
3466,Time from waking to first cigarette,100058,Smoking,"36,381",Categorical (single),Both sexes,Jan 2012,"37,632",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
3476,Difficulty not smoking for 1 day,100058,Smoking,"36,381",Categorical (single),Both sexes,Jan 2012,"37,632",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
3486,Ever tried to stop smoking,100058,Smoking,"39,514",Categorical (single),Both sexes,Jan 2012,"40,916",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
3496,Wants to stop smoking,100058,Smoking,"39,136",Categorical (single),Both sexes,Jan 2012,"40,514",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
3506,Smoking compared to 10 years previous,100058,Smoking,"39,514",Categorical (single),Both sexes,Jan 2012,"40,916",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
6158,Why reduced smoking,100058,Smoking,"17,157",Categorical (multiple),Both sexes,Jan 2012,"22,920",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
2867,Age started smoking in former smokers,100058,Smoking,"123,422","Integer, years",Both sexes,Jan 2012,"137,662",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
2877,Type of tobacco previously smoked,100058,Smoking,"123,422",Categorical (single),Both sexes,Jan 2012,"137,662",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
2887,Number of cigarettes previously smoked daily,100058,Smoking,"117,941","Integer, cigarettes/day",Both sexes,Jan 2012,"131,324",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
2897,Age stopped smoking,100058,Smoking,"123,422","Integer, years",Both sexes,Jan 2012,"137,662",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
2907,Ever stopped smoking for 6+ months,100058,Smoking,"122,664",Categorical (single),Both sexes,Jan 2012,"136,732",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
10827,Ever stopped smoking for 6+ months (pilot),100058,Smoking,930,Categorical (single),Both sexes,Jan 2012,930,Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
6157,Why stopped smoking,100058,Smoking,"122,664",Categorical (multiple),Both sexes,Jan 2012,"172,343",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
10115,Why stopped smoking (pilot),100058,Smoking,930,Categorical (single),Both sexes,Jan 2012,930,Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
2926,Number of unsuccessful stop-smoking attempts,100058,Smoking,"122,664",Integer,Both sexes,Jan 2012,"136,732",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
2936,Likelihood of resuming smoking,100058,Smoking,"122,664",Categorical (single),Both sexes,Jan 2012,"136,732",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
1259,Smoking/smokers in household,100058,Smoking,"461,174",Categorical (single),Both sexes,Jan 2012,"527,972",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
1269,Exposure to tobacco smoke at home,100058,Smoking,"464,090","Integer, hours/week",Both sexes,Jan 2012,"531,742",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
1279,Exposure to tobacco smoke outside home,100058,Smoking,"464,090","Integer, hours/week",Both sexes,Jan 2012,"531,742",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Smoking,0.0,0.0,0.0,0.0,0.0,0.0
1031,Frequency of friend/family visits,100061,Social support,"498,754",Categorical (single),Both sexes,Jan 2012,"568,497",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Social support,0.0,0.0,0.0,0.0,0.0,0.0
10740,Frequency of friend/family visits (pilot),100061,Social support,"3,770",Categorical (single),Both sexes,Jan 2012,"3,770",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Social support,0.0,0.0,0.0,0.0,0.0,0.0
6160,Leisure/social activities,100061,Social support,"501,641",Categorical (multiple),Both sexes,Jan 2012,"757,393",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Social support,0.0,0.0,0.0,0.0,0.0,0.0
2110,Able to confide,100061,Social support,"501,611",Categorical (single),Both sexes,Jan 2012,"572,237",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Psychosocial factors,Social support,0.0,0.0,0.0,0.0,0.0,0.0
101970,Double crust pastry intake,100109,Soup/snacks/pastries yesterday,"20,697",Categorical (single),Both sexes,Sep 2012,"22,601",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101980,Single crust pastry intake,100109,Soup/snacks/pastries yesterday,"18,687",Categorical (single),Both sexes,Sep 2012,"19,938",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
101990,Crumble intake,100109,Soup/snacks/pastries yesterday,"11,544",Categorical (single),Both sexes,Sep 2012,"12,344",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102000,Pizza intake,100109,Soup/snacks/pastries yesterday,"14,913",Categorical (single),Both sexes,Sep 2012,"15,793",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102010,Pancake intake,100109,Soup/snacks/pastries yesterday,"3,529",Categorical (single),Both sexes,Sep 2012,"3,586",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102020,Scotch pancake intake,100109,Soup/snacks/pastries yesterday,"3,113",Categorical (single),Both sexes,Sep 2012,"3,319",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102030,Yorkshire pudding intake,100109,Soup/snacks/pastries yesterday,"12,841",Categorical (single),Both sexes,Sep 2012,"13,823",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102040,Indian snacks intake,100109,Soup/snacks/pastries yesterday,"5,837",Categorical (single),Both sexes,Sep 2012,"6,092",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102050,Croissant intake,100109,Soup/snacks/pastries yesterday,"9,618",Categorical (single),Both sexes,Sep 2012,"10,780",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102060,Danish pastry intake,100109,Soup/snacks/pastries yesterday,"8,919",Categorical (single),Both sexes,Sep 2012,"9,539",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102070,Scone intake,100109,Soup/snacks/pastries yesterday,"19,536",Categorical (single),Both sexes,Sep 2012,"22,249",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102080,Yogurt/ice-cream consumers,100109,Soup/snacks/pastries yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102090,Yogurt intake,100109,Soup/snacks/pastries yesterday,"97,461",Categorical (single),Both sexes,Sep 2012,"154,868",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20106,Type of yogurt eaten,100109,Soup/snacks/pastries yesterday,"89,398",Categorical (multiple),Both sexes,Sep 2012,"137,717",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102120,Ice-cream intake,100109,Soup/snacks/pastries yesterday,"42,416",Categorical (single),Both sexes,Sep 2012,"51,330",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102130,Dessert consumers,100109,Soup/snacks/pastries yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102140,Milk-based pudding intake,100109,Soup/snacks/pastries yesterday,"16,826",Categorical (single),Both sexes,Sep 2012,"18,759",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102150,Other milk-based pudding intake,100109,Soup/snacks/pastries yesterday,"9,801",Categorical (single),Both sexes,Sep 2012,"10,510",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102170,Soya dessert intake,100109,Soup/snacks/pastries yesterday,"2,290",Categorical (single),Both sexes,Sep 2012,"2,585",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102180,Fruitcake intake,100109,Soup/snacks/pastries yesterday,"21,337",Categorical (single),Both sexes,Sep 2012,"24,052",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102190,Cake intake,100109,Soup/snacks/pastries yesterday,"50,708",Categorical (single),Both sexes,Sep 2012,"62,566",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102200,Doughnut intake,100109,Soup/snacks/pastries yesterday,"3,672",Categorical (single),Both sexes,Sep 2012,"3,810",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102210,Sponge pudding intake,100109,Soup/snacks/pastries yesterday,"9,834",Categorical (single),Both sexes,Sep 2012,"10,297",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102220,Cheesecake intake,100109,Soup/snacks/pastries yesterday,"10,112",Categorical (single),Both sexes,Sep 2012,"10,556",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102230,Other dessert intake,100109,Soup/snacks/pastries yesterday,"36,067",Categorical (single),Both sexes,Sep 2012,"41,099",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102250,Sweet snack consumers,100109,Soup/snacks/pastries yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102260,Chocolate bar intake,100109,Soup/snacks/pastries yesterday,"28,386",Categorical (single),Both sexes,Sep 2012,"33,308",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102270,White chocolate intake,100109,Soup/snacks/pastries yesterday,"2,371",Categorical (single),Both sexes,Sep 2012,"2,483",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102280,Milk chocolate intake,100109,Soup/snacks/pastries yesterday,"25,769",Categorical (single),Both sexes,Sep 2012,"30,033",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102290,Dark chocolate intake,100109,Soup/snacks/pastries yesterday,"22,611",Categorical (single),Both sexes,Sep 2012,"29,910",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102300,Chocolate-covered raisin intake,100109,Soup/snacks/pastries yesterday,"3,502",Categorical (single),Both sexes,Sep 2012,"3,727",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102310,Chocolate sweet intake,100109,Soup/snacks/pastries yesterday,"22,620",Categorical (single),Both sexes,Sep 2012,"25,451",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102320,Diet sweets intake,100109,Soup/snacks/pastries yesterday,"3,223",Categorical (single),Both sexes,Sep 2012,"3,523",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102330,Sweets intake,100109,Soup/snacks/pastries yesterday,"25,529",Categorical (single),Both sexes,Sep 2012,"30,713",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102340,Chocolate-covered biscuits intake,100109,Soup/snacks/pastries yesterday,"30,068",Categorical (single),Both sexes,Sep 2012,"36,865",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102350,Chocolate biscuits intake,100109,Soup/snacks/pastries yesterday,"37,743",Categorical (single),Both sexes,Sep 2012,"45,642",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102360,Sweet biscuits intake,100109,Soup/snacks/pastries yesterday,"63,924",Categorical (single),Both sexes,Sep 2012,"85,965",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102370,Cereal bar intake,100109,Soup/snacks/pastries yesterday,"21,596",Categorical (single),Both sexes,Sep 2012,"26,431",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102380,Other sweets intake,100109,Soup/snacks/pastries yesterday,"10,298",Categorical (single),Both sexes,Sep 2012,"10,938",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102400,Savoury snack consumers,100109,Soup/snacks/pastries yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102410,Salted peanuts intake,100109,Soup/snacks/pastries yesterday,"14,431",Categorical (single),Both sexes,Sep 2012,"17,118",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102420,Unsalted peanuts intake,100109,Soup/snacks/pastries yesterday,"3,745",Categorical (single),Both sexes,Sep 2012,"4,223",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102430,Salted nuts intake,100109,Soup/snacks/pastries yesterday,"10,290",Categorical (single),Both sexes,Sep 2012,"11,505",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102440,Unsalted nuts intake,100109,Soup/snacks/pastries yesterday,"27,025",Categorical (single),Both sexes,Sep 2012,"36,072",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102450,Seeds intake,100109,Soup/snacks/pastries yesterday,"11,988",Categorical (single),Both sexes,Sep 2012,"15,484",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102460,Crisp intake,100109,Soup/snacks/pastries yesterday,"63,331",Categorical (single),Both sexes,Sep 2012,"83,949",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102470,Savoury biscuits intake,100109,Soup/snacks/pastries yesterday,"3,811",Categorical (single),Both sexes,Sep 2012,"4,039",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102480,Cheesy biscuits intake,100109,Soup/snacks/pastries yesterday,"6,058",Categorical (single),Both sexes,Sep 2012,"6,564",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102490,Olives intake,100109,Soup/snacks/pastries yesterday,"14,813",Categorical (single),Both sexes,Sep 2012,"17,414",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102500,Other savoury snack intake,100109,Soup/snacks/pastries yesterday,"11,638",Categorical (single),Both sexes,Sep 2012,"12,773",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102520,Soup consumers,100109,Soup/snacks/pastries yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102530,Powdered/instant soup intake,100109,Soup/snacks/pastries yesterday,"8,837",Categorical (single),Both sexes,Sep 2012,"10,596",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102540,Canned soup intake,100109,Soup/snacks/pastries yesterday,"20,801",Categorical (single),Both sexes,Sep 2012,"23,850",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20108,Ingredients in canned soup,100109,Soup/snacks/pastries yesterday,"19,948",Categorical (multiple),Both sexes,Oct 2012,"24,196",Data,Defined (5),Oct 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
102620,Homemade soup intake,100109,Soup/snacks/pastries yesterday,"34,435",Categorical (single),Both sexes,Sep 2012,"41,777",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20109,Ingredients in homemade soup,100109,Soup/snacks/pastries yesterday,"32,728",Categorical (multiple),Both sexes,Oct 2012,"45,285",Data,Defined (5),Oct 2012,Complete,Online follow-up,Diet by 24-hour recall,Soup/snacks/pastries yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20031,Acceptability of each blow result (text),100020,Spirometry,"295,902",Text,Both sexes,Aug 2012,"603,316",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20042,Reason for skipping spirometry,100020,Spirometry,"2,013",Categorical (single),Both sexes,Aug 2012,"2,013",Data,Defined (1),Oct 2012,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20032,Acceptability of each blow result (text) (pilot),100020,Spirometry,"2,652",Text,Both sexes,Aug 2012,"6,505",Data,Defined (1),Aug 2012,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20152,Reproduciblity of spirometry measurement using ERS/ATS criteria,100020,Spirometry,"353,314",Categorical (single),Both sexes,Mar 2015,"353,314",Data,Defined (1),Mar 2015,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3088,Contra-indications for spirometry,100020,Spirometry,"500,835",Categorical (single),Both sexes,Jan 2012,"570,283",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3089,Caffeine drink within last hour,100020,Spirometry,"462,799",Categorical (single),Both sexes,Jan 2012,"523,406",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3090,Used an inhaler for chest within last hour,100020,Spirometry,"462,799",Categorical (single),Both sexes,Jan 2012,"523,406",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3159,Smoked cigarette or pipe within last hour,100020,Spirometry,"76,674",Categorical (single),Both sexes,Jan 2012,"80,625",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23,Spirometry method,100020,Spirometry,"460,150",Categorical (single),Both sexes,Jan 2012,"519,975",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3137,Number of measurements made,100020,Spirometry,"457,476",Integer,Both sexes,Jan 2012,"516,470",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10717,Number of measurements made (pilot),100020,Spirometry,"3,426",Integer,Both sexes,Jan 2012,"3,426",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20255,Spirometry QC measure,100020,Spirometry,"379,391",Categorical (single),Both sexes,Apr 2018,"379,391",Data,Singular,May 2018,Accruing,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3065,Ordering of blows,100020,Spirometry,"457,476",Categorical (single),Both sexes,Jan 2012,"1,412,511",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3059,Result ranking,100020,Spirometry,"457,476",Categorical (single),Both sexes,Jan 2012,"1,412,511",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10691,Result ranking (pilot),100020,Spirometry,"3,417",Categorical (single),Both sexes,Jan 2012,"10,180",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3066,Data points for blow,100020,Spirometry,"457,476",Compound,Both sexes,Jan 2012,"1,412,511",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10711,Spirometry method (pilot),100020,Spirometry,"3,431",Categorical (single),Both sexes,Jan 2012,"3,431",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10697,Data points for blow (pilot),100020,Spirometry,"3,417",Compound,Both sexes,Jan 2012,"10,180",Data,Defined (1),Feb 2013,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3061,Acceptability of each blow result,100020,Spirometry,"457,476",Integer,Both sexes,Jan 2012,"1,412,511",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10693,Acceptability of each blow result (pilot),100020,Spirometry,"3,417",Integer,Both sexes,Jan 2012,"10,180",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3062,Forced vital capacity (FVC),100020,Spirometry,"457,476","Continuous, litres",Both sexes,Jan 2012,"1,412,511",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10694,Forced vital capacity (FVC) (pilot),100020,Spirometry,"3,417","Continuous, litres",Both sexes,Jan 2012,"10,180",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20151,"Forced vital capacity (FVC), Best measure",100020,Spirometry,"353,314","Continuous, litres",Both sexes,Mar 2015,"353,314",Data,Defined (1),Mar 2015,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20257,Forced vital capacity (FVC) Z-score,100020,Spirometry,"379,391","Continuous, Z",Both sexes,Apr 2018,"379,391",Data,Singular,May 2018,Accruing,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3063,Forced expiratory volume in 1-second (FEV1),100020,Spirometry,"457,476","Continuous, litres",Both sexes,Jan 2012,"1,412,511",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10695,Forced expiratory volume in 1-second (FEV1) (pilot),100020,Spirometry,"3,417","Continuous, litres",Both sexes,Jan 2012,"10,180",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20150,"Forced expiratory volume in 1-second (FEV1), Best measure",100020,Spirometry,"353,314","Continuous, litres",Both sexes,Mar 2015,"353,314",Data,Defined (1),Mar 2015,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20153,"Forced expiratory volume in 1-second (FEV1), predicted",100020,Spirometry,"151,973","Continuous, litres",Both sexes,Mar 2015,"151,973",Data,Defined (1),Mar 2015,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20154,"Forced expiratory volume in 1-second (FEV1), predicted percentage",100020,Spirometry,"151,973","Continuous, percent",Both sexes,Mar 2015,"151,973",Data,Defined (1),Mar 2015,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20256,Forced expiratory volume in 1-second (FEV1) Z-score,100020,Spirometry,"379,391","Continuous, Z",Both sexes,Apr 2018,"379,391",Data,Singular,May 2018,Accruing,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20258,FEV1/ FVC ratio Z-score,100020,Spirometry,"379,391","Continuous, Z",Both sexes,Apr 2018,"379,391",Data,Singular,May 2018,Accruing,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3064,Peak expiratory flow (PEF),100020,Spirometry,"457,476","Integer, litres/min",Both sexes,Jan 2012,"1,412,511",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10696,Peak expiratory flow (PEF) (pilot),100020,Spirometry,"3,417",Integer,Both sexes,Jan 2012,"10,180",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3060,Time of blow measurement,100020,Spirometry,"457,476",Time,Both sexes,Jan 2012,"1,412,511",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42,Spirometer device ID,100020,Spirometry,"497,974",Text,Both sexes,Jan 2012,"566,547",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3132,Spirometry device serial number,100020,Spirometry,"457,476",Text,Both sexes,Jan 2012,"516,470",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10714,Spirometry device serial number (pilot),100020,Spirometry,"3,426",Text,Both sexes,Jan 2012,"3,426",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Physical measures,Spirometry,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103310,Spreads/sauces consumers,100110,Spreads/sauces/cooking oils yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Spreads/sauces/cooking oils yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20088,Types of spreads/sauces consumed,100110,Spreads/sauces/cooking oils yesterday,"145,999",Categorical (multiple),Both sexes,Sep 2012,"443,425",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Spreads/sauces/cooking oils yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
104660,Added salt to food,100110,Spreads/sauces/cooking oils yesterday,"63,886",Categorical (single),Both sexes,Sep 2012,"98,517",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Spreads/sauces/cooking oils yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20090,Type of fat/oil used in cooking,100110,Spreads/sauces/cooking oils yesterday,"191,514",Categorical (multiple),Both sexes,Sep 2012,"594,802",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Spreads/sauces/cooking oils yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103980,No fat for cooking,100110,Spreads/sauces/cooking oils yesterday,"67,325",Categorical (single),Both sexes,Sep 2012,"89,334",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Spreads/sauces/cooking oils yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42006,Date of stroke,43,Stroke outcomes,"13,134",Date,Both sexes,Nov 2016,"13,134",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Stroke outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42007,Source of stroke report,43,Stroke outcomes,"13,134",Categorical (single),Both sexes,Nov 2016,"13,134",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Stroke outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42008,Date of ischaemic stroke,43,Stroke outcomes,"6,087",Date,Both sexes,Nov 2016,"6,087",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Stroke outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42009,Source of ischaemic stroke report,43,Stroke outcomes,"6,087",Categorical (single),Both sexes,Nov 2016,"6,087",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Stroke outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42010,Date of intracerebral haemorrhage,43,Stroke outcomes,"1,341",Date,Both sexes,Nov 2016,"1,341",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Stroke outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42011,Source of intracerebral haemorrhage report,43,Stroke outcomes,"1,341",Categorical (single),Both sexes,Nov 2016,"1,341",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Stroke outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42012,Date of subarachnoid haemorrhage,43,Stroke outcomes,"1,441",Date,Both sexes,Nov 2016,"1,441",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Stroke outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
42013,Source of subarachnoid haemorrhage report,43,Stroke outcomes,"1,441",Categorical (single),Both sexes,Nov 2016,"1,441",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Algorithmically-defined outcomes,Stroke outcomes,0.0,0.0,0.0,0.0,0.0,0.0,0.0
25023,Volume of accumbens (left),1102,Subcortical volumes (FIRST),"39,755","Continuous, mm3",Both sexes,Oct 2015,"41,182",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Subcortical volumes (FIRST),0.0,0.0,0.0,0.0,0.0
25024,Volume of accumbens (right),1102,Subcortical volumes (FIRST),"39,755","Continuous, mm3",Both sexes,Oct 2015,"41,182",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Subcortical volumes (FIRST),0.0,0.0,0.0,0.0,0.0
25021,Volume of amygdala (left),1102,Subcortical volumes (FIRST),"39,755","Continuous, mm3",Both sexes,Oct 2015,"41,182",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Subcortical volumes (FIRST),0.0,0.0,0.0,0.0,0.0
25022,Volume of amygdala (right),1102,Subcortical volumes (FIRST),"39,755","Continuous, mm3",Both sexes,Oct 2015,"41,182",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Subcortical volumes (FIRST),0.0,0.0,0.0,0.0,0.0
25013,Volume of caudate (left),1102,Subcortical volumes (FIRST),"39,755","Continuous, mm3",Both sexes,Oct 2015,"41,182",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Subcortical volumes (FIRST),0.0,0.0,0.0,0.0,0.0
25014,Volume of caudate (right),1102,Subcortical volumes (FIRST),"39,755","Continuous, mm3",Both sexes,Oct 2015,"41,182",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Subcortical volumes (FIRST),0.0,0.0,0.0,0.0,0.0
25019,Volume of hippocampus (left),1102,Subcortical volumes (FIRST),"39,755","Continuous, mm3",Both sexes,Oct 2015,"41,182",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Subcortical volumes (FIRST),0.0,0.0,0.0,0.0,0.0
25020,Volume of hippocampus (right),1102,Subcortical volumes (FIRST),"39,755","Continuous, mm3",Both sexes,Oct 2015,"41,182",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Subcortical volumes (FIRST),0.0,0.0,0.0,0.0,0.0
25017,Volume of pallidum (left),1102,Subcortical volumes (FIRST),"39,755","Continuous, mm3",Both sexes,Oct 2015,"41,182",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Subcortical volumes (FIRST),0.0,0.0,0.0,0.0,0.0
25018,Volume of pallidum (right),1102,Subcortical volumes (FIRST),"39,755","Continuous, mm3",Both sexes,Oct 2015,"41,182",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Subcortical volumes (FIRST),0.0,0.0,0.0,0.0,0.0
25015,Volume of putamen (left),1102,Subcortical volumes (FIRST),"39,755","Continuous, mm3",Both sexes,Oct 2015,"41,182",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Subcortical volumes (FIRST),0.0,0.0,0.0,0.0,0.0
25016,Volume of putamen (right),1102,Subcortical volumes (FIRST),"39,755","Continuous, mm3",Both sexes,Oct 2015,"41,182",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Subcortical volumes (FIRST),0.0,0.0,0.0,0.0,0.0
25011,Volume of thalamus (left),1102,Subcortical volumes (FIRST),"39,755","Continuous, mm3",Both sexes,Oct 2015,"41,182",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Subcortical volumes (FIRST),0.0,0.0,0.0,0.0,0.0
25012,Volume of thalamus (right),1102,Subcortical volumes (FIRST),"39,755","Continuous, mm3",Both sexes,Oct 2015,"41,182",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,Subcortical volumes (FIRST),0.0,0.0,0.0,0.0,0.0
41232,Administrative and legal statuses,2001,Summary Administration,"148,621",Categorical (multiple),Both sexes,Jun 2013,"153,118",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Administration,0.0,0.0,0.0,0.0,0.0,0.0
41211,Destinations on discharge from hospital (polymorphic),2001,Summary Administration,"410,020",Text,Both sexes,Jun 2013,"540,200",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Administration,0.0,0.0,0.0,0.0,0.0,0.0
41248,Destinations on discharge from hospital (recoded),2001,Summary Administration,"410,024",Categorical (multiple),Both sexes,Jun 2013,"538,740",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Administration,0.0,0.0,0.0,0.0,0.0,0.0
41231,Hospital episode type,2001,Summary Administration,"366,429",Categorical (multiple),Both sexes,Jun 2013,"379,183",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Administration,0.0,0.0,0.0,0.0,0.0,0.0
41206,Intended management of patient (polymorphic),2001,Summary Administration,"382,535",Text,Both sexes,Jun 2013,"738,545",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Administration,0.0,0.0,0.0,0.0,0.0,0.0
41244,Intended management of patient (recoded),2001,Summary Administration,"382,539",Categorical (multiple),Both sexes,Jun 2013,"738,571",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Administration,0.0,0.0,0.0,0.0,0.0,0.0
41207,Main speciality of consultant (polymorphic),2001,Summary Administration,"382,532",Text,Both sexes,Jun 2013,"1,096,501",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Administration,0.0,0.0,0.0,0.0,0.0,0.0
41245,Main speciality of consultant (recoded),2001,Summary Administration,"382,535",Categorical (multiple),Both sexes,Jun 2013,"1,096,532",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Administration,0.0,0.0,0.0,0.0,0.0,0.0
41212,Methods of admission to hospital (polymorphic),2001,Summary Administration,"413,674",Text,Both sexes,Jun 2013,"1,003,637",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Administration,0.0,0.0,0.0,0.0,0.0,0.0
41249,Methods of admission to hospital (recoded),2001,Summary Administration,"413,678",Categorical (multiple),Both sexes,Jun 2013,"999,354",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Administration,0.0,0.0,0.0,0.0,0.0,0.0
41213,Methods of discharge from hospital (polymorphic),2001,Summary Administration,"413,672",Text,Both sexes,Jun 2013,"535,048",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Administration,0.0,0.0,0.0,0.0,0.0,0.0
41250,Methods of discharge from hospital (recoded),2001,Summary Administration,"413,676",Categorical (multiple),Both sexes,Jun 2013,"525,984",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Administration,0.0,0.0,0.0,0.0,0.0,0.0
41229,PCT responsible for patient data,2001,Summary Administration,"320,274",Categorical (multiple),Both sexes,Jun 2013,"337,749",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Administration,0.0,0.0,0.0,0.0,0.0,0.0
41230,PCT where patients GP was registered,2001,Summary Administration,"366,425",Categorical (multiple),Both sexes,Jun 2013,"521,997",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Administration,0.0,0.0,0.0,0.0,0.0,0.0
41209,Patient classification on admission (polymorphic),2001,Summary Administration,"410,021",Text,Both sexes,Jun 2013,"666,533",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Administration,0.0,0.0,0.0,0.0,0.0,0.0
41247,Patient classification on admission (recoded),2001,Summary Administration,"410,025",Categorical (multiple),Both sexes,Jun 2013,"666,804",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Administration,0.0,0.0,0.0,0.0,0.0,0.0
41233,Sources of admission to hospital (polymorphic),2001,Summary Administration,"413,674",Text,Both sexes,Jun 2013,"493,839",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Administration,0.0,0.0,0.0,0.0,0.0,0.0
41251,Sources of admission to hospital (recoded),2001,Summary Administration,"413,678",Categorical (multiple),Both sexes,Jun 2013,"476,100",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Administration,0.0,0.0,0.0,0.0,0.0,0.0
41235,Spells in hospital,2001,Summary Administration,"330,448","Integer, Spells",Both sexes,Jul 2013,"330,448",Data,Singular,Jul 2014,Ongoing,Health-related outcomes,Hospital inpatient,Summary Administration,0.0,0.0,0.0,0.0,0.0,0.0,0.0
41208,Treatment speciality of consultant (polymorphic),2001,Summary Administration,"413,672",Text,Both sexes,Jun 2013,"1,227,998",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Administration,0.0,0.0,0.0,0.0,0.0,0.0
41246,Treatment speciality of consultant (recoded),2001,Summary Administration,"413,676",Categorical (multiple),Both sexes,Jun 2013,"1,214,299",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Administration,0.0,0.0,0.0,0.0,0.0,0.0
40022,Inpatient record origin,2001,Summary Administration,"413,674",Categorical (multiple),Both sexes,Mar 2018,"418,042",Data,Singular,Aug 2019,Accruing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Administration,0.0,0.0,0.0,0.0,0.0,0.0
41253,Inpatient record format,2001,Summary Administration,"413,678",Categorical (multiple),Both sexes,Mar 2014,"726,717",Data,Singular,Aug 2019,Accruing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Administration,0.0,0.0,0.0,0.0,0.0,0.0
41270,Diagnoses - ICD10,2002,Summary Diagnoses,"410,321",Categorical (multiple),Both sexes,Jan 2019,"4,131,361",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,Hospital inpatient,Summary Diagnoses,0.0,0.0,0.0,0.0,0.0,0.0,0.0
41280,Date of first in-patient diagnosis - ICD10,2002,Summary Diagnoses,"410,323",Date,Both sexes,Jan 2019,"4,131,461",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Diagnoses,0.0,0.0,0.0,0.0,0.0,0.0
41271,Diagnoses - ICD9,2002,Summary Diagnoses,"20,303",Categorical (multiple),Both sexes,Jan 2019,"58,699",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,Hospital inpatient,Summary Diagnoses,0.0,0.0,0.0,0.0,0.0,0.0,0.0
41281,Date of first in-patient diagnosis - ICD9,2002,Summary Diagnoses,"20,303",Date,Both sexes,Jan 2019,"58,699",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Diagnoses,0.0,0.0,0.0,0.0,0.0,0.0
41202,Diagnoses - main ICD10,2002,Summary Diagnoses,"410,317",Categorical (multiple),Both sexes,Jun 2013,"1,726,222",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,Hospital inpatient,Summary Diagnoses,0.0,0.0,0.0,0.0,0.0,0.0,0.0
41262,Date of first in-patient diagnosis - main ICD10,2002,Summary Diagnoses,"410,319",Date,Both sexes,Jan 2019,"1,726,262",Data,Singular,Aug 2019,Updateable,Category 2000,Health-related outcomes,Hospital inpatient,Summary Diagnoses,0.0,0.0,0.0,0.0,0.0,0.0
41203,Diagnoses - main ICD9,2002,Summary Diagnoses,"20,303",Categorical (multiple),Both sexes,Jun 2013,"42,828",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,Hospital inpatient,Summary Diagnoses,0.0,0.0,0.0,0.0,0.0,0.0,0.0
41263,Date of first in-patient diagnosis - main ICD9,2002,Summary Diagnoses,"20,303",Date,Both sexes,Jan 2019,"42,828",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Diagnoses,0.0,0.0,0.0,0.0,0.0,0.0
41204,Diagnoses - secondary ICD10,2002,Summary Diagnoses,"340,905",Categorical (multiple),Both sexes,Jun 2013,"2,511,163",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,Hospital inpatient,Summary Diagnoses,0.0,0.0,0.0,0.0,0.0,0.0,0.0
41205,Diagnoses - secondary ICD9,2002,Summary Diagnoses,"8,714",Categorical (multiple),Both sexes,Jun 2013,"17,289",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,Hospital inpatient,Summary Diagnoses,0.0,0.0,0.0,0.0,0.0,0.0,0.0
41201,External causes - ICD10,2002,Summary Diagnoses,"77,485",Categorical (multiple),Both sexes,Jun 2013,"102,830",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,Hospital inpatient,Summary Diagnoses,0.0,0.0,0.0,0.0,0.0,0.0,0.0
41284,Baby birth weight,2003,Summary Maternity,"16,603","Integer, g",Females only,Jun 2019,"24,024",Data,Singular,Aug 2019,Accruing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Maternity,0.0,0.0,0.0,0.0,0.0,0.0
41278,Birth order,2003,Summary Maternity,"16,624",Categorical (single),Both sexes,Jun 2019,"21,276",Data,Singular,Aug 2019,Accruing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Maternity,0.0,0.0,0.0,0.0,0.0,0.0
41276,Number of weeks of gestation,2003,Summary Maternity,"16,624","Integer, weeks",Females only,Jun 2019,"22,355",Data,Singular,Aug 2019,Accruing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Maternity,0.0,0.0,0.0,0.0,0.0,0.0
41268,Date of first antenatal assessment,2003,Summary Maternity,"10,168",Date,Both sexes,May 2019,"12,994",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Maternity,0.0,0.0,0.0,0.0,0.0,0.0
41275,Duration of antenatal stay,2003,Summary Maternity,"11,042","Integer, days",Both sexes,May 2019,"12,587",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Maternity,0.0,0.0,0.0,0.0,0.0,0.0
41285,Duration of postnatal stay,2003,Summary Maternity,"10,982","Integer, days",Both sexes,May 2019,"13,305",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Maternity,0.0,0.0,0.0,0.0,0.0,0.0
41269,Gestation period at first antenatal assessment,2003,Summary Maternity,"8,152","Integer, weeks",Both sexes,May 2019,"9,640",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Maternity,0.0,0.0,0.0,0.0,0.0,0.0
41286,Mother age on date of delivery,2003,Summary Maternity,"11,071",Integer,Both sexes,May 2019,"14,215",Data,Singular,Aug 2019,Accruing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Maternity,0.0,0.0,0.0,0.0,0.0,0.0
41266,Number of babies delivered from single pregnancy,2003,Summary Maternity,"16,624",Categorical (single),Both sexes,May 2019,"20,872",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Maternity,0.0,0.0,0.0,0.0,0.0,0.0
41267,Number of previous pregnancies,2003,Summary Maternity,"16,622",Categorical (single),Both sexes,May 2019,"20,669",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Maternity,0.0,0.0,0.0,0.0,0.0,0.0
41277,Reason for changing delivery place,2003,Summary Maternity,"16,624",Categorical (single),Both sexes,May 2019,"20,154",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Maternity,0.0,0.0,0.0,0.0,0.0,0.0
41219,Anaesthetics administered during delivery,2003,Summary Maternity,"16,627",Categorical (multiple),Females only,Jun 2013,"21,599",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Maternity,0.0,0.0,0.0,0.0,0.0,0.0
41220,Anaesthetics administered post delivery,2003,Summary Maternity,"16,627",Categorical (multiple),Females only,Jun 2013,"20,414",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Maternity,0.0,0.0,0.0,0.0,0.0,0.0
41221,Delivery methods,2003,Summary Maternity,"16,624",Categorical (multiple),Females only,Jun 2013,"22,592",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Maternity,0.0,0.0,0.0,0.0,0.0,0.0
41222,Delivery onset methods,2003,Summary Maternity,"16,627",Categorical (multiple),Females only,Jun 2013,"21,736",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Maternity,0.0,0.0,0.0,0.0,0.0,0.0
41223,Delivery places,2003,Summary Maternity,"16,623",Categorical (multiple),Females only,Jun 2013,"21,031",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Maternity,0.0,0.0,0.0,0.0,0.0,0.0
41224,Intended delivery places,2003,Summary Maternity,"16,627",Categorical (multiple),Females only,Jun 2013,"20,795",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Maternity,0.0,0.0,0.0,0.0,0.0,0.0
41225,Resuscitation methods,2003,Summary Maternity,"16,627",Categorical (multiple),Females only,Jun 2013,"21,364",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Maternity,0.0,0.0,0.0,0.0,0.0,0.0
41226,Sex of baby,2003,Summary Maternity,"15,522",Categorical (multiple),Females only,Jun 2013,"18,679",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Maternity,0.0,0.0,0.0,0.0,0.0,0.0
41227,Status of baby at birth,2003,Summary Maternity,"16,627",Categorical (multiple),Females only,Jun 2013,"20,606",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Maternity,0.0,0.0,0.0,0.0,0.0,0.0
41228,Statuses of person conducting delivery,2003,Summary Maternity,"16,627",Categorical (multiple),Females only,Jun 2013,"21,387",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Maternity,0.0,0.0,0.0,0.0,0.0,0.0
41288,Date of birth of baby,2003,Summary Maternity,"11,073",Date,Both sexes,May 2019,"14,222",Data,Singular,Aug 2019,Accruing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Maternity,0.0,0.0,0.0,0.0,0.0,0.0
41272,Operative procedures - OPCS4,2005,Summary Operations,"410,257",Categorical (multiple),Both sexes,Jan 2019,"3,640,100",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,Hospital inpatient,Summary Operations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
41282,Date of first operative procedure - OPCS4,2005,Summary Operations,"410,253",Date,Both sexes,Jan 2019,"3,640,172",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,Hospital inpatient,Summary Operations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
41273,Operative procedures - OPCS3,2005,Summary Operations,"10,700",Categorical (multiple),Both sexes,Jan 2019,"18,581",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,Hospital inpatient,Summary Operations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
41283,Date of first operative procedure - OPCS3,2005,Summary Operations,"10,700",Date,Both sexes,Jan 2019,"18,581",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,Hospital inpatient,Summary Operations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
41200,Operative procedures - main OPCS4,2005,Summary Operations,"410,257",Categorical (multiple),Both sexes,Jun 2013,"1,655,791",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,Hospital inpatient,Summary Operations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
41260,Date of first operative procedure - main OPCS4,2005,Summary Operations,"410,253",Date,Both sexes,Jan 2019,"1,655,808",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,Hospital inpatient,Summary Operations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
41210,Operative procedures - secondary OPCS4,2005,Summary Operations,"367,478",Categorical (multiple),Both sexes,Jun 2013,"2,041,159",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,Hospital inpatient,Summary Operations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
41256,Operative procedures - main OPCS3,2005,Summary Operations,"10,700",Categorical (multiple),Both sexes,Jan 2019,"15,453",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,Hospital inpatient,Summary Operations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
41257,Date of first operative procedure - main OPCS3,2005,Summary Operations,"10,700",Date,Both sexes,Jan 2019,"15,453",Data,Singular,Aug 2019,Ongoing,Health-related outcomes,Hospital inpatient,Summary Operations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
41258,Operative procedures - secondary OPCS3,2005,Summary Operations,"2,970",Categorical (multiple),Both sexes,Jan 2019,"3,355",Data,Singular,Mar 2019,Ongoing,Health-related outcomes,Hospital inpatient,Summary Operations,0.0,0.0,0.0,0.0,0.0,0.0,0.0
41214,Carer support indicators,2004,Summary Psychiatric,"366,429",Categorical (multiple),Both sexes,Jun 2013,"464,200",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Psychiatric,0.0,0.0,0.0,0.0,0.0,0.0
41215,Detention categories,2004,Summary Psychiatric,"42,612",Categorical (multiple),Both sexes,Jun 2013,"43,108",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Psychiatric,0.0,0.0,0.0,0.0,0.0,0.0
41279,Detention date,2004,Summary Psychiatric,18,Date,Both sexes,Jun 2019,20,Data,Singular,Aug 2019,Accruing,Health-related outcomes,Hospital inpatient,Summary Psychiatric,0.0,0.0,0.0,0.0,0.0,0.0,0.0
41218,History of psychiatric care on admission,2004,Summary Psychiatric,"366,428",Categorical (multiple),Both sexes,Jun 2013,"416,609",Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Psychiatric,0.0,0.0,0.0,0.0,0.0,0.0
41216,Legal statuses,2004,Summary Psychiatric,7,Categorical (multiple),Both sexes,Jun 2013,8,Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Psychiatric,0.0,0.0,0.0,0.0,0.0,0.0
41217,Mental categories,2004,Summary Psychiatric,24,Categorical (multiple),Both sexes,Jun 2013,25,Data,Singular,Aug 2019,Ongoing,Category 2000,Health-related outcomes,Hospital inpatient,Summary Psychiatric,0.0,0.0,0.0,0.0,0.0,0.0
1050,Time spend outdoors in summer,100055,Sun exposure,"498,754","Integer, hours/day",Both sexes,Jan 2012,"568,497",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Sun exposure,0.0,0.0,0.0,0.0,0.0,0.0
1060,Time spent outdoors in winter,100055,Sun exposure,"498,754","Integer, hours/day",Both sexes,Jan 2012,"568,497",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Sun exposure,0.0,0.0,0.0,0.0,0.0,0.0
1717,Skin colour,100055,Sun exposure,"501,613",Categorical (single),Both sexes,Jan 2012,"533,613",Data,Defined (3),Nov 2016,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Sun exposure,0.0,0.0,0.0,0.0,0.0,0.0
1727,Ease of skin tanning,100055,Sun exposure,"498,413",Categorical (single),Both sexes,Jan 2012,"529,843",Data,Defined (3),Nov 2016,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Sun exposure,0.0,0.0,0.0,0.0,0.0,0.0
1737,Childhood sunburn occasions,100055,Sun exposure,"498,413","Integer, times",Both sexes,Jan 2012,"529,843",Data,Defined (3),Nov 2016,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Sun exposure,0.0,0.0,0.0,0.0,0.0,0.0
1747,"Hair colour (natural, before greying)",100055,Sun exposure,"501,613",Categorical (single),Both sexes,Jan 2012,"533,613",Data,Defined (3),Nov 2016,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Sun exposure,0.0,0.0,0.0,0.0,0.0,0.0
1757,Facial ageing,100055,Sun exposure,"498,736",Categorical (single),Both sexes,Jan 2012,"568,479",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Sun exposure,0.0,0.0,0.0,0.0,0.0,0.0
2267,Use of sun/uv protection,100055,Sun exposure,"498,717",Categorical (single),Both sexes,Jan 2012,"568,460",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Sun exposure,0.0,0.0,0.0,0.0,0.0,0.0
2277,Frequency of solarium/sunlamp use,100055,Sun exposure,"498,717","Integer, times/year",Both sexes,Jan 2012,"568,460",Data,Defined (4),Feb 2020,Complete,UK Biobank Assessment Centre,Touchscreen,Lifestyle and environment,Sun exposure,0.0,0.0,0.0,0.0,0.0,0.0
25927,Intensity scaling for SWI,109,Susceptibility weighted brain MRI,"36,305","Continuous, units",Both sexes,Dec 2019,"37,680",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Susceptibility weighted brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
20251,Susceptibility weighted brain images - NIFTI,109,Susceptibility weighted brain MRI,"36,017",Text,Both sexes,Oct 2015,"37,388",Bulk,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Susceptibility weighted brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
20219,Susceptibility weighted brain images - DICOM,109,Susceptibility weighted brain MRI,"38,443",Text,Both sexes,Jul 2014,"40,107",Bulk,Defined (2),Nov 2019,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Susceptibility weighted brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25738,Discrepancy between SWI brain image and T1 brain image,109,Susceptibility weighted brain MRI,"35,507","Continuous, AU",Both sexes,Oct 2015,"36,494",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Susceptibility weighted brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25038,Median T2star in accumbens (left),109,Susceptibility weighted brain MRI,"35,962","Continuous, ms",Both sexes,Oct 2015,"37,331",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Susceptibility weighted brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25039,Median T2star in accumbens (right),109,Susceptibility weighted brain MRI,"35,962","Continuous, ms",Both sexes,Oct 2015,"37,331",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Susceptibility weighted brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25036,Median T2star in amygdala (left),109,Susceptibility weighted brain MRI,"35,962","Continuous, ms",Both sexes,Oct 2015,"37,331",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Susceptibility weighted brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25037,Median T2star in amygdala (right),109,Susceptibility weighted brain MRI,"35,962","Continuous, ms",Both sexes,Oct 2015,"37,331",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Susceptibility weighted brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25028,Median T2star in caudate (left),109,Susceptibility weighted brain MRI,"35,962","Continuous, ms",Both sexes,Oct 2015,"37,331",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Susceptibility weighted brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25029,Median T2star in caudate (right),109,Susceptibility weighted brain MRI,"35,962","Continuous, ms",Both sexes,Oct 2015,"37,331",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Susceptibility weighted brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25034,Median T2star in hippocampus (left),109,Susceptibility weighted brain MRI,"35,962","Continuous, ms",Both sexes,Oct 2015,"37,331",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Susceptibility weighted brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25035,Median T2star in hippocampus (right),109,Susceptibility weighted brain MRI,"35,962","Continuous, ms",Both sexes,Oct 2015,"37,331",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Susceptibility weighted brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25032,Median T2star in pallidum (left),109,Susceptibility weighted brain MRI,"35,962","Continuous, ms",Both sexes,Oct 2015,"37,331",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Susceptibility weighted brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25033,Median T2star in pallidum (right),109,Susceptibility weighted brain MRI,"35,962","Continuous, ms",Both sexes,Oct 2015,"37,331",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Susceptibility weighted brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25030,Median T2star in putamen (left),109,Susceptibility weighted brain MRI,"35,962","Continuous, ms",Both sexes,Oct 2015,"37,331",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Susceptibility weighted brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25031,Median T2star in putamen (right),109,Susceptibility weighted brain MRI,"35,962","Continuous, ms",Both sexes,Oct 2015,"37,331",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Susceptibility weighted brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25026,Median T2star in thalamus (left),109,Susceptibility weighted brain MRI,"35,962","Continuous, ms",Both sexes,Oct 2015,"37,331",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Susceptibility weighted brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25027,Median T2star in thalamus (right),109,Susceptibility weighted brain MRI,"35,962","Continuous, ms",Both sexes,Oct 2015,"37,331",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Susceptibility weighted brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
20159,Number of symbol digit matches made correctly,122,Symbol digit substitution,"118,473","Integer, correct-answers",Both sexes,Jul 2015,"118,473",Data,Singular,Aug 2015,Complete,Online follow-up,Cognitive function online,Symbol digit substitution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20195,Number of symbol digit matches attempted,122,Symbol digit substitution,"118,473","Integer, attempts",Both sexes,Jul 2015,"118,473",Data,Defined (1),Aug 2015,Complete,Online follow-up,Cognitive function online,Symbol digit substitution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20196,First code array presented,122,Symbol digit substitution,"120,183",Categorical (single),Both sexes,Jul 2015,"120,183",Data,Defined (1),Aug 2015,Complete,Online follow-up,Cognitive function online,Symbol digit substitution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20198,Test array presented,122,Symbol digit substitution,"118,793",Categorical (single),Both sexes,Jul 2015,"3,350,042",Data,Defined (1),Aug 2015,Complete,Online follow-up,Cognitive function online,Symbol digit substitution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20200,Values wanted,122,Symbol digit substitution,"118,793",Integer,Both sexes,Jul 2015,"3,350,042",Data,Singular,Aug 2015,Complete,Online follow-up,Cognitive function online,Symbol digit substitution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20229,Values entered,122,Symbol digit substitution,"118,793",Integer,Both sexes,Jul 2015,"3,350,042",Data,Singular,Aug 2015,Complete,Online follow-up,Cognitive function online,Symbol digit substitution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20230,Duration to entering value,122,Symbol digit substitution,"118,793","Integer, milliseconds",Both sexes,Jul 2015,"3,350,042",Data,Singular,Aug 2015,Complete,Online follow-up,Cognitive function online,Symbol digit substitution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20245,Symbol digit completion status,122,Symbol digit substitution,"120,183",Categorical (single),Both sexes,Jul 2015,"120,183",Data,Singular,Aug 2015,Complete,Online follow-up,Cognitive function online,Symbol digit substitution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20137,When symbol digit substitution test completed,122,Symbol digit substitution,"120,183",Time,Both sexes,Jul 2015,"120,183",Data,Singular,Aug 2015,Complete,Online follow-up,Cognitive function online,Symbol digit substitution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23323,Number of symbol digit matches attempted,502,Symbol digit substitution,"32,501","Integer, attempts",Both sexes,Jun 2017,"34,662",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Symbol digit substitution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23324,Number of symbol digit matches made correctly,502,Symbol digit substitution,"32,501","Integer, correct-answers",Both sexes,Jun 2017,"34,662",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Symbol digit substitution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6362,First code array presented,502,Symbol digit substitution,"33,704",Categorical (single),Both sexes,Jun 2017,"35,926",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Symbol digit substitution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23321,Values wanted,502,Symbol digit substitution,"32,501",Integer,Both sexes,Jun 2017,"679,135",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Symbol digit substitution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
23322,Values entered,502,Symbol digit substitution,"32,501",Integer,Both sexes,Jun 2017,"679,135",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Symbol digit substitution,0.0,0.0,0.0,0.0,0.0,0.0,0.0
25925,Intensity scaling for T1,110,T1 structural brain MRI,"39,754","Continuous, units",Both sexes,Dec 2019,"41,181",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
26500,T2-FLAIR used (in addition to T1) to run FreeSurfer,110,T1 structural brain MRI,"40,098",Categorical (single),Both sexes,Apr 2019,"41,470",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
20252,T1 structural brain images - NIFTI,110,T1 structural brain MRI,"40,682",Text,Both sexes,Oct 2015,"42,184",Bulk,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
20216,T1 structural brain images - DICOM,110,T1 structural brain MRI,"42,234",Text,Both sexes,Jul 2014,"43,964",Bulk,Defined (2),Nov 2019,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
20263,T1 surface model files and additional structural segmentations,110,T1 structural brain MRI,"40,060",Text,Both sexes,Apr 2019,"41,505",Bulk,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25733,Amount of warping applied to non-linearly align T1 brain image to standard-space,110,T1 structural brain MRI,"39,772","Continuous, AU",Both sexes,Oct 2015,"41,199",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25731,Discrepancy between T1 brain image and standard-space brain template (linearly-aligned),110,T1 structural brain MRI,"39,772","Continuous, AU",Both sexes,Oct 2015,"41,199",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25732,Discrepancy between T1 brain image and standard-space brain template (nonlinearly-aligned),110,T1 structural brain MRI,"39,772","Continuous, AU",Both sexes,Oct 2015,"41,199",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25735,Inverted contrast-to-noise ratio in T1,110,T1 structural brain MRI,"39,772","Continuous, ratio",Both sexes,Oct 2015,"41,199",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25734,Inverted signal-to-noise ratio in T1,110,T1 structural brain MRI,"39,772","Continuous, ratio",Both sexes,Oct 2015,"41,199",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25000,Volumetric scaling from T1 head image to standard space,110,T1 structural brain MRI,"39,772","Continuous, ratio",Both sexes,Oct 2015,"41,199",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25010,"Volume of brain, grey+white matter",110,T1 structural brain MRI,"39,772","Continuous, mm3",Both sexes,Oct 2015,"41,199",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25009,"Volume of brain, grey+white matter (normalised for head size)",110,T1 structural brain MRI,"39,772","Continuous, mm3",Both sexes,Oct 2015,"41,199",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25008,Volume of white matter,110,T1 structural brain MRI,"39,772","Continuous, mm3",Both sexes,Oct 2015,"41,199",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25007,Volume of white matter (normalised for head size),110,T1 structural brain MRI,"39,772","Continuous, mm3",Both sexes,Oct 2015,"41,199",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25006,Volume of grey matter,110,T1 structural brain MRI,"39,772","Continuous, mm3",Both sexes,Oct 2015,"41,199",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25005,Volume of grey matter (normalised for head size),110,T1 structural brain MRI,"39,772","Continuous, mm3",Both sexes,Oct 2015,"41,199",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25002,Volume of peripheral cortical grey matter,110,T1 structural brain MRI,"39,772","Continuous, mm3",Both sexes,Oct 2015,"41,199",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25001,Volume of peripheral cortical grey matter (normalised for head size),110,T1 structural brain MRI,"39,772","Continuous, mm3",Both sexes,Oct 2015,"41,199",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25004,Volume of ventricular cerebrospinal fluid,110,T1 structural brain MRI,"39,772","Continuous, mm3",Both sexes,Oct 2015,"41,199",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25003,Volume of ventricular cerebrospinal fluid (normalised for head size),110,T1 structural brain MRI,"39,772","Continuous, mm3",Both sexes,Oct 2015,"41,199",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25025,Volume of brain stem + 4th ventricle,110,T1 structural brain MRI,"39,755","Continuous, mm3",Both sexes,Oct 2015,"41,182",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25756,Scanner lateral (X) brain position,110,T1 structural brain MRI,"40,679","Continuous, Units",Both sexes,Aug 2017,"42,181",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25757,Scanner transverse (Y) brain position,110,T1 structural brain MRI,"40,679","Continuous, Units",Both sexes,Aug 2017,"42,181",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25758,Scanner longitudinal (Z) brain position,110,T1 structural brain MRI,"40,679","Continuous, Units",Both sexes,Aug 2017,"42,181",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25759,Scanner table position,110,T1 structural brain MRI,"40,773","Continuous, Units",Both sexes,Aug 2017,"42,276",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T1 structural brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25926,Intensity scaling for T2_FLAIR,112,T2-weighted brain MRI,"39,025","Continuous, units",Both sexes,Dec 2019,"40,445",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T2-weighted brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
20253,T2 FLAIR structural brain images - NIFTI,112,T2-weighted brain MRI,"39,901",Text,Both sexes,Oct 2015,"41,396",Bulk,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T2-weighted brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
20220,T2 FLAIR structural brain images - DICOM,112,T2-weighted brain MRI,"41,446",Text,Both sexes,Jul 2014,"43,168",Bulk,Defined (2),Nov 2019,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T2-weighted brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25781,Total volume of white matter hyperintensities (from T1 and T2_FLAIR images),112,T2-weighted brain MRI,"38,426","Continuous, mm3",Both sexes,Jan 2017,"39,841",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T2-weighted brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25736,Discrepancy between T2 FLAIR brain image and T1 brain image,112,T2-weighted brain MRI,"38,431","Continuous, AU",Both sexes,Oct 2015,"39,846",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T2-weighted brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
20221,T2/PD brain images - DICOM,112,T2-weighted brain MRI,538,Text,Both sexes,Jul 2014,538,Bulk,Defined (1),May 2015,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,T2-weighted brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25924,Echo Time for tfMRI,106,Task functional brain MRI,"34,710","Continuous, milliseconds",Both sexes,Dec 2019,"36,008",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25930,Intensity scaling for tfMRI,106,Task functional brain MRI,"34,710","Continuous, units",Both sexes,Dec 2019,"36,008",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
20249,Functional brain images - task - NIFTI,106,Task functional brain MRI,"35,501",Text,Both sexes,Oct 2015,"36,866",Bulk,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
20217,Functional brain images - task - DICOM,106,Task functional brain MRI,"36,719",Text,Both sexes,Jul 2014,"38,284",Bulk,Defined (2),Nov 2019,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25740,Discrepancy between tfMRI brain image and T1 brain image,106,Task functional brain MRI,"32,994","Continuous, AU",Both sexes,Oct 2015,"34,288",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25748,Eprime txt file,106,Task functional brain MRI,"36,582",Text,Both sexes,Oct 2015,"37,993",Bulk,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25747,Eprime advisor file,106,Task functional brain MRI,"36,248",Text,Both sexes,Oct 2015,"37,652",Bulk,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25749,Eprime ed2 file,106,Task functional brain MRI,"36,248",Text,Both sexes,Oct 2015,"37,652",Bulk,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
12651,Duration of eprime test,106,Task functional brain MRI,"38,433","Integer, seconds",Both sexes,Sep 2015,"40,785",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
12706,Eprime error flag,106,Task functional brain MRI,381,Categorical (single),Both sexes,Sep 2015,381,Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25767,90th percentile of BOLD effect (in group-defined amygdala activation mask) for faces-shapes contrast,106,Task functional brain MRI,"32,983","Continuous, percent",Both sexes,Oct 2015,"34,277",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25763,90th percentile of BOLD effect (in group-defined mask) for faces activation,106,Task functional brain MRI,"32,983","Continuous, percent",Both sexes,Oct 2015,"34,277",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25761,90th percentile of BOLD effect (in group-defined mask) for shapes activation,106,Task functional brain MRI,"32,983","Continuous, percent",Both sexes,Oct 2015,"34,277",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25765,90th percentile of BOLD effect (in group-defined mask) for faces-shapes contrast,106,Task functional brain MRI,"32,983","Continuous, percent",Both sexes,Oct 2015,"34,277",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25768,90th percentile of z-statistic (in group-defined amygdala activation mask) for faces-shapes contrast,106,Task functional brain MRI,"32,983","Continuous, Z",Both sexes,Oct 2015,"34,277",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25764,90th percentile of z-statistic (in group-defined mask) for faces activation,106,Task functional brain MRI,"32,983","Continuous, Z",Both sexes,Oct 2015,"34,277",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25762,90th percentile of z-statistic (in group-defined mask) for shapes activation,106,Task functional brain MRI,"32,983","Continuous, Z",Both sexes,Oct 2015,"34,277",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25766,90th percentile of z-statistic (in group-defined mask) for faces-shapes contrast,106,Task functional brain MRI,"32,983","Continuous, Z",Both sexes,Oct 2015,"34,277",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25745,Inverted temporal signal-to-noise ratio in pre-processed tfMRI,106,Task functional brain MRI,"32,994","Continuous, ratio",Both sexes,Oct 2015,"34,288",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25742,"Mean tfMRI head motion, averaged across space and time points",106,Task functional brain MRI,"32,994","Continuous, mm",Both sexes,Oct 2015,"34,288",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25052,Median BOLD effect (in group-defined amygdala activation mask) for faces-shapes contrast,106,Task functional brain MRI,"32,983","Continuous, percent",Both sexes,Oct 2015,"34,277",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25044,Median BOLD effect (in group-defined mask) for faces activation,106,Task functional brain MRI,"32,983","Continuous, percent",Both sexes,Oct 2015,"34,277",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25040,Median BOLD effect (in group-defined mask) for shapes activation,106,Task functional brain MRI,"32,983","Continuous, percent",Both sexes,Oct 2015,"34,277",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25048,Median BOLD effect (in group-defined mask) for faces-shapes contrast,106,Task functional brain MRI,"32,983","Continuous, percent",Both sexes,Oct 2015,"34,277",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25054,Median z-statistic (in group-defined amygdala activation mask) for faces-shapes contrast,106,Task functional brain MRI,"32,983","Continuous, Z",Both sexes,Oct 2015,"34,277",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25046,Median z-statistic (in group-defined mask) for faces activation,106,Task functional brain MRI,"32,983","Continuous, Z",Both sexes,Oct 2015,"34,277",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25042,Median z-statistic (in group-defined mask) for shapes activation,106,Task functional brain MRI,"32,983","Continuous, Z",Both sexes,Oct 2015,"34,277",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
25050,Median z-statistic (in group-defined mask) for faces-shapes contrast,106,Task functional brain MRI,"32,983","Continuous, Z",Both sexes,Oct 2015,"34,277",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Task functional brain MRI,0.0,0.0,0.0,0.0,0.0,0.0
21004,Number of puzzles correct,503,Tower rearranging,"32,210","Integer, correct-answers",Both sexes,Nov 2017,"34,368",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Tower rearranging,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6382,Number of puzzles correct,503,Tower rearranging,"32,832","Integer, correct-answers",Both sexes,Jun 2017,"35,054",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Tower rearranging,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6383,Number of puzzles attempted,503,Tower rearranging,"32,832","Integer, attempts",Both sexes,Jun 2017,"35,054",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Tower rearranging,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6312,Value entered,503,Tower rearranging,"32,210",Categorical (single),Both sexes,Jun 2017,"450,863",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Tower rearranging,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6313,Duration to entering selection,503,Tower rearranging,"32,210","Integer, deciseconds",Both sexes,Jun 2017,"450,863",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Tower rearranging,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20156,Duration to complete numeric path (trail #1),121,Trail making,"104,036","Continuous, seconds",Both sexes,Jul 2015,"104,036",Data,Singular,Aug 2015,Complete,Online follow-up,Cognitive function online,Trail making,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20157,Duration to complete alphanumeric path (trail #2),121,Trail making,"104,034","Continuous, seconds",Both sexes,Jul 2015,"104,034",Data,Singular,Aug 2015,Complete,Online follow-up,Cognitive function online,Trail making,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20247,Total errors traversing numeric path (trail #1),121,Trail making,"26,362","Integer, error-count",Both sexes,Jul 2015,"26,362",Data,Singular,Aug 2015,Complete,Online follow-up,Cognitive function online,Trail making,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20248,Total errors traversing alphanumeric path (trail #2),121,Trail making,"42,774","Integer, error-count",Both sexes,Jul 2015,"42,774",Data,Singular,Aug 2015,Complete,Online follow-up,Cognitive function online,Trail making,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20149,Interval between previous point and current one in numeric path (trail #1),121,Trail making,"115,157","Integer, milliseconds",Both sexes,Jul 2015,"2,848,181",Data,Singular,Aug 2015,Complete,Online follow-up,Cognitive function online,Trail making,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20155,Interval between previous point and current one in alphanumeric path (trail #2),121,Trail making,"110,408","Integer, milliseconds",Both sexes,Jul 2015,"2,724,707",Data,Singular,Aug 2015,Complete,Online follow-up,Cognitive function online,Trail making,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20147,Errors before selecting correct item in numeric path (trail #1),121,Trail making,"26,362","Integer, error-count",Both sexes,Jul 2015,"44,191",Data,Singular,Jul 2015,Complete,Online follow-up,Cognitive function online,Trail making,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20148,Errors before selecting correct item in alphanumeric path (trail #2),121,Trail making,"42,774","Integer, error-count",Both sexes,Jul 2015,"72,326",Data,Singular,Jul 2015,Complete,Online follow-up,Cognitive function online,Trail making,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20246,Trail making completion status,121,Trail making,"120,466",Categorical (single),Both sexes,Jul 2015,"120,466",Data,Singular,Jul 2015,Complete,Online follow-up,Cognitive function online,Trail making,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20136,When trail making test completed,121,Trail making,"120,466",Time,Both sexes,Jul 2015,"120,466",Data,Singular,Jul 2015,Complete,Online follow-up,Cognitive function online,Trail making,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6348,Duration to complete numeric path (trail #1),505,Trail making,"32,832","Integer, deciseconds",Both sexes,Jun 2017,"35,054",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Trail making,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6350,Duration to complete alphanumeric path (trail #2),505,Trail making,"32,832","Integer, deciseconds",Both sexes,Jun 2017,"35,054",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Trail making,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6349,Total errors traversing numeric path (trail #1),505,Trail making,"32,832","Integer, error-count",Both sexes,Jun 2017,"35,054",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Trail making,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6351,Total errors traversing alphanumeric path (trail #2),505,Trail making,"32,832","Integer, error-count",Both sexes,Jun 2017,"35,054",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Trail making,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6772,Interval between previous point and current one in numeric path (trail #1),505,Trail making,"32,528","Integer, deciseconds",Both sexes,Jun 2017,"865,682",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Trail making,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6773,Interval between previous point and current one in alphanumeric path (trail #2),505,Trail making,"32,403","Integer, milliseconds",Both sexes,Jun 2017,"850,746",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Trail making,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6770,Errors before selecting correct item in numeric path (trail #1),505,Trail making,"10,566","Integer, error-count",Both sexes,Jun 2017,"13,290",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Trail making,0.0,0.0,0.0,0.0,0.0,0.0,0.0
6771,Errors before selecting correct item in alphanumeric path (trail #2),505,Trail making,"14,551","Integer, error-count",Both sexes,Jun 2017,"26,303",Data,Defined (2),Feb 2020,Accruing,UK Biobank Assessment Centre,Cognitive function,Trail making,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20489,Felt loved as a child,145,Traumatic events,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Traumatic events,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20488,Physically abused by family as a child,145,Traumatic events,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Traumatic events,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20487,Felt hated by family member as a child,145,Traumatic events,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Traumatic events,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20490,Sexually molested as a child,145,Traumatic events,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Traumatic events,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20491,Someone to take to doctor when needed as a child,145,Traumatic events,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Traumatic events,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20522,Been in a confiding relationship as an adult,145,Traumatic events,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Traumatic events,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20523,Physical violence by partner or ex-partner as an adult,145,Traumatic events,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Traumatic events,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20521,Belittlement by partner or ex-partner as an adult,145,Traumatic events,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Traumatic events,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20524,Sexual interference by partner or ex-partner without consent as an adult,145,Traumatic events,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Traumatic events,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20525,Able to pay rent/mortgage as an adult,145,Traumatic events,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Traumatic events,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20531,Victim of sexual assault,145,Traumatic events,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Traumatic events,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20529,Victim of physically violent crime,145,Traumatic events,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Traumatic events,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20526,Been in serious accident believed to be life-threatening,145,Traumatic events,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Traumatic events,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20530,Witnessed sudden violent death,145,Traumatic events,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Traumatic events,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20528,Diagnosed with life-threatening illness,145,Traumatic events,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Traumatic events,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20527,Been involved in combat or exposed to war-zone,145,Traumatic events,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Traumatic events,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20497,Repeated disturbing thoughts of stressful experience in past month,145,Traumatic events,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Traumatic events,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20498,Felt very upset when reminded of stressful experience in past month,145,Traumatic events,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Traumatic events,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20495,Avoided activities or situations because of previous stressful experience in past month,145,Traumatic events,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Traumatic events,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20496,Felt distant from other people in past month,145,Traumatic events,"71,193",Categorical (single),Both sexes,Oct 2016,"71,193",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Traumatic events,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20494,Felt irritable or had angry outbursts in past month,145,Traumatic events,"71,193",Categorical (single),Both sexes,Oct 2016,"71,193",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Traumatic events,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100010,Portion size,100097,Typical diet yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Typical diet yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
100020,Typical diet yesterday,100097,Typical diet yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Typical diet yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20085,Reason for not eating or drinking normally,100097,Typical diet yesterday,"67,937",Categorical (multiple),Both sexes,Sep 2012,"90,435",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Typical diet yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20086,Type of special diet followed,100097,Typical diet yesterday,"58,982",Categorical (multiple),Both sexes,Sep 2012,"112,184",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Typical diet yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20461,Age when first had unusual or psychotic experience,144,Unusual and psychotic experiences,"7,803",Integer,Both sexes,Oct 2016,"7,803",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Unusual and psychotic experiences,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20462,Distress caused by unusual or psychotic experiences,144,Unusual and psychotic experiences,"7,803",Categorical (single),Both sexes,Oct 2016,"7,803",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Unusual and psychotic experiences,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20468,Ever believed in an un-real conspiracy against self,144,Unusual and psychotic experiences,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Unusual and psychotic experiences,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20474,Ever believed in un-real communications or signs,144,Unusual and psychotic experiences,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Unusual and psychotic experiences,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20463,Ever heard an un-real voice,144,Unusual and psychotic experiences,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Unusual and psychotic experiences,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20466,Ever prescribed a medication for unusual or psychotic experiences,144,Unusual and psychotic experiences,"7,803",Categorical (single),Both sexes,Oct 2016,"7,803",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Unusual and psychotic experiences,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20471,Ever seen an un-real vision,144,Unusual and psychotic experiences,"157,349",Categorical (single),Both sexes,Oct 2016,"157,349",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Unusual and psychotic experiences,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20477,Ever talked to a health professional about unusual or psychotic experiences,144,Unusual and psychotic experiences,"7,803",Categorical (single),Both sexes,Oct 2016,"7,803",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Unusual and psychotic experiences,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20467,Frequency of unusual or psychotic experiences in past year,144,Unusual and psychotic experiences,"7,803",Categorical (single),Both sexes,Oct 2016,"7,803",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Unusual and psychotic experiences,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20470,Number of times believed in an un-real conspiracy against self,144,Unusual and psychotic experiences,"1,262",Integer,Both sexes,Oct 2016,"1,262",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Unusual and psychotic experiences,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20476,Number of times believed in un-real communications or signs,144,Unusual and psychotic experiences,"1,138",Integer,Both sexes,Oct 2016,"1,138",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Unusual and psychotic experiences,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20465,Number of times heard an un-real voice,144,Unusual and psychotic experiences,"2,777",Integer,Both sexes,Oct 2016,"2,777",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Unusual and psychotic experiences,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20473,Number of times seen an un-real vision,144,Unusual and psychotic experiences,"5,031",Integer,Both sexes,Oct 2016,"5,031",Data,Singular,Jul 2017,Accruing,Online follow-up,Mental health,Unusual and psychotic experiences,0.0,0.0,0.0,0.0,0.0,0.0,0.0
30510,Creatinine (enzymatic) in urine,100083,Urine assays,"484,962","Continuous, micromole/L",Both sexes,Oct 2016,"503,647",Data,Defined (2),Nov 2016,Accruing,Biological samples,Assay results,Urine assays,0.0,0.0,0.0,0.0,0.0,0.0,0.0
30515,Creatinine (enzymatic) in urine result flag,100083,Urine assays,4,Categorical (single),Both sexes,Oct 2016,4,Data,Defined (1),Nov 2016,Accruing,Biological samples,Assay results,Urine assays,0.0,0.0,0.0,0.0,0.0,0.0,0.0
30500,Microalbumin in urine,100083,Urine assays,"156,599","Continuous, mg/L",Both sexes,Oct 2016,"159,404",Data,Defined (2),Nov 2016,Accruing,Biological samples,Assay results,Urine assays,0.0,0.0,0.0,0.0,0.0,0.0,0.0
30505,Microalbumin in urine result flag,100083,Urine assays,"334,050",Categorical (single),Both sexes,Oct 2016,"344,222",Data,Defined (2),Nov 2016,Accruing,Biological samples,Assay results,Urine assays,0.0,0.0,0.0,0.0,0.0,0.0,0.0
30520,Potassium in urine,100083,Urine assays,"483,977","Continuous, millimole/L",Both sexes,Oct 2016,"502,595",Data,Defined (2),Nov 2016,Accruing,Biological samples,Assay results,Urine assays,0.0,0.0,0.0,0.0,0.0,0.0,0.0
30525,Potassium in urine result flag,100083,Urine assays,"1,049",Categorical (single),Both sexes,Oct 2016,"1,050",Data,Defined (2),Nov 2016,Accruing,Biological samples,Assay results,Urine assays,0.0,0.0,0.0,0.0,0.0,0.0,0.0
30530,Sodium in urine,100083,Urine assays,"483,947","Continuous, millimole/L",Both sexes,Oct 2016,"502,577",Data,Defined (2),Nov 2016,Accruing,Biological samples,Assay results,Urine assays,0.0,0.0,0.0,0.0,0.0,0.0,0.0
30535,Sodium in urine result flag,100083,Urine assays,"1,062",Categorical (single),Both sexes,Oct 2016,"1,066",Data,Defined (2),Nov 2016,Accruing,Biological samples,Assay results,Urine assays,0.0,0.0,0.0,0.0,0.0,0.0,0.0
30512,Creatinine (enzymatic) in urine acquisition time,148,Urine processing,"484,966",Date,Both sexes,Oct 2016,"503,651",Data,Defined (2),Nov 2016,Accruing,Biological samples,Assay results,Urine assays,Urine processing,0.0,0.0,0.0,0.0,0.0,0.0
30513,Creatinine (enzymatic) in urine device ID,148,Urine processing,"484,966",Categorical (single),Both sexes,Oct 2016,"503,651",Data,Defined (2),Nov 2016,Accruing,Biological samples,Assay results,Urine assays,Urine processing,0.0,0.0,0.0,0.0,0.0,0.0
30502,Microalbumin in urine acquisition time,148,Urine processing,"484,942",Date,Both sexes,Oct 2016,"503,626",Data,Defined (2),Nov 2016,Accruing,Biological samples,Assay results,Urine assays,Urine processing,0.0,0.0,0.0,0.0,0.0,0.0
30503,Microalbumin in urine device ID,148,Urine processing,"484,942",Categorical (single),Both sexes,Oct 2016,"503,626",Data,Defined (2),Nov 2016,Accruing,Biological samples,Assay results,Urine assays,Urine processing,0.0,0.0,0.0,0.0,0.0,0.0
30522,Potassium in urine acquisition time,148,Urine processing,"484,960",Date,Both sexes,Oct 2016,"503,645",Data,Defined (2),Nov 2016,Accruing,Biological samples,Assay results,Urine assays,Urine processing,0.0,0.0,0.0,0.0,0.0,0.0
30523,Potassium in urine device ID,148,Urine processing,"484,960",Categorical (single),Both sexes,Oct 2016,"503,645",Data,Defined (2),Nov 2016,Accruing,Biological samples,Assay results,Urine assays,Urine processing,0.0,0.0,0.0,0.0,0.0,0.0
30532,Sodium in urine acquisition time,148,Urine processing,"484,958",Date,Both sexes,Oct 2016,"503,643",Data,Defined (2),Nov 2016,Accruing,Biological samples,Assay results,Urine assays,Urine processing,0.0,0.0,0.0,0.0,0.0,0.0
30533,Sodium in urine device ID,148,Urine processing,"484,958",Categorical (single),Both sexes,Oct 2016,"503,643",Data,Defined (2),Nov 2016,Accruing,Biological samples,Assay results,Urine assays,Urine processing,0.0,0.0,0.0,0.0,0.0,0.0
20072,Reason no urine sample collected,100095,Urine sample collection,"3,560",Categorical (single),Both sexes,Aug 2012,"3,560",Data,Defined (1),Aug 2012,Complete,UK Biobank Assessment Centre,Biological sampling,Urine sample collection,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20035,Time urine sample collected,100095,Urine sample collection,"494,779",Time,Both sexes,Jan 2012,"494,779",Data,Defined (1),Mar 2012,Complete,UK Biobank Assessment Centre,Biological sampling,Urine sample collection,0.0,0.0,0.0,0.0,0.0,0.0,0.0
30394,Total volume of urine samples held by UKB,100087,Urine sample inventory,"483,306","Integer, microlitres",Both sexes,Jan 2012,"497,654",Samples,Defined (2),Jun 2014,Updateable,Biological samples,Sample inventory,Urine sample inventory,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103250,Vegetarian alternatives intake,100111,Vegetarian alternatives yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Vegetarian alternatives yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103260,Vegetarian sausages/burgers intake,100111,Vegetarian alternatives yesterday,"3,718",Categorical (single),Both sexes,Sep 2012,"4,215",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Vegetarian alternatives yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103270,Tofu intake,100111,Vegetarian alternatives yesterday,"2,936",Categorical (single),Both sexes,Sep 2012,"3,363",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Vegetarian alternatives yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103280,Quorn intake,100111,Vegetarian alternatives yesterday,"5,254",Categorical (single),Both sexes,Sep 2012,"6,397",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Vegetarian alternatives yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
103290,Other vegetarian alternative intake,100111,Vegetarian alternatives yesterday,"3,724",Categorical (single),Both sexes,Sep 2012,"3,963",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Vegetarian alternatives yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20057,Reason for skipping visual acuity (left),100017,Visual acuity,449,Categorical (single),Both sexes,Aug 2012,449,Data,Defined (1),Aug 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
20262,Myopia diagnosis,100017,Visual acuity,"114,699",Categorical (single),Both sexes,May 2018,"114,699",Data,Singular,May 2018,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
20261,avMSE,100017,Visual acuity,"114,699","Continuous, dioptres",Both sexes,May 2018,"114,699",Data,Singular,May 2018,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
20056,Reason for skipping visual acuity (right),100017,Visual acuity,410,Categorical (single),Both sexes,Aug 2012,410,Data,Defined (1),Aug 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
6075,Glasses worn/required (left),100017,Visual acuity,"96,803",Categorical (single),Both sexes,Jan 2012,"99,742",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
6074,Glasses worn/required (right),100017,Visual acuity,"96,828",Categorical (single),Both sexes,Jan 2012,"99,770",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5187,Visual acuity measured (left),100017,Visual acuity,"133,628",Categorical (single),Both sexes,Jan 2012,"137,886",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5185,Visual acuity measured (right),100017,Visual acuity,"133,633",Categorical (single),Both sexes,Jan 2012,"137,890",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5211,Distance of viewer to screen (left),100017,Visual acuity,"133,071","Continuous, metres",Both sexes,Jan 2012,"137,288",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5204,Distance of viewer to screen (right),100017,Visual acuity,"133,124","Continuous, metres",Both sexes,Jan 2012,"137,345",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5212,Direct or mirror view (left),100017,Visual acuity,"133,071",Categorical (single),Both sexes,Jan 2012,"137,288",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5205,Direct or mirror view (right),100017,Visual acuity,"133,124",Categorical (single),Both sexes,Jan 2012,"137,345",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5074,Number of letters shown in round (left),100017,Visual acuity,"133,070",Integer,Both sexes,Jan 2012,"391,848",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5075,Number of letters shown in round (right),100017,Visual acuity,"133,120",Integer,Both sexes,Jan 2012,"385,433",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5081,Displayed letters in round (left),100017,Visual acuity,"133,070",Text,Both sexes,Jan 2012,"391,848",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5080,Displayed letters in round (right),100017,Visual acuity,"133,120",Text,Both sexes,Jan 2012,"385,433",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5077,Number of letters correct in round (left),100017,Visual acuity,"133,070",Integer,Both sexes,Jan 2012,"391,848",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5076,Number of letters correct in round (right),100017,Visual acuity,"133,120",Integer,Both sexes,Jan 2012,"385,433",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5207,Final number of letters displayed (left),100017,Visual acuity,"133,071",Integer,Both sexes,Jan 2012,"137,288",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5200,Final number of letters displayed (right),100017,Visual acuity,"133,124",Integer,Both sexes,Jan 2012,"137,345",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5209,Number of rounds to result (left),100017,Visual acuity,"133,070",Integer,Both sexes,Jan 2012,"137,287",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5202,Number of rounds to result (right),100017,Visual acuity,"133,124",Integer,Both sexes,Jan 2012,"137,345",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5206,"logMAR, initial (left)",100017,Visual acuity,"133,071",Continuous,Both sexes,Jan 2012,"137,288",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5199,"logMAR, initial (right)",100017,Visual acuity,"133,124",Continuous,Both sexes,Jan 2012,"137,345",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5078,logMAR in round (left),100017,Visual acuity,"133,070",Continuous,Both sexes,Jan 2012,"391,848",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5079,logMAR in round (right),100017,Visual acuity,"133,120",Continuous,Both sexes,Jan 2012,"385,433",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5208,"logMAR, final (left)",100017,Visual acuity,"131,999",Continuous,Both sexes,Jan 2012,"136,185",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5201,"logMAR, final (right)",100017,Visual acuity,"132,003",Continuous,Both sexes,Jan 2012,"136,192",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5082,Visual acuity result in round (left),100017,Visual acuity,"133,070",Text,Both sexes,Jan 2012,"391,848",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5083,Visual acuity result in round (right),100017,Visual acuity,"133,120",Text,Both sexes,Jan 2012,"385,433",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5188,Duration visual-acuity screen displayed (left),100017,Visual acuity,"133,628","Integer, seconds",Both sexes,Jan 2012,"137,886",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
5186,Duration visual-acuity screen displayed (right),100017,Visual acuity,"133,633","Integer, seconds",Both sexes,Jan 2012,"137,890",Data,Defined (2),Jan 2012,Complete,UK Biobank Assessment Centre,Physical measures,Eye measures,Visual acuity,0.0,0.0,0.0,0.0,0.0,0.0
104670,Vitamin supplement user,100112,Vitamin/mineral supplements yesterday,"211,010",Categorical (single),Both sexes,Sep 2012,"458,594",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Vitamin/mineral supplements yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
20084,Vitamin and/or mineral supplement use,100112,Vitamin/mineral supplements yesterday,"103,844",Categorical (multiple),Both sexes,Sep 2012,"451,428",Data,Defined (5),Sep 2012,Complete,Online follow-up,Diet by 24-hour recall,Vitamin/mineral supplements yesterday,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10612,Number of words beginning with 'S' (pilot),100077,Word production,"3,744","Integer, words",Both sexes,Jan 2012,"3,744",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Cognitive function,Word production,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10610,Word count (pilot),100077,Word production,"3,744",Categorical (single),Both sexes,Jan 2012,"3,744",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Cognitive function,Word production,0.0,0.0,0.0,0.0,0.0,0.0,0.0
10609,Words answer array (pilot),100077,Word production,"3,739",Integer,Both sexes,Jan 2012,"67,083",Data,Defined (1),N/A,Complete,UK Biobank Assessment Centre,Cognitive function,Word production,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22500,When occupational data entered,123,Work environment,"121,277",Date,Both sexes,Jul 2015,"121,277",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22501,Year ended full time education,123,Work environment,"121,277","Integer, calendar year",Both sexes,Jul 2015,"121,277",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22016,"Invitation to complete online occupational questionnaire, date sent",123,Work environment,pending,Date,Both sexes,Jul 2015,pending,Data,Singular,N/A,Accruing,Online follow-up,Work environment,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
22499,Device used to enter occupational data,123,Work environment,"121,277",Categorical (single),Both sexes,Jul 2015,"121,277",Data,Singular,Jul 2017,Accruing,Online follow-up,Work environment,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
25079,Mean FA in anterior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25078,Mean FA in anterior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25073,Mean FA in anterior limb of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25072,Mean FA in anterior limb of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25059,Mean FA in body of corpus callosum on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25071,Mean FA in cerebral peduncle on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25070,Mean FA in cerebral peduncle on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25091,Mean FA in cingulum cingulate gyrus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25090,Mean FA in cingulum cingulate gyrus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25093,Mean FA in cingulum hippocampus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25092,Mean FA in cingulum hippocampus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25063,Mean FA in corticospinal tract on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25062,Mean FA in corticospinal tract on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25089,Mean FA in external capsule on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25088,Mean FA in external capsule on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25095,Mean FA in fornix cres+stria terminalis on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25094,Mean FA in fornix cres+stria terminalis on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25061,Mean FA in fornix on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25058,Mean FA in genu of corpus callosum on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25067,Mean FA in inferior cerebellar peduncle on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25066,Mean FA in inferior cerebellar peduncle on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25065,Mean FA in medial lemniscus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25064,Mean FA in medial lemniscus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25056,Mean FA in middle cerebellar peduncle on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25057,Mean FA in pontine crossing tract on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25083,Mean FA in posterior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25082,Mean FA in posterior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25075,Mean FA in posterior limb of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25074,Mean FA in posterior limb of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25085,Mean FA in posterior thalamic radiation on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25084,Mean FA in posterior thalamic radiation on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25077,Mean FA in retrolenticular part of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25076,Mean FA in retrolenticular part of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25087,Mean FA in sagittal stratum on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25086,Mean FA in sagittal stratum on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25060,Mean FA in splenium of corpus callosum on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25069,Mean FA in superior cerebellar peduncle on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25068,Mean FA in superior cerebellar peduncle on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25081,Mean FA in superior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25080,Mean FA in superior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25099,Mean FA in superior fronto-occipital fasciculus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25098,Mean FA in superior fronto-occipital fasciculus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25097,Mean FA in superior longitudinal fasciculus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25096,Mean FA in superior longitudinal fasciculus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25103,Mean FA in tapetum on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25102,Mean FA in tapetum on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25101,Mean FA in uncinate fasciculus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25100,Mean FA in uncinate fasciculus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25367,Mean ICVF in anterior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25366,Mean ICVF in anterior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25361,Mean ICVF in anterior limb of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25360,Mean ICVF in anterior limb of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25347,Mean ICVF in body of corpus callosum on FA skeleton,134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25359,Mean ICVF in cerebral peduncle on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25358,Mean ICVF in cerebral peduncle on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25379,Mean ICVF in cingulum cingulate gyrus on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25378,Mean ICVF in cingulum cingulate gyrus on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25381,Mean ICVF in cingulum hippocampus on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25380,Mean ICVF in cingulum hippocampus on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25351,Mean ICVF in corticospinal tract on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25350,Mean ICVF in corticospinal tract on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25377,Mean ICVF in external capsule on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25376,Mean ICVF in external capsule on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25383,Mean ICVF in fornix cres+stria terminalis on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25382,Mean ICVF in fornix cres+stria terminalis on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25349,Mean ICVF in fornix on FA skeleton,134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25346,Mean ICVF in genu of corpus callosum on FA skeleton,134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25355,Mean ICVF in inferior cerebellar peduncle on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25354,Mean ICVF in inferior cerebellar peduncle on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25353,Mean ICVF in medial lemniscus on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25352,Mean ICVF in medial lemniscus on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25344,Mean ICVF in middle cerebellar peduncle on FA skeleton,134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25345,Mean ICVF in pontine crossing tract on FA skeleton,134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25371,Mean ICVF in posterior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25370,Mean ICVF in posterior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25363,Mean ICVF in posterior limb of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25362,Mean ICVF in posterior limb of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25373,Mean ICVF in posterior thalamic radiation on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25372,Mean ICVF in posterior thalamic radiation on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25365,Mean ICVF in retrolenticular part of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25364,Mean ICVF in retrolenticular part of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25375,Mean ICVF in sagittal stratum on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25374,Mean ICVF in sagittal stratum on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25348,Mean ICVF in splenium of corpus callosum on FA skeleton,134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25357,Mean ICVF in superior cerebellar peduncle on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25356,Mean ICVF in superior cerebellar peduncle on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25369,Mean ICVF in superior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25368,Mean ICVF in superior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25387,Mean ICVF in superior fronto-occipital fasciculus on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25386,Mean ICVF in superior fronto-occipital fasciculus on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25385,Mean ICVF in superior longitudinal fasciculus on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25384,Mean ICVF in superior longitudinal fasciculus on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25391,Mean ICVF in tapetum on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25390,Mean ICVF in tapetum on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25389,Mean ICVF in uncinate fasciculus on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25388,Mean ICVF in uncinate fasciculus on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25463,Mean ISOVF in anterior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25462,Mean ISOVF in anterior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25457,Mean ISOVF in anterior limb of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25456,Mean ISOVF in anterior limb of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25443,Mean ISOVF in body of corpus callosum on FA skeleton,134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25455,Mean ISOVF in cerebral peduncle on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25454,Mean ISOVF in cerebral peduncle on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25475,Mean ISOVF in cingulum cingulate gyrus on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25474,Mean ISOVF in cingulum cingulate gyrus on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25477,Mean ISOVF in cingulum hippocampus on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25476,Mean ISOVF in cingulum hippocampus on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25447,Mean ISOVF in corticospinal tract on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25446,Mean ISOVF in corticospinal tract on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25473,Mean ISOVF in external capsule on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25472,Mean ISOVF in external capsule on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25479,Mean ISOVF in fornix cres+stria terminalis on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25478,Mean ISOVF in fornix cres+stria terminalis on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25445,Mean ISOVF in fornix on FA skeleton,134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25442,Mean ISOVF in genu of corpus callosum on FA skeleton,134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25451,Mean ISOVF in inferior cerebellar peduncle on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25450,Mean ISOVF in inferior cerebellar peduncle on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25449,Mean ISOVF in medial lemniscus on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25448,Mean ISOVF in medial lemniscus on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25440,Mean ISOVF in middle cerebellar peduncle on FA skeleton,134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25441,Mean ISOVF in pontine crossing tract on FA skeleton,134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25467,Mean ISOVF in posterior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25466,Mean ISOVF in posterior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25459,Mean ISOVF in posterior limb of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25458,Mean ISOVF in posterior limb of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25469,Mean ISOVF in posterior thalamic radiation on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25468,Mean ISOVF in posterior thalamic radiation on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25461,Mean ISOVF in retrolenticular part of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25460,Mean ISOVF in retrolenticular part of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25471,Mean ISOVF in sagittal stratum on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25470,Mean ISOVF in sagittal stratum on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25444,Mean ISOVF in splenium of corpus callosum on FA skeleton,134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25453,Mean ISOVF in superior cerebellar peduncle on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25452,Mean ISOVF in superior cerebellar peduncle on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25465,Mean ISOVF in superior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25464,Mean ISOVF in superior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25483,Mean ISOVF in superior fronto-occipital fasciculus on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25482,Mean ISOVF in superior fronto-occipital fasciculus on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25481,Mean ISOVF in superior longitudinal fasciculus on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25480,Mean ISOVF in superior longitudinal fasciculus on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25487,Mean ISOVF in tapetum on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25486,Mean ISOVF in tapetum on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25485,Mean ISOVF in uncinate fasciculus on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25484,Mean ISOVF in uncinate fasciculus on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25223,Mean L1 in anterior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25222,Mean L1 in anterior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25217,Mean L1 in anterior limb of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25216,Mean L1 in anterior limb of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25203,Mean L1 in body of corpus callosum on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25215,Mean L1 in cerebral peduncle on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25214,Mean L1 in cerebral peduncle on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25235,Mean L1 in cingulum cingulate gyrus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25234,Mean L1 in cingulum cingulate gyrus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25237,Mean L1 in cingulum hippocampus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25236,Mean L1 in cingulum hippocampus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25207,Mean L1 in corticospinal tract on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25206,Mean L1 in corticospinal tract on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25233,Mean L1 in external capsule on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25232,Mean L1 in external capsule on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25239,Mean L1 in fornix cres+stria terminalis on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25238,Mean L1 in fornix cres+stria terminalis on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25205,Mean L1 in fornix on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25202,Mean L1 in genu of corpus callosum on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25211,Mean L1 in inferior cerebellar peduncle on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25210,Mean L1 in inferior cerebellar peduncle on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25209,Mean L1 in medial lemniscus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25208,Mean L1 in medial lemniscus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25200,Mean L1 in middle cerebellar peduncle on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25201,Mean L1 in pontine crossing tract on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25227,Mean L1 in posterior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25226,Mean L1 in posterior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25219,Mean L1 in posterior limb of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25218,Mean L1 in posterior limb of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25229,Mean L1 in posterior thalamic radiation on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25228,Mean L1 in posterior thalamic radiation on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25221,Mean L1 in retrolenticular part of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25220,Mean L1 in retrolenticular part of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25231,Mean L1 in sagittal stratum on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25230,Mean L1 in sagittal stratum on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25204,Mean L1 in splenium of corpus callosum on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25213,Mean L1 in superior cerebellar peduncle on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25212,Mean L1 in superior cerebellar peduncle on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25225,Mean L1 in superior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25224,Mean L1 in superior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25243,Mean L1 in superior fronto-occipital fasciculus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25242,Mean L1 in superior fronto-occipital fasciculus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25241,Mean L1 in superior longitudinal fasciculus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25240,Mean L1 in superior longitudinal fasciculus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25247,Mean L1 in tapetum on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25246,Mean L1 in tapetum on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25245,Mean L1 in uncinate fasciculus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25244,Mean L1 in uncinate fasciculus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25271,Mean L2 in anterior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25270,Mean L2 in anterior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25265,Mean L2 in anterior limb of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25264,Mean L2 in anterior limb of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25251,Mean L2 in body of corpus callosum on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25263,Mean L2 in cerebral peduncle on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25262,Mean L2 in cerebral peduncle on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25283,Mean L2 in cingulum cingulate gyrus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25282,Mean L2 in cingulum cingulate gyrus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25285,Mean L2 in cingulum hippocampus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25284,Mean L2 in cingulum hippocampus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25255,Mean L2 in corticospinal tract on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25254,Mean L2 in corticospinal tract on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25281,Mean L2 in external capsule on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25280,Mean L2 in external capsule on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25287,Mean L2 in fornix cres+stria terminalis on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25286,Mean L2 in fornix cres+stria terminalis on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25253,Mean L2 in fornix on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25250,Mean L2 in genu of corpus callosum on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25259,Mean L2 in inferior cerebellar peduncle on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25258,Mean L2 in inferior cerebellar peduncle on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25257,Mean L2 in medial lemniscus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25256,Mean L2 in medial lemniscus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25248,Mean L2 in middle cerebellar peduncle on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25249,Mean L2 in pontine crossing tract on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25275,Mean L2 in posterior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25274,Mean L2 in posterior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25267,Mean L2 in posterior limb of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25266,Mean L2 in posterior limb of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25277,Mean L2 in posterior thalamic radiation on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25276,Mean L2 in posterior thalamic radiation on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25269,Mean L2 in retrolenticular part of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25268,Mean L2 in retrolenticular part of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25279,Mean L2 in sagittal stratum on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25278,Mean L2 in sagittal stratum on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25252,Mean L2 in splenium of corpus callosum on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25261,Mean L2 in superior cerebellar peduncle on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25260,Mean L2 in superior cerebellar peduncle on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25273,Mean L2 in superior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25272,Mean L2 in superior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25291,Mean L2 in superior fronto-occipital fasciculus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25290,Mean L2 in superior fronto-occipital fasciculus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25289,Mean L2 in superior longitudinal fasciculus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25288,Mean L2 in superior longitudinal fasciculus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25295,Mean L2 in tapetum on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25294,Mean L2 in tapetum on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25293,Mean L2 in uncinate fasciculus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25292,Mean L2 in uncinate fasciculus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25319,Mean L3 in anterior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25318,Mean L3 in anterior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25313,Mean L3 in anterior limb of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25312,Mean L3 in anterior limb of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25299,Mean L3 in body of corpus callosum on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25311,Mean L3 in cerebral peduncle on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25310,Mean L3 in cerebral peduncle on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25331,Mean L3 in cingulum cingulate gyrus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25330,Mean L3 in cingulum cingulate gyrus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25333,Mean L3 in cingulum hippocampus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25332,Mean L3 in cingulum hippocampus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25303,Mean L3 in corticospinal tract on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25302,Mean L3 in corticospinal tract on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25329,Mean L3 in external capsule on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25328,Mean L3 in external capsule on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25335,Mean L3 in fornix cres+stria terminalis on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25334,Mean L3 in fornix cres+stria terminalis on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25301,Mean L3 in fornix on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25298,Mean L3 in genu of corpus callosum on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25307,Mean L3 in inferior cerebellar peduncle on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25306,Mean L3 in inferior cerebellar peduncle on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25305,Mean L3 in medial lemniscus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25304,Mean L3 in medial lemniscus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25296,Mean L3 in middle cerebellar peduncle on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25297,Mean L3 in pontine crossing tract on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25323,Mean L3 in posterior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25322,Mean L3 in posterior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25315,Mean L3 in posterior limb of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25314,Mean L3 in posterior limb of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25325,Mean L3 in posterior thalamic radiation on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25324,Mean L3 in posterior thalamic radiation on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25317,Mean L3 in retrolenticular part of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25316,Mean L3 in retrolenticular part of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25327,Mean L3 in sagittal stratum on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25326,Mean L3 in sagittal stratum on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25300,Mean L3 in splenium of corpus callosum on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25309,Mean L3 in superior cerebellar peduncle on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25308,Mean L3 in superior cerebellar peduncle on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25321,Mean L3 in superior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25320,Mean L3 in superior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25339,Mean L3 in superior fronto-occipital fasciculus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25338,Mean L3 in superior fronto-occipital fasciculus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25337,Mean L3 in superior longitudinal fasciculus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25336,Mean L3 in superior longitudinal fasciculus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25343,Mean L3 in tapetum on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25342,Mean L3 in tapetum on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25341,Mean L3 in uncinate fasciculus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25340,Mean L3 in uncinate fasciculus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25127,Mean MD in anterior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25126,Mean MD in anterior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25121,Mean MD in anterior limb of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25120,Mean MD in anterior limb of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25107,Mean MD in body of corpus callosum on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25119,Mean MD in cerebral peduncle on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25118,Mean MD in cerebral peduncle on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25139,Mean MD in cingulum cingulate gyrus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25138,Mean MD in cingulum cingulate gyrus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25141,Mean MD in cingulum hippocampus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25140,Mean MD in cingulum hippocampus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25111,Mean MD in corticospinal tract on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25110,Mean MD in corticospinal tract on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25137,Mean MD in external capsule on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25136,Mean MD in external capsule on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25143,Mean MD in fornix cres+stria terminalis on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25142,Mean MD in fornix cres+stria terminalis on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25109,Mean MD in fornix on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25106,Mean MD in genu of corpus callosum on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25115,Mean MD in inferior cerebellar peduncle on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25114,Mean MD in inferior cerebellar peduncle on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25113,Mean MD in medial lemniscus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25112,Mean MD in medial lemniscus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25104,Mean MD in middle cerebellar peduncle on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25105,Mean MD in pontine crossing tract on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25131,Mean MD in posterior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25130,Mean MD in posterior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25123,Mean MD in posterior limb of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25122,Mean MD in posterior limb of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25133,Mean MD in posterior thalamic radiation on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25132,Mean MD in posterior thalamic radiation on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25125,Mean MD in retrolenticular part of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25124,Mean MD in retrolenticular part of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25135,Mean MD in sagittal stratum on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25134,Mean MD in sagittal stratum on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25108,Mean MD in splenium of corpus callosum on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25117,Mean MD in superior cerebellar peduncle on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25116,Mean MD in superior cerebellar peduncle on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25129,Mean MD in superior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25128,Mean MD in superior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25147,Mean MD in superior fronto-occipital fasciculus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25146,Mean MD in superior fronto-occipital fasciculus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25145,Mean MD in superior longitudinal fasciculus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25144,Mean MD in superior longitudinal fasciculus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25151,Mean MD in tapetum on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25150,Mean MD in tapetum on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25149,Mean MD in uncinate fasciculus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25148,Mean MD in uncinate fasciculus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25175,Mean MO in anterior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25174,Mean MO in anterior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25169,Mean MO in anterior limb of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25168,Mean MO in anterior limb of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25155,Mean MO in body of corpus callosum on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25167,Mean MO in cerebral peduncle on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25166,Mean MO in cerebral peduncle on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25187,Mean MO in cingulum cingulate gyrus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25186,Mean MO in cingulum cingulate gyrus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25189,Mean MO in cingulum hippocampus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25188,Mean MO in cingulum hippocampus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25159,Mean MO in corticospinal tract on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25158,Mean MO in corticospinal tract on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25185,Mean MO in external capsule on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25184,Mean MO in external capsule on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25191,Mean MO in fornix cres+stria terminalis on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25190,Mean MO in fornix cres+stria terminalis on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25157,Mean MO in fornix on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25154,Mean MO in genu of corpus callosum on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25163,Mean MO in inferior cerebellar peduncle on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25162,Mean MO in inferior cerebellar peduncle on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25161,Mean MO in medial lemniscus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25160,Mean MO in medial lemniscus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25152,Mean MO in middle cerebellar peduncle on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25153,Mean MO in pontine crossing tract on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25179,Mean MO in posterior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25178,Mean MO in posterior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25171,Mean MO in posterior limb of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25170,Mean MO in posterior limb of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25181,Mean MO in posterior thalamic radiation on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25180,Mean MO in posterior thalamic radiation on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25173,Mean MO in retrolenticular part of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25172,Mean MO in retrolenticular part of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25183,Mean MO in sagittal stratum on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25182,Mean MO in sagittal stratum on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25156,Mean MO in splenium of corpus callosum on FA skeleton,134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25165,Mean MO in superior cerebellar peduncle on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25164,Mean MO in superior cerebellar peduncle on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25177,Mean MO in superior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25176,Mean MO in superior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25195,Mean MO in superior fronto-occipital fasciculus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25194,Mean MO in superior fronto-occipital fasciculus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25193,Mean MO in superior longitudinal fasciculus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25192,Mean MO in superior longitudinal fasciculus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25199,Mean MO in tapetum on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25198,Mean MO in tapetum on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25197,Mean MO in uncinate fasciculus on FA skeleton (left),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25196,Mean MO in uncinate fasciculus on FA skeleton (right),134,dMRI skeleton,"37,519","Continuous, AU",Both sexes,Oct 2015,"38,935",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25415,Mean OD in anterior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25414,Mean OD in anterior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25409,Mean OD in anterior limb of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25408,Mean OD in anterior limb of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25395,Mean OD in body of corpus callosum on FA skeleton,134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25407,Mean OD in cerebral peduncle on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25406,Mean OD in cerebral peduncle on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25427,Mean OD in cingulum cingulate gyrus on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25426,Mean OD in cingulum cingulate gyrus on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25429,Mean OD in cingulum hippocampus on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25428,Mean OD in cingulum hippocampus on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25399,Mean OD in corticospinal tract on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25398,Mean OD in corticospinal tract on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25425,Mean OD in external capsule on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25424,Mean OD in external capsule on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25431,Mean OD in fornix cres+stria terminalis on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25430,Mean OD in fornix cres+stria terminalis on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25397,Mean OD in fornix on FA skeleton,134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25394,Mean OD in genu of corpus callosum on FA skeleton,134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25403,Mean OD in inferior cerebellar peduncle on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25402,Mean OD in inferior cerebellar peduncle on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25401,Mean OD in medial lemniscus on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25400,Mean OD in medial lemniscus on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25392,Mean OD in middle cerebellar peduncle on FA skeleton,134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25393,Mean OD in pontine crossing tract on FA skeleton,134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25419,Mean OD in posterior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25418,Mean OD in posterior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25411,Mean OD in posterior limb of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25410,Mean OD in posterior limb of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25421,Mean OD in posterior thalamic radiation on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25420,Mean OD in posterior thalamic radiation on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25413,Mean OD in retrolenticular part of internal capsule on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25412,Mean OD in retrolenticular part of internal capsule on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25423,Mean OD in sagittal stratum on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25422,Mean OD in sagittal stratum on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25396,Mean OD in splenium of corpus callosum on FA skeleton,134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25405,Mean OD in superior cerebellar peduncle on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25404,Mean OD in superior cerebellar peduncle on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25417,Mean OD in superior corona radiata on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25416,Mean OD in superior corona radiata on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25435,Mean OD in superior fronto-occipital fasciculus on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25434,Mean OD in superior fronto-occipital fasciculus on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25433,Mean OD in superior longitudinal fasciculus on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25432,Mean OD in superior longitudinal fasciculus on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25439,Mean OD in tapetum on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25438,Mean OD in tapetum on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25437,Mean OD in uncinate fasciculus on FA skeleton (left),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25436,Mean OD in uncinate fasciculus on FA skeleton (right),134,dMRI skeleton,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI skeleton,0.0,0.0,0.0,0.0,0.0
25488,Weighted-mean FA in tract acoustic radiation (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25489,Weighted-mean FA in tract acoustic radiation (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25490,Weighted-mean FA in tract anterior thalamic radiation (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25491,Weighted-mean FA in tract anterior thalamic radiation (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25492,Weighted-mean FA in tract cingulate gyrus part of cingulum (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25493,Weighted-mean FA in tract cingulate gyrus part of cingulum (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25496,Weighted-mean FA in tract corticospinal tract (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25497,Weighted-mean FA in tract corticospinal tract (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25498,Weighted-mean FA in tract forceps major,135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25499,Weighted-mean FA in tract forceps minor,135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25500,Weighted-mean FA in tract inferior fronto-occipital fasciculus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25501,Weighted-mean FA in tract inferior fronto-occipital fasciculus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25502,Weighted-mean FA in tract inferior longitudinal fasciculus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25503,Weighted-mean FA in tract inferior longitudinal fasciculus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25505,Weighted-mean FA in tract medial lemniscus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25506,Weighted-mean FA in tract medial lemniscus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25504,Weighted-mean FA in tract middle cerebellar peduncle,135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25494,Weighted-mean FA in tract parahippocampal part of cingulum (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25495,Weighted-mean FA in tract parahippocampal part of cingulum (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25507,Weighted-mean FA in tract posterior thalamic radiation (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25508,Weighted-mean FA in tract posterior thalamic radiation (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25509,Weighted-mean FA in tract superior longitudinal fasciculus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25510,Weighted-mean FA in tract superior longitudinal fasciculus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25511,Weighted-mean FA in tract superior thalamic radiation (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25512,Weighted-mean FA in tract superior thalamic radiation (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25513,Weighted-mean FA in tract uncinate fasciculus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25514,Weighted-mean FA in tract uncinate fasciculus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25650,Weighted-mean ICVF in tract acoustic radiation (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25651,Weighted-mean ICVF in tract acoustic radiation (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25652,Weighted-mean ICVF in tract anterior thalamic radiation (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25653,Weighted-mean ICVF in tract anterior thalamic radiation (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25654,Weighted-mean ICVF in tract cingulate gyrus part of cingulum (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25655,Weighted-mean ICVF in tract cingulate gyrus part of cingulum (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25658,Weighted-mean ICVF in tract corticospinal tract (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25659,Weighted-mean ICVF in tract corticospinal tract (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25660,Weighted-mean ICVF in tract forceps major,135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25661,Weighted-mean ICVF in tract forceps minor,135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25662,Weighted-mean ICVF in tract inferior fronto-occipital fasciculus (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25663,Weighted-mean ICVF in tract inferior fronto-occipital fasciculus (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25664,Weighted-mean ICVF in tract inferior longitudinal fasciculus (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25665,Weighted-mean ICVF in tract inferior longitudinal fasciculus (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25667,Weighted-mean ICVF in tract medial lemniscus (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25668,Weighted-mean ICVF in tract medial lemniscus (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25666,Weighted-mean ICVF in tract middle cerebellar peduncle,135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25656,Weighted-mean ICVF in tract parahippocampal part of cingulum (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25657,Weighted-mean ICVF in tract parahippocampal part of cingulum (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25669,Weighted-mean ICVF in tract posterior thalamic radiation (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25670,Weighted-mean ICVF in tract posterior thalamic radiation (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25671,Weighted-mean ICVF in tract superior longitudinal fasciculus (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25672,Weighted-mean ICVF in tract superior longitudinal fasciculus (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25673,Weighted-mean ICVF in tract superior thalamic radiation (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25674,Weighted-mean ICVF in tract superior thalamic radiation (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25675,Weighted-mean ICVF in tract uncinate fasciculus (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25676,Weighted-mean ICVF in tract uncinate fasciculus (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25704,Weighted-mean ISOVF in tract acoustic radiation (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25705,Weighted-mean ISOVF in tract acoustic radiation (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25706,Weighted-mean ISOVF in tract anterior thalamic radiation (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25707,Weighted-mean ISOVF in tract anterior thalamic radiation (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25708,Weighted-mean ISOVF in tract cingulate gyrus part of cingulum (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25709,Weighted-mean ISOVF in tract cingulate gyrus part of cingulum (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25712,Weighted-mean ISOVF in tract corticospinal tract (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25713,Weighted-mean ISOVF in tract corticospinal tract (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25714,Weighted-mean ISOVF in tract forceps major,135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25715,Weighted-mean ISOVF in tract forceps minor,135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25716,Weighted-mean ISOVF in tract inferior fronto-occipital fasciculus (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25717,Weighted-mean ISOVF in tract inferior fronto-occipital fasciculus (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25718,Weighted-mean ISOVF in tract inferior longitudinal fasciculus (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25719,Weighted-mean ISOVF in tract inferior longitudinal fasciculus (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25721,Weighted-mean ISOVF in tract medial lemniscus (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25722,Weighted-mean ISOVF in tract medial lemniscus (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25720,Weighted-mean ISOVF in tract middle cerebellar peduncle,135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25710,Weighted-mean ISOVF in tract parahippocampal part of cingulum (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25711,Weighted-mean ISOVF in tract parahippocampal part of cingulum (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25723,Weighted-mean ISOVF in tract posterior thalamic radiation (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25724,Weighted-mean ISOVF in tract posterior thalamic radiation (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25725,Weighted-mean ISOVF in tract superior longitudinal fasciculus (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25726,Weighted-mean ISOVF in tract superior longitudinal fasciculus (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25727,Weighted-mean ISOVF in tract superior thalamic radiation (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25728,Weighted-mean ISOVF in tract superior thalamic radiation (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25729,Weighted-mean ISOVF in tract uncinate fasciculus (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25730,Weighted-mean ISOVF in tract uncinate fasciculus (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25569,Weighted-mean L1 in tract acoustic radiation (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25570,Weighted-mean L1 in tract acoustic radiation (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25571,Weighted-mean L1 in tract anterior thalamic radiation (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25572,Weighted-mean L1 in tract anterior thalamic radiation (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25573,Weighted-mean L1 in tract cingulate gyrus part of cingulum (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25574,Weighted-mean L1 in tract cingulate gyrus part of cingulum (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25577,Weighted-mean L1 in tract corticospinal tract (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25578,Weighted-mean L1 in tract corticospinal tract (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25579,Weighted-mean L1 in tract forceps major,135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25580,Weighted-mean L1 in tract forceps minor,135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25581,Weighted-mean L1 in tract inferior fronto-occipital fasciculus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25582,Weighted-mean L1 in tract inferior fronto-occipital fasciculus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25583,Weighted-mean L1 in tract inferior longitudinal fasciculus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25584,Weighted-mean L1 in tract inferior longitudinal fasciculus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25586,Weighted-mean L1 in tract medial lemniscus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25587,Weighted-mean L1 in tract medial lemniscus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25585,Weighted-mean L1 in tract middle cerebellar peduncle,135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25575,Weighted-mean L1 in tract parahippocampal part of cingulum (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25576,Weighted-mean L1 in tract parahippocampal part of cingulum (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25588,Weighted-mean L1 in tract posterior thalamic radiation (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25589,Weighted-mean L1 in tract posterior thalamic radiation (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25590,Weighted-mean L1 in tract superior longitudinal fasciculus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25591,Weighted-mean L1 in tract superior longitudinal fasciculus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25592,Weighted-mean L1 in tract superior thalamic radiation (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25593,Weighted-mean L1 in tract superior thalamic radiation (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25594,Weighted-mean L1 in tract uncinate fasciculus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25595,Weighted-mean L1 in tract uncinate fasciculus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25596,Weighted-mean L2 in tract acoustic radiation (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25597,Weighted-mean L2 in tract acoustic radiation (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25598,Weighted-mean L2 in tract anterior thalamic radiation (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25599,Weighted-mean L2 in tract anterior thalamic radiation (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25600,Weighted-mean L2 in tract cingulate gyrus part of cingulum (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25601,Weighted-mean L2 in tract cingulate gyrus part of cingulum (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25604,Weighted-mean L2 in tract corticospinal tract (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25605,Weighted-mean L2 in tract corticospinal tract (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25606,Weighted-mean L2 in tract forceps major,135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25607,Weighted-mean L2 in tract forceps minor,135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25608,Weighted-mean L2 in tract inferior fronto-occipital fasciculus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25609,Weighted-mean L2 in tract inferior fronto-occipital fasciculus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25610,Weighted-mean L2 in tract inferior longitudinal fasciculus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25611,Weighted-mean L2 in tract inferior longitudinal fasciculus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25613,Weighted-mean L2 in tract medial lemniscus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25614,Weighted-mean L2 in tract medial lemniscus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25612,Weighted-mean L2 in tract middle cerebellar peduncle,135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25602,Weighted-mean L2 in tract parahippocampal part of cingulum (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25603,Weighted-mean L2 in tract parahippocampal part of cingulum (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25615,Weighted-mean L2 in tract posterior thalamic radiation (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25616,Weighted-mean L2 in tract posterior thalamic radiation (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25617,Weighted-mean L2 in tract superior longitudinal fasciculus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25618,Weighted-mean L2 in tract superior longitudinal fasciculus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25619,Weighted-mean L2 in tract superior thalamic radiation (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25620,Weighted-mean L2 in tract superior thalamic radiation (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25621,Weighted-mean L2 in tract uncinate fasciculus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25622,Weighted-mean L2 in tract uncinate fasciculus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25623,Weighted-mean L3 in tract acoustic radiation (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25624,Weighted-mean L3 in tract acoustic radiation (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25625,Weighted-mean L3 in tract anterior thalamic radiation (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25626,Weighted-mean L3 in tract anterior thalamic radiation (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25627,Weighted-mean L3 in tract cingulate gyrus part of cingulum (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25628,Weighted-mean L3 in tract cingulate gyrus part of cingulum (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25631,Weighted-mean L3 in tract corticospinal tract (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25632,Weighted-mean L3 in tract corticospinal tract (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25633,Weighted-mean L3 in tract forceps major,135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25634,Weighted-mean L3 in tract forceps minor,135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25635,Weighted-mean L3 in tract inferior fronto-occipital fasciculus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25636,Weighted-mean L3 in tract inferior fronto-occipital fasciculus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25637,Weighted-mean L3 in tract inferior longitudinal fasciculus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25638,Weighted-mean L3 in tract inferior longitudinal fasciculus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25640,Weighted-mean L3 in tract medial lemniscus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25641,Weighted-mean L3 in tract medial lemniscus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25639,Weighted-mean L3 in tract middle cerebellar peduncle,135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25629,Weighted-mean L3 in tract parahippocampal part of cingulum (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25630,Weighted-mean L3 in tract parahippocampal part of cingulum (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25642,Weighted-mean L3 in tract posterior thalamic radiation (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25643,Weighted-mean L3 in tract posterior thalamic radiation (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25644,Weighted-mean L3 in tract superior longitudinal fasciculus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25645,Weighted-mean L3 in tract superior longitudinal fasciculus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25646,Weighted-mean L3 in tract superior thalamic radiation (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25647,Weighted-mean L3 in tract superior thalamic radiation (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25648,Weighted-mean L3 in tract uncinate fasciculus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25649,Weighted-mean L3 in tract uncinate fasciculus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25515,Weighted-mean MD in tract acoustic radiation (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25516,Weighted-mean MD in tract acoustic radiation (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25517,Weighted-mean MD in tract anterior thalamic radiation (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25518,Weighted-mean MD in tract anterior thalamic radiation (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25519,Weighted-mean MD in tract cingulate gyrus part of cingulum (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25520,Weighted-mean MD in tract cingulate gyrus part of cingulum (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25523,Weighted-mean MD in tract corticospinal tract (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25524,Weighted-mean MD in tract corticospinal tract (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25525,Weighted-mean MD in tract forceps major,135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25526,Weighted-mean MD in tract forceps minor,135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25527,Weighted-mean MD in tract inferior fronto-occipital fasciculus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25528,Weighted-mean MD in tract inferior fronto-occipital fasciculus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25529,Weighted-mean MD in tract inferior longitudinal fasciculus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25530,Weighted-mean MD in tract inferior longitudinal fasciculus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25532,Weighted-mean MD in tract medial lemniscus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25533,Weighted-mean MD in tract medial lemniscus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25531,Weighted-mean MD in tract middle cerebellar peduncle,135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25521,Weighted-mean MD in tract parahippocampal part of cingulum (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25522,Weighted-mean MD in tract parahippocampal part of cingulum (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25534,Weighted-mean MD in tract posterior thalamic radiation (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25535,Weighted-mean MD in tract posterior thalamic radiation (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25536,Weighted-mean MD in tract superior longitudinal fasciculus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25537,Weighted-mean MD in tract superior longitudinal fasciculus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25538,Weighted-mean MD in tract superior thalamic radiation (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25539,Weighted-mean MD in tract superior thalamic radiation (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25540,Weighted-mean MD in tract uncinate fasciculus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25541,Weighted-mean MD in tract uncinate fasciculus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25542,Weighted-mean MO in tract acoustic radiation (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25543,Weighted-mean MO in tract acoustic radiation (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25544,Weighted-mean MO in tract anterior thalamic radiation (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25545,Weighted-mean MO in tract anterior thalamic radiation (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25546,Weighted-mean MO in tract cingulate gyrus part of cingulum (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25547,Weighted-mean MO in tract cingulate gyrus part of cingulum (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25550,Weighted-mean MO in tract corticospinal tract (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25551,Weighted-mean MO in tract corticospinal tract (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25552,Weighted-mean MO in tract forceps major,135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25553,Weighted-mean MO in tract forceps minor,135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25554,Weighted-mean MO in tract inferior fronto-occipital fasciculus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25555,Weighted-mean MO in tract inferior fronto-occipital fasciculus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25556,Weighted-mean MO in tract inferior longitudinal fasciculus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25557,Weighted-mean MO in tract inferior longitudinal fasciculus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25559,Weighted-mean MO in tract medial lemniscus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25560,Weighted-mean MO in tract medial lemniscus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25558,Weighted-mean MO in tract middle cerebellar peduncle,135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25548,Weighted-mean MO in tract parahippocampal part of cingulum (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25549,Weighted-mean MO in tract parahippocampal part of cingulum (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25561,Weighted-mean MO in tract posterior thalamic radiation (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25562,Weighted-mean MO in tract posterior thalamic radiation (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25563,Weighted-mean MO in tract superior longitudinal fasciculus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25564,Weighted-mean MO in tract superior longitudinal fasciculus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25565,Weighted-mean MO in tract superior thalamic radiation (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25566,Weighted-mean MO in tract superior thalamic radiation (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25567,Weighted-mean MO in tract uncinate fasciculus (left),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25568,Weighted-mean MO in tract uncinate fasciculus (right),135,dMRI weighted means,"37,517","Continuous, AU",Both sexes,Oct 2015,"38,933",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25677,Weighted-mean OD in tract acoustic radiation (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25678,Weighted-mean OD in tract acoustic radiation (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25679,Weighted-mean OD in tract anterior thalamic radiation (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25680,Weighted-mean OD in tract anterior thalamic radiation (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25681,Weighted-mean OD in tract cingulate gyrus part of cingulum (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25682,Weighted-mean OD in tract cingulate gyrus part of cingulum (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25685,Weighted-mean OD in tract corticospinal tract (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25686,Weighted-mean OD in tract corticospinal tract (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25687,Weighted-mean OD in tract forceps major,135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25688,Weighted-mean OD in tract forceps minor,135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25689,Weighted-mean OD in tract inferior fronto-occipital fasciculus (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25690,Weighted-mean OD in tract inferior fronto-occipital fasciculus (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25691,Weighted-mean OD in tract inferior longitudinal fasciculus (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25692,Weighted-mean OD in tract inferior longitudinal fasciculus (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25694,Weighted-mean OD in tract medial lemniscus (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25695,Weighted-mean OD in tract medial lemniscus (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25693,Weighted-mean OD in tract middle cerebellar peduncle,135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25683,Weighted-mean OD in tract parahippocampal part of cingulum (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25684,Weighted-mean OD in tract parahippocampal part of cingulum (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25696,Weighted-mean OD in tract posterior thalamic radiation (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25697,Weighted-mean OD in tract posterior thalamic radiation (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25698,Weighted-mean OD in tract superior longitudinal fasciculus (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25699,Weighted-mean OD in tract superior longitudinal fasciculus (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25700,Weighted-mean OD in tract superior thalamic radiation (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25701,Weighted-mean OD in tract superior thalamic radiation (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25702,Weighted-mean OD in tract uncinate fasciculus (left),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
25703,Weighted-mean OD in tract uncinate fasciculus (right),135,dMRI weighted means,"37,516","Continuous, AU",Both sexes,Oct 2015,"38,932",Data,Defined (2),Jan 2020,Accruing,UK Biobank Assessment Centre,Imaging,Brain MRI,Diffusion brain MRI,dMRI weighted means,0.0,0.0,0.0,0.0,0.0
